PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zickfeld, K; Fyfe, JC; Eby, M; Weaver, AJ				Zickfeld, Kirsten; Fyfe, John C.; Eby, Michael; Weaver, Andrew J.			Saturation of the southern ocean CO2 sink due to recent climate change	SCIENCE			English	Editorial Material									[Zickfeld, Kirsten; Eby, Michael; Weaver, Andrew J.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; [Fyfe, John C.] Environm Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada	University of Victoria; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma)	Zickfeld, K (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada.	zickfeld@ocean.seos.uvic.ca	Law, Rachel/A-1969-2012; Francey, Roger J/A-2345-2012; Weaver, Andrew J/E-7590-2011; matear, richard J/C-5133-2011; Law, Rachel/AAV-1949-2020; Eby, Michael/H-5278-2013	Law, Rachel/0000-0002-7346-0927; Weaver, Andrew J/0000-0001-8919-3598; matear, richard J/0000-0002-3225-0800; Law, Rachel/0000-0002-7346-0927; 				Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Fletcher SEM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002751; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fyfe JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025332; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lovenduski NS, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002900; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Zickfeld K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028797	9	55	57	10	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863								10.1126/science.1146886	http://dx.doi.org/10.1126/science.1146886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239109				2022-12-28	WOS:000252772000019
J	Britton, J; Macara, AW				Britton, John; Macara, Alexander W.			Should doctors advocate snus and other nicotine replacements?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Britton, John] City Hosp, Nottingham NG5 1PB, England; [Macara, Alexander W.] Natl Heart Forum, Bristol, Avon, England	University of Nottingham	Britton, J (corresponding author), City Hosp, Clin Sci Bldg, Nottingham NG5 1PB, England.	j.britton@virgin.net; alexandermacara@yahoo.co.uk							0	19	19	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					358	359		10.1136/bmj.39479.427477.AD	http://dx.doi.org/10.1136/bmj.39479.427477.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276711	Green Published			2022-12-28	WOS:000253550600036
J	Basham, P; Luik, J; Jeffery, RW; Sherwood, NE				Basham, Patrick; Luik, John; Jeffery, R. W.; Sherwood, N. E.			Is the obesity epidemic exaggerated?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Basham, Patrick] Johns Hopkins Univ, Washington, DC 20036 USA; [Jeffery, R. W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Sherwood, N. E.] HealthPartners Res Fdn, Minneapolis, MN 55440 USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research	Basham, P (corresponding author), Johns Hopkins Univ, 1717 Massachusetts Ave NW, Washington, DC 20036 USA.	patrickbasham@gmail.com; jefferyrw@gmail.com	Basham, Patrick/AAR-9496-2021	Sherwood, Nancy/0000-0002-3365-9018	NCI NIH HHS [CA116849] Funding Source: Medline; NIDDK NIH HHS [DK50456] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	49	49	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 2	2008	336	7638					244	245		10.1136/bmj.39458.480764.AD	http://dx.doi.org/10.1136/bmj.39458.480764.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18244993	Green Published			2022-12-28	WOS:000253102900032
J	Law, RM; Matear, RJ; Francey, RJ				Law, Rachel M.; Matear, Richard J.; Francey, Roger J.			Saturation of the Southern Ocean CO2 sink due to recent climate change	SCIENCE			English	Editorial Material								Unlike Le Quere et al. (Reports, 22 June 2007, p. 1735), we do not find a saturating Southern Ocean carbon sink due to recent climate change. In our ocean model, observed wind forcing causes reduced carbon uptake, but heat and freshwater flux forcing cause increased uptake. Our inversions of atmospheric carbon dioxide show that the Southern Ocean sink trend is dependent on network choice.	[Law, Rachel M.; Francey, Roger J.] CSIRO, Wealth Oceans Flagship, Aspendale, Vic 3195, Australia; [Matear, Richard J.] CSIRO, Wealth Oceans Flagship, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Law, RM (corresponding author), CSIRO, Wealth Oceans Flagship, PMB 1, Aspendale, Vic 3195, Australia.	rachel.law@csiro.au	Law, Rachel/A-1969-2012; Francey, Roger J/A-2345-2012; Weaver, Andrew J/E-7590-2011; matear, richard J/C-5133-2011; Law, Rachel/AAV-1949-2020; Eby, Michael/H-5278-2013	Law, Rachel/0000-0002-7346-0927; Weaver, Andrew J/0000-0001-8919-3598; matear, richard J/0000-0002-3225-0800; Law, Rachel/0000-0002-7346-0927; 				Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lenton A, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002714; RAMONET M, 2007, WORLD DATA CTR GREEN; TANS PP, 2007, WORLD DATA CTR GREEN	7	55	57	10	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					570	570		10.1126/science.1149077	http://dx.doi.org/10.1126/science.1149077			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239109				2022-12-28	WOS:000252772000018
J	Aoi, T; Yae, K; Nakagawa, M; Ichisaka, T; Okita, K; Takahashi, K; Chiba, T; Yamanaka, S				Aoi, Takashi; Yae, Kojiro; Nakagawa, Masato; Ichisaka, Tomoko; Okita, Keisuke; Takahashi, Kazutoshi; Chiba, Tsutomu; Yamanaka, Shinya			Generation of pluripotent stem cells from adult mouse liver and stomach cells	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION	Induced pluripotent stem ( iPS) cells have been generated from mouse and human fibroblasts by the retroviral transduction of four transcription factors. However, the cell origins and molecular mechanisms of iPS cell induction remain elusive. This report describes the generation of iPS cells from adult mouse hepatocytes and gastric epithelial cells. These iPS cell clones appear to be equivalent to embryonic stem cells in gene expression and are competent to generate germline chimeras. Genetic lineage tracings show that liver- derived iPS cells are derived from albumin-expressing cells. No common retroviral integration sites are found among multiple clones. These data suggest that iPS cells are generated by direct reprogramming of lineage- committed somatic cells and that retroviral integration into specific sites is not required.	[Aoi, Takashi; Yae, Kojiro; Nakagawa, Masato; Ichisaka, Tomoko; Okita, Keisuke; Takahashi, Kazutoshi; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Aoi, Takashi; Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yamanaka, Shinya] Kyoto Univ, Ctr Induced Pluripotent StemiPS Cell Res & Applic, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Wilson, Matthew H/K-3193-2013	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090				Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	17	759	954	1	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					699	702		10.1126/science.1154884	http://dx.doi.org/10.1126/science.1154884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18276851	Green Submitted			2022-12-28	WOS:000258077700046
J	Aynajian, P; Keller, T; Boeri, L; Shapiro, SM; Habicht, K; Keimer, B				Aynajian, P.; Keller, T.; Boeri, L.; Shapiro, S. M.; Habicht, K.; Keimer, B.			Energy gaps and Kohn anomalies in elemental superconductors	SCIENCE			English	Article							FERMI-SURFACE; DISPERSION; LEAD	The momentum and temperature dependence of the lifetimes of acoustic phonons in the elemental superconductors lead and niobium were determined by resonant spin- echo spectroscopy with neutrons. In both elements, the superconducting energy gap extracted from these measurements was found to converge with sharp anomalies originating from Fermi- surface nesting ( Kohn anomalies) at low temperatures. The results indicate electron many- body correlations beyond the standard theoretical framework for conventional superconductivity. A possible mechanism is the interplay between superconductivity and spin- or charge- density- wave fluctuations, which may induce dynamical nesting of the Fermi surface.	[Aynajian, P.; Keller, T.; Boeri, L.; Keimer, B.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Keller, T.] Tech Univ Munich, ZWE FRM 2, D-85748 Garching, Germany; [Shapiro, S. M.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Habicht, K.] Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany	Max Planck Society; Technical University of Munich; United States Department of Energy (DOE); Brookhaven National Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Keimer, B (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	b.keimer@fkf.mpg.de	Habicht, Klaus/K-3636-2013; Boeri, Lilia/B-6162-2015	Habicht, Klaus/0000-0002-9915-7221; Boeri, Lilia/0000-0003-1186-2207; Aynajian, Pegor/0000-0002-0123-527X; Keimer, Bernhard/0000-0001-5220-9023				ALLEN PB, 1972, PHYS REV B, V6, P2577, DOI 10.1103/PhysRevB.6.2577; ANDERSSO.JR, 1965, PHYS REV, V139, P1459, DOI 10.1103/PhysRev.139.A1459; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bayrakci SP, 2006, SCIENCE, V312, P1926, DOI 10.1126/science.1127756; BROCKHOUSE BN, 1962, PHYS REV, V128, P1099, DOI 10.1103/PhysRev.128.1099; Cappelluti E, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140505; Dolgov OV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014517; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; GASPAROVIC RF, 1966, SOLID STATE COMMUN, V4, P59, DOI 10.1016/0038-1098(66)90106-2; Keller T, 2002, APPL PHYS A-MATER, V74, pS332, DOI 10.1007/s003390201612; Kiss T, 2007, NAT PHYS, V3, P720, DOI 10.1038/nphys699; KOHN W, 1959, PHYS REV LETT, V2, P393, DOI 10.1103/PhysRevLett.2.393; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; MARIS HJ, 1970, PHYS REV LETT, V25, P220, DOI 10.1103/PhysRevLett.25.220; Marques MAL, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024546; MONCTON DE, 1977, PHYS REV B, V16, P801, DOI 10.1103/PhysRevB.16.801; OVERHAUSER AW, 1962, PHYS REV, V128, P1437, DOI 10.1103/PhysRev.128.1437; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; PITAYEVSKI LP, 1976, PHYS REV B, V14, P263, DOI 10.1103/PhysRevB.14.263; Schrieffer JR, 1999, THEORY SUPERCONDUCTI; SHAPIRO SM, 1975, PHYS REV B, V12, P4899, DOI 10.1103/PhysRevB.12.4899; STEDMAN R, 1967, PHYS REV, V163, P567, DOI 10.1103/PhysRev.163.567; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Terashima K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017003; WALDORF DL, 1960, B AM PHYS SOC, V5, P170	25	47	47	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1509	1512		10.1126/science.1154115	http://dx.doi.org/10.1126/science.1154115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18292306	Green Submitted			2022-12-28	WOS:000253943800033
J	George, DT; Gilman, J; Hersh, J; Thorsell, A; Herion, D; Geyer, C; Peng, X; Kielbasa, W; Rawlings, R; Brandt, JE; Gehlert, DR; Tauscher, JT; Hunt, SP; Hommer, D; Heilig, M				George, David T.; Gilman, Jodi; Hersh, Jacqueline; Thorsell, Annika; Herion, David; Geyer, Christopher; Peng, Xiaomei; Kielbasa, William; Rawlings, Robert; Brandt, John E.; Gehlert, Donald R.; Tauscher, Johannes T.; Hunt, Stephen P.; Hommer, Daniel; Heilig, Markus			Neurokinin 1 receptor antagonism as a possible therapy for alcoholism	SCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; MICE LACKING; STRESS; DRUG; REINSTATEMENT; DEPENDENCE; SEEKING	Alcohol dependence is a major public health challenge in need of new treatments. As alcoholism evolves, stress systems in the brain play an increasing role in motivating continued alcohol use and relapse. We investigated the role of the neurokinin 1 receptor ( NK1R), a mediator of behavioral stress responses, in alcohol dependence and treatment. In preclinical studies, mice genetically deficient in NK1R showed a marked decrease in voluntary alcohol consumption and had an increased sensitivity to the sedative effects of alcohol. In a randomized controlled experimental study, we treated recently detoxified alcoholic inpatients with an NK1R antagonist ( LY686017; n = 25) or placebo ( n = 25). LY686017 suppressed spontaneous alcohol cravings, improved overall well- being, blunted cravings induced by a challenge procedure, and attenuated concomitant cortisol responses. Brain functional magnetic resonance imaging responses to affective stimuli likewise suggested beneficial LY686017 effects. Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism.	[George, David T.; Gilman, Jodi; Hersh, Jacqueline; Thorsell, Annika; Herion, David; Rawlings, Robert; Hommer, Daniel; Heilig, Markus] NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD 20892 USA; [Geyer, Christopher] NIH, Dept Nursing, Mark O Hatfield Clin Res Ctr, Bethesda, MD 20892 USA; [Peng, Xiaomei; Kielbasa, William; Brandt, John E.; Gehlert, Donald R.; Tauscher, Johannes T.] Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA; [Hunt, Stephen P.] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; Eli Lilly; University of London; University College London	Heilig, M (corresponding author), NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD 20892 USA.	markus.heilig@mail.nih.gov	Gilman, Jodi/P-3864-2018; Tauscher, Johannes/M-5976-2016; HUNT, STEPHEN P/C-1646-2008; Thorsell, Annika/J-4188-2015	Gilman, Jodi/0000-0001-5180-6694; Thorsell, Annika/0000-0003-3535-3845; Hunt, Stephen/0000-0001-9453-5505	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000206, ZIAAA000081, Z01AA000081] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AMEGADZIE AK, 2003, Patent No. 2003091226; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; BROWNELL KD, 1986, AM PSYCHOL, V41, P765, DOI 10.1037/0003-066X.41.7.765; Crabbe JC, 2004, PSYCHOPHARMACOLOGY, V174, P539, DOI 10.1007/s00213-003-1608-6; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flannery BA, 2003, J STUD ALCOHOL, V64, P120, DOI 10.15288/jsa.2003.64.120; Furmark T, 2005, BIOL PSYCHIAT, V58, P132, DOI 10.1016/j.biopsych.2005.03.029; GILMAN JM, IN PRESS ADDICTION B; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Lang PJ, 1995, INT AFFECTIVE PICTUR; Le AD, 1998, PSYCHOPHARMACOLOGY, V135, P169, DOI 10.1007/s002130050498; Liu X, 2002, J NEUROSCI, V22, P7856; LUNDBERG JM, 1983, TRENDS NEUROSCI, V6, P325, DOI 10.1016/0166-2236(83)90149-2; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; Ripley TL, 2002, NEUROPHARMACOLOGY, V43, P1258, DOI 10.1016/S0028-3908(02)00295-2; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Sinha R, 2007, DRUG ALCOHOL REV, V26, P25, DOI 10.1080/09595230601036960; Spielberger CD, 1970, MANUAL STATE TRAIT A; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147	25	169	175	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1536	1539		10.1126/science.1153813	http://dx.doi.org/10.1126/science.1153813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18276852				2022-12-28	WOS:000253943800042
J	Galperin, M; Ratner, MA; Nitzan, A; Troisi, A				Galperin, Michael; Ratner, Mark A.; Nitzan, Abraham; Troisi, Alessandro			Nuclear coupling and polarization in molecular transport junctions: Beyond tunneling to function	SCIENCE			English	Review							NEGATIVE DIFFERENTIAL RESISTANCE; SHOT-NOISE MEASUREMENTS; SINGLE-MOLECULE; ELECTRON-TRANSFER; THERMAL CONDUCTANCE; SPECTROSCOPY; DEVICES; WIRES; DYNAMICS; SURFACE	Much current experimental research on transport in molecular junctions focuses on finite voltages, where substantial polarization- induced nonlinearities may result in technologically relevant device- type responses. Because molecules have strong polarization responses to changing charge state or external field, molecules isolated between electrodes can show strongly nonlinear current- voltage responses. For small applied voltages ( up to similar to 0.3 volt), weak interaction between transporting electrons and molecular vibrations provides the basis for inelastic electron tunneling spectroscopy. At higher voltages and for certain time scale regimes, strong coupling effects occur, including Coulomb blockade, negative differential resistance, dynamical switching and switching noise, current hysteresis, heating, and chemical reactions. We discuss a general picture for such phenomena that arise from charging, strong correlation, and polarization ( electronic and vibrational) effects in the molecule and at the interface.	[Galperin, Michael; Ratner, Mark A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Nitzan, Abraham] Tel Aviv Univ, Dept Chem, IL-69978 Tel Aviv, Israel; [Troisi, Alessandro] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Troisi, Alessandro] Univ Warwick, Ctr Comp Sci, Coventry CV4 7AL, W Midlands, England	Northwestern University; Tel Aviv University; University of Warwick; University of Warwick	Galperin, M (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.		Troisi, Alessandro/E-7318-2014; Galperin, Michael/B-2838-2011	Troisi, Alessandro/0000-0002-5447-5648; Galperin, Michael/0000-0002-1401-5970				ALLARA DL, 1985, LANGMUIR, V1, P45, DOI 10.1021/la00061a007; AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Basch H, 2005, NANO LETT, V5, P1668, DOI 10.1021/nl050702s; Beckman R, 2006, FARADAY DISCUSS, V131, P9, DOI 10.1039/b513148k; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; Bumm LA, 1996, SCIENCE, V271, P1705, DOI 10.1126/science.271.5256.1705; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; Cai LT, 2005, NANO LETT, V5, P2365, DOI 10.1021/nl051219k; CARTER FL, 1983, J VAC SCI TECHNOL B, V1, P959, DOI 10.1116/1.582717; Chen J, 2000, APPL PHYS LETT, V77, P1224, DOI 10.1063/1.1289650; Chen J, 1999, SCIENCE, V286, P1550, DOI 10.1126/science.286.5444.1550; Chen YC, 2005, NANO LETT, V5, P621, DOI 10.1021/nl047899t; CUNIBERTI G, 2005, SPRINGER LECT NOTES; Dallakyan S, 2003, APPL PHYS LETT, V82, P2488, DOI 10.1063/1.1567805; Danilov AV, 2006, NANO LETT, V6, P2184, DOI 10.1021/nl0612087; Datta S., 2005, THE EFFECT; Datta S., 1997, ELECT TRANSPORT MESO; Djukic D, 2006, NANO LETT, V6, P789, DOI 10.1021/nl060116e; Dulic D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.207402; Fagas G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.241314; Galperin M, 2005, NANO LETT, V5, P125, DOI 10.1021/nl048216c; Galperin M, 2004, J CHEM PHYS, V121, P11965, DOI 10.1063/1.1814076; GALPERIN M, 2004, NANO LETT, V4, P1605; Galperin M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075326; Galperin M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/10/103201; Guisinger NP, 2004, NANO LETT, V4, P55, DOI 10.1021/nl0348589; Haiss W, 2006, NAT MATER, V5, P995, DOI 10.1038/nmat1781; He J, 2005, NANOTECHNOLOGY, V16, P695, DOI 10.1088/0957-4484/16/6/012; He J, 2006, J AM CHEM SOC, V128, P14828, DOI 10.1021/ja0635433; Huang ZF, 2006, NANO LETT, V6, P1240, DOI 10.1021/nl0608285; HUSH NS, 2003, ANN NY ACAD SCI, V1006; Jiang J, 2005, NANO LETT, V5, P1551, DOI 10.1021/nl050789h; JORTNER J, 1976, J CHEM PHYS, V64, P4860, DOI 10.1063/1.432142; Kadanoff L., 1962, QUANTUM STAT MECH; Katsonis N, 2006, ADV MATER, V18, P1397, DOI 10.1002/adma.200600210; Keane ZK, 2006, NANO LETT, V6, P1518, DOI 10.1021/nl061117+; Kiehl RA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2195696; Kudernac T, 2006, CHEM COMMUN, P3597, DOI 10.1039/b609119a; KUHN H, 1971, ANGEW CHEM INT EDIT, V10, P620, DOI 10.1002/anie.197106201; Kushmerick JG, 2004, NANO LETT, V4, P639, DOI 10.1021/nl049871n; La Magna A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.136404; Lagerqvist J, 2004, NANOTECHNOLOGY, V15, pS459, DOI 10.1088/0957-4484/15/7/053; Le JD, 2003, APPL PHYS LETT, V83, P5518, DOI 10.1063/1.1636520; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Lortscher E, 2006, SMALL, V2, P973, DOI 10.1002/smll.200600101; Long DP, 2006, NAT MATER, V5, P901, DOI 10.1038/nmat1754; Lorente N, 2005, J PHYS-CONDENS MAT, V17, pS1049, DOI 10.1088/0953-8984/17/13/003; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Mayor M, 2004, ANGEW CHEM INT EDIT, V43, P2882, DOI 10.1002/anie.200301733; Mitra A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.076404; Moore AM, 2006, J AM CHEM SOC, V128, P1959, DOI 10.1021/ja055761m; Mozyrsky D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035104; Muralidharan B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155410; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Nitzan A, 2000, J PHYS CHEM B, V104, P5661, DOI 10.1021/jp0007235; Osorio EA, 2007, ADV MATER, V19, P281, DOI 10.1002/adma.200601876; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Paulsson M, 2006, NANO LETT, V6, P258, DOI 10.1021/nl052224r; Poot M, 2006, NANO LETT, V6, P1031, DOI 10.1021/nl0604513; Reddy P, 2007, SCIENCE, V315, P1568, DOI 10.1126/science.1137149; Schwarzer D, 2004, J CHEM PHYS, V121, P1754, DOI 10.1063/1.1765092; Segal D, 2003, J CHEM PHYS, V119, P6840, DOI 10.1063/1.1603211; Seideman T, 2003, J PHYS-CONDENS MAT, V15, pR521, DOI 10.1088/0953-8984/15/14/201; Selzer Y, 2006, ANNU REV PHYS CHEM, V57, P593, DOI 10.1146/annurev.physchem.57.032905.104709; Sergueev N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146803; Smit RHM, 2002, NATURE, V419, P906, DOI 10.1038/nature01103; Solomon GC, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166362; Solomon GC, 2006, NANO LETT, V6, P2431, DOI 10.1021/nl0614516; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Thielmann A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045341; Troisi A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.033408; Troisi A, 2003, J CHEM PHYS, V118, P6072, DOI 10.1063/1.1556854; Troisi A, 2007, P NATL ACAD SCI USA, V104, P14255, DOI 10.1073/pnas.0704208104; Troisi A, 2006, NANO LETT, V6, P1784, DOI 10.1021/nl0609394; Wakayama Y, 2004, APPL PHYS LETT, V85, P329, DOI 10.1063/1.1772867; Walczak K, 2004, PHYS STATUS SOLIDI B, V241, P2555, DOI 10.1002/pssb.200302036; Wang RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358856; Wang WY, 2004, NANO LETT, V4, P643, DOI 10.1021/nl049870v; Wang ZH, 2007, SCIENCE, V317, P787, DOI 10.1126/science.1145220; Xiao XY, 2006, CHEM PHYS, V326, P138, DOI 10.1016/j.chemphys.2006.02.022; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; YABLONOVITCH E, 1989, SCIENCE, V246, P347, DOI 10.1126/science.246.4928.347; Yasutomi S, 2004, SCIENCE, V304, P1944, DOI 10.1126/science.1098489; Zahid F, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1961289	85	256	259	6	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1056	1060		10.1126/science.1146556	http://dx.doi.org/10.1126/science.1146556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292333				2022-12-28	WOS:000253311700033
J	Katz, JN; Harris, MB				Katz, Jeffrey N.; Harris, Mitchel B.			Lumbar spinal stenosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORCINE CAUDA-EQUINA; EPIDURAL STEROID INJECTION; NERVE ROOT COMPRESSION; GRADED COMPRESSION; INTERMITTENT CLAUDICATION; NONSURGICAL MANAGEMENT; NONOPERATIVE TREATMENT; DECOMPRESSION; OUTCOMES; SURGERY		[Katz, Jeffrey N.; Harris, Mitchel B.] Brigham & Womens Hosp, Ctr Orthoped & Arthritis Outcomes Res, Dept Orthoped Surg, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Jeffrey N.; Harris, Mitchel B.] Harvard Univ, Sch Med, Boston, MA USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Katz, JN (corresponding author), Brigham & Womens Hosp, Ctr Orthoped & Arthritis Outcomes Res, Dept Orthoped Surg, 75 Francis St,B3, Boston, MA 02115 USA.	jnkatz@partners.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002123] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60 AR47788, K24 AR02123] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		[Anonymous], AHRQ PUBL; Armon C, 2007, NEUROLOGY, V68, P723, DOI 10.1212/01.wnl.0000256734.34238.e7; ARNOLDI CC, 1976, CLIN ORTHOP RELAT R, P4; Atlas SJ, 2000, SPINE, V25, P556, DOI 10.1097/00007632-200003010-00005; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Benoist M, 2002, JOINT BONE SPINE, V69, P450, DOI 10.1016/S1297-319X(02)00429-3; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; CIOL MA, 1994, SPINE, V19, P1329, DOI 10.1097/00007632-199406000-00005; Cooper Grant, 2004, Pain Physician, V7, P311; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; de Graaf I, 2006, SPINE, V31, P1168, DOI 10.1097/01.brs.0000216463.32136.7b; DEYO RA, 1992, J BONE JOINT SURG AM, V74A, P536, DOI 10.2106/00004623-199274040-00009; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; Fukusaki M, 1998, CLIN J PAIN, V14, P148, DOI 10.1097/00002508-199806000-00010; GROB D, 1993, ORTHOPADE, V22, P243; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; HERNO A, 1993, SPINE, V18, P1471; Herno A, 1995, Ann Chir Gynaecol Suppl, V210, P1; Iwatsuki K, 2007, SURG NEUROL, V68, P487, DOI 10.1016/j.surneu.2006.12.044; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jespersen SM, 1995, SPINE, V20, P2765, DOI 10.1097/00007632-199512150-00020; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Katz JN, 1996, SPINE, V21, P92, DOI 10.1097/00007632-199601010-00022; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; KENT DL, 1992, AM J ROENTGENOL, V158, P1135, DOI 10.2214/ajr.158.5.1533084; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; *NAT I CLIN EXC, 2006, INT DISTR PROC SPIN; OLMARKER K, 1989, SPINE, V14, P569, DOI 10.1097/00007632-198906000-00003; OLMARKER K, 1992, CLIN ORTHOP RELAT R, P35; OLMARKER K, 1991, SPINE, V16, P61, DOI 10.1097/00007632-199101000-00012; OLMARKER K, 1989, J ORTHOP RES, V7, P817, DOI 10.1002/jor.1100070607; Podichetty VK, 2006, J SPINAL DISORD TECH, V19, P161, DOI 10.1097/01.bsd.0000188663.46391.73; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; Rivest C, 1998, ARTHRIT CARE RES, V11, P291, DOI 10.1002/art.1790110410; Rosen DS, 2007, NEUROSURGERY, V60, P503, DOI 10.1227/01.NEU.0000255332.87909.58; Sekiguchi Miho, 2005, Clin Calcium, V15, P51; Simotas AC, 2000, SPINE, V25, P197, DOI 10.1097/00007632-200001150-00009; Takenobu Y, 2001, J NEUROSCI METH, V104, P191, DOI 10.1016/S0165-0270(00)00342-3; TURNER JA, 1992, SPINE, V17, P1, DOI 10.1097/00007632-199201000-00001; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Zucherman JF, 2005, SPINE, V30, P1351, DOI 10.1097/01.brs.0000166618.42749.d1; Zucherman JF, 2004, EUR SPINE J, V13, P22, DOI 10.1007/s00586-003-0581-4	44	316	332	3	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					818	825		10.1056/NEJMcp0708097	http://dx.doi.org/10.1056/NEJMcp0708097			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287604				2022-12-28	WOS:000253257700007
J	Segers, VFM; Lee, RT				Segers, Vincent F. M.; Lee, Richard T.			Stem-cell therapy for cardiac disease	NATURE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; PROGENITOR CELLS; INTRACORONARY TRANSPLANTATION; SKELETAL MYOBLASTS; ADULT; HEART; REGENERATION; MUSCLE; CARDIOMYOCYTES	Heart failure is the leading cause of death worldwide, and current therapies only delay progression of the disease. Laboratory experiments and recent clinical trials suggest that cell-based therapies can improve cardiac function, and the implications of this for cardiac regeneration are causing great excitement. Bone-marrow-derived progenitor cells and other progenitor cells can differentiate into vascular cell types, restoring blood flow. More recently, resident cardiac stem cells have been shown to differentiate into multiple cell types present in the heart, including cardiac muscle cells, indicating that the heart is not terminally differentiated. These new findings have stimulated optimism that the progression of heart failure can be prevented or even reversed with cell-based therapy.	[Segers, Vincent F. M.; Lee, Richard T.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Dept Med,Sch Med,Partners Res Facil, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Lee, RT (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Dept Med,Sch Med,Partners Res Facil, 65 Landsdowne St, Cambridge, MA 02139 USA.	rlee@partners.org	Segers, Vincent F/J-1191-2019	Segers, Vincent F/0000-0001-7796-2222; Lee, Richard/0000-0003-4687-1381				Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Ahmadi H, 2007, CURR NEUROVASC RES, V4, P153; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Borchardt T, 2007, THROMB HAEMOSTASIS, V98, P311, DOI 10.1160/TH07-02-0153; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; Choi JH, 2007, CIRC J, V71, P486, DOI 10.1253/circj.71.486; Cleland JGF, 2007, EUR J HEART FAIL, V9, P92, DOI 10.1016/j.ejheart.2006.12.001; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Erbs S, 2007, CIRCULATION, V116, P366, DOI 10.1161/CIRCULATIONAHA.106.671545; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Gavira JJ, 2006, J THORAC CARDIOV SUR, V131, P799, DOI 10.1016/j.jtcvs.2005.11.030; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Ince H, 2004, J ENDOVASC THER, V11, P695, DOI 10.1583/04-1386R.1; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Liao R, 2007, PROG CARDIOVASC DIS, V50, P18, DOI 10.1016/j.pcad.2007.03.001; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Meluzin J, 2008, INT J CARDIOL, V128, P185, DOI 10.1016/j.ijcard.2007.04.098; Meluzin J, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.004; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Naseem RH, 2007, PHYSIOL GENOMICS, V30, P44, DOI 10.1152/physiolgenomics.00070.2006; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oh H, 2004, ANN NY ACAD SCI, V1015, P182, DOI 10.1196/annals.1302.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Puceat M, 2007, CLIN PHARMACOL THER, V82, P337, DOI 10.1038/sj.clpt.6100298; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stamm C, 2007, J THORAC CARDIOV SUR, V133, P717, DOI 10.1016/j.jtcvs.2006.08.077; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tatsumi T, 2007, CIRC J, V71, P1199, DOI 10.1253/circj.71.1199; Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	77	890	967	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					937	942		10.1038/nature06800	http://dx.doi.org/10.1038/nature06800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288183				2022-12-28	WOS:000253313100034
J	Newman, JH; Phillips, JA; Loyd, JE				Newman, John H.; Phillips, John A., III; Loyd, James E.			Narrative review: The enigma of pulmonary arterial hypertension: New insights from genetic studies	ANNALS OF INTERNAL MEDICINE			English	Review							MORPHOGENETIC PROTEIN-RECEPTOR; TGF-BETA RECEPTOR; SIGNAL-TRANSDUCTION; GERMLINE MUTATIONS; MARFAN-SYNDROME; II RECEPTOR; BMPR2 GENE; BONE; FIBROBLASTS; EXPRESSION	Pulmonary arterial hypertension (PAH) occurs as an idiopathic disease (formerly called primary pulmonary hypertension) and as a consequence of other illnesses. These illnesses include connective tissue diseases, portal hypertension, diet and stimulant drug use, HIV infection, and congenital heart disease. Inherited susceptibility to PAH occurs in families and is almost always due to mutations in genes of the TGF-beta family of receptors. The most common mutation leading to PAH is in bone morphogenetic protein receptor type 2 (BMPR2), originally discovered to be involved in bone healing. Mutations in BMPR2 have also been found in patients with idiopathic PAR although the true prevalence of this susceptibility has not been determined. About 20% of individuals with a BMPR2 mutation develop symptomatic pulmonary hypertension. Evidence is growing that imbalanced activation of other TGF-beta receptors coupled with reduced activity of mutated BMPR2 increases the likelihood of development of PAR Many signaling systems have been found to participate in PAH, including K channels, serotonin, angiopoietin, and cyclooxygenases. An interaction of these signaling systems with BMPR2 is a focus of research in PAH. Approaches to altering the imbalance of activation of BMPR2 and other TGF-beta receptors may yield future therapies for PAH.	[Newman, John H.] Vanderbilt Univ, Sch Med, Div Pulm & Crit Care Med, Nashville, TN 37212 USA	Vanderbilt University	Newman, JH (corresponding author), Vanderbilt Univ, Sch Med, Div Pulm & Crit Care Med, T 1219 Vanderbilt Med Ctr, Nashville, TN 37212 USA.	john.newman@vanderbilt.edu		Loyd, James/0000-0002-5042-7390	NCRR NIH HHS [M01-RR-00095] Funding Source: Medline; PHS HHS [P01 072058] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akhurst RJ, 2004, NAT GENET, V36, P790, DOI 10.1038/ng0804-790; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Bernards R, 2006, NEW ENGL J MED, V355, P2391, DOI 10.1056/NEJMp068242; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Ensenauer RE, 2005, MAYO CLIN PROC, V80, P63; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Harvey KA, 2007, J CELL PHYSIOL, V211, P353, DOI 10.1002/jcp.20939; Hu H, 2006, BIOCHEM BIOPH RES CO, V339, P59, DOI 10.1016/j.bbrc.2005.10.187; Ishikura K, 2006, CIRC J, V70, P174, DOI 10.1253/circj.70.174; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2000, GENE DEV, V14, P627; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McMurtry IF, 2003, ADV EXP MED BIOL, V543, P127; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; POLING JS, 2007, P AM THORAC SOC, pA557; POLING JS, 2007, IN PRESS AM SOC HUM; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Rubin LJ, 2004, J AM COLL CARDIOL, V43, p89S, DOI 10.1016/j.jacc.2004.02.030; Sankelo M, 2005, HUM MUTAT, V26, P119, DOI 10.1002/humu.20200; Sheares KKK, 2004, AM J PHYSIOL-LUNG C, V287, pL919, DOI 10.1152/ajplung.00012.2004; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wong WKP, 2006, GENE, V368, P84, DOI 10.1016/j.gene.2005.10.025; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200	47	70	74	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					278	283		10.7326/0003-4819-148-4-200802190-00006	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283205				2022-12-28	WOS:000253316400004
J	Arimond, M; Daelmans, B; Dewey, K				Arimond, Mary; Daelmans, Bernadette; Dewey, Kathryn		Working Grp Infant & Young Child F	Indicators for feeding practices in children	LANCET			English	Editorial Material									[Daelmans, Bernadette] WHO, CH-1211 Geneva 27, Switzerland; [Arimond, Mary] Int Food Policy Res Inst, Washington, DC 20036 USA; [Dewey, Kathryn] Univ Calif Davis, Davis, CA 95616 USA	World Health Organization; CGIAR; International Food Policy Research Institute (IFPRI); University of California System; University of California Davis	Daelmans, B (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.							[Anonymous], 2003, GUIDING PRINCIPLES C; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P289; *US AG INT DEV, 2006, INF YOUNG CHILDR FEE; WHO, IND ASS INF YOUNG CH; Working Group on Infant and Young Child Feeding Indicators, 2006, DEV VAL SIMPL IND DI; Working Group on Infant and Young Child Feeding Indicators, 2007, DEV VAL SIMPL IND DI; World Health Organization, 1991, WHOCDDSER9114; World Health Organization, 2005, GUID PRINC FEED NONB	9	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					541	542		10.1016/S0140-6736(08)60250-0	http://dx.doi.org/10.1016/S0140-6736(08)60250-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280315				2022-12-28	WOS:000253202600009
J	Cohen, JT; Neumann, PJ; Weinstein, MC				Cohen, Joshua T.; Neumann, Peter J.; Weinstein, Milton C.			Does preventive care save money? Health economics and the presidential candidates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, Joshua T.; Neumann, Peter J.] Tufts Univ, New England Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Tufts Medical Center; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Cohen, JT (corresponding author), Tufts Univ, New England Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA.			Cohen, Joshua/0000-0003-1737-0991				Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; RUSSELL LB, 1993, NEW ENGL J MED, V329, P352, DOI 10.1056/NEJM199307293290511; Russell LB., 2007, PREVENTIONS POTENTIA; Weinstein MC, 1999, ANN INTERN MED, V130, P857, DOI 10.7326/0003-4819-130-10-199905180-00021	6	286	291	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					661	663		10.1056/NEJMp0708558	http://dx.doi.org/10.1056/NEJMp0708558			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	262CX	18272889				2022-12-28	WOS:000253127700001
J	Teles, MG; Bianco, SDC; Brito, VN; Trarbach, EB; Kuohung, W; Xu, SY; Seminara, SB; Mendonca, BB; Kaiser, UB; Latronico, AC				Teles, Milena Gurgel; Bianco, Suzy D. C.; Brito, Vinicius Nahime; Trarbach, Ericka B.; Kuohung, Wendy; Xu, Shuyun; Seminara, Stephanie B.; Mendonca, Berenice B.; Kaiser, Ursula B.; Latronico, Ana Claudia			A GPR54-activating mutation in a patient with central precocious puberty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONKEY MACACA-MULATTA; HYPOGONADOTROPIC HYPOGONADISM; RECEPTOR GPR54; KISS-1 PEPTIDE; HORMONE; ACTIVATION; ONSET; G-PROTEIN-COUPLED-RECEPTOR-54; KISSPEPTIN; EXPRESSION	Gonadotropin-dependent, or central, precocious puberty is caused by early maturation of the hypothalamic-pituitary-gonadal axis. In girls, this condition is most often idiopathic. Recently, a G protein-coupled receptor, GPR54, and its ligand, kisspeptin, were described as an excitatory neuroregulator system for the secretion of gonadotropin-releasing hormone (GnRH). In this study, we have identified an autosomal dominant GPR54 mutation - the substitution of proline for arginine at codon 386 (Arg386Pro) - in an adopted girl with idiopathic central precocious puberty (whose biologic family was not available for genetic studies). In vitro studies have shown that this mutation leads to prolonged activation of intracellular signaling pathways in response to kisspeptin. The Arg386Pro mutant appears to be associated with central precocious puberty.	[Teles, Milena Gurgel; Brito, Vinicius Nahime; Trarbach, Ericka B.; Mendonca, Berenice B.; Latronico, Ana Claudia] Univ Sao Paulo, Hosp Clin, Disciplina Endocrinol & Metabol, Fac Med,Med Sch,Med Invest Lab, BR-05403900 Sao Paulo, Brazil; [Teles, Milena Gurgel; Brito, Vinicius Nahime; Trarbach, Ericka B.; Mendonca, Berenice B.; Latronico, Ana Claudia] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Teles, Milena Gurgel; Bianco, Suzy D. C.; Kuohung, Wendy; Xu, Shuyun; Seminara, Stephanie B.; Kaiser, Ursula B.] Harvard Reprod Endocrine Sci Ctr, Boston, MA USA; [Kuohung, Wendy] Boston Univ, Sch Med, Boston, MA 02118 USA; [Seminara, Stephanie B.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA	Universidade de Sao Paulo; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts General Hospital	Latronico, AC (corresponding author), Univ Sao Paulo, Hosp Clin, Disciplina Endocrinol & Metabol, Fac Med,Med Sch,Med Invest Lab, Av Dr Eneas Carvalho Aguiar 155-2 Andar Bloco 6, BR-05403900 Sao Paulo, Brazil.	anacl@usp.br	Oka, Yoshitaka/C-9670-2010; Bianco, Suzy D.C./E-8892-2010; Latronico, Ana Claudia/AAC-5112-2019; Mendonca, Berenice B/C-2827-2012; BRITO, VINICIUS/C-1938-2012; BRITO, VINICIUS N/B-3776-2013; Latronico, Ana Claudia/E-1198-2012; Brito, Vinicius Nahime/AAA-2013-2020; Trarbach, Ericka/I-5395-2012; Mendonca, Berenice/AAS-3742-2021; Teles, Milena G/H-7026-2012; Mendonca, Berenice B/J-6917-2015	Oka, Yoshitaka/0000-0002-3482-3051; Bianco, Suzy D.C./0000-0003-3794-9853; Latronico, Ana Claudia/0000-0001-6782-693X; BRITO, VINICIUS N/0000-0003-4140-6296; Latronico, Ana Claudia/0000-0001-6782-693X; Mendonca, Berenice/0000-0003-1762-1084; Teles, Milena G/0000-0002-0303-5335; Mendonca, Berenice B/0000-0003-1762-1084; Kuohung, Wendy/0000-0003-1764-2264; Brito, Vinicius Nahime/0000-0002-1052-2246	NICHD NIH HHS [U54 HD028138, U54 HD28138, U54 HD028138-140002] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bedecarrats GY, 2003, J CLIN ENDOCR METAB, V88, P834, DOI 10.1210/jc.2002-020806; Brito VN, 1999, J CLIN ENDOCR METAB, V84, P3539, DOI 10.1210/jc.84.10.3539; Brito VN, 2004, J CLIN ENDOCR METAB, V89, P4338, DOI 10.1210/jc.2003-031537; Cerrato F, 2006, EUR J ENDOCRINOL, V155, pS3, DOI 10.1530/eje.1.02235; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; Delemarre-van de Waal H, 2005, ENDOCRIN DEV, V8, P1, DOI 10.1159/000084082; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GREULICH WW, 1959, RADIOGRAPHIC ATLAS S, V51, P103; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Papathanasiou Asteroula, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P182; PESCOVITZ OH, 1988, J CLIN ENDOCR METAB, V67, P474, DOI 10.1210/jcem-67-3-474; Plant TM, 2006, ENDOCRINOLOGY, V147, P1007, DOI 10.1210/en.2005-1261; Seminara SB, 2006, ENDOCRINOLOGY, V147, P2122, DOI 10.1210/en.2005-1550; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Swords FM, 2002, MOL ENDOCRINOL, V16, P2746, DOI 10.1210/me.2002-0099; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111	26	366	386	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					709	715		10.1056/NEJMoa073443	http://dx.doi.org/10.1056/NEJMoa073443			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272894	Bronze, Green Accepted			2022-12-28	WOS:000253127700007
J	Mouton, R; Finch, D; Davies, I; Binks, A; Zacharowski, K				Mouton, Ronelle; Finch, David; Davies, Ian; Binks, Andrea; Zacharowski, Kai			Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study	LANCET			English	Article							HIGH-DOSE APROTININ; BYPASS GRAFT-SURGERY; PROPENSITY SCORE; CORONARY REVASCULARIZATION; BLOOD-TRANSFUSION; TRANEXAMIC ACID; DOUBLE-BLIND; FAILURE; MULTICENTER; METAANALYSIS	Background Aprotinin is used during cardiac surgery for its blood-saving effects. However, reports suggest a possible association between use of this drug and increased renal dysfunction and mortality. We investigated the effect of aprotinin on renal dysfunction in cardiac surgery, considering the cofactors on-pump versus off-pump surgery and co-medication with angiotensin-converting enzyme (ACE) inhibitors. Methods Our analysis included 9875 patients undergoing on-pump or off-pump cardiac surgery from Jan 1, 2000, to Sept 30, 2007. Of these patients, 9106 were included in the retrospective observational study analysis. With propensity-adjusted, multivariate staged logistic regression, we analysed separately the incidence of renal dysfunction in patients receiving aprotinin, tranexamic acid, or no antifibrinolytic treatment in the presence or absence of preoperative ACE inhibitor treatment, for both on-pump and off-pump surgical techniques. Findings In 5434 patients undergoing on-pump cardiac surgery, the odds ratio (OR) between aprotinin and an increased risk of renal dysfunction without ACE inhibitor was 1. 81 (95% CI 0 . 79-4.13, p=0.162) and with ACE inhibitor 1.73 (0.56-5.32, p=0.342). In the 848 patients taking ACE inhibitors and undergoing off-pump cardiac surgery, aprotinin was associated with a greater than two-fold increase in the risk of renal dysfunction after off-pump cardiac surgery (OR 2.87 [1.25-6.58], p=0. 013). Interpretation Our results have shown that aprotinin seems to be safe during on-pump cardiac surgery. However, the combination of aprotinin and ACE inhibitors during off-pump cardiac surgery is associated with a significant risk of postoperative renal dysfunction.	[Mouton, Ronelle; Finch, David; Davies, Ian; Binks, Andrea; Zacharowski, Kai] Bristol Royal Infirm & Gen Hosp, Dept Anaesthesia, Bristol, Avon, England	Bristol Royal Infirmary	Zacharowski, K (corresponding author), Bristol Royal Infirm & Gen Hosp, Sir Humphry Davy Dept Anaesthesia, Upper Maudlin Rd, Bristol BS2 8HW, Avon, England.	kai.zacharowski@bristol.ac.uk	Mouton, Ronelle/A-9934-2012	Mouton, Ronelle/0000-0001-9562-8199				Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0; Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4; Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; BLAUHUT B, 1991, J THORAC CARDIOV SUR, V101, P958; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Chertow GM, 1997, CIRCULATION, V95, P878; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031, DOI 10.1016/0003-4975(92)90066-D; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAmbra MN, 1996, J THORAC CARDIOV SUR, V112, P1081, DOI 10.1016/S0022-5223(96)70110-1; Dietrich W, 2006, ANESTH ANALG, V103, P1074, DOI 10.1213/01.ane.0000238446.30034.c8; FEINDT PR, 1995, ANN THORAC SURG, V60, P1076, DOI 10.1016/0003-4975(95)00525-P; Furnary AP, 2007, CIRCULATION, V116, pI127, DOI 10.1161/CIRCULATIONAHA.106.681395; Godet G, 1997, ANESTH ANALG, V85, P1227, DOI 10.1097/00000539-199712000-00009; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Hogue CW, 2006, ANESTH ANALG, V103, P1067, DOI 10.1213/01.ane.0000247881.20257.6d; Horl WH, 2000, BRIT J ANAESTH, V84, P3; Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Keogh B, 2004, 5 NATL ADULT CARDIAC; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kincaid EH, 2005, ANN THORAC SURG, V80, P1388, DOI 10.1016/j.athoracsur.2005.03.136; LEMMER JH, 1995, ANN THORAC SURG, V59, P132, DOI 10.1016/0003-4975(94)00813-M; LEVY JH, 1995, CIRCULATION, V92, P2236, DOI 10.1161/01.CIR.92.8.2236; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mannucci PM, 1998, NEW ENGL J MED, V339, P245, DOI 10.1056/NEJM199807233390407; *MED HEALTHC PROD, 2007, APR TRAS SUSP UK MAR; MYERS BD, 1986, NEW ENGL J MED, V314, P97; O'Connor CJ, 1999, ANESTH ANALG, V89, P1101; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Royston D, 1992, J Cardiothorac Vasc Anesth, V6, P76, DOI 10.1016/1053-0770(91)90052-U; ROYSTON D, 1987, LANCET, V2, P1289; Royston D, 2006, ANESTH ANALG, V103, P1082, DOI 10.1213/01.ane.0000238447.74029.f5; Schweizer A, 2000, BRIT J ANAESTH, V84, P16, DOI 10.1093/oxfordjournals.bja.a013374; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; SOSLAU G, 1991, AM J HEMATOL, V38, P113, DOI 10.1002/ajh.2830380208; SUNDT TM, 1993, ANN THORAC SURG, V55, P1418, DOI 10.1016/0003-4975(93)91082-X; Textor SC, 1997, SEMIN NEPHROL, V17, P67; Tuttle KR, 2003, AM J KIDNEY DIS, V41, P76, DOI 10.1053/ajkd.2003.50025; *US FDA, 2007, FDA REQ MARK SUSP TR; van der Linden J, 2005, CIRCULATION, V112, pI276, DOI 10.1161/CIRCULATIONAHA.104.524611; VAN OW, 1987, ANN THORAC SURG, V44, P640; Watters MPR, 2001, EUR J CARDIO-THORAC, V19, P34, DOI 10.1016/S1010-7940(00)00603-5; Waxler B, 2003, CURR PHARM DESIGN, V9, P777, DOI 10.2174/1381612033455468; WESTABY S, 1994, EUR J CARDIO-THORAC, V8, P82, DOI 10.1016/1010-7940(94)90097-3; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	50	42	45	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					475	482		10.1016/S0140-6736(08)60237-8	http://dx.doi.org/10.1016/S0140-6736(08)60237-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262039				2022-12-28	WOS:000253169200027
J	Sandhu, MS; Waterworth, DM; Debenham, SL; Wheeler, E; Papadakis, K; Zhao, JH; Song, KJ; Yuan, X; Johnson, T; Ashford, S; Inouye, M; Luben, R; Sims, M; Hadley, D; McArdle, W; Barter, P; Kesaniemi, YA; Mahley, RW; McPherson, R; Grundy, SM; Bingham, SA; Khaw, KT; Loos, RJF; Waeber, G; Barroso, I; Strachan, DP; Deloukas, P; Vollenweider, P; Wareham, NJ; Mooser, V				Sandhu, Manjinder S.; Waterworth, Dawn M.; Debenham, Sally L.; Wheeler, Eleanor; Papadakis, Konstantinos; Zhao, Jing Hua; Song, Kijoung; Yuan, Xin; Johnson, Toby; Ashford, Sofie; Inouye, Michael; Luben, Robert; Sims, Matthew; Hadley, David; McArdle, Wendy; Barter, Philip; Kesaeniemi, Y. Antero; Mahley, Robert W.; McPherson, Ruth; Grundy, Scott M.; Bingham, Sheila A.; Khaw, Kay-Tee; Loos, Ruth J. F.; Waeber, Gerard; Barroso, Ines; Strachan, David P.; Deloukas, Panagiotis; Vollenweider, Peter; Wareham, Nicholas J.; Mooser, Vincent		Wellcome Trust Case Control Consor	LDL-cholesterol concentrations: a genome-wide association study	LANCET			English	Article							LIPID-LEVELS; APOLIPOPROTEIN-E; COMMON DISEASES; PLASMA; HYPERCHOLESTEROLEMIA; PCSK9	Background LDL cholesterol has a causal role in the development of cardiovascular disease. Improved understanding of the biological mechanisms that underlie the metabolism and regulation of LDL cholesterol might help to identify novel therapeutic targets. We therefore did a genome-wide association study of LDL-cholesterol concentrations. Methods We used genome-wide association data from up to 11685 participants with measures of circulating LDL-cholesterol concentrations across five studies, including data for 293461 autosomal single nucleotide polymorphisms (SNPs) with a minor allele frequency of 5% or more that passed our quality control criteria. We also used data from a second genome-wide array in up to 4337 participants from three of these five studies, with data for 290140 SNPs. We did replication studies in two independent populations consisting of up to 4979 participants. Statistical approaches, including meta-analysis and linkage disequilibrium plots, were used to refine association signals; we analysed pooled data from all seven populations to determine the effect of each SNP on variations in circulating LDL-cholesterol concentrations. Findings In our initial scan, we found two SNPs (rs599839 [p=1.7x10(-15)] and rs4970834 [p=3 .0x10(-11)]) that showed genome-wide statistical association with LDL cholesterol at chromosomal locus 1p13.3. The second genome screen found a third statistically associated SNP at the same locus (rs646776 [p=4.3x10(-9)]). Meta-analysis of data from all studies showed an association of SNPs rs599839 (combined p=1.2x10(-33)) and rs646776 (p=4.8x10(-20)) with LDL-cholesterol concentrations. SNPs rs599839 and rs646776 both explained around 1% of the variation in circulating LDL-cholesterol concentrations and were associated with about 15% of an SD change in LDL cholesterol per allele, assuming an SD of 1 mmol/L. Interpretation We found evidence for a novel locus for LDL cholesterol on chromosome 1p13.3. These results potentially provide insight into the biological mechanisms that underlie the regulation of LDL cholesterol and might help in the discovery of novel therapeutic targets for cardiovascular disease.	[Sandhu, Manjinder S.; Debenham, Sally L.; Ashford, Sofie; Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Sandhu, Manjinder S.; Debenham, Sally L.; Zhao, Jing Hua; Ashford, Sofie; Sims, Matthew; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Waterworth, Dawn M.; Song, Kijoung; Yuan, Xin; Mooser, Vincent] GlaxoSmithKline, Div Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA USA; [Wheeler, Eleanor; Inouye, Michael; Barroso, Ines; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Johnson, Toby] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Johnson, Toby] Univ Lausanne, Univ Inst Social & Prevent Med, Lausanne, Switzerland; [Johnson, Toby] CHU Vaudois, Lausanne, Switzerland; [Papadakis, Konstantinos; Hadley, David; Strachan, David P.] Univ London St Georges Hosp, Div Community Hlth Sci, London, England; [McArdle, Wendy] Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; [Barter, Philip] Heart Res Inst, Sydney, NSW, Australia; [Kesaeniemi, Y. Antero] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; [Kesaeniemi, Y. Antero] Univ Oulu, Bioctr, SF-90220 Oulu, Finland; [Mahley, Robert W.] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Mahley, Robert W.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [McPherson, Ruth] Univ Ottawa, Ctr Heart, Div Cardiol, Ottawa, ON, Canada; [Grundy, Scott M.] Univ Texas Dallas, SW Med Ctr, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75230 USA; [Bingham, Sheila A.] MRC Dunn Human Nutr Unit, Cambridge, England; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; GlaxoSmithKline; Wellcome Trust Sanger Institute; University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); St Georges University London; University of Bristol; University of Sydney; Heart Research Institute; University of Oulu; University of Oulu; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Ottawa; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Sandhu, MS (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk	Hadley, David/I-6902-2012; Loos, Ruth J F/Q-2862-2016; Luben, Robert N/H-5519-2015; Deloukas, Panos/B-2922-2013; Colaus, PsyColaus/K-6607-2013; Khaw, Kay-Tee/AAZ-3209-2021; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; Luben, Robert N/0000-0002-5088-6343; Deloukas, Panos/0000-0001-9251-070X; Waeber, Gerard/0000-0003-4193-788X; Wheeler, Eleanor/0000-0002-8616-6444; Inouye, Michael/0000-0001-9413-6520; Johnson, Toby/0000-0002-5998-3270; Ricketts, Sally/0000-0002-5644-7958; Barroso, Ines/0000-0001-5800-4520	MRC [MC_U106188470, MC_U105630924, G0701863, MC_qA137934, G0000934] Funding Source: UKRI; Medical Research Council [MC_qA137934] Funding Source: researchfish; Medical Research Council [G0000934, MC_U105630924, MC_U106188470, MC_QA137934, G0701863] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cambien F, 2007, CIRCULATION, V116, P1714, DOI 10.1161/CIRCULATIONAHA.106.661751; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Day N, 1999, BRIT J CANCER, V80, P95; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356; INOUYE M, WTSI HIGH THROUGHPUT; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kruglyak L, 2005, NAT GENET, V37, P1299, DOI 10.1038/ng1205-1299; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marques-Vidal P, 2009, EUR J CLIN NUTR, V63, P273, DOI 10.1038/sj.ejcn.1602932; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; GENETIC INFORM BRIT; WHOLE GENOME SCAN TY	28	276	279	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					483	491		10.1016/S0140-6736(08)60208-1	http://dx.doi.org/10.1016/S0140-6736(08)60208-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262040	Green Published, Green Submitted			2022-12-28	WOS:000253169200028
J	Goodwin, AL; Calleja, M; Conterio, MJ; Dove, MT; Evans, JSO; Keen, DA; Peters, L; Tucker, MG				Goodwin, Andrew L.; Calleja, Mark; Conterio, Michael J.; Dove, Martin T.; Evans, John S. O.; Keen, David A.; Peters, Lars; Tucker, Matthew G.			Colossal positive and negative thermal expansion in the framework material Ag-3[Co(CN)(6)]	SCIENCE			English	Article							CHEMISTRY	We show that silver( I) hexacyanocobaltate(III), Ag-3[Co(CN)(6)], exhibits positive and negative thermal expansion an order of magnitude greater than that seen in other crystalline materials. This framework material expands along one set of directions at a rate comparable to the most weakly bound solids known. By flexing like lattice fencing, the framework couples this to a contraction along a perpendicular direction. This gives negative thermal expansion that is 14 times larger than in ZrW2O8. Density functional theory calculations quantify both the low energy associated with this flexibility and the role of argentophilic (Ag+...Ag+) interactions. This study illustrates how the mechanical properties of a van der Waals solid might be engineered into a rigid, useable framework.	[Goodwin, Andrew L.; Conterio, Michael J.; Dove, Martin T.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Calleja, Mark] Cambridge eSci Ctr, Cambridge CB3 0WA, England; [Evans, John S. O.; Peters, Lars] Univ Durham, Dept Chem, Univ Sci Labs, Durham DH1 3LE, England; [Keen, David A.; Tucker, Matthew G.] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Keen, David A.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Cambridge; University of Cambridge; Durham University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford	Goodwin, AL (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	alg44@cam.ac.uk	Evans, John SO/E-6345-2012; Tucker, Matt G/C-9867-2016; Goodwin, Andrew/A-5256-2016; Dove, Martin/D-1517-2010; Dove, Martin/GSD-4950-2022	Evans, John SO/0000-0001-6305-6341; Tucker, Matt G/0000-0002-2891-7086; Goodwin, Andrew/0000-0001-9231-3749; Dove, Martin/0000-0002-8030-1457; Peters, Lars/0000-0002-4677-850X	Engineering and Physical Sciences Research Council [EP/C538927/1] Funding Source: researchfish; Natural Environment Research Council [NE/C515698/1] Funding Source: researchfish; EPSRC [EP/C538927/1] Funding Source: UKRI; NERC [NE/C515698/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Coelho A. A, 2000, TOPAS V2 0 GEN PROFI; Dubbeldam D, 2007, ANGEW CHEM INT EDIT, V46, P4496, DOI 10.1002/anie.200700218; Geiser U, 2003, ACTA CRYSTALLOGR C, V59, pI21, DOI 10.1107/S0108270103001264; Goodwin AL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.075502; Goodwin AL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.140301; GUDEL HU, 1972, J CHEM PHYS, V56, P674, DOI 10.1063/1.1676928; GUDEL HU, 1970, J CHEM PHYS, V53, P1917, DOI 10.1063/1.1674269; Hannon AC, 2005, NUCL INSTRUM METH A, V551, P88, DOI 10.1016/j.nima.2005.07.053; Keen DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225501; Krishnan R.S., 1979, THERMAL EXPANSION CR; Larson A.C., 2000, 86748 LAUR; LUDI A, 1967, HELV CHIM ACTA, V50, P2035, DOI 10.1002/hlca.19670500737; Pantea C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.214118; PAULING L, 1968, P NATL ACAD SCI USA, V60, P362, DOI 10.1073/pnas.60.2.362; Pyykko P, 2004, ANGEW CHEM INT EDIT, V43, P4412, DOI 10.1002/anie.200300624; Ravindran TR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054302; Schmidbaur H, 2001, NATURE, V413, P31, DOI 10.1038/35092657; SEARS DR, 1962, J CHEM PHYS, V37, P3002, DOI 10.1063/1.1733133; Sharpe A.G., 1976, CHEM CYANO COMPLEXES; Wasserman E.F., 1990, FERROMAGNETIC MAT, V5	25	491	497	6	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					794	797		10.1126/science.1151442	http://dx.doi.org/10.1126/science.1151442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258911				2022-12-28	WOS:000252963000056
J	Zeng, N; Ding, YH; Pan, JH; Wang, HJ; Gregg, J				Zeng, Ning; Ding, Yihui; Pan, Jiahua; Wang, Huijun; Gregg, Jay			Sustainable development - Climate change - the Chinese challenge	SCIENCE			English	Editorial Material									[Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Ding, Yihui] Chinese Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Pan, Jiahua] Chinese Acad Social Sci, Res Ctr Sustainable Dev, Beijing, Peoples R China; [Wang, Huijun] Chinese Acad Sci, Inst Atmospher Phys, Beijing, Peoples R China; [Gregg, Jay] Univ Maryland, Dept Geog, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; China Meteorological Administration; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; University System of Maryland; University of Maryland College Park	Zeng, N (corresponding author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.	zeng@atmos.umd.edu	Zeng, Ning/A-3130-2008; Gregg, Jay Sterling/K-4242-2017	Zeng, Ning/0000-0002-7489-7629; Gregg, Jay Sterling/0000-0001-8759-9658				Committee of  China's National Assessment Report on Climate Change, 2007, CHINAS NATL ASSESSME; IEA, 2007, WORLD EN OUTL; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Katzer J, 2007, THE FUTURE OF COAL; National Development and Reform Commission, 2019, CHIN NAT CLIM CHANG; NDRC, 2007, CHIN MED LONG TERM R; Peng CH, 2007, SCIENCE, V316, P546, DOI 10.1126/science.1134134; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Wang T., 2007, 23 TYND CTR; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	10	96	116	9	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					730	731		10.1126/science.1153368	http://dx.doi.org/10.1126/science.1153368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258882				2022-12-28	WOS:000252963000024
J	Ferrari, MJ; Grais, RF; Bharti, N; Conlan, AJK; Bjornstad, ON; Wolfson, LJ; Guerin, PJ; Djibo, A; Grenfell, BT				Ferrari, Matthew J.; Grais, Rebecca F.; Bharti, Nita; Conlan, Andrew J. K.; Bjornstad, Ottar N.; Wolfson, Lara J.; Guerin, Philippe J.; Djibo, Ali; Grenfell, Bryan T.			The dynamics of measles in sub-Saharan Africa	NATURE			English	Article							TIME-SERIES; DEVELOPING-COUNTRIES; CHILDHOOD DISEASES; VACCINATION; EPIDEMICS; COMMUNITY; IMMUNIZATION; PERSISTENCE; OUTBREAK; ENGLAND	Although vaccination has almost eliminated measles in parts of the world, the disease remains a major killer in some high birth rate countries of the Sahel. On the basis of measles dynamics for industrialized countries, high birth rate regions should experience regular annual epidemics. Here, however, we show that measles epidemics in Niger are highly episodic, particularly in the capital Niamey. Models demonstrate that this variability arises from powerful seasonality in transmission - generating high amplitude epidemics - within the chaotic domain of deterministic dynamics. In practice, this leads to frequent stochastic fadeouts, interspersed with irregular, large epidemics. A metapopulation model illustrates how increased vaccine coverage, but still below the local elimination threshold, could lead to increasingly variable major outbreaks in highly seasonally forced contexts. Such erratic dynamics emphasize the importance both of control strategies that address build- up of susceptible individuals and efforts to mitigate the impact of large outbreaks when they occur.	[Ferrari, Matthew J.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bharti, Nita; Bjornstad, Ottar N.; Grenfell, Bryan T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Grais, Rebecca F.; Guerin, Philippe J.] Epictr, F-75011 Paris, France; [Conlan, Andrew J. K.] Ctr Math Sci, DAMTP, Cambridge CB3 0WA, England; [Bjornstad, Ottar N.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Wolfson, Lara J.] WHO, CH-1211 Geneva 27, Switzerland; [Djibo, Ali] Minist Sante, Direct Gen Sante Publ, Niamey, Niger	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); World Health Organization	Ferrari, MJ (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	mferrari@psu.edu	Conlan, Andrew/Q-3861-2019; Bjornstad, Ottar N/I-4518-2012; Wolfson, Lara/AAC-1400-2019; Guerin, Philippe/AAH-8873-2021	Conlan, Andrew/0000-0002-2593-6353; Wolfson, Lara/0000-0002-6454-3368; Freeman Grais, Rebecca/0000-0002-5037-8218; Bharti, Nita/0000-0003-1940-7794; Guerin, Philippe/0000-0002-6008-2963				ANDERSON R M, 1991; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P897; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P657; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P757; Central Intelligence Agency (CIA), WORLD FACTB NIG; Cliff A, 1993, MEASLES HIST GEOGRAP, P1840; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; Cummings DAT, 2006, INT J INFECT DIS, V10, P148, DOI 10.1016/j.ijid.2004.10.010; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; FINE PEM, 1983, INT J EPIDEMIOL, V12, P332, DOI 10.1093/ije/12.3.332; FINE PEM, 1982, INT J EPIDEMIOL, V11, P15, DOI 10.1093/ije/11.1.15; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; GRENFELL BT, 1994, PHILOS T R SOC A, V348, P515, DOI 10.1098/rsta.1994.0108; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Griffin DE, 2007, MICROBE, V1, P409; Guris D, 1998, PEDIATR INFECT DIS J, V17, P33, DOI 10.1097/00006454-199801000-00008; Hyde TB, 2006, INT J EPIDEMIOL, V35, P299, DOI 10.1093/ije/dyi222; Kambire C, 2003, J INFECT DIS, V187, pS80, DOI 10.1086/368043; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; MALFAIT P, 1994, PEDIATR INFECT DIS J, V13, P38, DOI 10.1097/00006454-199401000-00009; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Morton A, 2005, J R STAT SOC C-APPL, V54, P575, DOI 10.1111/j.1467-9876.2005.05366.x; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; Rain D., 2018, EATERS DRY SEASON CI, DOI 10.4324/9780429500886; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Sniadack DH, 1999, B WORLD HEALTH ORGAN, V77, P545; Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Strebel P, 2003, J INFECT DIS, V187, pS1, DOI 10.1086/368226; TIDD CW, 1993, P ROY SOC B-BIOL SCI, V254, P257, DOI 10.1098/rspb.1993.0155; Venczel L, 2003, J INFECT DIS, V187, pS127, DOI 10.1086/368029; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	46	236	243	0	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					679	684		10.1038/nature06509	http://dx.doi.org/10.1038/nature06509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256664	Bronze			2022-12-28	WOS:000252929500033
J	Shimada, M; Niida, H; Zineldeen, DH; Tagami, H; Tanaka, M; Saito, H; Nakanishi, M				Shimada, Midori; Niida, Hiroyuki; Zineldeen, Doaa H.; Tagami, Hideaki; Tanaka, Masafumi; Saito, Hiroyuki; Nakanishi, Makoto			Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression	CELL			English	Article							TATA-BINDING PROTEIN; CELL-CYCLE ARREST; SAGA COMPLEX; GCN5; ACTIVATION; CHECKPOINT; H3; PHOSPHORYLATION; ACETYLATION; ACETYLTRANSFERASE	DNA damage results in activation or suppression of transcription of a large number of genes. Transcriptional activation has been well characterized in the context of sequence-specific DNA-bound activators, whereas mechanisms of transcriptional suppression are largely unexplored. We show here that DNA damage rapidly reduces histone H3 Threonine 11 (T11) phosphorylation. This correlates with repression of genes, including cyclin B1 and cdk1. H3-T11 phosphorylation occurs throughout the cell cycle and is Chk1 dependent in vivo. Following DNA damage, Chk1 undergoes rapid chromatin dissociation, concomitant with reduced H3-T11 phosphorylation. Furthermore, we find that loss of H3-T11 phosphorylation correlates with reduced binding of the histone acetyltransferase GCN5 at cyclin B1 and cdk1 promoters and reduced H3-K9 acetylation. We propose a mechanism for Chk1 as a histone kinase, responsible for DNA-damage-induced transcriptional repression by loss of histone acetylation.	[Shimada, Midori; Niida, Hiroyuki; Zineldeen, Doaa H.; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem & Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Tagami, Hideaki] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Tanaka, Masafumi; Saito, Hiroyuki] Kobe Pharmaceut Univ, Biophys Chem Lab, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Nagoya City University; Nagoya City University; Kobe Pharmaceutical University	Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Biochem & Cell Biol, Mizuho Ku, 1 Kawasumi Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mkt-naka@med.nagoya-cu.ac.jp	Zineldeen, Doaa/AAK-4525-2020; zineldeen, Doaa/GZG-4789-2022	Zineldeen, Doaa/0000-0002-7877-8571; 				BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Liu QH, 2000, GENE DEV, V14, P1448; Luger K, 1999, METHOD ENZYMOL, V304, P3; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takai H, 2000, GENE DEV, V14, P1439; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109	32	198	204	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					221	232		10.1016/j.cell.2007.12.013	http://dx.doi.org/10.1016/j.cell.2007.12.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243098	Bronze			2022-12-28	WOS:000253427700009
J	LANGSTON, GI; CONNER, SR; LEHAR, J; BURKE, BF; WEILER, KW				LANGSTON, GI; CONNER, SR; LEHAR, J; BURKE, BF; WEILER, KW			GALAXY MASS DEDUCED FROM THE STRUCTURE OF EINSTEIN RING MG1654+1346	NATURE			English	Article									USN,RES LAB,EO HULBURT CTR SPACE RES,WASHINGTON,DC 20375; MIT,DEPT PHYS,CAMBRIDGE,MA 02139	United States Department of Defense; United States Navy; Naval Research Laboratory; Massachusetts Institute of Technology (MIT)								BLANDFORD R, 1989, GRAVITATIONAL LENSES, P38; BOURASSA RR, 1975, ASTROPHYS J, V195, P13, DOI 10.1086/153300; BRIDLE AH, 1984, ANNU REV ASTRON ASTR, V22, P319, DOI 10.1146/annurev.aa.22.090184.001535; HEWITT JN, 1988, NATURE, V333, P537, DOI 10.1038/333537a0; KOCHANEK CS, 1989, MON NOT R ASTRON SOC, V238, P43, DOI 10.1093/mnras/238.1.43; LANGSTON GI, 1989, ASTRON J, V97, P1283, DOI 10.1086/115071; LAWRENCE CR, 1986, ASTROPHYS J SUPPL S, V61, P105, DOI 10.1086/191109; NARAYAN R, 1989, GRAVITATIONAL LENSES, P31; SOUCAIL G, 1987, ASTRON ASTROPHYS, V172, pL14; TURNER EL, 1984, ASTROPHYS J, V284, P1, DOI 10.1086/162379	10	25	25	3	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					43	45		10.1038/344043a0	http://dx.doi.org/10.1038/344043a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278020				2022-12-28	WOS:A1990CQ97200052
J	Jha, P; Jacob, B; Gajalakshmi, V; Gupta, PC; Dhingra, N; Kumar, R; Sinha, DN; Dikshit, RP; Parida, DK; Kamadod, R; Boreham, J; Peto, R				Jha, Prabhat; Jacob, Binu; Gajalakshmi, Vendhan; Gupta, Prakash C.; Dhingra, Neeraj; Kumar, Rajesh; Sinha, Dhirendra N.; Dikshit, Rajesh P.; Parida, Dillip K.; Kamadod, Rajeev; Boreham, Jillian; Peto, Richard		RGI-CGHR Investigators	A nationally representative case-control study of smoking and death in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; MORTALITY; TUBERCULOSIS; RISK; DISEASES; MADRAS; SEX	Background: The nationwide effects of smoking on mortality in India have not been assessed reliably. Methods: In a nationally representative sample of 1.1 million homes, we compared the prevalence of smoking among 33,000 deceased women and 41,000 deceased men (case subjects) with the prevalence of smoking among 35,000 living women and 43,000 living men (unmatched control subjects). Mortality risk ratios comparing smokers with nonsmokers were adjusted for age, educational level, and use of alcohol. Results: About 5% of female control subjects and 37% of male control subjects between the ages of 30 and 69 years were smokers. In this age group, smoking was associated with an increased risk of death from any medical cause among both women (risk ratio, 2.0; 99% confidence interval [CI], 1.8 to 2.3) and men (risk ratio, 1.7; 99% CI, 1.6 to 1.8). Daily smoking of even a small amount of tobacco was associated with increased mortality. Excess deaths among smokers, as compared with nonsmokers, were chiefly from tuberculosis among both women (risk ratio, 3.0; 99% CI, 2.4 to 3.9) and men (risk ratio, 2.3; 99% CI, 2.1 to 2.6) and from respiratory, vascular, or neoplastic disease. Smoking was associated with a reduction in median survival of 8 years for women (99% CI, 5 to 11) and 6 years for men (99% CI, 5 to 7). If these associations are mainly causal, smoking in persons between the ages of 30 and 69 years is responsible for about 1 in 20 deaths of women and 1 in 5 deaths of men. In 2010, smoking will cause about 930,000 adult deaths in India; of the dead, about 70% (90,000 women and 580,000 men) will be between the ages of 30 and 69 years. Because of population growth, the absolute number of deaths in this age group is rising by about 3% per year. Conclusions: Smoking causes a large and growing number of premature deaths in India.	[Jha, Prabhat; Jacob, Binu; Kamadod, Rajeev] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5C 1N8, Canada; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Madras, Tamil Nadu, India; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Bombay, Maharashtra, India; [Dhingra, Neeraj] Rural Hlth Training Ctr, New Delhi, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Sinha, Dhirendra N.] Sch Prevent Oncol, Patna, Bihar, India; [Dikshit, Rajesh P.] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Parida, Dillip K.] NE Indira Gandhi Reg Inst Hlth & Med Sci, Shillong, Meghalaya, India; [Boreham, Jillian; Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Boreham, Jillian; Peto, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Tata Memorial Centre (TMC); Tata Memorial Hospital; North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS); University of Oxford; University of Oxford	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Jayakumar, Sylvia/HHC-2583-2022; Bassani, Diego/G-2827-2015; Corsi, Daniel J/S-4689-2018	Bassani, Diego/0000-0001-6704-3820; Corsi, Daniel J/0000-0001-7063-3354; Suraweera, Wilson/0000-0001-9673-5746; Pednekar, Mangesh/0000-0001-6266-5356; K T, Shenoy/0000-0002-2826-6869	Cancer Research UK Funding Source: Medline; FIC NIH HHS [R01-TW05993-02, R01-TW05991-01, TW007939-01] Funding Source: Medline; Medical Research Council [MC_U137686857] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW005991, R01TW007939, R01TW005993] Funding Source: NIH RePORTER; MRC [MC_U137686857] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, SAMPL REG SYST BAS R; [Anonymous], 2005, SPEC FERT MORT SURV; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dresler C, 2007, IARC HDB CANC PREVEN, V11, P15; Gajalakshmi CK, 1996, EUR J CANCER PREV, V5, P63; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; *INT I POP SCI MAC, 2007, NAT FAM HLTH SURV 3; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2006, LANCET, V367, P1730; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2002, AM J PUBLIC HEALTH, V92, P1002, DOI 10.2105/AJPH.92.6.1002; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kumar R, 2006, Indian J Public Health, V50, P90; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; *MIN HLTH FAM WELF, TB IND 2007 RNTCP ST; Office of the Surgeon General, 2004, HLTH CONS SMOK REP S; Pais P, 2001, Indian Heart J, V53, P731; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Peto R, MORTALITY SMOKING DE; Peto R, 1994, MORTALITY SMOKING DE; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rastogi T, 2005, TOB CONTROL, V14, P356, DOI 10.1136/tc.2005.011965; *REG GEN IND, 2005, SAMPL REG SYST STAT; SINHA DN, 2006, 7 U TOR; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; World Health Organization, 1992, INT CLASS DIS REL HL	35	346	352	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1137	1147		10.1056/NEJMsa0707719	http://dx.doi.org/10.1056/NEJMsa0707719			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18272886				2022-12-28	WOS:000253877200007
J	Pollock, AM; Godden, S				Pollock, Allyson M.; Godden, Sylvia			Independent sector treatment centres: evidence so far	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pollock, Allyson M.; Godden, Sylvia] Univ Edinburgh, Ctr Int Publ Hlth, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Pollock, AM (corresponding author), Univ Edinburgh, Ctr Int Publ Hlth, Edinburgh EH8 9AG, Midlothian, Scotland.	allyson.pollock@ed.ac.uk		pollock, allyson/0000-0002-7388-3110				BOSELY S, 2006, GUARDIAN        0310; CARVEL J, 2007, GUARDIAN        0705; *DEP HLTH, ISTC MAN IND SECT TR; *DEP HLTH, 2007, RESP FREED INF REQ S; *DEP HLTH, 2007, FREED INF RESP S PLA; *DEP HLTH COMM DIR, 2004, IS TC MARK SUST AN; Department of Health, 2002, GROW CAP NEW ROL EXT; Department of Health, 2007, JOHNS OUTL NEW MEAS; Healthcare Commission, 2007, IND SECT TREATM CTR; *INF CTR HLTH SOC, 2006, RESP FREED INF REQ; *ISTC, 2007, HEALTHCARE MARKE JUL; *NAT CTR HLTH OUTC, PREL OV REP SCHEM GS; NEWMAN M, 2007, HOSP DOCTOR     0101; *NHS EMPL, ISTC PROGR PHAS 2 HU; *NHS LIT AUTH, 2006, IND SECT TREATM CTR; Oliver A, 2007, HEALTH ECON POLICY L, V2, P93, DOI 10.1017/S1744133106006220; The Information Centre; Hospital Episode Statistics, 2006, OUTP DAT QUAL REP 20; TIMMINS N, 2007, FINANCIAL TIMES 0104; TIMMINS N, 2007, FINANCIAL TIMES 0704; 2007, HEALTHCARE MARKE JUL	20	30	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					421	424		10.1136/bmj.39470.505556.80	http://dx.doi.org/10.1136/bmj.39470.505556.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292168	Green Published, Green Submitted			2022-12-28	WOS:000253664000036
J	Blustein, J				Blustein, Jan			Who is accountable for racial equity in health care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PAY-FOR-PERFORMANCE; QUALITY-OF-CARE; INFORMATION-TECHNOLOGY; DISPARITIES; HOSPITALS; MEDICAID; CENTERS; IMPROVEMENT; PHYSICIANS		[Blustein, Jan] NYU, Wagner Grad Sch, New York, NY 10012 USA; [Blustein, Jan] NYU, Sch Med, Dept Med, Div Gen Internal Med, New York, NY USA	New York University; New York University	Blustein, J (corresponding author), NYU, Wagner Grad Sch, 295 Lafayette St, New York, NY 10012 USA.	jan.blustein@wagner.nyu.edu						Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bazzoli GJ, 2007, MED CARE RES REV, V64, P148, DOI 10.1177/1077558706298289; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Browne R, 2006, STRATEGIES ALIGN PER; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Felt-Lisk S, 2007, HEALTH AFFAIR, V26, pW516, DOI 10.1377/hlthaff.26.4.w516; Fiscella K, 2006, HEALTH AFFAIR, V25, P405, DOI 10.1377/hlthaff.25.2.405; Goldman LE, 2007, MED CARE, V45, P579, DOI 10.1097/MLR.0b013e318041f723; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; JOLLIFFE D, 2004, RURAL POVERTY GLANCE; Lewin ME, 2000, AM HLTH CARE SAFETY; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; *NAPH, 2006, COR PRINC HLTH INF T; Perloff JD, 1997, MED CARE, V35, P142, DOI 10.1097/00005650-199702000-00005; Rosenblatt RA, 2006, JAMA-J AM MED ASSOC, V295, P1042, DOI 10.1001/jama.295.9.1042; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Shields AE, 2007, HEALTH AFFAIR, V26, P1373, DOI 10.1377/hlthaff.26.5.1373; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; ZAMAN O, AM PUBLIC HOSP HLTH; 2006, SAFETY NET HOSP SHOU	25	32	32	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					814	816		10.1001/jama.299.7.814	http://dx.doi.org/10.1001/jama.299.7.814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285593				2022-12-28	WOS:000253226900024
J	Pannu, N; Klarenbach, S; Wiebe, N; Manns, B; Tonelli, M				Pannu, Neesh; Klarenbach, Scott; Wiebe, Natasha; Manns, Braden; Tonelli, Marcello		Alberta Kidney Dis Network	Renal replacement therapy in patients with acute renal failure - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; INTENSIVE-CARE UNITS; INTERMITTENT HEMODIALYSIS; GLOMERULAR-FILTRATION; METHODOLOGICAL QUALITY; CONTINUOUS DIALYSIS; HOSPITAL MORTALITY; PROGNOSTIC-FACTORS	Context Acute renal failure requiring dialytic support is associated with a high risk of mortality and substantial morbidity. Objectives To summarize current evidence guiding provision of dialysis for patients with acute renal failure, to make recommendations for management, and to identify areas in which additional research is needed. Data Sources Systematic searches of peer- reviewed publications in MEDLINE, EMBASE, and All EBM Reviews through October 2007. Study Selection Randomized controlled trials ( RCTs) and prospective cohort studies studying dialytic support in adults with acute renal failure that reported the incidence of clinical outcomes such as mortality, length of stay, need for chronic dialysis, or development of hypotension. Data Extraction Quality was independently assessed by 2 reviewers using the Jadad score ( RCTs) and the Downs and Black checklist ( cohort studies). A single reviewer extracted data, which were independently verified by a second reviewer. Results of RCTs were pooled using a random- effects model. Data Synthesis From 173 retrieved articles, 30 RCTs and 8 prospective cohort studies were eligible. No conclusions could be drawn about optimal indications for or timing of renal replacement. Available data comparing continuous renal replacement therapy ( CRRT) with intermittent hemodialysis demonstrated no clinically relevant difference between modalities, including for all- cause mortality ( relative risk [ RR], 1.10; 95% confidence interval [ CI], 0.99- 1.23; I-2= 0%) or for the requirement for chronic dialysis treatment in survivors ( RR, 0.91; 95% CI, 0.56- 1.49; I-2= 0%). For patients treated with CRRT, limited data suggest that bicarbonate may be preferable to other forms of dialysate alkali and that citrate infusion may be an alternative to systemic anticoagulation in patients at high risk of bleeding. Among patients treated with continuous venovenous hemofiltration ( CVVHF), the risk of death was lower at doses of 35 mL/ kg per hour ( RR of death compared with doses of 20 mL/ kg per hour, 0.74; 95% CI, 0.63- 0.88). The use of unsubstituted cellulosic membranes should be avoided in intermittent hemodialysis ( RR of death compared with biocompatible membranes, 1.23; 95% CI, 1.01- 1.50). Conclusions Based on current data, intermittent hemodialysis and CRRT appear to lead to similar clinical outcomes for patients with ARF. If CVVHF is used, a dose of 35 mL/ kg per hour should be provided. Given the paucity of good- quality evidence in this important area, additional large randomized trials are needed to evaluate clinically important outcomes.	[Pannu, Neesh; Klarenbach, Scott; Wiebe, Natasha; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB T6B 2B7, Canada; [Pannu, Neesh; Tonelli, Marcello] Univ Alberta, Div Crit Care Med, Edmonton, AB T6B 2B7, Canada; [Manns, Braden] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6B 2B7, Canada; [Klarenbach, Scott; Manns, Braden; Tonelli, Marcello] Inst Hlth Econ, Edmonton, AB, Canada; [Manns, Braden] Univ Calgary, Dept Med, Div Nephrol, Calgary, AB, Canada; [Manns, Braden] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Calgary	Tonelli, M (corresponding author), Univ Alberta, Dept Med, 7-129 Clin Sci Bldg,8440 112, Edmonton, AB T6B 2B7, Canada.		Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009; Manns, Braden J/I-8942-2012	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; 				Albright RC, 2000, MAYO CLIN PROC, V75, P1141, DOI 10.4065/75.11.1141; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Andreev E, 1999, J INTERN MED, V246, P247, DOI 10.1046/j.1365-2796.1999.00515.x; *ANZICS CLIN TRIAL, RENAL STUD; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Barenbrock M, 2000, KIDNEY INT, V58, P1751, DOI 10.1046/j.1523-1755.2000.00336.x; Barletta JF, 2006, PEDIATR NEPHROL, V21, P842, DOI 10.1007/s00467-006-0049-y; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Brause M, 2003, CRIT CARE MED, V31, P841, DOI 10.1097/01.CCM.0000054866.45509.D0; Bret M, 1998, RENAL FAILURE, V20, P493, DOI 10.3109/08860229809045138; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Clark WR, 2004, CONTRIB NEPHROL, V144, P264; CONGER JD, 1975, J TRAUMA, V15, P1056, DOI 10.1097/00005373-197512000-00003; DAVENPORT A, 1993, KIDNEY INT, V43, pS245; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Favre H, 1996, SEMIN DIALYSIS, V9, P112, DOI 10.1111/j.1525-139X.1996.tb00637.x; FEEST TG, 1993, BMJ-BRIT MED J, V306, P481, DOI 10.1136/bmj.306.6876.481; Gasparovic V, 2003, RENAL FAILURE, V25, P855, DOI 10.1081/JDI-120024300; Gastaldello K, 2000, NEPHROL DIAL TRANSPL, V15, P224, DOI 10.1093/ndt/15.2.224; Gettings LG, 1999, INTENS CARE MED, V25, P805, DOI 10.1007/s001340050956; GILLUM DM, 1986, CLIN NEPHROL, V25, P249; Guerin C, 2002, INTENS CARE MED, V28, P1411, DOI 10.1007/s00134-002-1433-0; HAKIM RM, 1994, NEW ENGL J MED, V331, P1338, DOI 10.1056/NEJM199411173312003; Hein OV, 2004, RENAL FAILURE, V26, P297, DOI 10.1081/JDI-120039529; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P153; Herget-Rosenthal S, 2005, CLIN NEPHROL, V64, P41; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Himmelfarb J, 1998, J AM SOC NEPHROL, V9, P257; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2007, CURR OPIN NEPHROL HY, V16, P221, DOI 10.1097/MNH.0b013e3280895ad9; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; John S, 2001, NEPHROL DIAL TRANSPL, V16, P320, DOI 10.1093/ndt/16.2.320; Jones CH, 1998, ARTIF ORGANS, V22, P638, DOI 10.1046/j.1525-1594.1998.06165.x; Jorres A, 1999, LANCET, V354, P1337, DOI 10.1016/S0140-6736(99)01213-1; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; Kielstein JT, 2004, AM J KIDNEY DIS, V43, P342, DOI 10.1053/j.ajkd.2003.10.021; KIHARA M, 1994, NEPHRON, V67, P36, DOI 10.1159/000187885; Kumar VA, 2004, INT J ARTIF ORGANS, V27, P371, DOI 10.1177/039139880402700505; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; KURTAL H, 1995, ARTIF ORGANS, V19, P391, DOI 10.1111/j.1525-1594.1995.tb02347.x; Kutsogiannis DJ, 2005, KIDNEY INT, V67, P2361, DOI 10.1111/j.1523-1755.2005.00342.x; Levraut J, 1997, CRIT CARE MED, V25, P58, DOI 10.1097/00003246-199701000-00013; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morgera S, 1997, RENAL FAILURE, V19, P155, DOI 10.3109/08860229709026270; Morgera S, 2006, CRIT CARE MED, V34, P2099, DOI 10.1097/01.CCM.0000229147.50592.F9; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; Noble JSC, 2006, RENAL FAILURE, V28, P323, DOI 10.1080/08860220600591487; Ostermann ME, 2005, INTENS CARE MED, V31, P250, DOI 10.1007/s00134-004-2523-y; Palevsky PM, 2005, CLIN TRIALS, V2, P423, DOI 10.1191/1740774505cn116oa; Pannu Neesh, 2005, Ther Clin Risk Manag, V1, P141, DOI 10.2147/tcrm.1.2.141.62908; Pettila V, 2001, CLIN NEPHROL, V56, P324; Ponikvar JB, 2001, ARTIF ORGANS, V25, P946, DOI 10.1046/j.1525-1594.2001.06753.x; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Ronco C, 2006, CRIT CARE, V10, DOI 10.1186/cc4843; Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SCHIFFL H, 1994, LANCET, V344, P570, DOI 10.1016/S0140-6736(94)91964-X; SCHRADER J, 1990, T AM SOC ART INT ORG, V36, P28; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; STEFANIDIS I, 1995, CONTRIB NEPHROL, V116, P140; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugahara Souichi, 2004, Hemodial Int, V8, P320, DOI 10.1111/j.1492-7535.2004.80404.x; Swartz RD, 2005, CLIN NEPHROL, V63, P335; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uehlinger DE, 2005, NEPHROL DIAL TRANSPL, V20, P1630, DOI 10.1093/ndt/gfh880; US Renal Data System, 2006, USRDS 2006 ANN DAT R; VANACKER BAC, 1992, LANCET, V340, P1326, DOI 10.1016/0140-6736(92)92502-7; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; WEBB AR, 1995, INTENS CARE MED, V21, P84, DOI 10.1007/BF02425162; Wells M, 1997, S AFR J SURG, V35, P20; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668	87	206	235	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					793	805		10.1001/jama.299.7.793	http://dx.doi.org/10.1001/jama.299.7.793			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285591				2022-12-28	WOS:000253226900022
J	Bell, KJL; Irwig, L; Craig, JC; Macaskill, P				Bell, Katy J. L.; Irwig, Les; Craig, Jonathan C.; Macaskill, Petra			Use of randomised trials to decide when to monitor response to new treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPY		[Bell, Katy J. L.; Irwig, Les; Craig, Jonathan C.; Macaskill, Petra] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Bell, KJL (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.	katyb@health.usyd.edu.au	Craig, Jonathan/E-2813-2013; Bell, Katy/B-9650-2013	Craig, Jonathan/0000-0002-2548-4035; Bell, Katy/0000-0002-0137-3218; Macaskill, Petra/0000-0001-5879-6193				Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; GLASZIOU P, 2007, EVIDENCE BASED MED M, P245; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Sellin L, 2005, J HYPERTENS, V23, P2083, DOI 10.1097/01.hjh.0000186022.74245.01; Senn S, 2001, DRUG INF J, V35, P1479, DOI 10.1177/009286150103500443; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	11	24	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2008	336	7640					361	365		10.1136/bmj.39476.623611.25	http://dx.doi.org/10.1136/bmj.39476.623611.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276713	Green Submitted, Green Published			2022-12-28	WOS:000253550600038
J	Irifune, T; Higo, Y; Inoue, T; Kono, Y; Ohfuji, H; Funakoshi, K				Irifune, T.; Higo, Y.; Inoue, T.; Kono, Y.; Ohfuji, H.; Funakoshi, K.			Sound velocities of majorite garnet and the composition of the mantle transition region	NATURE			English	Article							SEISMIC DISCONTINUITY; SPINEL TRANSITIONS; HIGH-TEMPERATURES; WAVE VELOCITIES; HIGH-PRESSURE; GPA; RINGWOODITE; ELASTICITY; PHASE; CONSTRAINTS	The composition of the mantle transition region, characterized by anomalous seismic- wave velocity and density changes at depths of similar to 400 to 700 km, has remained controversial. Some have proposed that the mantle transition region has an olivine- rich 'pyrolite' composition(1,2), whereas others have inferred that it is characterized by pyroxene- and garnet- rich compositions ('piclogite'), because the sound velocities in pyrolite estimated from laboratory data are substantially higher than those seismologically observed(3-5). Although the velocities of the olivine polymorphs at these pressures ( wadsleyite and ringwoodite) have been well documented, those of majorite ( another significant high- pressure phase in the mantle transition region) with realistic mantle compositions have never been measured. Here we use combined in situ X- ray and ultrasonic measurements under the pressure and temperature conditions of the mantle transition region to show that majorite in a pyrolite composition has sound velocities substantially lower than those of earlier estimates, owing to strong nonlinear decreases at high temperature, particularly for shear- wave velocity. We found that pyrolite yields seismic velocities more consistent with typical seismological models than those of piclogite in the upper to middle parts of the region, except for the potentially larger velocity jumps in pyrolite relative to those observed at a depth of 410 km. In contrast, both of these compositions lead to significantly low shear- wave velocities in the lower part of the region, suggesting possible subadiabatic temperatures or the existence of a layer of harzburgite- rich material supplied by the subducted slabs stagnant at these depths.	[Irifune, T.; Higo, Y.; Inoue, T.; Kono, Y.; Ohfuji, H.] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Higo, Y.; Funakoshi, K.] Japan Synchrotron Res Inst, Hyogo 6795198, Japan	Ehime University; Japan Synchrotron Radiation Research Institute	Irifune, T (corresponding author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	irifune@dpc.ehime-u.ac.jp	Ohfuji, Hiroaki/A-3923-2016	Kono, Yoshio/0000-0001-5916-7524				Agee CB, 1998, REV MINERAL, V37, P165; AKAOGI M, 1989, J GEOPHYS RES-SOLID, V94, P15671, DOI 10.1029/JB094iB11p15671; ANDERSON DL, 1986, NATURE, V320, P321, DOI 10.1038/320321a0; ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; BINA CR, 1987, J GEOPHYS RES-SOLID, V92, P4853, DOI 10.1029/JB092iB06p04853; Cammarano F, 2003, PHYS EARTH PLANET IN, V138, P197, DOI 10.1016/S0031-9201(03)00156-0; DECKER DL, 1971, J APPL PHYS, V42, P3239, DOI 10.1063/1.1660714; DUFFY TS, 1995, NATURE, V378, P170, DOI 10.1038/378170a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Gwanmesia GD, 1998, GEOPHYS RES LETT, V25, P4553, DOI 10.1029/1998GL900189; HIGO Y, IN PRESS PHYS EARTH; Higo Y, 2006, PHYS EARTH PLANET IN, V159, P276, DOI 10.1016/j.pepi.2006.08.004; IRIFUNE T, 1994, NATURE, V370, P131, DOI 10.1038/370131a0; Irifune T, 1998, NATURE, V392, P702, DOI 10.1038/33663; Irifune T, 1987, HIGH PRESSURE RES MI, P221; ITA L, 1992, J GEOPHYS RES, V97, P6849; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Li B., 2004, PHYS EARTH PLANET IN, V98, P79; Li BS, 1998, SCIENCE, V281, P675, DOI 10.1126/science.281.5377.675; Li BS, 2003, AM MINERAL, V88, P1312; Liu J, 2000, PHYS EARTH PLANET IN, V120, P153, DOI 10.1016/S0031-9201(00)00152-7; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; Nishihara Y, 2001, EARTH PLANET SC LETT, V190, P65, DOI 10.1016/S0012-821X(01)00378-8; Ringwood A.E, 1975, COMPOSITION PETROLOG; Sinogeikin S. V, 2002, GEOPHYS RES LETT, V29; Sinogeikin SV, 2003, PHYS EARTH PLANET IN, V136, P41, DOI 10.1016/S0031-9201(03)00022-0; Sinogeikin SV, 2002, EARTH PLANET SC LETT, V203, P549, DOI 10.1016/S0012-821X(02)00851-8; Vacher P, 1998, PHYS EARTH PLANET IN, V106, P275, DOI 10.1016/S0031-9201(98)00076-4	29	109	116	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					814	817		10.1038/nature06551	http://dx.doi.org/10.1038/nature06551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273016				2022-12-28	WOS:000253191400039
J	Kamerow, D				Kamerow, Douglas			What's missing in the US candidates' healthcare proposals - Primary care is nowhere to be seen, either as a problem or a solution	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@yahoo.com		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					305	305		10.1136/bmj.39478.692766.59	http://dx.doi.org/10.1136/bmj.39478.692766.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18258965	Green Published			2022-12-28	WOS:000253437400029
J	Monkhorst, K; Jonkers, I; Rentmeester, E; Grosveld, F; Gribnau, J				Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Grosveld, Frank; Gribnau, Joost			X inactivation counting and choice is a stochastic process: Evidence for involvement of an X-linked activator	CELL			English	Article							CHROMOSOME INACTIVATION; XIST GENE; TSIX; TRANSCRIPTION; EXPRESSION; ANTISENSE; REGION; CELLS; XITE; MICE	Female mammalian cells achieve dosage compensation of X-encoded genes by X chromosome inactivation (XCI). This process is thought to involve X chromosome counting and choice. To explore how this process is initiated, we analyzed XCI in tetraploid XXXX, XXXY, and XXYY embryonic stem cells and found that every X chromosome within a single nucleus has an independent probability to initiate XCI. This finding suggests a stochastic mechanism directing XCI counting and choice. The probability is directly proportional to the X chromosome:ploidy ratio, indicating the presence of an X-encoded activator of XCI, that itself is inactivated by the XCI process. Deletion of a region including Xist, Tsix, and Xite still results in XCI on the remaining wild-type X chromosome in female cells. This result supports a stochastic model in which each X chromosome in a nucleus initiates XCI independently and positions an X-encoded trans-acting XCI-activator outside the deleted region.	[Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Grosveld, Frank; Gribnau, Joost] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Gribnau, Joost] Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Erasmus MC, Dept Cell Biol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl						Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gribnau J, 2005, J CELL BIOL, V168, P365, DOI 10.1083/jcb.200405117; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matveeva NM, 2005, MOL REPROD DEV, V71, P305, DOI 10.1002/mrd.20266; Mlynarczyk-Evans S, 2006, PLOS BIOL, V4, P906, DOI 10.1371/journal.pbio.0040159; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; TAKAGI N, 1993, GENETICA, V88, P107, DOI 10.1007/BF02424467; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; WEBB S, 1992, GENET RES, V59, P205, DOI 10.1017/S0016672300030494; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	39	118	119	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					410	421		10.1016/j.cell.2007.12.036	http://dx.doi.org/10.1016/j.cell.2007.12.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267073	Bronze			2022-12-28	WOS:000253180700016
J	Yang, J; Brown, MS; Liang, G; Grishin, NV; Goldstein, JL				Yang, Jing; Brown, Michael S.; Liang, Guosheng; Grishin, Nick V.; Goldstein, Joseph L.			Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone	CELL			English	Article							FOOD-INTAKE; ACYLATED PEPTIDE; FATTY-ACIDS; BODY-WEIGHT; PROTEIN; SECRETION; OBESTATIN; OBESITY; HUMANS; ESTABLISHMENT	Ghrelin is a 28 amino acid, appetite-stimulating peptide hormone secreted by the food-deprived stomach. Serine-3 of ghrelin is acylated with an eight-carbon fatty acid, octanoate, which is required for its endocrine actions. Here, we identify GOAT ((G) under bar hrelin (O) under bar-(A) under bar cyl (t) under bar ransferase), a polytopic membrane-bound enzyme that attaches octanoate to serine-3 of ghrelin. Analysis of the mouse genome revealed that GOAT belongs to a family of 16 hydrophobic membrane-bound acyltransferases that includes Porcupine, which attaches long-chain fatty acids to Wnt proteins. GOAT is the only member of this family that octanoylates ghrelin when coexpressed in cultured endocrine cell lines with prepro-ghrelin. GOAT activity requires catalytic asparagine and histidine residues that are conserved in this family. Consistent with its function, GOAT mRNA is largely restricted to stomach and intestine, the major ghrelin-secreting tissues. Identification of GOAT will facilitate the search for inhibitors that reduce appetite and diminish obesity in humans.	[Yang, Jing; Brown, Michael S.; Liang, Guosheng; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu	Yang, Jing/D-4039-2009; Yang, Jing/M-2831-2017	Yang, Jing/0000-0002-2048-735X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Gourcerol G, 2007, OBESITY, V15, P2643, DOI 10.1038/oby.2007.316; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kaiya H, 2004, GEN COMP ENDOCR, V138, P50, DOI 10.1016/j.ygcen.2004.05.005; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Karreman C, 1998, BIOTECHNIQUES, V24, P736, DOI 10.2144/98245bm08; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Sambrook J., 2001, MOL CLONING LAB MANU; Small CJ, 2004, TRENDS ENDOCRIN MET, V15, P259, DOI 10.1016/j.tem.2004.06.002; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; WALKER DR, 1997, INTELL SYST MOL BIOL, V5, P333; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zigman JM, 2006, P NATL ACAD SCI USA, V103, P12961, DOI 10.1073/pnas.0605959103; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zorrilla EP, 2006, P NATL ACAD SCI USA, V103, P13226, DOI 10.1073/pnas.0605376103	33	868	901	5	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					387	396		10.1016/j.cell.2008.01.017	http://dx.doi.org/10.1016/j.cell.2008.01.017			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267071	Bronze			2022-12-28	WOS:000253180700014
J	Kuttner, R				Kuttner, Robert			Market-based failure - A second opinion on US health care costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kuttner, Robert] Demos, New York, NY USA		Kuttner, R (corresponding author), Demos, New York, NY USA.							*AM MED GROUP ASS, 2007, 2007 MED GROUP COMP; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; *RW JOHNS FDN, 2003, GOING HLTH INS NEARL; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102	5	33	33	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					549	551		10.1056/NEJMp0800265	http://dx.doi.org/10.1056/NEJMp0800265			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259CJ	18256389				2022-12-28	WOS:000252916400001
J	Padian, K				Padian, Kevin			Darwin's enduring legacy	NATURE			English	Editorial Material									[Padian, Kevin] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Padian, Kevin] Natl Ctr Sci Educ, Oakland, CA USA	University of California System; University of California Berkeley	Padian, K (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.							Browne J., 1996, C DARWIN VOYAGING; DESMOND A, 1991, C DARWIN LIFE TORMEN; Eldredge N., 1972, P82; Ellegard A., 1958, DARWIN GEN READER; PADIAN K, 1997, NATURE, V390, P460; Quammen D., 2006, RELUCTANT MR DARWIN	6	24	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					632	634		10.1038/451632a	http://dx.doi.org/10.1038/451632a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256649	Bronze			2022-12-28	WOS:000252929500019
J	Sareli, AE; Janssen, WJ; Sterman, D; Saint, S; Pyeritz, RE				Sareli, Aharon E.; Janssen, William J.; Sterman, Daniel; Saint, Sanjay; Pyeritz, Reed E.			What's the connection?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EHLERS-DANLOS-SYNDROME; SYNDROME TYPE-IV		[Sareli, Aharon E.; Sterman, Daniel; Pyeritz, Reed E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Janssen, William J.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA; [Saint, Sanjay] Univ Michigan, Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Pennsylvania; National Jewish Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sareli, AE (corresponding author), Hosp Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19141 USA.	aharon.sareli@uphs.upenn.edu	Saint, Sanjay/AAF-5126-2019	Sterman, Daniel/0000-0003-1249-0804				Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Dowton SB, 1996, CLIN GENET, V50, P510; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Oderich GS, 2005, J VASC SURG, V42, P98, DOI 10.1016/j.jvs.2005.03.053; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin M, 2001, NEW ENGL J MED, V344, P392; Pyeritz RE, 2000, NEW ENGL J MED, V342, P730, DOI 10.1056/NEJM200003093421009; Watanabe A, 2002, EUR RESPIR J, V19, P195, DOI 10.1183/09031936.02.00219202; YOST BA, 1995, CHEST, V107, P1465, DOI 10.1378/chest.107.5.1465	9	10	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					626	632		10.1056/NEJMcps067315	http://dx.doi.org/10.1056/NEJMcps067315			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256398				2022-12-28	WOS:000252916400011
J	Svilaas, T; Vlaar, PJ; van der Horst, IC; Diercks, GFH; de Smet, BJGL; van den Heuvel, AFM; Anthonio, RL; Jessurun, GA; Tan, ES; Suurmeijer, AJH; Zijlstra, F				Svilaas, Tone; Vlaar, Pieter J.; van der Horst, Iwan C.; Diercks, Gilles F. H.; de Smet, Bart J. G. L.; van den Heuvel, Ad F. M.; Anthonio, Rutger L.; Jessurun, Gillian A.; Tan, Eng-Shiong; Suurmeijer, Albert J. H.; Zijlstra, Felix			Thrombus aspiration during primary percutaneous coronary intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT RESOLUTION; PRIMARY ANGIOPLASTY; DISTAL EMBOLIZATION; RHEOLYTIC THROMBECTOMY; THROMBOLYTIC THERAPY; REPERFUSION; REDUCTION; OCCLUSION; RECOVERY	Background: Primary percutaneous coronary intervention (PCI) is effective in opening the infarct-related artery in patients with myocardial infarction with ST-segment elevation. However, the embolization of atherothrombotic debris induces microvascular obstruction and diminishes myocardial reperfusion. Methods: We performed a randomized trial assessing whether manual aspiration was superior to conventional treatment during primary PCI. A total of 1071 patients were randomly assigned to the thrombus-aspiration group or the conventional-PCI group before undergoing coronary angiography. Aspiration was considered to be successful if there was histopathological evidence of atherothrombotic material. We assessed angiographic and electrocardiographic signs of myocardial reperfusion, as well as clinical outcome. The primary end point was a myocardial blush grade of 0 or 1 (defined as absent or minimal myocardial reperfusion, respectively). Results: A myocardial blush grade of 0 or 1 occurred in 17.1% of the patients in the thrombus-aspiration group and in 26.3% of those in the conventional-PCI group (P<0.001). Complete resolution of ST-segment elevation occurred in 56.6% and 44.2% of patients, respectively (P<0.001). The benefit did not show heterogeneity among the baseline levels of the prespecified covariates. At 30 days, the rate of death in patients with a myocardial blush grade of 0 or 1, 2, and 3 was 5.2%, 2.9%, and 1.0%, respectively (P=0.003), and the rate of adverse events was 14.1%, 8.8%, and 4.2%, respectively (P<0.001). Histopathological examination confirmed successful aspiration in 72.9% of patients. Conclusions: Thrombus aspiration is applicable in a large majority of patients with myocardial infarction with ST-segment elevation, and it results in better reperfusion and clinical outcomes than conventional PCI, irrespective of clinical and angiographic characteristics at baseline. (Current Controlled Trials number, ISRCTN16716833.).	[Svilaas, Tone; Vlaar, Pieter J.; van der Horst, Iwan C.; Diercks, Gilles F. H.; de Smet, Bart J. G. L.; van den Heuvel, Ad F. M.; Anthonio, Rutger L.; Jessurun, Gillian A.; Tan, Eng-Shiong; Suurmeijer, Albert J. H.; Zijlstra, Felix] Univ Groningen, Ctr Thorax, Dept Cardiol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands	University of Groningen	Svilaas, T (corresponding author), Univ Groningen, Ctr Thorax, Dept Cardiol, Univ Med Ctr Groningen, Gang LM1-004,POB 30-001, NL-9700 RB Groningen, Netherlands.	fzijlstra@thorax.umcg.nl	Diercks, Gilles/P-7413-2019	Diercks, Gilles/0000-0001-8053-216X; Suurmeijer, Albert/0000-0003-1361-9454				Ali A, 2006, J AM COLL CARDIOL, V48, P244, DOI 10.1016/j.jacc.2006.03.044; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Antoniucci D, 2004, AM J CARDIOL, V93, P1033, DOI 10.1016/j.amjcard.2004.01.011; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; De Luca G, 2006, HEART, V92, P867, DOI 10.1136/hrt.2005.082214; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; FALK E, 1983, BRIT HEART J, V50, P127; Henriques JPS, 2003, AM J CARDIOL, V91, P708, DOI 10.1016/S0002-9149(02)03409-4; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; JORIS I, 1982, EXP MOL PATHOL, V37, P393, DOI 10.1016/0014-4800(82)90051-X; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kotani J, 2002, CIRCULATION, V106, P1672, DOI 10.1161/01.CIR.0000030189.27175.4E; Lefevre T, 2005, J AM COLL CARDIOL, V46, P246, DOI 10.1016/j.jacc.2005.04.031; Limbruno U, 2005, AM HEART J, V150, P102, DOI 10.1016/j.ahj.2005.01.016; MABIN TA, 1985, J AM COLL CARDIOL, V5, P198, DOI 10.1016/S0735-1097(85)80037-1; McLaughlin MG, 2004, J AM COLL CARDIOL, V44, P1215, DOI 10.1016/j.jacc.2004.06.053; Napodano M, 2003, J AM COLL CARDIOL, V42, P1395, DOI 10.1016/S0735-1097(03)01041-6; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Poli A, 2002, CIRCULATION, V106, P313, DOI 10.1161/01.CIR.0000022691.71708.94; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Silva-Orrego P, 2006, J AM COLL CARDIOL, V48, P1552, DOI 10.1016/j.jacc.2006.03.068; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Stone GW, 2002, J AM COLL CARDIOL, V39, P591, DOI 10.1016/S0735-1097(01)01779-X; Svilaas T, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.010; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; Ueda Y, 1996, J AM COLL CARDIOL, V27, P606, DOI 10.1016/0735-1097(95)00534-X; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; vantHof AWJ, 1997, LANCET, V350, P615, DOI 10.1016/S0140-6736(96)07120-6; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	35	781	860	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					557	567		10.1056/NEJMoa0706416	http://dx.doi.org/10.1056/NEJMoa0706416			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256391				2022-12-28	WOS:000252916400003
J	BAUBRON, JC; ALLARD, P; TOUTAIN, JP				BAUBRON, JC; ALLARD, P; TOUTAIN, JP			DIFFUSE VOLCANIC EMISSIONS OF CARBON-DIOXIDE FROM VULCANO-ISLAND, ITALY	NATURE			English	Article									CEA,CNRS,CTR FAIBLES RADIOACT,F-91190 GIF SUR YVETTE,FRANCE; OSSERV VESUVIANO,I-80123 NAPLES,ITALY	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Istituto Nazionale Geofisica e Vulcanologia (INGV)	BAUBRON, JC (corresponding author), BUR RECH GEOL & MINIERES,DT ANA,F-45060 ORLEANS,FRANCE.		ALLARD, Patrick/H-9480-2017	ALLARD, Patrick/0000-0001-7836-3117				ALLARD P, 1989, J VOLCANOL GEOTH RES, V39, P195, DOI 10.1016/0377-0273(89)90058-9; Allard P, 1987, TERRA COGNITA, V7, P407; ALLARD P, 1987, TERRA COGNITA, V7, pG17; ALLARD P, 1978, THESIS U PARIS 7; ALLARD P, 1983, FORECASTING VOLCANIC, P338; AUBERT M, 1988, J VOLCANOL GEOTH RES, V35, P217, DOI 10.1016/0377-0273(88)90018-2; BAUBRON JC, 1987, DTANA21 BUR RECH GEO; BAUBRON JC, IN PRESS J GEOL SOC; BERTRAMI R, 1984, C RC SOC ITAL MINER, V39, P343; CANNATA S, 1988, SOC ITAL MINER PETRO, V43, P153; Carapezza M., 1981, B VOLCANOL, V44, P547, DOI DOI 10.1007/BF02600585; CARBONNELLE J, 1985, B PIRPSEV CNRS, V108; CIONI R, 1984, GEOTHERMICS, V13, P375, DOI 10.1016/0375-6505(84)90051-8; FERRUCCI F, 1989, GEOPHYS RES LETT, V16, P1317, DOI 10.1029/GL016i011p01317; HOOKER PJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2505, DOI 10.1016/0016-7037(85)90118-8; Keller J., 1980, REND SOC ITAL MINERA, V36, P369; MARTINI M, 1986, GEOTHERMICS, V15, P205, DOI 10.1016/0375-6505(86)90127-6; MAZOR E, 1988, B VOLCANOL, V50, P71, DOI 10.1007/BF01275170; POLYAK BG, 1979, DOKL AKAD NAUK SSSR, V247, P1220; SANO Y, 1989, GEOPHYS RES LETT, V16, P511, DOI 10.1029/GL016i006p00511; Sicardi L., 1940, B VOLCANOL, V7, P85, DOI [DOI 10.1007/BF02994895, 10.1007/BF02994895]; TEDESCO D, 1988, SCI EVENT ALERT NETW, V13, P10	22	174	176	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					51	53		10.1038/344051a0	http://dx.doi.org/10.1038/344051a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278024				2022-12-28	WOS:A1990CQ97200056
J	Gavriil, FP; Gonzalez, ME; Gotthelf, EV; Kaspi, VM; Livingstone, MA; Woods, PM				Gavriil, F. P.; Gonzalez, M. E.; Gotthelf, E. V.; Kaspi, V. M.; Livingstone, M. A.; Woods, P. M.			Magnetar-like emission from the young pulsar in Kes 75	SCIENCE			English	Article							X-RAY PULSAR; SOFT GAMMA-REPEATERS; TRANSIENT MAGNETAR; XTE J1810-197; RADIO PULSARS; NEUTRON-STARS; SPIN-DOWN; BURSTS; FIELD; 1E-1048.1-5937	We report the detection of magnetar- like x- ray bursts from the young pulsar PSR J1846- 0258, at the center of the supernova remnant Kes 75. This pulsar, long thought to be exclusively rotation- powered, has an inferred surface dipolar magnetic field of 4.9 x 10(13) gauss, which is higher than those of the vast majority of rotation- powered pulsars, but lower than those of the approximately 12 previously identified magnetars. The bursts were accompanied by a sudden flux increase and an unprecedented change in timing behavior. These phenomena lower the magnetic and rotational thresholds associated with magnetar- like behavior and suggest that in neutron stars there exists a continuum of magnetic activity that increases with inferred magnetic field strength.	[Gavriil, F. P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Gavriil, F. P.] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA; [Gonzalez, M. E.; Kaspi, V. M.; Livingstone, M. A.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Gotthelf, E. V.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Kaspi, V. M.; Woods, P. M.] Dynetics, Huntsville, AL 35806 USA; [Woods, P. M.] Natl Space Sci & Technol Ctr, Huntsville, AL 35805 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; McGill University; Columbia University	Gavriil, FP (corresponding author), NASA, Goddard Space Flight Ctr, Code 662, Greenbelt, MD 20771 USA.	fotis.p.gavriil@nasa.gov		Gotthelf, Eric/0000-0003-3847-3957				Beloborodov AM, 2007, ASTROPHYS J, V657, P967, DOI 10.1086/508917; Camilo F, 2007, ASTROPHYS J, V666, pL93, DOI 10.1086/521826; Camilo F, 2006, NATURE, V442, P892, DOI 10.1038/nature04986; Dib R, 2007, ASTROPHYS J, V666, P1152, DOI 10.1086/519726; Ferrario L, 2006, MON NOT R ASTRON SOC, V367, P1323, DOI 10.1111/j.1365-2966.2006.10058.x; Gavriil FP, 2006, ASTROPHYS J, V641, P418, DOI 10.1086/499094; Gavriil FP, 2004, ASTROPHYS J, V609, pL67, DOI 10.1086/422751; Gavriil FP, 2004, ASTROPHYS J, V607, P959, DOI 10.1086/383564; Gavriil FP, 2002, NATURE, V419, P142, DOI 10.1038/nature01011; Gogus E, 2001, ASTROPHYS J, V558, P228, DOI 10.1086/322463; Gonzalez ME, 2005, ASTROPHYS J, V630, P489, DOI 10.1086/432032; Gotthelf EV, 2000, ASTROPHYS J, V542, pL37, DOI 10.1086/312923; Harding AK, 1999, ASTROPHYS J, V525, pL125, DOI 10.1086/312339; Helfand DJ, 2003, ASTROPHYS J, V582, P783, DOI 10.1086/344725; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Ibrahim AI, 2004, ASTROPHYS J, V609, pL21, DOI 10.1086/422636; Kaspi VM, 2005, ASTROPHYS J, V618, pL41, DOI 10.1086/427628; Kaspi VM, 1996, ASTRON J, V111, P2028, DOI 10.1086/117938; Kaspi VM, 2003, ASTROPHYS J, V588, pL93, DOI 10.1086/375683; Leahy DA, 2008, ASTRON ASTROPHYS, V480, pL25, DOI 10.1051/0004-6361:20079149; Livingstone MA, 2006, ASTROPHYS J, V647, P1286, DOI 10.1086/505570; LYNE AG, 2004, IAU S, V218, P257; NG CY, 2008, 10 M HIGH EN ASTR DI; THOMPSON C, 1993, ASTROPHYS J, V408, P194, DOI 10.1086/172580; Thompson C, 2002, ASTROPHYS J, V574, P332, DOI 10.1086/340586; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Woods PM, 2004, ASTROPHYS J, V605, P378, DOI 10.1086/382233; Woods PM, 2005, ASTROPHYS J, V629, P985, DOI 10.1086/431476; WOODS PM, 2006, COMPACT STELLAR XRAY, P547, DOI DOI 10.1017/CBO9780511536281	30	188	191	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1802	1805		10.1126/science.1153465	http://dx.doi.org/10.1126/science.1153465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18292305	Green Submitted			2022-12-28	WOS:000254394000040
J	Baily, MA				Baily, Mary Ann			Harming through protection?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE; QUALITY; ETHICS		[Baily, Mary Ann] Hastings Ctr, Garrison, NY USA		Baily, MA (corresponding author), Hastings Ctr, Garrison, NY USA.							Baily MA, 2006, HASTINGS CENT REP, V36, pS1, DOI 10.1353/hcr.2006.0054; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; *US DEP HHS, OHRP STAT REG NEW YO; US Department of Health and Human Services, 2004, HUM SUBJ REG DEC CHA	5	53	53	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					768	769		10.1056/NEJMp0800372	http://dx.doi.org/10.1056/NEJMp0800372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287599				2022-12-28	WOS:000253257700002
J	Yang, XY; Ongusaha, PP; Miles, PD; Havstad, JC; Zhang, FX; So, WV; Kudlow, JE; Michell, RH; Olefsky, JM; Field, SJ; Evans, RM				Yang, Xiaoyong; Ongusaha, Pat P.; Miles, Philip D.; Havstad, Joyce C.; Zhang, Fengxue; So, W. Venus; Kudlow, Jeffrey E.; Michell, Robert H.; Olefsky, Jerrold M.; Field, Seth J.; Evans, Ronald M.			Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance	NATURE			English	Article							N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC GLYCOSYLATION; CYTOSOLIC PROTEINS; ACTIVATION; MUSCLE; NUCLEAR; GLUCOSE; IDENTIFICATION; GLCNACYLATION; PHOSPHATASES	Glucose flux through the hexosamine biosynthetic pathway leads to the post-translational modification of cytoplasmic and nuclear proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc). This tandem system serves as a nutrient sensor to couple systemic metabolic status to cellular regulation of signal transduction, transcription, and protein degradation. Here we show that O-GlcNAc transferase (OGT) harbours a previously unrecognized type of phosphoinositide-binding domain. After induction with insulin, phosphatidylinositol 3,4,5-trisphosphate recruits OGT from the nucleus to the plasma membrane, where the enzyme catalyses dynamic modification of the insulin signalling pathway by O-GlcNAc. This results in the alteration in phosphorylation of key signalling molecules and the attenuation of insulin signal transduction. Hepatic overexpression of OGT impairs the expression of insulin-responsive genes and causes insulin resistance and dyslipidaemia. These findings identify a molecular mechanism by which nutritional cues regulate insulin signalling through O-GlcNAc, and underscore the contribution of this modification to the aetiology of insulin resistance and type 2 diabetes.	[Yang, Xiaoyong; Havstad, Joyce C.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Yang, Xiaoyong; Havstad, Joyce C.; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Ongusaha, Pat P.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Ongusaha, Pat P.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Miles, Philip D.; Olefsky, Jerrold M.; Field, Seth J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zhang, Fengxue; Kudlow, Jeffrey E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [So, W. Venus] Hoffmann La Roche Inc, Roche Grp Res Informat, Nutley, NJ 07110 USA; [Michell, Robert H.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; Roche Holding; University of Birmingham	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Michell, Robert H/AAT-4974-2020; Evans, Ronald/AAF-4001-2019	Michell, Robert H/0000-0001-9422-9858; Evans, Ronald/0000-0002-9986-5965; Field, Seth/0000-0002-8893-4806	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA014195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Joost HG, 2000, METH MOL B, V155, P77; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Roos MD, 1998, P ASSOC AM PHYSICIAN, V110, P422; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	50	422	439	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					964	U1		10.1038/nature06668	http://dx.doi.org/10.1038/nature06668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288188				2022-12-28	WOS:000253313100042
J	Korf, B				Korf, Bruce			Focus on research: Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Korf, Bruce] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Korf, B (corresponding author), Univ Alabama, Dept Genet, Birmingham, AL 35294 USA.		Korf, Bruce R/H-4882-2012					Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	5	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					552	555		10.1056/NEJMp0800071	http://dx.doi.org/10.1056/NEJMp0800071			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256390				2022-12-28	WOS:000252916400002
J	Angell, CA				Angell, C. Austen			Insights into phases of liquid water from study of its unusual glass-forming properties	SCIENCE			English	Review							SUPERCOOLED WATER; HEAT-CAPACITY; DIELECTRIC-RELAXATION; 1ST-ORDER TRANSITION; ENERGY LANDSCAPES; AMORPHOUS WATER; SELF-DIFFUSION; NUCLEATION; DYNAMICS; BEHAVIOR	The vitrification of pure water is compared with that of molecular solutions rich in water, and gross differences are noted. Thermodynamic reasoning and direct observations on noncrystallizing nanoconfined water indicate that the glass transition in ambient- pressure water is qualitatively distinct from that found in the usual molecular liquids. It belongs instead to the order- disorder class of transition seen in molecular and ionic crystalline materials. The distinctive "folding funnel" energy landscape for this type of system explains the extreme weakness of the glass transition of water as well as the consequent confusion that has characterized its scientific history; it also explains the very small excess entropy at the glass transition temperature. The relation of confined water behavior to that of bulk is discussed, and the "fragile- to- strong" transition for supercooled water is interpreted by adding a "critical point - free" scenario to the two competing scenarios for understanding supercooled bulk water.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Angell, CA (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	caa@asu.edu						ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Angell A, 2007, NAT NANOTECHNOL, V2, P396, DOI 10.1038/nnano.2007.201; ANGELL CA, 1993, J PHYS CHEM-US, V97, P6339, DOI 10.1021/j100126a005; Angell CA, 2005, PHILOS T R SOC A, V363, P415, DOI 10.1098/rsta.2004.1500; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; Angell CA, 2003, J PHYS-CONDENS MAT, V15, pS1051, DOI 10.1088/0953-8984/15/11/327; Angell CA, 1996, J NON-CRYST SOLIDS, V207, P463, DOI 10.1016/S0022-3093(96)00261-X; Angell CA, 2002, CHEM REV, V102, P2627, DOI 10.1021/cr000689q; Angell CA, 2002, J THERM ANAL CALORIM, V69, P785, DOI 10.1023/A:1020691519283; ANGELL CA, 1983, ANNU REV PHYS CHEM, V34, P593, DOI 10.1146/annurev.pc.34.100183.003113; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Angell CA, 2000, METALL MATER TRANS B, V31, P587, DOI 10.1007/s11663-000-0095-y; ANGELL CA, 2007, B MAT RES SOC; Bhat MH, 2007, NATURE, V448, P787, DOI 10.1038/nature06044; Biroli G, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1955527; Brovchenko I, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734963; Burton EF, 1935, NATURE, V135, P505, DOI 10.1038/135505b0; Chandler D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1955528; Chonde M, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338524; CORNISH BD, 1984, J PHYS CHEM-US, V88, P1888, DOI 10.1021/j150653a043; Debenedetti PG, 2003, J PHYS CHEM B, V107, P14434, DOI 10.1021/jp030885b; Debenedetti PG, 2003, J PHYS-CONDENS MAT, V15, pR1669, DOI 10.1088/0953-8984/15/45/R01; Dyre JC, 2006, REV MOD PHYS, V78, P953, DOI 10.1103/RevModPhys.78.953; Faraone A, 2004, J CHEM PHYS, V121, P10843, DOI 10.1063/1.1832595; Fleissner G, 1998, J PHYS CHEM B, V102, P6239, DOI 10.1021/jp981779q; Franzese G, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011103; Franzese G, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205126; Fuentevilla DA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.195702; Garrahan JP, 2003, P NATL ACAD SCI USA, V100, P9710, DOI 10.1073/pnas.1233719100; Giovambattista N, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.047801; HAGEN MHJ, 1993, NATURE, V365, P425, DOI 10.1038/365425a0; HALLBRUCKER A, 1989, J PHYS CHEM-US, V93, P4986, DOI 10.1021/j100349a061; HANDA YP, 1988, J PHYS CHEM-US, V92, P3323, DOI 10.1021/j100323a005; HINDMAN JC, 1974, J CHEM PHYS, V60, P4488, DOI 10.1063/1.1680928; HOFER K, 1991, J PHYS CHEM-US, V95, P7100, DOI 10.1021/j100171a071; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; Johari GP, 1997, J CHEM PHYS, V107, P10154, DOI 10.1063/1.475322; KAY BD, 2005, AM CHEM SOC 2, P229; Kim YJ, 2004, J PHYS CHEM A, V108, P4365, DOI 10.1021/jp037030j; Kivelson D, 2001, J PHYS CHEM B, V105, P6620, DOI 10.1021/jp010104b; Kohl I, 2005, NATURE, V435, pE1, DOI 10.1038/nature03707; LANG EW, 1982, ANGEW CHEM INT EDIT, V21, P315, DOI 10.1002/anie.198203153; Liu L, 2004, J PHYS-CONDENS MAT, V16, pS5403, DOI 10.1088/0953-8984/16/45/007; MACFARLANE DR, 1984, J PHYS CHEM-US, V88, P759, DOI 10.1021/j150648a029; Mallamace F, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2193159; Maruyama S, 2004, AIP CONF PROC, V708, P675, DOI 10.1063/1.1764256; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; MATSUO T, 1992, SOLID STATE COMMUN, V83, P711, DOI 10.1016/0038-1098(92)90149-4; Matyushov DV, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2538712; Matyushov DV, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949211; MAYER E, 1985, J APPL PHYS, V58, P663, DOI 10.1063/1.336179; McClure SM, 2006, J PHYS CHEM B, V110, P11033, DOI 10.1021/jp0623286; Minoguchi A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.215703; Mishima O, 2004, J CHEM PHYS, V121, P3161, DOI 10.1063/1.1774151; MISHIMA O, 1994, J CHEM PHYS, V100, P5910, DOI 10.1063/1.467103; Mizuno F, 2006, J NON-CRYST SOLIDS, V352, P5147, DOI 10.1016/j.jnoncrysol.2006.06.006; Mondal P, 1996, Z PHYS B CON MAT, V99, P527, DOI 10.1007/s002570050072; Moynihan CT, 1997, MAT RES S C, V455, P411, DOI 10.1557/PROC-455-411; OGUNI M, 1980, J CHEM PHYS, V73, P1948, DOI 10.1063/1.440303; Oguni M, 2007, CHEM-ASIAN J, V2, P514, DOI 10.1002/asia.200600362; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Price WS, 1999, J PHYS CHEM A, V103, P448, DOI 10.1021/jp9839044; PRYDE JA, 1952, NATURE, V170, P685, DOI 10.1038/170685a0; RASMUSSEN DH, 1973, SCIENCE, V181, P342, DOI 10.1126/science.181.4097.342; Rault J, 2003, EUR PHYS J B, V36, P627, DOI 10.1140/epjb/e2004-00017-1; Sastry S, 2003, NAT MATER, V2, P739, DOI 10.1038/nmat994; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Sciortino F, 1997, PHYS REV E, V55, P727, DOI 10.1103/PhysRevE.55.727; Smith RS, 1999, NATURE, V398, P788, DOI 10.1038/19725; Speedy RJ, 1996, J CHEM PHYS, V105, P240, DOI 10.1063/1.471869; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; Stanley HE, 1997, PHYSICA A, V236, P19, DOI 10.1016/S0378-4371(96)00429-3; STANLEY HE, 2005, PHYS TODAY; Starr FW, 2003, PHYSICA A, V323, P51, DOI 10.1016/S0378-4371(03)00012-8; STICKEL F, 1995, J CHEM PHYS, V102, P6251, DOI 10.1063/1.469071; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Swenson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.247802; Tanaka H, 1999, J CHEM PHYS, V111, P3175, DOI 10.1063/1.479597; Tanaka H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.055701; Tanaka H, 2000, PHYS REV E, V62, P6968, DOI 10.1103/PhysRevE.62.6968; Tombari E, 1999, CHEM PHYS LETT, V300, P749, DOI 10.1016/S0009-2614(98)01392-X; Velikov V, 2001, SCIENCE, V294, P2335, DOI 10.1126/science.1061757; Wang LM, 2007, J NON-CRYST SOLIDS, V353, P3829, DOI 10.1016/j.jnoncrysol.2007.04.041; WHALLEY E, 1989, NATURE, V342, P782, DOI 10.1038/342782a0; WOLYNES PG, 1995, SCIENCE, V268, P960, DOI 10.1126/science.268.5213.960; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990; Xu LM, 2005, P NATL ACAD SCI USA, V102, P16558, DOI 10.1073/pnas.0507870102; Yue YZ, 2004, NATURE, V427, P717, DOI 10.1038/nature02295; Zheng Q, 2002, NATO SCI SER II-MATH, V84, P33; ZHENG Q, 1991, SCIENCE, V254, P829, DOI 10.1126/science.254.5033.829	91	431	439	1	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					582	587		10.1126/science.1131939	http://dx.doi.org/10.1126/science.1131939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239117				2022-12-28	WOS:000252772000030
J	Atkinson, QD; Meade, A; Venditti, C; Greenhill, SJ; Pagel, M				Atkinson, Quentin D.; Meade, Andrew; Venditti, Chris; Greenhill, Simon J.; Pagel, Mark			Languages evolve in punctuational bursts	SCIENCE			English	Article							SPECIATION; PHYLOGENY; EVOLUTION		[Atkinson, Quentin D.; Meade, Andrew; Venditti, Chris; Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6AS, Berks, England; [Greenhill, Simon J.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Pagel, Mark] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Reading; University of Auckland; The Santa Fe Institute	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AS, Berks, England.	m.pagel@reading.ac.uk	Greenhill, Simon/I-3554-2019; Greenhill, Simon J/B-3114-2011; Greenhill, Simon/A-9555-2010	Greenhill, Simon/0000-0001-7832-6156; Greenhill, Simon J/0000-0001-7832-6156; Atkinson, Quentin/0000-0002-8499-7535	Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		CHAMBERS Jack, 1995, SOCIOLINGUISTIC THEO; Dixon R.M.W., 1997, RISE FALL LANGUAGES; Eldredge N., 1972, P82; Joseph Brian D., 2003, HDB HIST LINGUISTICS, P3; KIRCH PV, 1987, CURR ANTHROPOL, V28, P431, DOI 10.1086/203547; Labov W., 1994, LANGUAGE; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202; Webster Noah, 1789, DISSERTATIONS ENGLIS, P20	10	141	143	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					588	588		10.1126/science.1149683	http://dx.doi.org/10.1126/science.1149683			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239118	Green Submitted			2022-12-28	WOS:000252772000031
J	Fakhraai, Z; Forrest, JA				Fakhraai, Z.; Forrest, J. A.			Measuring the surface dynamics of glassy polymers	SCIENCE			English	Article							TRANSITION TEMPERATURES; FORCE MICROSCOPY; THIN-FILMS; POLYSTYRENE; RELAXATIONS; LAYER; FLOW	The motion of polymer chain segments cooled below the glass transition temperature slows markedly; with sufficient cooling, segmental motion becomes completely arrested. There is debate as to whether the chain segments near the free surface, or in thin films, are affected in the same way as the bulk material. By partially embedding and then removing gold nanospheres, we produced a high surface coverage of well- defined nanodeformations on a polystyrene surface; to probe the surface dynamics, we measured the time- dependent relaxation of these surface deformations as a function of temperature from 277 to 369 kelvin. Surface relaxation was observed at all temperatures, providing strong direct evidence for enhanced surface mobility relative to the bulk. The deviation from bulk a relaxation became more pronounced as the temperature was decreased below the bulk glass transition temperature. The temperature dependence of the relaxation time was much weaker than that of the bulk a relaxation of polystyrene, and the process exhibited no discernible temperature dependence between 277 and 307 kelvin.	[Forrest, J. A.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Guelph Waterloo Phys Inst, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Guelph; University of Waterloo; Guelph - Waterloo Physics Institute	Forrest, JA (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	jforrest@uwaterloo.ca						[Anonymous], 1980, VISCOELASTIC PROPERT; Buck E, 2004, MACROMOLECULES, V37, P8647, DOI 10.1021/ma049595z; CAVAILLE JY, 1987, J POLYM SCI POL PHYS, V25, P1235, DOI 10.1002/polb.1987.090250605; Christensen R.M., 1971, THEORY VISCOELASTICI; DHINOJWALA A, 1994, J CHEM PHYS, V100, P6046, DOI 10.1063/1.467115; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fakhraai Z, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.025701; Forrest JA, 2002, EUR PHYS J E, V8, P261, DOI 10.1140/epje/i2002-10005-5; Gasemjit P, 2006, J POLYM SCI POL PHYS, V44, P3031, DOI 10.1002/polb.20922; Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340; Hammerschmidt JA, 1999, MACROMOLECULES, V32, P3360, DOI 10.1021/ma981966m; Hutcheson SA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.076103; Jean YC, 1997, PHYS REV B, V56, pR8459, DOI 10.1103/PhysRevB.56.R8459; Karapanagiotis I, 2005, MACROMOLECULES, V38, P3420, DOI 10.1021/ma048216z; Kerle T, 2001, MACROMOLECULES, V34, P3484, DOI 10.1021/ma0020335; Liu Y, 1997, MACROMOLECULES, V30, P7768, DOI 10.1021/ma970869a; MEYERS GF, 1992, LANGMUIR, V8, P2330, DOI 10.1021/la00045a042; Papaleo RM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094203; Rudoy VM, 2002, COLLOID J+, V64, P746, DOI 10.1023/A:1021558424276; Schwab AD, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021802; Sharp JS, 2007, EUR PHYS J E, V22, P287, DOI 10.1140/epje/e2007-00035-8; Sharp JS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.235701; Strobl G.R., 1997, PHYS POLYM; Teichroeb JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016104; Turkevich J., 1954, J COLLOID SCI, P26; XIE L, 1995, PHYS REV LETT, V74, P4947, DOI 10.1103/PhysRevLett.74.4947	26	511	516	3	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					600	604		10.1126/science.1151205	http://dx.doi.org/10.1126/science.1151205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239120				2022-12-28	WOS:000252772000035
J	Chen, KM; Harjes, E; Gross, PJ; Fahmy, A; Lu, YJ; Shindo, K; Harris, RS; Matsuo, H				Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Fahmy, Amr; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi			Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G	NATURE			English	Article							3-DIMENSIONAL NMR-SPECTROSCOPY; CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; SEDIMENTATION-VELOCITY; RETROVIRAL INFECTION; HIGH-SENSITIVITY; PROTEIN; RESONANCE; ASSIGNMENT; COMPLEX	The human APOBEC3G ( apolipoprotein B messenger- RNA-editing enzyme, catalytic polypeptide- like 3G) protein is a single-strand DNA deaminase that inhibits the replication of human immunodeficiency virus-1 (HIV-1), other retroviruses and retrotransposons(1-6). APOBEC3G anti- viral activity is circumvented by most retroelements, such as through degradation by HIV-1 Vif(7). APOBEC3G is a member of a family of polynucleotide cytosine deaminases, several of which also target distinct physiological substrates. For instance, APOBEC1 edits APOB mRNA and AID deaminates antibody gene DNA(8-10). Although structures of other family members exist, none of these proteins has elicited polynucleotide cytosine deaminase or anti- viral activity(11-16). Here we report a solution structure of the human APOBEC3G catalytic domain. Five alpha- helices, including two that form the zinc- coordinating active site, are arranged over a hydrophobic platform consisting of five beta-strands. NMR DNA titration experiments, computational modelling, phylogenetic conservation and Escherichia coli- based activity assays combine to suggest a DNA-binding model in which a brim of positively charged residues positions the target cytosine for catalysis. The structure of the APOBEC3G catalytic domain will help us to understand functions of other family members and interactions that occur with pathogenic proteins such as HIV- 1 Vif.	[Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Gross, Phillip J.; Shindo, Keisuke; Harris, Reuben S.] Univ Minnesota, Arnold & Mabel Beckman Ctr Genome Engn, Minneapolis, MN 55455 USA; [Fahmy, Amr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Matsuo, H (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu; matsu029@umn.edu		Harjes, Elena/0000-0002-3643-9432; Shindo, Keisuke/0000-0001-8793-8189; Chen, Kuan-Ming/0000-0003-1715-5319	NIAID NIH HHS [R21 AI073167] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073167] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Devany M, 2004, PROTEIN SCI, V13, P2252, DOI 10.1110/ps.04797104; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GOLDSTEIN RF, 1994, BIOPHYS J, V66, P1335, DOI 10.1016/S0006-3495(94)80923-3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KELLER R, 2004, THESIS SWISS FED I T; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; Matsuo H, 1996, J MAGN RESON SER B, V110, P112, DOI 10.1006/jmrb.1996.0018; Matsuo H, 1996, J MAGN RESON SER B, V113, P91, DOI 10.1006/jmrb.1996.0161; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	53	178	200	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					116	U16		10.1038/nature06638	http://dx.doi.org/10.1038/nature06638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288108				2022-12-28	WOS:000253671900058
J	Marchionni, L; Wilson, RF; Wolff, AC; Marinopoulos, S; Parmigiani, G; Bass, EB; Goodman, SN				Marchionni, Luigi; Wilson, Renee F.; Wolff, Antonio C.; Marinopoulos, Spyridon; Parmigiani, Giovanni; Bass, Eric B.; Goodman, Steven N.			Systematic review: Gene expression profiling assays in early-stage breast cancer	ANNALS OF INTERNAL MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; REPORTING RECOMMENDATIONS; MOLECULAR CLASSIFICATION; PREDICTION; TAMOXIFEN; WOMEN; SIGNATURE; RECEPTOR; RATIO; CHEMOTHERAPY	Background: Three gene expression-based prognostic breast cancer tests have been licensed for use. Purpose: To summarize evidence on the validity and utility of 3 gene expression-based prognostic breast cancer tests: Oncotype DX ( Genomic Health, Redwood City, California), MammaPrint ( Agendia BV, Amsterdam, the Netherlands), and H/ I ( AvariaDX, Carlsbad, California). Data Sources: MEDLINE, EMBASE, and Cochrane databases ( from 1990 through January 2007), Web sites of test manufacturers, and discussion with the manufacturers. Study Selection: Original data studies published in English that addressed prognostic accuracy and discrimination or treatment benefit prediction of any of the 3 tests in women with breast cancer. Data Extraction: Information was extracted about the clinical characteristics of the study population ( particularly clinical and therapeutic homogeneity), tumor characteristics, and whether the marketed test or underlying signature was evaluated. Data Synthesis: The tests are based on distinct gene lists, using 2 different technologies. Overall, the body of evidence showed that this new generation of tests may improve prognostic and therapeutic prediction, but the tests are at different stages of development. Evidence shows that the tests offer clinically relevant, improved risk stratification over standard predictors. Oncotype DX has the strongest evidence, closely followed by MammaPrint and H/ I ( which is still maturing). Limitations: For all tests, the relationship of predicted to observed risk in different populations and their incremental contribution over conventional predictors, optimal implementation, and relevance to patients receiving current therapies need further study. Conclusion: Gene expression technologies show great promise to improve predictions of prognosis and treatment benefit for women with early-stage breast cancer. More information is needed on the extent of improvement in prediction, characteristics of women in whom the tests should be used, and how best to incorporate test results into decision making about breast cancer treatment.	[Marchionni, Luigi; Wilson, Renee F.; Wolff, Antonio C.; Marinopoulos, Spyridon; Parmigiani, Giovanni; Bass, Eric B.; Goodman, Steven N.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Goodman, SN (corresponding author), Johns Hopkins Univ, Sch Med, 550 Bldg,Room 11-03, Baltimore, MD 21205 USA.	sgoodman@jhmi.edu	Marinopoulos, Spyridon/C-4541-2008; Wolff, Antonio C./T-8796-2019; Marchionni, Luigi/S-6774-2017	Wolff, Antonio C./0000-0003-3734-1063; Marchionni, Luigi/0000-0002-7336-8071; Bass, Eric/0000-0001-9106-527X; Goodman, Steven/0000-0002-3872-5723	PHS HHS [290-02-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ach RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-148; Adjuvan! Inc, 2011, ADJ ONL DEC MAK TOOL; Alizadeh AA, 2001, J PATHOL, V195, P41, DOI 10.1002/path.889; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2000, NIH Consens Statement, V17, P1; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bossuyt PM, 2003, LANCET, V361, P71, DOI 10.1016/S0140-6736(03)12122-8; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BRYANT J, 2005, 9 INT ST GALL ONC C; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Carlson Robert W, 2007, J Natl Compr Canc Netw, V5, P246; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4, P971; Carlson RW, 2000, ONCOLOGY-NY, V14, P33; CHANG JC, 2007, BREAST CANC RES 0428; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Goetz MP, 2007, NEW ENGL J MED, V356, P752; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Jansen MPHM, 2007, J CLIN ONCOL, V25, P662, DOI 10.1200/JCO.2006.07.3676; Jerevall PL, 2008, BREAST CANCER RES TR, V107, P225, DOI 10.1007/s10549-007-9541-8; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mina L, 2007, BREAST CANCER RES TR, V103, P197, DOI 10.1007/s10549-006-9366-x; National Cancer Institute, TAILORX BREAST CANC; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; PAIK S, 2005, 28 ANN SAN ANT BREAS; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reid JF, 2005, JNCI-J NATL CANCER I, V97, P927, DOI 10.1093/jnci/dji153; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Simon R, 2006, PHARMACOGENOMICS J, V6, P166, DOI 10.1038/sj.tpj.6500349; Simon R, 2005, JNCI-J NATL CANCER I, V97, P866, DOI 10.1093/jnci/dji168; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; THORLACIUS S, 1995, EUR J CANCER, V31A, P1856, DOI 10.1016/0959-8049(95)00399-4; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	58	117	119	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					358	W81		10.7326/0003-4819-148-5-200803040-00208	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00208			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18252678				2022-12-28	WOS:000253600800005
J	Searchinger, T; Heimlich, R; Houghton, RA; Dong, FX; Elobeid, A; Fabiosa, J; Tokgoz, S; Hayes, D; Yu, TH				Searchinger, Timothy; Heimlich, Ralph; Houghton, R. A.; Dong, Fengxia; Elobeid, Amani; Fabiosa, Jacinto; Tokgoz, Simla; Hayes, Dermot; Yu, Tun-Hsiang			Use of US croplands for biofuels increases greenhouse gases through emissions from land-use change	SCIENCE			English	Article							SOIL CARBON	Most prior studies have found that substituting biofuels for gasoline will reduce greenhouse gases because biofuels sequester carbon through the growth of the feedstock. These analyses have failed to count the carbon emissions that occur as farmers worldwide respond to higher prices and convert forest and grassland to new cropland to replace the grain ( or cropland) diverted to biofuels. By using a worldwide agricultural model to estimate emissions from land- use change, we found that corn- based ethanol, instead of producing a 20% savings, nearly doubles greenhouse emissions over 30 years and increases greenhouse gases for 167 years. Biofuels from switchgrass, if grown on U. S. corn lands, increase emissions by 50%. This result raises concerns about large biofuel mandates and highlights the value of using waste products.	[Searchinger, Timothy] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Searchinger, Timothy] German Marshall Fund US, Washington, DC 20009 USA; [Searchinger, Timothy] Georgetown Environm Law & Policy Inst, Washington, DC 20001 USA; [Heimlich, Ralph] Agr Conservat Econ, Laurel, MD 20723 USA; [Houghton, R. A.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Dong, Fengxia; Elobeid, Amani; Fabiosa, Jacinto; Tokgoz, Simla; Hayes, Dermot; Yu, Tun-Hsiang] Iowa State Univ, Ctr Agr & Rural Dev, Ames, IA 50011 USA	Princeton University; Woods Hole Research Center; Iowa State University	Searchinger, T (corresponding author), Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA.	tsearchi@princeton.edu	Molina, Carolina/E-3898-2015	Molina, Carolina/0000-0001-6659-994X; Hayes, Dermot/0000-0002-6278-7238; Tokgoz, Simla/0000-0002-9358-0491				[Anonymous], 4 IPCC; [Anonymous], WORLD AGR 2015 30 FA; Argonne National Laboratory, 2007, GREENH GAS REG EM EN; Commission of the European Communities, 2006, COM2006845 COMM EUR; DELUCHI M, 2005, UCDITSRR0510; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; *IA CORN GROW ASS, US CORN FACT SHEET; IPCC, 2001, ADV CLIM CHANG RES; JOHANNS M, 2007, ADV REN EN C US DEP; MACEDO IDC, 2004, ASSESSMENT GREENHOUS; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; PERLACK RD, 2005, 20666 ORNLTM; Righelato R, 2007, SCIENCE, V317, P902, DOI 10.1126/science.1141361; SCHNEPF RD, 2001, WRS0103 USDA EC RES; SHEAN MJ, 2003, BRAZIL FUTURE AGR EX; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; TOKGOZ S, 2007, DATA FILES REVISED 2; Tokgoz S., 2007, 07SR101 IOW STAT U C; Wang M., 2005, 15 INT S ALC FUELS S; WANG M, 1999, EFFECTS FUEL ETHANTO	25	3029	3091	22	1343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1238	1240		10.1126/science.1151861	http://dx.doi.org/10.1126/science.1151861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258860				2022-12-28	WOS:000253530600042
J	Perel, P; Arango, M; Clayton, T; Edwards, P; Komolafe, E; Pocock, S; Roberts, I; Shakur, H; Steyerberg, E; Yutthakasemsunt, S				Perel, Pablo; Arango, Miguel; Clayton, Tim; Edwards, Phil; Komolafe, Edward; Pocock, Stuart; Roberts, Ian; Shakur, Haleema; Steyerberg, Ewout; Yutthakasemsunt, Surakrant		MRC CRASH Trial Collaborators	Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; MRC CRASH; MANAGEMENT; COUNTRIES; VARIABLES; ADULTS	Objective To develop and validate practical prognostic models for death at 14 days and for death or severe disability six months after traumatic brain injury. Design Multivariable logistic regression to select variables that were independently associated with two patient outcomes. Two models designed: "basic" model (demographic and clinical variables only) and "CT" model (basic model plus results of computed tomography). The models were subsequently developed for high and low-middle income countries separately. Setting Medical Research Council (MRC) CRASH Trial. Subjects 10 008 patients with traumatic brain injury. Models externally validated in a cohort of 8509. Results The basic model included four predictors: age, Glasgow coma scale, pupil reactivity, and the presence of major extracranial injury. The CT model also included the presence of petechial haemorrhages, obliteration of the third ventricle or basal cisterns, subarachnoid bleeding, midline shift, and non-evacuated haematoma. In the derivation sample the models showed excellent discrimination (C statistic above 0.80). The models showed good calibration graphically. The Hosmer-Lemeshow test also indicated good calibration, except for the CT model in low-middle income countries. External validation for unfavourable outcome at six months in high income countries showed that basic and CT models had good discrimination (C statistic 0.77 for both models) but poorer calibration. Conclusion Simple prognostic models can be used to obtain valid predictions of relevant outcomes in patients with traumatic brain injury.	[Perel, Pablo] London Sch Hyg & Trop Med, London WC1B 3DP, England	University of London; London School of Hygiene & Tropical Medicine	Perel, P (corresponding author), London Sch Hyg & Trop Med, London WC1B 3DP, England.	Pablo.perel@lshtm.ac.uk	Gallardo, Angel Jesús Lacerda/AAZ-9478-2020; LORIA-CASTELLANOS, JORGE/J-2410-2016; Nabil H, khalil/A-9528-2015; LORIA-CASTELLANOS, JORGE/N-2363-2019; Abdullah, J/C-2828-2011; Kramar, Filip/O-5860-2017; Chytra, Ivan/B-2075-2008	Gallardo, Angel Jesús Lacerda/0000-0001-9171-2000; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Nabil H, khalil/0000-0001-6293-7972; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Abdullah, J/0000-0002-0258-7410; Cakar, Nahit/0000-0002-1302-9596; Maliawan, Sri/0000-0003-2389-3481; Kramar, Filip/0000-0003-0833-2360; Shakur-Still, Haleema/0000-0002-6511-109X; Clayton, Tim/0000-0002-1266-3288; Chytra, Ivan/0000-0001-5342-5537; Edwards, Phil/0000-0003-4431-8822; /0000-0002-2342-301X; komolafe, edward/0000-0003-1261-3501; Maliawan, Prof. Sri/0000-0002-6151-3155; Ochoa-Parra, Marcelo/0000-0003-0432-8962; KOMOLAFE, MORENIKEJI/0000-0002-0592-5120				Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; *BRAIN TRAUM FDN U, 2000, MAN PROGN SEV TRAUM; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Edwards P, 2005, LANCET, V365, P1957; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JENNETT B, 1975, LANCET, V1, P480; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; *WORLD BANK, 2006, WORLD DEV IND	22	676	683	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					425	429		10.1136/bmj.39461.643438.25	http://dx.doi.org/10.1136/bmj.39461.643438.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18270239	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000253664000037
J	Ortiz, C; Boyce, MC				Ortiz, Christine; Boyce, Mary C.			Materials science - Bioinspired structural materials	SCIENCE			English	Editorial Material							NANOSCALE; DESIGN		[Ortiz, Christine; Boyce, Mary C.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ortiz, C (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cortiz@mit.edu						Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Bruet BJF, 2005, J MATER RES, V20, P2400, DOI 10.1557/JMR.2005.0273; Carrington E, 2004, AM MALACOL BULL, V18, P135; Daget J, 2001, FISH FISH, V2, P113, DOI 10.1046/j.1467-2960.2001.00046.x; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Li XD, 2006, NANO LETT, V6, P2301, DOI 10.1021/nl061775u; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Qi H.J., 2005, MECH BIOL TISSUES, P175; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wainwright S.A., 1976, MECH DESIGN ORGANISM; Weiner S, 2006, BIOINTERPHASES, V1, pP12, DOI 10.1116/1.2207607; Yao N, 2006, J MATER RES, V21, P1939, DOI 10.1557/JMR.2006.0252	17	293	297	16	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1053	1054		10.1126/science.1154295	http://dx.doi.org/10.1126/science.1154295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292331	Green Submitted			2022-12-28	WOS:000253311700031
J	Bruneau, BG				Bruneau, Benoit G.			The developmental genetics of congenital heart disease	NATURE			English	Article							OF-FUNCTION MUTATIONS; HOLT-ORAM-SYNDROME; SMOOTH-MUSCLE; CAUSE NOONAN; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; ALAGILLE-SYNDROME; CURRENT KNOWLEDGE; PROGENITOR CELLS; OKIHIRO-SYNDROME	Congenital heart disease is the leading cause of infant morbidity in the Western world, but only in the past ten years has its aetiology been understood. Recent studies have uncovered the genetic basis for some common forms of the disease and provide new insight into how the heart develops and how dysregulation of heart development leads to disease.	[Bruneau, Benoit G.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Bruneau, BG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	bbruneau@gladstone.ucsf.edu		Bruneau, Benoit/0000-0002-0804-7597				Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li QY, 1997, NAT GENET, V15, P21; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	68	539	565	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					943	948		10.1038/nature06801	http://dx.doi.org/10.1038/nature06801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288184				2022-12-28	WOS:000253313100035
J	Moore, RB; Obornik, M; Janouskovec, J; Chrudimsky, T; Vancova, M; Green, DH; Wright, SW; Davies, NW; Bolch, CJS; Heimann, K; Slapeta, J; Hoegh-Guldberg, O; Logsdon, JM; Carter, DA				Moore, Robert B.; Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie; Green, David H.; Wright, Simon W.; Davies, Noel W.; Bolch, Christopher J. S.; Heimann, Kirsten; Slapeta, Jan; Hoegh-Guldberg, Ove; Logsdon, John M., Jr.; Carter, Dee A.			A photosynthetic alveolate closely related to apicomplexan parasites	NATURE			English	Article							CRYPTOSPORIDIUM-PARVUM; TOXOPLASMA-GONDII; COMMON ORIGIN; DINOFLAGELLATE; PHYLOGENY; DIVERSITY; SPOROZOAN; PLASTIDS; TAXONOMY; PROTEIN	Many parasitic Apicomplexa, such as Plasmodium falciparum, contain an unpigmented chloroplast remnant termed the apicoplast, which is a target for malaria treatment. However, no close relative of apicomplexans with a functional photosynthetic plastid has yet been described. Here we describe a newly cultured organism that has ultrastructural features typical for alveolates, is phylogenetically related to apicomplexans, and contains a photosynthetic plastid. The plastid is surrounded by four membranes, is pigmented by chlorophyll a, and uses the codon UGA to encode tryptophan in the psbA gene. This genetic feature has been found only in coccidian apicoplasts and various mitochondria. The UGA-Trp codon and phylogenies of plastid and nuclear ribosomal RNA genes indicate that the organism is the closest known photosynthetic relative to apicomplexan parasites and that its plastid shares an origin with the apicoplasts. The discovery of this organism provides a powerful model with which to study the evolution of parasitism in Apicomplexa.	[Moore, Robert B.; Carter, Dee A.] Univ Sydney, Sch Mol & Microbial Biosci, Darlington, NSW 2006, Australia; [Moore, Robert B.; Logsdon, John M., Jr.] Univ Iowa, Roy J Carver Ctr Comparat Genom, Dept Biol Sci, Iowa City, IA 52242 USA; [Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie] Acad Sci Czech Republ, Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Green, David H.] Dunstaffnage Marine Lab Oban, Scottish Assoc Marine Sci, Argyll PA37 1QA, Scotland; [Wright, Simon W.] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Davies, Noel W.] Univ Tasmania, Cent Sci Lab, Hobart, Tas 7001, Australia; [Bolch, Christopher J. S.] Univ Tasmania, Sch Aquaculture, Launceston, Tas 7250, Australia; [Heimann, Kirsten] James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Slapeta, Jan] Univ Sydney, Fac Vet Sci, Camperdown, NSW 2006, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia	University of Sydney; University of Iowa; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Australian Antarctic Division; University of Tasmania; University of Tasmania; James Cook University; University of Sydney; University of Queensland	Carter, DA (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Darlington, NSW 2006, Australia.	d.carter@mmb.usyd.edu.au	Green, David/E-2533-2012; Janouškovec, Jan/ABA-2568-2021; Carter, Dee/C-1331-2010; Hoegh-Guldberg, Ove/ABA-5420-2020; Chrudimský, Tomáš/L-5628-2014; Heimann, Kirsten/M-4814-2019; Hoegh-Guldberg, Ove/H-6169-2011; Vancova, Marie/G-8347-2014; Logsdon, John M/B-7812-2009; Obornik, Miroslav/G-9350-2014; Heimann, Kirsten/C-4539-2012; Heimann, Kirsten/N-1512-2013; Bolch, Christopher J/J-7619-2014; Davies, Noel W/J-7714-2014	Green, David/0000-0001-7499-6021; Janouškovec, Jan/0000-0001-6547-749X; Carter, Dee/0000-0002-4638-0059; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Heimann, Kirsten/0000-0003-2691-9659; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Vancova, Marie/0000-0003-0678-8268; Heimann, Kirsten/0000-0003-2691-9659; Bolch, Christopher J/0000-0001-9047-2391; Davies, Noel W/0000-0002-9624-0935; Slapeta, Jan/0000-0003-1459-9117	Natural Environment Research Council [dml010007] Funding Source: researchfish; NERC [dml010007] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adl SM, 2007, SYST BIOL, V56, P684, DOI 10.1080/10635150701494127; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; CAVALIERSMITH T, 1991, SYST ASSOC SPEC VOL, V45, P113; DODGE J D, 1971, Protistologica, V7, P295; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; Kremp A, 2005, J PHYCOL, V41, P629, DOI 10.1111/j.1529-8817.2005.00070.x; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; Lang-Unnasch N, 1998, INT J PARASITOL, V28, P1743, DOI 10.1016/S0020-7519(98)00136-2; Lang-Unnasch N, 1999, INT J PARASITOL, V29, P1557, DOI 10.1016/S0020-7519(99)00119-8; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Scheer Hugo, 2003, Advances in Photosynthesis and Respiration, V13, P29; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P163, DOI 10.1016/j.ejop.2007.02.002; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Toso MA, 2007, J EUKARYOT MICROBIOL, V54, P66, DOI 10.1111/j.1550-7408.2006.00229.x; Wakefield TS, 2000, BIOL BULL-US, V199, P76, DOI 10.2307/1542709; York R. H., 1986, CORAL REEF POPULATIO, P486; Zhang ZD, 2000, J MOL EVOL, V51, P26, DOI 10.1007/s002390010064; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315	30	325	334	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					959	963		10.1038/nature06635	http://dx.doi.org/10.1038/nature06635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288187				2022-12-28	WOS:000253313100041
J	Rozendaal, RM; Koes, BW; Van Osch, GJVM; Md, EJU; Garling, EH; Willemsen, SP; Ginai, AZ; Verhaar, JAN; Weinans, H; Bierma-Zeinstra, SMA				Rozendaal, Rianne M.; Koes, Bart W.; Van Osch, Gerjo J. V. M.; Md, Elian J. Uitterlinden; Garling, Eric H.; Willemsen, Sten P.; Ginai, Abida Z.; Verhaar, Jan A. N.; Weinans, Harrie; Bierma-Zeinstra, Sita M. A.			Effect of glucosamine sulfate on hip osteoarthritis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							JOINT SPACE WIDTH; STRUCTURE-MODIFYING DRUG; KNEE OSTEOARTHRITIS; CLINICAL-TRIALS; DOUBLE-BLIND; RESEARCH-SOCIETY; PROGRESSION; PAIN; RADIOGRAPHS; ARTHROSIS	Background: The effectiveness of glucosamine sulfate as a symptom and disease modifier for osteoarthritis is still under debate. Objective: To assess whether glucosamine sulfate has an effect on the symptoms and structural progression of hip osteoarthritis during 2 years of treatment. Design: Randomized, controlled trial. Setting: Primary care in the Netherlands. Patients: 222 patients with hip osteoarthritis who were recruited by their general practitioner. Patients were eligible if they met the American College of Rheumatology clinical criteria for hip osteoarthritis. Intervention: 2 years of treatment with 1500 mg of oral glucosamine sulfate or placebo once daily. Measurements: Primary outcome measures were Western Ontario and McMaster Universities (WOMAC) pain and function subscales over 24 months and joint space narrowing after 24 months. The main secondary outcome measures were WOMAC pain, function, and stiffness after 3, 12, and 24 months. Results: At baseline, both groups were similar in demographic and clinical variables. Overall, WOMAC pain did not differ (mean difference [glucosamine sulfate minus placebo], -1.54 [95% CI, - 5.43 to 2.36]), nor did WOMAC function (mean difference, -2.01 [CI, - 5.38 to 1.36]). Joint space narrowing also did not differ after 24 months (mean difference, - 0.029 [CI, - 0.122 to 0.064]). Only 1 of the sensitivity analyses, based on extreme assumptions regarding missing assessments due to total hip replacement, provided results consistent with a glucosamine effect. Limitations: Twenty patients had total hip replacement during the trial. Half of the patients had a Kellgren and Lawrence score of 1. Conclusion: Glucosamine sulfate was no better than placebo in reducing symptoms and progression of hip osteoarthritis.	[Rozendaal, Rianne M.] Erasmus MC, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rozendaal, RM (corresponding author), Erasmus MC, Dept Gen Practice, Room Fg 351,POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.rozendaal@erasmusmc.ni	Koes, Bart w/K-4614-2016; Bierma-Zeinstra, Sita/AAF-2122-2019; Verhaar, Jan/AAH-1372-2020	Koes, Bart w/0000-0002-0450-9969; Verhaar, Jan/0000-0003-3016-9600; Weinans, Harrie/0000-0002-2275-6170				ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Auleley GR, 1998, ANN RHEUM DIS, V57, P519, DOI 10.1136/ard.57.9.519; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Brandt KD, 2002, J RHEUMATOL, V29, P1308; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Conrozier T, 2001, OSTEOARTHR CARTILAGE, V9, P281, DOI 10.1053/joca.2000.0386; CROLLE G, 1980, CURR MED RES OPIN, V7, P104, DOI 10.1185/03007998009112035; DAMBROSIO E, 1981, PHARMATHERAPEUTICA, V2, P504; Dougados M, 1996, ANN RHEUM DIS, V55, P356, DOI 10.1136/ard.55.6.356; DROVANTI A, 1980, CLIN THER, V3, P260; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; Hochberg MC, 1997, J RHEUMATOL, V24, P792; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lievense AM, 2002, ARTHRIT RHEUM-ARTHR, V47, P556, DOI 10.1002/art.10660; Maheu E, 2005, ARTHRITIS RES THER, V7, pR1375, DOI 10.1186/ar1831; Mazzuca SA, 2001, ARTHRITIS RHEUM, V44, P1786, DOI 10.1002/1529-0131(200108)44:8<1786::AID-ART315>3.0.CO;2-L; McAlindon T, 2003, RHEUM DIS CLIN N AM, V29, P789, DOI 10.1016/S0889-857X(03)00064-4; Messier SP, 2007, OSTEOARTHR CARTILAGE, V15, P1256, DOI 10.1016/j.joca.2007.04.016; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Pavelka K, 2003, OSTEOARTHR CARTILAGE, V11, P730, DOI 10.1016/S1063-4584(03)00166-3; Persiani S, 2005, OSTEOARTHR CARTILAGE, V13, P1041, DOI 10.1016/j.joca.2005.07.009; Peters TJ, 2005, BRIT J GEN PRACT, V55, P205; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Reginster JY, 2001, LANCET, V357, P251, DOI 10.1016/S0140-6736(00)03610-2; Reijman M, 2005, BMJ-BRIT MED J, V330, P1183, DOI 10.1136/bmj.38442.457488.8F; Reijman M, 2004, ANN RHEUM DIS, V63, P1427, DOI 10.1136/ard.2003.016477; Rindone JP, 2000, WESTERN J MED, V172, P91, DOI 10.1136/ewjm.172.2.91; Roorda LD, 2004, ANN RHEUM DIS, V63, P36, DOI 10.1136/ard.2002.001784; Rozendaal RM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-20; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Towheed TE, 2003, ARTHRIT RHEUM-ARTHR, V49, P601, DOI 10.1002/art.11183; van Dijk GM, 2006, ARTHRIT RHEUM-ARTHR, V55, P779, DOI 10.1002/art.22244; Vlad SC, 2007, ARTHRITIS RHEUM-US, V56, P2267, DOI 10.1002/art.22728	34	89	95	3	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					268	277		10.7326/0003-4819-148-4-200802190-00005	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283204				2022-12-28	WOS:000253316400003
J	Ottino, JM; Lueptow, RM				Ottino, Julio M.; Lueptow, Richard M.			Materials science - On mixing and demixing	SCIENCE			English	Editorial Material							SIZE SEPARATION; SEGREGATION; FLOW; SYSTEMS		[Ottino, Julio M.] Northwestern Univ, NW Inst Complex Syst, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Ottino, Julio M.; Lueptow, Richard M.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Ottino, JM (corresponding author), Northwestern Univ, NW Inst Complex Syst, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	jm-ottino@northwestern.edu; r-lueptow@northwestern.edu	Lueptow, Richard M/J-4998-2012; Lueptow, Richard/B-6740-2009; Ottino, Julio/B-6682-2009	Lueptow, Richard M/0000-0002-1855-1471; 				ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Brucks A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.032301; Conway SL, 2005, CHEM ENG SCI, V60, P7091, DOI 10.1016/j.ces.2005.03.008; Fiedor SJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.244301; Hill KM, 2005, COMPLEXITY, V10, P79, DOI 10.1002/cplx.20082; Jain N, 2001, PHYS REV LETT, V86, P3771, DOI 10.1103/PhysRevLett86.3771; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; Li HM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.184301; Meier SW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031310; Meier SW, 2007, ADV PHYS, V56, P757, DOI 10.1080/00018730701611677; MiDi GDR, 2004, EUR PHYS J E, V14, P341, DOI [10.1140/epje/i2004-10022-4, 10.1140/epje/i2003-10153-0]; Moakher M, 2000, POWDER TECHNOL, V109, P58, DOI 10.1016/S0032-5910(99)00227-2; Mobius ME, 2001, NATURE, V414, P270, DOI 10.1038/35104697; Rapaport DC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031301; SAVAGE SB, 1988, J FLUID MECH, V189, P311, DOI 10.1017/S002211208800103X; Shi D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148001; Shinbrot T, 1998, PHYS REV LETT, V81, P4365, DOI 10.1103/PhysRevLett.81.4365; Ulrich S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.042301	19	34	35	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					912	913		10.1126/science.1152849	http://dx.doi.org/10.1126/science.1152849			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276878				2022-12-28	WOS:000253165700032
J	Simmons, NB; Seymour, KL; Habersetzer, J; Gunnell, GF				Simmons, Nancy B.; Seymour, Kevin L.; Habersetzer, Joerg; Gunnell, Gregg F.			Primitive Early Eocene bat from Wyoming and the evolution of flight and echolocation	NATURE			English	Article							BIOGEOGRAPHY; CHIROPTERA; FOSSIL	Bats ( Chiroptera) represent one of the largest and most diverse radiations of mammals, accounting for one- fifth of extant species(1). Although recent studies unambiguously support bat monophyly(2-4) and consensus is rapidly emerging about evolutionary relationships among extant lineages(5-8), the fossil record of bats extends over 50 million years, and early evolution of the group remains poorly understood(5,7-9). Here we describe a new bat from the Early Eocene Green River Formation of Wyoming, USA, with features that are more primitive than seen in any previously known bat. The evolutionary pathways that led to flapping flight and echolocation in bats have been in dispute(7-18), and until now fossils have been of limited use in documenting transitions involved in this marked change in lifestyle. Phylogenetically informed comparisons of the new taxon with other bats and non- flying mammals reveal that critical morphological and functional changes evolved incrementally. Forelimb anatomy indicates that the new bat was capable of powered flight like other Eocene bats, but ear morphology suggests that it lacked their echolocation abilities, supporting a 'flight first' hypothesis for chiropteran evolution. The shape of the wings suggests that an undulating gliding - fluttering flight style may be primitive for bats, and the presence of a long calcar indicates that a broad tail membrane evolved early in Chiroptera, probably functioning as an additional airfoil rather than as a prey-capture device. Limb proportions and retention of claws on all digits indicate that the new bat may have been an agile climber that employed quadrupedal locomotion and under- branch hanging behaviour.	[Simmons, Nancy B.] Amer Museum Nat Hist, New York, NY 10024 USA; [Seymour, Kevin L.] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Habersetzer, Joerg] Forschungsinst Senckenberg, D-60325 Frankfurt, Germany; [Gunnell, Gregg F.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	American Museum of Natural History (AMNH); Royal Ontario Museum; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Michigan System; University of Michigan	Simmons, NB (corresponding author), Amer Museum Nat Hist, Cent Park W & 79th St, New York, NY 10024 USA.	simmons@amnh.org		Simmons, Nancy B./0000-0001-8807-7499				[Anonymous], 1987, AM MUS NOVIT; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Buchheim H. P., 1994, CONTRIBUTIONS GEOLOG, V30, P3; Clyde WC, 2001, PALAEOGEOGR PALAEOCL, V167, P175, DOI 10.1016/S0031-0182(00)00238-8; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Grande Lance, 1994, Contributions to Geology University of Wyoming, V30, P33; Gunnell Gregg F., 2003, Palaeontologia Electronica, V5, pUnpaginated; Gunnell Gregg F., 2005, Journal of Mammalian Evolution, V12, P209, DOI 10.1007/s10914-005-6945-2; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; Habersetzer J., 1987, COURIER FORSCHUNGSIN, V91, P11; JEPSEN GL, 1966, SCIENCE, V154, P1333, DOI 10.1126/science.154.3754.1333; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Norberg U.M., 1986, Biona Report, V5, P13; Norberg U.M., 1989, P197; NOVACEK MJ, 1985, NATURE, V315, P140, DOI 10.1038/315140a0; RAYNAUD JP, 1974, J PHARMACOL-PARIS, V5, P27; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; Schutt William A. Jr., 1998, Journal of Mammalian Evolution, V5, P1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons N. B., 2006, FUNCTIONAL EVOLUTION, P15; Simmons Nancy B., 1994, American Museum Novitates, V3103, P1; Simmons NB, 1998, B AM MUS NAT HIST, P1; Simmons NB, 1995, SYM ZOOL S, P27; SPEAKMAN JR, 1991, NATURE, V350, P421, DOI 10.1038/350421a0; Speakman JR, 2001, MAMMAL REV, V31, P111, DOI 10.1046/j.1365-2907.2001.00082.x; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Storch Gerhard, 2002, Palaeontologische Zeitschrift, V76, P189; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2; Vaughan T.A., 1970, P127; Woodburne Michael O., 2004, P315	38	258	278	3	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					818	U6		10.1038/nature06549	http://dx.doi.org/10.1038/nature06549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18270539	Green Published			2022-12-28	WOS:000253191400040
J	Martin, BI; Deyo, RA; Mirza, SK; Turner, JA; Comstock, BA; Hollingworth, W; Sullivan, SD				Martin, Brook I.; Deyo, Richard A.; Mirza, Sohail K.; Turner, Judith A.; Comstock, Bryan A.; Hollingworth, William; Sullivan, Sean D.			Expenditures and health status among adults with back and neck problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; MEDICARE POPULATION; CARE EXPENDITURES; SPINE SURGERY; PANEL SURVEY; TRENDS; PAIN; INDIVIDUALS; PREVALENCE; PATTERNS	Context Back and neck problems are among the symptoms most commonly encountered in clinical practice. However, few studies have examined national trends in expenditures for back and neck problems or related these trends to health status measures. Objectives To estimate inpatient, outpatient, emergency department, and pharmacy expenditures related to back and neck problems in the United States from 1997 through 2005 and to examine associated trends in health status. Design and Setting Age- and sex- adjusted analysis of the nationally representative Medical Expenditure Panel Survey ( MEPS) from 1997 to 2005 using complex survey regression methods. The MEPS is a household survey of medical expenditures weighted to represent national estimates. Respondents were US adults ( > 17 years) who self-reported back and neck problems ( referred to as "spine problems" based on MEPS descriptions and International Classification of Diseases, Ninth Revision, Clinical Modification definitions). Main Outcome Measures Spine- related expenditures for health services ( inflation-adjusted); annual surveys of self- reported health status. Results National estimates were based on annual samples of survey respondents with and without self- reported spine problems from 1997 through 2005. A total of 23 045 respondents were sampled in 1997, including 3139 who reported spine problems. In 2005, the sample included 22 258 respondents, including 3187 who reported spine problems. In 1997, the mean age- and sex- adjusted medical costs for respondents with spine problems was $4695 ( 95% confidence interval [ CI], $4181-$ 5209), compared with $2731 ( 95% CI, $2557-$ 2904) among those without spine problems ( inflation- adjusted to 2005 dollars). In 2005, the mean age- and sex- adjusted medical expenditure among respondents with spine problems was $6096 ( 95% CI, $5670-$6522), compared with $ 3516 ( 95% CI, $ 3266-$ 3765) among those without spine problems. Total estimated expenditures among respondents with spine problems increased 65% ( adjusted for inflation) from 1997 to 2005, more rapidly than overall health expenditures. The estimated proportion of persons with back or neck problems who self- reported physical functioning limitations increased from 20.7% ( 95% CI, 19.9%- 21.4%) to 24.7% ( 95% CI, 23.7%-25.6%) from 1997 to 2005. Age- and sex- adjusted self- reported measures of mental health, physical functioning, work or school limitations, and social limitations among adults with spine problems were worse in 2005 than in 1997. Conclusions In this survey population, self- reported back and neck problems accounted for a large proportion of health care expenditures. These spine- related expenditures have increased substantially from 1997 to 2005, without evidence of corresponding improvement in self- assessed health status.	[Martin, Brook I.; Deyo, Richard A.; Mirza, Sohail K.; Turner, Judith A.; Comstock, Bryan A.; Hollingworth, William; Sullivan, Sean D.] Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA 98104 USA; [Martin, Brook I.; Mirza, Sohail K.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Martin, Brook I.; Sullivan, Sean D.] Univ Washington, Dept Hlth Sci, Seattle, WA 98195 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Comstock, Bryan A.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Sullivan, Sean D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	Martin, BI (corresponding author), Univ Washington, Ctr Cost & Outcomes Res, Box 359736-PSB5073,325 9th Ave, Seattle, WA 98104 USA.	bim@u.washington.edu	Fahimifar, Sepideh/M-5303-2019; Martin, Brook/L-4698-2019	Hollingworth, William/0000-0002-0840-6254	NIAMS NIH HHS [K23AR48979, P60AR48093] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR048979, P60AR048093] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM PAIN SOC, PROM PAIN REL PREV A; *AM PAIN SOC, US OP TREATM CHRON P; American Heart Association, 2005, HEART DIS STROKE STA; [Anonymous], MED EXP PAN SURV; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Carrino JA, 2002, RADIOLOGY, V225, P723, DOI 10.1148/radiol.2253011401; CHANTALA K, 2001, USING STATA ANAL DAT; CHERKIN DC, 1992, SPINE, V17, P817, DOI 10.1097/00007632-199207000-00015; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Cohen SB, 2003, MED CARE, V41, P5; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Feuerstein Michael, 2004, Spine J, V4, P56, DOI 10.1016/j.spinee.2003.08.003; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; FRYMOYER JW, 1997, ADULT SPINE PRINCIPL, V2; Gray DT, 2006, SPINE, V31, P1957, DOI 10.1097/01.brs.0000229148.63418.c1; GRAZIER KL, 1984, FREQUENCY OCCURRENCE, P72; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Luo XM, 2004, SPINE, V29, P884, DOI 10.1097/00007632-200404150-00012; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; *NAT HEART LUNG BL, 2006, NHLBI FACTB DIR IND; Petersen M, 2003, DIABETES CARE, V26, P917; Savage SR, 2003, J PAIN SYMPTOM MANAG, V26, P655, DOI 10.1016/S0885-3924(03)00219-7; StataCorp, 2005, STAT BAS REF MAN REL; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; *US BUR CENS, POP EST TABL; *US BUR LAB STAT, CONS PRIC IND CALC; Von Korff M, 2004, PAIN, V109, P207, DOI 10.1016/j.pain.2004.02.019; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiner DK, 2006, PAIN MED, V7, P143, DOI 10.1111/j.1526-4637.2006.00112.x; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25	37	1041	1065	2	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					656	664		10.1001/jama.299.6.656	http://dx.doi.org/10.1001/jama.299.6.656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270354	Bronze			2022-12-28	WOS:000253095200023
J	Gornall, J				Gornall, Jonathan			Does cot death still exist?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNEXPECTED DEATH; SUDDEN					Jgornall@mac.com						Bergman AB, 1997, PEDIATRICS, V99, P119, DOI 10.1542/peds.99.1.119; BERGMAN AB, 1970, SUDDEN INFANT DEATH; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Corbin Tania, 2005, Health Stat Q, P17; DATTANI N, 2001, HLTH STAT Q, V10, P20; *FDN STUD INF DEAT, 2006, COT DEATH FACTS FIG; Fleming P., 2000, SUDDEN UNEXPECTED DE; Fleming P, 2007, EARLY HUM DEV, V83, P721, DOI 10.1016/j.earlhumdev.2007.07.011; Gornall J, 2007, BMJ-BRIT MED J, V334, P1083, DOI 10.1136/bmj.39206.389711.AD; HARGROVE T, 2007, 1000 BABIES DIE PREV; HAWKES N, 2006, TIMES           1101; *INF CTR HLTH CAR, 2005, INF FEED SURV 2005; Kennedy H, 2004, SUDDEN UNEXPECTED DE; *NAT CTR HLTH STAT, 2005, DEATHS PRELIMINAR; *NAT I CHILD HLTH, 2000, TARG SUDD INF DEATH; *OFF NAT STAT, 2006, HLTH STAT Q, V31, P85; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Pickett KE, 2005, AM J PUBLIC HEALTH, V95, P1976, DOI 10.2105/AJPH.2004.059063; STEELE R, 1966, CAN MED ASSOC J, V94, P1165; VALDESDAPENA MA, 1967, PEDIATRICS, V39, P123; Weese-Mayer DE, 2007, AM J MED GENET A, V143A, P771, DOI 10.1002/ajmg.a.31722; 2006, DAILY TELEGRAPH 1101	22	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					302	304		10.1136/bmj.39455.496146.AD	http://dx.doi.org/10.1136/bmj.39455.496146.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18258964	Green Published			2022-12-28	WOS:000253437400028
J	Donelan, JM; Li, Q; Naing, V; Hoffer, JA; Weber, DJ; Kuo, AD				Donelan, J. M.; Li, Q.; Naing, V.; Hoffer, J. A.; Weber, D. J.; Kuo, A. D.			Biomechanical energy harvesting: Generating electricity during walking with minimal user effort	SCIENCE			English	Article							PROSTHETIC KNEE; ENERGETICS; LOADS; COST; LEG	We have developed a biomechanical energy harvester that generates electricity during human walking with little extra effort. Unlike conventional human- powered generators that use positive muscle work, our technology assists muscles in performing negative work, analogous to regenerative braking in hybrid cars, where energy normally dissipated during braking drives a generator instead. The energy harvester mounts at the knee and selectively engages power generation at the end of the swing phase, thus assisting deceleration of the joint. Test subjects walking with one device on each leg produced an average of 5 watts of electricity, which is about 10 times that of shoe- mounted devices. The cost of harvesting - the additional metabolic power required to produce 1 watt of electricity - is less than one- eighth of that for conventional human power generation. Producing substantial electricity with little extra effort makes this method well- suited for charging powered prosthetic limbs and other portable medical devices.	[Donelan, J. M.; Li, Q.; Naing, V.; Hoffer, J. A.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada; [Weber, D. J.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Kuo, A. D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kuo, A. D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Donelan, JM (corresponding author), Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada.	mdonelan@sfu.ca	Donelan, James/G-1443-2011; Kuo, Arthur/L-3359-2013; Weber, Douglas/E-7554-2011	Kuo, Arthur/0000-0001-5233-9709; 				Berry Dale, 2006, Phys Med Rehabil Clin N Am, V17, P91, DOI 10.1016/j.pmr.2005.10.006; Brooks GA, 2005, EXERCISE PHYSL HUMAN, V4th; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; International Energy Agency, 2006, WORLD EN OUTL; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2005, SCIENCE, V309, P1686, DOI 10.1126/science.1118058; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Margaria R., 1976, BIOMECHANICS ENERGET; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Seymour R, 2007, PROSTHET ORTHOT INT, V31, P51, DOI 10.1080/03093640600982255; SOULE RG, 1969, J APPL PHYSIOL, V27, P687, DOI 10.1152/jappl.1969.27.5.687; SOYKAN O, 2002, BUSINESS BRIEFING ME, P76; Starner T, 1996, IBM SYST J, V35, P618, DOI 10.1147/sj.353.0618; Winter DA, 1990, BIOMECHANICS MOTOR C	21	525	538	23	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					807	810		10.1126/science.1149860	http://dx.doi.org/10.1126/science.1149860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258914				2022-12-28	WOS:000252963000060
J	Armand, M; Tarascon, JM				Armand, M.; Tarascon, J. -M.			Building better batteries	NATURE			English	Article							ELECTRODE MATERIALS		[Armand, M.; Tarascon, J. -M.] Univ Picardie, LRCS, CNRS, UMR 6007, Amiens, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Tarascon, JM (corresponding author), Univ Picardie, LRCS, CNRS, UMR 6007, Amiens, France.	jean-marie.tarascon@sc.u-picardie.fr	Tarascon, Jean-Marie/B-5952-2016; Zhang, Jingyu/E-1249-2012; Garcia, Johanna/U-4302-2017	Garcia, Johanna/0000-0002-8985-1682				Abraham KM, 1996, J ELECTROCHEM SOC, V143, P1, DOI 10.1149/1.1836378; Amatucci GG, 2007, J FLUORINE CHEM, V128, P243, DOI 10.1016/j.jfluchem.2006.11.016; Anastas P. T., 1998, GREEN CHEM; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Aurbach D, 2002, J ELECTROCHEM SOC, V149, pA115, DOI 10.1149/1.1429925; CHEN H, IN PRESS CHEMSUSCHEM; Croce F, 1998, NATURE, V394, P456, DOI 10.1038/28818; Fischer AE, 2007, NANO LETT, V7, P281, DOI 10.1021/nl062263i; GLASSTONE S, 1943, FUNDAMENTALS ELECTRO; HACHETTE, 1899, TRAVERS MONDE, P213; HOARE RJ, 1975, NATURE, V255, P653, DOI 10.1038/255653a0; ISIHARA K, 2002, 5 INT C EC TSUK; KAMAVARAM V, 2002, ELECTROCHEMICAL STUD; Linden D., 2002, HDB BATTERIES; Long JW, 2004, CHEM REV, V104, P4463, DOI 10.1021/cr020740l; Lutgens F.K., 2000, ESSENTIALS GEOLOGY; MACDIARMID AG, 1987, SYNTHETIC MET, V18, P393, DOI 10.1016/0379-6779(87)90911-8; Nagaura T., 1990, PROG BATT SOLAR CELL, V9, P209; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o; Ogasawara T, 2006, J AM CHEM SOC, V128, P1390, DOI 10.1021/ja056811q; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; RAVET N, 1999, EL SOC M HAW; Rosso M, 2006, ELECTROCHIM ACTA, V51, P5334, DOI 10.1016/j.electacta.2006.02.004; Sadoway DR, 2001, J POWER SOURCES, V97-8, P621, DOI 10.1016/S0378-7753(01)00642-5; WARD RD, 2000, RARE EARTH; 1920, SCI VIET	27	14509	14868	362	8969	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					652	657		10.1038/451652a	http://dx.doi.org/10.1038/451652a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256660				2022-12-28	WOS:000252929500029
J	Smit, B; Maesen, TLM				Smit, Berend; Maesen, Theo L. M.			Towards a molecular understanding of shape selectivity	NATURE			English	Review							ZEOLITE CATALYSIS; MONTE-CARLO; N-HEXANE; SILICALITE; ALKANES; ADSORPTION; ALUMINOSILICATES; HYDROCONVERSION; HYDROCARBONS; CONVERSION	Shape selectivity is a simple concept: the transformation of reactants into products depends on how the processed molecules fit the active site of the catalyst. Nature makes abundant use of this concept, in that enzymes usually process only very few molecules, which fit their active sites. Industry has also exploited shape selectivity in zeolite catalysis for almost 50 years, yet our mechanistic understanding remains rather limited. Here we review shape selectivity in zeolite catalysis, and argue that a simple thermodynamic analysis of the molecules adsorbed inside the zeolite pores can explain which products form and guide the identification of zeolite structures that are particularly suitable for desired catalytic applications.	[Smit, Berend] Ecole Normale Super Lyon, CECAM, F-69364 Lyon 7, France; [Smit, Berend] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Smit, Berend] Univ Amsterdam, Vant Hoff Inst Mol Sci, NL-1018 WV Amsterdam, Netherlands; [Maesen, Theo L. M.] Chevron Energy Technol Co, Richmond, CA 94802 USA	Ecole Normale Superieure de Lyon (ENS de LYON); University of California System; University of California Berkeley; University of Amsterdam; Chevron	Smit, B (corresponding author), Ecole Normale Super Lyon, CECAM, 46 Allee Italie, F-69364 Lyon 7, France.	berend-smit@berkeley.edu; tmaesen@chevron.com	Smit, Berend/B-7580-2009	Smit, Berend/0000-0003-4653-8562				Auerbach S. M., 2004, HDB ZEOLITE SCI TECH; Auerbach SM, 2005, CURR OPIN COLLOID IN, V10, P220, DOI 10.1016/j.cocis.2005.09.012; Baerlocher C., DATABASE ZEOLITE STR; Beerdsen E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.248301; Calero S, 2006, J PHYS CHEM B, V110, P5838, DOI 10.1021/jp060174o; Calero S, 2004, J CATAL, V228, P121, DOI 10.1016/j.jcat.2004.08.019; CHEN NY, 1984, J CATAL, V86, P24, DOI 10.1016/0021-9517(84)90344-0; Clark LA, 2004, J AM CHEM SOC, V126, P936, DOI 10.1021/ja0381712; CORMA A, 1995, CHEM REV, V95, P559, DOI 10.1021/cr00035a006; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Degnan TF, 2003, J CATAL, V216, P32, DOI 10.1016/S0021-9517(02)00105-7; Demontis P, 1997, CHEM REV, V97, P2845, DOI 10.1021/cr950253o; Dubbeldam D, 2004, J PHYS CHEM B, V108, P12301, DOI 10.1021/jp0376727; Dubbeldam D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.088302; Dubbeldam D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.245901; Dubbeldam D, 2003, ANGEW CHEM INT EDIT, V42, P3624, DOI 10.1002/anie.200351110; Earl DJ, 2006, IND ENG CHEM RES, V45, P5449, DOI 10.1021/ie0510728; FRENKEL D, 1992, J PHYS-CONDENS MAT, V4, P3053, DOI 10.1088/0953-8984/4/12/006; Frenkel D., 2000, UNDERSTANDING MOL SI; Froment G. F, 1987, CATAL TODAY, V1, P455; Garcia-Perez E, 2007, ANGEW CHEM INT EDIT, V46, P276, DOI 10.1002/anie.200603136; JACOBS PA, 1981, FARADAY DISCUSS, V72, P353, DOI 10.1039/dc9817200353; JUNE RL, 1992, J PHYS CHEM-US, V96, P1051, DOI 10.1021/j100182a009; Krishna R, 1998, J PHYS CHEM A, V102, P7727, DOI 10.1021/jp982438f; Maesen TLM, 1999, J CATAL, V188, P403, DOI 10.1006/jcat.1999.2673; Maesen TLM, 2006, J CATAL, V237, P278, DOI 10.1016/j.jcat.2005.11.007; Maesen TLM, 2004, J CATAL, V221, P241, DOI 10.1016/j.jcat.2003.07.003; Morell H, 2002, CHEM MATER, V14, P2192, DOI 10.1021/cm011267f; ROSENBLUTH MN, 1955, J CHEM PHYS, V23, P356, DOI 10.1063/1.1741967; Rozanska X, 2003, J PHYS CHEM B, V107, P1309, DOI 10.1021/jp021646b; Santilli D.S., 1993, MICROPOROUS MATER, V1, P329; Schenk M, 2003, J CATAL, V214, P88, DOI 10.1016/S0021-9517(03)00023-X; Schenk M, 2002, ANGEW CHEM INT EDIT, V41, P2500; Schenk M, 2001, ANGEW CHEM INT EDIT, V40, P736; Siepmann JI, 1997, MOL PHYS, V90, P687, DOI 10.1080/00268979709482654; SIEPMANN JI, 1993, NATURE, V365, P330, DOI 10.1038/365330a0; SIEPMANN JI, 1992, MOL PHYS, V75, P59, DOI 10.1080/00268979200100061; SMIT B, 1994, SCIENCE, V264, P1118, DOI 10.1126/science.264.5162.1118; SMIT B, 1995, NATURE, V374, P42, DOI 10.1038/374042a0; Thomas JM, 2007, ANGEW CHEM INT EDIT, V46, P7160, DOI 10.1002/anie.200700666; van Santen R.A., MOL HETEROGENEOUS CA; Vlugt TJH, 2002, J PHYS CHEM B, V106, P12757, DOI 10.1021/jp0263931; WEISZ PB, 1960, J PHYS CHEM-US, V64, P382, DOI 10.1021/j100832a513; Weitkamp J., 2001, CATALYSIS ZEOLITES, P327; YASHONATH S, 1988, NATURE, V331, P601, DOI 10.1038/331601a0; Yu M, 2005, LANGMUIR, V21, P7390, DOI 10.1021/la050856n	46	391	398	15	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					671	678		10.1038/nature06552	http://dx.doi.org/10.1038/nature06552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256663	Green Published			2022-12-28	WOS:000252929500032
J	Hellings, WE; Moll, FL; De Vries, JPPM; Ackerstaff, RGA; Seldenrijk, KA; Met, R; Velema, E; Derksen, WJM; De Kleijn, DPV; Pasterkamp, G				Hellings, Willem E.; Moll, Frans L.; De Vries, Jean-Paul P. M.; Ackerstaff, Rob G. A.; Seldenrijk, Kees A.; Met, Rosemarie; Velema, Evelyn; Derksen, Wouter J. M.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard			Atherosclerotic plaque composition and occurrence of Restenosis after carotid endarterectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERY STENOSIS; CARDIOVASCULAR EVENTS; ELUTING STENTS; PREDICTORS; DIAGNOSIS; STROKE; IMPACT; RISK	Context Previous studies have assessed the predictive value of clinical and angiographic parameters for development of restenosis after vascular interventions. The composition of the atherosclerotic plaque at the intervention site has not been evaluated as a marker for restenosis. Objective To investigate the relationship between atherosclerotic plaque histology and the occurrence of restenosis after carotid endarterectomy. Design, Setting, and Patients The Athero- Express study is a longitudinal vascular biobank study that includes the collection of atherosclerotic plaques of patients undergoing primary carotid endarterectomy. Five hundred patients were prospectively followed up between April 1, 2002, and March 14, 2006, to assess carotid artery restenosis measured by duplex ultrasound 1 year after the intervention. Main Outcome Measures Risk of carotid restenosis in relation to predefined histological characteristics ( macrophage and smooth muscle cell infiltration, collagen, calcifications, intraplaque bleeding, luminal thrombus, and lipid core size), adjusted for clinical characteristics ( multivariate logistic regression analysis). Results At 1 year, 85 patients ( 17%) developed 50% or greater restenosis, including 40 patients ( 8%) who developed 70% or greater restenosis of the target vessel. Patients whose histological examination of the plaque revealed marked macrophage infiltration ( n= 286) had a lower risk than those with none or minor macrophage infiltration ( n= 214) of developing 50% or greater restenosis ( risk difference, 11.5% vs 24.3%; adjusted odds ratio [ OR], 0.43; 95% confidence interval [ CI], 0.26- 0.72) and a lower risk of developing 70% or greater restenosis ( risk difference, 4.5% vs 12.6%; adjusted OR, 0.36; 95% CI, 0.17- 0.74). Patients ( n= 177) with a plaque having a large lipid core size ( > 40%) had a lower risk than those ( n= 94) with a plaque having a lipid core size of less than 10% of developing 50% or greater restenosis ( risk difference, 11.3% vs 25.5%; adjusted OR, 0.40; 95% CI, 0.19- 0.81) and a lower risk of developing 70% or greater restenosis ( risk difference, 5.6% vs 14.9%; adjusted OR, 0.42; 95% CI, 0.17- 1.04), independent of clinical characteristics. Conclusions Plaque composition is an independent predictor of restenosis after carotid endarterectomy. The dissection of a lipid- rich, inflammatory plaque is associated with reduced risk of restenosis.	[Met, Rosemarie; Velema, Evelyn; Derksen, Wouter J. M.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Utrecht, Med Ctr, Expt Cardiol Lab, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands; [Hellings, Willem E.; Moll, Frans L.] Univ Utrecht, Med Ctr, Dept Vasc Surg, NL-3584 CX Utrecht, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Ackerstaff, Rob G. A.] St Antonius Hosp, Dept Clin Neurophysiol, Nieuwegein, Netherlands; [Seldenrijk, Kees A.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands	Utrecht University; Utrecht University; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	Pasterkamp, G (corresponding author), Univ Utrecht, Med Ctr, Expt Cardiol Lab, Div Heart & Lungs, Heidelberglaan 100,Ste G02-523, NL-3584 CX Utrecht, Netherlands.	g.pasterkamp@umcutrecht.nl						CLAGETT GP, 1986, J VASC SURG, V3, P10; CLAGETT GP, 1983, SURGERY, V93, P313; Farb A, 2002, CIRCULATION, V105, P2974, DOI 10.1161/01.CIR.0000019071.72887.BD; Frericks H, 1998, STROKE, V29, P244, DOI 10.1161/01.STR.29.1.244; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halliday A, 2004, LANCET, V363, P1491; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HEALY DA, 1989, J VASC SURG, V10, P662, DOI 10.1067/mva.1989.16374; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hermiller JB, 2005, J AM COLL CARDIOL, V45, P1172, DOI 10.1016/j.jacc.2004.10.075; Higuchi Maria L., 2002, Arq. Bras. Cardiol., V79, P20, DOI 10.1590/S0066-782X2002001000003; Lee CW, 2006, AM J CARDIOL, V97, P506, DOI 10.1016/j.amjcard.2005.09.084; Lee SG, 1999, CATHETER CARDIO INTE, V47, P406, DOI 10.1002/(SICI)1522-726X(199908)47:4<406::AID-CCD5>3.3.CO;2-G; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Liapis CD, 2002, EUR J VASC ENDOVASC, V24, P239, DOI 10.1053/ejvs.2002.1714; Lovett JK, 2004, CEREBROVASC DIS, V18, P117, DOI 10.1159/000079259; Marek JM, 1998, J SURG RES, V74, P27, DOI 10.1006/jsre.1997.5222; Mauri L, 2004, AM J CARDIOL, V93, P1340, DOI 10.1016/j.amjcard.2004.02.027; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Naylor R, 2004, J VASC SURG, V39, P985, DOI 10.1016/j.jvs.2004.01.037; Netuka D, 2006, ACTA NEUROCHIR, V148, P511, DOI 10.1007/s00701-006-0756-y; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Pasterkamp G, 2000, CARDIOVASC RES, V45, P843, DOI 10.1016/S0008-6363(99)00377-6; Pasterkamp G, 2000, ATHEROSCLEROSIS, V150, P245, DOI 10.1016/S0021-9150(99)00371-8; Post MJ, 1997, CIRCULATION, V96, P996; Puppini G, 2006, RADIOL MED, V111, P921, DOI 10.1007/s11547-006-0091-7; Reina-Gutierrez T, 2005, EUR J VASC ENDOVASC, V29, P334, DOI 10.1016/j.ejvs.2004.10.007; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sabeti S, 2005, J ENDOVASC THER, V12, P6, DOI 10.1583/04-1359.1; Schulte-Altedorneburg G, 2005, J NEUROL, V252, P575, DOI 10.1007/s00415-005-0703-5; SCHWARCZ TH, 1987, J VASC SURG, V5, P280, DOI 10.1067/mva.1987.avs0050280; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Valentine RJ, 1996, STROKE, V27, P1502, DOI 10.1161/01.STR.27.9.1502; Verhoeven B, 2005, J VASC SURG, V42, P1075, DOI 10.1016/j.jvs.2005.08.009; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WIKSTRAND J, 1994, J INTERN MED, V236, P555, DOI 10.1111/j.1365-2796.1994.tb00845.x	40	91	94	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					547	554		10.1001/jama.299.5.547	http://dx.doi.org/10.1001/jama.299.5.547			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252885	Bronze			2022-12-28	WOS:000252886100020
J	Fahrenkopf, AM; Sectish, TC; Barger, LK; Sharek, PJ; Lewin, D; Chiang, VW; Edwards, S; Wiedermann, BL; Landrigan, CP				Fahrenkopf, Amy M.; Sectish, Theodore C.; Barger, Laura K.; Sharek, Paul J.; Lewin, Daniel; Chiang, Vincent W.; Edwards, Sarah; Wiedermann, Bernhard L.; Landrigan, Christopher P.			Rates of medication errors among depressed and burnt out residents: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PATIENT-CARE; WORK HOURS; INTERNS; ANXIETY; INPATIENTS; EDUCATION; DISTRESS; PROGRAM; EMPATHY; EVENTS	Objective To determine the prevalence of depression and burnout among residents in paediatrics and to establish if a relation exists between these disorders and medication errors. Design Prospective cohort study. Setting Three urban freestanding children's hospitals in the United States. Participants 123 residents in three paediatric residency programmes. Main outcome measures Prevalence of depression using the Harvard national depression screening day scale, burnout using the Maslach burnout inventory, and rate of medication errors per resident month. Results 24 (20%) of the participating residents met the criteria for depression and 92 (74%) met the criteria for burnout. Active surveillance yielded 45 errors made by participants. Depressed residents made 6.2 times as many medication errors per resident month as residents who were not depressed: 1.55 (95% confidence interval 0.57 to 4.22) compared with 0.25 (0.14 to 0.46, P<0.001). Burnt out residents and non-burnt out residents made similar rates of errors per resident month: 0.45 (0.20 to 0.98) compared with 0.53 (0.21 to 1.33, P=0.2). Conclusions Depression and burnout are major problems among residents in paediatrics. Depressed residents made significantly more medical errors than their non-depressed peers; however, burnout did not seem to correlate with an increased rate of medical errors.	[Fahrenkopf, Amy M.; Chiang, Vincent W.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Dept Med, Childrens Hosp, Boston, MA 02115 USA; [Sectish, Theodore C.; Sharek, Paul J.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Barger, Laura K.; Edwards, Sarah; Landrigan, Christopher P.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lewin, Daniel; Wiedermann, Bernhard L.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Washington, DC USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Lucile Packard Children's Hospital (LPCH); Stanford University; Harvard University; Brigham & Women's Hospital; Children's National Health System; George Washington University	Fahrenkopf, AM (corresponding author), Harvard Univ, Sch Med, Dept Med, Childrens Hosp, Boston, MA 02115 USA.	amy.fahrenkopf@tch.harvard.edu		Landrigan, Christopher/0000-0001-8386-4100	AHRQ HHS [K08 HS13333] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013333] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Arnedt JT, 2001, ACCIDENT ANAL PREV, V33, P337, DOI 10.1016/S0001-4575(00)00047-6; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Baer L, 2000, PSYCHOTHER PSYCHOSOM, V69, P35, DOI 10.1159/000012364; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; COLFORD JM, 1989, JAMA-J AM MED ASSOC, V261, P889, DOI 10.1001/jama.261.6.889; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Goitein L, 2005, ARCH INTERN MED, V165, P2601, DOI 10.1001/archinte.165.22.2601; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; HENDRIE HC, 1990, J NERV MENT DIS, V178, P204, DOI 10.1097/00005053-199003000-00009; HSU K, 1987, AM J PSYCHIAT, V144, P1561; *I MED, 1999, TO ERR IS HUM BUILD; *I MED, 1999, TO ERR IS HUMAN BUIL; Institute of Medicine, 2006, PREV MED ERR; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leape LL, 2000, BMJ-BRIT MED J, V320, P725, DOI 10.1136/bmj.320.7237.725; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Peterlini M, 2002, MED EDUC, V36, P66, DOI 10.1046/j.1365-2923.2002.01104.x; Roseman C, 1995, NURS RES, V44, P226; Rothberg MB, 2005, MED CARE, V43, P785, DOI 10.1097/01.mlr.0000170408.35854.fa; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; SCHNEIDER SE, 1993, PSYCHOL REP, V72, P1145, DOI 10.2466/pr0.1993.72.3c.1145; Scott LD, 2006, AM J CRIT CARE, V15, P30; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	33	694	713	0	47	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					488	491		10.1136/bmj.39469.763218.BE	http://dx.doi.org/10.1136/bmj.39469.763218.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274JL	18258931	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000253997500041
J	Lee, SH; Choi, JH; Lee, N; Lee, HR; Kim, JI; Yu, NK; Choi, SL; Lee, SH; Kim, H; Kaang, BK				Lee, Sue-Hyun; Choi, Jun-Hyeok; Lee, Nuribalhae; Lee, Hye-Ryeon; Kim, Jae-Ick; Yu, Nam-Kyung; Choi, Sun-Lim; Lee, Seung-Hee; Kim, Hyoung; Kaang, Bong-Kiun			Synaptic protein degradation underlies destabilization of retrieved fear memory	SCIENCE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; LONG-TERM FACILITATION; RECONSOLIDATION; EXTINCTION; CONSOLIDATION; EXPRESSION; PLASTICITY; GENES; MODULATION; STABILITY	Reactivated memory undergoes a rebuilding process that depends on de novo protein synthesis. This suggests that retrieval is dynamic and serves to incorporate new information into preexisting memories. However, little is known about whether or not protein degradation is involved in the reorganization of retrieved memory. We found that postsynaptic proteins were degraded in the hippocampus by polyubiquitination after retrieval of contextual fear memory. Moreover, the infusion of proteasome inhibitor into the CA1 region immediately after retrieval prevented anisomycin- induced memory impairment, as well as the extinction of fear memory. This suggests that ubiquitin- and proteasome-dependent protein degradation underlies destabilization processes after fear memory retrieval. It also provides strong evidence for the existence of reorganization processes whereby preexisting memory is disrupted by protein degradation, and updated memory is reconsolidated by protein synthesis.	[Lee, Sue-Hyun; Choi, Jun-Hyeok; Lee, Nuribalhae; Lee, Hye-Ryeon; Kim, Jae-Ick; Yu, Nam-Kyung; Choi, Sun-Lim; Lee, Seung-Hee; Kim, Hyoung; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat Ctr Memory, Seoul 151747, South Korea	Seoul National University (SNU)	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat Ctr Memory, San 56-1 Silim Dong, Seoul 151747, South Korea.	kaang@snu.ac.kr	Lee, Sue-Hyun/F-5490-2015; Kim, Jae-Ick/AAY-6005-2020; Lee, Seung-Hee/J-5971-2013; Kim, Jae-Ick/R-4007-2017	Lee, Sue-Hyun/0000-0002-5318-5657; Kim, Jae-Ick/0000-0001-9705-0394				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Ferrell K, 1996, FEBS LETT, V381, P143, DOI 10.1016/0014-5793(96)00101-9; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000	31	289	298	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1253	1256		10.1126/science.1150541	http://dx.doi.org/10.1126/science.1150541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258863				2022-12-28	WOS:000253530600047
J	Melese, M; Alemayehu, W; Lakew, T; Yi, E; House, J; Chidambaram, JD; Zhou, ZX; Cevallos, V; Ray, K; Hong, KC; Porco, TC; Phan, I; Zaidi, A; Gaynor, BD; Whitcher, JP; Lietman, TM				Melese, Muluken; Alemayehu, Wondu; Lakew, Takele; Yi, Elizabeth; House, Jenafir; Chidambaram, Jaya D.; Zhou, Zhaoxia; Cevallos, Vicky; Ray, Kathryn; Hong, Kevin Cyrus; Porco, Travis C.; Phan, Isabella; Zaidi, Ali; Gaynor, Bruce D.; Whitcher, John P.; Lietman, Thomas M.			Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SINGLE-DOSE AZITHROMYCIN; CHLAMYDIA-TRACHOMATIS; STREPTOCOCCUS-PNEUMONIAE; GLOBAL ELIMINATION; CONTROL PROGRAMS; IMPACT; COMMUNITY; PREVALENCE; SUSCEPTIBILITY; REINFECTION	Context Treatment recommendations assume that repeated mass antibiotic distributions can control, but not eradicate or even locally eliminate, the ocular strains of chlamydia that cause trachoma. Elimination may be an important end point because of concern that infection will return to communities that have lost immunity to chlamydia after antibiotics are discontinued. Objective To determine whether biannual treatment can eliminate ocular chlamydial infection from preschool children and to compare results with the World Health Organization - recommended annual treatment. Design, Setting, and Participants A cluster- randomized clinical trial of biannual vs annual mass azithromycin administrations to all residents of 16 rural villages in the Gurage Zone, Ethiopia, from March 2003 to April 2005. Interventions At scheduled treatments, all individuals aged 1 year or older ere offered a single dose of oral azithromycin either annually or biannually. Main Outcome Measure Village prevalence of ocular chlamydial infection and presence of elimination at 24 months in preschool children determined by polymerase chain reaction, correcting for baseline prevalence. Antibiotic treatments were performed after sample collections. Results Overall, 14 897 of 16 403 eligible individuals ( 90.8%) received their scheduled treatment. In the villages in which residents were treated annually, the prevalence of infection in preschool children was reduced from a mean of 42.6% ( range, 14.7%-56.4%) to 6.8% ( range, 0.0%- 22.0%) at 24 months. In the villages in which residents were treated biannually, infection was reduced from 31.6% pretreatment ( range, 6.1%-48.6%) to 0.9% ( range, 0.0%- 4.8%) at 24 months. Biannual treatment was associated with a lower prevalence at 24 months ( P=. 03, adjusting for baseline prevalence). At 24 months, no infection could be identified in 6 of 8 of those treated biannually and in 1 of 8 of those treated annually ( P=. 049, adjusting for baseline prevalence). Conclusion Local elimination of ocular chlamydial infection appears feasible even in the most severely affected areas, although it may require biannual mass antibiotic distributions at a high coverage level. Trial Registration clinicaltrials. gov Identifier: NCT00221364.	[Lakew, Takele; Yi, Elizabeth; House, Jenafir; Chidambaram, Jaya D.; Zhou, Zhaoxia; Cevallos, Vicky; Ray, Kathryn; Hong, Kevin Cyrus; Porco, Travis C.; Phan, Isabella; Zaidi, Ali; Gaynor, Bruce D.; Whitcher, John P.; Lietman, Thomas M.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Phan, Isabella; Gaynor, Bruce D.; Whitcher, John P.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Porco, Travis C.; Whitcher, John P.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Whitcher, John P.; Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; [Melese, Muluken; Alemayehu, Wondu; Lakew, Takele] Orbis Int, Addis Ababa, Ethiopia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, 513 Parnassus Ave,Room S309, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu		Chidambaram, Jaya/0000-0001-5438-2858	NATIONAL EYE INSTITUTE [U10EY016214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055752] Funding Source: NIH RePORTER; NEI NIH HHS [U10 EY016214] Funding Source: Medline; NIAID NIH HHS [R21 AI 55752] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2004, 8 M WHO ALL GLOB EL; Atik B, 2006, JAMA-J AM MED ASSOC, V296, P1488, DOI 10.1001/jama.296.12.1488; Batt SL, 2003, ANTIMICROB AGENTS CH, V47, P2765, DOI 10.1128/AAC.47.9.2765-2769.2003; Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Chidambaram JD, 2005, LANCET INFECT DIS, V5, P194, DOI 10.1016/S1473-3099(05)70032-3; Chidambaram JD, 2004, CLIN INFECT DIS, V39, pE95, DOI 10.1086/424747; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Gaynor Bruce D., 2002, International Ophthalmology Clinics, V42, P85; KATZ J, 1988, INT J EPIDEMIOL, V17, P865, DOI 10.1093/ije/17.4.865; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lee DC, 2005, AM J TROP MED HYG, V72, P468, DOI 10.4269/ajtmh.2005.72.468; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Lietman TM, 2005, NEW ENGL J MED, V352, P414; Mariotti SP, 2004, NEW ENGL J MED, V351, P2004, DOI 10.1056/NEJMe048205; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Murray DM, 1998, DESIGN ANAL GROUP RA; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Potter DM, 2005, STAT MED, V24, P693, DOI 10.1002/sim.1931; Ray KJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-91; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SACKS JM, 1989, AM J VET RES, V50, P205; Solomon AW, 2005, NEW ENGL J MED, V352, P414; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Taylor H, 1999, NAT MED, V5, P492, DOI 10.1038/8376; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; West SK, 2006, LANCET, V368, P596, DOI 10.1016/S0140-6736(06)69203-9; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; Yang Jon L, 2007, Arch Ophthalmol, V125, P989, DOI 10.1001/archopht.125.7.989; Zhang JZ, 2004, PEDIATR INFECT DIS J, V23, P217, DOI 10.1097/01.inf.0000115501.60397.a6	39	64	64	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					778	784		10.1001/jama.299.7.778	http://dx.doi.org/10.1001/jama.299.7.778			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285589	Bronze			2022-12-28	WOS:000253226900020
J	Beninca, E; Huisman, J; Heerkloss, R; Johnk, KD; Branco, P; Van Nes, EH; Scheffer, M; Ellner, SP				Beninca, Elisa; Huisman, Jef; Heerkloss, Reinhard; Johnk, Klaus D.; Branco, Pedro; Van Nes, Egbert H.; Scheffer, Marten; Ellner, Stephen P.			Chaos in a long-term experiment with a plankton community	NATURE			English	Article							CYCLES; SERIES; OSCILLATIONS; MODELS	Mathematical models predict that species interactions such as competition and predation can generate chaos(1-8). However, experimental demonstrations of chaos in ecology are scarce, and have been limited to simple laboratory systems with a short duration and artificial species combinations(9-12). Here, we present the first experimental demonstration of chaos in a long- term experiment with a complex food web. Our food web was isolated from the Baltic Sea, and consisted of bacteria, several phytoplankton species, herbivorous and predatory zooplankton species, and detritivores. The food web was cultured in a laboratory mesocosm, and sampled twice a week for more than 2,300 days. Despite constant external conditions, the species abundances showed striking fluctuations over several orders of magnitude. These fluctuations displayed a variety of different periodicities, which could be attributed to different species interactions in the food web. The population dynamics were characterized by positive Lyapunov exponents of similar magnitude for each species. Predictability was limited to a time horizon of 15 - 30 days, only slightly longer than the local weather forecast. Hence, our results demonstrate that species interactions in food webs can generate chaos. This implies that stability is not required for the persistence of complex food webs, and that the long- term prediction of species abundances can be fundamentally impossible.	[Beninca, Elisa; Huisman, Jef; Johnk, Klaus D.; Branco, Pedro] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; [Beninca, Elisa; Van Nes, Egbert H.; Scheffer, Marten] Univ Wageningen & Res Ctr, Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Heerkloss, Reinhard] Univ Rostock, Inst Biosci, Rostock, Germany; [Ellner, Stephen P.] Cornell Univ, Ithaca, NY 14853 USA	University of Amsterdam; Wageningen University & Research; University of Rostock; Cornell University	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Nieuwe Achtergracht 127, NL-1018 WS Amsterdam, Netherlands.	jef.huisman@science.uva.nl	Huisman, Jef/A-1089-2013; Jöhnk, Klaus/B-3382-2008; Scheffer, Marten/C-1852-2012; van Nes, Egbert H/F-2681-2011	Huisman, Jef/0000-0001-9598-3211; Jöhnk, Klaus/0000-0002-5972-4201; van Nes, Egbert/0000-0002-6345-104X; Branco, Pedro/0000-0002-5010-0419				Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GAEDEKE A, 1986, OECOLOGIA, V71, P25, DOI 10.1007/BF00377315; GILPIN ME, 1979, AM NAT, V113, P306, DOI 10.1086/283389; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Heerkloss R, 1998, INT VER THEOR ANGEW, V26, P1952; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kantz H., 2003, NONLINEAR TIME SERIE, V2nd ed; Kendall BE, 2001, CHAOS SOLITON FRACT, V12, P321, DOI 10.1016/S0960-0779(00)00180-6; LORENZ EN, 1982, TELLUS, V34, P505, DOI 10.1111/j.2153-3490.1982.tb01839.x; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; NYCHKA D, 1992, J ROY STAT SOC B MET, V54, P399; REDFIELD AC, 1958, AM SCI, V46, P205; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Scheffer M, 2000, FRESHWATER BIOL, V45, P265, DOI 10.1046/j.1365-2427.2000.00674.x; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; van Nes EH, 2004, AM NAT, V164, P255, DOI 10.1086/422204; VANDERMEER J, 1993, AM NAT, V141, P687, DOI 10.1086/285500; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	30	247	256	6	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					822	U7		10.1038/nature06512	http://dx.doi.org/10.1038/nature06512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273017				2022-12-28	WOS:000253191400041
J	Nicholson, TRJ; Cutter, W; Hotopf, M				Nicholson, Timothy R. J.; Cutter, William; Hotopf, Matthew			Assessing mental capacity: the Mental Capacity Act	BRITISH MEDICAL JOURNAL			English	Review							PREVALENCE; INPATIENTS; INCAPACITY; CONSENT		[Nicholson, Timothy R. J.; Hotopf, Matthew] Inst Psychiat, Western Educ Ctr, Dept Psychol Med, London SE5 9RJ, England; [Cutter, William] Hampshire Partnership NHS Trust, Directorate Older Persons Mental Hlth Serv, Southampton SO40 2RZ, Hants, England	University of London; King's College London	Hotopf, M (corresponding author), Inst Psychiat, Western Educ Ctr, Dept Psychol Med, London SE5 9RJ, England.	m.hotopf@iop.kcl.ac.uk	Hotopf, Matthew/E-4971-2010	Hotopf, Matthew/0000-0002-3980-4466; Nicholson, Timothy/0000-0002-2350-2332				Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Evans K, 2007, EMERG MED J, V24, P391, DOI 10.1136/emj.2006.041293; Jackson E, 2002, J ROY SOC MED, V95, P601, DOI 10.1258/jrsm.95.12.601; Okai D, 2007, BRIT J PSYCHIAT, V191, P291, DOI 10.1192/bjp.bp.106.035162; Ranjith G, 2004, J ROY SOC MED, V97, P480, DOI 10.1258/jrsm.97.10.480; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3	6	39	40	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					322	325		10.1136/bmj.39457.485347.80	http://dx.doi.org/10.1136/bmj.39457.485347.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18258967	Green Published			2022-12-28	WOS:000253437400034
J	Mace, R				Mace, Ruth			Reproducing in cities	SCIENCE			English	Editorial Material							SUB-SAHARAN AFRICA; SEXUAL SELECTION; FERTILITY; POPULATION; ETHIOPIA; IMPACT	Reproducing in cities has always been costly, leading to lower fertility (that is, lower birth rates) in urban than in rural areas. Historically, although cities provided job opportunities, initially residents incurred the penalty of higher infant mortality, but as mortality rates fell at the end of the 19th century, European birth rates began to plummet. Fertility decline in Africa only started recently and has been dramatic in some cities. Here it is argued that both historical and evolutionary demographers are interpreting fertility declines across the globe in terms of the relative costs of child rearing, which increase to allow children to outcompete their peers. Now largely free from the fear of early death, postindustrial societies may create an environment that generates runaway parental investment, which will continue to drive fertility ever lower.	UCL, Dept Anthropol, London WC1H 0BW, England	University of London; University College London	Mace, R (corresponding author), UCL, Dept Anthropol, Taviton St, London WC1H 0BW, England.	r.mace@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739				Adler A., 1997, UNDERSTAND HUMAN NAT; Birchenall JA, 2007, WORLD DEV, V35, P543, DOI 10.1016/j.worlddev.2006.06.003; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Boyd R., 1985, CULTURE EVOLUTIONARY; Central Statistical Agency, 2006, ETH DEM HLTH SURV; Cohen B, 1998, WORLD DEV, V26, P1431, DOI 10.1016/S0305-750X(98)00058-8; DOWNEY DB, 1995, AM SOCIOL REV, V60, P746, DOI 10.2307/2096320; Fisher R.A., 1930, GENETICAL THEORY NAT; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; GURMU E, 2008, J BIOSOC SCI; Hrdy Sarah, 2000, MOTHER NATURE MATERN; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Lack D., 1954, P143; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Low BS, 2000, ADAPTATION HUMAN BEH, P323; Mace R, 1998, PHILOS T R SOC B, V353, P389, DOI 10.1098/rstb.1998.0217; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; MACE R, 2007, OXFORD HDB EVOLUTION, P383; McNarmara John M., 2006, SOCIAL INFORM TRANSM, P59; Panter-Brick Catherine, 2000, ABANDONED CHILDREN; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; ROTH EA, 1993, AM ANTHROPOL, V95, P597, DOI 10.1525/aa.1993.95.3.02a00030; Sibanda A, 2003, STUD FAMILY PLANN, V34, P1, DOI 10.1111/j.1728-4465.2003.00001.x; Szreter Simon., 1996, FERTILITY CLASS GEND; Voland E, 1997, J BIOSOC SCI, V29, P355, DOI 10.1017/S0021932097003556	27	52	54	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					764	766		10.1126/science.1153960	http://dx.doi.org/10.1126/science.1153960			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258904				2022-12-28	WOS:000252963000047
J	Mallal, S; Phillips, E; Carosi, G; Molina, JM; Workman, C; Tomazic, J; Jagel-Guedes, E; Rugina, S; Kozyrev, O; Cid, JF; Hay, P; Nolan, D; Hughes, S; Hughes, A; Ryan, S; Fitch, N; Thorborn, D; Benbow, A				Mallal, Simon; Phillips, Elizabeth; Carosi, Giampiero; Molina, Jean-Michel; Workman, Cassy; Tomazic, Janez; Jaegel-Guedes, Eva; Rugina, Sorin; Kozyrev, Oleg; Cid, Juan Flores; Hay, Phillip; Nolan, David; Hughes, Sara; Hughes, Arlene; Ryan, Susanna; Fitch, Nicholas; Thorborn, Daren; Benbow, Alastair		PREDICT-1 Study Team	HLA-B*5701 screening for hypersensitivity to abacavir	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-INFECTED ADULTS; HLA-B REGION; GENETIC-VARIATIONS; ASSOCIATION; ZIDOVUDINE; LAMIVUDINE; TRIAL	Background: Hypersensitivity reaction to abacavir is strongly associated with the presence of the HLA-B*5701 allele. This study was designed to establish the effectiveness of prospective HLA-B*5701 screening to prevent the hypersensitivity reaction to abacavir. Methods: This double-blind, prospective, randomized study involved 1956 patients from 19 countries, who were infected with human immunodeficiency virus type 1 and who had not previously received abacavir. We randomly assigned patients to undergo prospective HLA-B*5701 screening, with exclusion of HLA-B*5701-positive patients from abacavir treatment (prospective-screening group), or to undergo a standard-of-care approach of abacavir use without prospective HLA-B*5701 screening (control group). All patients who started abacavir were observed for 6 weeks. To immunologically confirm, and enhance the specificity of, the clinical diagnosis of hypersensitivity reaction to abacavir, we performed epicutaneous patch testing with the use of abacavir. Results: The prevalence of HLA-B*5701 was 5.6% (109 of 1956 patients). Of the patients receiving abacavir, 72% were men, 84% were white, and 18% had not previously received antiretroviral therapy. Screening eliminated immunologically confirmed hypersensitivity reaction (0% in the prospective-screening group vs. 2.7% in the control group, P<0.001), with a negative predictive value of 100% and a positive predictive value of 47.9%. Hypersensitivity reaction was clinically diagnosed in 93 patients, with a significantly lower incidence in the prospective-screening group (3.4%) than in the control group (7.8%) (P<0.001). Conclusions: HLA-B*5701 screening reduced the risk of hypersensitivity reaction to abacavir. In predominantly white populations, similar to the one in this study, 94% of patients do not carry the HLA-B*5701 allele and are at low risk for hypersensitivity reaction to abacavir. Our results show that a pharmacogenetic tst can be used to prevent a specific toxic effect of a drug. (ClinicalTrials.gov number, NCT00340080.).	[Mallal, Simon; Phillips, Elizabeth; Nolan, David] Royal Perth Hosp, Perth, WA, Australia; [Mallal, Simon; Phillips, Elizabeth; Nolan, David] Murdoch Univ, Perth, WA, Australia; [Carosi, Giampiero] Univ Brescia, Brescia, Italy; Hop St Louis, Paris, France; [Workman, Cassy] AIDS Res Initiat, Darlinghurst, NSW, Australia; [Tomazic, Janez] Univ Ljubljana, Med Ctr, Ljubljana 61000, Slovenia; [Jaegel-Guedes, Eva] HIV Res & Clin Care Ctr Munich, Munich, Germany; [Rugina, Sorin] Infect Constanta, Bucharest, Romania; [Kozyrev, Oleg] Volgograd Reg Ctr AIDS, Volgograd, Russia; [Cid, Juan Flores] Hosp Arnau Vilanova, Valencia, Spain; [Hay, Phillip] Gen Hosp St Georg, London, England; [Rugina, Sorin] MediTech Media, London, England; [Hughes, Sara] GlaxoSmithKline Inc, Greenford, Middx, England; [Hughes, Arlene] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Fitch, Nicholas; Thorborn, Daren; Benbow, Alastair] GlaxoSmithKline Inc, Brentwood, Essex, England	Royal Perth Hospital; University of Western Australia; Murdoch University; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Ljubljana; St Georges University London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Mallal, S (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, South St, Murdoch, WA 6150, Australia.	s.mallal@murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022; Rugina, Sorin/U-5168-2019; Streinu-Cercel, Adrian/M-5835-2017	Mallal, Simon Alexander/0000-0002-7036-1309; Streinu-Cercel, Adrian/0000-0001-6382-5067				DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Hammond E, 2007, ANTIVIR THER, V12, P1027; Hernandez J, 2003, ANTIVIR THER, V8, pL88; HERNANDEZ JE, 2003, 43 INT C ANT AG CHEM, P339; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; HUGHES S, IN PRESS PHARM STAT; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Martin AM, 2005, TISSUE ANTIGENS, V65, P571, DOI 10.1111/j.1399-0039.2005.00401.x; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; Martin AM, 2006, PHARMACOGENET GENOM, V16, P353, DOI 10.1097/01.fpc.0000197468.16126.cd; MOSTELLER M, 2006, 16 INT AIDS C TOR AU, V2, P76; PHILLIPS E, 2007, 4 IAS C HIV PATH TRE, P49; PHILLIPS E, 2006, REV ANTIVIR THER, V3, P57; Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb; Phillips EJ, 2002, AIDS, V16, P2223, DOI 10.1097/00002030-200211080-00017; Phillips EJ, 2006, CURR OPIN HIV AIDS, V1, P249, DOI 10.1097/01.COH.0000221600.64659.d3; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Reeves I, 2006, ANTIVIR THER, V11, pL11; SAAG M, IN PRESS CLIN INFECT; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; STASZEWSKI S, 2001, JAMA-J AM MED ASSOC, V285, P2858; *SUST EMEA, 2007, SUMM PROD CHAR; TESCH N, 2006, 8 INT C DRUG THER HI, P44; *VIR EMEA, 2007, SUMM PROD CHAR; Zucman D, 2007, JAIDS-J ACQ IMM DEF, V45, P1, DOI 10.1097/QAI.0b013e318046ea31	28	1243	1284	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					568	579		10.1056/NEJMoa0706135	http://dx.doi.org/10.1056/NEJMoa0706135			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256392	Green Published			2022-12-28	WOS:000252916400004
J	Williams, JM				Williams, Jill M.			Eliminating tobacco use in mental health facilities - Patients' rights, public health, and policy issues	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING BANS; NICOTINE; SCHIZOPHRENIA; SETTINGS; DISORDER; ILLNESS; SMOKERS		[Williams, Jill M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Addict Psychiat, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Williams, JM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Addict Psychiat, 317 George St,Ste 105, New Brunswick, NJ 08901 USA.	jill.williams@umdnj.edu		Williams, Jill/0000-0001-8664-4373	NIMH NIH HHS [R01-MH076672-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076672] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burke M, 2006, TECHNICAL REPORT SMO; Conners CK, 1996, PSYCHOPHARMACOL BULL, V32, P67; Covey LS, 1994, TOB CONTROL, V3, P222, DOI DOI 10.1136/TC.3.3.222; Dalack GW, 1999, NEUROPSYCHOPHARMACOL, V21, P195, DOI 10.1016/S0893-133X(98)00121-3; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1617, DOI 10.1176/appi.ps.53.12.1617; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; HAGMAN BT, 2002, ADDICT BEHAV; Henningfield J E, 1999, Nicotine Tob Res, V1 Suppl 2, pS31; KLEISS K, 2005, EDMONTON J      0707, pB3; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawn S, 2005, AUST NZ J PSYCHIAT, V39, P866, DOI 10.1080/j.1440-1614.2005.01697.x; Longo DR, 1996, JAMA-J AM MED ASSOC, V275, P1252, DOI 10.1001/jama.275.16.1252; MARTINEAU K, 2007, HARTFORD COURAN 1002, pB9; Mauer B., 2006, MORBIDITY MORTALITY; Miller BJ, 2006, PSYCHIAT SERV, V57, P1482, DOI 10.1176/appi.ps.57.10.1482; *NEW JERS PROT ADV, HIGHL NJP AS ADV PAT; *PRES NEW FREED CO, 2003, DEP HHS PUBL; Prochaska J, 2004, PSYCHIAT SERV, V55, P1265, DOI 10.1176/appi.ps.55.11.1265; Russell MA, 1990, NICOTINE PSYCHOPHARM, P374; TYLER ML, 1998, GEORGETOWN LAW J, P86; Williams JM, 2005, SCHIZOPHR RES, V79, P323, DOI 10.1016/j.schres.2005.04.016; 2003, VENTURA COUNTY  0701	23	47	49	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					571	573		10.1001/jama.299.5.571	http://dx.doi.org/10.1001/jama.299.5.571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252888				2022-12-28	WOS:000252886100024
J	Cohen, AT; Tapson, VF; Bergmann, JF; Goldhaber, SZ; Kakkar, AK; Deslandes, B; Huang, W; Zayaruzny, M; Emery, L; Anderson, FA				Cohen, Alexander T.; Tapson, Victor F.; Bergmann, Jean-Francois; Goldhaber, Samuel Z.; Kakkar, Ajay K.; Deslandes, Bruno; Huang, Wei; Zayaruzny, Maksim; Emery, Leigh; Anderson, Frederick A., Jr.		ENDORSE Investigators	Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study	LANCET			English	Article							ILL MEDICAL PATIENTS; PULMONARY-EMBOLISM; PREVENTION; THROMBOPROPHYLAXIS; GUIDELINES; PLACEBO	Background information about the variation in the risk for venous thromboembolism (VTE) and in prophylaxis practices around the world is scarce. The ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study is a multinational cross-sectional survey designed to assess the prevalence of VTE risk in the acute hospital care setting, and to determine the proportion of at-risk patients who receive effective prophylaxis. Methods All hospital inpatients aged 40 years or over admitted to a medical ward, or those aged 18 years or over admitted to a surgical ward, in 358 hospitals across 32 countries were assessed for risk of VTE on the basis of hospital chart review. The 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess VTE risk and to determine whether patients were receiving recommended prophylaxis. Findings 68183 patients were enrolled; 30 827 (45%) were categorised as surgical, and 37 356 (55%) as medical. On the basis of ACCP criteria, 35 329 (51.8%; 95% CI 51.4-52.2; between-country range 35.6-72.6) patients were judged to be at risk for VTE, including 19 842 (64.4%; 63.8-64.9; 44.1-80.2) surgical patients and 15 487 (41. 5%; 41.0-42. 0; 21.1-71.2) medical patients. Of the surgical patients at risk, 11613 (58.5%; 57.8-59.2; 0.2-92.1) received ACCP-recommended VTE prophylaxis, compared with 6119 (39.5%; 38.7-40.3; 3.1-70.4) at-risk medical patients. Interpretation A large proportion of hospitalised patients are at risk for VTE, but there is a low rate of appropriate prophylaxis. Our data reinforce the rationale for the use of hospital-wide strategies to assess patients' VTE risk and to implement measures that ensure that at-risk patients receive appropriate prophylaxis.	[Cohen, Alexander T.] Kings Coll Hosp London, London SE5 9RS, England; [Tapson, Victor F.] Duke Univ, Med Ctr, Durham, NC USA; [Bergmann, Jean-Francois] Univ Paris 07, Hop Lariboisiere, Paris, France; [Goldhaber, Samuel Z.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Kakkar, Ajay K.] Barts & London Queen Marys Sch Med & Dent, Thrombosis Res Inst, London, England; [Deslandes, Bruno] Sanofi Aventis, Paris, France; [Huang, Wei; Zayaruzny, Maksim; Emery, Leigh; Anderson, Frederick A., Jr.] Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA	King's College Hospital NHS Foundation Trust; King's College Hospital; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Thrombosis Research Institute; University of London; Queen Mary University London; Sanofi-Aventis; University of Massachusetts System; University of Massachusetts Worcester	Cohen, AT (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	alexander.cohen@kcl.ac.uk	Bergmann, Jean-Francois/L-6044-2017; Kaynar, Leylagul/F-6991-2013	Bergmann, Jean-Francois/0000-0001-6861-9748; Kaynar, Leylagul/0000-0002-2035-9462; Franca, Ana/0000-0001-6925-0196; Epelde, Francisco/0000-0001-5547-4025				Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; Amin A, 2007, J THROMB HAEMOST, V5, P1610, DOI 10.1111/j.1538-7836.2007.02650.x; Anderson FA, 2007, AM J HEMATOL, V82, P777, DOI 10.1002/ajh.20983; Baglin T, 2006, BRIT J HAEMATOL, V133, P19, DOI 10.1111/j.1365-2141.2005.05953.x; CLAGETT GP, 1992, CHEST S, V102, P391; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Eikelboom JW, 2004, HAEMATOLOGICA, V89, P586; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Kahn SR, 2007, THROMB RES, V119, P145, DOI 10.1016/j.thromres.2006.01.011; KAKKAR V V, 1975, Lancet, V2, P45; LINBLAD B, 1991, BRIT MED J, V302, P709; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Otero R, 2001, EUR J SURG, V167, P163; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Prandoni P, 1997, HAEMATOLOGICA, V82, P423; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Yu HT, 2007, AM J HEALTH-SYST PH, V64, P69, DOI 10.2146/ajhp060115; 2006, AM HOSP ASS ANN SURV	22	999	1088	0	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					387	394		10.1016/S0140-6736(08)60202-0	http://dx.doi.org/10.1016/S0140-6736(08)60202-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242412				2022-12-28	WOS:000252992700028
J	Guarente, L				Guarente, Leonard			Mitochondria - A nexus for aging, calorie restriction, and sirtuins?	CELL			English	Article							LIFE-SPAN; INDUCED LONGEVITY; PROTEIN SIR2; MUTATIONS; COMPLEX; BIOGENESIS; GENERATION; PHENOTYPES; EXTENSION; OXIDATION	Recent studies of calorie restriction in several organisms demonstrate an increase in mitochondrial activity that is associated with the salutary effects of this dietary restriction regimen. In this Essay, I speculate on how an increase in mitochondrial activity might provide benefit and discuss how diet, mitochondria, and sirtuins might interact in a pathway to slow aging and associated diseases.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	leng@mit.edu			NIA NIH HHS [R01 AG015339-04, R01 AG015339, R01 AG011119-08, R01 AG011119] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011119, R01AG015339] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JIA K, 2000, AUTOPHAGY, V3, P597; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pamplona R, 2007, AGEING RES REV, V6, P189, DOI 10.1016/j.arr.2007.06.002; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weindruch R., 1988, RETARDATION AGING DI; YANG H, 2007, CELL, V130, P432; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	45	398	415	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					171	176		10.1016/j.cell.2008.01.007	http://dx.doi.org/10.1016/j.cell.2008.01.007			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243090	Bronze, Green Accepted			2022-12-28	WOS:000253427700001
J	FEINBERG, EL				FEINBERG, EL			THE PHYSICIST AND THE SOVIET CITIZEN	NATURE			English	Editorial Material											FEINBERG, EL (corresponding author), PN LEBEDEV PHYS INST,LENINSKY PROSP 53,MOSCOW 117924,RUSSIA.								0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					11	14		10.1038/344011a0	http://dx.doi.org/10.1038/344011a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278002				2022-12-28	WOS:A1990CQ97200028
J	Reddy, KL; Zullo, JM; Bertolino, E; Singh, H				Reddy, K. L.; Zullo, J. M.; Bertolino, E.; Singh, H.			Transcriptional repression mediated by repositioning of genes to the nuclear lamina	NATURE			English	Article							CELL DIFFERENTIATION; MEMBRANE PROTEIN; GENOME; LOCUS; EMERIN; COMPARTMENTALIZATION; ORGANIZATION; ARCHITECTURE; ASSOCIATION; EXPRESSION	Nuclear compartmentalization seems to have an important role in regulating metazoan genes(1,2). Although studies on immunoglobulin and other loci have shown a correlation between positioning at the nuclear lamina and gene repression, the functional consequences of this compartmentalization remain untested(2,3). We devised an approach for inducible tethering of genes to the inner nuclear membrane ( INM), and tested the consequences of such repositioning on gene activity in mouse fibroblasts. Here, using three- dimensional DNA- immunoFISH, we demonstrate repositioning of chromosomal regions to the nuclear lamina that is dependent on breakdown and reformation of the nuclear envelope during mitosis. Moreover, tethering leads to the accumulation of lamin and INM proteins, but not to association with pericentro-meric heterochromatin or nuclear pore complexes. Recruitment of genes to the INM can result in their transcriptional repression. Finally, we use targeted adenine methylation ( DamID) to show that, as is the case for our model system, inactive immunoglobulin loci at the nuclear periphery are contacted by INM and lamina proteins. We propose that these molecular interactions may be used to compartmentalize and to limit the accessibility of immunoglobulin loci to transcription and recombination factors.	[Reddy, K. L.; Zullo, J. M.; Singh, H.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Reddy, K. L.; Zullo, J. M.; Bertolino, E.; Singh, H.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, GCIS W522,929 E 57th St, Chicago, IL 60637 USA.	hsingh@uchicago.edu		Reddy, Karen/0000-0003-4548-5999	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jolly C, 1997, J HISTOCHEM CYTOCHEM, V45, P1585, DOI 10.1177/002215549704501201; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; SCHMID M, 2006, MOL CELL, V31, P279; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tsuchiya Y, 1999, EUR J BIOCHEM, V259, P859, DOI 10.1046/j.1432-1327.1999.00112.x; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	28	554	571	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					243	247		10.1038/nature06727	http://dx.doi.org/10.1038/nature06727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18272965				2022-12-28	WOS:000253925600046
J	Johnnidis, JB; Harris, MH; Wheeler, RT; Stehling-Sun, S; Lam, MH; Kirak, O; Brummelkamp, TR; Fleming, MD; Camargo, FD				Johnnidis, Jonathan B.; Harris, Marian H.; Wheeler, Robert T.; Stehling-Sun, Sandra; Lam, Michael H.; Kirak, Oktay; Brummelkamp, Thijn R.; Fleming, Mark D.; Camargo, Fernando D.			Regulation of progenitor cell proliferation and granulocyte function by microRNA-223	NATURE			English	Article							GROWTH-FACTOR-I; RESPIRATORY BURST; NEUTROPHILS; INFLAMMATION; EXPRESSION; MECHANISM; CAPACITY; HORMONE	MicroRNAs are abundant in animal genomes and have been predicted to have important roles in a broad range of gene expression programmes(1,2). Despite this prominence, there is a dearth of functional knowledge regarding individual mammalian microRNAs. Using a loss- of- function allele in mice, we report here that the myeloid- specific microRNA- 223 ( miR- 223) negatively regulates progenitor proliferation and granulocyte differentiation and activation. miR- 223 ( also called Mirn223) mutant mice have an expanded granulocytic compartment resulting from a cell-autonomous increase in the number of granulocyte progenitors. We show that Mef2c, a transcription factor that promotes myeloid progenitor proliferation, is a target of miR- 223, and that genetic ablation of Mef2c suppresses progenitor expansion and corrects the neutrophilic phenotype in miR- 223 null mice. In addition, granulocytes lacking miR- 223 are hypermature, hypersensitive to activating stimuli and display increased fungicidal activity. As a consequence of this neutrophil hyperactivity, miR- 223 mutant mice spontaneously develop inflammatory lung pathology and exhibit exaggerated tissue destruction after endotoxin challenge. Our data support a model in which miR- 223 acts as a fine- tuner of granulocyte production and the inflammatory response.	[Johnnidis, Jonathan B.; Wheeler, Robert T.; Stehling-Sun, Sandra; Lam, Michael H.; Kirak, Oktay; Brummelkamp, Thijn R.; Camargo, Fernando D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Harris, Marian H.; Fleming, Mark D.] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Camargo, FD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	camargo@wi.mit.edu	; Kirak, Oktay/H-6347-2013	Fleming, Mark/0000-0003-0948-4024; Kirak, Oktay/0000-0002-6524-4685				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; BOHINJEC J, 1981, BLUT, V42, P191, DOI 10.1007/BF01026389; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FU YK, 1991, J IMMUNOL, V146, P1602; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Inoue T, 1998, SHOCK, V10, P278, DOI 10.1097/00024382-199810000-00008; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; ROTHE G, 1991, J IMMUNOL METHODS, V138, P133, DOI 10.1016/0022-1759(91)90074-P; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371	26	926	1002	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1125	U11		10.1038/nature06607	http://dx.doi.org/10.1038/nature06607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18278031				2022-12-28	WOS:000253453600046
J	Lill, T; Joubert, O				Lill, Thorsten; Joubert, Olivier			Materials science - The cutting edge of plasma etching	SCIENCE			English	Editorial Material									[Lill, Thorsten] Appl Mat Inc, Santa Clara, CA 95054 USA; [Joubert, Olivier] CNRS, Lab Technol Microelect, F-38054 Grenoble, France	Applied Materials Inc; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Lill, T (corresponding author), Appl Mat Inc, Santa Clara, CA 95054 USA.	thorsten_lill@amat.com						COBURN JW, 1979, J APPL PHYS, V50, P3189, DOI 10.1063/1.326355; Ramos R, 2007, THIN SOLID FILMS, V515, P4846, DOI 10.1016/j.tsf.2006.10.025	2	24	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1050	1051		10.1126/science.1153901	http://dx.doi.org/10.1126/science.1153901			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292328				2022-12-28	WOS:000253311700028
J	Mudd, JO; Kass, DA				Mudd, James O.; Kass, David A.			Tackling heart failure in the twenty-first century	NATURE			English	Article							LEFT-VENTRICULAR FUNCTION; CHANNEL RYANODINE RECEPTOR; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; MYOCARDIAL-INFARCTION; ASSIST DEVICE; FATTY-ACID; IN-VIVO; INHIBITION; KINASE	Heart failure, or congestive heart failure, is a condition in which the heart cannot supply the body's tissues with enough blood. The result is a cascade of changes that lead to severe fatigue, breathlessness and, ultimately, death. In the past quarter century, much progress has been made in understanding the molecular and cellular processes that contribute to heart failure, leading to the development of effective therapies. Despite this, chronic heart failure remains a major cause of illness and death. And because the condition becomes more common with increasing age, the number of affected individuals is rising with the rapidly ageing global population. New treatments that target disease mechanisms at the cellular and whole-organ level are needed to halt and reverse the devastating consequences of this disease.	[Mudd, James O.; Kass, David A.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Kass, DA (corresponding author), Johns Hopkins Med Inst, Ross 835,720 Rutland Ave, Baltimore, MD 21205 USA.	dkass@jhmi.edu						Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brodde OE, 2007, N-S ARCH PHARMACOL, V374, P361, DOI 10.1007/s00210-006-0125-7; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; CHAKIR K, IN PRESS CIRCULATION; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Forfia PR, 2007, J AM COLL CARDIOL, V49, P1079, DOI 10.1016/j.jacc.2006.08.066; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Heerdt PM, 2000, CIRCULATION, V102, P2713, DOI 10.1161/01.CIR.102.22.2713; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Imai M, 2007, J AM COLL CARDIOL, V49, P2120, DOI 10.1016/j.jacc.2006.10.082; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lai NC, 2004, CIRCULATION, V110, P330, DOI 10.1161/01.CIR.0000136033.21777.4D; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; Liggett SB, 2007, HUM MOL GENET, V16, P2740, DOI 10.1093/hmg/ddm229; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; LUTZ JE, 1988, AM J CARDIOL, V61, P494, DOI 10.1016/0002-9149(88)90323-2; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; MIALET PJ, 2003, NAT MED, V9, P1300, DOI DOI 10.1038/NM930; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schwartzbauer G, 2001, J BIOL CHEM, V276, P35786, DOI 10.1074/jbc.M102479200; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Spragg DD, 2006, PROG CARDIOVASC DIS, V49, P26, DOI 10.1016/j.pcad.2006.05.001; Taha M, 2007, ANN MED, V39, P594, DOI 10.1080/07853890701618305; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wagoner LE, 2000, CIRC RES, V86, P834, DOI 10.1161/01.RES.86.8.834; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	100	299	321	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					919	928		10.1038/nature06798	http://dx.doi.org/10.1038/nature06798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288181				2022-12-28	WOS:000253313100032
J	Mercat, A; Richard, JCM; Vielle, B; Jaber, S; Osman, D; Diehl, JL; Lefrant, JY; Prat, G; Richecoeur, J; Nieszkowska, A; Gervais, C; Baudot, J; Bouadma, L; Brochard, L				Mercat, Alain; Richard, Jean-Christophe M.; Vielle, Bruno; Jaber, Samir; Osman, David; Diehl, Jean-Luc; Lefrant, Jean-Yves; Prat, Gwenael; Richecoeur, Jack; Nieszkowska, Ania; Gervais, Claude; Baudot, Jerome; Bouadma, Lila; Brochard, Laurent		Expiratory Pressure Express Study	Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIDAL VOLUME; MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; ALVEOLAR RECRUITMENT; AIRWAY PRESSURES; PULMONARY-EDEMA; DERECRUITMENT; STRATEGY; MORTALITY; MANEUVERS	Context The need for lung protection is universally accepted, but the optimal level of positive end- expiratory pressure ( PEEP) in patients with acute lung injury ( ALI) or acute respiratory distress syndrome remains debated. Objective To compare the effect on outcome of a strategy for setting PEEP aimed at increasing alveolar recruitment while limiting hyperinflation to one aimed at minimizing alveolar distension in patients with ALI. Design, Setting, and Patients A multicenter randomized controlled trial of 767 adults ( mean [ SD] age, 59.9 [ 15.4] years) with ALI conducted in 37 intensive care units in France from September 2002 to December 2005. Intervention Tidal volume was set at 6 mL/ kg of predicted body weight in both strategies. Patients were randomly assigned to a moderate PEEP strategy ( 5- 9 cm H2O) ( minimal distension strategy; n= 382) or to a level of PEEP set to reach a plateau pressure of 28 to 30 cm H2O ( increased recruitment strategy; n= 385). Main Outcome Measures The primary end point was mortality at 28 days. Secondary end points were hospital mortality at 60 days, ventilator- free days, and organ failure - free days at 28 days. Results The 28- day mortality rate in the minimal distension group was 31.2% ( n= 119) vs 27.8% ( n= 107) in the increased recruitment group ( relative risk, 1.12 [ 95% confidence interval, 0.90- 1.40]; P=. 31). The hospital mortality rate in the minimal distension group was 39.0% ( n= 149) vs 35.4% ( n= 136) in the increased recruitment group ( relative risk, 1.10 [ 95% confidence interval, 0.92- 1.32]; P=. 30). The increased recruitment group compared with the minimal distension group had a higher median number of ventilator- free days ( 7 [ interquartile range {IQR}, 0- 19] vs 3 [ IQR, 0- 17]; P=. 04) and organ failure - free days ( 6 [ IQR, 0- 18] vs 2 [ IQR, 0- 16]; P=. 04). This strategy also was associated with higher compliance values, better oxygenation, less use of adjunctive therapies, and larger fluid requirements. Conclusions A strategy for setting PEEP aimed at increasing alveolar recruitment while limiting hyperinflation did not significantly reduce mortality. However, it did improve lung function and reduced the duration of mechanical ventilation and the duration of organ failure. Trial Registration clinicaltrials. gov Identifier: NCT00188058.	[Mercat, Alain] CHU Angers, Dept Reanimat Med & Med Hyperbare, F-49933 Angers 09, France; [Richard, Jean-Christophe M.] CHU Rouen, Serv Reanimat Med, Rouen, France; [Richard, Jean-Christophe M.] CHU Rouen, UPRES EA 38 30, Rouen, France; [Vielle, Bruno] CHU Angers, Serv Biostat & Modelisat Informat, Angers, France; [Jaber, Samir] CHU Montpellier, Serv Anesthesie Reanimat B, Montpellier, France; [Osman, David] CHU Bicetre, Assistance Publ Hop Paris, Serv Reanimat Med, Le Kremlin Bicetre, France; [Diehl, Jean-Luc] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Reanimat Med, Paris, France; [Lefrant, Jean-Yves; Gervais, Claude] CHU Nimes, Div Anesthesie Reanimat Douleur Urgences, Unite Reanimat Chirurg, Nimes, France; [Lefrant, Jean-Yves; Gervais, Claude] CHU Nimes, Div Anesthesie Reanimat Douleur Urgences, Unite Med, Nimes, France; [Prat, Gwenael] CHU Brest, Serv Reanimat Med, F-29285 Brest, France; [Richecoeur, Jack] CH Pontoise, Serv Reanimat Polyvalente, Pontoise, France; [Nieszkowska, Ania] CHU Pitie Salpetriere, Assistance Publ Hop Paris, Serv Reanimat Med, Paris, France; [Baudot, Jerome] CH Nevers, Serv Reanimat Polyvalente, Nevers, France; [Bouadma, Lila] CHU Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Reanimat Med, Paris, France; [Brochard, Laurent] CHU Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, INSERM,U841, F-94010 Creteil, France; [Brochard, Laurent] Univ Paris 12, Creteil, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Rouen; CHU de Rouen; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; CHU Brest; Centre Hospitalier Rene Dubos, Pontoise; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Mercat, A (corresponding author), CHU Angers, Dept Reanimat Med & Med Hyperbare, 4 Rue Larrey, F-49933 Angers 09, France.	almercat@chu-angers.fr	Mercat, Alain/AFU-4426-2022					Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; ASHBAUGH DG, 1967, LANCET, V2, P319; Boussarsar M, 2002, INTENS CARE MED, V28, P406, DOI 10.1007/s00134-001-1178-1; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; Ferguson ND, 2005, CRIT CARE MED, V33, P21, DOI 10.1097/01.CCM.0000150652.91411.66; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Grasso S, 2005, AM J RESP CRIT CARE, V171, P1002, DOI 10.1164/rccm.200407-940OC; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Knoben JE, 1993, HDB CLIN DRUG DATA, V7th; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Maggiore SM, 2001, AM J RESP CRIT CARE, V164, P795, DOI 10.1164/ajrccm.164.5.2006071; MERCAT A, 2006, REANIMATION, V15, P74; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Pelosi P, 2001, AM J RESP CRIT CARE, V164, P122, DOI 10.1164/ajrccm.164.1.2007010; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Richard JC, 2003, CRIT CARE MED, V31, P89, DOI 10.1097/00003246-200301000-00014; Richard JC, 2001, AM J RESP CRIT CARE, V163, P1609, DOI 10.1164/ajrccm.163.7.2004215; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Villagra A, 2002, AM J RESP CRIT CARE, V165, P165, DOI 10.1164/ajrccm.165.2.2104092; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Whitehead J, 1997, DESIGN ANAL SEQUENTI	31	837	902	2	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					646	655		10.1001/jama.299.6.646	http://dx.doi.org/10.1001/jama.299.6.646			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270353	Bronze			2022-12-28	WOS:000253095200022
J	Batty, M				Batty, Michael			The size, scale, and shape of cities	SCIENCE			English	Editorial Material							GROWTH; LIFE; LAW	Despite a century of effort, our understanding of how cities evolve is still woefully inadequate. Recent research, however, suggests that cities are complex systems that mainly grow from the bottom up, their size and shape following well-defined scaling laws that result from intense competition for space. An integrated theory of how cities evolve, linking urban economics and transportation behavior to developments in network science, allometric growth, and fractal geometry, is being slowly developed. This science provides new insights into the resource limits facing cities in terms of the meaning of density, compactness, and sprawl, and related questions of sustainability. It has the potential to enrich current approaches to city planning and replace traditional top-down strategies with realistic city plans that benefit all city dwellers.	UCL, Ctr Adv Spatial Anal, London WC1E 6BT, England	University of London; University College London	Batty, M (corresponding author), UCL, Ctr Adv Spatial Anal, 1-19 Torrington Pl, London WC1E 6BT, England.	m.batty@ucl.ac.uk	Batty, Michael/I-5638-2014; Batty, Michael/D-4422-2011	Batty, Michael/0000-0002-9931-1305	Economic and Social Research Council [RES-149-25-1023] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Batty M., 2005, CITIES COMPLEXITY; Batty M., 1994, FRACTAL CITIES; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Benenson I, 2004, GEOSIMULATION AUTOMA; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Blank A, 2000, PHYSICA A, V287, P279, DOI 10.1016/S0378-4371(00)00464-7; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Christaller W., 1933, ZENTRALEN ORTE SUDDE; CLARK C, 1951, J ROY STAT SOC A STA, V114, P490, DOI 10.2307/2981088; CLAUSET A, 2007, ARXIVORGABS07061062V; Duranton G, 2007, AM ECON REV, V97, P197, DOI 10.1257/aer.97.1.197; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Fujita M., 1999, SPATIAL EC CITIES RE; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gibrat R., 1931, INEGALITES EC; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Howard E., 2003, TOMORROW PEACEFUL PA; Jacobs Jane, 1961, DEATH LIFE GREAT AM; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; Morris, 1902, ARCHITECTURE IND WEA; Newman M., 2005, STRUCTURE DYNAMICS N; Pareto V, 1896, COURS EC POLITIQUE; Scellato S, 2006, EUR PHYS J B, V50, P221, DOI 10.1140/epjb/e2006-00066-4; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wilson A. G., 1970, ENTROPY URBAN REGION; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; [No title captured]	30	731	783	39	497	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					769	771		10.1126/science.1151419	http://dx.doi.org/10.1126/science.1151419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258906				2022-12-28	WOS:000252963000049
J	Gaucher, EA; Govindarajan, S; Ganesh, OK				Gaucher, Eric A.; Govindarajan, Sridhar; Ganesh, Omjoy K.			Palaeotemperature trend for Precambrian life inferred from resurrected proteins	NATURE			English	Article							OXYGEN-ISOTOPE GEOCHEMISTRY; 3.4 BILLION YEARS; WESTERN-AUSTRALIA; SOUTH-AFRICA; EVOLUTION; CHERTS; ORIGIN; RECONSTRUCTION; BACTERIA; SEAWATER	Biosignatures and structures in the geological record indicate that microbial life has inhabited Earth for the past 3.5 billion years or so(1,2). Research in the physical sciences has been able to generate statements about the ancient environment that hosted this life(3-6). These include the chemical compositions and temperatures of the early ocean and atmosphere. Only recently have the natural sciences been able to provide experimental results describing the environments of ancient life. Our previous work with resurrected proteins indicated that ancient life lived in a hot environment(7,8). Here we expand the timescale of resurrected proteins to provide a palaeotemperature trend of the environments that hosted life from 3.5 to 0.5 billion years ago. The thermostability of more than 25 phylogenetically dispersed ancestral elongation factors suggest that the environment supporting ancient life cooled progressively by 30 degrees C during that period. Here we show that our results are robust to potential statistical bias associated with the posterior distribution of inferred character states, phylogenetic ambiguity, and uncertainties in the amino- acid equilibrium frequencies used by evolutionary models. Our results are further supported by a nearly identical cooling trend for the ancient ocean as inferred from the deposition of oxygen isotopes. The convergence of results from natural and physical sciences suggest that ancient life has continually adapted to changes in environmental temperatures throughout its evolutionary history.	[Gaucher, Eric A.] Fdn Appl Mol Evolut, Gainesville, FL 32601 USA; [Govindarajan, Sridhar] DNA2 0 Inc, Menlo Pk, CA 94025 USA; [Ganesh, Omjoy K.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Gaucher, EA (corresponding author), Fdn Appl Mol Evolut, Gainesville, FL 32601 USA.	egaucher@ffame.org	Gaucher, Eric/I-7313-2013					Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brooks D.J., 2007, ANCESTRAL SEQUENCE R, P200; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gaucher E. A., 2007, ANCESTRAL SEQUENCE R, P20; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; HOYLE F, 1972, Q J ROY ASTRON SOC, V13, P328; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; KNAUTH LP, 1978, EARTH PLANET SC LETT, V41, P209, DOI 10.1016/0012-821X(78)90011-0; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Williams RAD, 1992, PROKARYOTES, P3745; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	245	252	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					704	U2		10.1038/nature06510	http://dx.doi.org/10.1038/nature06510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256669				2022-12-28	WOS:000252929500038
J	Schoelkopf, RJ; Girvin, SM				Schoelkopf, R. J.; Girvin, S. M.			Wiring up quantum systems	NATURE			English	Article							SUPERCONDUCTING QUBITS; SINGLE-PHOTON; STATE; ATOM; ENTANGLEMENT; FIELD; DYNAMICS; COLLAPSE; DOT		[Schoelkopf, R. J.; Girvin, S. M.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Schoelkopf, R. J.; Girvin, S. M.] Yale Univ, Dept Phys, New Haven, CT 06520 USA	Yale University; Yale University	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.		Schoelkopf, Robert J/J-8178-2012					Al-Saidi WA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224512; Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Blais A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.127901; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; BRAGINSKY VB, 1987, PHYS LETT A, V120, P300, DOI 10.1016/0375-9601(87)90676-1; BRAGINSKY VB, 1979, IEEE T MAGN, V15, P30, DOI 10.1109/TMAG.1979.1060194; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; BUISSON O, 2001, MACROSCOPIC QUANTUM; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; CLARKE J, 1988, SCIENCE, V239, P992, DOI 10.1126/science.239.4843.992; DEVORET MH, 1985, PHYS REV LETT, V55, P1908, DOI 10.1103/PhysRevLett.55.1908; DEVORET MH, 1992, QUANTUM TUNNELLING C; Devoret M, 2007, ANN PHYS-BERLIN, V16, P767, DOI 10.1002/andp.200710261; Devoret MH, 2004, QUANTUM INF PROCESS, V3, P163, DOI 10.1007/s11128-004-3101-5; Frunzio L, 2005, IEEE T APPL SUPERCON, V15, P860, DOI 10.1109/TASC.2005.850084; GABRIELSE G, 1985, PHYS REV LETT, V55, P67, DOI 10.1103/PhysRevLett.55.67; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haroche S., 2006, EXPLORING QUANTUM; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; HOUCK AA, 2007, UNPUB; Hyafil P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.103001; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kuhr S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724816; LEGGETT AJ, 1980, SUP PROG THEOR PHYS, P80, DOI 10.1143/PTPS.69.80; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Marquardt F, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054514; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; MESCHEDE D, 1985, PHYS REV LETT, V54, P551, DOI 10.1103/PhysRevLett.54.551; MILLER TE, 2005, J PHYS B ATOM MOL PH, V38, pS551; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nirrengarten T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200405; Osnaghi S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037902; PELLIZZARI T, 1995, PHYS REV LETT, V75, P3788, DOI 10.1103/PhysRevLett.75.3788; Plastina F, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.224514; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; REMPE G, 1987, PHYS REV LETT, V58, P353, DOI 10.1103/PhysRevLett.58.353; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; Shnirman A, 1997, PHYS REV LETT, V79, P2371, DOI 10.1103/PhysRevLett.79.2371; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Sorensen AS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.063601; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; TURLOT E, 1989, PHYS REV LETT, V62, P1788, DOI 10.1103/PhysRevLett.62.1788; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walther H, 2006, REP PROG PHYS, V69, P1325, DOI 10.1088/0034-4885/69/5/R02; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015; Yang CP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.042311; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; You JQ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064509	64	692	705	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					664	669		10.1038/451664a	http://dx.doi.org/10.1038/451664a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256662				2022-12-28	WOS:000252929500031
J	Tay, S; Blanche, PA; Voorakaranam, R; Tunc, AV; Lin, W; Rokutanda, S; Gu, T; Flores, D; Wang, P; Li, G; St Hilaire, P; Thomas, J; Norwood, RA; Yamamoto, M; Peyghambarian, N				Tay, Savas; Blanche, P. -A.; Voorakaranam, R.; Tunc, A. V.; Lin, W.; Rokutanda, S.; Gu, T.; Flores, D.; Wang, P.; Li, G.; St Hilaire, P.; Thomas, J.; Norwood, R. A.; Yamamoto, M.; Peyghambarian, N.			An updatable holographic three-dimensional display	NATURE			English	Article							3D; SYSTEM; POLYMERS; DESIGN	Holographic three- dimensional ( 3D) displays(1,2) provide realistic images without the need for special eyewear, making them valuable tools for applications that require situational awareness, such as medical, industrial and military imaging. Currently commercially available holographic 3D displays(3) use photopolymers that lack image- updating capability, resulting in restricted use and high cost. Photorefractive polymers(4-9) are dynamic holographic recording materials that allow updating of images and have a wide range of applications, including optical correlation(10), imaging through scattering media(11) and optical communication(12,13). To be suitable for 3D displays, photorefractive polymers need to have nearly 100% diffraction efficiency, fast writing time, hours of image persistence, rapid erasure, and large area - a combination of properties that has not been shown before. Here, we report an updatable holographic 3D display based on photorefractive polymers with such properties, capable of recording and displaying new images every few minutes. This is the largest photorefractive 3D display to date ( 4x4 inches in size); it can be recorded within a few minutes, viewed for several hours without the need for refreshing, and can be completely erased and updated with new images when desired.	[Tay, Savas; Blanche, P. -A.; Voorakaranam, R.; Tunc, A. V.; Li, G.; St Hilaire, P.; Thomas, J.; Norwood, R. A.; Peyghambarian, N.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Lin, W.; Rokutanda, S.; Gu, T.; Flores, D.; Wang, P.; Yamamoto, M.] Nitto Denko Tech Corp, Oceanside, CA 92054 USA	University of Arizona; Nitto Denko Corporation	Tay, S (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	savas.tay@optics.arizona.edu; nnp@u.arizona.edu	Blanche, Pierre-Alexandre/A-7025-2018	Blanche, Pierre-Alexandre/0000-0002-9592-2010; TUNC, Ali Veysel/0000-0002-0477-2249				Benton S. A., 2001, SELECTED PAPERS 3 DI; BENTON SA, 1982, P SOC PHOTO-OPT INST, V367, P15; Chatterjee MR, 2006, DIGITAL HOLOGRAPHY AND THREE DIMENSIONAL DISPLAY: PRINCIPLES AND APPLICATIONS, P379, DOI 10.1007/0-387-31397-4_13; Cheng N, 1997, APPL PHYS LETT, V71, P1828, DOI 10.1063/1.119412; Choi K, 2005, OPT EXPRESS, V13, P10494, DOI 10.1364/OPEX.13.010494; Dodgson NA, 2005, COMPUTER, V38, P31, DOI 10.1109/MC.2005.252; Downing E, 1996, SCIENCE, V273, P1185, DOI 10.1126/science.273.5279.1185; DUCHARME S, 1991, PHYS REV LETT, V66, P1846, DOI 10.1103/PhysRevLett.66.1846; Eralp M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354037; Favalora GE, 2005, COMPUTER, V38, P37, DOI 10.1109/MC.2005.276; HALLE MW, 1994, P SOC PHOTO-OPT INS, V2176, P73, DOI 10.1117/12.172620; Hesselink L, 2004, P IEEE, V92, P1231, DOI 10.1109/JPROC.2004.831212; Huebschman ML, 2003, OPT EXPRESS, V11, P437, DOI 10.1364/OE.11.000437; Iizuka K, 2006, OPT PHOTONICS NEWS, V17, P42, DOI 10.1364/OPN.17.7.000042; Kippelen B, 1998, SCIENCE, V279, P54, DOI 10.1126/science.279.5347.54; Kippelen B., 1996, NONLINEAR OPTICS ORG, P507; Li GQ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1898432; Marder SR, 1997, NATURE, V388, P845, DOI 10.1038/42190; Mecher E, 2002, NATURE, V418, P959, DOI 10.1038/nature00975; Meerholz K., 1994, NATURE, V357, P479; Miyazaki D, 2006, OPT EXPRESS, V14, P12760, DOI 10.1364/OE.14.012760; Ostroverkhova O, 2004, CHEM REV, V104, P3267, DOI 10.1021/cr960055c; Pastoor S, 2005, 3D VIDEOCOMMUNICATION: ALGORITHMS, CONCEPTS AND REAL-TIME SYSTEMS IN HUMAN CENTRED COMMUNICATION, P235; Slinger C, 2004, P SOC PHOTO-OPT INS, V5290, P27, DOI 10.1117/12.526690; STHILAIRE P, 1992, J OPT SOC AM A, V9, P1969, DOI 10.1364/JOSAA.9.001969; Tay S, 2004, APPL PHYS LETT, V85, P4561, DOI 10.1063/1.1826224; Thayn JR, 1999, P SOC PHOTO-OPT INS, V3690, P180, DOI 10.1117/12.357592; Volodin BL, 1996, NATURE, V383, P58, DOI 10.1038/383058a0; [No title captured]	29	318	343	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					694	698		10.1038/nature06596	http://dx.doi.org/10.1038/nature06596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256667				2022-12-28	WOS:000252929500036
J	Proskurowski, G; Lilley, MD; Seewald, JS; Fruh-Green, GL; Olson, EJ; Lupton, JE; Sylva, SP; Kelley, DS				Proskurowski, Giora; Lilley, Marvin D.; Seewald, Jeffery S.; Fruh-Green, Gretchen L.; Olson, Eric J.; Lupton, John E.; Sylva, Sean P.; Kelley, Deborah S.			Abiogenic hydrocarbon production at Lost City hydrothermal field	SCIENCE			English	Article							MID-ATLANTIC RIDGE; STABLE-ISOTOPE; MIDOCEAN RIDGES; VENT FLUIDS; METHANE; SERPENTINIZATION; CARBON; SYSTEMS; DEEP; ENVIRONMENTS	Low- molecular- weight hydrocarbons in natural hydrothermal fluids have been attributed to abiogenic production by Fischer- Tropsch type ( FTT) reactions, although clear evidence for such a process has been elusive. Here, we present concentration, and stable and radiocarbon isotope, data from hydrocarbons dissolved in hydrogen- rich fluids venting at the ultramafic- hosted Lost City Hydrothermal Field. A distinct "inverse" trend in the stable carbon and hydrogen isotopic composition of C-1 to C-4 hydrocarbons is compatible with FTT genesis. Radiocarbon evidence rules out seawater bicarbonate as the carbon source for FTT reactions, suggesting that a mantle- derived inorganic carbon source is leached from the host rocks. Our findings illustrate that the abiotic synthesis of hydrocarbons in nature may occur in the presence of ultramafic rocks, water, and moderate amounts of heat.	[Proskurowski, Giora; Lilley, Marvin D.; Olson, Eric J.; Kelley, Deborah S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Proskurowski, Giora; Seewald, Jeffery S.; Sylva, Sean P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Fruh-Green, Gretchen L.] ETH Zentrum, Dept Earth Sci, Zurich, Switzerland; [Lupton, John E.] NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA	University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA	Proskurowski, G (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	giora@whoi.edu	Proskurowski, Giora/B-3862-2013; Sylva, Sean/D-4400-2014	Sylva, Sean/0000-0002-4727-440X				ABRAJANO TA, 1988, CHEM GEOL, V71, P211, DOI 10.1016/0009-2541(88)90116-7; Allen DE, 2004, GEOCHIM COSMOCHIM AC, V68, P1347, DOI 10.1016/j.gca.2003.09.003; Alt JC, 1999, GEOCHIM COSMOCHIM AC, V63, P1527, DOI 10.1016/S0016-7037(99)00123-4; ANDERSON RB, 1984, FISCHERTROPSCH SYNTH; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; DELACOUR A, 2006, EOS T AGU, V87, pB318; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Fruh-Green GL, 2004, GEOPHYS MONOGR SER, V144, P119, DOI 10.1029/144GM08; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Giggenbach WF, 1997, GEOCHIM COSMOCHIM AC, V61, P3763, DOI 10.1016/S0016-7037(97)00171-3; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Karson JA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001109; Kelley DS, 1999, J GEOPHYS RES-SOL EA, V104, P10439, DOI 10.1029/1999JB900058; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, GEOCHIM COSMOCHIM AC, V65, P3325, DOI 10.1016/S0016-7037(01)00667-6; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; Lowell RP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014411; MARTIN B, 1970, CHEM GEOL, V6, P185, DOI 10.1016/0009-2541(70)90018-5; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; Proskurowski G, 2004, EARTH PLANET SC LETT, V225, P53, DOI 10.1016/j.epsl.2004.06.007; Proskurowski G, 2006, CHEM GEOL, V229, P331, DOI 10.1016/j.chemgeo.2005.11.005; RONA PA, 1987, J GEOPHYS RES-SOLID, V92, P1417, DOI 10.1029/JB092iB02p01417; Schimmelmann A, 2006, ANNU REV EARTH PL SC, V34, P501, DOI 10.1146/annurev.earth.34.031405.125011; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Seyfried WE, 2007, GEOCHIM COSMOCHIM AC, V71, P3872, DOI 10.1016/j.gca.2007.05.015; Taran YA, 2007, GEOCHIM COSMOCHIM AC, V71, P4474, DOI 10.1016/j.gca.2007.06.057; WELHAN JA, 1987, AAPG BULL, V71, P215; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3	35	546	577	7	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					604	607		10.1126/science.1151194	http://dx.doi.org/10.1126/science.1151194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239121				2022-12-28	WOS:000252772000036
J	Drescher, T; Potthast, S; Laifer, G				Drescher, Tilman; Potthast, Silke; Laifer, Gerd			Back pain from a burger	LANCET			English	Editorial Material							SALMONELLA; INFECTIONS		[Drescher, Tilman; Laifer, Gerd] Univ Basel Hosp, Div Infect Dis & Internal Med, CH-4031 Basel, Switzerland; [Potthast, Silke] Univ Basel Hosp, Dept Radiol, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Drescher, T (corresponding author), Univ Basel Hosp, Div Internal Med, CH-4031 Basel, Switzerland.	dreschert@uhbs.ch						COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Collazos J, 1999, CLIN INFECT DIS, V29, P673, DOI 10.1086/598652; DAOUST JY, 1994, INT J FOOD MICROBIOL, V24, P11, DOI 10.1016/0168-1605(94)90103-1; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2008	371	9609					358	358		10.1016/S0140-6736(08)60171-3	http://dx.doi.org/10.1016/S0140-6736(08)60171-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18295001				2022-12-28	WOS:000252616500031
J	EWING, T				EWING, T			MISCONDUCT IN SCIENCE - AUSTRALIA NEW GUIDELINES	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					7	7		10.1038/344007a0	http://dx.doi.org/10.1038/344007a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277995	Bronze			2022-12-28	WOS:A1990CQ97200018
J	TRUMPINGTON				TRUMPINGTON			RESPONSIBILITIES NOT DUCKED	NATURE			English	Letter											TRUMPINGTON (corresponding author), MAFF, WHITEHALL PL, LONDON SW1A 2HH, ENGLAND.							1990, NATURE, V343, P293	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					10	10		10.1038/344010a0	http://dx.doi.org/10.1038/344010a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278001	Bronze			2022-12-28	WOS:A1990CQ97200025
J	Yang, JW; Chandler, C; Stadler, M; Kampen, D; List, B				Yang, Jung Woon; Chandler, Carley; Stadler, Michael; Kampen, Daniela; List, Benjamin			Proline-catalysed Mannich reactions of acetaldehyde	NATURE			English	Article							BETA-AMINO ACIDS; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ALDOL REACTIONS; ALDEHYDES; UK-427,857; INHIBITOR; MARAVIROC; IMINES; POTENT	Small organic molecules recently emerged as a third class of broadly useful asymmetric catalysts that direct reactions to yield predominantly one chiral product, complementing enzymes and metal complexes(1). For instance, the amino acid proline and its derivatives are useful for the catalytic activation of carbonyl compounds via nucleophilic enamine intermediates. Several important carbon carbon bond- forming reactions, including the Mannich reaction, have been developed using this approach(2), all of which are useful for making chiral, biologically relevant compounds. Remarkably, despite attempts(3,4), the simplest of all nucleophiles, acetaldehyde, could not be used in this way. Here we show that acetaldehyde is a powerful nucleophile in asymmetric, proline- catalysed Mannich reactions with N- tert- butoxycarbonyl ( N- Boc)- imines, yielding beta- amino aldehydes with extremely high enantioselectivities- desirable products as drug intermediates and in the synthesis of other biologically active molecules. Although acetaldehyde has been used as a nucleophile in reactions with biological catalysts such as aldolases(5) and thiamine- dependent enzymes(6), and has also been employed indirectly(7-9), its use as an inexpensive and versatile two- carbon nucleophile in asymmetric, small- molecule catalysis will find many practical applications.	[Yang, Jung Woon; Chandler, Carley; Stadler, Michael; Kampen, Daniela; List, Benjamin] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	list@mpi-muelheim.mpg.de	List, Benjamin/A-2121-2014; Yang, Jung Woon/A-5072-2013; Yang, Jung Woon/N-6725-2019	Yang, Jung Woon/0000-0001-8636-0901; Yang, Jung Woon/0000-0001-8636-0901				Bogevig A, 2002, CHEM COMMUN, P620, DOI 10.1039/b200681b; Boxer MB, 2006, J AM CHEM SOC, V128, P48, DOI 10.1021/ja054725k; Chi YG, 2007, J AM CHEM SOC, V129, P6050, DOI 10.1021/ja070063i; Cordova A, 2002, J ORG CHEM, V67, P301, DOI 10.1021/jo015881m; Davies SG, 2006, ORG BIOMOL CHEM, V4, P2753, DOI 10.1039/b604073j; Davis FA, 1998, TETRAHEDRON LETT, V39, P5951, DOI 10.1016/S0040-4039(98)01223-4; Denmark SE, 2005, J ORG CHEM, V70, P10190, DOI 10.1021/jo0517500; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; ENDERS D, 1987, CHEM BER-RECL, V120, P1223, DOI 10.1002/cber.19871200718; Enders D, 2006, SYNTHESIS-STUTTGART, P2155, DOI 10.1055/s-2006-942413; Fodor G. B., 1985, ALKALOIDS CHEM BIOL, P1; Goetz G, 2001, BIOTECHNOL BIOENG, V74, P317, DOI 10.1002/bit.1122; List B, 2000, J AM CHEM SOC, V122, P9336, DOI 10.1021/ja001923x; List B, 2006, SCIENCE, V313, P1584, DOI 10.1126/science.1131945; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Price DA, 2005, TETRAHEDRON LETT, V46, P5005, DOI 10.1016/j.tetlet.2005.05.082; Ramachandran PV, 2005, CHEM-EUR J, V11, P4387, DOI 10.1002/chem.200401295; Seebach D, 2000, HELV CHIM ACTA, V83, P2115, DOI 10.1002/1522-2675(20000906)83:9<2115::AID-HLCA2115>3.0.CO;2-E; Siddiqui SA, 2007, TETRAHEDRON-ASYMMETR, V18, P2099, DOI 10.1016/j.tetasy.2007.07.028; Song J, 2006, J AM CHEM SOC, V128, P6048, DOI 10.1021/ja060716f; Sorbera LA, 2004, DRUG FUTURE, V29, P1201, DOI 10.1358/dof.2004.029.12.865936; Yang JW, 2007, ANGEW CHEM INT EDIT, V46, P609, DOI 10.1002/anie.200603188	24	242	245	10	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					453	455		10.1038/nature06740	http://dx.doi.org/10.1038/nature06740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	279FU	18288105				2022-12-28	WOS:000254341300027
J	Sakai, W; Swisher, EM; Karlan, BY; Agarwal, MK; Higgins, J; Friedman, C; Villegas, E; Jacquemont, C; Farrugia, DJ; Couch, FJ; Urban, N; Taniguchi, T				Sakai, Wataru; Swisher, Elizabeth M.; Karlan, Beth Y.; Agarwal, Mukesh K.; Higgins, Jake; Friedman, Cynthia; Villegas, Emily; Jacquemont, Celine; Farrugia, Daniel J.; Couch, Fergus J.; Urban, Nicole; Taniguchi, Toshiyasu			Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; BRCA MUTANT-CELLS; FANCONI-ANEMIA; OVARIAN-CANCER; BREAST-CANCER; IN-VIVO; PATHWAY; GENE; INHIBITORS; DEFECT	Ovarian carcinomas with mutations in the tumour suppressor BRCA2 are particularly sensitive to platinum compounds(1). However, such carcinomas ultimately develop cisplatin resistance. The mechanism of that resistance is largely unknown(2). Here we show that acquired resistance to cisplatin can be mediated by secondary intragenic mutations in BRCA2 that restore the wildtype BRCA2 reading frame. First, in a cisplatin- resistant BRCA2-mutated breast- cancer cell line, HCC1428, a secondary genetic change in BRCA2 rescued BRCA2 function. Second, cisplatin selection of a BRCA2- mutated pancreatic cancer cell line, Capan- 1 ( refs 3, 4), led to five different secondary mutations that restored the wild- type BRCA2 reading frame. All clones with secondary mutations were resistant both to cisplatin and to a poly( ADP- ribose) polymerase ( PARP) inhibitor ( AG14361). Finally, we evaluated recurrent cancers from patients whose primary BRCA2- mutated ovarian carcinomas were treated with cisplatin. The recurrent tumour that acquired cisplatin resistance had undergone reversion of its BRCA2 mutation. Our results suggest that secondary mutations that restore the wild- type BRCA2 reading frame may be a major clinical mediator of acquired resistance to platinum- based chemotherapy.	[Sakai, Wataru; Friedman, Cynthia; Villegas, Emily; Jacquemont, Celine; Taniguchi, Toshiyasu] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Sakai, Wataru; Villegas, Emily; Jacquemont, Celine; Urban, Nicole; Taniguchi, Toshiyasu] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Swisher, Elizabeth M.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Swisher, Elizabeth M.; Higgins, Jake] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Agarwal, Mukesh K.; Farrugia, Daniel J.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Higgins, Jake] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Mayo Clinic; University of Washington; University of Washington Seattle	Taniguchi, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	ttaniguc@fhcrc.org	Taniguchi, Toshiyasu/ADD-8489-2022; Sakai, Wataru/J-6917-2012; Farrugia, Daniel/E-4752-2015	Sakai, Wataru/0000-0002-6561-5773; Taniguchi, Toshiyasu/0000-0002-7746-3658	NCI NIH HHS [R01 CA125636-02, R01 CA125636, P50 CA083636, P50 CA083636-10, K08 CA096610-01, K08 CA096610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA125636, K08CA096610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; COLLINS N, 1995, ONCOGENE, V10, P1673; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Goggins M, 1996, CANCER RES, V56, P5360; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Hamanoue S, 2006, BRIT J HAEMATOL, V132, P630, DOI 10.1111/j.1365-2141.2005.05916.x; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Ikeda H, 2003, CANCER RES, V63, P2688; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Li A J, 2001, Curr Oncol Rep, V3, P27, DOI 10.1007/s11912-001-0039-y; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Naf D, 1998, MOL CELL BIOL, V18, P5952; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Trask B, 1999, GENOME ANAL, V4, P303; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Wu KJ, 2005, CANCER RES, V65, P417; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Yuan SSF, 1999, CANCER RES, V59, P3547	39	762	789	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1116	U9		10.1038/nature06633	http://dx.doi.org/10.1038/nature06633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18264087	Green Accepted			2022-12-28	WOS:000253453600044
J	Knollmann, BC; Roden, DM				Knollmann, Bjorn C.; Roden, Dan M.			A genetic framework for improving arrhythmia therapy	NATURE			English	Article							CARDIAC RYANODINE RECEPTOR; LEFT-VENTRICULAR DYSFUNCTION; POLYUNSATURATED FATTY-ACIDS; LONG-QT SYNDROME; RECENT MYOCARDIAL-INFARCTION; CALMODULIN KINASE-II; RETICULUM CA2+ LEAK; ATRIAL-FIBRILLATION; DRUG-THERAPY; SUDDEN-DEATH	Abnormalities in heart rhythm continue to cause high rates of illness and death. Better treatment could be provided by solving two main challenges: the early identification of patients who are at risk, and the characterization of molecular pathways that culminate in arrhythmias. By analysing mechanisms that increase susceptibility to arrhythmia in individuals with genetic syndromes, it might be possible to improve current therapies and to develop new ways to treat and prevent common arrhythmias.	[Knollmann, Bjorn C.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, 1285 Med Res Bldg 4, Nashville, TN 37232 USA.	dan.roden@vanderbilt.edu	Roden, Dan/ABD-5412-2021	Knollmann, Bjorn/0000-0003-4956-9735				Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Allessie MA, 2001, CIRCULATION, V103, P769; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Anyukhovsky EP, 2005, CARDIOVASC RES, V66, P353, DOI 10.1016/j.cardiores.2004.10.033; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Ashrafian H, 2007, J AM COLL CARDIOL, V49, P1251, DOI 10.1016/j.jacc.2006.10.073; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; Bers DM, 2005, NAT MED, V11, P379, DOI 10.1038/nm0405-379; Bucchi A, 2006, CIRCULATION, V114, P992, DOI 10.1161/CIRCULATIONAHA.106.617613; Camm AJ, 2004, CIRCULATION, V109, P990, DOI 10.1161/01.CIR.0000117090.01718.2A; Cardin S, 2007, CIRC RES, V100, P425, DOI 10.1161/01.RES.0000258428.09589.1a; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; COROMILAS J, 1995, CIRCULATION, V91, P2245, DOI 10.1161/01.CIR.91.8.2245; Crotti L, 2007, CIRCULATION, V116, P2366, DOI 10.1161/CIRCULATIONAHA.107.726950; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; DARBAR D, IN PRESS J AM COLL C; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Dobrev D, 2003, BASIC RES CARDIOL, V98, P137, DOI 10.1007/s00395-003-0409-8; Dun W, 2003, AM J PHYSIOL-HEART C, V285, pH1378, DOI 10.1152/ajpheart.00137.2003; Ellinor Patrick T, 2003, J Cardiovasc Electrophysiol, V14, P1007, DOI 10.1046/j.1540-8167.2003.03307.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Han W, 2001, CIRCULATION, V104, P2095, DOI 10.1161/hc4201.097134; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Kober L, 2000, LANCET, V356, P2052, DOI 10.1016/S0140-6736(00)03402-4; KRISHNAN SC, 1993, CIRCULATION, V87, P562, DOI 10.1161/01.CIR.87.2.562; Kumagai K, 2004, CARDIOVASC RES, V62, P105, DOI 10.1016/j.cardiores.2004.01.018; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lehnart S, 2007, CIRC RES, V101, P746, DOI 10.1161/CIRCRESAHA.107.162479; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; LUKAS A, 1993, CIRCULATION, V88, P2903, DOI 10.1161/01.CIR.88.6.2903; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mazur A, 1999, CIRCULATION, V100, P2437, DOI 10.1161/01.CIR.100.24.2437; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Morady F, 1999, NEW ENGL J MED, V340, P534, DOI 10.1056/NEJM199902183400707; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Murray KT, 2007, HEART RHYTHM, V4, pS88, DOI 10.1016/j.hrthm.2006.12.027; Nakano Y, 2004, J AM COLL CARDIOL, V43, P818, DOI 10.1016/j.jacc.2003.08.060; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2006, NAT REV DRUG DISCOV, V5, P1034, DOI 10.1038/nrd2112; Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Page RL, 2005, NAT REV DRUG DISCOV, V4, P899, DOI 10.1038/nrd1876; Pedersen OD, 1999, CIRCULATION, V100, P376, DOI 10.1161/01.CIR.100.4.376; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; ROSEN MR, 1991, CIRCULATION, V84, P1831; Sarrazin JF, 2007, J AM COLL CARDIOL, V50, P1505, DOI 10.1016/j.jacc.2007.05.046; Sasano T, 2006, NAT MED, V12, P1256, DOI 10.1038/nm1503; Schwartz PJ, 2006, J INTERN MED, V259, P39, DOI 10.1111/j.1365-2796.2005.01583.x; Schwartz PJ, 2003, J CARDIOVASC ELECTR, V14, P1120, DOI 10.1046/j.1540-8167.2003.03339.x; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Shiroshita-Takeshita A, 2004, CIRCULATION, V110, P2313, DOI 10.1161/01.CIR.0000145163.56529.D1; Sirenko SG, 2006, J PHYSIOL-LONDON, V575, P201, DOI 10.1113/jphysiol.2006.107557; Spach MS, 2007, CIRC RES, V101, P743, DOI 10.1161/CIRCRESAHA.107.163956; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Spooner PM, 2001, CIRCULATION, V103, P2361; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wijffels MCEF, 1997, CIRCULATION, V96, P3710; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Yue LX, 1999, CIRC RES, V84, P776; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	100	54	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					929	936		10.1038/nature06799	http://dx.doi.org/10.1038/nature06799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288182				2022-12-28	WOS:000253313100033
J	Sanz, J; Fayad, ZA				Sanz, Javier; Fayad, Zahi A.			Imaging of atherosclerotic cardiovascular disease	NATURE			English	Article							CORONARY-ARTERY-DISEASE; CARDIAC MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; IN-VIVO; PLAQUE INFLAMMATION; VULNERABLE PLAQUE; RISK-ASSESSMENT; CONTRAST AGENT; WORKING GROUP; ANGIOGRAPHY	Atherosclerosis is characterized by thickening of the walls of the arteries, a process that occurs slowly and 'silently' over decades. This prolonged course of disease provides a window of opportunity for diagnosis before symptoms occur. But, until recently, only advanced atherosclerotic disease could be observed. Now, developments in imaging technology offer many enticing prospects, including detecting atherosclerosis early, grouping individuals by the probability that they will develop symptoms of atherosclerosis, assessing the results of treatment and improving the current understanding of the biology of atherosclerosis.	[Sanz, Javier; Fayad, Zahi A.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Sanz, Javier; Fayad, Zahi A.] Mt Sinai Sch Med, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; [Fayad, Zahi A.] Mt Sinai Sch Med, Translat & Mol Imaging Inst, Imaging Sci Labs, Dept Radiol, New York, NY 10029 USA; [Fayad, Zahi A.] Mt Sinai Sch Med, Translat & Mol Imaging Inst, Imaging Sci Labs, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fayad, ZA (corresponding author), Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.	zahi.fayad@mssm.edu	Sanz, Javier/J-7251-2016; Fayad, Zahi/Z-3272-2019	Fayad, Zahi/0000-0002-3439-7347				Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Briley-Saebo KC, 2007, J MAGN RESON IMAGING, V26, P460, DOI 10.1002/jmri.20989; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Clouse ME, 2006, CIRCULATION, V113, P125, DOI 10.1161/CIRCULATIONAHA.104.478354; Cordeiro MAS, 2006, J AM COLL CARDIOL, V47, pC40, DOI 10.1016/j.jacc.2005.09.076; Corti R, 2005, J AM COLL CARDIOL, V46, P106, DOI 10.1016/j.jacc.2005.03.054; Fenchel M, 2006, RADIOLOGY, V238, P280, DOI 10.1148/radiol.2381041532; Flaumenhaft R, 2007, CIRCULATION, V115, P84, DOI 10.1161/CIRCULATIONAHA.106.643908; Gershlick AH, 2007, HEART, V93, P423, DOI 10.1136/hrt.2006.108779; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Ibanez B, 2007, CIRCULATION, V115, P2909, DOI 10.1161/circulationaha.106.679639; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Khera A, 2006, CIRCULATION, V113, P38, DOI 10.1161/CIRCULATIONAHA.105.575241; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MacNeill BD, 2003, ARTERIOSCL THROM VAS, V23, P1333, DOI 10.1161/01.ATV.0000080948.08888.BF; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAGHAVI M, 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Sakuma H, 2007, J MAGN RESON IMAGING, V26, P3, DOI 10.1002/jmri.20976; Sirol M, 2005, CIRCULATION, V112, P1594, DOI 10.1161/CIRCULATIONAHA.104.522110; Sosnovik DE, 2007, CIRCULATION, V115, P2076, DOI 10.1161/CIRCULATIONAHA.106.658930; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Villanueva FS, 2007, CIRCULATION, V115, P345, DOI 10.1161/CIRCULATIONAHA.106.633917; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068; Wickline SA, 2007, J MAGN RESON IMAGING, V25, P667, DOI 10.1002/jmri.20866; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Wu JC, 2007, RADIOLOGY, V244, P337, DOI 10.1148/radiol.2442060136	40	407	425	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					953	957		10.1038/nature06803	http://dx.doi.org/10.1038/nature06803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288186				2022-12-28	WOS:000253313100037
J	Gawronski, H; Mehlhorn, M; Morgenstern, K				Gawronski, H.; Mehlhorn, M.; Morgenstern, K.			Imaging phonon excitation with atomic resolution	SCIENCE			English	Article							MOLECULE VIBRATIONAL SPECTROSCOPY; SCANNING TUNNELING MICROSCOPE; NOBLE-METALS; TEMPERATURE; AU(111); MODES	Inelastic electron tunneling spectroscopy at low temperatures was used to investigate vibrations of Au( 111) and Cu( 111). The low- energy peaks at 9 millielectron volts ( meV) on Au( 111) and 21 meV on Cu( 111) are attributed to phonons at surfaces. On Au( 111), the phonon energy is not influenced by the different stacking of the surface atoms, but it is considerably influenced by different atomic distances within the surface layer. The spatial variation of the phonon excitation is measured in inelastic electron tunneling maps on Au( 111), which display atomic resolution. This atomic resolution is explained in terms of site- specific phonon excitation probabilities.	[Gawronski, H.; Mehlhorn, M.; Morgenstern, K.] Leibniz Univ Hannover, Inst Solid State Phys, Dept Surface Sci, D-30167 Hannover, Germany	Leibniz University Hannover	Gawronski, H (corresponding author), Leibniz Univ Hannover, Inst Solid State Phys, Dept Surface Sci, Appelstr 2, D-30167 Hannover, Germany.	gawronski@fkp.uni-hannover.de	Morgenstern, Karina/P-1563-2019	Morgenstern, Karina/0000-0002-6660-5286				Agrait N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216803; Bartels L, 1999, SURF SCI, V432, pL621, DOI 10.1016/S0039-6028(99)00640-8; BINNIG G, 1982, HELV PHYS ACTA, V55, P726; Borisova SD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165412; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Gawronski H, 2005, EUR PHYS J D, V35, P349, DOI 10.1140/epjd/e2005-00224-4; HARTEN U, 1985, FARADAY DISCUSS, V80, P137, DOI 10.1039/dc9858000137; Hofer WA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.236104; JAYANTHI CS, 1987, PHYS REV LETT, V59, P795, DOI 10.1103/PhysRevLett.59.795; Kim Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126104; KRESS W, 1991, SPRINGER SERIES SURF, V21; Lauhon LJ, 2001, REV SCI INSTRUM, V72, P216, DOI 10.1063/1.1327311; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Lorente N, 2000, PHYS REV LETT, V85, P2997, DOI 10.1103/PhysRevLett.85.2997; Mehlhorn M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432244; Morgenstern K, 2002, J CHEM PHYS, V116, P5746, DOI 10.1063/1.1453965; NARASIMHAN S, 1992, PHYS REV LETT, V69, P1564, DOI 10.1103/PhysRevLett.69.1564; Pascual JI, 2001, PHYS REV LETT, V86, P1050, DOI 10.1103/PhysRevLett.86.1050; PERSSON BNJ, 1987, PHYS REV LETT, V59, P339, DOI 10.1103/PhysRevLett.59.339; Qiu XH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.206102; Stipe BC, 1999, PHYS REV LETT, V82, P1724, DOI 10.1103/PhysRevLett.82.1724; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Untiedt C, 2000, PHYS REV B, V62, P9962, DOI 10.1103/PhysRevB.62.9962; Vitali L, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121414; WIESENDANGER R, 1998, SCANNING PROBE MICRO	26	59	60	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					930	933		10.1126/science.1152473	http://dx.doi.org/10.1126/science.1152473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276884				2022-12-28	WOS:000253165700039
J	King, N; Westbrook, MJ; Young, SL; Kuo, A; Abedin, M; Chapman, J; Fairclough, S; Hellsten, U; Isogai, Y; Letunic, I; Marr, M; Pincus, D; Putnam, N; Rokas, A; Wright, KJ; Zuzow, R; Dirks, W; Good, M; Goodstein, D; Lemons, D; Li, WQ; Lyons, JB; Morris, A; Nichols, S; Richter, DJ; Salamov, A; Bork, P; Lim, WA; Manning, G; Miller, WT; McGinnis, W; Shapiro, H; Tjian, R; Grigoriev, IV; Rokhsar, D				King, Nicole; Westbrook, M. Jody; Young, Susan L.; Kuo, Alan; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Hellsten, Uffe; Isogai, Yoh; Letunic, Ivica; Marr, Michael; Pincus, David; Putnam, Nicholas; Rokas, Antonis; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Good, Matthew; Goodstein, David; Lemons, Derek; Li, Wanqing; Lyons, Jessica B.; Morris, Andrea; Nichols, Scott; Richter, Daniel J.; Salamov, Asaf; Bork, Peer; Lim, Wendell A.; Manning, Gerard; Miller, W. Todd; McGinnis, William; Shapiro, Harris; Tjian, Robert; Grigoriev, Igor V.; Rokhsar, Daniel		JGI Sequencing	The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans	NATURE			English	Article							UNICELLULAR RELATIVES; EVOLUTIONARY ORIGIN; CELL-ADHESION; INSIGHTS; CONSERVATION; ARCHITECTURE; PROTEINS; FAMILY	Choanoflagellates are the closest known relatives of metazoans. To discover potential molecular mechanisms underlying the evolution of metazoan multicellularity, we sequenced and analysed the genome of the unicellular choanoflagellate Monosiga brevicollis. The genome contains approximately 9,200 intron- rich genes, including a number that encode cell adhesion and signalling protein domains that are otherwise restricted to metazoans. Here we show that the physical linkages among protein domains often differ between M. brevicollis and metazoans, suggesting that abundant domain shuffling followed the separation of the choanoflagellate and metazoan lineages. The completion of the M. brevicollis genome allows us to reconstruct with increasing resolution the genomic changes that accompanied the origin of metazoans.	[King, Nicole; Westbrook, M. Jody; Young, Susan L.; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Isogai, Yoh; Putnam, Nicholas; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Goodstein, David; Lyons, Jessica B.; Nichols, Scott; Richter, Daniel J.; Tjian, Robert; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [King, Nicole; Westbrook, M. Jody; Young, Susan L.; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Isogai, Yoh; Putnam, Nicholas; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Goodstein, David; Lyons, Jessica B.; Nichols, Scott; Richter, Daniel J.; Tjian, Robert; Rokhsar, Daniel] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [King, Nicole] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kuo, Alan; Hellsten, Uffe; Salamov, Asaf; Shapiro, Harris; Grigoriev, Igor V.; Rokhsar, Daniel; JGI Sequencing] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Letunic, Ivica; Bork, Peer] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Marr, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Pincus, David; Good, Matthew; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Lemons, Derek; McGinnis, William] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Li, Wanqing; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Morris, Andrea] Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Bioinformat Ctr, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; European Molecular Biology Laboratory (EMBL); Brandeis University; University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; Salk Institute	King, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nking@berkeley.edu; dsrokhsar@lbl.gov	Good, Matthew C/GLS-0964-2022; Letunic, Ivica/A-6032-2009; Putnam, Nicholas/B-9968-2008; Puigbò, Pere/A-2214-2008; Bork, Peer/F-1813-2013; Manning, Gerard/C-8308-2009; Rokas, Antonis/A-9775-2008; Lyons, Jessica/ABB-5014-2020; Letunic, Ivica/K-1102-2019	Putnam, Nicholas/0000-0002-1315-782X; Bork, Peer/0000-0002-2627-833X; Rokas, Antonis/0000-0002-7248-6551; Lyons, Jessica/0000-0002-3886-2146; Letunic, Ivica/0000-0003-3560-4288; Richter, Daniel/0000-0002-9238-5571; Rokhsar, Daniel/0000-0002-8704-2224; Zhi, Iris/0000-0003-4263-7272; Manning, Gerard/0000-0002-5087-9151; Goodstein, David/0000-0001-6287-2697; Rojahn, Susan/0000-0001-5888-7693; Good, Matthew/0000-0002-6367-1034; Sigg, Monika/0000-0001-8522-9127; Grigoriev, Igor/0000-0002-3136-8903	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA058530] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077197] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058530, R01 CA058530-14] Funding Source: Medline; NHGRI NIH HHS [R01 HG004164, R01 HG004164-01] Funding Source: Medline; NICHD NIH HHS [R37 HD028315] Funding Source: Medline; NIGMS NIH HHS [R01 GM077197] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Akiyama S K, 1996, Hum Cell, V9, P181; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arndt H., 2000, FLAGELLATES, P240; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Boenigk J, 2002, ANTON LEEUW INT J G, V81, P465, DOI 10.1023/A:1020509305868; BUCK KR, 1988, MAR BIOL, V98, P263, DOI 10.1007/BF00391204; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; CSUROS M, 2005, P 3 RECOMB SAT WORKS, P47; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; ERWIN DH, 1993, BIOL J LINN SOC, V50, P255, DOI 10.1006/bijl.1993.1058; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; James-Clark H., 1868, BOWERBANK ANN MAG NA, V1, P133; James-Clark H, 1868, ANN MAG NAT HIST, V1, P250; James-Clark H, 1868, ANN MAG NAT HIST, V1, P188; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Knoll AH., 2003, LIFE YOUNG PLANET; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LEADBEATER BSC, 1983, J MAR BIOL ASSOC UK, V63, P135, DOI 10.1017/S0025315400049857; LEADBEATER BSC, 1979, PROC R SOC SER B-BIO, V204, P57, DOI 10.1098/rspb.1979.0012; LEADBEATER BSC, 1994, EUR J PROTISTOL, V30, P111, DOI 10.1016/S0932-4739(11)80204-X; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Saville Kent W., 1880, MANUAL INFUSORIA; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Snell EA, 2006, P ROY SOC B-BIOL SCI, V273, P401, DOI 10.1098/rspb.2005.3263; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Sullivan James C, 2006, Genome Inform, V17, P219; THOMSEN HA, 1992, POLAR BIOL, V12, P53; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	50	776	832	1	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					783	788		10.1038/nature06617	http://dx.doi.org/10.1038/nature06617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273011	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000253191400033
J	Fox, R				Fox, Robin			10-minute consultation - Management of recurrent gout	BRITISH MEDICAL JOURNAL			English	Editorial Material									Ctr Hlth, Bicester OX27 0EY, Oxon, England		Fox, R (corresponding author), Ctr Hlth, Bicester OX27 0EY, Oxon, England.	Robin.Fox@gp-K84052.nhs.uk							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					329	329		10.1136/bmj.39273.712674.94	http://dx.doi.org/10.1136/bmj.39273.712674.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18258969	Green Published			2022-12-28	WOS:000253437400036
J	Horvath, J; Landis, T; Burkhard, PR				Horvath, Judit; Landis, Theodor; Burkhard, Pierre R.			Restless arms	LANCET			English	Editorial Material							LEGS SYNDROME		[Horvath, Judit; Landis, Theodor; Burkhard, Pierre R.] Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland	University of Geneva	Horvath, J (corresponding author), Univ Hosp Geneva, Dept Neurol, Rue Micheli Crest 24, CH-1211 Geneva, Switzerland.	judit.horvath@hcuge.ch						Chabli A, 2000, EUR NEUROL, V44, P133, DOI 10.1159/000008221; Freedom T, 2003, ARCH NEUROL-CHICAGO, V60, P1013, DOI 10.1001/archneur.60.7.1013; Michaud M, 2000, MOVEMENT DISORD, V15, P289, DOI 10.1002/1531-8257(200003)15:2<289::AID-MDS1012>3.0.CO;2-E; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; WEBB AT, 1976, JAMA-J AM MED ASSOC, V236, P822, DOI 10.1001/jama.1976.03270080014015	5	29	30	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2008	371	9611					530	530		10.1016/S0140-6736(08)60240-8	http://dx.doi.org/10.1016/S0140-6736(08)60240-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262044				2022-12-28	WOS:000253169200033
J	Nishide, H; Oyaizu, K				Nishide, Hiroyuki; Oyaizu, Kenichi			Materials science - Toward flexible batteries	SCIENCE			English	Editorial Material									[Nishide, Hiroyuki; Oyaizu, Kenichi] Waseda Univ, Dept Appl Chem, Tokyo 1698555, Japan	Waseda University	Nishide, H (corresponding author), Waseda Univ, Dept Appl Chem, Tokyo 1698555, Japan.	nishide@waseda.jp	Nishide, Hiroyuki/A-8221-2012; Oyaizu, Kenichi/E-5290-2013	Nishide, Hiroyuki/0000-0002-4036-4840; Oyaizu, Kenichi/0000-0002-8425-1063				Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Berridge R, 2006, J PHYS CHEM B, V110, P3140, DOI 10.1021/jp057256h; Cooper JM, 2004, J AM CHEM SOC, V126, P15362, DOI 10.1021/ja044682s; HEEGER AJ, 1981, CHEM COMMUN, V317; Hong J, 2007, J ELECTROCHEM SOC, V154, pA805, DOI 10.1149/1.2746804; HUVILA R, 2007, 3 GLOB PLAST EL C SH; Miller SA, 2004, J AM CHEM SOC, V126, P6226, DOI 10.1021/ja0496322; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nishide H., 2005, Electrochemical Society Interface, V14, P32; Scrosati B, 2007, NAT NANOTECHNOL, V2, P598, DOI 10.1038/nnano.2007.318; Song HK, 2006, ADV MATER, V18, P1764, DOI 10.1002/adma.200600375; Suga T, 2007, CHEM COMMUN, P1730, DOI 10.1039/b618710b; Taberna L, 2006, NAT MATER, V5, P567, DOI 10.1038/nmat1672; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644	14	934	952	9	469	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					737	738		10.1126/science.1151831	http://dx.doi.org/10.1126/science.1151831			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258887				2022-12-28	WOS:000252963000030
J	Pique, M; Lopez, JM; Foissac, S; Guigo, R; Mendez, R				Pique, Maria; Lopez, Jose Manuel; Foissac, Sylvain; Guigo, Roderic; Mendez, Raul			A combinatorial code for CPE-mediated translational control	CELL			English	Article							B1 MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION ELEMENTS; C-MOS; OOCYTE MATURATION; MEIOTIC MATURATION; SPECIFICITY FACTOR; XENOPUS PUMILIO; BINDING PROTEIN; CYCLIN; PHOSPHORYLATION	Cytoplasmic polyadenylation plays a key role in the translational control of mRNAs driving biological processes such as gametogenesis, cell-cycle progression, and synaptic plasticity. What determines the distinct time of polyadenylation and extent of translational control of a given mRNA, however, is poorly understood. The polyadenylation-regulated translation is controlled by the cytoplasmic polyadenylation element (CPE) and its binding protein, CPEB, which can assemble both translational repression or activation complexes. Using a combination of mutagenesis and experimental validation of genome-wide computational predictions, we show that the number and relative position of two elements, the CPE and the Pumilio-binding element, with respect to the polyadenylation signal define a combinatorial code that determines whether an mRNA will be translationally repressed by CPEB, as well as the extent and time of cytoplasmic polyadenylation-dependent translational activation.	[Pique, Maria; Lopez, Jose Manuel; Foissac, Sylvain; Guigo, Roderic; Mendez, Raul] UPF, Ctr Genom Regulat CRG, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendez, R (corresponding author), UPF, Ctr Genom Regulat CRG, C-Dr Aiguader 88, Barcelona, Spain.	rau1.mendez@crg.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020; Guigo, Roderic/D-1303-2010	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262; Guigo, Roderic/0000-0002-5738-4477; Mendez, Raul/0000-0002-1952-6905; Foissac, Sylvain/0000-0002-2631-5356				Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Okano H, 2002, J CELL SCI, V115, P1355; Pique Maria, 2006, V322, P183; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Rouhana L, 2007, RNA, V13, P188, DOI 10.1261/rna.333507; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x	32	261	267	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					434	448		10.1016/j.cell.2007.12.038	http://dx.doi.org/10.1016/j.cell.2007.12.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267074	Bronze			2022-12-28	WOS:000253180700018
J	Kaler, SG; Holmes, CS; Goldstein, DS; Tang, JR; Godwin, SC; Donsante, A; Liew, CJ; Sato, S; Patronas, N				Kaler, Stephen G.; Holmes, Courtney S.; Goldstein, David S.; Tang, Jingrong; Godwin, Sarah C.; Donsante, Anthony; Liew, Clarissa J.; Sato, Susumu; Patronas, Nicholas			Neonatal diagnosis and treatment of Menkes disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPPER-TRANSPORTING ATPASE; TANDEM MASS-SPECTROMETRY; OCCIPITAL-HORN-SYNDROME; KINKY HAIR SYNDROME; CANDIDATE GENE; HISTIDINE TREATMENT; THERAPY; ENCODES; MUTATIONS; PHENOTYPE	Background: Menkes disease is a fatal neurodegenerative disorder of infancy caused by diverse mutations in a copper-transport gene, ATP7A. Early treatment with copper injections may prevent death and illness, but presymptomatic detection is hindered by the inadequate sensitivity and specificity of diagnostic tests. Exploiting the deficiency of a copper enzyme, dopamine-(beta)-hydroxylase, we prospectively evaluated the diagnostic usefulness of plasma neurochemical levels, assessed the clinical effect of early detection, and investigated the molecular bases for treatment outcomes. Methods: Between May 1997 and July 2005, we measured plasma dopamine, norepinephrine, dihydroxyphenylacetic acid, and dihydroxyphenylglycol in 81 infants at risk. In 12 newborns who met the eligibility criteria and began copper-replacement therapy within 22 days after birth, we tracked survival and neurodevelopment longitudinally for 1.5 to 8 years. We characterized ATP7A mutations using yeast complementation, reverse-transcriptase-polymerase-chain-reaction analysis, and immunohistochemical analysis. Results: Of 81 infants at risk, 46 had abnormal neurochemical findings indicating low dopamine-(beta)-hydroxylase activity. On the basis of longitudinal follow-up, patients were classified as affected or unaffected by Menkes disease, and the neurochemical profiles were shown to have high sensitivity and specificity for detecting disease. Among 12 newborns with positive screening tests who were treated early with copper, survival at a median follow-up of 4.6 years was 92%, as compared with 13% at a median follow-up of 1.8 years for a historical control group of 15 late-diagnosis and late-treatment patients. Two of the 12 patients had normal neurodevelopment and brain myelination; 1 of these patients had a mutation that complemented a Saccharomyces cerevisiae copper-transport mutation, indicating partial ATPase activity, and the other had a mutation that allowed some correct ATP7A splicing. Conclusions: Neonatal diagnosis of Menkes disease by plasma neurochemical measurements and early treatment with copper may improve clinical outcomes. Affected newborns who have mutations that do not completely abrogate ATP7A function may be especially responsive to early copper treatment. (ClinicalTrials.gov number, NCT00001262.).	[Kaler, Stephen G.; Godwin, Sarah C.; Donsante, Anthony] NICHHD, NIH, Unit Pediat Genet, Bethesda, MD 20892 USA; [Holmes, Courtney S.; Goldstein, David S.] Natl Inst Neurol Disorders & Stroke, Clin Neurocardiol Sect, NIH, Bethesda, MD USA; [Liew, Clarissa J.; Sato, Susumu] Natl Inst Neurol Disorders & Stroke, Electroencephalog Sect, NIH, Bethesda, MD USA; [Patronas, Nicholas] NIH, Imaging Sci Program, Mark O Hatfield Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA	Kaler, SG (corresponding author), NICHHD, NIH, Unit Pediat Genet, Bldg 10,Rm 5-2571,10 Ctr Dr,MSC 1832, Bethesda, MD 20892 USA.	kalers@mail.nih.gov	Kaler, Stephen/GPT-3845-2022	Donsante, Anthony/0000-0002-7591-7417	Intramural NIH HHS [Z01 HD008768-04, Z01 HD008768-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008768, ZIAHD008892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003033, ZIANS003034] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambrosini L, 1999, HUM MOL GENET, V8, P1547, DOI 10.1093/hmg/8.8.1547; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DEGISLAIN C, 1986, CANCER CHEMOTH PHARM, V18, P276, DOI 10.1007/BF00273402; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; GARNICA A, 1994, J PEDIATR-US, V125, P336, DOI 10.1016/S0022-3476(94)70236-5; GARNICA AD, 1977, CLIN GENET, V11, P154, DOI 10.1111/j.1399-0004.1977.tb01294.x; GUNN TR, 1984, CLIN PEDIATR, V23, P514, DOI 10.1177/000992288402300915; Hao CY, 2002, RAPID COMMUN MASS SP, V16, P591, DOI 10.1002/rcm.589; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; Kaler S G, 1994, Adv Pediatr, V41, P263; KALER SG, 1993, ANN NEUROL, V33, P171, DOI 10.1002/ana.410330206; KALER SG, 1993, J INHERIT METAB DIS, V16, P907, DOI 10.1007/BF00714295; Kaler SG, 1996, NAT GENET, V13, P21, DOI 10.1038/ng0596-21; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Liu PC, 2005, MOL GENET METAB, V85, P291, DOI 10.1016/j.ymgme.2005.04.007; Liu PC, 2002, GENET TEST, V6, P255, DOI 10.1089/10906570260471778; LOCKITCH G, 1988, CLIN CHEM, V34, P1625; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; NADAL D, 1988, EUR J PEDIATR, V147, P621, DOI 10.1007/BF00442477; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; SHERWOOD G, 1989, J INHERIT METAB DIS, V12, P393, DOI 10.1007/BF03335432; Tang JR, 2006, GENET MED, V8, P711, DOI 10.1097/01.gim.0000245578.94312.1e; TUMER Z, 1996, NAT GENET, V12, P113; VULPE C, 1993, NAT GENET, V3, P273, DOI 10.1038/ng0393-273a; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	31	171	181	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					605	614		10.1056/NEJMoa070613	http://dx.doi.org/10.1056/NEJMoa070613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256395	Green Accepted			2022-12-28	WOS:000252916400007
J	Meyer-Luehmann, M; Spires-Jones, TL; Prada, C; Garcia-Alloza, M; de Calignon, A; Rozkalne, A; Koenigsknecht-Talboo, J; Holtzman, DM; Bacskai, BJ; Hyman, BT				Meyer-Luehmann, Melanie; Spires-Jones, Tara L.; Prada, Claudia; Garcia-Alloza, Monica; de Calignon, Alix; Rozkalne, Anete; Koenigsknecht-Talboo, Jessica; Holtzman, David M.; Bacskai, Brian J.; Hyman, Bradley T.			Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease	NATURE			English	Article							TRANSGENIC MICE; MULTIPHOTON MICROSCOPY; PRECURSOR PROTEIN; IN-VIVO; MICROGLIA; ABNORMALITIES; NEUROTOXICITY; DISRUPTION; DEFICITS; MEMORY	Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia(1). This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques(2). The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/ PS1d9xYFP ( B6C3-YFP) transgenic mice(3). Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.	[Meyer-Luehmann, Melanie; Spires-Jones, Tara L.; Prada, Claudia; Garcia-Alloza, Monica; de Calignon, Alix; Rozkalne, Anete; Bacskai, Brian J.; Hyman, Bradley T.] Harvard Univ, Massgen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA 02129 USA; [Koenigsknecht-Talboo, Jessica; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Hyman, BT (corresponding author), Harvard Univ, Massgen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA 02129 USA.	bhyman@partners.org	Garcia-Alloza, Monica/F-3313-2016; Bacskai, Brian/AAE-9583-2021; Spires-Jones, Tara/AAR-7697-2020; Garcia-Alloza, Monica/AAN-9799-2021	Garcia-Alloza, Monica/0000-0003-1610-4114; Spires-Jones, Tara/0000-0003-2530-0598; Garcia-Alloza, Monica/0000-0003-1610-4114; Meyer-Luehmann, Melanie/0000-0003-3661-2220	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, P50AG005134] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG008487, P50 AG005134, P30 AG062421, R01 AG008487-20] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-08, P30 DK056341-07, P30 DK056341] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Combs CK, 2001, J NEUROSCI, V21, P1179; Frautschy SA, 1998, AM J PATHOL, V152, P307; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KAWAI M, 1990, AM J PATHOL, V137, P1435; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Le R, 2001, J NEUROPATH EXP NEUR, V60, P753, DOI 10.1093/jnen/60.8.753; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	27	770	789	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					720	U5		10.1038/nature06616	http://dx.doi.org/10.1038/nature06616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256671	Green Accepted			2022-12-28	WOS:000252929500042
J	Shin, YI; Schunck, CH; Schirotzek, A; Ketterle, W				Shin, Yong-Il; Schunck, Christian H.; Schirotzek, Andre; Ketterle, Wolfgang			Phase diagram of a two-component Fermi gas with resonant interactions	NATURE			English	Article							CRITICAL FIELD; SUPERCONDUCTORS; SUPERFLUIDITY	The pairing of fermions lies at the heart of superconductivity and superfluidity. The stability of these pairs determines the robustness of the superfluid state, and the quest for superconductors with high critical temperature equates to a search for systems with strong pairing mechanisms. Ultracold atomic Fermi gases present a highly controllable model system for studying strongly interacting fermions(1). Tunable interactions ( through Feshbach collisional resonances) and the control of population or mass imbalance among the spin components provide unique opportunities to investigate the stability of pairing(2-4) - and possibly to search for exotic forms of superfluidity(5,6). A major controversy has surrounded the stability of superfluidity against an imbalance between the two spin components when the fermions interact resonantly ( that is, at unitarity). Here we present the phase diagram of a spin- polarized Fermi gas of Li-6 atoms at unitarity, experimentally mapping out the superfluid phases versus temperature and density imbalance. Using tomographic techniques, we reveal spatial discontinuities in the spin polarization; this is the signature of a first- order superfluid- to- normal phase transition, and disappears at a tricritical point where the nature of the phase transition changes from first- order to second- order. At zero temperature, there is a quantum phase transition from a fully paired superfluid to a partially polarized normal gas. These observations and the implementation of an in situ ideal gas thermometer provide quantitative tests of theoretical calculations on the stability of resonant superfluidity.	[Shin, Yong-Il; Schunck, Christian H.; Schirotzek, Andre; Ketterle, Wolfgang] MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Shin, Yong-Il; Schunck, Christian H.; Schirotzek, Andre; Ketterle, Wolfgang] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shin, YI (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yishin@mit.edu	Schunck, Christian H/A-3625-2010; Shin, Yong-il/B-1955-2008	Schunck, Christian H/0000-0002-7917-8180; Shin, Yong-il/0000-0003-0481-9841				Bedaque PF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247002; Bulgac A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090404; Bulgac A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.031605; Burovski E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.160402; Carlson J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060401; Chevy F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063628; Chien CC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.110404; De Silva TN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.070402; FULDE P, 1964, PHYS REV           A, V135, P550; GIORGINI S, 2007, THEORY ULTRACOLD FER; Griffiths R. B., 1970, Physical Review Letters, V24, P715, DOI 10.1103/PhysRevLett.24.715; Gubbels KB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.210402; Haque M, 2006, PHYS REV LETT, V98; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; LARKIN AI, 1965, ZH EKSP TEOR FIZ, V20, P762; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Machida K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120407; Parish MM, 2007, NAT PHYS, V3, P124, DOI 10.1038/nphys520; Partridge GB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.190407; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; SARMA G, 1963, J PHYS CHEM SOLIDS, V24, P1029, DOI 10.1016/0022-3697(63)90007-6; Schunck CH, 2007, SCIENCE, V316, P867, DOI 10.1126/science.1140749; Sheehy DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.060401; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Yi W, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013610; Zwierlein MW, 2006, NATURE, V442, P54, DOI 10.1038/nature04936; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318	30	272	276	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					689	U1		10.1038/nature06473	http://dx.doi.org/10.1038/nature06473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256666	Green Submitted			2022-12-28	WOS:000252929500035
J							US Preventive Services Task Force	Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							WOMEN; METRONIDAZOLE; BIRTH; TRIAL	Description: Update of the 2001 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for bacterial vaginosis in pregnancy. Methods: The USPSTF weighed the benefits and harms of screening for bacterial vaginosis in pregnancy by identifying new evidence addressing previously identified gaps from the 2001 USPSTF recommendation. Published literature on this topic was identified by using MEDLINE, Cochrane Library databases, the Database of Abstracts of Reviews of Effects, reference lists, and consultation with experts and was systematically reviewed. When data allowed, a series of meta-analyses (using new and 2001 report data) was done to estimate the pooled effect of treatment on preterm delivery (<37 weeks, <34 weeks, or <32 weeks) and on low birthweight and preterm, premature rupture of membranes. Recommendation: Do not screen for bacterial vaginosis in pregnant women at low risk for preterm delivery. (D recommendation) Current evidence is insufficient to assess the balance of benefits and harms of screening for bacterial vaginosis in pregnant women at high risk for preterm delivery. (I statement).										*AAFP, 2007, REC CLIN PREV SERV B; Andrews WW, 2003, SEMIN PERINATOL, V27, P231, DOI 10.1016/S0146-0005(03)00006-5; [Anonymous], 2017, ACOG PRACTICE BULLET, V130; *BASHH CEG, 2007, REV NAT GUID MAN BAC; Bradt Joke, 2016, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000262.PUB3, 10.1002/14651858.CD006911.pub3, DOI 10.1002/14651858.CD006911.PUB3]; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P50; Guise JM, 2001, AM J PREV MED, V20, P62, DOI 10.1016/S0749-3797(01)00256-2; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Honest H, 2004, BJOG-INT J OBSTET GY, V111, P409, DOI 10.1111/j.1471-0528.2004.00124.x; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; NYGREN P, 2008, AHRQ PUBLICATION; Odendaal HJ, 2002, SAMJ S AFR MED J, V92, P235; Vermeulen GM, 1999, BRIT J OBSTET GYNAEC, V106, P652, DOI 10.1111/j.1471-0528.1999.tb08363.x	15	39	44	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					214	219		10.7326/0003-4819-148-3-200802050-00007	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18252683				2022-12-28	WOS:000252849700005
J	Rad, EM; Navabi, MA; Kocharian, A; Momtazmanesh, N; Golbidi, E				Rad, Elaheh Malakan; Navabi, Mohammad Ali; Kocharian, Armen; Momtazmanesh, Nader; Golbidi, Elham			Not mumps	LANCET			English	Editorial Material									[Rad, Elaheh Malakan; Kocharian, Armen] Univ Tehran Med Sci, Imam Khomeini Gen Hosp, Dept Paediat Cardiol, Childrens Med Ctr, Tehran, Iran; [Golbidi, Elham] Univ Tehran Med Sci, Imam Khomeini Gen Hosp, Dept Paediat, Childrens Med Ctr, Tehran, Iran; [Navabi, Mohammad Ali] Univ Tehran Med Sci, Imam Khomeini Gen Hosp, Dept Cardiac Surg, Childrens Med Ctr, Tehran, Iran; [Momtazmanesh, Nader] Shaheed Beheshti Univ Med Sci, Dept Paediat, Loghman Gen Hosp, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Rad, EM (corresponding author), 3rd Floor 38,28th St,Gisha Ave, Tehran 14488, Iran.	emalakanrad@yahoo.com	Malakan Rad, Elaheh/K-3404-2016	Malakan Rad, Elaheh/0000-0001-7824-6973				DREWS RE, SUPERIOR VENA CAVA S; GEORGE S, TREATMENT METASTATIC; Rheingold SR, 2006, PRINCIPLES PRACTICE, P1202	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					446	446		10.1016/S0140-6736(08)60206-8	http://dx.doi.org/10.1016/S0140-6736(08)60206-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242416				2022-12-28	WOS:000252992700034
J	DalCorso, G; Pesaresi, P; Masiero, S; Aseeva, E; Nemann, DS; Finazzi, G; Joliot, P; Barbato, R; Leister, D				DalCorso, Giovanni; Pesaresi, Paolo; Masiero, Simona; Aseeva, Elena; Schuenemann, Danja; Finazzi, Giovanni; Joliot, Pierre; Barbato, Roberto; Leister, Dario			A complex containing PGRL1 and PGR5 is involved in the switch between linear and cyclic electron flow in Arabidopsis	CELL			English	Article							CYTOCHROME B(6)F COMPLEX; PHOTOSYSTEM-I; PHOTOACOUSTIC MEASUREMENTS; CHLAMYDOMONAS-REINHARDTII; DEHYDROGENASE COMPLEX; STATE TRANSITIONS; ENERGY-STORAGE; NUCLEAR GENES; HIGHER-PLANTS; REDOX STATE	During photosynthesis, two photoreaction centers located in the thylakoid membranes of the chloroplast, photosystems I and II (PSI and PSII), use light energy to mobilize electrons to generate ATP and NADPH. Different modes of electron flow exist, of which the linear electron flow is driven by PSI and PSII, generating ATP and NADPH, whereas the cyclic electron flow (CEF) only generates ATP and is driven by the PSI alone. Different environmental and metabolic conditions require the adjustment of ATP/NADPH ratios and a switch of electron distribution between the two photosystems. With the exception of PGR5, other components facilitating CEF are unknown. Here, we report the identification of PGRL1, a transmembrane protein present in thylakoids of Arabidopsis thaliana. Plants lacking PGRL1 show perturbation of CEF, similar to PGR5-deficient plants. We find that PGRL1 and PGR5 interact physically and associate with PSI. We therefore propose that the PGRL1-PGR5 complex facilitates CEF in eukaryotes.	[DalCorso, Giovanni; Aseeva, Elena; Leister, Dario] Univ Munich, Dept Biol, Lehrstuhl Bot, D-80638 Munich, Germany; [Pesaresi, Paolo] Univ Statale Milano, Dipartimento Prod Veget, I-26900 Lodi, Italy; [Masiero, Simona] Univ Milan, Dipartimento Biol, I-20133 Milan, Italy; [Schuenemann, Danja] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, D-44780 Bochum, Germany; [Finazzi, Giovanni; Joliot, Pierre] Inst Biol Physicochim, CNRS, UMR 7141, F-75005 Paris, France; [Barbato, Roberto] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, I-15100 Alessandria, Italy	University of Munich; University of Milan; University of Milan; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Eastern Piedmont Amedeo Avogadro	Leister, D (corresponding author), Univ Munich, Dept Biol, Lehrstuhl Bot, Menzinger Str 67, D-80638 Munich, Germany.	leister@lrz.uni-muenchen.de	Leister, Dario/D-5587-2009; Masiero, Simona/J-2898-2013; Pesaresi, Paolo/F-9476-2014	Leister, Dario/0000-0003-1897-8421; Pesaresi, Paolo/0000-0002-3236-7005; masiero, simona/0000-0002-7563-7634; DalCorso, GIOVANNI/0000-0002-0594-5930; Schuenemann, Danja/0000-0001-8894-7685				Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Biehl A, 2005, GENE, V344, P33, DOI 10.1016/j.gene.2004.09.009; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Clarke JE, 2001, PLANTA, V212, P808, DOI 10.1007/s004250000432; CLELAND RE, 1992, PHOTOSYNTH RES, V34, P409, DOI 10.1007/BF00029815; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Golding AJ, 2004, PLANTA, V220, P356, DOI 10.1007/s00425-004-1345-z; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; Haldrup A, 2003, J BIOL CHEM, V278, P33276, DOI 10.1074/jbc.M305106200; HARBINSON J, 1991, PLANT PHYSIOL, V97, P41, DOI 10.1104/pp.97.1.41; Havaux M, 2005, BBA-BIOENERGETICS, V1709, P203, DOI 10.1016/j.bbabio.2005.07.010; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2004.02011.x; Ihnatowicz A, 2007, PLANTA, V226, P889, DOI 10.1007/s00425-007-0534-y; Joet T, 2002, PLANT PHYSIOL, V128, P760, DOI 10.1104/pp.010775; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Joliot P, 2004, BBA-BIOENERGETICS, V1656, P166, DOI 10.1016/j.bbabio.2004.03.010; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; MI H, 1994, PLANT CELL PHYSIOL, V35, P163; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; MOSS DA, 1984, BIOCHIM BIOPHYS ACTA, V767, P389, DOI 10.1016/0005-2728(84)90036-7; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Okegawa Y, 2005, J BIOL CHEM, V280, P28332, DOI 10.1074/jbc.M505703200; RAVENEL J, 1994, PLANTA, V193, P251; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Takabayashi A, 2005, P NATL ACAD SCI USA, V102, P16898, DOI 10.1073/pnas.0507095102; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; YU L, 1993, PLANT PHYSIOL, V103, P171, DOI 10.1104/pp.103.1.171; Zhang HM, 2001, J BIOL CHEM, V276, P38159	44	397	419	7	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 25	2008	132	2					273	285		10.1016/j.cell.2007.12.028	http://dx.doi.org/10.1016/j.cell.2007.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243102	Bronze, Green Submitted			2022-12-28	WOS:000253427700013
J	Hauf, S				Hauf, Silke			Mps1 checks up on chromosome attachment	CELL			English	Editorial Material							KINASE	The protein kinase Mps1, a crucial regulator of the spindle-assembly checkpoint, now turns out to be essential for correcting errors in chromosome attachment (Jelluma et al., 2008). Mps1 exerts this effect by regulating the activity of the Aurora B kinase through phosphorylation of its partner protein Borealin.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Hauf, S (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany.	silke.hauf@tuebingen.mpg.de	Hauf, Silke/H-7321-2012	Hauf, Silke/0000-0001-5938-721X				HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; JELLUMA N, 2008, CELL; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	9	0	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					181	182		10.1016/j.cell.2008.01.008	http://dx.doi.org/10.1016/j.cell.2008.01.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243093	Bronze			2022-12-28	WOS:000253427700004
J	ANDERSON, GC				ANDERSON, GC			LASKER PRIZE HIATUS	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					5	5		10.1038/344005d0	http://dx.doi.org/10.1038/344005d0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277990	Bronze			2022-12-28	WOS:A1990CQ97200014
J	Viswanathan, SR; Daley, GQ; Gregory, RI				Viswanathan, Srinivas R.; Daley, George Q.; Gregory, Richard I.			Selective blockade of MicroRNA processing by Lin28	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; LET-7 MICRORNA; BIOGENESIS; PROFILE; COMPLEX; RNA	MicroRNAs ( miRNAs) play critical roles in development, and dysregulation of miRNA expression has been observed in human malignancies. Recent evidence suggests that the processing of several primary miRNA transcripts (pri- miRNAs) is blocked posttranscriptionally in embryonic stem cells, embryonal carcinoma cells, and primary tumors. Here we show that Lin28, a developmentally regulated RNA binding protein, selectively blocks the processing of pri- let- 7 miRNAs in embryonic cells. Using in vitro and in vivo studies, we found that Lin28 is necessary and sufficient for blocking Microprocessor- mediated cleavage of pri- let- 7 miRNAs. Our results identify Lin28 as a negative regulator of miRNA biogenesis and suggest that Lin28 may play a central role in blocking miRNA-mediated differentiation in stem cells and in certain cancers.	[Viswanathan, Srinivas R.; Daley, George Q.; Gregory, Richard I.] Harvard Univ, Childrens Hosp Boston, Dept Biol Chem & Mol Pharmacol, Stem Cell Program,Sch Med,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Pediat Hematol Oncol, Childrens Hosp Boston, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp Boston, Dept Biol Chem & Mol Pharmacol, Stem Cell Program,Sch Med,Harvard Stem Cell Inst, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; rgregory@enders.tch.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK70055] Funding Source: Medline; NIH HHS [DP1 OD000256] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	1126	1189	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					97	100		10.1126/science.1154040	http://dx.doi.org/10.1126/science.1154040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18292307	Green Accepted			2022-12-28	WOS:000254633000039
J	Biddle, L; Brock, A; Brookes, ST; Gunnell, D				Biddle, Lucy; Brock, Anita; Brookes, Sara T.; Gunnell, David			Suicide rates in young men in England and Wales in the 21st century: time trend study	BRITISH MEDICAL JOURNAL			English	Article							SSRI PRESCRIPTIONS; ADOLESCENTS; DEPRESSION; CHILDREN; DECLINE; IMPACT	Objectives To explore trends in suicide in young people to investigate the recent observation that after year on year rises in the 1970s, 1980s, and early 1990s, rates in young men are now declining. Design Time trend analysis. Setting England and Wales, 1968-2005. Population Men and women aged 15-34 years. Results Since the 1990s, rates of suicide in young men have declined steadily and by 2005 they were at their lowest level for almost 30 years. This decline is partly because of a reduction in poisoning with car exhaust gas as an increased number of cars have catalytic converters; but there have been declines in suicides from all common methods, including hanging, suggesting a more pervasive effect. Other risk factors for suicide, such as unemployment and divorce, have also decreased. Possible recent reductions in alcohol use among young men and increases in prescribing of antidepressants do not seem to be temporally related to the decline In suicide. Conclusions Suicide rates in young men have declined markedly in the past 10 years in England and Wales. Reductions in key risk factors for suicide, such as unemployment, might be contributing to lower rates.	[Biddle, Lucy; Brookes, Sara T.; Gunnell, David] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Brock, Anita] Off Natl Stat, London SW1V 2QQ, England	University of Bristol	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	D.J.Gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470				Amos T, 2001, PSYCHOL MED, V31, P935, DOI 10.1017/S0033291701003920; Brock A, 2003, HLTH STAT Q, V20, P7; Cantor C. H., 2000, INT HDB SUICIDE ATTE; *DEP HLTH, 2007, HOSP EP STAT DAT; Department of Health, 2002, NAT SUIC PREV STRAT; Department of Health, 1992, HLTH NAT STRAT HLTH; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Goddard E, 2005, SMOKING DRINKING ADU; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Gunnell D, 1999, LANCET, V353, P556, DOI 10.1016/S0140-6736(99)00408-0; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X; *IMS HLTH, 2007, INT MED STAT; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lineberry TW, 2007, MAYO CLIN PROC, V82, P518, DOI 10.4065/82.4.518; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Martin RM, 2006, BRIT J CLIN PHARMACO, V61, P224, DOI 10.1111/j.1365-2125.2005.02527.x; *MED HEALTHC PROD, 2005, SEL SER REUPTG INH S; Morrell S, 2007, SOC SCI MED, V64, P747, DOI 10.1016/j.socscimed.2006.09.027; Murray ML, 2005, DRUG SAFETY, V28, P1151, DOI 10.2165/00002018-200528120-00009; *NAT I HLTH CLIN E, 2005, 28 BRIT PSYCH SOC NA; *OFF NAT STAT, 2007, NAT STAT; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Olfson M, 2007, AM J PSYCHIAT, V164, P1907, DOI 10.1176/appi.ajp.2007.07091467; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	27	80	80	1	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					539	+		10.1136/bmj.39475.603935.25	http://dx.doi.org/10.1136/bmj.39475.603935.25			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274JV	18276666	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000253998500028
J	Davies, MJ; Heller, S; Skinner, TC; Campbell, MJ; Carey, ME; Cradock, S; Dallosso, HM; Daly, H; Doherty, Y; Eaton, S; Fox, C; Oliver, L; Rantell, K; Rayman, G; Khunti, K				Davies, M. J.; Heller, S.; Skinner, T. C.; Campbell, M. J.; Carey, M. E.; Cradock, S.; Dallosso, H. M.; Daly, H.; Doherty, Y.; Eaton, S.; Fox, C.; Oliver, L.; Rantell, K.; Rayman, G.; Khunti, K.		Diabet Educ Self Management Ongoin	Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PERSONAL-MODEL BELIEFS; QUALITY-OF-LIFE; PRIMARY-CARE; PERCEPTION QUESTIONNAIRE; SECONDARY PREVENTION; PATIENT EMPOWERMENT; OUTCOMES FRAMEWORK; PHYSICAL-ACTIVITY; ILLNESS	Objective To evaluate the effectiveness of a structured group education programme on biomedical, psychosocial, and lifestyle measures in people with newly diagnosed type 2 diabetes. Design Multicentre cluster randomised controlled trial in primary care with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United Kingdom. Participants 824 adults (55% men, mean age 59.5 years). Intervention A structured group education programme for six hours delivered in the community by two trained healthcare professional educators compared with usual care. Main outcome measures Haemoglobin A(1c) levels, blood pressure, weight, blood lipid levels, smoking status, physical activity, quality of life, beliefs about illness, depression, and emotional impact of diabetes at baseline and up to 12 months. Main results Haemoglobin A(1c) levels at 12 months had decreased by 1.49% in the intervention group compared with 1.21% in the control group. After adjusting for baseline and cluster, the difference was not significant: 0.05% (95% confidence interval -0.10% to 0.20%). The intervention group showed a greater weight loss: -2.98 kg (95% confidence interval -3.54 to -2.41) compared with 1.86 kg (-2.44 to -1.28), P=0.027 at 12 months. The odds of not smoking were 3.56 (95% confidence interval 1.11 to 11.45), P=0.033 higher in the intervention group at 12 months. The intervention group showed significantly greater changes in illness belief scores (P=0.001); directions of change were positive indicating greater understanding of diabetes. The intervention group had a tower depression score at 12 months: mean difference was -0.50 (95% confidence interval -0.96 to -0.04); P=0.032. A positive association was found between change in perceived personal responsibility and weight loss at 12 months (beta=0.12; P=0.008). Conclusion A structured group education programme for patients with newly diagnosed type 2 diabetes resulted in greater improvements in weight loss and smoking cessation and positive improvements in beliefs about illness but no difference in haemoglobin A(1c) levels up to 12 months after diagnosis. Trial registration Current Controlled Trials ISRCTN17844016.	[Davies, M. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 5WW, Leics, England; [Heller, S.] Univ Sheffield, Sch Med, Acad Unit Diabet Endocrinol & Metab, Sheffield S10 2TN, S Yorkshire, England; [Skinner, T. C.] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England; [Campbell, M. J.; Carey, M. E.; Dallosso, H. M.; Rantell, K.] Univ Hosp Leicester NHS Trust, DESMOND Programme, Diabet Res Team, Leicester, Leics, England; [Cradock, S.] Northumbria Healthcare NHS Fdn Trust, Diabet Resource Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Daly, H.] Northampton Gen Hosp, Northampton, England; [Doherty, Y.; Eaton, S.; Oliver, L.] Ipswich Gen Hosp NHS Trust, Ipswich Diabet Serv, Ipswich, Suffolk, England; [Fox, C.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Rayman, G.; Khunti, K.] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Leicester; University of Sheffield; University of Sheffield; University Hospitals of Leicester NHS Trust; University of Leicester; Ipswich Hospital NHS Trust; University of Wollongong; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Davies, MJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 5WW, Leics, England.	melanie.davies@uhl-tr.nhs.uk	Skinner, Timothy C/N-2221-2013; Davies, Michael/GWV-2527-2022; Davies, Michael/AGX-9184-2022; /ABC-9527-2021	Skinner, Timothy C/0000-0002-0018-6963; Davies, Michael/0000-0002-5196-6919; Davies, Melanie/0000-0002-9987-9371; Heller, Simon/0000-0002-2425-9565; Khunti, Kamlesh/0000-0003-2343-7099				ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; ANDERSON RM, 1995, DIABETES CARE, V18, P412, DOI 10.2337/diacare.18.3.412; Audit Commission, 2000, TEST TIM REV DIAB SE; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barth J, 2006, ANN BEHAV MED, V32, P10, DOI 10.1207/s15324796abm3201_2; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Chaiken S., 1996, SOCIAL PSYCHOL HDB B; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davies MJ, 2006, DIABETOLOGIA, V49, P535; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x; Department of Health, 2001, NAT SERV FRAM DIAB S; Department of Health, 2002, NAT SERV FRAM DIAB S; Dillner L, 1999, BRIT MED J, V318, P1265; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; Forouhi NG, 2006, DIABETIC MED, V23, P189, DOI 10.1111/j.1464-5491.2005.01787.x; Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556; HAMPSON SE, 1990, HEALTH PSYCHOL, V9, P632, DOI 10.1037/0278-6133.9.5.632; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; *INT DIAB FED, 2007, IDF DIAB ATL PREV ES; Khunti K, 2007, DIABETIC MED, V24, P1436, DOI 10.1111/j.1464-5491.2007.02276.x; Khunti K, 2007, HEART, V93, P1398, DOI 10.1136/hrt.2006.106955; Kinmonth AL, 1998, BMJ-BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202; KRONSBEIN P, 1988, LANCET, V2, P1407; Leventhal H., 1980, CONTRIBUTIONS MED PS; Lorig K, 2002, LANCET, V359, P814, DOI 10.1016/S0140-6736(02)07959-X; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Massi-Benedetti M, 2002, DIABETOLOGIA, V45, pS1, DOI 10.1007/s00125-002-0860-3; Moher M, 2001, BMJ-BRIT MED J, V322, P1338, DOI 10.1136/bmj.322.7298.1338; Morris AD, 2002, DIABETES-METAB RES, V18, pS32, DOI 10.1002/dmrr.295; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; National Institute for Health and Care Excellence, 2003, GUID US PAT ED MOD D; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Porta M, 2004, DIABETIC MED, V21, P644, DOI 10.1111/j.1464-5491.2004.01170.x; Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6; Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35; Rutten G, 2005, DIABETIC MED, V22, P671, DOI 10.1111/j.1464-5491.2005.01497.x; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Skinner T, 2003, DIABETES SPECTRUM, V16, P75, DOI [DOI 10.2337/DIASPECT.16.2.75, 10.2337/diaspect.16.2.75]; Skinner TC, 2006, PATIENT EDUC COUNS, V64, P369, DOI 10.1016/j.pec.2006.04.007; Skinner TC, 2003, DIABETIC MED, V20, P283, DOI 10.1046/j.1464-5491.2003.00923.x; Skinner TC, 2002, HEALTH PSYCHOL, V21, P61, DOI 10.1037//0278-6133.21.1.61; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; *WHOQOL GROUP, 2005, SOC SCI MED, V46, P1569; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	473	484	3	108	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2008	336	7642					491	495		10.1136/bmj.39474.922025.BE	http://dx.doi.org/10.1136/bmj.39474.922025.BE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18276664	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000253997500042
J	Doull, L; Campbell, F				Doull, Linda; Campbell, Fiona			Human resources for health in fragile states	LANCET			English	Editorial Material									[Doull, Linda; Campbell, Fiona] Merlin, Hlth & Policy Dept, London EC1V 9NR, England		Doull, L (corresponding author), Merlin, Hlth & Policy Dept, London EC1V 9NR, England.	doull@merlin.org.uk						Department for International Development, 2005, WHY WE NEED WORK MOR; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; *INT HLTH EV LIB, 2005, FIN REP; WHO, 2006, WORK TOG HLTH WORLD	4	17	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					626	627		10.1016/S0140-6736(08)60278-0	http://dx.doi.org/10.1016/S0140-6736(08)60278-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295006				2022-12-28	WOS:000253436700005
J	Dudzinski, DM; Kesselheim, AS				Dudzinski, David M.; Kesselheim, Aaron S.			Scientific and legal viability of follow-on protein drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPENDITURES; MARKET		[Dudzinski, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Dudzinski, DM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Ainsworth SJ, 2005, CHEM ENG NEWS, V83, P21, DOI 10.1021/cen-v083n023.p021; *BAXT PHARM SOL, 2006, HYL REC HYAL HUM INJ; *BIO, 2006, BIO POS STAT NAM LAB; *BIO, 2007, DIFF BIOL SCI LEG RE; *BIO, 2008, FOLL ON BIOL REG STR; *COMM MED PROD HUM, 2006, 2006 PLEN M MONTHL R; *COMM MED PROD HUM, 2006, ANN GUID SIM BIOL ME; *COMM MED PROD HUM, 2006, GUID SIM BIOL MED PR; *COMM PROPR MED PR, 2003, GUID COMP MED PROD C; Committee for Medicinal Products for Human Use, 2005, GUID SIM BIOL MED PR; CONDON W, 2006, LIFE SCI INSIGH 0509; *CTR DRUG EV RES, 2005, 21859 CTR DRUG EV RE; CUMMINS HJ, 2005, STAR TRIBUNE    0322; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Dudzinski DM, 2005, FOOD DRUG LAW J, V60, P143; *EUR GEN MED ASS, 2007, EGA WELC APPR 1 BIOS; *FOOD DRUG ADM, 2006, OMN SOM RDNA OR QUES; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; GALSON SK, 2006, COMMUNICATION   0530; GOLDBERGER MJ, 2008, COMMUNICATION   0201; Grabowski H, 2006, HEALTH AFFAIR, V25, P1291, DOI 10.1377/hlthaff.25.5.1291; Grabowski HG, 2007, MANAG DECIS ECON, V28, P439, DOI 10.1002/mde.1352; Griffiths S, 2004, NAT REV DRUG DISCOV, V3, P197, DOI 10.1038/nrd1333; Hoffman JM, 2007, AM J HEALTH-SYST PH, V64, P298, DOI 10.2146/ajhp060545; Hoffman JM, 2006, AM J HEALTH-SYST PH, V63, P123, DOI 10.2146/ajhp050446; Hoffman JM, 2005, AM J HEALTH-SYST PH, V62, P149, DOI 10.1093/ajhp/62.2.149; Hoffman JM, 2004, AM J HEALTH-SYST PH, V61, P145, DOI 10.1093/ajhp/61.2.145; *IMS HLTH, 2007, TOP 10 PROD US SAL; *IMS HLTH, 2007, IMS REP US PRESCR SA; INSLEE J, 2007, SEATTLE POST IN 0627; KAUFMAN M, 2005, WASHINGTON POST 1115, pA1; Kesselheim AS, 2006, HEALTH AFFAIR, V25, P1637, DOI 10.1377/hlthaff.25.6.1637; Kesselheim AS, 2006, JAMA-J AM MED ASSOC, V295, P434, DOI 10.1001/jama.295.4.434; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; LAMB E, 2007, PHARM TIMES      MAY; LEVY RS, 2005, COMMUNICATION   0411; Louet S, 2003, NAT BIOTECHNOL, V21, P956, DOI 10.1038/nbt0903-956; LUDWIG SR, 2007, INTELLECTUAL PRO AUG, P7; Mossinghoff GJ, 1999, FOOD DRUG LAW J, V54, P187; ORLOFF DG, 2005, COMMUNICATION   0812; *SAND, 2004, AUSTR AG APPR OMN; Schellekens H, 2004, NAT BIOTECHNOL, V22, P1357, DOI 10.1038/nbt1104-1357; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Simon F, 2006, HEALTH AFFAIR, V25, P1363, DOI 10.1377/hlthaff.25.5.1363; Soumerai S, 2003, J CLIN PSYCHIAT, V64, P19; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; TSAO A, 2003, BUSINESS WEEK O 1024; 2006, NAT BIOTECHNOL, V24, P367	48	37	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					843	849		10.1056/NEJMhle0706973	http://dx.doi.org/10.1056/NEJMhle0706973			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287608				2022-12-28	WOS:000253257700012
J	Butalia, S; Palda, VA; Sargeant, RJ; Detsky, AS; Mourad, O				Butalia, Sonia; Palda, Valerie A.; Sargeant, Robert J.; Detsky, Allan S.; Mourad, Ophyr			Does this patient with diabetes have osteomyelitis of the lower extremity?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TO-BONE TEST; FOOT OSTEOMYELITIS; CLINICAL EXAMINATION; PEDAL OSTEOMYELITIS; DIAGNOSIS; ULCERS; METAANALYSIS; INFECTIONS; DISEASE; SCINTIGRAPHY	Context Osteomyelitis of the lower extremity is a commonly encountered problem in patients with diabetes and is an important cause of amputation and admission to the hospital. The diagnosis of lower limb osteomyelitis in patients with diabetes remains a challenge. Objective To determine the accuracy of historical features, physical examination, and laboratory and basic radiographic testing. We searched for systematic reviews of magnetic resonance imaging ( MRI) in the diagnosis of lower extremity osteomyelitis in patients with diabetes to compare its performance with the reference standard. Data Sources MEDLINE search of English- language articles published between 1966 and March 2007 related to osteomyelitis in patients with diabetes. Additional articles were identified through a hand search of references from retrieved articles, previous reviews, and polling experts. Study Selection Original studies were selected if they ( 1) described historical features, physical examination, laboratory investigations, or plain radiograph in the diagnosis of lower extremity osteomyelitis in patients with diabetes mellitus, ( 2) data could be extracted to construct 2 x 2 tables or had reported operating characteristics of the diagnostic measure, and ( 3) the diagnostic test was compared with a reference standard. Of 279 articles retrieved, 21 form the basis of this review. Data from a single high- quality meta- analysis were used to summarize the diagnostic characteristics of MRI in osteomyelitis. Data Extraction Two authors independently assigned each study a quality grade using previously published criteria and abstracted operating characteristic data using a standardized instrument. Data Synthesis The gold standard for diagnosis is bone biopsy. No studies were identified that addressed the utility of the history in the diagnosis of osteomyelitis. An ulcer area larger than 2 cm(2) ( positive likelihood ratio [ LR], 7.2; 95% confidence interval [ CI], 1.1- 49; negative LR, 0.48; 95% CI, 0.31- 0.76) and a positive "probe- to- bone" test result ( summary positive LR, 6.4; 95% CI, 3.6- 11; negative LR, 0.39; 95% CI, 0.20- 0.76) were the best clinical findings. A erythrocyte sedimentation rate of more than 70 mm/ h increases the probability of a diagnosis of osteomyelitis ( summary LR, 11; 95% CI, 1.6-79). An abnormal plain radiograph doubles the odds of osteomyelitis ( summary LR, 2.3; 95% CI, 1.6- 3.3). A positive MRI result increases the likelihood of osteomyelitis ( summary LR, 3.8; 95% CI, 2.5- 5.8). However, a normal MRI result makes osteomyelitis much less likely ( summary LR, 0.14; 95% CI, 0.08- 0.26). The overall accuracy ( ie, the weighted average of the sensitivity and specificity) of the MRI is 89% ( 95% CI, 83.0%- 94.5%). Conclusions An ulcer area larger than 2 cm(2), a positive probe- to- bone test result, an erythrocyte sedimentation rate of more than 70 mm/ h, and an abnormal plain radiograph result are helpful in diagnosing the presence of lower extremity osteomyelitis in patients with diabetes. A negative MRI result makes the diagnosis much less likely when all of these findings are absent. No single historical feature or physical examination reliably	[Butalia, Sonia; Palda, Valerie A.; Sargeant, Robert J.; Mourad, Ophyr] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Palda, Valerie A.; Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mourad, O (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	mourado@smh.toronto.on.ca		Butalia, Sonia/0000-0001-7865-9161				Armstrong D G, 1996, J Foot Ankle Surg, V35, P280; BAMBERGER DM, 1987, AM J MED, V83, P653, DOI 10.1016/0002-9343(87)90894-1; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS1; Capriotti G, 2006, NUCL MED COMMUN, V27, P757, DOI 10.1097/01.mnm.0000230065.85705.b3; Croll SD, 1996, J VASC SURG, V24, P266, DOI 10.1016/S0741-5214(96)70102-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Enderle MD, 1999, DIABETES CARE, V22, P294, DOI 10.2337/diacare.22.2.294; GRAYSON ML, 1995, JAMA-J AM MED ASSOC, V273, P721, DOI 10.1001/jama.273.9.721; Green MF, 2002, SOUTH MED J, V95, P95; Harrington C, 2000, DIABETES CARE, V23, P1333, DOI 10.2337/diacare.23.9.1333; Hill SL, 1999, AM J SURG, V177, P282, DOI 10.1016/S0002-9610(99)00050-1; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Johnson JE, 1996, FOOT ANKLE INT, V17, P10, DOI 10.1177/107110079601700103; Kaleta JL, 2001, J AM PODIAT MED ASSN, V91, P445, DOI 10.7547/87507315-91-9-445; Kapoor A, 2007, ARCH INTERN MED, V167, P125, DOI 10.1001/archinte.167.2.125; KEENAN AM, 1989, ARCH INTERN MED, V149, P2262, DOI 10.1001/archinte.149.10.2262; Kessler L, 2006, DIABETIC MED, V23, P99, DOI 10.1111/j.1464-5491.2005.01764.x; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; LARCOS G, 1991, AM J ROENTGENOL, V157, P527, DOI 10.2214/ajr.157.3.1872240; Lavery L A, 1995, J Foot Ankle Surg, V34, P61; Lavery LA, 2007, DIABETES CARE, V30, P270, DOI 10.2337/dc06-1572; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; LEE SM, 1986, SKELETAL RADIOL, V15, P625, DOI 10.1007/BF00349857; LEVINE SE, 1994, FOOT ANKLE INT, V15, P151, DOI 10.1177/107110079401500311; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; London NJM, 2000, BRIT MED J, V320, P1589, DOI 10.1136/bmj.320.7249.1589; Mettler MA, 2005, ESSENTIALS RADIOLOGY; NEWMAN LG, 1991, JAMA-J AM MED ASSOC, V266, P1246, DOI 10.1001/jama.266.9.1246; OYEN WJG, 1992, J NUCL MED, V33, P1330; PARK HM, 1982, J NUCL MED, V23, P569; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; SELDIN DW, 1985, J NUCL MED, V26, P988; Senneville E, 2006, CLIN INFECT DIS, V42, P57, DOI 10.1086/498112; Shone A, 2006, DIABETES CARE, V29, P945, DOI 10.2337/diacare.29.04.06.dc05-2450; SHULTS DW, 1989, AM J SURG, V158, P525, DOI 10.1016/0002-9610(89)90184-0; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Subramaniam B, 2005, ANESTH ANALG, V100, P1241, DOI 10.1213/01.ANE.0000147705.94738.31; Vesco L, 1999, METABOLISM, V48, P922, DOI 10.1016/S0026-0495(99)90230-5; Wagner F W Jr, 1981, Foot Ankle, V2, P64; WANG A, 1990, MAGN RESON IMAGING, V8, P805, DOI 10.1016/0730-725X(90)90017-V; WEINSTEIN D, 1993, FOOT ANKLE, V14, P18, DOI 10.1177/107110079301400104; Williams DT, 2004, CLIN INFECT DIS, V39, pS83, DOI 10.1086/383267; YUH WTC, 1989, AM J ROENTGENOL, V152, P795, DOI 10.2214/ajr.152.4.795	47	119	124	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					806	813		10.1001/jama.299.7.806	http://dx.doi.org/10.1001/jama.299.7.806			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285592				2022-12-28	WOS:000253226900023
J	Xu, YP; Ramu, Y; Lu, Z				Xu, Yanping; Ramu, Yajamana; Lu, Zhe			Removal of phospho-head groups of membrane lipids immobilizes voltage sensors of K+ channels	NATURE			English	Article							POTASSIUM CHANNELS; GATING CHARGE; SODIUM-CHANNELS; LYMPHOCYTE-T; ACTIVATION; SEQUENCE; CURRENTS; TOXIN; SPHINGOMYELIN; TARANTULA	A fundamental question about the gating mechanism of voltage-activated K+ ( Kv) channels is how five positively charged voltage-sensing residues(1,2) in the fourth transmembrane segment are energetically stabilized, because they operate in a low- dielectric cell membrane. The simplest solution would be to pair them with negative charges(3). However, too few negatively charged channel residues are positioned for such a role(4,5). Recent studies suggest that some of the channel's positively charged residues are exposed to cell membrane phospholipids and interact with their head groups(5-9). A key question nevertheless remains: is the phosphohead of membrane lipids necessary for the proper function of the voltage sensor itself? Here we show that a given type of Kv channel may interact with several species of phospholipid and that enzymatic removal of their phospho-head creates an insuperable energy barrier for the positively charged voltage sensor to move through the initial gating step( s), thus immobilizing it, and also raises the energy barrier for the downstream step( s).	[Xu, Yanping; Ramu, Yajamana; Lu, Zhe] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055560] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055560] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DOERY HM, 1963, NATURE, V198, P1091, DOI 10.1038/1981091a0; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Glenny AT, 1935, J PATHOL BACTERIOL, V40, P201, DOI 10.1002/path.1700400202; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; PROJAN SJ, 1989, NUCLEIC ACIDS RES, V17, P3305, DOI 10.1093/nar/17.8.3305; Ramu Y, 2007, P NATL ACAD SCI USA, V104, P6448, DOI 10.1073/pnas.0701354104; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2	31	147	150	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					826	U8		10.1038/nature06618	http://dx.doi.org/10.1038/nature06618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273018	Green Accepted			2022-12-28	WOS:000253191400042
J	Krauss, RM				Krauss, Ronald M.			What can the genome tell us about LDL cholesterol?	LANCET			English	Editorial Material							RISK; LOCI		[Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Krauss, RM (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	rkrauss@chori.org						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; *BRIT HEART FDN, 2007, LOW DENS LIP REC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DAMMERMAN M, 1995, CIRCULATION, V91, P505, DOI 10.1161/01.CIR.91.2.505; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; KRAUSS RM, IN PRESS CIRCULATION; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Ordovas JM, 2007, FORUM NUTR, V60, P102, DOI 10.1159/000107079; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pollex RL, 2007, NAT CLIN PRACT CARD, V4, P600, DOI 10.1038/ncpcardio1005; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	16	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					450	452		10.1016/S0140-6736(08)60213-5	http://dx.doi.org/10.1016/S0140-6736(08)60213-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262024				2022-12-28	WOS:000253169200005
J	Koentges, G				Koentges, Georgy			Evolution of anatomy and gene control	NATURE			English	Article							TRANSGENIC ANALYSIS; HIGH-THROUGHPUT; EXPRESSION; PATTERNS; ORIGINS; NOISE		[Koentges, Georgy] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick	Koentges, G (corresponding author), Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	g.koentges@warwick.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Alon U., 2006, INTRO SYSTEMS BIOL D; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Beckers J, 1996, DEV BIOL, V180, P543, DOI 10.1006/dbio.1996.0327; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Damle S, 2006, DEV BIOL, V299, P543, DOI 10.1016/j.ydbio.2006.06.016; Davidson EH, 2006, REG GEN GEN REG; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Faro-Trindade I, 2006, BIOCHEM SOC T, V34, P1133, DOI 10.1042/BST0341133; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gehring WJ, 2001, ZOOL-ANAL COMPLEX SY, V104, P171, DOI 10.1078/0944-2006-00022; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hansen Annika, 2004, Genome Inform, V15, P141; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Janvier P., 1996, EARLY VERTEBRATES; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kontges G, 1996, DEVELOPMENT, V122, P3229; Larsen CW, 2001, J NEUROSCI, V21, P4699, DOI 10.1523/JNEUROSCI.21-13-04699.2001; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pournara I, 2004, BIOINFORMATICS, V20, P2934, DOI 10.1093/bioinformatics/bth337; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Raff RA, 2007, NAT REV GENET, V8, P911, DOI 10.1038/nrg2225; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; RUMI MJ, 1925, MATHNAWI YIMA NAWI M, V3, P1259; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	60	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					658	663		10.1038/451658a	http://dx.doi.org/10.1038/451658a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256661				2022-12-28	WOS:000252929500030
J	Ogushi, S; Palmieri, C; Fulka, H; Saitou, M; Miyano, T; Fulka, J				Ogushi, Sugako; Palmieri, Chiara; Fulka, Helena; Saitou, Mitinori; Miyano, Takashi; Fulka, Josef, Jr.			The maternal nucleolus is essential for early embryonic development in mammals	SCIENCE			English	Article							RNA GENE-EXPRESSION; PORCINE OOCYTES; PREIMPLANTATION EMBRYOS; MOUSE ZYGOTES; NUCLEOLOGENESIS; SPERMIOGENESIS; FERTILIZATION; INHERITANCE; DNA	With fertilization, the paternal and maternal contributions to the zygote are not equal. The oocyte and spermatozoon are equipped with complementary arsenals of cellular structures and molecules necessary for the creation of a developmentally competent embryo. We show that the nucleolus is exclusively of maternal origin. The maternal nucleolus is not necessary for oocyte maturation; however, it is necessary for the formation of pronuclear nucleoli after fertilization or parthenogenetic activation and is essential for further embryonic development. In addition, the nucleolus in the embryo produced by somatic cell nuclear transfer originates from the oocyte, demonstrating that the maternal nucleolus supports successful embryonic development.	[Ogushi, Sugako; Miyano, Takashi] Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Ogushi, Sugako; Saitou, Mitinori] RIKEN, Kobe Inst, Lab Mammalian Germ Cell Biol, Kobe, Hyogo 6500047, Japan; [Ogushi, Sugako; Fulka, Helena; Fulka, Josef, Jr.] Inst Anim Sci, Prague 10401, Czech Republic; [Fulka, Helena] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Palmieri, Chiara] Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy	Kobe University; RIKEN; Czech Research Institute of Animal Science; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Teramo	Ogushi, S (corresponding author), Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan.	ogushi@cdb.riken.jp	Palmieri, Chiara/J-4003-2013; Palmieri, Chiara/AAV-8908-2020	Palmieri, Chiara/0000-0002-5791-6066; Palmieri, Chiara/0000-0002-5791-6066; Ogushi, Sugako/0000-0001-8497-6972; Fulka, Helena/0000-0001-7414-5024				Bjerregaard B, 2004, ANIM REPROD SCI, V82-3, P605, DOI 10.1016/j.anireprosci.2004.04.023; CROZET N, 1981, BIOL CELL, V41, P35; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Fulka J, 2003, THERIOGENOLOGY, V59, P1879, DOI 10.1016/S0093-691X(02)01226-8; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; Hyttel P, 2001, REPRODUCTION, V122, P21, DOI 10.1530/rep.0.1220021; KOPECNY V, 1989, REPROD NUTR DEV, V29, P589, DOI 10.1051/rnd:19890508; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SCHULTZ MC, 1990, AM J ANAT, V189, P1, DOI 10.1002/aja.1001890102; Sutovsky P, 1998, REPROD NUTR DEV, V38, P629, DOI 10.1051/rnd:19980605; TAKEUCHI IK, 1990, J STRUCT BIOL, V103, P104, DOI 10.1016/1047-8477(90)90014-4; TESARIK J, 1987, DEVELOPMENT, V101, P777; Viuff D, 2002, BIOL REPROD, V66, P629, DOI 10.1095/biolreprod66.3.629	17	110	117	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					613	616		10.1126/science.1151276	http://dx.doi.org/10.1126/science.1151276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239124				2022-12-28	WOS:000252772000039
J	Jones, OAH; Maguire, ML; Griffin, JL				Jones, Oliver A. H.; Maguire, Mahon L.; Griffin, Julian L.			Environmental pollution and diabetes: a neglected association	LANCET			English	Editorial Material							PERSISTENT ORGANIC POLLUTANTS; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; TOXICITY; VETERANS; EXPOSURE; BURDEN; DIOXIN		[Jones, Oliver A. H.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Maguire, Mahon L.] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, British Heart Fdn Magnet Resonance Unit, Oxford OX3 7BN, England	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Jones, OAH (corresponding author), Univ Cambridge, Dept Biochem, Hopkins Bldg, Cambridge CB2 1QW, England.	oahj2@mole.bio.cam.ac.uk	Jones, Oliver A.H./B-9778-2008	Jones, Oliver A.H./0000-0002-4541-662X				Azmi J, 2005, XENOBIOTICA, V35, P839, DOI 10.1080/00498250500297940; Cranmer M, 2000, TOXICOL SCI, V56, P431, DOI 10.1093/toxsci/56.2.431; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Fujiyoshi PT, 2006, ENVIRON HEALTH PERSP, V114, P1677, DOI 10.1289/ehp.9262; Griffin JL, 2007, J PROTEOME RES, V6, P54, DOI 10.1021/pr0601640; Henriksen GL, 1997, EPIDEMIOLOGY, V8, P252, DOI 10.1097/00001648-199705000-00005; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jones OAH, 2007, COMP BIOCHEM PHYS D, V2, P316, DOI 10.1016/j.cbd.2007.06.003; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Porta M, 2006, LANCET, V368, P558, DOI 10.1016/S0140-6736(06)69174-5; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28	13	53	53	2	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					287	288		10.1016/S0140-6736(08)60147-6	http://dx.doi.org/10.1016/S0140-6736(08)60147-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294985				2022-12-28	WOS:000252616500010
J	COYNE, JA				COYNE, JA			GENETICS, SPECIATION AND THE FOUNDER PRINCIPLE - GIDDINGS,LV, KENESHIRO,KY, ANDERSON,WW	NATURE			English	Book Review											COYNE, JA (corresponding author), UNIV CHICAGO,DEPT ECOL & EVOLUT,CHICAGO,IL 60637, USA.							[No title captured]	1	4	4	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					30	30		10.1038/344030a0	http://dx.doi.org/10.1038/344030a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278018	Bronze			2022-12-28	WOS:A1990CQ97200049
J	PRINN, RG; GOLOMBEK, A				PRINN, RG; GOLOMBEK, A			GLOBAL ATMOSPHERIC CHEMISTRY OF CFC-123	NATURE			English	Article									ISRAEL INST BIOL RES,DEPT ENVIRONM SCI,IL-70450 NESS ZIONA,ISRAEL		PRINN, RG (corresponding author), MIT,DEPT EARTH ATMOSPHER & PLANETARY SCI,CAMBRIDGE,MA 02139, USA.							ATKINSON R, 1989, J PHYS CHEM REF DATA, V18, P881, DOI 10.1063/1.555832; DAVIDSON JA, 1978, J CHEM PHYS, V69, P4277, DOI 10.1063/1.437113; DEMORE W, IN PRESS NASA JPL PU; DEMORE WB, 1987, NASA JPL PUBLICATION, V8741; GILLOTAY D, IN PRESS PLANETARY S; GOLOMBEK A, 1989, GEOPHYS RES LETT, V16, P1153, DOI 10.1029/GL016i010p01153; GOLOMBEK A, 1986, J GEOPHYS RES-ATMOS, V91, P3985, DOI 10.1029/JD091iD03p03985; HERMAN JR, 1982, J GEOPHYS RES-OCEANS, V87, P8967, DOI 10.1029/JC087iC11p08967; KO MKW, 1982, NATURE, V297, P317, DOI 10.1038/297317a0; PRINN R, 1987, SCIENCE, V238, P945, DOI 10.1126/science.238.4829.945; Protocol M., 1987, MONTREAL PROTOCOL SU; RAMANATHAN V, 1985, J GEOPHYS RES-ATMOS, V90, P5547, DOI 10.1029/JD090iD03p05547; ROWLAND FS, 1975, REV GEOPHYS, V13, P1, DOI 10.1029/RG013i001p00001	13	11	11	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					47	49		10.1038/344047a0	http://dx.doi.org/10.1038/344047a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278022				2022-12-28	WOS:A1990CQ97200054
J	Barnett, TP; Pierce, DW; Hidalgo, HG; Bonfils, C; Santer, BD; Das, T; Bala, G; Wood, AW; Nozawa, T; Mirin, AA; Cayan, DR; Dettinger, MD				Barnett, Tim P.; Pierce, David W.; Hidalgo, Hugo G.; Bonfils, Celine; Santer, Benjamin D.; Das, Tapash; Bala, Govindasamy; Wood, Andrew W.; Nozawa, Toru; Mirin, Arthur A.; Cayan, Daniel R.; Dettinger, Michael D.			Human-induced changes in the hydrology of the western United States	SCIENCE			English	Article							NORTH-AMERICA; CLIMATE-CHANGE; TRENDS; WATER; MODEL; ATTRIBUTION; STREAMFLOW; SNOWPACK; CYCLE	Observations have shown that the hydrological cycle of the western United States changed significantly over the last half of the 20th century. We present a regional, multivariable climate change detection and attribution study, using a high- resolution hydrologic model forced by global climate models, focusing on the changes that have already affected this primarily arid region with a large and growing population. The results show that up to 60% of the climate- related trends of river flow, winter air temperature, and snow pack between 1950 and 1999 are human- induced. These results are robust to perturbation of study variates and methods. They portend, in conjunction with previous work, a coming crisis in water supply for the western United States.	[Barnett, Tim P.; Pierce, David W.; Hidalgo, Hugo G.; Das, Tapash; Cayan, Daniel R.; Dettinger, Michael D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Bonfils, Celine; Santer, Benjamin D.; Bala, Govindasamy; Mirin, Arthur A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Wood, Andrew W.] Univ Washington, Land Surface Hydrol Res Grp, Seattle, WA 98195 USA; [Nozawa, Toru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Cayan, Daniel R.; Dettinger, Michael D.] US Geol Survey, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; National Institute for Environmental Studies - Japan; United States Department of the Interior; United States Geological Survey	Barnett, TP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	tbarnett-ul@ucsd.edu	Santer, Ben/ABA-1099-2021; Bala, Govindasamy/ABF-3255-2020; Dettinger, Michael/AAW-5759-2020; Santer, Benjamin D/F-9781-2011; Hidalgo, Hugo G./I-7170-2019; Wood, Andrew/L-5133-2013; Bonfils, Celine/H-2356-2012	Bala, Govindasamy/0000-0002-3079-0600; Hidalgo, Hugo G./0000-0003-4638-0742; Wood, Andrew/0000-0002-6231-0085; Bonfils, Celine/0000-0002-4674-5708				*ACPI, 2004, CLIMATIC CHANGE, V62, P444; Barnett T, 2004, CLIMATIC CHANGE, V62, P1, DOI 10.1023/B:CLIM.0000013695.21726.b8; BARNETT TP, 1987, J GEOPHYS RES-ATMOS, V92, P14772, DOI 10.1029/JD092iD12p14772; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; CHRISTENSEN N., 2006, HYDROL EARTH SYST SC, V3, P1; *COL RIV BAS WAT M, 2007, EV ADJ HYDR VAR; DETTINGER MD, 1995, J CLIMATE, V8, P606, DOI 10.1175/1520-0442(1995)008<0606:LSAFOR>2.0.CO;2; GLEICK PH, 1987, WATER RESOUR RES, V23, P1049, DOI 10.1029/WR023i006p01049; Groisman PY, 2004, J HYDROMETEOROL, V5, P64, DOI 10.1175/1525-7541(2004)005<0064:CCOTHC>2.0.CO;2; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; HASUMI H, 2004, K1 COUPLED MODEL MIR; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nozawa T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023540; NOZAWA T, 2007, CGERS SUPERCOMPUTER, V12; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; Santer BD, 2007, P NATL ACAD SCI USA, V104, P15248, DOI 10.1073/pnas.0702872104; Santer BD, 1995, CLIM DYNAM, V12, P77, DOI 10.1007/BF00223722; Schnur R, 2005, CLIM DYNAM, V24, P45, DOI 10.1007/s00382-004-0456-3; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; UDALL B, 2007, INTERMOUNTAIN W CLIM; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; WOOD A, 2004, CLIM DYNAM, V16, P755; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	29	814	861	10	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1080	1083		10.1126/science.1152538	http://dx.doi.org/10.1126/science.1152538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18239088	Green Submitted			2022-12-28	WOS:000253311700040
J	Marchiori, D; Warglien, M				Marchiori, Davide; Warglien, Massimo			Predicting human interactive learning by regret-driven neural networks	SCIENCE			English	Article							GAMES; EXPERIENCE; DECISIONS; UNIQUE	Much of human learning in a social context has an interactive nature: What an individual learns is affected by what other individuals are learning at the same time. Games represent a widely accepted paradigm for representing interactive decision- making. We explored the potential value of neural networks for modeling and predicting human interactive learning in repeated games. We found that even very simple learning networks, driven by regret- based feedback, accurately predict observed human behavior in different experiments on 21 games with unique equilibria in mixed strategies. Introducing regret in the feedback dramatically improved the performance of the neural network. We show that regret- based models provide better predictions of learning than established economic models.	[Warglien, Massimo] Ca Foscari Univ, Adv Sch Econ, Venice, Italy; [Warglien, Massimo] Ca Foscari Univ, Dept Business Econ & Management, Venice, Italy; [Marchiori, Davide] Univ Trent, Interdept Ctr Res Training Econ & Management CIFR, I-38100 Trento, Italy	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; University of Trento	Warglien, M (corresponding author), Ca Foscari Univ, Adv Sch Econ, Venice, Italy.	warglien@unive.it		Marchiori, Davide/0000-0001-7914-5568; warglien, massimo/0000-0002-0615-4938				Avrahami J, 2005, THEOR DECIS, V59, P255, DOI 10.1007/s11238-005-2883-y; Busemeyer JR, 2000, J MATH PSYCHOL, V44, P171, DOI 10.1006/jmps.1999.1282; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Camerer C, 2003, BEHAV GAME THEORY; Camerer CF, 2003, SCIENCE, V300, P1673, DOI 10.1126/science.1086215; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Erev I, 1998, AM ECON REV, V88, P848; Erev I, 2007, ECON THEOR, V33, P29, DOI 10.1007/s00199-007-0214-y; Ert E, 2007, J BEHAV DECIS MAKING, V20, P305, DOI 10.1002/bdm.556; Hertz JA, 2018, INTRO THEORY NEURAL; Ho TH, 2007, J ECON THEORY, V133, P177, DOI 10.1016/j.jet.2005.12.008; HOPFIELD JJ, 1987, P NATL ACAD SCI USA, V84, P8429, DOI 10.1073/pnas.84.23.8429; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lee D, 2006, NATURE, V441, P822, DOI 10.1038/441822a; MALCOLM D, 1965, PSYCHON SCI, V2, P373; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; ONEILL B, 1987, P NATL ACAD SCI USA, V84, P2106, DOI 10.1073/pnas.84.7.2106; RAPOPORT A, 1992, GAME ECON BEHAV, V4, P261, DOI 10.1016/0899-8256(92)90019-O; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; SELTEN R, 1986, J ECON BEHAV ORGAN, V7, P47, DOI 10.1016/0167-2681(86)90021-1; Selten R, 2005, EXP ECON, V8, P5, DOI 10.1007/s10683-005-1407-5; Selten R., 1998, EXP ECON, V1, P43, DOI [10.1023/A:1009957816843, DOI 10.1007/BF01426214]; Sgroi D, 2007, PHYSICA A, V375, P717, DOI 10.1016/j.physa.2006.10.026; Suppes P., 1960, MARKOV LEARNING MODE	27	63	68	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1111	1113		10.1126/science.1151185	http://dx.doi.org/10.1126/science.1151185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264SW	18292345				2022-12-28	WOS:000253311700049
J	Ternes, M; Lutz, CP; Hirjibehedin, CF; Giessibl, FJ; Heinrich, AJ				Ternes, Markus; Lutz, Christopher P.; Hirjibehedin, Cyrus F.; Giessibl, Franz J.; Heinrich, Andreas J.			The force needed to move an atom on a surface	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; SINGLE ATOMS; LATERAL MANIPULATION; SPECTROSCOPY; RESOLUTION; MOLECULE; STEPS; GOLD; TIP	Manipulation of individual atoms and molecules by scanning probe microscopy offers the ability of controlled assembly at the single- atom scale. However, the driving forces behind atomic manipulation have not yet been measured. We used an atomic force microscope to measure the vertical and lateral forces exerted on individual adsorbed atoms or molecules by the probe tip. We found that the force that it takes to move an atom depends strongly on the adsorbate and the surface. Our results indicate that for moving metal atoms on metal surfaces, the lateral force component plays the dominant role. Furthermore, measuring spatial maps of the forces during manipulation yielded the full potential energy landscape of the tip- sample interaction.	[Ternes, Markus; Lutz, Christopher P.; Hirjibehedin, Cyrus F.; Heinrich, Andreas J.] IBM Corp, Almaden Res Ctr, Div Res, San Jose, CA 95120 USA; [Giessibl, Franz J.] Univ Regensburg, Inst Expt & Appl Phys, D-93053 Regensburg, Germany	International Business Machines (IBM); University of Regensburg	Ternes, M (corresponding author), IBM Corp, Almaden Res Ctr, Div Res, 650 Harry Rd, San Jose, CA 95120 USA.	markust@us.ibm.com	Giessibl, Franz J/K-8022-2013; Ternes, Markus/M-9239-2015	Giessibl, Franz J/0000-0002-5585-1326; Ternes, Markus/0000-0001-6800-4129; Hirjibehedin, Cyrus/0000-0003-1706-2147				ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; [Anonymous], 2005, PHYS REV LETT; Bahn SR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266101; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Braun KF, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.033406; BULUSCHEK P, 2007, THESIS ECOLE POLYTEC; Chen W, 1999, PHYS REV B, V60, pR8529, DOI 10.1103/PhysRevB.60.R8529; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Holscher H, 2002, APPL PHYS LETT, V81, P4428, DOI 10.1063/1.1525056; Nilius N, 2002, SCIENCE, V297, P1853, DOI 10.1126/science.1075242; Oyabu N, 2005, NANOTECHNOLOGY, V16, pS112, DOI 10.1088/0957-4484/16/3/021; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Sugimoto Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106104; Tsivlin DV, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205411; Wong KL, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2124687; Yamachika R, 2004, SCIENCE, V304, P281, DOI 10.1126/science.1095069	24	341	342	6	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1066	1069		10.1126/science.1150288	http://dx.doi.org/10.1126/science.1150288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292336	Green Published			2022-12-28	WOS:000253311700036
J	Goes, S; Capitanio, FA; Morra, G				Goes, Saskia; Capitanio, Fabio A.; Morra, Gabriele			Evidence of lower-mantle slab penetration phases in plate motions	NATURE			English	Article							TRENCH MIGRATION; SUBDUCTION ZONES; LITHOSPHERE; TRANSITION; CONVECTION; TECTONICS; MECHANISM; BUOYANCY; STRESSES; STRENGTH	It is well accepted that subduction of the cold lithosphere is a crucial component of the Earth's plate tectonic style of mantle convection. But whether and how subducting plates penetrate into the lower mantle is the subject of continuing debate, which has substantial implications for the chemical and thermal evolution of the mantle(1,2). Here we identify lower-mantle slab penetration events by comparing Cenozoic plate motions at the Earth's main subduction zones(3) with motions predicted by fully dynamic models of the upper- mantle phase of subduction, driven solely by downgoing plate density(4). Whereas subduction of older, intrinsically denser, lithosphere occurs at rates consistent with the model, younger lithosphere (of ages less than about 60 Myr) often subducts up to two times faster, while trench motions are very low. We conclude that the most likely explanation is that older lithosphere, subducting under significant trench retreat, tends to lie down flat above the transition to the high- viscosity lower mantle, whereas younger lithosphere, which is less able to drive trench retreat and deforms more readily, buckles and thickens. Slab thickening enhances buoyancy (volume times density) and thereby Stokes sinking velocity, thus facilitating fast lowermantle penetration. Such an interpretation is consistent with seismic images of the distribution of subducted material in upper and lower mantle(5,6). Thus we identify a direct expression of time- dependent flow between the upper and lower mantle.	[Goes, Saskia] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Capitanio, Fabio A.; Morra, Gabriele] ETH, Inst Geophys, CH-8093 Zurich, Switzerland	Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich	Goes, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	s.goes@imperial.ac.uk	Capitanio, Fabio/E-8774-2010; Morra, Gabriele/E-4311-2013; Capitanio, Fabio/Q-8670-2019	Morra, Gabriele/0000-0002-0787-6107; Capitanio, Fabio/0000-0003-2131-8723; Goes, Saskia/0000-0002-2231-2553				[Anonymous], 2000, HIST DYNAMICS GLOBAL, DOI DOI 10.1029/GM121P0277; Bellahsen N, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002999; Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; Capitanio FA, 2007, EARTH PLANET SC LETT, V262, P284, DOI 10.1016/j.epsl.2007.07.039; CARLSON RL, 1983, GEOPHYS RES LETT, V10, P297, DOI 10.1029/GL010i004p00297; Christensen UR, 1996, EARTH PLANET SC LETT, V140, P27, DOI 10.1016/0012-821X(96)00023-4; Cizkova H, 1999, GEOPHYS RES LETT, V26, P1501, DOI 10.1029/1999GL900261; CLOOS M, 1993, GEOL SOC AM BULL, V105, P715, DOI 10.1130/0016-7606(1993)105<0715:LBACOS>2.3.CO;2; Conrad CP, 1999, J GEOPHYS RES-SOL EA, V104, P17551, DOI 10.1029/1999JB900149; CREAGER KC, 1995, GEOPHYS RES LETT, V22, P2321, DOI 10.1029/95GL02321; Enns A, 2005, GEOPHYS J INT, V160, P761, DOI 10.1111/j.1365-246X.2005.02519.x; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Grand SP., 1997, GSA TODAY, V7, P1; GUILLOU-FROTTIER L, 1995, EARTH PLANET SC LETT, V133, P19, DOI 10.1016/0012-821X(95)00045-E; GURNIS M, 1988, NATURE, V335, P317, DOI 10.1038/335317a0; ISACKS B, 1971, REV GEOPHYS SPACE GE, V9, P103, DOI 10.1029/RG009i001p00103; Ita J, 1998, GEOPHYS RES LETT, V25, P1463, DOI 10.1029/98GL51033; Lallemand S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000917; McNamara AK, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000045; MOLNAR P, 1978, EARTH PLANET SC LETT, V41, P330, DOI 10.1016/0012-821X(78)90187-5; Moresi L, 1996, EARTH PLANET SC LETT, V138, P15, DOI 10.1016/0012-821X(95)00221-W; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; Royden LH, 2006, GEOPHYS J INT, V167, P881, DOI 10.1111/j.1365-246X.2006.03079.x; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Sdrolias M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001090; Stegman DR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001056; TACKLEY PJ, 1993, NATURE, V361, P699, DOI 10.1038/361699a0; Van der Voo R, 1999, NATURE, V397, P246, DOI 10.1038/16686; van Keken PE, 2002, ANNU REV EARTH PL SC, V30, P493, DOI 10.1146/annurev.earth.30.091201.141236; ZHONG SJ, 1995, SCIENCE, V267, P838, DOI 10.1126/science.267.5199.838	30	113	115	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					981	984		10.1038/nature06691	http://dx.doi.org/10.1038/nature06691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288192				2022-12-28	WOS:000253313100046
J	Mellman, DL; Gonzales, ML; Song, CH; Barlow, CA; Wang, P; Kendziorski, C; Anderson, RA				Mellman, David L.; Gonzales, Michael L.; Song, Chunhua; Barlow, Christy A.; Wang, Ping; Kendziorski, Christina; Anderson, Richard A.			A PtdIns4,5P(2)-regulatednuclear poly(A) polymerase controls expression of select mRNAs	NATURE			English	Article							POLYADENYLATION; COMPLEX; FAMILY; MECHANISM; KINASES; BINDING; REGION; DOMAIN; GAMMA; ENDS	Phosphoinositides are a family of lipid signalling molecules that regulate many cellular functions in eukaryotes. Phosphatidylinositol-4,5- bisphosphate ( PtdIns4,5P(2)), the central component in the phosphoinositide signalling circuitry, is generated primarily by type I phosphatidylinositol 4- phosphate 5- kinases ( PIPKI alpha, PIPKI beta and PIPKI gamma)(1). In addition to functions in the cytosol, phosphoinositides are present in the nucleus(2,3), where they modulate several functions(4-6); however, the mechanism by which they directly regulate nuclear functions remains unknown. PIPKIs regulate cellular functions through interactions with protein partners, often PtdIns4,5P(2) effectors, that target PIPKIs to discrete subcellular compartments, resulting in the spatial and temporal generation of PtdIns4,5P(2) required for the regulation of specific signalling pathways(1,7). Therefore, to determine roles for nuclear PtdIns4,5P(2) we set out to identify proteins that interacted with the nuclear PIPK, PIPKI alpha. Here we show that PIPKI alpha co- localizes at nuclear speckles and interacts with a newly identified non- canonical poly( A) polymerase, which we have termed Star- PAP ( nuclear speckle targeted PIPKIa regulated- poly( A) polymerase) and that the activity of Star- PAP can be specifically regulated by PtdIns4,5P(2). Star- PAP and PIPKIa function together in a complex to control the expression of select mRNAs, including the transcript encoding the key cytoprotective enzyme haem oxygenase- 1 ( refs 8, 9) and other oxidative stress response genes by regulating the 3 '-end formation of their mRNAs. Taken together, the data demonstrate a model by which phosphoinositide signalling works in tandem with complement pathways to regulate the activity of Star- PAP and the subsequent biosynthesis of its target mRNA. The results reveal a mechanism for the integration of nuclear phosphoinositide signals and a method for regulating gene expression.	[Mellman, David L.; Gonzales, Michael L.; Anderson, Richard A.] Univ Wisconsin, Sch Med, Mol & Cellular Biol Program, Madison, WI 53706 USA; [Song, Chunhua; Barlow, Christy A.; Anderson, Richard A.] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA; [Wang, Ping; Kendziorski, Christina] Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med, Mol & Cellular Biol Program, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Anderson, Richard/0000-0001-6265-8359; song, chunhua/0000-0002-4081-2543; Barlow, Christy/0000-0002-1239-3767	NIGMS NIH HHS [R01 GM051968, R01 GM114386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114386, R01GM051968] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; Cocco L, 2004, ADV ENZYME REGUL, V44, P51, DOI 10.1016/j.advenzreg.2003.11.009; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hirose Y, 2000, GENE DEV, V14, P1415; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Nagaoka K, 2006, BBA-GENE STRUCT EXPR, V1759, P132, DOI 10.1016/j.bbaexp.2006.04.004; Osborne SL, 2001, J CELL SCI, V114, P2501; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	32	179	187	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					1013	U9		10.1038/nature06666	http://dx.doi.org/10.1038/nature06666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288197				2022-12-28	WOS:000253313100053
J	Murayama, Y; Kurokawa, Y; Mayanagi, K; Iwasaki, H				Murayama, Yasuto; Kurokawa, Yumiko; Mayanagi, Kouta; Iwasaki, Hiroshi			Formation and branch migration of Holliday junctions mediated by eukaryotic recombinases	NATURE			English	Article							DNA STRAND EXCHANGE; ESCHERICHIA-COLI RECA; HUMAN RAD51 PROTEIN; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; HETERODUPLEX FORMATION; ATP HYDROLYSIS; BREAK REPAIR; DUPLEX DNA; IN-VITRO	Holliday junctions ( HJs) are key intermediates in homologous recombination and are especially important for the production of crossover recombinants(1-4). Bacterial RecA family proteins promote the formation and branch migration of HJs in vitro by catalysing a reciprocal DNA- strand exchange reaction between two duplex DNA molecules, one of which contains a single- stranded DNA region that is essential for initial nucleoprotein filament formation(5). This activity has been reported only for prokaryotic RecA family recombinases(5), although eukaryotic homologues are also essential for HJ production in vivo(6,7). Here we show that fission yeast ( Rhp51) and human ( hRad51) RecA homologues promote duplex - duplex DNA- strand exchange in vitro. As with RecA, a HJ is formed between the two duplex DNA molecules, and reciprocal strand exchange proceeds through branch migration of the HJ. In contrast to RecA, however, strand exchange mediated by eukaryotic recombinases proceeds in the 3 '-->5 ' direction relative to the single- stranded DNA region of the substrate DNA. The opposite polarity of Rhp51 makes it especially suitable for the repair of DNA double- strand breaks, whose repair is initiated at the processed ends of breaks that have protruding 3 ' termini(1,2).	[Murayama, Yasuto; Kurokawa, Yumiko; Iwasaki, Hiroshi] Yokohama City Univ, Div Mol & Cellular Biol, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Mayanagi, Kouta] Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; [Mayanagi, Kouta] JST, BIRD, Shiga 5260829, Japan	Yokohama City University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Yokohama City Univ, Div Mol & Cellular Biol, Int Grad Sch Arts & Sci, 1-7-29 Suehirocho, Kanagawa 2300045, Japan.	iwasaki@tsurumi.yokohama-cu.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873				Baumann P, 1999, J MOL BIOL, V291, P363, DOI 10.1006/jmbi.1999.2954; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; CHOW SA, 1992, J MOL BIOL, V223, P79, DOI 10.1016/0022-2836(92)90717-X; Constantinou Angelos, 2004, Methods Mol Biol, V262, P239; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Haruta N, 2008, DNA REPAIR, V7, P1, DOI 10.1016/j.dnarep.2007.07.004; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KMIEC EB, 1983, CELL, V33, P857, DOI 10.1016/0092-8674(83)90028-4; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; WEST SC, 1982, MOL GEN GENET, V187, P209, DOI 10.1007/BF00331119; Yoshikawa M, 2000, GENES CELLS, V5, P803, DOI 10.1046/j.1365-2443.2000.00371.x	33	38	38	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1018	U10		10.1038/nature06609	http://dx.doi.org/10.1038/nature06609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18256600				2022-12-28	WOS:000253313100054
J	Boutron, I; Moher, D; Altman, DG; Schulz, KF; Ravaud, P				Boutron, Isabelle; Moher, David; Altman, Douglas G.; Schulz, Kenneth F.; Ravaud, Philippe		CONSORT Grp	Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration	ANNALS OF INTERNAL MEDICINE			English	Review							8 COMMON OPERATIONS; CLINICAL-TRIALS; HOSPITAL VOLUME; SURGICAL VOLUME; SURGEON VOLUME; CAROTID-ENDARTERECTOMY; PROVIDER VOLUME; HEALTH-CARE; QUALITY; OUTCOMES	Adequate reporting of randomized, controlled trials (RCTs) is necessary to allow accurate critical appraisal of the validity and applicability of the results. The CONSORT (Consolidated Standards of Reporting Trials) Statement, a 22-item checklist and flow diagram, is intended to address this problem by improving the reporting of RCTs. However, some specific issues that apply to trials of non-pharmacologic treatments (for example, surgery, technical interventions, devices, rehabilitation, psychotherapy, and behavioral intervention) are not specifically addressed in the CONSORT Statement. Furthermore, considerable evidence suggests that the reporting of nonpharmacologic trials still needs improvement. Therefore, the CONSORT group developed an extension of the CONSORT Statement for trials assessing nonpharmacologic treatments. A consensus meeting of 33 experts was organized in Paris, France, in February 2006, to develop an extension of the CONSORT Statement for trials of nonpharmacologic treatments. The participants extended 11 items from the CONSORT Statement, added 1 item, and developed a modified flow diagram. To allow adequate understanding and implementation of the CONSORT extension, the CONSORT group developed this elaboration and explanation document from a review of the literature to provide examples of adequate reporting. This extension, in conjunction with the main CONSORT Statement and other CONSORT extensions, should help to improve the reporting of RCTs performed in this field.	Univ Paris 7 Denis Dideror, INSERM, AP HP, Hop Bichat Claude Bernard,U738, F-75018 Paris, France; Univ Ottawa, Childrens Hosp, Eastern Ontario Res Unit, Chalmers Res Grp, Ottawa, ON, Canada; Univ Oxford, Oxford, England; Family Hlth Int, Res Triangle Pk, NC 27709 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; Children's Hospital of Eastern Ontario; University of Oxford	Boutron, I (corresponding author), Univ Paris 7 Denis Dideror, INSERM, AP HP, Hop Bichat Claude Bernard,U738, 46 Rue Henri Huchard, F-75018 Paris, France.	isabelleisabelle.boutron@bch.aphp.fr	ravaud, philippe/C-1694-2009	Moher, David/0000-0003-2434-4206; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	MRC [MC_U105260792] Funding Source: UKRI; Medical Research Council [MC_U105260792] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Altman DG, 2004, BMJ-BRIT MED J, V328, P1135, DOI 10.1136/bmj.328.7448.1135-a; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Anyanwu AC, 2004, EUR J CARDIO-THORAC, V25, P299, DOI 10.1016/j.ejcts.2003.12.004; Berg AO, 2002, ANN INTERN MED, V137, P205, DOI 10.7326/0003-4819-137-3-200208060-00014; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P485, DOI 10.2106/00004623-200203000-00023; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P388, DOI 10.2106/00004623-200203000-00009; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bond R, 2003, STROKE, V34, P824, DOI 10.1161/01.STR.0000059381.17983.77; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; BOUTRON I, 2003, JAMA-J AM MED ASSOC, V290, P10620; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bradley JD, 2002, ARTHRITIS RHEUM-US, V46, P100, DOI 10.1002/1529-0131(200201)46:1<100::AID-ART10037>3.0.CO;2-V; Brennan MF, 1999, ANN SURG, V230, P411; Burns KEA, 2005, CRIT CARE MED, V33, P1937, DOI 10.1097/01.CCM.0000178361.73895.24; Campbell MJ, 2004, BMJ-BRIT MED J, V328, P654, DOI 10.1136/bmj.328.7441.654; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Cowan JA, 2002, J AM COLL SURGEONS, V195, P814, DOI 10.1016/S1072-7515(02)01345-5; CRITSCHRISTOPH P, 1991, J CONSULT CLIN PSYCH, V59, P20, DOI 10.1037/0022-006X.59.1.20; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Dijkers M, 2002, AM J PHYS MED REHAB, V81, P21, DOI 10.1097/00002060-200201000-00005; Dimick JB, 2004, ARCH SURG-CHICAGO, V139, P137, DOI 10.1001/archsurg.139.2.137; Ellis C, 2005, ANZ J SURG, V75, P874, DOI 10.1111/j.1445-2197.2005.03554.x; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Feldon SE, 2003, CONTROL CLIN TRIALS, V24, P294, DOI 10.1016/S0197-2456(02)00303-3; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Guittet Lydia, 2005, BMC Med Res Methodol, V5, P25, DOI 10.1186/1471-2288-5-25; Halm EA, 2005, J VASC SURG, V42, P420, DOI 10.1016/j.jvs.2005.05.029; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HARLOW T, 2004, BMJ-BRIT MED J, V32, P1450; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; Harris AHS, 2002, J PSYCHOL, V136, P141, DOI 10.1080/00223980209604145; Herbert RD, 2005, BMJ-BRIT MED J, V331, P507, DOI 10.1136/bmj.331.7515.507; Hodgson DC, 2003, J NATL CANCER I, V95, P708, DOI 10.1093/jnci/95.10.708; Homs MYV, 2004, LANCET, V364, P1497, DOI 10.1016/S0140-6736(04)17272-3; Hopewell S, 2005, CLIN TRIALS, V2, P265, DOI 10.1191/1740774505cn091oa; HOPEWELL S, 2008, IN PRESS PLOS MED; HOPEWELL S, 2007, 14 COCHR C SAO PAUL; HOPEWELL S, IN PRESS LANCET; Hopewell S, 2006, J CLIN EPIDEMIOL, V59, P681, DOI 10.1016/j.jclinepi.2005.09.016; Hrobjartsson A, 2002, J CLIN EPIDEMIOL, V55, P430, DOI 10.1016/S0895-4356(01)00496-6; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kreder HJ, 1997, J BONE JOINT SURG AM, V79A, P485, DOI 10.2106/00004623-199704000-00003; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Lee KJ, 2005, CLIN TRIALS, V2, P163, DOI 10.1191/1740774505cn082oa; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Li LC, 2006, ARTHRIT RHEUM-ARTHR, V55, P42, DOI 10.1002/art.21692; LILFORD R, 2004, BRIT J SURG, V91, P16; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9; Martling A, 2002, BRIT J SURG, V89, P1008, DOI 10.1046/j.1365-2168.2002.02151.x; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Moffett JAK, 2005, BRIT MED J, V330, P75, DOI 10.1136/bmj.38286.493206.82; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Moore WS, 1996, J VASC SURG, V23, P323, DOI 10.1016/S0741-5214(96)70277-X; Mor V, 2000, SURGERY, V128, P847, DOI 10.1067/msy.2000.109530; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Neumayer LA, 2005, ANN SURG, V242, P344, DOI 10.1097/01.sla.0000179644.02187.ea; PATERSON C, 2000, BMJ-BRIT MED J, V330, P1202; Peng SY, 2007, ANN SURG, V245, P692, DOI 10.1097/01.sla.0000255588.50964.5d; Pengel LHM, 2007, ANN INTERN MED, V146, P787, DOI 10.7326/0003-4819-146-11-200706050-00007; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pignone MP, 2003, AM J PREV MED, V24, P75, DOI 10.1016/S0749-3797(02)00580-9; Pitkin RM, 1998, JAMA-J AM MED ASSOC, V280, P267, DOI 10.1001/jama.280.3.267; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Pitkin RM, 2000, JAMA-J AM MED ASSOC, V283, P481, DOI 10.1001/jama.283.4.481-a; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Roberts C, 1999, STAT MED, V18, P2605, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2605::AID-SIM237>3.0.CO;2-N; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rockman CB, 2005, J VASC SURG, V42, P870, DOI 10.1016/j.jvs.2005.07.043; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scherer RW, 1998, JAMA-J AM MED ASSOC, V280, P269, DOI 10.1001/jama.280.3.269; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2005, CONTEMP CLIN TRIALS, V26, P626, DOI 10.1016/j.cct.2005.09.001; Schnurr PP, 2001, CONTROL CLIN TRIALS, V22, P74, DOI 10.1016/S0197-2456(00)00118-5; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 1996, BRIT MED J, V312, P742; Shaw BF, 1999, J CONSULT CLIN PSYCH, V67, P837, DOI 10.1037/0022-006X.67.6.837; Soljak M, 2002, BRIT MED J, V325, P787, DOI 10.1136/bmj.325.7368.787; Tansella M, 2006, PSYCHOL MED, V36, P711, DOI 10.1017/S003329170600715X; Tate DG, 1999, AM J PHYS MED REHAB, V78, P486, DOI 10.1097/00002060-199909000-00016; Urbach DR, 2004, QUAL SAF HEALTH CARE, V13, P379, DOI 10.1136/qhc.13.5.379; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Vierron E, 2007, CONTEMP CLIN TRIALS, V28, P451, DOI 10.1016/j.cct.2006.11.003; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Williams AC, 1999, LANCET, V354, P1697, DOI 10.1016/S0140-6736(99)03748-4; Wright JG, 2005, LANCET, V365, P1153, DOI 10.1016/S0140-6736(05)71878-X; Wyrsch B, 1996, J BONE JOINT SURG AM, V78A, P1646, DOI 10.2106/00004623-199611000-00003	113	1759	1772	2	96	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					295	309		10.7326/0003-4819-148-4-200802190-00008	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00008			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283207	Green Submitted			2022-12-28	WOS:000253316400006
J	Boutron, I; Moher, D; Altman, DG; Schulz, KF; Ravaud, P				Boutron, Isabelle; Moher, David; Altman, Douglas G.; Schulz, Kenneth F.; Ravaud, Philippe		CONSORT Group	Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; QUALITY; STATEMENT; EXPLANATION; STANDARDS; INTERVENTION; GUIDELINES; CHECKLIST; SURGERY	Background: The conduct of randomized, controlled trials of nonpharmacologic treatments presents specific challenges that are not adequately addressed in trial reports. Objective: To develop an extension of the CONSORT (Consolidated Standards of Reporting Trials) Statement for trials of nonpharmacologic treatments. Design: A consensus meeting was organized to develop an extension of the CONSORT Statement that addresses randomized trials of nonpharmacologic treatments. To prepare for the meeting, a survey was conducted to identify the specific issues for discussion. Setting: Consensus meeting in Paris, France. Participants: A total of 33 experts attended the meeting. The experts were methodologists (n = 17); surgeons (n = 6); editors (n = 5); and clinicians involved in rehabilitation (n = 1), psychotherapy (n = 2), education (n = 1), and implantable devices (n = 1). Measurements: Experts indicated which of the 22 items on the CONSORT checklist should be modified or which additional items should be added specifically for nonpharmacologic treatments. During a 3-day consensus meeting, all items were discussed and additional methodological issues related to nonpharmacologic research were identified. Results: The consensus was that 11 items on the CONSORT checklist needed some modifications for nonpharmacologic trials: item 1 (title and abstract), item 3 (participants), item 4 (interventions), item 7 (sample size), item 8 (randomization), item 11 (blinding), item 12 (statistical methods), item 13 (participant flow), item 15 (baseline data), item 20 (discussion: interpretation), and item 21 (generalizability). In addition, the meeting participants added 1 item related to implementation of the intervention. Limitation: Evidence was not always available to support the inclusion of each checklist item. Conclusion: The methods and processes used to develop this extension could be used for other reporting guidelines. The use of this extension to the CONSORT Statement should improve the quality of reporting randomized, controlled trials assessing nonpharmacologic treatments.	Univ Paris 07 Denis Diderot, Dept Epidemiol Biostat & Rech Clin, INSERM U738, AP HP,Hop Bichat Claude Bernard, F-75018 Paris, France; Univ Ottawa, Chalmers Res Grp, Childrens Hosp, E Ontario Res Unit, Ottawa, ON, Canada; Univ Oxford, Oxford, England; Family Hlth Int, Res Triangle Pk, NC 27709 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; University of Oxford	Boutron, I (corresponding author), Univ Paris 07 Denis Diderot, Dept Epidemiol Biostat & Rech Clin, INSERM U738, AP HP,Hop Bichat Claude Bernard, 46 Rue Henri Huchard, F-75018 Paris, France.	isabelle.boutron@bch.aphp.fr	ravaud, philippe/C-1694-2009	Boutron, Isabelle/0000-0002-5263-6241; Moher, David/0000-0003-2434-4206; Ravaud, Philippe/0000-0001-8264-9206				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2005, MED CLIN-BARCELONA, V125, P8, DOI 10.1016/S0025-7753(05)72203-X; Anyanwu AC, 2004, EUR J CARDIO-THORAC, V25, P299, DOI 10.1016/j.ejcts.2003.12.004; Balasubramanian SP, 2006, ANN SURG, V244, P663, DOI 10.1097/01.sla.0000217640.11224.05; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P485, DOI 10.2106/00004623-200203000-00023; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P388, DOI 10.2106/00004623-200203000-00009; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Dijkers M, 2002, AM J PHYS MED REHAB, V81, P21, DOI 10.1097/00002060-200201000-00005; Ellis C, 2005, ANZ J SURG, V75, P874, DOI 10.1111/j.1445-2197.2005.03554.x; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Lilford R, 2004, BRIT J SURG, V91, P6, DOI 10.1002/bjs.4418; Manterola C, 2006, ANN SURG, V244, P827, DOI 10.1097/01.sla.0000242708.51631.66; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McLeod R, 2006, ANN SURG, V244, P684, DOI 10.1097/01.sla.0000243593.93571.98; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Ravaud P, 2006, NAT CLIN PRACT RHEUM, V2, P313, DOI 10.1038/ncprheum0194; Stephenson J, 1998, BMJ-BRIT MED J, V316, P611, DOI 10.1136/bmj.316.7131.611; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	29	119	121	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					W60	W66		10.7326/0003-4819-148-4-200802190-00008-w1	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00008-w1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283201				2022-12-28	WOS:000253316400021
J	Choi, HK; Curhan, G				Choi, Hyon K.; Curhan, Gary			Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; ADENINE-NUCLEOTIDE TURNOVER; METABOLIC SYNDROME; INDUCED HYPERURICEMIA; VEGETABLE INTAKE; HEALTH-PROFESSIONALS; INSULIN-RESISTANCE; DIETARY FRUCTOSE; URATE PRODUCTION	Objective To examine the relation between intake of sugar sweetened soft drinks and fructose and the risk of incident gout in men. Design Prospective cohort over 12 years. Setting Health professionals follow-up study. Participants 46 393 men with no history of gout at baseline who provided information on intake of soft drinks and fructose through validated food frequency questionnaires. Main outcome measure Incident cases of gout meeting the American College of Rheumatology survey criteria for gout. Results During the 12 years of follow-up 755 confirmed incident cases of gout were reported. Increasing intake of sugar sweetened soft drinks was associated with an increasing risk of gout. Compared with consumption of less than one serving of sugar sweetened soft drinks a month the multivariate relative risk of gout for 5-6 servings a week was 1.29 (95% confidence interval 1.00 to 1.68), for one serving a day was 1.45 (1.02 to 2.08), and for two or more servings a day was 1.85 (1.08 to 3.16; P for trend=0.002). Diet soft drinks were not associated with risk of gout (P for trend=0.99). The multivariate relative risk of gout according to increasing fifths of fructose intake were 1.00, 1.29, 1.41, 1.84, and 2.02 (1.49 to 2.75; P for trend <0.001). Other major contributors to fructose intake such as total fruit juice or fructose rich fruits (apples and oranges) were also associated with a higher risk of gout (P values for trend (0.05). Conclusions Prospective data suggest that consumption of sugar sweetened soft drinks and fructose is strongly associated with an increased risk of gout in men. Furthermore, fructose rich fruits and fruit juices may also increase the risk. Diet soft drinks were not associated with the risk of gout.	[Choi, Hyon K.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Arthrit Res Ctr Canada, Vancouver, BC V5Z 1L7, Canada; [Curhan, Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA	University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, HK (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Arthrit Res Ctr Canada, Vancouver, BC V5Z 1L7, Canada.	hchoi@arthritisresearch.ca			NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NIDDK NIH HHS [DK58573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; ANDERSON JW, 1989, DIABETES CARE, V12, P337, DOI 10.2337/diacare.12.5.337; Apovian CM, 2004, JAMA-J AM MED ASSOC, V292, P978, DOI 10.1001/jama.292.8.978; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arromdee E, 2002, J RHEUMATOL, V29, P2403; BECKNIELSEN H, 1980, AM J CLIN NUTR, V33, P273, DOI 10.1093/ajcn/33.2.273; BLAKELY SR, 1981, J NUTR, V111, P307, DOI 10.1093/jn/111.2.307; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; CHOI HK, IN PRESS ARTHRITIS R; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Fam AG, 2002, J RHEUMATOL, V29, P1350; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FOX IH, 1987, NEW ENGL J MED, V317, P111, DOI 10.1056/NEJM198707093170209; FOX IH, 1972, METABOLISM, V21, P713, DOI 10.1016/0026-0495(72)90120-5; Gibson T, 1977, Adv Exp Med Biol, V76B, P46; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; GOUT OW, 1893, PRINCIPLES PRACTICE, P287; Gross LS, 2004, AM J CLIN NUTR, V79, P774; HALLFRISCH J, 1983, J NUTR, V113, P1819, DOI 10.1093/jn/113.9.1819; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee WY, 2004, DIABETES RES CLIN PR, V65, P143, DOI 10.1016/j.diabres.2003.12.007; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; MCGARRY JD, 1994, J CELL BIOCHEM, V55, P29, DOI 10.1002/jcb.240550005; Moeller SM, 2004, J NUTR, V134, P1812, DOI 10.1093/jn/134.7.1812; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; PERHEENT.J, 1967, LANCET, V2, P528; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIZKALLA SW, 1993, BRIT J NUTR, V70, P199, DOI 10.1079/BJN19930117; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shadick NA, 2000, J RHEUMATOL, V27, P1708; SHARPE CR, 1984, CAN MED ASSOC J, V131, P563; STIRPE F, 1970, LANCET, V2, P1310; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; *USDA, 2005, DIET GUID AM; *USDA, 1993, COMP FOODS RAW PROC; Vainio H, 2003, IARC HDB CANC PREVEN; Vazquez-Mellado JV, 2004, JCR-J CLIN RHEUMATOL, V10, P105, DOI 10.1097/01.rhu.0000129082.42094.fc; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu TY, 2004, AM J CLIN NUTR, V80, P1043, DOI 10.1093/ajcn/80.4.1043; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4	66	352	384	5	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					309	+		10.1136/bmj.39449.819271.BE	http://dx.doi.org/10.1136/bmj.39449.819271.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18244959	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000253437400031
J	Waddington, SN; Mcvey, JH; Bhella, D; Parker, AL; Barker, K; Atoda, H; Pink, R; Buckley, SMK; Greig, JA; Denby, L; Custers, J; Morita, T; Francischetti, IMB; Monteiro, RQ; Barouch, DH; van Rooijen, N; Napoli, C; Hlavenga, MJE; Nicklin, SA; Baker, AH				Waddington, Simon N.; McVey, John H.; Bhella, David; Parker, Alan L.; Barker, Kristeen; Atoda, Hideko; Pink, Rebecca; Buckley, Suzanne M. K.; Greig, Jenny A.; Denby, Laura; Custers, Jerome; Morita, Takashi; Francischetti, Ivo M. B.; Monteiro, Robson Q.; Barouch, Dan H.; van Rooijen, Nico; Napoli, Claudio; Hlavenga, Menzo J. E.; Nicklin, Stuart A.; Baker, Andrew H.			Adenovirus serotype 5 hexon mediates liver gene transfer	CELL			English	Article							HEPARIN-BINDING EXOSITE; IN-VIVO; ALPHA(V) INTEGRIN; VACCINE VECTORS; CELL INFECTION; CAR-BINDING; FIBER SHAFT; SUBGROUP-B; RECEPTOR; DELIVERY	Adenoviruses are used extensively as gene transfer agents, both experimentally and clinically. However, targeting of liver cells by adenoviruses compromises their potential efficacy. In cell culture, the adenovirus serotype 5 fiber protein engages the coxsackievirus and adenovirus receptor (CAR) to bind cells. Paradoxically, following intravascular delivery, CAR is not used for liver transduction, implicating alternate pathways. Recently, we demonstrated that coagulation factor (F)X directly binds adenovirus leading to liver infection. Here, we show that FX binds to the Ad5 hexon, not fiber, via an interaction between the FX Gla domain and hypervariable regions of the hexon surface. Binding occurs in multiple human adenovirus serotypes. Liver infection by the FX-Ad5 complex is mediated through a heparin-binding exosite in the FX serine protease domain. This study reveals an unanticipated function for hexon in mediating liver gene transfer in vivo.	[Parker, Alan L.; Barker, Kristeen; Greig, Jenny A.; Denby, Laura; Nicklin, Stuart A.; Baker, Andrew H.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Waddington, Simon N.] UCL Royal Free & Univ Coll Med Sch, Dept Haematol, Haemophilia Ctr, London NW3 2PF, England; [McVey, John H.] UCL Royal Free & Univ Coll Med Sch, Haemostasis Unit, London NW3 2PF, England; [Bhella, David; Pink, Rebecca] Univ Glasgow, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Atoda, Hideko; Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Tokyo, Japan; [Custers, Jerome; Hlavenga, Menzo J. E.] Crucell, NL-2301 CA Leiden, Netherlands; [Francischetti, Ivo M. B.] NIAID NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; [Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Napoli, Claudio] Univ Naples 2, Dept Gen Pathol, I-80138 Naples, Italy; [Napoli, Claudio] Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	University of Glasgow; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of Glasgow; Meiji Pharmaceutical University; Johnson & Johnson; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vrije Universiteit Amsterdam; Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Baker, AH (corresponding author), Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	ab11f@clinmed.gla.ac.uk	Van Rooijen, Nico/Z-1578-2019; Monteiro, Robson/GRX-0672-2022; Barouch, Dan/Y-3918-2019; Baker, Andy/AAO-5250-2021; Parker, Alan L/B-8187-2009; Bhella, David/J-8514-2012; de Queiroz Monteiro, Robson/M-7097-2019; Waddington, Simon/G-3778-2011; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Denby, Laura/AAO-9765-2020	Monteiro, Robson/0000-0002-5260-2332; Baker, Andy/0000-0003-1441-5576; Parker, Alan L/0000-0002-9302-1761; Bhella, David/0000-0003-2096-8310; Waddington, Simon/0000-0003-4970-4730; Denby, Laura/0000-0003-1277-708X; Napoli, Claudio/0000-0002-5455-555X; McVey, John/0000-0002-7416-533X; Nicklin, Stuart/0000-0002-9691-6210; Buckley, Suzanne/0000-0003-1286-1003	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, Z01AI000810] Funding Source: NIH RePORTER; BBSRC [BB/E021301/1, BB/E02145X/1] Funding Source: UKRI; MRC [MC_U130115834, MC_U120074259] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02145X/1, BB/E021301/1] Funding Source: Medline; Medical Research Council [MC_U130115834, MC_U120074259] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; ATHAPPILLY FK, 1994, J MOL BIOL, V242, P430, DOI 10.1006/jmbi.1994.1593; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hiltunen MO, 2000, FASEB J, V14, P2230, DOI 10.1096/fj.00-0145com; HUARD J, 1995, GENE THER, V2, P107; Kawabata K, 2006, MOL PHARMACEUT, V3, P95, DOI 10.1021/mp0500925; Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Lecollinet S, 2006, J VIROL, V80, P2747, DOI 10.1128/JVI.80.6.2747-2759.2006; Li JL, 2006, J VIROL, V80, P12324, DOI 10.1128/JVI.01331-06; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Murakami MT, 2007, J MOL BIOL, V366, P602, DOI 10.1016/j.jmb.2006.11.040; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Parker AL, 2007, J VIROL, V81, P3627, DOI 10.1128/JVI.02786-06; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; RUX JJ, 1999, METH MOLEC MED, V21, P259; Sakurai F, 2006, GENE THER, V13, P1118, DOI 10.1038/sj.gt.3302749; San Martin C, 2003, CURR TOP MICROBIOL, V272, P57; Schenk-Braat EAM, 2007, J GENE MED, V9, P910, DOI 10.1002/jgm.1096; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2002, CANCER RES, V62, P1063; Smith TAG, 2003, HUM GENE THER, V14, P1595, DOI 10.1089/104303403322542248; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E	55	480	495	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					397	409		10.1016/j.cell.2008.01.016	http://dx.doi.org/10.1016/j.cell.2008.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267072	Bronze			2022-12-28	WOS:000253180700015
J	Murray-Rust, P				Murray-Rust, Peter			Chemistry for everyone	NATURE			English	Article									Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England	University of Cambridge	Murray-Rust, P (corresponding author), Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Lensfield Rd, Cambridge CB2 1EW, England.	pm286@cam.ac.uk		Murray-Rust, Peter/0000-0003-3386-3972					0	32	32	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					648	651		10.1038/451648a	http://dx.doi.org/10.1038/451648a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256659	Bronze			2022-12-28	WOS:000252929500028
J	Hoddinott, J; Maluccio, JA; Behrman, JR; Flores, R; Martorell, R				Hoddinott, John; Maluccio, John A.; Behrman, Jere R.; Flores, Rafael; Martorell, Reynaldo			Effect of a nutrition intervention during early childhood on economic productivity in Guatemalan adults	LANCET			English	Article							DEVELOPING-COUNTRIES; SAMPLE ATTRITION; MICHIGAN PANEL	Background Substantial, but indirect, evidence suggests that improving nutrition in early childhood in developing countries is a long-term economic investment. We investigated the direct effect of a nutrition intervention in early childhood on adult economic productivity. Methods We obtained economic data from 1424 Guatemalan individuals (aged 25-42 years) between 2002 and 2004. They accounted for 60% of the 2392 children (aged 0-7 years) who had been enrolled in a nutrition intervention study during 1969-77. In this initial study, two villages were randomly assigned a nutritious supplement (atole) for all children and two villages a less nutritious one (fresco). We estimated annual income, hours worked, and average hourly wages from all economic activities. We used linear regression models, adjusting for potentially confounding factors, to assess the relation between economic variables and exposure to atole or fresco at specific ages between birth and 7 years. Findings Exposure to atole before, but not after, age 3 years was associated with higher hourly wages, but only for men. For exposure to atole from 0 to 2 years, the increase was US$0.67 per hour (95% CI 0 .16-1.17), which meant a 46% increase in average wages. There was a non-significant tendency for hours worked to be reduced and for annual incomes to be greater for those exposed to atole from 0 to 2 years. Interpretation Improving nutrition in early childhood led to substantial increases in wage rates for men, which suggests that investments in early childhood nutrition can be long-term drivers of economic growth.	[Flores, Rafael; Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hoddinott, John] Int Food Policy Res Inst, Washington, DC 20036 USA; [Maluccio, John A.] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Behrman, Jere R.] Univ Penn, Dept Econ, Philadelphia, PA 19104 USA	Emory University; Rollins School Public Health; CGIAR; International Food Policy Research Institute (IFPRI); University of Pennsylvania	Martorell, R (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	rmart77@sph.emory.edu	Behrman, Jere R/A-9734-2009; Martorell, Reynaldo/I-2539-2012		FIC NIH HHS [TW-05598] Funding Source: Medline; NICHD NIH HHS [HD-046125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005598] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ALDERMAN H, 2001, DEMOGR RES, V5, P79, DOI DOI 10.4054/DEMRES.2001.5.4; BEHRMAN JR, 2005, DOES IT PAY TO BECOM; Chen YY, 2007, J HEALTH ECON, V26, P659, DOI 10.1016/j.jhealeco.2006.12.006; Fitzgerald J, 1998, J HUM RESOUR, V33, P300, DOI 10.2307/146434; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; GRAJEDA R, 2005, FOOD NUTR BULL, V26, P15; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HAAS JD, 1995, J NUTR, V125, pS1078; HABICHT JP, 1995, J NUTR, V125, pS1042; HODDINOTT J, 2005, FOOD NUTR BULL, V26, P98; Li HJ, 2003, PEDIATRICS, V112, P1156, DOI 10.1542/peds.112.5.1156; Maluccio J. A., 2006, 0614 MIDDL COLL; MALUCCIO JA, 2005, FOOD NUTR B S1, V26, P25; MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S; Martorell R, 1993, FOOD NUTR BULL, V14, P270; Martorell R., 2005, FOOD NUTR BULL, V26, P5, DOI [10.1177/15648265050262S102, DOI 10.1177/15648265050262S102]; Murray DM, 1998, DESIGN ANAL GROUP RA; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; RIVERA JA, 1995, J NUTR, V125, pS1068; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Schroeder Dirk G., 1992, Food and Nutrition Bulletin, V14, P191; Strauss J., 1996, OPPORTUNITY FOREGONE, P147; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736_07)61692-4; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; World Bank, 2006, REP NUTR CENTR DEV S	26	414	419	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					411	416		10.1016/S0140-6736(08)60205-6	http://dx.doi.org/10.1016/S0140-6736(08)60205-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242415				2022-12-28	WOS:000252992700031
J	Milly, PCD; Betancourt, J; Falkenmark, M; Hirsch, RM; Kundzewicz, ZW; Lettenmaier, DP; Stouffer, RJ				Milly, P. C. D.; Betancourt, Julio; Falkenmark, Malin; Hirsch, Robert M.; Kundzewicz, Zbigniew W.; Lettenmaier, Dennis P.; Stouffer, Ronald J.			Climate change - Stationarity is dead: Whither water management?	SCIENCE			English	Editorial Material							MODEL; AVAILABILITY; SENSITIVITY; STREAMFLOW; FLOODS; TIME		[Milly, P. C. D.; Stouffer, Ronald J.] NOAA, US Geol Survey, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Betancourt, Julio] US Geol Survey, Tucson, AZ 85745 USA; [Falkenmark, Malin] Stockholm Int Water Inst, SE-11151 Stockholm, Sweden; [Hirsch, Robert M.] US Geol Survey, Reston, VA 20192 USA; [Kundzewicz, Zbigniew W.] Polish Acad Sci, Res Ctr Agr & Forest Environm, Poznan, Poland; [Kundzewicz, Zbigniew W.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Lettenmaier, Dennis P.] Univ Washington, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Polish Academy of Sciences; Potsdam Institut fur Klimafolgenforschung; University of Washington; University of Washington Seattle	Milly, PCD (corresponding author), NOAA, US Geol Survey, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA.	cmilly@usgs.gov	Milly, Paul C. D./H-1169-2019; Quinn, Patrick/B-5489-2010; lettenmaier, dennis p/F-8780-2011	Milly, Paul C. D./0000-0003-4389-3139; lettenmaier, dennis p/0000-0003-3317-1327; Kundzewicz, Zbigniew/0000-0002-3579-5072; Hirsch, Robert/0000-0002-4534-075X				Ashley R., 2006, INFRASTRUCTURE 2030; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; EAGLESON PS, 1982, SCI BASIS WATER RESO; EHRLICH E, 2005, PUBLIC WORKS PUBLIC; Knox JC, 2000, QUATERNARY SCI REV, V19, P439, DOI 10.1016/S0277-3791(99)00074-8; Kundzewicz ZW, 1997, WATER RESOUR MANAG, V11, P407, DOI 10.1023/A:1007984001105; Kundzewicz ZW, 2005, HYDROLOG SCI J, V50, P797, DOI 10.1623/hysj.2005.50.5.797; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Maass A., 1962, DESIGN WATER RESOURC, DOI [10.4159/harvard.9780674421042, DOI 10.4159/HARVARD.9780674421042]; MANABE S, 1980, J GEOPHYS RES-OCEANS, V85, P5529, DOI 10.1029/JC085iC10p05529; MATALAS NC, 1998, GLOBAL CHANGE WATER; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Miles EL, 2006, P NATL ACAD SCI USA, V103, P19616, DOI 10.1073/pnas.0609090103; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; MOSS ME, 1979, WATER RESOUR RES, V15, P1797, DOI 10.1029/WR015i006p01797; Parry ML, 2007, CLIMATE CHANGE 2007; Reuss M, 2003, J WATER RES PL-ASCE, V129, P357, DOI 10.1061/(ASCE)0733-9496(2003)129:5(357); SCHILLING KE, 1998, GLOBAL CHANGE WATER; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEDINGER JR, 1985, WATER RESOUR RES, V21, P665, DOI 10.1029/WR021i005p00665; WEBB RH, 1992, US GEOLOGICAL SURVEY, V2379, P1; Woodhouse C. A., 2006, Water Resources Research, V42, pW05415, DOI 10.1029/2005WR004455	25	2690	2785	30	722	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					573	574		10.1126/science.1151915	http://dx.doi.org/10.1126/science.1151915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239110				2022-12-28	WOS:000252772000023
J	WALLIS, MK				WALLIS, MK			LEAKY ANSWER TO GREENHOUSE GAS	NATURE			English	Letter											WALLIS, MK (corresponding author), UNIV WALES COLL CARDIFF,SCH MATH,CARDIFF CF2 4AG,WALES.							BLAKE DR, 1988, SCIENCE, V239, P1121; BOHLIN B, 1986, SCOPE29 REP; BRASSEUR G, 1988, SOLAR TERRESTRIAL EN, P166; KARAS JHW, 1988, HEAT TRAP; MCELROY M, 1988, NEW SCI, V119, P34; SMITH I, 1988, CO2 CLIMATE CHANGE; 1989, 6 HOUS COMM EN COMM, V1; 1989, ENDS REPORT, V175, P3	8	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					25	26		10.1038/344025b0	http://dx.doi.org/10.1038/344025b0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278012				2022-12-28	WOS:A1990CQ97200042
J	Palacios, G; Druce, J; Du, L; Tran, T; Birch, C; Briese, T; Conlan, S; Quan, P; Hui, J; Marshall, J; Simons, JF; Egholm, M; Paddock, CD; Shieh, W; Goldsmith, CS; Zaki, SR; Catton, M; Lipkin, WI				Palacios, Gustavo; Druce, Julian; Du, Lei; Tran, Thomas; Birch, Chris; Briese, Thomas; Conlan, Sean; Quan, Phenix-Lan; Hui, Jeffrey; Marshall, John; Simons, Jan Fredrik; Egholm, Michael; Paddock, Christopher D.; Shieh, Wun-Ju; Goldsmith, Cynthia S.; Zaki, Sherif R.; Catton, Mike; Lipkin, W. Ian			A new arenavirus in a cluster of fatal transplant-associated diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SEQUENCE; PROGRAM	Background: Three patients who received visceral-organ transplants from a single donor on the same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, polymerase-chain-reaction (PCR) and serologic assays, and oligonucleotide microarray analysis for a wide range of infectious agents were not informative. Methods: We evaluated RNA obtained from the liver and kidney transplant recipients. Unbiased high-throughput sequencing was used to identify microbial sequences not found by means of other methods. The specificity of sequences for a new candidate pathogen was confirmed by means of culture and by means of PCR, immunohistochemical, and serologic analyses. Results: High-throughput sequencing yielded 103,632 sequences, of which 14 represented an Old World arenavirus. Additional sequence analysis showed that this new arenavirus was related to lymphocytic choriomeningitis viruses. Specific PCR assays based on a unique sequence confirmed the presence of the virus in the kidneys, liver, blood, and cerebrospinal fluid of the recipients. Immunohistochemical analysis revealed arenavirus antigen in the liver and kidney transplants in the recipients. IgM and IgG antiviral antibodies were detected in the serum of the donor. Seroconversion was evident in serum specimens obtained from one recipient at two time points. Conclusions: Unbiased high-throughput sequencing is a powerful tool for the discovery of pathogens. The use of this method during an outbreak of disease facilitated the identification of a new arenavirus transmitted through solid-organ transplantation.	[Palacios, Gustavo; Briese, Thomas; Conlan, Sean; Quan, Phenix-Lan; Hui, Jeffrey; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Druce, Julian; Tran, Thomas; Birch, Chris; Marshall, John; Catton, Mike] Victorian Infect Dis Reference Lab, Carlton, Vic 3053, Australia; [Du, Lei; Simons, Jan Fredrik; Egholm, Michael] 454 Life Sci, Branford, CT USA; [Paddock, Christopher D.; Shieh, Wun-Ju; Goldsmith, Cynthia S.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Atlanta, GA USA	Columbia University; Victorian Infectious Diseases Reference Laboratory; Centers for Disease Control & Prevention - USA	Lipkin, WI (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	mike.catton@mh.org.au; wil2001@columbia.edu	Conlan, Sean/B-4401-2008; Palacios, Gustavo/I-7773-2015; Lipkin, W. Ian/ABE-6216-2020	Conlan, Sean/0000-0001-6848-3465; Palacios, Gustavo/0000-0001-5062-1938; Lipkin, W. Ian/0000-0002-8768-9386; Druce, Julian/0000-0002-3521-3298	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062705, U54AI057158, U01AI070411] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083850] Funding Source: Medline; NIAID NIH HHS [U54AI57158, AI062705, U01AI070411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ike F, 2007, COMPARATIVE MED, V57, P272; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Jamieson DJ, 2006, AM J OBSTET GYNECOL, V194, P1532, DOI 10.1016/j.ajog.2005.11.040; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIPKIN WI, 2007, GLOBAL INFECT DIS SU, P177; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MERITET JF, 2006, HUMAN FETAL LYMPHOCY; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	16	473	511	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					991	998		10.1056/NEJMoa073785	http://dx.doi.org/10.1056/NEJMoa073785			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18256387	Green Published, Bronze			2022-12-28	WOS:000253644700003
J	Greenhagh, R; Cohen, CR; Burling, D; Taylor, SA				Greenhagh, Rebecca; Cohen, C. Richard; Burling, David; Taylor, Stuart Andrew			Rational imaging - Investigating perianal pain of uncertain cause	BRITISH MEDICAL JOURNAL			English	Editorial Material							FISTULA-IN-ANO; PROTECTION; STANDARD; MRI		[Greenhagh, Rebecca; Cohen, C. Richard; Taylor, Stuart Andrew] Univ Coll Hosp, London NW1 2BU, England; [Burling, David] St Marks Hosp, Harrow HA1 3UJ, Middx, England; [Taylor, Stuart Andrew] UCL, London, England	University of London; University College London; Imperial College London; University of London; University College London	Taylor, SA (corresponding author), Univ Coll Hosp, London NW1 2BU, England.	stuart.taylor@uclh.nhs.uk		Taylor, Stuart/0000-0002-6765-8806				Buchanan G, 2002, LANCET, V360, P1661, DOI 10.1016/S0140-6736(02)11605-9; Buchanan GN, 2004, RADIOLOGY, V233, P674, DOI 10.1148/radiol.2333031724; deSouza NM, 1998, J COMPUT ASSIST TOMO, V22, P357, DOI 10.1097/00004728-199805000-00004; Halligan S, 1998, AM J ROENTGENOL, V171, P407, DOI 10.2214/ajr.171.2.9694465; Matthes R, 2004, HEALTH PHYS, V87, P197; Nyborg WL, 2002, SEMIN ULTRASOUND CT, V23, P377, DOI 10.1016/S0887-2171(02)90008-9; REPACHOLI MH, 1991, HEALTH PHYS, V61, P923; SAINIO P, 1984, ANN CHIR GYNAECOL FE, V73, P219	8	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					387	389		10.1136/bmj.39455.393299.AD	http://dx.doi.org/10.1136/bmj.39455.393299.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276716	Green Published			2022-12-28	WOS:000253550600044
J	Gaudi, BS; Bennett, DP; Udalski, A; Gould, A; Christie, GW; Maoz, D; Dong, S; McCormick, J; Szymanski, MK; Tristram, PJ; Nikolaev, S; Paczynski, B; Kubiak, M; Pietrzynski, G; Soszynski, I; Szewczyk, O; Ulaczyk, K; Wyrzykowski, L; Depoy, DL; Han, C; Kaspi, S; Lee, CU; Mallia, F; Natusch, T; Pogge, RW; Park, BG; Abe, F; Bond, IA; Botzler, CS; Fukui, A; Hearnshaw, JB; Itow, Y; Kamiya, K; Korpela, AV; Kilmartin, PM; Lin, W; Masuda, K; Matsubara, Y; Motomura, M; Muraki, Y; Nakamura, S; Okumura, T; Ohnishi, K; Rattenbury, NJ; Sako, T; Saito, T; Sato, S; Skuljan, L; Sullivan, DJ; Sumi, T; Sweatman, WL; Yock, PCM; Albrow, MD; Allan, A; Beaulieu, JP; Burgdorf, MJ; Cook, KH; Coutures, C; Dominik, M; Dieters, S; Fouque, P; Greenhill, J; Horne, K; Steele, I; Tsapras, Y; Chaboyer, B; Crocker, A; Frank, S; Macintosh, B				Gaudi, B. S.; Bennett, D. P.; Udalski, A.; Gould, A.; Christie, G. W.; Maoz, D.; Dong, S.; McCormick, J.; Szymanski, M. K.; Tristram, P. J.; Nikolaev, S.; Paczynski, B.; Kubiak, M.; Pietrzynski, G.; Soszynski, I.; Szewczyk, O.; Ulaczyk, K.; Wyrzykowski, L.; Depoy, D. L.; Han, C.; Kaspi, S.; Lee, C. -U.; Mallia, F.; Natusch, T.; Pogge, R. W.; Park, B. -G.; Abe, F.; Bond, I. A.; Botzler, C. S.; Fukui, A.; Hearnshaw, J. B.; Itow, Y.; Kamiya, K.; Korpela, A. V.; Kilmartin, P. M.; Lin, W.; Masuda, K.; Matsubara, Y.; Motomura, M.; Muraki, Y.; Nakamura, S.; Okumura, T.; Ohnishi, K.; Rattenbury, N. J.; Sako, T.; Saito, To.; Sato, S.; Skuljan, L.; Sullivan, D. J.; Sumi, T.; Sweatman, W. L.; Yock, P. C. M.; Albrow, M. D.; Allan, A.; Beaulieu, J. -P.; Burgdorf, M. J.; Cook, K. H.; Coutures, C.; Dominik, M.; Dieters, S.; Fouque, P.; Greenhill, J.; Horne, K.; Steele, I.; Tsapras, Y.; Chaboyer, B.; Crocker, A.; Frank, S.; Macintosh, B.		OGLE Collaboration; uFUN Collaboration; MOA Collaboration; PLANET Collaboration; RoboNET Collaborations	Discovery of a Jupiter/Saturn analog with gravitational microlensing	SCIENCE			English	Article							LENSING EXPERIMENT; PLANETARY SYSTEMS; SEARCH; COMPANION; TRANSITS; DISK	Searches for extrasolar planets have uncovered an astonishing diversity of planetary systems, yet the frequency of solar system analogs remains unknown. The gravitational microlensing planet search method is potentially sensitive to multiple- planet systems containing analogs of all the solar system planets except Mercury. We report the detection of a multiple- planet system with microlensing. We identify two planets with masses of similar to 0.71 and similar to 0.27 times the mass of Jupiter and orbital separations of similar to 2.3 and similar to 4.6 astronomical units orbiting a primary star of mass similar to 0.50 solar mass at a distance of similar to 1.5 kiloparsecs. This system resembles a scaled version of our solar system in that the mass ratio, separation ratio, and equilibrium temperatures of the planets are similar to those of Jupiter and Saturn. These planets could not have been detected with other techniques; their discovery from only six confirmed microlensing planet detections suggests that solar system analogs may be common.	[Gaudi, B. S.; Gould, A.; Dong, S.; Depoy, D. L.; Pogge, R. W.; Frank, S.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Bennett, D. P.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Udalski, A.; Szymanski, M. K.; Kubiak, M.; Pietrzynski, G.; Soszynski, I.; Szewczyk, O.; Ulaczyk, K.; Wyrzykowski, L.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Christie, G. W.; Mallia, F.; Natusch, T.] Auckland Observ, Auckland, New Zealand; [Maoz, D.; Kaspi, S.] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [McCormick, J.] Farm Cove Observ, Auckland 1706, New Zealand; [Tristram, P. J.; Kilmartin, P. M.] Mt John Observ, Lake Tekapo 8770, New Zealand; [Nikolaev, S.; Cook, K. H.; Macintosh, B.] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; [Paczynski, B.] Princeton Univ Observ, Princeton, NJ 08544 USA; [Pietrzynski, G.] Univ Concepcion, Dept Fis, Concepcion, Chile; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Han, C.] Chungbuk Natl Univ, Program Brain Korea, Dept Phys, Chonju 371763, South Korea; [Lee, C. -U.; Park, B. -G.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Mallia, F.] Campo Catino Astron Observ, I-03016 Guarcino, Frosinone, Italy; [Abe, F.; Fukui, A.; Itow, Y.; Kamiya, K.; Masuda, K.; Matsubara, Y.; Motomura, M.; Nakamura, S.; Okumura, T.; Sako, T.; Sumi, T.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Bond, I. A.; Lin, W.; Skuljan, L.; Sweatman, W. L.] Massey Univ, Inst Informat & Math Sci, Auckland 1330, New Zealand; [Botzler, C. S.; Yock, P. C. M.] Univ Auckland, Dept Phys, Auckland 1001, New Zealand; [Hearnshaw, J. B.; Albrow, M. D.] Univ Canterbury, Dept Phys & Astron, Christchurch 8020, New Zealand; [Korpela, A. V.; Sullivan, D. J.] Univ Victoria, Sch Chem & Phys Sci, Wellington, New Zealand; [Muraki, Y.] Konan Univ, Dept Phys, Kobe, Hyogo 6588501, Japan; [Ohnishi, K.] Nagano Natl Coll Technol, Nagano 3818550, Japan; [Rattenbury, N. J.] Univ Manchester, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Saito, To.] Tokyo Metropolitan Coll Aeronaut, Tokyo 1168523, Japan; [Sato, S.] Nagoya Univ, Dept Phys & Astrophys, Fac Sci, Nagoya, Aichi 4648602, Japan; [Allan, A.] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Beaulieu, J. -P.; Coutures, C.] Univ Paris 06, Inst Astrophys Paris, CNRS, UMR7095, F-75014 Paris, France; [Burgdorf, M. J.; Steele, I.; Tsapras, Y.] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Dominik, M.; Horne, K.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Dieters, S.; Greenhill, J.] Univ Tasmania, Sch Math & Phys, Hobart, Tas 7001, Australia; [Fouque, P.] Univ Toulouse 3, Observ Midi Pyrenees, Astrophys Lab, F-31400 Toulouse, France; [Chaboyer, B.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Crocker, A.] Univ Oxford, Oxford OX1 3RH, England	University System of Ohio; Ohio State University; University of Notre Dame; University of Warsaw; Warsaw University Observatory; Tel Aviv University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Princeton University; Universidad de Concepcion; University of Cambridge; Chungbuk National University; Korea Astronomy & Space Science Institute (KASI); Nagoya University; Massey University; University of Auckland; University of Canterbury; Victoria University Wellington; Konan University; University of Manchester; Jodrell Bank Centre for Astrophysics; Tokyo Metropolitan University; Nagoya University; University of Exeter; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Liverpool John Moores University; University of St Andrews; University of Tasmania; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Dartmouth College; University of Oxford	Gaudi, BS (corresponding author), Ohio State Univ, Dept Astron, 140 W 18Th Ave, Columbus, OH 43210 USA.	gaudi@astronomy.ohio-state.edu	Fukui, Akihiko/W-2238-2017; Fukui, Akihiko/ABE-4506-2020; Szymański, Michał Krzysztof/X-5627-2019; Gaudi, Bernard/I-7732-2012; Burgdorf, Martin/H-5576-2019; Dominik, Martin/AAA-9501-2020; Dong, Subo/AIB-2671-2022; Szymański, Michał K/H-6951-2018; Fukui, Akihiko/ABF-2092-2021; Greenhill, John G/C-8367-2013; Dong, Subo/J-7319-2012; Sweatman, Winston/S-4931-2019; Rattenbury, Nicholas James/ABB-2102-2021	Fukui, Akihiko/0000-0002-4909-5763; Szymański, Michał Krzysztof/0000-0002-0548-8995; Dominik, Martin/0000-0002-3202-0343; Dong, Subo/0000-0002-1027-0990; Szymański, Michał K/0000-0002-0548-8995; Rattenbury, Nicholas James/0000-0001-5069-319X; Fouque, Pascal/0000-0002-1436-7351; Chaboyer, Brian/0000-0003-3096-4161; Tsapras, Yiannis/0000-0001-8411-351X; Soszynski, Igor/0000-0002-7777-0842; Lee, Chung-Uk/0000-0003-0043-3925; Burgdorf, Martin/0000-0002-5854-4217; Udalski, Andrzej/0000-0001-5207-5619; Beaulieu, Jean-Philippe/0000-0003-0014-3354; Ulaczyk, Krzysztof/0000-0001-6364-408X; Macintosh, Bruce/0000-0003-1212-7538; Yock, Philip/0000-0001-9716-7752; Pietrzynski, Grzegorz/0000-0002-9443-4138; Albrow, Michael/0000-0003-3316-4012; Wyrzykowski, Lukasz/0000-0002-9658-6151	STFC [PP/D000890/1, PP/E002137/1, PP/E001149/1, PP/E003303/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E003303/1, PP/D000890/1, PP/E002137/1, PP/E001149/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Abe F, 2004, SCIENCE, V305, P1264, DOI 10.1126/science.1100714; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Bennett DP, 2002, ASTROPHYS J, V574, P985, DOI 10.1086/340977; Burgdorf MJ, 2007, PLANET SPACE SCI, V55, P582, DOI 10.1016/j.pss.2006.04.036; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Dong S, 2007, ASTROPHYS J, V664, P862, DOI 10.1086/518536; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; GAUDI BS, 1998, APJ, V502, P33; Gould A., 2006, Astrophysical Journal, Letters, V644, pL37, DOI 10.1086/505421; GOULD A, 1992, ASTROPHYS J, V396, P104, DOI 10.1086/171700; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Gould A., 1994, APJ, V421, P71; Griest K, 1998, ASTROPHYS J, V500, P37, DOI 10.1086/305729; Han C, 2005, ASTROPHYS J, V629, P1102, DOI 10.1086/431143; Ida S, 2005, ASTROPHYS J, V626, P1045, DOI 10.1086/429953; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; LISSAUER JJ, 1987, ICARUS, V69, P249, DOI 10.1016/0019-1035(87)90104-7; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; Rattenbury NJ, 2002, MON NOT R ASTRON SOC, V335, P159, DOI 10.1046/j.1365-8711.2002.05607.x; Rhie SH, 2000, ASTROPHYS J, V533, P378, DOI 10.1086/308634; Udalski A, 2005, ASTROPHYS J, V628, pL109, DOI 10.1086/432795; Udalski A, 2002, ACTA ASTRONOM, V52, P1; Wambsganss J, 1997, MON NOT R ASTRON SOC, V284, P172, DOI 10.1093/mnras/284.1.172; Wittenmyer RA, 2007, ASTROPHYS J, V654, P625, DOI 10.1086/509110; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; Yoo J, 2004, ASTROPHYS J, V603, P139, DOI 10.1086/381241	29	257	257	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					927	930		10.1126/science.1151947	http://dx.doi.org/10.1126/science.1151947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276883	Green Submitted			2022-12-28	WOS:000253165700038
J	Blow, N				Blow, Nathan			In search of common ground	NATURE			English	Editorial Material							STEM-CELL LINES											Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	12	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					855	860		10.1038/451855a	http://dx.doi.org/10.1038/451855a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273022	Bronze			2022-12-28	WOS:000253191400048
J	De Schrijver, A; Verheyen, K; Mertens, J; Staelens, J; Wuyts, K; Muys, B				De Schrijver, An; Verheyen, Kris; Mertens, Jan; Staelens, Jeroen; Wuyts, Karen; Muys, Bart			Nitrogen saturation and net ecosystem production	NATURE			English	Letter							FOREST ECOSYSTEMS; EUROPEAN FORESTS; TEMPERATE; DEPOSITION; NITRATE		[De Schrijver, An; Verheyen, Kris; Mertens, Jan; Staelens, Jeroen; Wuyts, Karen] Univ Ghent, Lab Forestry, B-9090 Gontrode, Belgium; [Muys, Bart] Katholieke Univ Leuven, Div Forest Nat & Landscape, B-3001 Heverlee, Belgium	Ghent University; KU Leuven	De Schrijver, A (corresponding author), Univ Ghent, Lab Forestry, Geraardsbergse Steenweg 267, B-9090 Gontrode, Belgium.	An.Deschrijver@Ugent.be	Mertens, Jan/AAM-5319-2021; Muys, Bart/ABN-3906-2022; Wuyts, Karen/E-3021-2012; Muys, Bart/A-3194-2015	Mertens, Jan/0000-0003-0656-4459; Wuyts, Karen/0000-0002-3371-6828; Muys, Bart/0000-0001-9421-527X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Dise NB, 1998, WATER AIR SOIL POLL, V105, P143, DOI 10.1023/A:1005068501864; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gundersen P, 2006, ENVIRON REV, V14, P1, DOI [10.1139/a05-015, 10.1139/A05-015]; KARJALAINEN T, IN PRESS CAUSES CONS; Lorenz M., 2005, FOREST CONDITION EUR; MacDonald JA, 2002, GLOBAL CHANGE BIOL, V8, P1028, DOI 10.1046/j.1365-2486.2002.00532.x; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Pilegaard K, 2006, BIOGEOSCIENCES, V3, P651, DOI 10.5194/bg-3-651-2006; van der Salm C, 2007, FOREST ECOL MANAG, V238, P81, DOI 10.1016/j.foreco.2006.09.092	12	55	58	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					E1	E1		10.1038/nature06578	http://dx.doi.org/10.1038/nature06578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18272969	Bronze			2022-12-28	WOS:000253191400030
J	Klagsbrun, M; Moses, MA				Klagsbrun, Michael; Moses, Marsha A.			M. Judah Folkman (1933-2008) - Obituary	NATURE			English	Biographical-Item									[Klagsbrun, Michael; Moses, Marsha A.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Klagsbrun, Michael; Moses, Marsha A.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Klagsbrun, Michael; Moses, Marsha A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Klagsbrun, M (corresponding author), Childrens Hosp, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.klagsbrun@childrens.harvard.edu; marsha.moses@childrens.harvard.edu						Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; FOLKMAN MJ, PUBLICATION LIST	2	9	9	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					781	781		10.1038/451781a	http://dx.doi.org/10.1038/451781a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273010	Bronze			2022-12-28	WOS:000253191400029
J	Qin, Y; Wang, XD; Wang, ZL				Qin, Yong; Wang, Xudong; Wang, Zhong Lin			Microfibre-nanowire hybrid structure for energy scavenging	NATURE			English	Article							PIEZOELECTRIC NANOGENERATORS; POWER SOURCES	A self- powering nanosystem that harvests its operating energy from the environment is an attractive proposition for sensing, personal electronics and defence technologies(1). This is in principle feasible for nanodevices owing to their extremely low power consumption(2-5). Solar, thermal and mechanical ( wind, friction, body movement) energies are common and may be scavenged from the environment, but the type of energy source to be chosen has to be decided on the basis of specific applications. Military sensing/ surveillance node placement, for example, may involve difficult- to- reach locations, may need to be hidden, and may be in environments that are dusty, rainy, dark and/ or in deep forest. In a moving vehicle or aeroplane, harvesting energy from a rotating tyre or wind blowing on the body is a possible choice to power wireless devices implanted in the surface of the vehicle. Nanowire nanogenerators built on hard substrates were demonstrated for harvesting local mechanical energy produced by high- frequency ultrasonic waves(6,7). To harvest the energy from vibration or disturbance originating from footsteps, heartbeats, ambient noise and air flow, it is important to explore innovative technologies that work at low frequencies ( such as < 10 Hz) and that are based on flexible soft materials. Here we present a simple, low- cost approach that converts low- frequency vibration/ friction energy into electricity using piezoelectric zinc oxide nanowires grown radially around textile fibres. By entangling two fibres and brushing the nanowires rooted on them with respect to each other, mechanical energy is converted into electricity owing to a coupled piezoelectric - semiconductor process(8,9). This work establishes a methodology for scavenging light- wind energy and body- movement energy using fabrics.	[Qin, Yong; Wang, Xudong; Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zlwang@gatech.edu	Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022; Qin, Yong/G-5890-2010; Qin, Yong/T-5235-2019; Wang, Xudong/A-7067-2009	Wang, Zhong Lin/0000-0002-5530-0380; Qin, Yong/0000-0002-6713-480X; Qin, Yong/0000-0002-6713-480X; 				Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Gao PX, 2007, ADV MATER, V19, P67, DOI 10.1002/adma.200601162; Gao Y, 2007, NANO LETT, V7, P2499, DOI 10.1021/nl071310j; Hsu JWP, 2005, NANO LETT, V5, P83, DOI 10.1021/nl048322e; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Li Y, 2006, MATER TODAY, V9, P18, DOI 10.1016/S1369-7021(06)71650-9; Liu J, 2008, NANO LETT, V8, P328, DOI 10.1021/nl0728470; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Song JH, 2006, NANO LETT, V6, P1656, DOI 10.1021/nl060820v; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Wang XD, 2007, NANO LETT, V7, P2475, DOI 10.1021/nl0712567; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Wu YL, 2007, APPL SURF SCI, V253, P5473, DOI 10.1016/j.apsusc.2006.12.091	14	1338	1384	27	1113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					809	U5		10.1038/nature06601	http://dx.doi.org/10.1038/nature06601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273015				2022-12-28	WOS:000253191400038
J	Nykypanchuk, D; Maye, MM; van der Lelie, D; Gang, O				Nykypanchuk, Dmytro; Maye, Mathew M.; van der Lelie, Daniel; Gang, Oleg			DNA-guided crystallization of colloidal nanoparticles	NATURE			English	Article							SUPERLATTICES; ASSEMBLIES; HYBRIDIZATION; NANOCRYSTALS; PROTEIN; ARRAYS	Many nanometre-sized building blocks will readily assemble into macroscopic structures. If the process is accompanied by effective control over the interactions between the blocks and all entropic effects(1,2), then the resultant structures will be ordered with a precision hard to achieve with other fabrication methods. But it remains challenging to use self- assembly to design systems comprised of different types of building blocks - to realize novel magnetic, plasmonic and photonic metamaterials(3-5), for example. A conceptually simple idea for overcoming this problem is the use of 'encodable' interactions between building blocks; this can in principle be straightforwardly implemented using biomolecules(6-10). Strategies that use DNA programmability to control the placement of nanoparticles in one and two dimensions have indeed been demonstrated(11-13). However, our theoretical understanding of how to extend this approach to three dimensions is limited(14,15), and most experiments have yielded amorphous aggregates(16-19) and only occasionally crystallites of close- packed micrometre- sized particles(9,10). Here, we report the formation of three- dimensional crystalline assemblies of gold nanoparticles mediated by interactions between complementary DNA molecules attached to the nanoparticles' surface. We find that the nanoparticle crystals form reversibly during heating and cooling cycles. Moreover, the body- centred- cubic lattice structure is temperature-tuneable and structurally open, with particles occupying only similar to 4% of the unit cell volume. We expect that our DNA-mediated crystallization approach, and the insight into DNA design requirements it has provided, will facilitate both the creation of new classes of ordered multicomponent metamaterials and the exploration of the phase behaviour of hybrid systems with addressable interactions.	[Nykypanchuk, Dmytro; Maye, Mathew M.; Gang, Oleg] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [van der Lelie, Daniel] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Gang, O (corresponding author), Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA.	ogang@bnl.gov	Han, Kyuhee/B-6201-2009					[Anonymous], 1992, INTERMOLECULAR SURFA; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; DAN N, 1992, MACROMOLECULES, V25, P2890, DOI 10.1021/ma00037a016; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; KATZ E, 1996, NATURE, V382, P609; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Lee J, 2007, NAT MATER, V6, P291, DOI 10.1038/nmat1869; Lukatsky DB, 2006, J PHYS-CONDENS MAT, V18, pS567, DOI 10.1088/0953-8984/18/18/S05; Lytton-Jean AKR, 2005, J AM CHEM SOC, V127, P12754, DOI 10.1021/ja052255o; Maye MM, 2007, SMALL, V3, P1678, DOI 10.1002/smll.200700357; Maye MM, 2006, J AM CHEM SOC, V128, P14020, DOI 10.1021/ja0654229; MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005; MIRKIN CA, 1996, NATURE, V382, P609; Nykypanchuk D, 2007, LANGMUIR, V23, P6305, DOI 10.1021/la0637566; Park SJ, 2001, ANGEW CHEM INT EDIT, V40, P2909, DOI 10.1002/1521-3773(20010803)40:15<2909::AID-ANIE2909>3.0.CO;2-O; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Pinto YY, 2005, NANO LETT, V5, P2399, DOI 10.1021/nl0515495; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Rogers PH, 2005, LANGMUIR, V21, P5562, DOI 10.1021/la046790y; Rubinstein M., 2003, POLYM PHYS; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Tang ZY, 2005, ADV MATER, V17, P951, DOI 10.1002/adma.200401593; Tkachenko AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148303; Urban JJ, 2007, NAT MATER, V6, P115, DOI 10.1038/nmat1826; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; WARREN BE, 1969, XRAY DIFFRACTION, pCH13; Zhang H, 2006, PHYS CHEM CHEM PHYS, V8, P3288, DOI 10.1039/b604745a; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l	28	1232	1257	12	779	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					549	552		10.1038/nature06560	http://dx.doi.org/10.1038/nature06560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235496				2022-12-28	WOS:000252739900036
J	Irvine, KD				Irvine, Kenneth D.			A notch sweeter	CELL			English	Editorial Material							GLYCOSYLATION	Notch is a key signaling protein mediating cell-fate decisions during development. In this issue, Acar et al. ( 2008) describe a new gene called rumi that is required for Notch signaling in Drosophila. This gene encodes an O-glucosyltransferase that attaches glucose sugars to serine residues in the multiple EGF domains of the extracellular region of Notch. This modification by Rumi likely influences Notch folding and trafficking.	[Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; [Irvine, Kenneth D.] Rutgers State Univ, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu						ACAR M, 2008, CELL; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; OKAJIMA T, 2008, BMC BIOL; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809	10	8	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 25	2008	132	2					177	179		10.1016/j.cell.2008.01.005	http://dx.doi.org/10.1016/j.cell.2008.01.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243091	Bronze			2022-12-28	WOS:000253427700002
J	Xu, XB; D'Hoker, J; Stange, G; Bonne, S; De Leu, N; Xiao, XW; De Casteele, MV; Mellitzer, G; Ling, ZD; Pipeleers, D; Bouwens, L; Scharfmann, R; Gradwohl, G; Heimberg, H				Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; Xiao, Xiangwei; De Casteele, Mark Van; Mellitzer, Georg; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry			beta cells can be generated from endogenous progenitors in injured adult mouse pancreas	CELL			English	Article							IN-VITRO; HUMAN ISLETS; DUCT-CELL; ENDOCRINE; DIFFERENTIATION; NEUROGENIN3; NEOGENESIS; IDENTIFICATION; REGENERATION; EXPRESSION	Novel strategies in diabetes therapy would obviously benefit from the use of beta (beta) cell stem/progenitor cells. However, whether or not adult b cell progenitors exist is one of the most controversial issues in today's diabetes research. Guided by the expression of Neurogenin 3 (Ngn3), the earliest islet cell-specific transcription factor in embryonic development, we show that b cell progenitors can be activated in injured adult mouse pancreas and are located in the ductal lining. Differentiation of the adult progenitors is Ngn3 dependent and gives rise to all islet cell types, including glucose responsive b cells that subsequently proliferate, both in situ and when cultured in embryonic pancreas explants. Multipotent progenitor cells thus exist in the pancreas of adult mice and can be activated cell autonomously to increase the functional b cell mass by differentiation and proliferation rather than by self-duplication of pre-existing beta cells only.	[Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; Xiao, Xiangwei; De Casteele, Mark Van; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, B-1090 Brussels, Belgium; [Mellitzer, Georg; Gradwohl, Gerard] INSERM, U682, F-67200 Strasbourg, France; [Scharfmann, Raphael] INSERM, U845, F-75730 Paris, France; [Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry] Beta Cell Biol Consortium, Nashville, TN 37323 USA; [Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; De Casteele, Mark Van; Mellitzer, Georg; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry] JRDF, Ctr Beta Cell Therapy Diabet, B-1090 Brussels, Belgium	Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Heimberg, H (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Laarbeeklan 103, B-1090 Brussels, Belgium.	harry.heimberg@vub.ac.be	stange, geert m/C-1092-2009; xiao, xiangwei/K-1218-2012; Gradwohl, Gérard/H-8543-2014; Georg, Mellitzer/R-4180-2016; Gradwohl, Gérard/AFM-9024-2022; scharfmann, raphael/L-3296-2017	stange, geert m/0000-0003-3148-1372; Gradwohl, Gérard/0000-0002-6730-2615; Georg, Mellitzer/0000-0003-4467-0789; Gradwohl, Gérard/0000-0002-6730-2615; Heimberg, Harry/0000-0003-1954-7375; Pipeleers, Daniel/0000-0002-6440-2485; Van De Casteele, mark/0000-0002-8594-9260; Xiao, Xiangwei/0000-0003-0890-9203; Scharfmann, Raphael/0000-0001-7619-337X; De Leu, Nico/0000-0002-0542-5708; Bouwens, Luc/0000-0001-5767-7002				Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; BLUME N, 1990, BIOMED BIOCHIM ACTA, V49, P1247; Bogdani M, 2003, DIABETOLOGIA, V46, P830, DOI 10.1007/s00125-003-1118-4; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Lee CS, 2006, DIABETES, V55, P269; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Miralles F, 1998, DEVELOPMENT, V125, P1017; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; Ramiya VK, 2000, NAT MED, V6, P278; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Scoggins CR, 2000, AM J PHYSIOL-GASTR L, V279, pG827, DOI 10.1152/ajpgi.2000.279.4.G827; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Zahn S, 2004, HYBRIDOMA HYBRIDOM, V23, P385, DOI 10.1089/hyb.2004.23.385	35	760	800	0	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					197	207		10.1016/j.cell.2007.12.015	http://dx.doi.org/10.1016/j.cell.2007.12.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243096	Bronze			2022-12-28	WOS:000253427700007
J	HEWITT, CN; KOK, GL; FALL, R				HEWITT, CN; KOK, GL; FALL, R			HYDROPEROXIDES IN PLANTS EXPOSED TO OZONE MEDIATE AIR-POLLUTION DAMAGE TO ALKENE EMITTERS	NATURE			English	Article									UNIV COLORADO,NOAA,COOPERAT INST RES ENVIRONM SCI,BOULDER,CO 80309; UNIV COLORADO,DEPT CHEM & BIOCHEM,BOULDER,CO 80309; NATL CTR ATMOSPHER RES,BOULDER,CO 80307	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Center Atmospheric Research (NCAR) - USA	HEWITT, CN (corresponding author), UNIV LANCASTER,INST ENVIRONM & BIOL SCI,LANCASTER LA1 4YQ,ENGLAND.		Hewitt, Charles Nicholas/B-1219-2009; Hewitt, Charles Nicholas/ABF-9429-2020	Hewitt, Charles Nicholas/0000-0001-7973-2666; Hewitt, Charles Nicholas/0000-0001-7973-2666				ARNDT U, 1985, ALLG FORST Z, V40, P19; ASHMORE M, 1985, AMBIO, V14, P81; AYERS GP, 1988, J ATMOS CHEM, V7, P177, DOI 10.1007/BF00048045; CORKILL JAJ, 1988, HIGH RESOLUTION CHRO, V11, P212; DICKEY FH, 1949, P NATL ACAD SCI USA, V35, P581, DOI 10.1073/pnas.35.10.581; DUCE RA, 1983, REV GEOPHYS, V21, P921, DOI 10.1029/RG021i004p00921; GAB S, 1985, NATURE, V316, P525; HANST PL, 1983, ATMOS ENVIRON, V17, P2259, DOI 10.1016/0004-6981(83)90223-8; HECK WW, 1968, ANNU REV PHYTOPATHOL, V6, P165, DOI 10.1146/annurev.py.06.090168.001121; HELLPOINTNER E, 1989, NATURE, V337, P631, DOI 10.1038/337631a0; Keusch E., 1971, GES BER SCHWEIZ BOT, P180; KOK GL, 1986, ANAL CHEM, V58, P1192, DOI 10.1021/ac00297a047; LAMB B, 1987, ATMOS ENVIRON, V21, P1695, DOI 10.1016/0004-6981(87)90108-9; LEONE JA, 1985, INT J CHEM KINET, V17, P177, DOI 10.1002/kin.550170206; LOVELESS A, 1951, NATURE, V167, P338, DOI 10.1038/167338a0; MALLANT RKA, 1986, AEROSOLS, P901; MALLANT RKA, 1987, AIR POLLUTION ECOSYS, P306; MARKLUND S, 1972, BIOCHIM BIOPHYS ACTA, V258, P9, DOI 10.1016/0005-2744(72)90962-X; MARKLUND S, 1971, ACTA CHEM SCAND, V25, P3517, DOI 10.3891/acta.chem.scand.25-3517; MARKLUND S, 1971, EUR J BIOCHEM, V21, P348, DOI 10.1111/j.1432-1033.1971.tb01475.x; MARKLUND S, 1973, ARCH BIOCHEM BIOPHYS, V154, P614, DOI 10.1016/0003-9861(73)90016-7; MARTINEZ RI, 1981, J AM CHEM SOC, V103, P3807, DOI 10.1021/ja00403a031; MASUCH G, 1986, INT J ENVIRON AN CH, V27, P183, DOI 10.1080/03067318608079815; MCLAREN SE, UNPUB ANAL CHEM; MEHLHORN H, 1988, Plant Physiology (Rockville), V86, P148; MEHLHORN H, 1987, NATURE, V327, P417, DOI 10.1038/327417a0; PERCHOROWICZ JT, 1974, AM J BOT, V61, P787, DOI 10.2307/2441795; RASMUSSEN RA, 1988, J GEOPHYS RES-ATMOS, V93, P1417, DOI 10.1029/JD093iD02p01417; RASMUSSEN RA, 1978, SPEC REP OREGON GRAD; Schonbaum G. R., 1976, ENZYMES, V13, P363, DOI [10.1016/S1874-6047(08)60245-0, DOI 10.1016/S1874-6047(08)60245-0]; SKARBY L, 1984, AMBIO, V13, P68; SOBELS FH, 1982, NATURE, V177, P979; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; WEITZEL G, 1961, H-S Z PHYSIOL CHEM, V325, P65, DOI 10.1515/bchm2.1961.325.1.65; WEITZEL G, 1961, H-S Z PHYSIOL CHEM, V323, P211, DOI 10.1515/bchm2.1961.323.1.211; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	36	140	147	1	23	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					56	58		10.1038/344056a0	http://dx.doi.org/10.1038/344056a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278026				2022-12-28	WOS:A1990CQ97200058
J	Bingel-Erlenmeyer, R; Kohler, R; Kramer, G; Sandikci, A; Antolic, S; Maier, T; Schaffitzel, C; Wiedmann, B; Bukau, B; Ban, N				Bingel-Erlenmeyer, Rouven; Kohler, Rebecca; Kramer, Guenter; Sandikci, Arzu; Antolic, Snjezana; Maier, Timm; Schaffitzel, Christiane; Wiedmann, Brigitte; Bukau, Bernd; Ban, Nenad			A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; TRIGGER FACTOR; IN-VITRO; INITIATION; TRANSLATION; EXCISION; RESIDUE; DOMAIN; AGENTS	Messenger- RNA- directed protein synthesis is accomplished by the ribosome(1-3). In eubacteria, this complex process is initiated by a specialized transfer RNA charged with formylmethionine ( tRNA(fMet))(4-6). The amino- terminal formylated methionine of all bacterial nascent polypeptides blocks the reactive amino group to prevent unfavourable side- reactions and to enhance the efficiency of translation initiation(7,8). The first enzymatic factor that processes nascent chains is peptide deformylase ( PDF)(5,9-11); it removes this formyl group as polypeptides emerge from the ribosomal tunnel(12,13) and before the newly synthesized proteins can adopt their native fold, which may bury the N terminus. Next, the N-terminal methionine is excised by methionine aminopeptidase(14). Bacterial PDFs are metalloproteases sharing a conserved N- terminal catalytic domain. All Gram- negative bacteria, including Escherichia coli, possess class- 1 PDFs characterized by a carboxy- terminal alpha- helical extension(15). Studies focusing on PDF as a target for antibacterial drugs(14,16) have not revealed the mechanism of its co- translational mode of action despite indications in early work that it co- purifies with ribosomes(17). Here we provide biochemical evidence that E. coli PDF interacts directly with the ribosome via its C- terminal extension. Crystallographic analysis of the complex between the ribosome- interacting helix of PDF and the ribosome at 3.7 angstrom resolution reveals that the enzyme orients its active site towards the ribosomal tunnel exit for efficient co- translational processing of emerging nascent chains. Furthermore, we have found that the interaction of PDF with the ribosome enhances cell viability. These results provide the structural basis for understanding the coupling between protein synthesis and enzymatic processing of nascent chains, and offer insights into the interplay of PDF with the ribosome- associated chaperone trigger factor.	[Bingel-Erlenmeyer, Rouven; Kohler, Rebecca; Antolic, Snjezana; Maier, Timm; Schaffitzel, Christiane; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Kramer, Guenter; Sandikci, Arzu; Bukau, Bernd] Univ Heidelberg, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany; [Wiedmann, Brigitte] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; Novartis	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016; Bingel-Erlenmeyer, Rouven/AAH-3962-2019	Maier, Timm/0000-0002-7459-1363; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				ADAMS JM, 1966, P NATL ACAD SCI USA, V55, P147, DOI 10.1073/pnas.55.1.147; ADAMS JM, 1968, J MOL BIOL, V33, P571, DOI 10.1016/0022-2836(68)90307-0; Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P7166, DOI 10.1021/bi0501176; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; BALL LA, 1973, J MOL BIOL, V79, P531, DOI 10.1016/0022-2836(73)90404-X; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EISENSTADT J, 1966, SCIENCE, V154, P524; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; FRY KT, 1967, J MOL BIOL, V28, P423, DOI 10.1016/S0022-2836(67)80091-3; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Guilloteau JP, 2002, J MOL BIOL, V320, P951, DOI 10.1016/S0022-2836(02)00549-1; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HARVEY RJ, 1973, J BACTERIOL, V114, P309, DOI 10.1128/JB.114.1.309-322.1973; HOUSMAN D, 1972, J MOL BIOL, V65, P163, DOI 10.1016/0022-2836(72)90498-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Liljas A, 2006, ACS CHEM BIOL, V1, P567, DOI 10.1021/cb600407u; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; Meinnel T, 1996, FEBS LETT, V385, P91, DOI 10.1016/0014-5793(96)00357-2; Moore PB, 2005, TRENDS BIOCHEM SCI, V30, P281, DOI 10.1016/j.tibs.2005.04.006; PINE MJ, 1969, BIOCHIM BIOPHYS ACTA, V174, P359, DOI 10.1016/0005-2787(69)90261-5; Ragusa S, 1998, J MOL BIOL, V280, P515, DOI 10.1006/jmbi.1998.1883; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; TAKEDA M, 1968, P NATL ACAD SCI USA, V60, P1487, DOI 10.1073/pnas.60.4.1487; Vetro JA, 2002, J CELL BIOCHEM, V85, P678, DOI 10.1002/jcb.10161; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z	37	78	81	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					108	U13		10.1038/nature06683	http://dx.doi.org/10.1038/nature06683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288106				2022-12-28	WOS:000253671900056
J	Edwards, SL; Brough, R; Lord, CJ; Natrajan, R; Vatcheva, R; Levine, DA; Boyd, J; Reis, JS; Ashworth, A				Edwards, Stacey L.; Brough, Rachel; Lord, Christopher J.; Natrajan, Rachael; Vatcheva, Radost; Levine, Douglas A.; Boyd, Jeff; Reis-Filho, Jorge S.; Ashworth, Alan			Resistance to therapy caused by intragenic deletion in BRCA2	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; ADP-RIBOSE POLYMERASE; GENOMIC STABILITY; IMPROVED SURVIVAL; MUTANT-CELLS; CANCER; MUTATIONS; PROTEIN; BREAKS; DEFECT	Cells with loss of BRCA2 function are defective in homologous recombination ( HR) and are highly sensitive to inhibitors of poly( ADP- ribose) polymerase ( PARP)(1,2), which provides the basis for a new therapeutic approach. Here we show that resistance to PARP inhibition can be acquired by deletion of a mutation in BRCA2. We derived PARP- inhibitor- resistant ( PIR) clones from the human CAPAN1 pancreatic cancer cell line, which carries the protein- truncating c.6174delT frameshift mutation. PIR clones could form DNA- damage- induced RAD51 nuclear foci and were able to limit genotoxin- induced genomic instability, both hallmarks of a competent HR pathway. New BRCA2 isoforms were expressed in the resistant lines as a result of intragenic deletion of the c.6174delT mutation and restoration of the open reading frame ( ORF). Reconstitution of BRCA2- deficient cells with these revertant BRCA2 alleles rescued PARP inhibitor sensitivity and HR deficiency. Most of the deletions in BRCA2 were associated with small tracts of homology, and possibly arose from error-prone repair caused by BRCA2 deficiency(3,4). Similar ORF-restoring mutations were present in carboplatin- resistant ovarian tumours from c.6174delT mutation carriers. These observations have implications for understanding drug resistance in BRCA mutation carriers as well as in defining functionally important domains within BRCA2.	[Edwards, Stacey L.; Brough, Rachel; Lord, Christopher J.; Natrajan, Rachael; Vatcheva, Radost; Reis-Filho, Jorge S.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Boyd, Jeff] Mem Hlth Univ Med Ctr, Anderson Canc Inst, Savannah, GA 31404 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	alan.ashworth@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Edwards, Stacey/A-4980-2011; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515; Levine, Douglas/0000-0003-1038-8232; Boyd, Jeff/0000-0002-3517-7637; Natrajan, Rachael/0000-0002-9987-2946; Edwards, Stacey/0000-0001-7428-4139	Cancer Research UK [A8363] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Abaji C, 2005, CANCER RES, V65, P4117, DOI 10.1158/0008-5472.CAN-04-3071; Bertwistle D, 1997, CANCER RES, V57, P5485; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Goggins M, 1996, CANCER RES, V56, P5360; Gudmundsdottir K, 2004, EMBO REP, V5, P989, DOI 10.1038/sj.embor.7400255; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Pal T, 2007, FAM CANCER, V6, P113, DOI 10.1007/s10689-006-9112-x; POCH G, 1995, J PHARMACOL TOXICOL, V33, P137, DOI 10.1016/1056-8719(94)00068-F; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Reis JS, 2005, J PATHOL, V207, P1, DOI 10.1002/path.1806; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	30	744	767	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1111	U8		10.1038/nature06548	http://dx.doi.org/10.1038/nature06548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18264088				2022-12-28	WOS:000253453600043
J	Kumar, PR; Yu, Y; Sternglanz, R; Johnston, SA; Joshua-Tor, L				Kumar, P. Rajesh; Yu, Yao; Sternglanz, Rolf; Johnston, Stephen Albert; Joshua-Tor, Leemor			NADP regulates the yeast GAL induction system	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-BINDING; ACTIVATION; REGULON; PROTEIN	Transcriptional regulation of the galactose- metabolizing genes in Saccharomyces cerevisiae depends on three core proteins: Gal4p, the transcriptional activator that binds to upstream activating DNA sequences (UAS(GAL)); Gal80p, a repressor that binds to the carboxyl terminus of Gal4p and inhibits transcription; and Gal3p, a cytoplasmic transducer that, upon binding galactose and adenosine 5 '-triphosphate, relieves Gal80p repression. The current model of induction relies on Gal3p sequestering Gal80p in the cytoplasm. However, the rapid induction of this system implies that there is a missing factor. Our structure of Gal80p in complex with a peptide from the carboxyl- terminal activation domain of Gal4p reveals the existence of a dinucleotide that mediates the interaction between the two. Biochemical and in vivo experiments suggests that nicotinamide adenine dinucleotide phosphate ( NADP) plays a key role in the initial induction event.	[Kumar, P. Rajesh; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yu, Yao; Sternglanz, Rolf] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Johnston, Stephen Albert] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Sch Life Sci, Tempe, AZ 85287 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu		Joshua-Tor, Leemor/0000-0001-8185-8049; Yu, Yao/0000-0003-0090-8193; Kumar, P. Rajesh/0000-0002-0576-6967	NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641, R01GM074075] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA045508] Funding Source: Medline; NIGMS NIH HHS [GM074075, R01 GM074075, GM55641, R01 GM074075-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; EINARSON MB, 2001, MOL CLONING LAB MANU; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Han Y, 2000, J BIOL CHEM, V275, P14979, DOI 10.1074/jbc.275.20.14979; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	12	42	44	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1090	1092		10.1126/science.1151903	http://dx.doi.org/10.1126/science.1151903			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292341	Green Accepted			2022-12-28	WOS:000253311700043
J	Li, JZ; Absher, DM; Tang, H; Southwick, AM; Casto, AM; Ramachandran, S; Cann, HM; Barsh, GS; Feldman, M; Cavalli-Sforza, LL; Myers, RM				Li, Jun Z.; Absher, Devin M.; Tang, Hua; Southwick, Audrey M.; Casto, Amanda M.; Ramachandran, Sohini; Cann, Howard M.; Barsh, Gregory S.; Feldman, Marcus; Cavalli-Sforza, Luigi L.; Myers, Richard M.			Worldwide human relationships inferred from genome-wide patterns of variation	SCIENCE			English	Article							ALLELE FREQUENCY-SPECTRUM; HUMAN-POPULATIONS; EVOLUTIONARY TREES; GENETIC DIVERSITY; DISTANCE; AFRICA	Human genetic diversity is shaped by both demographic and biological factors and has fundamental implications for understanding the genetic basis of diseases. We studied 938 unrelated individuals from 51 populations of the Human Genome Diversity Panel at 650,000 common single- nucleotide polymorphism loci. Individual ancestry and population substructure were detectable with very high resolution. The relationship between haplotype heterozygosity and geography was consistent with the hypothesis of a serial founder effect with a single origin in sub- Saharan Africa. In addition, we observed a pattern of ancestral allele frequency distributions that reflects variation in population dynamics among geographic regions. This data set allows the most comprehensive characterization to date of human genetic variation.	[Ramachandran, Sohini; Feldman, Marcus] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Li, Jun Z.; Absher, Devin M.; Tang, Hua; Southwick, Audrey M.; Casto, Amanda M.; Barsh, Gregory S.; Cavalli-Sforza, Luigi L.; Myers, Richard M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Absher, Devin M.; Southwick, Audrey M.; Myers, Richard M.] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Stanford, CA 94305 USA; [Barsh, Gregory S.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Cann, Howard M.] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France	Stanford University; Stanford University; Stanford University; Stanford University; Foundation Jean Dausset-CEPH	Feldman, M (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marc@charles.stanford.edu; cavalli@stanford.edu; myers@shgc.stanford.edu		Casto, Amanda/0000-0001-8332-8578; Li, Jun/0000-0001-6727-0812	NIGMS NIH HHS [GM28016, GM073059] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016, R01GM073059] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KIMURA M, 1973, GENETICS, V75, P199; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramachandran Sohini, 2004, Human Genomics, V1, P87; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir B.S., 1996, GENETIC DATA ANAL; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	29	1353	1393	2	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1100	1104		10.1126/science.1153717	http://dx.doi.org/10.1126/science.1153717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292342				2022-12-28	WOS:000253311700046
J	Arany, Z; Foo, SY; Ma, YH; Ruas, JL; Bommi-Reddy, A; Girnun, G; Cooper, M; Laznik, D; Chinsomboon, J; Rangwala, SM; Baek, KH; Rosenzweig, A; Spiegelman, BM				Arany, Zoltan; Foo, Shi-Yin; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Rangwala, Shamina M.; Baek, Kwan Hyuck; Rosenzweig, Anthony; Spiegelman, Bruce M.			HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 alpha	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CONTROLLING MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; GENE-EXPRESSION; ERR-ALPHA; PGC-1; METABOLISM; FIBERS; DRIVES; CELLS	Ischaemia of the heart, brain and limbs is a leading cause of morbidity and mortality worldwide. Hypoxia stimulates the secretion of vascular endothelial growth factor ( VEGF) and other angiogenic factors, leading to neovascularization and protection against ischaemic injury(1). Here we show that the transcriptional coactivator PGC-1 alpha ( peroxisome- proliferator- activated receptor-gamma coactivator-1 alpha), a potent metabolic sensor and regulator(2), is induced by a lack of nutrients and oxygen, and PGC-1 alpha powerfully regulates VEGF expression and angiogenesis in cultured muscle cells and skeletal muscle in vivo. PGC-1 alpha(-/-) mice show a striking failure to reconstitute blood flow in a normal manner to the limb after an ischaemic insult, whereas transgenic expression of PGC-1 alpha in skeletal muscle is protective. Surprisingly, the induction of VEGF by PGC-1 alpha does not involve the canonical hypoxia response pathway and hypoxia inducible factor ( HIF). Instead, PGC-1 alpha coactivates the orphan nuclear receptor ERR-alpha ( oestrogen- related receptor- alpha) on conserved binding sites found in the promoter and in a cluster within the first intron of the VEGF gene. Thus, PGC-1 alpha and ERR-alpha, major regulators of mitochondrial function in response to exercise and other stimuli, also control a novel angiogenic pathway that delivers needed oxygen and substrates. PGC-1 alpha may provide a novel therapeutic target for treating ischaemic diseases.	[Arany, Zoltan; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Arany, Zoltan; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Arany, Zoltan; Foo, Shi-Yin; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Arany, Zoltan; Foo, Shi-Yin; Rosenzweig, Anthony] Harvard Stem Cell Inst, Boston, MA 02215 USA; [Rangwala, Shamina M.] Novartis Inst Biomed Res Diabet & Metab, Cambridge, MA 02139 USA; [Baek, Kwan Hyuck] Harvard Univ, Sch Med, Vasc Biol Program, Dept Surg,Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Arany, Z (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	zarany1@partners.org; bruce_spiegelman@dfci.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019; MA, YAN/HHN-2912-2022; Ruas, Jorge/AAE-6094-2019	Ruas, Jorge/0000-0002-1110-2606	NIDDK NIH HHS [P30 DK040561, R01 DK054477, P30 DK040561-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK054477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Pajusola K, 2005, FASEB J, V19, P1365, DOI 10.1096/fj.05-3720fje; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	23	786	833	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1008	U8		10.1038/nature06613	http://dx.doi.org/10.1038/nature06613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288196	Bronze			2022-12-28	WOS:000253313100052
J	Holmstrom, M; Ekenback, A; Selsis, F; Penz, T; Lammer, H; Wurz, P				Holmstroem, M.; Ekenbaeck, A.; Selsis, F.; Penz, T.; Lammer, H.; Wurz, P.			Energetic neutral atoms as the explanation for the high-velocity hydrogen around HD 209458b	NATURE			English	Article							EXTRASOLAR PLANETS; UPPER-ATMOSPHERE; HD209458B; AERONOMY; MARS	Absorption in the stellar Lyman-alpha (Ly alpha) line observed during the transit of the extrasolar planet HD 209458b in front of its host star reveals high-velocity atomic hydrogen at great distances from the planet(1,2). This has been interpreted as hydrogen atoms escaping from the planet's exosphere(1,3), possibly undergoing hydrodynamic blow-off(4), and being accelerated by stellar radiation pressure. Energetic neutral atoms around Solar System planets have been observed to form from charge exchange between solar wind protons and neutral hydrogen from the planetary exospheres(5-7), however, and this process also should occur around extrasolar planets. Here we show that the measured transit-associated Ly alpha absorption can be explained by the interaction between the exosphere of HD 209458b and the stellar wind, and that radiation pressure alone cannot explain the observations. As the stellar wind protons are the source of the observed energetic neutral atoms, this provides a way of probing stellar wind conditions, and our model suggests a slow and hot stellar wind near HD 209458b at the time of the observations.	[Holmstroem, M.; Ekenbaeck, A.] Swedish Inst Space Phys, SE-98128 Kiruna, Sweden; [Selsis, F.] Univ Bordeaux 1, Astrophys Lab, CNRS, F-33270 Floirac, France; [Selsis, F.] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Ctr Rech Astrophys Lyon, F-69007 Lyon, France; [Penz, T.] INAF Osserv Astron Palermo, I-90134 Palermo, Italy; [Lammer, H.] Austrian Acad Sci, Inst Space Res, A-8042 Graz, Austria; [Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Istituto Nazionale Astrofisica (INAF); Austrian Academy of Sciences; University of Bern	Holmstrom, M (corresponding author), Swedish Inst Space Phys, POB 812, SE-98128 Kiruna, Sweden.	matsh@irf.se	Wurz, Peter/R-2273-2017	Wurz, Peter/0000-0002-2603-1169; Selsis, Franck/0000-0001-9619-5356				BARTH CA, 1968, J ATMOS SCI, V25, P564, DOI 10.1175/1520-0469(1968)025<0564:IOTMLA>2.0.CO;2; BARTH CA, 1969, SCIENCE, V165, P1004, DOI 10.1126/science.165.3897.1004; Ben-Jaffel L, 2007, ASTROPHYS J LETT, V671, pL61, DOI 10.1086/524706; Collier MR, 2001, J GEOPHYS RES-SPACE, V106, P24893, DOI 10.1029/2000JA000382; Futaana Y, 2006, ICARUS, V182, P413, DOI 10.1016/j.icarus.2005.08.024; Galli A, 2008, PLANET SPACE SCI, V56, P807, DOI 10.1016/j.pss.2007.12.011; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; Lichtenegger HIM, 2006, SPACE SCI REV, V126, P469, DOI 10.1007/s11214-006-9082-1; Munoz AG, 2007, PLANET SPACE SCI, V55, P1426, DOI 10.1016/j.pss.2007.03.007; Penz T, 2008, ASTRON ASTROPHYS, V477, P309, DOI 10.1051/0004-6361:20078364; Preusse S, 2007, PLANET SPACE SCI, V55, P589, DOI 10.1016/j.pss.2006.04.037; Preusse S, 2005, ASTRON ASTROPHYS, V434, P1191, DOI 10.1051/0004-6361:20041680; Schneider J, 1998, ASTR SOC P, V134, P241; Vidal-Madjar A, 2004, ASTR SOC P, V321, P152; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Yelle RV, 2006, ICARUS, V183, P508, DOI 10.1016/j.icarus.2006.05.001; Yelle RV, 2004, ICARUS, V170, P167, DOI 10.1016/j.icarus.2004.02.008	18	123	125	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					970	972		10.1038/nature06600	http://dx.doi.org/10.1038/nature06600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288189	Green Submitted			2022-12-28	WOS:000253313100043
J	Larsson, SC; Wolk, A				Larsson, Susanna C.; Wolk, Alicja			Excess body fatness: an important cause of most cancers	LANCET			English	Editorial Material							OBESITY; RISK		[Larsson, Susanna C.; Wolk, Alicja] Karolinska Inst, Div Nutr Epidemiol, Natl Inst Environm Med, SE-17177 Stockholm, Sweden	Karolinska Institutet	Larsson, SC (corresponding author), Karolinska Inst, Div Nutr Epidemiol, Natl Inst Environm Med, SE-17177 Stockholm, Sweden.	Susanna.Larsson@ki.se	Larsson, Susanna C./F-6065-2015	Larsson, Susanna C./0000-0003-0118-0341				Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Larsson SC, 2006, CONTEMP DIAB, P15; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	6	20	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					536	537		10.1016/S0140-6736(08)60247-0	http://dx.doi.org/10.1016/S0140-6736(08)60247-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280312				2022-12-28	WOS:000253202600006
J	Behnke, E; Collar, JI; Cooper, PS; Crum, K; Crisler, M; Hu, M; Levine, I; Nakazawa, D; Nguyen, H; Odom, B; Ramberg, E; Rasmussen, J; Riley, N; Sonnenschein, A; Szydagis, M; Tschirhart, R				Behnke, E.; Collar, J. I.; Cooper, P. S.; Crum, K.; Crisler, M.; Hu, M.; Levine, I.; Nakazawa, D.; Nguyen, H.; Odom, B.; Ramberg, E.; Rasmussen, J.; Riley, N.; Sonnenschein, A.; Szydagis, M.; Tschirhart, R.			Spin-dependent WIMP limits from a bubble chamber	SCIENCE			English	Article							DARK-MATTER SEARCH; NUCLEUS SCATTERING; LIQUIDS	Bubble chambers were the dominant technology used for particle detection in accelerator experiments for several decades, eventually falling into disuse with the advent of other techniques. We report here on a new application for these devices. We operated an ultraclean, room- temperature bubble chamber containing 1.5 kilograms of superheated CF3I, a target maximally sensitive to spin- dependent and - independent weakly interacting massive particle ( WIMP) couplings. An extreme intrinsic insensitivity to the backgrounds that commonly limit direct searches for dark matter was measured in this device under operating conditions leading to the detection of low- energy nuclear recoils like those expected from WIMPs. Improved limits on the spin- dependent WIMP- proton scattering cross section were extracted during our experiments, excluding this type of coupling as a possible explanation for a recent claim of particle dark- matter detection.	[Collar, J. I.; Crum, K.; Nakazawa, D.; Odom, B.; Rasmussen, J.; Riley, N.; Szydagis, M.] Univ Chicago, Enrico Fermi Inst, Dept Phys, Chicago, IL 60637 USA; [Behnke, E.; Levine, I.] Indiana Univ, Dept Phys & Astron, South Bend, IN 46634 USA; [Collar, J. I.; Crum, K.; Nakazawa, D.; Odom, B.; Rasmussen, J.; Riley, N.; Szydagis, M.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Cooper, P. S.; Crisler, M.; Hu, M.; Nguyen, H.; Ramberg, E.; Sonnenschein, A.; Tschirhart, R.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA	University of Chicago; Indiana University System; Indiana University South Bend; University of Chicago; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Collar, JI (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Phys, Chicago, IL 60637 USA.	collar@uchicago.edu		Odom, Brian/0000-0002-3992-8864; Szydagis, Matthew/0000-0002-9334-4659; Riley, Nathan/0000-0002-9412-1297				Barnabe-Heider M, 2005, PHYS LETT B, V624, P186, DOI 10.1016/j.physletb.2005.08.021; BELL CR, 1974, NUCL SCI ENG, V53, P458, DOI 10.13182/NSE74-A23376; Bernabei R, 2003, RIV NUOVO CIMENTO, V26, P1; Bertone G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.151301; BLANDER M, 1975, AICHE J, V21, P833, DOI 10.1002/aic.690210502; Bolte WJ, 2007, NUCL INSTRUM METH A, V577, P569, DOI 10.1016/j.nima.2007.04.149; Collar JI, 1996, PHYS REV D, V54, pR1247, DOI 10.1103/PhysRevD.54.R1247; Collar JI, 2000, NEW J PHYS, V2, P151, DOI 10.1088/1367-2630/2/1/14; Collar JI, 2000, PHYS REV LETT, V85, P3083, DOI 10.1103/PhysRevLett.85.3083; DRUKIER AK, 1986, PHYS REV D, V33, P3495, DOI 10.1103/PhysRevD.33.3495; ELLIS J, 1991, PHYS LETT B, V263, P259, DOI 10.1016/0370-2693(91)90597-J; Giuliani F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.161301; GLASER DA, 1994, NUCL PHYS B, P3, DOI 10.1016/0920-5632(94)90762-5; Gondolo P, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.123520; JAMES F, 1972, P 1972 CERN COMP DAT; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Lewin JD, 1996, ASTROPART PHYS, V6, P87, DOI 10.1016/S0927-6505(96)00047-3; Ressell MT, 1997, PHYS REV C, V56, P535, DOI 10.1103/PhysRevC.56.535; RUBBIA C, 1994, NUCL PHYS B, pR17; Savage C, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.123513; SEITZ F, 1958, PHYS FLUIDS, V1, P2, DOI 10.1063/1.1724333; Tovey DR, 2000, PHYS LETT B, V488, P17, DOI 10.1016/S0370-2693(00)00846-7	23	131	131	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					933	936		10.1126/science.1149999	http://dx.doi.org/10.1126/science.1149999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276885	Green Submitted			2022-12-28	WOS:000253165700040
J	Corbin, BD; Seeley, EH; Raab, A; Feldmann, J; Miller, MR; Torres, VJ; Anderson, KL; Dattilo, BM; Dunman, PM; Gerads, R; Caprioli, RM; Nacken, W; Chazin, WJ; Skaar, EP				Corbin, Brian D.; Seeley, Erin H.; Raab, Andrea; Feldmann, Joerg; Miller, Michael R.; Torres, Victor J.; Anderson, Kelsi L.; Dattilo, Brian M.; Dunman, Paul M.; Gerads, Russell; Caprioli, Richard M.; Nacken, Wolfgang; Chazin, Walter J.; Skaar, Eric P.			Metal chelation and inhibition of bacterial growth in tissue abscesses	SCIENCE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; PROTEINS 8; CALPROTECTIN; EXPRESSION	Bacterial infection often results in the formation of tissue abscesses, which represent the primary site of interaction between invading bacteria and the innate immune system. We identify the host protein calprotectin as a neutrophil- dependent factor expressed inside Staphylococcus aureus abscesses. Neutrophil- derived calprotectin inhibited S. aureus growth through chelation of nutrient Mn2+ and Zn2+: an activity that results in reprogramming of the bacterial transcriptome. The abscesses of mice lacking calprotectin were enriched in metal, and staphylococcal proliferation was enhanced in these metal- rich abscesses. These results demonstrate that calprotectin is a critical factor in the innate immune response to infection and define metal chelation as a strategy for inhibiting microbial growth inside abscessed tissue.	[Corbin, Brian D.; Torres, Victor J.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Seeley, Erin H.; Miller, Michael R.; Dattilo, Brian M.; Caprioli, Richard M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Seeley, Erin H.; Miller, Michael R.; Dattilo, Brian M.; Caprioli, Richard M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA; [Miller, Michael R.; Dattilo, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Ctr Struct Biol, Nashville, TN 37232 USA; [Anderson, Kelsi L.; Dunman, Paul M.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Nacken, Wolfgang] Univ Munster, Inst Expt Dermatol, D-48149 Munster, Germany; [Raab, Andrea; Feldmann, Joerg] Univ Aberdeen, Coll Phys Sci, Aberdeen AB24 3UE, Scotland; [Gerads, Russell] Appl Speciat & Consulting, Tukwila, WA 98188 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Nebraska System; University of Nebraska Medical Center; University of Munster; University of Aberdeen	Skaar, EP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA.	eric.skaar@vanderbilt.edu	Feldmann, Jörg/AAT-3703-2020; Feldmann, Jorg/B-8079-2011; Johnson, Michael D. L./B-4352-2012	Torres, Victor/0000-0002-7126-0489; Feldmann, Joerg/0000-0002-0524-8254; Miller, Michael/0000-0002-7726-0519; Seeley, Erin/0000-0002-8000-5754	NCI NIH HHS [P50 CA068485] Funding Source: Medline; NHLBI NIH HHS [T32 HL069765] Funding Source: Medline; NIAID NIH HHS [F32 AI071487] Funding Source: Medline; NIGMS NIH HHS [T32 GM008320, 5R01 GM58008-09, T32 GM08320, R01 GM62112] Funding Source: Medline; Engineering and Physical Sciences Research Council [GR/S98689/01, GR/S98696/01] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R01GM062112, T32GM008320] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Benedyk M, 2007, J INVEST DERMATOL, V127, P2001, DOI 10.1038/sj.jid.5700820; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Yui S, 2003, BIOL PHARM BULL, V26, P753	11	628	655	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					962	965		10.1126/science.1152449	http://dx.doi.org/10.1126/science.1152449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276893				2022-12-28	WOS:000253165700049
J	Karpicke, JD; Roediger, HL				Karpicke, Jeffrey D.; Roediger, Henry L., III			The critical importance of retrieval for learning	SCIENCE			English	Article							LONG-TERM RETENTION; MODEL; TIME	Learning is often considered complete when a student can produce the correct answer to a question. In our research, students in one condition learned foreign language vocabulary words in the standard paradigm of repeated study- test trials. In three other conditions, once a student had correctly produced the vocabulary item, it was repeatedly studied but dropped from further testing, repeatedly tested but dropped from further study, or dropped from both study and test. Repeated studying after learning had no effect on delayed recall, but repeated testing produced a large positive effect. In addition, students' predictions of their performance were uncorrelated with actual performance. The results demonstrate the critical role of retrieval practice in consolidating learning and show that even university students seem unaware of this fact.	[Karpicke, Jeffrey D.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Roediger, Henry L., III] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL)	Karpicke, JD (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	karpicke@purdue.edu						BATTIG WF, 1965, PSYCHONOMIC MONOGR S, V1, P1; Bjork R.A., 1975, INFORM PROCESSING CO, P123; CARRIER M, 1992, MEM COGNITION, V20, P633, DOI 10.3758/BF03202713; Dunlosky J., 2002, APPL METACOGNITION, P68, DOI DOI 10.1017/CBO9780511489976.005; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; FRANK S, 1996, EVERYTHING STUDY BOO; Gates A. I., 1917, ARCH PSYCHOL, V40, P1; IZAWA C, 1971, J MATH PSYCHOL, V8, P200, DOI 10.1016/0022-2496(71)90012-5; KARPICKE JD, 2007, THESIS WASHINGTON U; Karpicke JD, 2007, J MEM LANG, V57, P151, DOI 10.1016/j.jml.2006.09.004; Kornell N, 2007, PSYCHON B REV, V14, P219, DOI 10.3758/BF03194055; McGeoch JA., 1942, PSYCHOL HUMAN LEARNI; Metcalfe J, 2003, J EXP PSYCHOL GEN, V132, P530, DOI 10.1037/0096-3445.132.4.530; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; SLAMECKA NJ, 1983, J EXP PSYCHOL LEARN, V9, P384, DOI 10.1037/0278-7393.9.3.384; Thiede KW, 1999, J EXP PSYCHOL LEARN, V25, P1024, DOI 10.1037/0278-7393.25.4.1024; TULVING E, 1967, J VERB LEARN VERB BE, V6, P175, DOI 10.1016/S0022-5371(67)80092-6; UNDERWOOD BJ, 1964, J VERB LEARN VERB BE, V3, P112, DOI 10.1016/S0022-5371(64)80028-1	19	971	992	13	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					966	968		10.1126/science.1152408	http://dx.doi.org/10.1126/science.1152408			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	262RM	18276894	Green Published			2022-12-28	WOS:000253165700050
J	Meade, MO; Cook, DJ; Guyatt, GH; Slutsky, AS; Arabi, YM; Cooper, DJ; Davies, AR; Hand, LE; Zhou, Q; Thabane, L; Austin, P; Lapinsky, S; Baxter, A; Russell, J; Skrobik, Y; Ronco, JJ; Stewart, TE				Meade, Maureen O.; Cook, Deborah J.; Guyatt, Gordon H.; Slutsky, Arthur S.; Arabi, Yaseen M.; Cooper, D. James; Davies, Andrew R.; Hand, Lori E.; Zhou, Qi; Thabane, Lehana; Austin, Peggy; Lapinsky, Stephen; Baxter, Alan; Russell, James; Skrobik, Yoanna; Ronco, Juan J.; Stewart, Thomas E.		Lung Open Ventilation Study	Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; OUTCOMES; DISEASE	Context Low- tidal- volume ventilation reduces mortality in critically ill patients with acute lung injury and acute respiratory distress syndrome. Instituting additional strategies to open collapsed lung tissue may further reduce mortality. Objective To compare an established low- tidal- volume ventilation strategy with an experimental strategy based on the original "open-lung approach," combining low tidal volume, lung recruitment maneuvers, and high positive- end - expiratory pressure. Design and Setting Randomized controlled trial with concealed allocation and blinded data analysis conducted between August 2000 and March 2006 in 30 intensive care units in Canada, Australia, and Saudi Arabia. Patients Nine hundred eighty- three consecutive patients with acute lung injury and a ratio of arterial oxygen tension to inspired oxygen fraction not exceeding 250. Interventions The control strategy included target tidal volumes of 6 mL/kg of predicted body weight, plateau airway pressures not exceeding 30 cm H2O, and conventional levels of positive end- expiratory pressure ( n= 508). The experimental strategy included target tidal volumes of 6 mL/kg of predicted body weight, plateau pressures not exceeding 40 cm H2O, recruitment maneuvers, and higher positive end- expiratory pressures ( n= 475). Main Outcome Measure All- cause hospital mortality. Results Eighty- five percent of the 983 study patients met criteria for acute respiratory distress syndrome at enrollment. Tidal volumes remained similar in the 2 groups, and mean positive end- expiratory pressures were 14.6 ( SD, 3.4) cm H2O in the experimental group vs 9.8 ( SD, 2.7) cm H2O among controls during the first 72 hours ( P <. 001). All- cause hospital mortality rates were 36.4% and 40.4%, respectively ( relative risk [ RR], 0.90; 95% confidence interval [ CI], 0.77- 1.05; P=. 19). Barotrauma rates were 11.2% and 9.1%( RR, 1.21; 95% CI, 0.83- 1.75; P=. 33). The experimental group had lower rates of refractory hypoxemia ( 4.6% vs 10.2%; RR, 0.54; 95% CI, 0.34- 0.86; P =.01), death with refractory hypoxemia ( 4.2% vs 8.9%; RR, 0.56; 95% CI, 0.34- 0.93; P =.03), and previously defined eligible use of rescue therapies ( 5.1% vs 9.3%; RR, 0.61; 95% CI, 0.38- 0.99; P =.045). Conclusions For patients with acute lung injury and acute respiratory distress syndrome, a multifaceted protocolized ventilation strategy designed to recruit and open the lung resulted in no significant difference in all- cause hospital mortality or barotrauma compared with an established low- tidal- volume protocolized ventilation strategy. This "open-lung" strategy did appear to improve secondary end points related to hypoxemia and use of rescue therapies. Trial Registration clinicaltrials. gov Identifier: NCT00182195.	[Meade, Maureen O.; Cook, Deborah J.; Guyatt, Gordon H.; Hand, Lori E.; Zhou, Qi; Thabane, Lehana; Austin, Peggy] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Meade, Maureen O.; Cook, Deborah J.; Guyatt, Gordon H.; Hand, Lori E.; Zhou, Qi; Thabane, Lehana; Austin, Peggy] McMaster Univ, Dept Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Slutsky, Arthur S.; Lapinsky, Stephen; Stewart, Thomas E.] Univ Toronto, Toronto, ON, Canada; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ, Riyadh, Saudi Arabia; [Cooper, D. James; Davies, Andrew R.] Monash Univ, Melbourne, Vic 3004, Australia; [Baxter, Alan] Univ Ottawa, Ottawa, ON, Canada; [Russell, James; Ronco, Juan J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Skrobik, Yoanna] Univ Montreal, Montreal, PQ, Canada	McMaster University; McMaster University; University of Toronto; King Saud Bin Abdulaziz University for Health Sciences; Monash University; University of Ottawa; University of British Columbia; Universite de Montreal	Meade, MO (corresponding author), McMaster Univ, Dept Med, 1200 Main St W,Room 210C, Hamilton, ON L8N 3Z5, Canada.	meadema@hhsc.ca	Skrobik, Yoanna/K-8165-2014; Slutsky, Arthur/M-3325-2019; Cooper, D. James/G-7961-2013; Skrobik, Yoanna/J-6393-2013; Zhou, Qi/GSM-9583-2022; Arabi, Yaseen/ABF-3316-2020; Lapinsky, Stephen/C-4624-2015; Martin, Claudio/G-3327-2011	Skrobik, Yoanna/0000-0002-5315-6020; Cooper, D. James/0000-0002-5872-9051; Arabi, Yaseen/0000-0001-5735-6241; Lapinsky, Stephen/0000-0002-6930-0306; 				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Ely EW, 2001, CHEST, V120, p454S, DOI 10.1378/chest.120.6_suppl.454S; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MERCAT A, 2006, INTENS CARE MED, V32, pS97; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Tobin MJ, 2001, NEW ENGL J MED, V344, P1986, DOI 10.1056/NEJM200106283442606; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01	22	901	975	2	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					637	645		10.1001/jama.299.6.637	http://dx.doi.org/10.1001/jama.299.6.637			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270352	Bronze			2022-12-28	WOS:000253095200021
J	Arnott, D; Joossens, L; Bianco, E; Assunta, M; Ogwell, A				Arnott, Deborah; Joossens, Luk; Bianco, Eduardo; Assunta, Mary; Ogwell, Ahmed			Smuggling treaty could reduce tobacco toll	LANCET			English	Editorial Material									[Arnott, Deborah] Act Smoking & Hlth, London E1 6JE, England; [Joossens, Luk; Bianco, Eduardo; Assunta, Mary; Ogwell, Ahmed] Framework Convent Alliance, Geneva, Switzerland		Arnott, D (corresponding author), Act Smoking & Hlth, London E1 6JE, England.	deborah.arnott@ash.org.uk						BEELMAN MS, 2001, TOBACCO CO LINKED CR; *BRIT AM TOB, 2007, BRIT AM TOB VIEWS FC; Clarke K., 2000, GUARDIAN 0203 GUARDIAN 0203; *FRAM CONV ALL, 2007, FCA EX SUMM COMM TEM; Framework Convention Alliance, 2007, BIG WAS ILL TOB TRAD; *HM REV CUST, 2006, ANN REP 2005 6 AUT P; Joossens L, 2000, BRIT MED J, V321, P947, DOI 10.1136/bmj.321.7266.947; Lee K, 2006, PLOS MED, V3, P1080, DOI 10.1371/journal.pmed.0030228; LEIGH D, 2000, GUARDIAN        0131; *TOB FREE IN WHO, WHY IS TOB PUBL HLTH; US General Accounting Office, 2003, TERR FIN US AG SHOUL; *WHO, 2007, 3 WHO COMM A; *WHO, 2007, TOB FREE IN TOB FACT; World Bank, 1999, CURB EP GOV EC TOB C	14	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2008	371	9611					458	460		10.1016/S0140-6736(08)60217-2	http://dx.doi.org/10.1016/S0140-6736(08)60217-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262028				2022-12-28	WOS:000253169200009
J	Caplan, JL; Mamillapalli, P; Burch-Smith, TM; Czymmek, K; Dinesh-Kumar, SP				Caplan, Jeffrey L.; Mamillapalli, Padmavathi; Burch-Smith, Tessa M.; Czymmek, Kirk; Dinesh-Kumar, S. P.			Chloroplastic protein NRIP1 mediates innate immune receptor recognition of a viral effector	CELL			English	Article							DISEASE-RESISTANCE; HYPERSENSITIVE RESPONSE; VIRULENCE EFFECTOR; PLANT-RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS; GENE; STROMULES; COMPLEX; LOCALIZATION	Plant innate immunity relies on the recognition of pathogen effector molecules by nucleotide-binding-leucine-rich repeat (NB-LRR) immune receptor families. Previously we have shown the N immune receptor, a member of TIR-NB-LRR family, indirectly recognizes the 50 kDa helicase (p50) domain of Tobacco mosaic virus (TMV) through its TIR domain. We have identified an N receptor-interacting protein, NRIP1, that directly interacts with both N's TIR domain and p50. NRIP1 is a functional rhodanese sulfur-transferase and is required for N to provide complete resistance to TMV. Interestingly, NRIP1 that normally localizes to the chloroplasts is recruited to the cytoplasm and nucleus by the p50 effector. As a consequence, NRIP1 interacts with N only in the presence of the p50 effector. Our findings show that a chloroplastic protein is intimately involved in pathogen recognition. We propose that N's activation requires a prerecognition complex containing the p50 effector and NRIP1.	[Caplan, Jeffrey L.; Mamillapalli, Padmavathi; Burch-Smith, Tessa M.; Dinesh-Kumar, S. P.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Czymmek, Kirk] Univ Delaware, Dept Biol Sci, Delaware Biotechnol Inst, Newark, DE 19711 USA	Yale University; University of Delaware	Dinesh-Kumar, SP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	savithramma.dinesh-kumar@yale.edu	Rechsteiner, Cindy/I-4137-2013; Dinesh-Kumar, Savithramma/E-1153-2011	Czymmek, Kirk/0000-0002-5471-7395; Burch-Smith, Tessa/0000-0002-5994-4343; Caplan, Jeffrey/0000-0002-3991-0912	NIGMS NIH HHS [GM62625, R01 GM062625, R01 GM062625-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062625] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbink TEM, 2002, VIROLOGY, V295, P307, DOI 10.1006/viro.2002.1332; Abbink TEM, 2001, MOL PLANT MICROBE IN, V14, P1086, DOI 10.1094/MPMI.2001.14.9.1086; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Holzinger A, 2007, PROTOPLASMA, V230, P23, DOI 10.1007/s00709-006-0222-y; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ishibashi K, 2007, P NATL ACAD SCI USA, V104, P13833, DOI 10.1073/pnas.0703203104; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Lehto K, 2003, MOL PLANT MICROBE IN, V16, P1135, DOI 10.1094/MPMI.2003.16.12.1135; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MILLERMARTINI DM, 1994, J BIOL CHEM, V269, P12414; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Natesan SKA, 2005, J EXP BOT, V56, P787, DOI 10.1093/jxb/eri088; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shapiro AD, 2005, VITAM HORM, V72, P339, DOI 10.1016/S0083-6729(05)72010-0; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang SH, 2003, PLANT CELL PHYSIOL, V44, P1037, DOI 10.1093/pcp/pcg122; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	43	270	286	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					449	462		10.1016/j.cell.2007.12.031	http://dx.doi.org/10.1016/j.cell.2007.12.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267075	Green Accepted, Bronze			2022-12-28	WOS:000253180700019
J	Schmidt, J; Brilliantov, N; Spahn, F; Kempf, S				Schmidt, Juergen; Brilliantov, Nikolai; Spahn, Frank; Kempf, Sascha			Slow dust in Enceladus' plume from condensation and wall collisions in tiger stripe fractures	NATURE			English	Article							SATURNS E-RING; WATER; ORIGIN	One of the spectacular discoveries of the Cassini spacecraft was the plume of water vapour and icy particles ( dust) originating near the south pole of Saturn's moon Enceladus(1-5). The data imply considerably smaller velocities for the grains(2,5,6) than for the vapour(4,7), which has been difficult to understand. The gas and dust are too dilute in the plume to interact, so the difference must arise below the surface. Here we report a model for grain condensation and growth in channels of variable width. We show that repeated wall collisions of grains, with re- acceleration by the gas, induce an effective friction, offering a natural explanation for the reduced grain velocity. We derive particle speed and size distributions that reproduce the observed and inferred properties of the dust plume. The gas seems to form near the triple point of water; gas densities corresponding to sublimation from ice at temperatures less than 260K are generally too low to support the measured particle fluxes(2). This in turn suggests liquid water below Enceladus' south pole.	[Schmidt, Juergen; Brilliantov, Nikolai; Spahn, Frank] Univ Potsdam, Neuen Palais 10, D-14469 Potsdam, Germany; [Brilliantov, Nikolai] Univ Leicester, Dept Math, Leicester LE1 7RH, Leics, England; [Brilliantov, Nikolai] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119991, Russia; [Kempf, Sascha] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Kempf, Sascha] Tech Univ Carolo Wilhelmina Braunschweig, IGEP, D-38106 Braunschweig, Germany	University of Potsdam; University of Leicester; Lomonosov Moscow State University; Max Planck Society; Braunschweig University of Technology	Schmidt, J (corresponding author), Univ Potsdam, Neuen Palais 10, D-14469 Potsdam, Germany.	jschmidt@agnld.uni-potsdam.de	Brilliantov, Nikolay V./A-7423-2014; Spahn, Frank/AAP-6234-2020	Brilliantov, Nikolay V./0000-0002-7107-0693; KEMPF, SASCHA/0000-0001-5236-3004				Batista ER, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.223201; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Collins GC, 2007, ICARUS, V189, P72, DOI 10.1016/j.icarus.2007.01.010; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Gioia G, 2007, P NATL ACAD SCI USA, V104, P13578, DOI 10.1073/pnas.0706018104; HAFF PK, 1983, ICARUS, V56, P426, DOI 10.1016/0019-1035(83)90164-1; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; Hurford TA, 2007, NATURE, V447, P292, DOI 10.1038/nature05821; INGERSOLL AP, 2006, B AM ASTRON SOC, V38, P508; JUHASZ A, 2002, J GEOPHYS RES, V107, P1, DOI DOI 10.1029/2001JA000182; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KEMPF S, IN PRESS ICARUS; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Matson DL, 2007, ICARUS, V187, P569, DOI 10.1016/j.icarus.2006.10.016; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; PANG KD, 1984, J GEOPHYS RES, V89, P9459, DOI 10.1029/JB089iB11p09459; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Shaw RA, 1999, J CHEM PHYS, V111, P10659, DOI 10.1063/1.480419; SHOWALTER MR, 1991, ICARUS, V94, P451, DOI 10.1016/0019-1035(91)90241-K; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; VIISANEN Y, 1993, J CHEM PHYS, V99, P4680, DOI 10.1063/1.466066; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	28	126	127	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					685	688		10.1038/nature06491	http://dx.doi.org/10.1038/nature06491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256665				2022-12-28	WOS:000252929500034
J	Thomson, WM; Poulton, R; Broadbent, JM; Moffitt, TE; Caspi, A; Beck, JD; Welch, D; Hancox, RJ				Thomson, W. Murray; Poulton, Richie; Broadbent, Jonathan M.; Moffitt, Terrie E.; Caspi, Avshalom; Beck, James D.; Welch, David; Hancox, Robert J.			Cannabis smoking and periodontal disease among young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-REPORTED SMOKING; CIGARETTE-SMOKING; NEW-ZEALAND; VALIDITY; INDEX	Context Tobacco smoking is a recognized behavioral risk factor for periodontal disease ( through its systemic effects), and cannabis smoking may contribute in a similar way. Objective To determine whether cannabis smoking is a risk factor for periodontal disease. Design and Setting Prospective cohort study of the general population, with cannabis use determined at ages 18, 21, 26, and 32 years and dental examinations conducted at ages 26 and 32 years. The most recent data collection ( at age 32 years) was completed in June 2005. Participants A complete birth cohort born in 1972 and 1973 in Dunedin, New Zealand, and assessed periodically ( with a 96% follow- up rate of the 1015 participants who survived to age 32 years). Complete data for this analysis were available from 903 participants ( comprising 89.0% of the surviving birth cohort). Main Outcome Measure Periodontal disease status at age 32 years ( and changes from ages 26 to 32 years) determined from periodontal combined attachment loss ( CAL) measured at 3 sites per tooth. Results Three cannabis exposure groups were determined: no exposure ( 293 individuals, or 32.3%), some exposure ( 428; 47.4%), and high exposure ( 182; 20.2%). At age 32 years, 265 participants ( 29.3%) had 1 or more sites with 4 mm or greater CAL, and 111 participants ( 12.3%) had 1 or more sites with 5 mm or greater CAL. Incident attachment loss between the ages of 26 and 32 years in the none, some, and high cannabis exposure groups was 6.5%, 11.2%, and 23.6%, respectively. After controlling for tobacco smoking ( measured in pack- years), sex, irregular use of dental services, and dental plaque, the relative risk estimates for the highest cannabis exposure group were as follows: 1.6 ( 95% confidence interval [ CI], 1.2- 2.2) for having 1 or more sites with 4 mm or greater CAL; 3.1 ( 95% CI, 1.5- 6.4) for having 1 or more sites with 5 mm or greater CAL; and 2.2 ( 95% CI, 1.2- 3.9) for having incident attachment loss ( in comparison with those who had never smoked cannabis). Tobacco smoking was strongly associated with periodontal disease experience, but there was no interaction between cannabis use and tobacco smoking in predicting the condition's occurrence. Conclusion Cannabis smoking may be a risk factor for periodontal disease that is independent of the use of tobacco.	[Thomson, W. Murray; Broadbent, Jonathan M.] Sir John Walsh Res Inst, Sch Dent, Dept Oral Sci, Dunedin, New Zealand; [Poulton, Richie; Welch, David; Hancox, Robert J.] Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Moffitt, Terrie E.; Caspi, Avshalom] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Beck, James D.] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA	University of Otago; University of London; King's College London; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Thomson, WM (corresponding author), Sir John Walsh Res Inst, Sch Dent, Dept Oral Sci, POB 647, Dunedin, New Zealand.	murray.thomson@otago.ac.nz	Hancox, Robert/G-4746-2011; Thomson, William Murray/A-4971-2008; Thomson, William Murray/AAC-8575-2019; Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011; caspi, avshalom/AAJ-5874-2020; Broadbent, Jonathan M/R-9976-2019	Thomson, William Murray/0000-0003-0588-6843; Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Broadbent, Jonathan M/0000-0002-8905-398X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045070, R29MH049414, R01MH077874, R01MH049414] Funding Source: NIH RePORTER; MRC [G0601483, G0100527] Funding Source: UKRI; Medical Research Council [G0100527, G0601483] Funding Source: Medline; NIDCR NIH HHS [R01 DE-015260, R01 DE015260-02, R01 DE015260-01A1, R01 DE015260, R01 DE015260-04, R01 DE015260-03] Funding Source: Medline; NIMH NIH HHS [R01 MH045070, R01 MH077874, MH077874, MH45070, R01 MH049414, MH49414] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Dolcini MM, 2003, NICOTINE TOB RES, V5, P473, DOI 10.1080/1462220031000118586; Fendrich M, 2005, ADDICT BEHAV, V30, P175, DOI 10.1016/j.addbeh.2004.04.009; Gelskey SC, 1999, COMMUNITY DENT ORAL, V27, P16, DOI 10.1111/j.1600-0528.1999.tb01987.x; Gilthorpe MS, 2003, J DENT RES, V82, P200, DOI 10.1177/154405910308200310; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Hujoel PP, 2003, COMMUNITY DENT ORAL, V31, P1, DOI 10.1034/j.1600-0528.2003.00061.x; IRVING JC, 1977, NEW ZEAL J EDUC STUD, V12, P154; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Johnson N, 2001, J Dent Educ, V65, P328; Kinane DF, 2000, CRIT REV ORAL BIOL M, V11, P356, DOI 10.1177/10454411000110030501; Mak YW, 2005, ADDICT BEHAV, V30, P841, DOI 10.1016/j.addbeh.2004.08.008; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PHIPPS KR, 1995, J PUBLIC HEALTH DENT, V55, P250, DOI 10.1111/j.1752-7325.1995.tb02377.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Silva P., 1996, CHILD ADULT DUNEDIN; Susin C, 2005, J PERIODONTOL, V76, P262, DOI 10.1902/jop.2005.76.2.262; Taylor DR, 2003, INTERN MED J, V33, P310, DOI 10.1046/j.1445-5994.2003.00401.x; Thomson WM, 2006, J PERIODONTOL, V77, P947, DOI 10.1902/jop.2006.050319; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Yoshie H, 2007, PERIODONTOL 2000, V43, P102, DOI 10.1111/j.1600-0757.2006.00164.x	22	82	85	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					525	531		10.1001/jama.299.5.525	http://dx.doi.org/10.1001/jama.299.5.525			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252882	Green Accepted, Green Submitted			2022-12-28	WOS:000252886100017
J	Claxton, K; Lindsay, AB; Buxton, MJ; Culyer, AJ; McCabe, C; Walker, S; Sculpher, MJ				Claxton, Karl; Lindsay, Andrew Briggs; Buxton, Martin J.; Culyer, Anthony J.; McCabe, Christopher; Walker, Simon; Sculpher, Mark J.			Value based pricing for NHS drugs: an opportunity not to be missed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Claxton, Karl; Walker, Simon; Sculpher, Mark J.] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Claxton, Karl; Culyer, Anthony J.] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Lindsay, Andrew Briggs] Univ Glasgow, Glasgow, Lanark, Scotland; [Buxton, Martin J.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Culyer, Anthony J.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [McCabe, Christopher] Univ Leeds, Inst Hlth Sci, Leeds, W Yorkshire, England	University of York - UK; University of York - UK; University of Glasgow; Brunel University; University of Toronto; University of Leeds	Sculpher, MJ (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	mjs23@york.ac.uk	McCabe, Christopher/E-2051-2016	Walker, Simon Mark/0000-0002-5750-3691; Sculpher, Mark/0000-0003-3746-9913	Medical Research Council [MC_U145079308] Funding Source: Medline; MRC [MC_U145079308] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, PHARM PRIC REG SCHEM; Claxton KP, 2006, PHARMACOECONOMICS, V24, P1055, DOI 10.2165/00019053-200624110-00003; Collier J, 2008, BRIT MED J, V336, P56, DOI 10.1136/bmj.39454.496748.80; Collier J, 2007, BRIT MED J, V334, P435, DOI 10.1136/bmj.39136.464421.BE; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; *DEP BUS ENT REG R, 2007, INT GOV RESP OFF FAI; MARTIN S, 2007, 24 U YORK CTR HLTH E; *NIH CLIN EXC, 2008, HC27I STAT OFF NIH C; *NIH CLIN EXC, 2007, CLIN PUBL HLTH DIR P	9	129	133	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					251	254		10.1136/bmj.39434.500185.25	http://dx.doi.org/10.1136/bmj.39434.500185.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18244997	Green Published, Green Submitted			2022-12-28	WOS:000253102900036
J	Ligi, I; Arnaud, F; Jouve, E; Tardieu, S; Sambuc, R; Simeoni, U				Ligi, Isabelle; Arnaud, Frederique; Jouve, Elisabeth; Tardieu, Sophie; Sambuc, Roland; Simeoni, Umberto			Iatrogenic events in admitted neonates: a prospective cohort study	LANCET			English	Article							INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; MEDICATION ERRORS; HOSPITALIZED-PATIENTS; QUALITY IMPROVEMENT; SYSTEM	Background Iatrogenic events are increasingly recognised as an important problem in all people admitted to hospital. However, few epidemiological data are available for iatrogenic events in neonatal high-risk units. We aimed to assess the incidence, nature, preventability, and severity of iatrogenic events in a neonatal Centre and to establish the association of patient characteristics with the occurrence of iatrogenic events in neonates. Methods We undertook an observational, prospective study from Jan 1, 2005, to Sept 1, 2005, including all neonates admitted in the Division of Neonatology of an academic, tertiary neonatal centre in southern France. Iatrogenic events were defined as any event that compromised the safety margin for the patient, in the presence or absence of harm. The report of an iatrogenic event was voluntary, anonymous, and non-punitive. The primary outcome was the rate of iatrogenic events per 1000 patient days. Findings A total of 388 patients were studied during 10436 patient days. We recorded 267 iatrogenic events in 116 patients. The incidence of iatrogenic events was 25.6 per 1000 patient days. 92 (34%) were preventable and 78 (29%) were severe. Two iatrogenic events (1%) were fatal, but neither was preventable. The most severe iatrogenic events were nosocomial infections (49/62 [79%]) and respiratory events (nine of 26 [35%]). Cutaneous injuries were frequent (n=94) but generally minor (89 [95%]), as were medication errors (15/19 [76%]). Most medication errors occurred during administration stage (12/19 [63%]) and were ten-fold errors (nine of 19 [47%]). The major risk factors were low birthweight and gestational age (both p<0.0001), length of stay (p<0.0001), a central venous line (p<0. 0001), mechanical ventilation (p=0. 0021), and support with continuous positive airwary pressure (p=0. 0076). Interpretation Iatrogenic events occur frequently and are often serious in neonates, especially in infants of low birthweight. Improved knowledge of the incidence and characteristics of iatrogenic events, and continuous monitoring could help to improve quality of health care for this vulnerable population.	[Ligi, Isabelle; Arnaud, Frederique; Simeoni, Umberto] La Concept Hosp, AP HM, Div Neonatol, F-13385 Marseille, France; [Jouve, Elisabeth; Tardieu, Sophie; Sambuc, Roland] Univ Mediterranee, Med Evaluat Dept, Dept Publ Hlth, Fac Med,Assistance Publ Hop Marseille,EA 3279, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Simeoni, U (corresponding author), La Concept Hosp, AP HM, Div Neonatol, 147 Blvd Baille, F-13385 Marseille, France.	umberto.simeoni@ap-hm.fr	Jouve, Elisabeth/GSN-9120-2022; Simeoni, Umberto/GRO-6971-2022; SIMEONI, Umberto/AAQ-1870-2021	Jouve, Elisabeth/0000-0002-4873-6522; Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337				Ahluwalia J, 2005, SEMIN FETAL NEONAT M, V10, P31, DOI 10.1016/j.siny.2004.09.012; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Beckmann U, 2003, CRIT CARE MED, V31, P1006, DOI 10.1097/01.CCM.0000060016.21525.3C; Beckmann U, 1996, ANAESTH INTENS CARE, V24, P314, DOI 10.1177/0310057X9602400303; Branch WT, 2005, J GEN INTERN MED, V20, P1063, DOI 10.1111/j.1525-1497.2005.00231.x; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Capuzzo M, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-3; Chappell K, 2004, ARCH DIS CHILD-FETAL, V89, pF483, DOI 10.1136/adc.2003.041608; Fox PE, 1998, EARLY HUM DEV, V51, P171, DOI 10.1016/S0378-3782(97)00112-6; Frey B, 2000, INTENS CARE MED, V26, P69, DOI 10.1007/s001340050014; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HARTWIG SC, 1991, AM J HOSP PHARM, V48, P2611, DOI 10.1093/ajhp/48.12.2611; *INT NEON NETW, 1993, CRIB CLIN RISK IND B, V342, P193; Kanter David E, 2004, Pediatr Crit Care Med, V5, P119; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Michel P, 2004, BMJ-BRIT MED J, V328, P1; RAJU TNK, 1989, LANCET, V2, P374; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Sadowski R, 2004, PEDIATRICS, V114, P628, DOI 10.1542/peds.2003-0735-L; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Simpson JH, 2004, ARCH DIS CHILD-FETAL, V89, pF480, DOI 10.1136/adc.2003.044438; Thomas EJ, 2000, INT J QUAL HEALTH C, V12, P371, DOI 10.1093/intqhc/12.5.371; Veldman A, 2006, PEDIATR ANESTH, V16, P968, DOI 10.1111/j.1460-9592.2006.01902.x; Woods D, 2005, PEDIATRICS, V115, P155, DOI 10.1542/peds.2004-0410	28	69	76	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					404	410		10.1016/S0140-6736(08)60204-4	http://dx.doi.org/10.1016/S0140-6736(08)60204-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242414				2022-12-28	WOS:000252992700030
J	Sharp, D				Sharp, David			Hugging the kilogram	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							FILDES J, 2007, GETTING MEASURE KILO; *NAT MEAS I AUSTR, 2007, RED KIL AV CONST; Robinson A., 2007, STORY MEASUREMENT; Robinson IA, 2007, METROLOGIA, V44, P427, DOI 10.1088/0026-1394/44/6/001; *WOODL TRUST, ANC TREE HUNT	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					371	372		10.1016/S0140-6736(08)60184-1	http://dx.doi.org/10.1016/S0140-6736(08)60184-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242402				2022-12-28	WOS:000252992700011
J	Peer, D; Park, EJ; Morishita, Y; Carman, CV; Shimaoka, M				Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Carman, Christopher V.; Shimaoka, Motomu			Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target	SCIENCE			English	Article							SMALL INTERFERING RNAS; GENE	Cyclin D1 ( CyD1) is a pivotal cell cycle - regulatory molecule and a well- studied therapeutic target for cancer. Although CyD1 is also strongly up- regulated at sites of inflammation, its exact roles in this context remain uncharacterized. To address this question, we developed a strategy for selectively silencing CyD1 in leukocytes in vivo. Targeted stabilized nanoparticles ( tsNPs) were loaded with CyD1 - small interfering RNA ( siRNA). Antibodies to beta(7) integrin ( beta(7) I) were then used to target specific leukocyte subsets involved in gut inflammation. Systemic application of beta(7) I-tsNPs silenced CyD1 in leukocytes and reversed experimentally induced colitis in mice by suppressing leukocyte proliferation and T helper cell 1 cytokine expression. This study reveals CyD1 to be a potential anti- inflammatory target, and suggests that the application of similar modes of targeting by siRNA may be feasible in other therapeutic settings.	[Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Shimaoka, Motomu] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Shimaoka, Motomu] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Carman, Christopher V.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Carman, Christopher V.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shimaoka, M (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	shimaoka@cbrinstitute.org	Park, Eun Jeong/AAV-2056-2020; Carman, Christopher V./AAX-8995-2020; Peer, Dan/A-1785-2011; Carman, Christopher/L-8108-2016	Park, Eun Jeong/0000-0002-4288-5893; Carman, Christopher V./0000-0001-7358-2548; Peer, Dan/0000-0001-8238-0673; Carman, Christopher/0000-0001-7358-2548	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063421] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL048675, P01 HL048675-150013, HL048675] Funding Source: Medline; NIAID NIH HHS [R01 AI063421, R01 AI063421-04, AI63421] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREW DP, 1994, J IMMUNOL, V153, P3847; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Dass CR, 2004, J MOL MED, V82, P579, DOI 10.1007/s00109-004-0558-8; Dykxhoorn DM, 2006, ANNU REV BIOMED ENG, V8, P377, DOI 10.1146/annurev.bioeng.8.061505.095848; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Lindsay JO, 2004, DIGEST DIS SCI, V49, P1327, DOI 10.1023/B:DDAS.0000037830.22065.71; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Peer D, 2003, BBA-BIOMEMBRANES, V1612, P76, DOI 10.1016/S0005-2736(03)00106-8; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; van Dekken H, 2007, ACTA HISTOCHEM, V109, P266, DOI 10.1016/j.acthis.2007.02.007; Yang RY, 2006, CELL CYCLE, V5, P180, DOI 10.4161/cc.5.2.2306	21	415	466	7	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					627	630		10.1126/science.1149859	http://dx.doi.org/10.1126/science.1149859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239128	Green Accepted			2022-12-28	WOS:000252772000043
J	Reddy, P; Liu, L; Adhikari, D; Jagarlamudi, K; Rajareddy, S; Shen, Y; Du, C; Tang, WL; Hamalainen, T; Peng, SL; Lan, ZJ; Cooney, AJ; Huhtaniemi, I; Liu, K				Reddy, Pradeep; Liu, Lian; Adhikari, Deepak; Jagarlamudi, Krishna; Rajareddy, Singareddy; Shen, Yan; Du, Chun; Tang, Wenli; Hamalainen, Tuula; Peng, Stanford L.; Lan, Zi-Jian; Cooney, Austin J.; Huhtaniemi, Ilpo; Liu, Kui			Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool	SCIENCE			English	Article							PATHWAY; GROWTH	In the mammalian ovary, progressive activation of primordial follicles from the dormant pool serves as the source of fertilizable ova. Menopause, or the end of female reproductive life, occurs when the primordial follicle pool is exhausted. However, the molecular mechanisms underlying follicle activation are poorly understood. We provide genetic evidence that in mice lacking PTEN ( phosphatase and tensin homolog deleted on chromosome 10) in oocytes, a major negative regulator of phosphatidylinositol 3- kinase ( PI3K), the entire primordial follicle pool becomes activated. Subsequently, all primordial follicles become depleted in early adulthood, causing premature ovarian failure ( POF). Our results show that the mammalian oocyte serves as the headquarters of programming of follicle activation and that the oocyte PTEN- PI3K pathway governs follicle activation through control of initiation of oocyte growth.	[Reddy, Pradeep; Liu, Lian; Adhikari, Deepak; Jagarlamudi, Krishna; Rajareddy, Singareddy; Shen, Yan; Du, Chun; Tang, Wenli; Liu, Kui] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Liu, Lian] Shandong Univ, Qilu Hosp, Ctr Canc, Dept Chemotherapy, Jinan 250012, Peoples R China; [Hamalainen, Tuula; Huhtaniemi, Ilpo] Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland; [Peng, Stanford L.] Roche Palo Alto, Clin Res & Exploratory Dev, Palo Alto, CA 94304 USA; [Lan, Zi-Jian] Univ Louisville, Hlth Sci Ctr, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40202 USA; [Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Reprod Biol, London W12 0NN, England	Umea University; Shandong University; University of Turku; Roche Holding; University of Louisville; Baylor College of Medicine; Imperial College London	Liu, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	kui.liu@medchem.umu.se	Lan, Zi-Jian/F-2747-2012; Adhikari, Deepak/H-6176-2013; Reddy, Pradeep/G-1770-2014; Peng, Stanford/S-6723-2019; SINGAREDDY, RAJAREDDY/C-8771-2011	Adhikari, Deepak/0000-0003-0656-9858; Reddy, Pradeep/0000-0002-9173-3845; Lan, Zi-Jian/0000-0002-5904-6834; Liu, Lian/0000-0001-5868-4482; Liu, Kui/0000-0002-7519-3332; Peng, Stanford/0000-0001-7445-2542; Adhikari, Deepak/0000-0002-3404-8753				Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Erickson GF, 2001, J SOC GYNECOL INVEST, V8, pS13, DOI 10.1016/S1071-5576(00)00098-8; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Wassarman Paul M., 1994, P79	10	533	583	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					611	613		10.1126/science.1152257	http://dx.doi.org/10.1126/science.1152257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239123				2022-12-28	WOS:000252772000038
J	Ammon, CJ; Kanamori, H; Lay, T				Ammon, Charles J.; Kanamori, Hiroo; Lay, Thorne			A great earthquake doublet and seismic stress transfer cycle in the central Kuril islands	NATURE			English	Article							COUPLED SUBDUCTION ZONES; OUTER RISE EARTHQUAKES; SOLOMON-ISLANDS; MANTLE; TRENCH; PLATE; MODEL	Temporal variations of the frictional resistance on subduction-zone plate boundary faults associated with the stick - slip cycle of large interplate earthquakes are thought to modulate the stress regime and earthquake activity within the subducting oceanic plate(1-3). Here we report on two great earthquakes that occurred near the Kuril islands, which shed light on this process and demonstrate the enhanced seismic hazard accompanying triggered faulting. On 15 November 2006, an event of moment magnitude 8.3 ruptured the shallow- dipping plate boundary along which the Pacific plate descends beneath the central Kuril arc. The thrust ruptured a seismic gap that previously had uncertain seismogenic potential(4,5), although the earlier occurrence of outer- rise compressional events had suggested the presence of frictional resistance(1,2). Within minutes of this large underthrusting event, intraplate extensional earthquakes commenced in the outer rise region seaward of the Kuril trench, and on 13 January 2007, an event of moment magnitude 8.1 ruptured a normal fault extending through the upper portion of the Pacific plate, producing one of the largest recorded shallow extensional earthquakes. This energetic earthquake sequence demonstrates the stress transfer process within the subducting lithosphere, and the distinct rupture characteristics of these great earthquakes illuminate differences in seismogenic properties and seismic hazard of such interplate and intraplate faults.	[Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Ammon, Charles J.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Kanamori, Hiroo] CALTECH, Seismol Lab, Pasadena, CA 91125 USA	University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; California Institute of Technology	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	thorne@pmc.ucsc.edu	Lay, Thorne/ABE-6272-2021					ABE K, 1972, PHYS EARTH PLANET IN, V5, P190, DOI DOI 10.1016/0031-9201(72)90091-X; Ammon CJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026303; Ammon CJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028005; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; CHRISTENSEN DH, 1988, J GEOPHYS RES-SOLID, V93, P13421, DOI 10.1029/JB093iB11p13421; DMOWSKA R, 1988, J GEOPHYS RES-SOLID, V93, P7869, DOI 10.1029/JB093iB07p07869; Gibowicz S. J., 2005, ACTA GEOPHYS, V53, P239; HARTZELL SH, 1983, B SEISMOL SOC AM, V73, P1153; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; Kagan YY, 1999, B SEISMOL SOC AM, V89, P1147; Kanamori H., 1971, PHYS EARTH PLANET IN, V4, P289, DOI [DOI 10.1016/0031-9201(71)90013-6, 10.1016/0031-9201(71)90013-6]; LAY T, 1982, EARTHQUAKE PRED RES, V1, P3; LAY T, 1989, PHYS EARTH PLANET IN, V54, P258, DOI 10.1016/0031-9201(89)90247-1; LAY T, 1980, PHYS EARTH PLANET IN, V21, P283, DOI 10.1016/0031-9201(80)90134-X; Lin J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002607; LIU XP, 1993, PURE APPL GEOPHYS, V140, P211, DOI 10.1007/BF00879406; LYNNES CS, 1988, J GEOPHYS RES-SOLID, V93, P13407, DOI 10.1029/JB093iB11p13407; MCCANN WR, 1979, PURE APPL GEOPHYS, V117, P1082, DOI 10.1007/BF00876211; MELOSH HJ, 1976, J GEOPHYS RES, V81, P5621, DOI 10.1029/JB081i032p05621; Nomanbhoy N, 1996, J GEOPHYS RES-SOL EA, V101, P5707, DOI 10.1029/95JB02884; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; Ranero CR, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000997; Ranero CR, 2004, GEOLOGY, V32, P549, DOI 10.1130/G20379.1; Ranero CR, 2003, NATURE, V425, P367, DOI 10.1038/nature01961; Song TRA, 2003, SCIENCE, V301, P630, DOI 10.1126/science.1085557; Taylor MAJ, 1996, J GEOPHYS RES-SOL EA, V101, P8363, DOI 10.1029/95JB03561; Velasco AA, 2000, J GEOPHYS RES-SOL EA, V105, P28065, DOI 10.1029/2000JB900282; Venkataraman A., 2004, J GEOPHYS RES, V109; Wells RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002072; XU ZY, 1993, PURE APPL GEOPHYS, V140, P365, DOI 10.1007/BF00879412	30	135	139	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					561	U4		10.1038/nature06521	http://dx.doi.org/10.1038/nature06521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235499				2022-12-28	WOS:000252739900039
J	Miller, EJ; Li, J; Leng, L; McDonald, C; Atsumi, T; Bucala, R; Young, LH				Miller, Edward J.; Li, Ji; Leng, Lin; McDonald, Courtney; Atsumi, Toshiya; Bucala, Richard; Young, Lawrence H.			Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart	NATURE			English	Article							FACTOR MIF GENE; GLUCOSE-UPTAKE; CARDIAC DYSFUNCTION; DISEASE SEVERITY; REGULATORY ROLE; CYTOKINE; INJURY; TRANSLOCATION; POLYMORPHISM; BINDING	Understanding cellular response to environmental stress has broad implications for human disease. AMP- activated protein kinase ( AMPK) orchestrates the regulation of energy- generating and - consuming pathways, and protects the heart against ischaemic injury and apoptosis(1). A role for circulating hormones such as adiponectin(2) and leptin(3) in the activation of AMPK has received recent attention. Whether local autocrine and paracrine factors within target organs such as the heart modulate AMPK is unknown. Here we show that macrophage migration inhibitory factor ( MIF), an upstream regulator of inflammation(4), is released in the ischaemic heart, where it stimulates AMPK activation through CD74, promotes glucose uptake and protects the heart during ischaemia- reperfusion injury. Germline deletion of the Mif gene impairs ischaemic AMPK signalling in the mouse heart. Human fibroblasts with a low- activity MIF promoter polymorphism(5) have diminished MIF release and AMPK activation during hypoxia. Thus, MIF modulates the activation of the cardioprotective AMPK pathway during ischaemia, functionally linking inflammation and metabolism in the heart. We anticipate that genetic variation in MIF expression may impact on the response of the human heart to ischaemia by the AMPK pathway, and that diagnostic MIF genotyping might predict risk in patients with coronary artery disease.	[Miller, Edward J.; Li, Ji; Young, Lawrence H.] Yale Univ, Sch Med, Dept Internal Med, Cardiovasc Med Sect, New Haven, CT 06520 USA; [Leng, Lin; McDonald, Courtney; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Bucala, Richard] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Young, Lawrence H.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Atsumi, Toshiya] Hokkaido Univ, Dept Med 2, Sapporo, Hokkaido 0608638, Japan	Yale University; Yale University; Yale University; Yale University; Hokkaido University	Young, LH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Cardiovasc Med Sect, 333 Cedar St, New Haven, CT 06520 USA.	lawrence.young@yale.edu		Leng, Lin/0000-0002-0605-358X; Miller, Edward/0000-0002-2156-5962				Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; Zhong XB, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni123	32	342	354	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					578	U9		10.1038/nature06504	http://dx.doi.org/10.1038/nature06504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235500				2022-12-28	WOS:000252739900043
J	Wachs, TD				Wachs, Theodore D.			Mechanisms linking parental education and stunting	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; MATERNAL DEPRESSION; NUTRITIONAL-STATUS; DEVELOPING-WORLD; DECISION-MAKING; CHILD HEALTH; RISK-FACTORS; COMMUNITY; HOUSEHOLD; MOTHERS		Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wachs, TD (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	wachs@psych.purdue.edu	Ebot, Jane/B-6983-2012					Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Becker S, 2006, SOC SCI MED, V62, P2313, DOI 10.1016/j.socscimed.2005.10.006; Boyle MH, 2006, SOC SCI MED, V63, P2242, DOI 10.1016/j.socscimed.2006.04.034; EVANS G, 1997, ADV ENV BEHAV DESIGN, P255; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Kusago T, 2001, WORLD DEV, V29, P1237, DOI 10.1016/S0305-750X(01)00031-6; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Pfeiffer J, 2001, SOC SCI MED, V53, P83, DOI 10.1016/S0277-9536(00)00311-7; Pongou R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-98; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Wachs TD, 1996, INTELLIGENCE, V22, P129, DOI 10.1016/S0160-2896(96)90013-6; WACHS TD, IN PRESS PHYSL BEHAV; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2	17	21	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2008	371	9609					280	281		10.1016/S0140-6736(08)60144-0	http://dx.doi.org/10.1016/S0140-6736(08)60144-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254VQ	18294982				2022-12-28	WOS:000252616500006
J	ANDERSON, GC				ANDERSON, GC			UNITED-STATES POLITICS - HIGH-COST OF DEMOCRACY	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					9	9		10.1038/344009a0	http://dx.doi.org/10.1038/344009a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ972	18277999	Bronze			2022-12-28	WOS:A1990CQ97200023
J	Wilt, TJ; MacDonald, R; Rutks, I; Shamilyan, TA; Taylor, BC; Kane, RL				Wilt, Timothy J.; MacDonald, Roderick; Rutks, Indulis; Shamilyan, Tatyana A.; Taylor, Brent C.; Kane, Robert L.			Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Review							INTENSITY FOCUSED ULTRASOUND; LAPAROSCOPIC RADICAL PROSTATECTOMY; RANDOMIZED CONTROLLED-TRIAL; NEOADJUVANT ANDROGEN ABLATION; MODULATED RADIATION-THERAPY; RADIOTHERAPY 70 GY; CRYOSURGICAL ABLATION; FOLLOW-UP; PERCUTANEOUS CRYOABLATION; DOSE RADIOTHERAPY	Background: The comparative effectiveness of localized prostate cancer treatments is largely unknown. Purpose: To compare the effectiveness and harms of treatments for localized prostate cancer. Data Sources: MEDLINE (through September 2007), the Cochrane Library (through Issue 3, 2007), and the Cochrane Review Group in Prostate Diseases and Urologic Malignancies registry (through November 2007). Study Selection: Randomized, controlled trials (RCTs) published in any language and observational studies published in English that evaluated treatments and reported clinical or biochemical outcomes in localized prostate cancer. Data Extraction: 2 researchers extracted information on study design, sample characteristics, interventions, and outcomes. Data Synthesis: 18 RCTs and 473 observational studies met inclusion criteria. One RCT enrolled mostly men without prostate-specific antigen (PSA)-detected disease and reported that, compared with watchful waiting, radical prostatectomy reduced all-cause mortality (24% vs. 30%; P = 0.04) and prostate cancer-specific mortality (5% vs. 10%; P = 0.01) at 10 years (P = 0.04). Effectiveness was limited to men younger than age 65 years but was not associated with Gleason score or baseline PSA level. An older, smaller trial found no significant overall survival differences between radical prostatectomy and watchful waiting (risk difference, 0% [95% Cl, -19% to 18%]). Radical prostatectomy reduced disease recurrence at 5 years compared with external-beam radiation therapy in 1 small, older trial (14% vs. 39%; risk difference, 21%; P = 0.04). No external-beam radiation regimen was superior to another in reducing mortality. No randomized trials evaluated primary androgen deprivation. Androgen deprivation used adjuvant to radical prostatectomy did not improve biochemical progression compared with radical prostatectomy alone (risk difference, 0% [Cl, -7% to 7%]). No randomized trial evaluated brachy-therapy, cryotherapy, robotic radical prostatectomy, or photon-beam or intensity-modulated radiation therapy. Observational studies showed wide and overlapping effectiveness estimates within and between treatments. Adverse event definitions and severity varied widely. The Prostate Cancer Outcomes Study reported that urinary leakage (>= 1 event/d) was more common with radical pros-tatectomy (35%) than with radiation therapy (12%) or androgen deprivation 0 1 %). Bowel urgency occurred more often with radiation (3%) or androgen deprivation (3%) than with radical prostatectomy (1 %). Erectile dysfunction occurred frequently after all treatments (radical prostatectomy, 58%; radiation therapy, 43%; androgen deprivation, 86%). A higher risk score incorporating histologic grade, PSA level, and tumor stage was associated with increased risk for disease progression or recurrence regardless of treatment. Limitations: Only 3 randomized trials compared effectiveness between primary treatments. No trial enrolled patients with prostate cancer primarily detected with PSA testing. Conclusion: Assessment of the comparative effectiveness and harms of localized prostate cancer treatments is difficult because of limitations in the evidence.	Univ Minnesota, Sch Med, Ctr Chorn Dis Outcomes Res, Vet Affairs Med Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth Hlth Policy & Management, Clin Outcomes Res Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Wilt, TJ (corresponding author), Univ Minnesota, Sch Med, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	tim.wilt@med.va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Shamliyan, Tatyana/0000-0003-3584-2008	PHS HHS [290-02-0009] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Acher PL, 2007, BJU INT, V99, P28, DOI 10.1111/j.1464-410X.2006.06523.x; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Artibani W, 2003, EUR UROL, V44, P401, DOI 10.1016/S0302-2838(03)00315-4; Aus G, 2002, EUR UROL, V42, P133, DOI 10.1016/S0302-2838(02)00261-0; Bahn DK, 2002, UROLOGY, V60, P3, DOI 10.1016/S0090-4295(02)01678-3; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Blana A, 2004, UROLOGY, V63, P297, DOI 10.1016/j.urology.2003.09.020; Blana A, 2006, WORLD J UROL, V24, P585, DOI 10.1007/s00345-006-0107-x; Chaussy Christian, 2003, Curr Urol Rep, V4, P248, DOI 10.1007/s11934-003-0077-0; Cohen JK, 1996, UROLOGY, V47, P395, DOI 10.1016/S0090-4295(99)80459-2; COOGAN CL, 1995, J UROLOGY, V154, P1813, DOI 10.1016/S0022-5347(01)66791-0; COX RL, 1995, UROLOGY, V45, P932; Crook J, 2004, INT J RADIAT ONCOL, V60, P15, DOI 10.1016/j.ijrobp.2004.02.022; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; De Meerleer GO, 2007, RADIOTHER ONCOL, V82, P160, DOI 10.1016/j.radonc.2006.12.007; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donnelly BJ, 2002, UROLOGY, V60, P645, DOI 10.1016/S0090-4295(02)01839-3; Donovan JL, 2003, J CLIN EPIDEMIOL, V56, P605, DOI 10.1016/S0895-4356(03)00083-0; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Ellis DS, 2002, UROLOGY, V60, P34, DOI 10.1016/S0090-4295(02)01682-5; Gelet A, 2001, EUR UROL, V40, P124, DOI 10.1159/000049761; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Guazzoni G, 2006, EUR UROL, V50, P98, DOI 10.1016/j.eururo.2006.02.051; Herstein A, 2005, CANCER J, V11, P385, DOI 10.1097/00130404-200509000-00005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Homma Y, 2004, INT J UROL, V11, P295, DOI 10.1111/j.1442-2042.2004.00795.x; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Klotz LH, 2003, J UROLOGY, V170, P791, DOI 10.1097/01.ju.0000081404.98273.fd; Koppie TM, 1999, J UROLOGY, V162, P427, DOI 10.1016/S0022-5347(05)68576-X; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1463, DOI 10.1016/j.ijrobp.2005.05.054; Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5; LEE F, 1994, RADIOLOGY, V192, P769, DOI 10.1148/radiology.192.3.8058945; Long JP, 1998, J UROLOGY, V159, P477, DOI 10.1016/S0022-5347(01)63953-3; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Nihei K, 2005, JPN J CLIN ONCOL, V35, P745, DOI 10.1093/jjco/hyi193; *NORD COCHR CTR, 2003, REV MAN REVMAN COMP; Patel VR, 2007, BJU INT, V99, P1109, DOI 10.1111/j.1464-410X.2007.06762.x; PAULSON DF, 1982, J UROLOGY, V128, P502, DOI 10.1016/S0022-5347(17)53016-5; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Poissonnier L, 2007, EUR UROL, V51, P381, DOI 10.1016/j.eururo.2006.04.012; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; Rossi CJ, 2004, UROLOGY, V64, P729, DOI 10.1016/j.urology.2004.04.043; Roumeguere T, 2002, WORLD J UROL, V20, P360, DOI 10.1007/s00345-002-0306-z; Salomon L, 2002, EUR UROL, V42, P104, DOI 10.1016/S0302-2838(02)00263-4; Sathya JR, 2005, J CLIN ONCOL, V23, P1192, DOI 10.1200/JCO.2005.06.154; Schulman CC, 2000, EUR UROL, V38, P706, DOI 10.1159/000020366; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shinohara K, 1997, J UROLOGY, V158, P2209; Shinohara K, 1997, J UROLOGY, V158, P2206, DOI 10.1016/S0022-5347(01)68198-9; Shinohara K, 1996, J UROLOGY, V156, P121; Shinohara K, 1996, J UROLOGY, V156, P115, DOI 10.1016/S0022-5347(01)65958-5; Slater JD, 1999, UROLOGY, V53, P978, DOI 10.1016/S0090-4295(99)00014-X; Slater JD, 2004, INT J RADIAT ONCOL, V59, P348, DOI 10.1016/j.ijrobp.2003.10.011; Soloway MS, 2002, J UROLOGY, V167, P112, DOI 10.1016/S0022-5347(05)65393-1; SOSA RE, 1996, J UROL S, V155, pA361; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Tewari A, 2003, BJU INT, V92, P205, DOI 10.1046/j.1464-410X.2003.04311.x; THOMPSON I, 2008, GUIDELINE MANAGEMENT; Thuroff S, 2003, J ENDOUROL, V17, P673, DOI 10.1089/089277903322518699; Tooher R, 2006, J UROLOGY, V175, P2011, DOI 10.1016/S0022-5347(06)00265-5; Touijer K, 2006, EUR UROL, V49, P625, DOI 10.1016/j.eururo.2006.01.018; Uchida T, 2006, BJU INT, V97, P56, DOI 10.1111/j.1464-410X.2006.05864.x; Uchida Toyoaki, 2005, Hinyokika Kiyo, V51, P651; Wake RW, 1996, J UROLOGY, V155, P1663, DOI 10.1016/S0022-5347(01)66158-5; Wallner K, 2005, RADIOTHER ONCOL, V75, P307, DOI 10.1016/j.radonc.2005.03.019; Wallner K, 2003, INT J RADIAT ONCOL, V57, P1297, DOI 10.1016/S0360-3016(03)01448-2; WIEDER J, 1995, J UROLOGY, V154, P435, DOI 10.1016/S0022-5347(01)67069-1; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; WILT TJ, 2008, IN PRESS COMP EFFECT, V13; Wilt TJ, 1997, ONCOLOGY WILLISTON P, V11, P1143; WILT TJ, 2007, ONCOLOGY WILLISTON P, V11, P1139; Wirth MP, 2004, J UROLOGY, V172, P1865, DOI 10.1097/01.ju.0000140159.94703.80; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Yeoh EE, 2006, INT J RADIAT ONCOL, V66, P1072, DOI 10.1016/j.ijrobp.2006.06.005; Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; Zeliadt SB, 2006, CANCER-AM CANCER SOC, V106, P1865, DOI 10.1002/cncr.21822; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	81	421	440	2	82	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					435	448		10.7326/0003-4819-148-6-200803180-00209	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00209			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18252677				2022-12-28	WOS:000254354800004
J	Brust, JCM; Delbanco				Brust, John C. M.; Delbanco			A 74-year-old man with memory loss and neuropathy who enjoys alcoholic beverages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MILD COGNITIVE IMPAIRMENT; MINI-MENTAL-STATE; LEISURE ACTIVITIES; ALZHEIMERS-DISEASE; WINE CONSUMPTION; WORKING-MEMORY; BRAIN-DAMAGE; LEWY BODIES; DEMENTIA; RISK	Adverse effects of alcohol on the peripheral and central nervous system can be direct ( ie, neurotoxicity) or indirect ( eg, nutritional deficiency). Using the case of Mr E, an older, moderate to heavy drinker experiencing memory difficulty, the diagnostic considerations, which include mild cognitive impairment, early Alzheimer dementia, Wernicke-Korsakoff syndrome, and "alcoholic dementia," are discussed. These disorders are not mutually exclusive, and in a patient with either mild cognitive impairment or dementia, the contributory role of alcohol can be difficult to determine. In fact, epidemiological studies suggest that mild to moderate intake of alcohol actually reduces the risk of developing mild cognitive impairment or dementia, including Alzheimer dementia. Appropriate management includes measures to reduce alcohol dependence ( eg, behavioral or pharmacological therapy) and to delay progression of the cognitive impairment ( eg, engaging in healthy behaviors such as cognitive leisure activities).	[Brust, John C. M.] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Dept Neurol, New York, NY 10037 USA	Columbia University	Brust, JCM (corresponding author), Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Dept Neurol, 506 Lenox Ave, New York, NY 10037 USA.	jcb2@columbia.edu						*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; Assini A, 2004, NEUROLOGY, V63, P828, DOI 10.1212/01.WNL.0000137040.64252.ED; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Bendszus M, 2001, AM J NEURORADIOL, V22, P1926; Bogaerts V, 2007, BRAIN, V130, P2277, DOI 10.1093/brain/awm167; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Brust JCM, 2002, NEUROLOGY, V59, P1300, DOI 10.1212/WNL.59.9.1300; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; CADETELEITE A, 1989, ALCOHOL, V6, P303, DOI 10.1016/0741-8329(89)90087-6; Caine D, 1997, J NEUROL NEUROSUR PS, V62, P51, DOI 10.1136/jnnp.62.1.51; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; Davis KM, 2001, J BIOMED SCI, V8, P7, DOI 10.1159/000054008; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Devanand DP, 1997, J AM GERIATR SOC, V45, P321, DOI 10.1111/j.1532-5415.1997.tb00947.x; DIEHL AM, 1989, MED CLIN N AM, V73, P815, DOI 10.1016/S0025-7125(16)30640-X; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; DURAND D, 1989, BRAIN RES, V477, P373, DOI 10.1016/0006-8993(89)91430-3; Fernandez A, 2006, ARCH NEUROL-CHICAGO, V63, P427, DOI 10.1001/archneur.63.3.427; FernandezSola J, 1996, CURR OPIN NEUROL, V9, P400, DOI 10.1097/00019052-199610000-00015; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galanis DJ, 2000, AM J PUBLIC HEALTH, V90, P1254, DOI 10.2105/AJPH.90.8.1254; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gazdzinski S, 2005, DRUG ALCOHOL DEPEN, V78, P263, DOI 10.1016/j.drugalcdep.2004.11.004; HARPER C, 1987, BRIT MED J, V294, P534, DOI 10.1136/bmj.294.6571.534; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; HARPER C, 1995, METAB BRAIN DIS, V10, P17, DOI 10.1007/BF01991779; HARPER C, 1983, J NEUROL NEUROSUR PS, V46, P593, DOI 10.1136/jnnp.46.7.593; HARRINGTON R, 1990, ARCH GEN PSYCHIAT, V47, P465; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ihara H, 2000, J NEUROL NEUROSUR PS, V68, P731, DOI 10.1136/jnnp.68.6.731; JACOBSEN FM, 1987, AM J PSYCHIAT, V144, P248; KARHUNEN PJ, 1994, BRIT MED J, V308, P1663, DOI 10.1136/bmj.308.6945.1663; Katzman R, 1992, PRINCIPLES GERIATRIC; Kohler CG, 2000, NEUROPSY NEUROPSY BE, V13, P67; Koike H, 2003, ANN NEUROL, V54, P19, DOI 10.1002/ana.10550; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; LARSON EB, 1986, ARCH INTERN MED, V146, P1917, DOI 10.1001/archinte.146.10.1917; Launer LJ, 1996, AM J EPIDEMIOL, V143, P219; LEIFER D, 1990, NEUROLOGY, V40, P911, DOI 10.1212/WNL.40.6.911; Lemeshow S, 1998, AM J EPIDEMIOL, V148, P298; Lien D, 1999, J EMERG MED, V17, P841, DOI 10.1016/S0736-4679(99)00093-1; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Lopez OL, 2007, ARCH NEUROL-CHICAGO, V64, P416, DOI 10.1001/archneur.64.3.416; Lundqvist C, 1995, ALCOHOL ALCOHOLISM, V30, P737; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Maruyama M, 2004, ARCH NEUROL-CHICAGO, V61, P716, DOI 10.1001/archneur.61.5.716; MAST H, 2004, STROKE PATHOPHYSIOLO, P679; Missonnier P, 2005, J GERONTOL A-BIOL, V60, P660, DOI 10.1093/gerona/60.5.660; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; Nebes RD, 2000, PSYCHOL MED, V30, P679, DOI 10.1017/S0033291799001968; Noe E, 2004, MOVEMENT DISORD, V19, P60, DOI 10.1002/mds.10633; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PENDERY ML, 1982, SCIENCE, V217, P169, DOI 10.1126/science.7089552; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; PHILLIPS SC, 1989, EXP NEUROL, V104, P68, DOI 10.1016/0014-4886(89)90010-1; PHILLIPS SC, 1987, BRAIN, V110, P301, DOI 10.1093/brain/110.2.301; Price BH, 2000, NEW ENGL J MED, V342, P1126, DOI 10.1056/NEJM200004133421511; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; Rundek T, 2006, NEUROLOGY, V66, P794, DOI 10.1212/01.wnl.0000209497.38834.d7; Seitz HK, 1998, RECENT DEV ALCOHOL, V14, P67, DOI 10.1007/0-306-47148-5_4; SERDARU M, 1988, BRAIN, V111, P829, DOI 10.1093/brain/111.4.829; Shumaker SA, 2006, JAMA-J AM MED ASSOC, V296, P2852, DOI 10.1001/jama.296.23.2852; SIVYER G, 1989, MED J AUSTRALIA, V151, P541, DOI 10.5694/j.1326-5377.1989.tb128516.x; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Stabler SP, 1997, AM J CLIN NUTR, V66, P741, DOI 10.1093/ajcn/66.4.741; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Tangalos EG, 1996, MAYO CLIN PROC, V71, P829, DOI 10.4065/71.9.829; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Tsai GC, 1998, ANNU REV MED, V49, P173; Tuokko H, 2003, ARCH NEUROL-CHICAGO, V60, P577, DOI 10.1001/archneur.60.4.577; *US PREV SERV TASK, SCREEN DEPR; Vanneste JAL, 2000, J NEUROL, V247, P5, DOI 10.1007/s004150050003; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; VICTOR M, 1959, ARCH NEUROL-CHICAGO, V1, P579, DOI 10.1001/archneur.1959.03840060001001; VICTOR M, 1989, WERNICKEKORSAKOFF SY; Wang JYJ, 2006, NEUROLOGY, V66, P911, DOI 10.1212/01.wnl.0000192165.99963.2a; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; WOOD B, 1995, METAB BRAIN DIS, V10, P57, DOI 10.1007/BF01991783; WORMSLEY KG, 1993, DRUGS, V46, P976, DOI 10.2165/00003495-199346060-00004; Young P, 2003, CELL MOL LIFE SCI, V60, P2547, DOI 10.1007/s00018-003-3133-5; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190	103	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1046	1054		10.1001/jama.299.5.jrr80000	http://dx.doi.org/10.1001/jama.299.5.jrr80000			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JH	18252872				2022-12-28	WOS:000253644800022
J	Minton, J; Clayton, J; Sandoe, J; Mc Gann, H; Wilcox, M				Minton, Jane; Clayton, James; Sandoe, Jonathan; Mc Gann, Hugh; Wilcox, Mark			Quality improvement report - Improving early management of bloodstream infection: a quality improvement project	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPREHENSIVE ANALYSIS; CLINICAL-SIGNIFICANCE; 500 EPISODES; BACTEREMIA; FUNGEMIA; CULTURES; THERAPY; ADULTS; SEPSIS	Problem Bloodstream infection is a common but serious illness with high mortality and morbidity, which is seen in many clinical specialties. Errors such as delay in diagnosis and lack of effective treatment often occur. Design Initial observational study followed by prospective study before and after intervention in a high risk clinical area. Setting 1400 bed teaching hospital in the United Kingdom where the initial management of all inpatients with bloodstream infections was surveyed over six weeks. This showed 55 major errors in 46 (30%) of 157 episodes of bloodstream infection. Most (44) were in general areas of the hospital without a specific protocol for managing sepsis. 29 of the 55 errors were caused by delay in giving effective antibiotics to critically ill patients. In 19 cases, effective antibiotics were still not given despite advice from infection services based on blood culture results. A diagnosis of bloodstream infection had not been considered in 7 patients already in hospital despite clear signs of sepsis for more than 48 hours. Strategy for improvement Development of guidelines for recognition and initial management of patients with severe sepsis and bloodstream infection, implementation of an education programme on clinical standards for managing sepsis, and introduction of a bacteraemia service that included feedback. Key measure of improvement Reduction in incidence of major errors in early management of bloodstream infection. Effects of change In the second part of the study, major errors were found in 11 of 37 episodes (30%) immediately before the intervention in the main high risk area (medical wards), whereas such errors were found in 6 of 79 episodes (8%) after the intervention. Lessons learnt The early management of patients with bloodstream infection was often suboptimal. The underlying factors included failure to recognise patients with serious infection; delays in giving antibiotics as a result of poor communication between medical, nursing, and pharmacy teams; and lack of understanding of empirical antimicrobial selection. Introduction of improvement measures was associated with considerable improvement in the early management of severe sepsis caused by bloodstream infection.	[Minton, Jane; Mc Gann, Hugh] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Clayton, James; Sandoe, Jonathan; Wilcox, Mark] Leeds Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS1 3EX, W Yorkshire, England	Saint James's University Hospital; Leeds General Infirmary; University of Leeds	Minton, J (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	jane.minton@leedsth.nhs.uk	Sandoe, Jonathan/AAL-2117-2020	Sandoe, Jonathan/0000-0003-0193-8677				BATES DW, 1995, ARCH INTERN MED, V155, P593, DOI 10.1001/archinte.155.6.593; DAVEY PG, 1995, J ANTIMICROB CHEMOTH, V36, P561, DOI 10.1093/jac/36.3.561; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; DUNAGAN WC, 1989, AM J MED, V87, P253; ISPAHANI P, 1987, Q J MED, V63, P427; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lin MT, 2004, CRIT CARE MED, V32, P569, DOI 10.1097/01.CCM.0000110878.49476.42; MILLER PJ, 1987, J INFECT DIS, V156, P471, DOI 10.1093/infdis/156.3.471; Nathwani D, 1996, QJM-MON J ASSOC PHYS, V89, P789, DOI 10.1093/qjmed/89.10.789; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P54; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35	12	25	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					440	443		10.1136/bmj.39454.634502.80	http://dx.doi.org/10.1136/bmj.39454.634502.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292170	Green Published			2022-12-28	WOS:000253664000041
J	Bonderer, LJ; Studart, AR; Gauckler, LJ				Bonderer, Lorenz J.; Studart, Andre R.; Gauckler, Ludwig J.			Bioinspired design and assembly of platelet reinforced polymer films	SCIENCE			English	Article							MECHANICAL-PROPERTIES; NACRE; NANOCOMPOSITES; COMPOSITES; STIFFNESS; MOTHER; PEARL; MODEL	Although strong and stiff human- made composites have long been developed, the microstructure of today's most advanced composites has yet to achieve the order and sophisticated hierarchy of hybrid materials built up by living organisms in nature. Clay- based nanocomposites with layered structure can reach notable stiffness and strength, but these properties are usually not accompanied by the ductility and flaw tolerance found in the structures generated by natural hybrid materials. By using principles found in natural composites, we showed that layered hybrid films combining high tensile strength and ductile behavior can be obtained through the bottom- up colloidal assembly of strong submicrometer- thick ceramic platelets within a ductile polymer matrix.	[Bonderer, Lorenz J.; Studart, Andre R.; Gauckler, Ludwig J.] ETH, Dept Mat, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Studart, AR (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Dept Phys, Expt Soft Condensed Matter Grp, Cambridge, MA 02138 USA.	studart@seas.harvard.edu; ludwig.gauckler@mat.ethz.ch	Studart, Andre R/A-2550-2008; Gauckler, Ludwig/AAM-5856-2020; Gauckler, Ludwig Julius/C-2784-2009	Gauckler, Ludwig Julius/0000-0003-4668-4025				Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1; BALLARD DGH, 1983, J MATER SCI, V18, P545, DOI 10.1007/BF00560644; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Chasiotis I, 2005, EXP MECH, V45, P507, DOI 10.1177/0014485105059992; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; GLAVINCHEVSKI B, 1973, J MATER SCI, V8, P1373, DOI 10.1007/BF00551660; Hull D., 1996, INTRO COMPOSITE MAT; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370; LANDIS WJ, 1995, J BONE MINER RES, V10, P859, DOI 10.1002/jbmr.5650100606; Lowenstam H.A., 1989, BIOMINERALIZATION, DOI [10.1093/oso/9780195049770.001.0001, DOI 10.1093/OSO/9780195049770.001.0001]; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; MESSERSMITH PB, 1994, CHEM MATER, V6, P1719, DOI 10.1021/cm00046a026; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; Okada A, 1995, MAT SCI ENG C-BIOMIM, V3, P109, DOI 10.1016/0928-4931(95)00110-7; PADAWER GE, 1970, POLYM ENG SCI, V10, P185, DOI 10.1002/pen.760100310; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; REXER J, 1979, POLYM ENG SCI, V19, P1, DOI 10.1002/pen.760190102; SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201; Schmidt D, 2002, CURR OPIN SOLID ST M, V6, P205, DOI 10.1016/S1359-0286(02)00049-9; Sheng N, 2004, POLYMER, V45, P487, DOI 10.1016/j.polymer.2003.10.100; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; WAGNER HD, 1992, J BIOMECH, V25, P1311, DOI 10.1016/0021-9290(92)90286-A; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340	28	821	843	30	984	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1069	1073		10.1126/science.1148726	http://dx.doi.org/10.1126/science.1148726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292337				2022-12-28	WOS:000253311700037
J	Eustis, SN; Radisic, D; Bowen, KH; Bachorz, RA; Haranczyk, M; Schenter, GK; Gutowski, M				Eustis, Soren N.; Radisic, Dunja; Bowen, Kit H.; Bachorz, Rafal A.; Haranczyk, Maciej; Schenter, Gregory K.; Gutowski, Maciej			Electron-driven acid-base chemistry: Proton transfer from hydrogen chloride to ammonia	SCIENCE			English	Article							AB-INITIO; HALIDE-COMPLEXES; VAPOR-PHASE; DIPOLE; BINDING; ANION; DIMER; SPECTROSCOPY; AFFINITIES; PARTICLES	In contrast to widely familiar acid- base behavior in solution, single molecules of NH3 and HCl do not react to form the ionic salt, NH4+Cl-, in isolation. We applied anion photoelectron spectroscopy and ab initio theory to investigate the interaction of an excess electron with the hydrogen- bonded complex NH3. HCl. Our results show that an excess electron induces this complex to form the ionic salt. We propose a mechanism that proceeds through a dipole- bound state to form the negative ion of ionic ammonium chloride, a species that can also be characterized as a deformed Rydberg radical, NH4, polarized by a chloride anion, Cl-.	[Eustis, Soren N.; Radisic, Dunja; Bowen, Kit H.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Bachorz, Rafal A.] Univ Karlsruhe, CFN, D-76128 Karlsruhe, Germany; [Bachorz, Rafal A.] Univ Karlsruhe, Inst Chem Phys, D-76128 Karlsruhe, Germany; [Bachorz, Rafal A.; Haranczyk, Maciej; Schenter, Gregory K.; Gutowski, Maciej] Pacific NW Natl Lab, Div Chem & Mat Sci, Richland, WA 99352 USA; [Haranczyk, Maciej; Gutowski, Maciej] Univ Gdansk, Dept Chem, PL-80952 Gdansk, Poland; [Gutowski, Maciej] Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	Johns Hopkins University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Fahrenheit Universities; University of Gdansk; Heriot Watt University	Bowen, KH (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	kbowen@jhu.edu; m.gutowski@hw.ac.uk	Schenter, Gregory K/I-7655-2014; Haranczyk, Maciej/A-6380-2014; Eustis, Soren/F-1911-2011; Gutowski, Maciej/G-9283-2019	Schenter, Gregory K/0000-0001-5444-5484; Haranczyk, Maciej/0000-0001-7146-9568; Gutowski, Maciej/0000-0001-5523-7388; Eustis, Soren/0000-0003-2416-7916				Alkorta I, 2001, J PHYS CHEM A, V105, P7481, DOI 10.1021/jp0116407; Bachorz RA, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1899144; BARNES AJ, 1984, J CHEM SOC FARAD T 2, V80, P455, DOI 10.1039/f29848000455; Brauer CS, 2006, J PHYS CHEM A, V110, P10025, DOI 10.1021/jp062101a; BRCIZ A, 1984, CHEM PHYS, V89, P337, DOI 10.1016/0301-0104(84)85061-2; Cazar R, 1998, CHEM PHYS LETT, V287, P549, DOI 10.1016/S0009-2614(98)00232-2; Cherng B, 2001, J CHEM PHYS, V114, P1720, DOI 10.1063/1.1328392; COE JV, 1987, J CHEM PHYS, V87, P4302, DOI 10.1063/1.452888; COLBERT DT, 1992, J CHEM PHYS, V96, P1982, DOI 10.1063/1.462100; Compton RN, 1996, J CHEM PHYS, V105, P3472, DOI 10.1063/1.472993; Corongiu G, 1996, INT J QUANTUM CHEM, V59, P119, DOI 10.1002/(SICI)1097-461X(1996)59:2<119::AID-QUA4>3.0.CO;2-0; DESFRANCOIS C, 1994, PHYS REV LETT, V72, P48, DOI 10.1103/PhysRevLett.72.48; Famulari A, 2000, PROG THEOR CHEM PHYS, V2, P361; Fang JY, 1997, J CHEM PHYS, V106, P8442, DOI 10.1063/1.473903; Frisch M.J., 2016, GAUSSIAN16 REV B01; GARRETT BC, 1979, J AM CHEM SOC, V101, P5207, DOI 10.1021/ja00512a016; HERZBERG G, 1987, ANNU REV PHYS CHEM, V38, P27, DOI 10.1146/annurev.physchem.38.1.27; HOWARD NW, 1988, J CHEM PHYS, V88, P4694, DOI 10.1063/1.453783; Jordan MJT, 2000, J AM CHEM SOC, V122, P2101, DOI 10.1021/ja993981s; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; LATAJKA Z, 1984, CHEM PHYS LETT, V110, P464, DOI 10.1016/0009-2614(84)87071-2; LEGON AC, 1993, CHEM SOC REV, V22, P153, DOI 10.1039/cs9932200153; MILLER TM, 1986, J CHEM PHYS, V85, P2368, DOI 10.1063/1.451091; MULLIKEN RS, 1969, MOL COMPLEXES LECT; Radisic D, 2005, J AM CHEM SOC, V127, P6443, DOI 10.1021/ja050724g; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Skurski P, 1999, J CHEM PHYS, V111, P3004, DOI 10.1063/1.479614; Tao FM, 1999, J CHEM PHYS, V110, P11121, DOI 10.1063/1.479054; Taylor P.R., 1994, LECT NOTES QUANTUM C, V2; WERNER HJ, MOLPRO VERSION 2006	30	61	61	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					936	939		10.1126/science.1151614	http://dx.doi.org/10.1126/science.1151614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276886				2022-12-28	WOS:000253165700041
J	Lee, C; Morton, CC				Lee, Charles; Morton, Cynthia C.			Structural genomic variation and personalized medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MAP		[Lee, Charles; Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA.							Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	6	41	43	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					740	741		10.1056/NEJMcibr0708452	http://dx.doi.org/10.1056/NEJMcibr0708452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272898				2022-12-28	WOS:000253127700014
J	Chakravarty, S				Chakravarty, Sudip			Physics - From complexity to simplicity	SCIENCE			English	Editorial Material							FERMI-SURFACE; SUPERCONDUCTIVITY; SYSTEM		[Chakravarty, Sudip] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Chakravarty, S (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	sudip@physics.ucla.edu						ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Armitage NP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147003; Bangura AF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047004; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; CHAKRAVARTY S, 2007, ARXIVORGABS07100608; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Franz M, 2000, PHYS REV LETT, V84, P554, DOI 10.1103/PhysRevLett.84.554; JAUDET C, 2007, ARXIVORGABS07113559; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LUTTINGER JM, 1960, PHYS REV, V119, P1153, DOI 10.1103/PhysRev.119.1153; YELLAND DA, 2007, ARXIVORGABS07070057	11	41	41	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					735	736		10.1126/science.1154320	http://dx.doi.org/10.1126/science.1154320			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258885	Green Submitted			2022-12-28	WOS:000252963000028
J	Saunders, MA; Lea, AS				Saunders, Mark A.; Lea, Adam S.			Large contribution of sea surface warming to recent increase in Atlantic hurricane activity	NATURE			English	Article							NORTH-ATLANTIC; CLIMATE; METEOROLOGY; INTENSITY	Atlantic hurricane activity has increased significantly since 1995 ( refs 1 - 4), but the underlying causes of this increase remain uncertain(2,5) (-15). It is widely thought that rising Atlantic sea surface temperatures have had a role in this(16,17), but the magnitude of this contribution is not known. Here we quantify this contribution for storms that formed in the tropical North Atlantic, Caribbean Sea and Gulf of Mexico; these regions together account for most of the hurricanes that make landfall in the United States. We show that a statistical model based on two environmental variables local sea surface temperature and an atmospheric wind field - can replicate a large proportion of the variance in tropical Atlantic hurricane frequency and activity between 1965 and 2005. We then remove the influence of the atmospheric wind field to assess the contribution of sea surface temperature. Our results indicate that the sensitivity of tropical Atlantic hurricane activity to August September sea surface temperature over the period we consider is such that a 0.5 degrees C increase in sea surface temperature is associated with a similar to 40% increase in hurricane frequency and activity. The results also indicate that local sea surface warming was responsible for similar to 40% of the increase in hurricane activity relative to the 1950 2000 average between 1996 and 2005. Our analysis does not identify whether warming induced by greenhouse gases contributed to the increase in hurricane activity, but the ability of climate models to reproduce the observed relationship between hurricanes and sea surface temperature will serve as a useful means of assessing whether they are likely to provide reliable projections of future changes in Atlantic hurricane activity.	[Saunders, Mark A.; Lea, Adam S.] UCL, Dept Space & Climate Phys, Benfield UCL Hazard Res Ctr, Dorking RH5 6NT, Surrey, England	University of London; University College London	Saunders, MA (corresponding author), UCL, Dept Space & Climate Phys, Benfield UCL Hazard Res Ctr, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	mas@mssl.ucl.ac.uk		Saunders, Mark/0000-0001-9606-7389				[Anonymous], 2006, Nature, V441, P549; Bell G. D., 2006, B AM METEOROL SOC, V87, pS44; Bell GD, 2006, J CLIMATE, V19, P590, DOI 10.1175/JCLI3659.1; Bengtsson L, 2006, J CLIMATE, V19, P3518, DOI 10.1175/JCLI3815.1; Elsner JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026869; ELSNER JB, 1994, WEATHER FORECAST, V9, P619, DOI 10.1175/1520-0434(1994)009<0619:AFSTCV>2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2005, NATURE, V438, pE13, DOI 10.1038/nature04427; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kleinbaum D, 1988, APPL REGRESSION ANAL; Klotzbach PJ, 2006, B AM METEOROL SOC, V87, P1325, DOI 10.1175/BAMS-87-10-1325; Knutson TR, 2007, B AM METEOROL SOC, V88, P1549, DOI 10.1175/BAMS-88-10-1549; Landsea C, 2007, EOS T AGU, V88, P197, DOI [10.1029/2007EO180001, DOI 10.1029/2007EO180001]; Landsea CW, 2005, NATURE, V438, pE11, DOI 10.1038/nature04477; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; McDonald RE, 2005, CLIM DYNAM, V25, P19, DOI 10.1007/s00382-004-0491-0; NEUMANN CJ, 1999, HIST CLIMATOLOGY SER, V62; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Saunders MA, 2005, NATURE, V434, P1005, DOI 10.1038/nature03454; Saunders MA, 1997, GEOPHYS RES LETT, V24, P1255, DOI 10.1029/97GL01164; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Vimont DJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029683; Waple AM, 2002, B AM METEOROL SOC, V83, pS1; Wilks DS., 2006, STAT METHODS ATMOSPH, V3, P133	31	139	145	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					557	U3		10.1038/nature06422	http://dx.doi.org/10.1038/nature06422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235498				2022-12-28	WOS:000252739900038
J	Acar, M; Jafar-Nejad, H; Takeuchi, H; Rajan, A; Ibrani, D; Rana, NA; Pan, H; Haltiwanger, RS; Bellen, HJ				Acar, Melih; Jafar-Nejad, Hamed; Takeuchi, Hideyuki; Rajan, Akhila; Ibrani, Dafina; Rana, Nadia A.; Pan, Hongling; Haltiwanger, Robert S.; Bellen, Hugo J.			Rumi is a CAP10 domain glycosyltransferase that modifies notch and is required for notch signaling	CELL			English	Article							GROWTH FACTOR-LIKE; THROMBOSPONDIN TYPE-1 REPEATS; O-FUCOSYL-TRANSFERASE; UNFOLDED PROTEIN RESPONSE; DROSOPHILA NOTCH; CELL FATE; CRYPTOCOCCUS-NEOFORMANS; LIGAND ENDOCYTOSIS; DELTA INTERACTIONS; ALAGILLE-SYNDROME	Notch signaling is broadly used to regulate cell-fate decisions. We have identified a gene, rumi, with a temperature-sensitive Notch phenotype. At 28 degrees C-30 degrees C, rumi clones exhibit a full-blown loss of Notch signaling in all tissues tested. However, at 18 degrees C only a mild Notch phenotype is evident. In vivo analyses reveal that the target of Rumi is the extracellular domain of Notch. Notch accumulates intracellularly and at the cell membrane of rumi cells but fails to be properly cleaved, despite normal binding to Delta. Rumi is an endoplasmic reticulum-retained protein with a highly conserved CAP10 domain. Our studies show that Rumi is a protein O-glucosyltransferase, capable of adding glucose to serine residues in Notch EGF repeats with the consensus C-1-X-S-X-P-C-2 sequence. These data indicate that by O-glucosylating Notch in the ER, Rumi regulates its folding and/or trafficking and allows signaling at the cell membrane.	[Acar, Melih; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Acar, Melih; Jafar-Nejad, Hamed; Rajan, Akhila; Ibrani, Dafina; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pan, Hongling; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Takeuchi, Hideyuki; Rana, Nadia A.; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Jafar-Nejad, Hamed/B-9216-2008; Takeuchi, Hideyuki/AAZ-9210-2020	Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064] Funding Source: Medline; NIGMS NIH HHS [5R01GM061126-07, R01 GM061126, R01 GM084135, R01 GM084135-01] Funding Source: Medline; PHS HHS [T32-GMO7526] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084135, R01GM061126] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2000, DEVELOPMENT, V127, P1373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shao L, 2003, CELL MOL LIFE SCI, V60, P241, DOI 10.1007/s000180300019; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	70	221	226	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					247	258		10.1016/j.cell.2007.12.016	http://dx.doi.org/10.1016/j.cell.2007.12.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243100	Green Accepted, Bronze			2022-12-28	WOS:000253427700011
J	FRANKKAMENETSKII, M				FRANKKAMENETSKII, M			A GLIMPSE OF ANDREI,DMITRIEVICH	NATURE			English	Editorial Material											FRANKKAMENETSKII, M (corresponding author), RUSSIAN ACAD SCI,INST MOLEC GENET,MOSCOW 123182,RUSSIA.								0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					13	13		10.1038/344013a0	http://dx.doi.org/10.1038/344013a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278003				2022-12-28	WOS:A1990CQ97200029
J	Coop, G; Wen, XQ; Ober, C; Pritchard, JK; Przeworski, M				Coop, Graham; Wen, Xiaoquan; Ober, Carole; Pritchard, Jonathan K.; Przeworski, Molly			High-resolution mapping of crossovers reveals extensive variation in fine-scale recombination patterns among humans	SCIENCE			English	Article							MEIOTIC RECOMBINATION; HUMAN GENOME; HUMAN MALES; EVOLUTION; HOTSPOT; RATES; MAP; POPULATIONS; CHIMPANZEES; COMPLEX	Recombination plays a crucial role in meiosis, ensuring the proper segregation of chromosomes. Recent linkage disequilibrium ( LD) and sperm- typing studies suggest that recombination rates vary tremendously across the human genome, with most events occurring in narrow "hotspots." To examine variation in fine- scale recombination patterns among individuals, we used dense, genome- wide single- nucleotide polymorphism data collected in nuclear families to localize crossovers with high spatial resolution. This analysis revealed that overall recombination hotspot usage is similar in males and females, with individual hotspots often active in both sexes. Across the genome, roughly 60% of crossovers occurred in hotspots inferred from LD studies. Notably, however, we found extensive and heritable variation among both males and females in the proportion of crossovers occurring in these hotspots.	[Coop, Graham; Wen, Xiaoquan; Ober, Carole; Pritchard, Jonathan K.; Przeworski, Molly] Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Coop, G (corresponding author), Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, 920 E 58th St, Chicago, IL 60637 USA.	gcoop@uchicago.edu; pritch@uchicago.edu; mfp@uchicago.edu		Ober, Carole/0000-0003-4626-9809; Coop, Graham/0000-0001-8431-0302; Wen, Xiaoquan/0000-0001-8990-2737	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, R43HL056533, R44HL056533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002772, HG002772] Funding Source: Medline; NHLBI NIH HHS [HL56533, HL56399] Funding Source: Medline; NICHD NIH HHS [HD21244] Funding Source: Medline; NIGMS NIH HHS [GM83098] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lenormand T, 2003, GENETICS, V163, P811; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Vallente RU, 2006, CHROMOSOMA, V115, P241, DOI 10.1007/s00412-006-0058-4; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yu J, 1996, AM J HUM GENET, V59, P1186	31	274	281	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1395	1398		10.1126/science.1151851	http://dx.doi.org/10.1126/science.1151851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18239090				2022-12-28	WOS:000253712900045
J	Szemenyei, H; Hannon, M; Long, JA				Szemenyei, Heidi; Hannon, Mike; Long, Jeff A.			TOPLESS mediates auxin-dependent transcriptional repression during Arabidopsis embryogenesis	SCIENCE			English	Article							BOX PROTEIN TIR1; AUX/IAA PROTEINS; GENE FAMILY; EXPRESSION; ENCODES; GROUCHO; MOTIF; AXIS	The transcriptional response to auxin is critical for root and vascular development during Arabidopsis embryogenesis. Auxin induces the degradation of AUXIN/ INDOLE- 3- ACETIC ACID ( AUX/ IAA) transcriptional repressors, freeing their binding partners, the AUXIN RESPONSE FACTOR ( ARF) proteins, which can activate transcription of auxin response genes. We show that TOPLESS ( TPL) can physically interact with IAA12/ BODENLOS ( IAA12/ BDL) through an ETHYLENE RESPONSE FACTOR ( ERF) - associated amphiphilic repression ( EAR) motif. TPL can repress transcription in vivo and is required for IAA12/ BDL repressive activity. In addition, tpl- 1 can suppress the patterning defects of the bdl- 1 mutant. Direct interaction between TPL and ARF5/ MONOPTEROS, which is regulated by IAA12/ BDL, results in a loss- of- function arf5/ mp phenotype. These observations show that TPL is a transcriptional co- repressor and further our understanding of how auxin regulates transcription during plant development.	[Szemenyei, Heidi; Hannon, Mike; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Szemenyei, Heidi; Hannon, Mike] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Long, JA (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	long@salk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM072764, R01 GM072764] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BERLETH T, 1993, DEVELOPMENT, V118, P575; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 2006, PLANT J, V48, P380, DOI 10.1111/j.1365-313X.2006.02882.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Long JA, 2002, DEVELOPMENT, V129, P2797; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Wu KQ, 2002, PLANT PHYSIOL, V128, P30, DOI 10.1104/pp.010696	27	505	557	6	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1384	1386		10.1126/science.1151461	http://dx.doi.org/10.1126/science.1151461			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18258861				2022-12-28	WOS:000253712900042
J	Martimo, KP; Verbeek, J; Karppinen, J; Furlan, AD; Takala, EP; Kuijer, PPFM; Jauhiainen, M; Viikari-Juntura, E				Martimo, Kari-Pekka; Verbeek, Jos; Karppinen, Jaro; Furlan, Andrea D.; Takala, Esa-Pekka; Kuijer, P. Paul F. M.; Jauhiainen, Merja; Viikari-Juntura, Eira			Effect of training and lifting equipment for preventing back pain in lifting and handling: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INJURIES; TRIALS	Objectives To determine whether advice and training on working techniques and lifting equipment prevent back pain in jobs that involve heavy lifting. Data sources Medline, Embase, CENTRAL, Cochrane Back Group's specialised register, CINAHL, Nioshtic, CISdoc, Science Citation Index, and PsychLIT were searched up to September-November 2005. Review methods The primary search focused on randomised controlled trials and the secondary search on cohort studies with a concurrent control group. Interventions aimed to modify techniques for lifting and handling heavy objects or patients and including measurements for back pain, consequent disability, or sick leave as the main outcome were considered for the review. Two authors independently assessed eligibility of the studies and methodological quality of those included. For data synthesis, we summarised the results of studies comparing similar interventions. We used odds ratios and effect sizes to combine the results in a meta-analysis. Finally, we compared the conclusions of the primary and secondary analyses. Results Six randomised trials and five cohort studies met the inclusion criteria. Two randomised trials and all. cohort studies were labelled as high quality. Eight studies looked at lifting and moving patients, and three studies were conducted among baggage handlers or postal workers. Those in control groups received no intervention or minimal training, physical exercise, or use of back belts. None of the comparisons in randomised trials (17 720 participants) yielded significant differences. In the secondary analysis, none of the cohort studies (772 participants) had significant results, which supports the results of the randomised trials. Conclusions There is no evidence to support use of advice or training in working techniques with or without lifting equipment for preventing back pain or consequent disability. The findings challenge current widespread practice of advising workers on correct lifting technique.	[Martimo, Kari-Pekka; Takala, Esa-Pekka; Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Musculoskeletal Disorders Grp, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Verbeek, Jos] Finnish Inst Occupat Hlth, Knowledge Transfer Occupat Hlth & Safety Grp, Ctr Expertise Good Practices & Competence, Kuopio, Finland; [Karppinen, Jaro] Finnish Inst Occupat Hlth, Musculoskeletal Disorders Grp, Ctr Expertise Hlth & Work Abil, Oulu, Finland; [Furlan, Andrea D.] Inst Work & Hlth, Toronto, ON, Canada; [Kuijer, P. Paul F. M.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands; [Jauhiainen, Merja] Finnish Inst Occupat Hlth, Knowledge Transfer Occupat Hlth & Safety Grp, Ctr Expertise Good Practices & Competence, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Institute for Work & Health; University of Amsterdam; Academic Medical Center Amsterdam; Finnish Institute of Occupational Health	Martimo, KP (corresponding author), Finnish Inst Occupat Hlth, Musculoskeletal Disorders Grp, Ctr Expertise Hlth & Work Abil, Helsinki, Finland.	kari-pekka.martimo@ttl.fi	Verbeek, Jos H.A.M./F-8382-2013; Kuijer, P. Paul F.M./A-5556-2013; Furlan, Andrea/J-9888-2012; Kuijer, P. Paul F.M./AAB-2635-2020; Furlan, Andrea/AAH-2711-2019	Verbeek, Jos H.A.M./0000-0002-6537-6100; Furlan, Andrea/0000-0001-6138-8510; Kuijer, P. Paul F.M./0000-0002-8277-3730				Bos EH, 2006, ERGONOMICS, V49, P706, DOI 10.1080/00140130600578005; Burke MJ, 2006, AM J PUBLIC HEALTH, V96, P315, DOI 10.2105/AJPH.2004.059840; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; DALTROY LH, 1993, HEALTH EDUC QUART, V20, P43, DOI 10.1177/109019819302000106; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; *EUR AG SAF HLTH W, 2007, HAZ RISKS ASS MAN HA; Jellema P, 2001, SPINE, V26, P377, DOI 10.1097/00007632-200102150-00014; Jensen LD, 2006, SPINE, V31, P1761, DOI 10.1097/01.brs.0000227326.35149.38; Kuiper JI, 1999, INT J IND ERGONOM, V24, P389, DOI 10.1016/S0169-8141(99)00006-2; Lavender SA, 2007, SPINE, V32, P487, DOI 10.1097/01.brs.0000255203.96898.f2; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Martimo KP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005958; *NAT I OCC SAF HLT, 2007, NIOSH PUBL; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Straker Leon M, 2002, Work, V19, P9; Straker Leon M, 2003, Work, V20, P83; van Poppel MNM, 2004, OCCUP MED-OXFORD, V54, P345, DOI 10.1093/occmed/kqh065; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Verbeek J, 2005, OCCUP ENVIRON MED, V62, P682, DOI 10.1136/oem.2004.019117	20	109	109	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					429	431		10.1136/bmj.39463.418380.BE	http://dx.doi.org/10.1136/bmj.39463.418380.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18244957	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000253664000038
J	Colucciello, M				Colucciello, Michael			Images in clinical medicine - Retinal arteriolar cholesterol emboli	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									S Jersey Eye Phys, Moorestown, NJ USA		Colucciello, M (corresponding author), S Jersey Eye Phys, Moorestown, NJ USA.	michael@macula.us	Colucciello, Michael/P-8580-2014	Colucciello, Michael/0000-0002-1693-9587					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					826	826		10.1056/NEJMicm067294	http://dx.doi.org/10.1056/NEJMicm067294			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287605				2022-12-28	WOS:000253257700008
J	Chae, HG; Kumar, S				Chae, Han Gi; Kumar, Satish			Materials science - Making strong fibers	SCIENCE			English	Editorial Material							HIGH-PERFORMANCE FIBERS; CARBON NANOTUBE FIBERS; SINGLE; STRENGTH		[Chae, Han Gi; Kumar, Satish] Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Chae, HG (corresponding author), Georgia Inst Technol, Sch Polymer Text & Fiber Engn, Atlanta, GA 30332 USA.	satish.kumar@ptfe.gatech.edu	Kumar, Satish/F-7308-2011; Chae, Han Gi/M-5427-2016	Kumar, Satish/0000-0002-3415-170X; Chae, Han Gi/0000-0003-2196-0986				Chae HG, 2007, POLYMER, V48, P3781, DOI 10.1016/j.polymer.2007.04.072; Chawla K, 1998, FIBROUS MAT; Dumitrica T, 2006, P NATL ACAD SCI USA, V103, P6105, DOI 10.1073/pnas.0600945103; Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398; Gupta V.B., 1997, MANUFACTURED FIBRE T; KOZEY VV, 1995, J MATER RES, V10, P1044, DOI 10.1557/JMR.1995.1044; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Miaudet P, 2005, NANO LETT, V5, P2212, DOI 10.1021/nl051419w; Minus ML, 2006, POLYMER, V47, P3705, DOI 10.1016/j.polymer.2006.03.076; Minus ML, 2005, JOM-US, V57, P52, DOI 10.1007/s11837-005-0217-8; Motta M, 2007, ADV MATER, V19, P3721, DOI 10.1002/adma.200700516; SMITH P, 1980, J MATER SCI, V15, P505, DOI 10.1007/BF02396802; Wang Z, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455709; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276	14	221	232	12	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					908	909		10.1126/science.1153911	http://dx.doi.org/10.1126/science.1153911			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276875				2022-12-28	WOS:000253165700029
J	Tobias, JA; Bates, JM; Hackett, SJ; Seddon, N				Tobias, Joseph A.; Bates, John M.; Hackett, Shannon J.; Seddon, Nathalie			Comment on the latitudinal gradient in recent speciation and extinction rates of birds and mammals	SCIENCE			English	Editorial Material							SPECIES LIMITS; AVES; MITOCHONDRIAL; COMPLEX; DIFFERENTIATION; PHYLOGENY; DIVERSITY		[Tobias, Joseph A.; Seddon, Nathalie] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Bates, John M.; Hackett, Shannon J.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA	University of Oxford; Field Museum of Natural History (Chicago)	Tobias, JA (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	joseph.tobias@zoo.ox.ac.uk		Tobias, Joseph/0000-0003-2429-6179; Seddon, Nathalie/0000-0002-1880-6104				[Anonymous], 1878, TROPICAL NATURE OTHE; Avise J.C., 2000, PHYLOGEOGRAPHY HIST; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Cadena CD, 2007, MOL PHYLOGENET EVOL, V44, P993, DOI 10.1016/j.ympev.2006.12.012; Cadena CD, 2004, CONDOR, V106, P664, DOI 10.1650/7471; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Griffiths CS, 2004, MOL PHYLOGENET EVOL, V32, P101, DOI 10.1016/j.ympev.2003.11.019; Isler ML, 2007, WILSON J ORNITHOL, V119, P53, DOI 10.1676/05-121.1; Isler ML, 2007, AUK, V124, P11, DOI 10.1642/0004-8038(2007)124[11:SLIATT]2.0.CO;2; Isler Morton L., 1997, Ornithological Monographs, V48, P355; Lougheed SC, 2000, MOL PHYLOGENET EVOL, V17, P367, DOI 10.1006/mpev.2000.0843; Marks BD, 2002, MOL PHYLOGENET EVOL, V24, P153, DOI 10.1016/S1055-7903(02)00233-6; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Questiau S, 1999, HEREDITY, V83, P196, DOI 10.1046/j.1365-2540.1999.00551.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SEUTIN G, 1995, EVOLUTION, V49, P962, DOI 10.1111/j.1558-5646.1995.tb02331.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Winker K, 2006, AUK, V123, P1052, DOI 10.1642/0004-8038(2006)123[1052:SMSAMC]2.0.CO;2	21	50	50	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865								10.1126/science.1150568	http://dx.doi.org/10.1126/science.1150568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276872				2022-12-28	WOS:000253165700024
J	Krishnakumar, R; Gamble, MJ; Frizzell, KM; Berrocal, JG; Kininis, M; Kraus, WL				Krishnakumar, Raga; Gamble, Matthew J.; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kininis, Miltiadis; Kraus, W. Lee			Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes	SCIENCE			English	Article							CHROMATIN-STRUCTURE; POLY(ADP-RIBOSYL)ATION; DISTINCT; DOMAINS; GENOME	Nucleosome- binding proteins act to modulate the promoter chromatin architecture and transcription of target genes. We used genomic and gene- specific approaches to show that two such factors, histone H1 and poly( ADP- ribose) polymerase- 1 ( PARP- 1), exhibit a reciprocal pattern of chromatin binding at many RNA polymerase II - transcribed promoters. PARP- 1 was enriched and H1 was depleted at these promoters. This pattern of binding was associated with actively transcribed genes. Furthermore, we showed that PARP- 1 acts to exclude H1 from a subset of PARP- 1 - stimulated promoters, suggesting a functional interplay between PARP- 1 and H1 at the level of nucleosome binding. Thus, although H1 and PARP- 1 have similar nucleosome- binding properties and effects on chromatin structure in vitro, they have distinct roles in determining gene expression outcomes in vivo.	[Krishnakumar, Raga; Gamble, Matthew J.; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kininis, Miltiadis; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Krishnakumar, Raga; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Kininis, Miltiadis; Kraus, W. Lee] Cornell Univ, Grad Field Genet & Dev, Ithaca, NY 14853 USA; [Kraus, W. Lee] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu		Krishnakumar, Raga/0000-0002-2479-754X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110, R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK069710, R01 DK069710, DK058110] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3	17	308	316	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					819	821		10.1126/science.1149250	http://dx.doi.org/10.1126/science.1149250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258916				2022-12-28	WOS:000252963000064
J	Resch, KJ				Resch, K. J.			Physics - Amplifying a tiny optical effect	SCIENCE			English	Editorial Material							SPIN; COMPONENT; PARTICLE		[Resch, K. J.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Resch, K. J.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Resch, KJ (corresponding author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	kresch@iqc.ca						AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; DUCK IM, 1989, PHYS REV D, V40, P2112, DOI 10.1103/PhysRevD.40.2112; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; RITCHIE NWM, 1991, PHYS REV LETT, V66, P1107, DOI 10.1103/PhysRevLett.66.1107; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; STEINBERG AM, 1995, PHYS REV LETT, V74, P2405, DOI 10.1103/PhysRevLett.74.2405; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204	9	38	38	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					733	734		10.1126/science.1154149	http://dx.doi.org/10.1126/science.1154149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258884				2022-12-28	WOS:000252963000026
J	Ishii, KJ; Kawagoe, T; Koyama, S; Matsui, K; Kumar, H; Kawai, T; Uematsu, S; Takeuchi, O; Takeshita, F; Coban, C; Akira, S				Ishii, Ken J.; Kawagoe, Tatsukata; Koyama, Shohei; Matsui, Kosuke; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Takeshita, Fumihiko; Coban, Cevayir; Akira, Shizuo			TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines	NATURE			English	Article							DENDRITIC CELLS; I INTERFERON; ACTIVATION; RECOGNITION; INDUCTION; INFECTION; MICE; VACCINATION; INFLUENZA; PATHWAY	Successful vaccines contain not only protective antigen(s) but also an adjuvant component that triggers innate immune activation and is necessary for their optimal immunogenicity(1,2). In the case of DNA vaccines(3), this consists of plasmid DNA; however, the adjuvant element( s) as well as its intra- and inter- cellular innate immune signalling pathway( s) leading to the encoded antigen- specific T- and B- cell responses remain unclear. Here we demonstrate in vivo that TANK- binding kinase 1 ( TBK1), a non- canonical I kappa B kinase, mediates the adjuvant effect of DNA vaccines and is essential for its immunogenicity in mice. Plasmid-DNA- activated, TBK1- dependent signalling and the resultant type- I interferon receptor- mediated signalling was required for induction of antigen- specific B and T cells, which occurred even in the absence of innate immune signalling through a well known CpG DNA sensor - Toll- like receptor 9 ( TLR9) or Z- DNA binding protein 1 ( ZBP1, also known as DAI, which was recently reported as a potential B- form DNA sensor(4)). Moreover, bone- marrow-transfer experiments revealed that TBK1- mediated signalling in haematopoietic cells was critical for the induction of antigenspecific B and CD4(+) T cells, whereas in non- haematopoietic cells TBK1 was required for CD8(+) T- cell induction. These data suggest that TBK1 is a key signalling molecule for DNA- vaccine- induced immunogenicity, by differentially controlling DNA- activated innate immune signalling through haematopoietic and nonhaematopoietic cells.	[Ishii, Ken J.; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Ishii, Ken J.] Osaka Univ, Dept Mol Protozool, Suita, Osaka 5650871, Japan; [Ishii, Ken J.; Kawagoe, Tatsukata; Koyama, Shohei; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Coban, Cevayir; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kawagoe, Tatsukata; Koyama, Shohei; Matsui, Kosuke; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Coban, Cevayir; Akira, Shizuo] Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; [Coban, Cevayir; Akira, Shizuo] Osaka Univ, Century Ctr Excellence COE 21, Combined Program Microbiol & Immunol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Takeshita, Fumihiko] Yokohama City Univ, Dept Mol Biodef Res, Grad Sch Med, Kanagawa 2360004, Japan; [Koyama, Shohei] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Yokohama City University; Tohoku University	Ishii, KJ (corresponding author), Osaka Univ, ERATO, Japan Sci & Technol Agcy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kenishii@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Kumar, Himanshu/A-8070-2010; Takeuchi, Osamu/AAG-9359-2019; Coban, Cevayir/B-2129-2012; Takeuchi, Osamu/D-6007-2011; Koyama, Shohei/AAU-4113-2021; Akira, Shizuo/C-3134-2009; COBAN, Cevayir/P-1928-2019; Kumar, Himanshu/J-4494-2012	Ishii, Ken J/0000-0002-6728-3872; Takeuchi, Osamu/0000-0002-1260-6232; Koyama, Shohei/0000-0002-6897-9417; COBAN, Cevayir/0000-0002-4467-7799; Kumar, Himanshu/0000-0001-5246-2694; Kawai, Taro/0000-0001-7510-4662				Babiuk S, 2004, IMMUNOLOGY, V113, P114, DOI 10.1111/j.1365-2567.2004.01938.x; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishii KJ, 2005, EUR J IMMUNOL, V35, P2397, DOI 10.1002/eji.200425795; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Sasaki S, 2002, J VIROL, V76, P6652, DOI 10.1128/JVI.76.13.6652-6659.2002; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06; Tudor D, 2005, VACCINE, V23, P1258, DOI 10.1016/j.vaccine.2004.09.001; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463	30	471	506	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					725	U6		10.1038/nature06537	http://dx.doi.org/10.1038/nature06537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256672				2022-12-28	WOS:000252929500043
J	Ageno, W; Dentali, F				Ageno, Walter; Dentali, Francesco			Prevention of in-hospital VTE: why can't we do better?	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM; MEDICAL PATIENTS; SURGERY; METAANALYSIS; PROPHYLAXIS		[Ageno, Walter; Dentali, Francesco] Univ Insubria, Dept Clin Med, I-21100 Varese, Italy	University of Insubria	Ageno, W (corresponding author), Univ Insubria, Dept Clin Med, I-21100 Varese, Italy.	agewal@yahoo.com		ageno, walter/0000-0002-1922-8879				Ageno W, 2002, HAEMATOLOGICA, V87, P746; Agnelli G, 2006, ANN SURG, V243, P89, DOI 10.1097/01.sla.0000193959.44677.48; CLAGETT GP, 1995, CHEST S, V108, P312; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; HUNT SA, 2005, ACC AHA 2005 GUIDELI; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Mismetti P, 2001, BRIT J SURG, V88, P913, DOI 10.1046/j.0007-1323.2001.01800.x; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; PIOVELLA F, 2007, THROMB HAEMOSTASIS, V98, P756; Ricci S, 2007, LANCET, V370, P735, DOI 10.1016/S0140-6736(07)61365-8; Stratton MA, 2000, ARCH INTERN MED, V160, P334, DOI 10.1001/archinte.160.3.334	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					361	362		10.1016/S0140-6736(08)60177-4	http://dx.doi.org/10.1016/S0140-6736(08)60177-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242395				2022-12-28	WOS:000252992700004
J	Butcher, J				Butcher, James			Mind games do they work?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK					james@two-cultures.com						Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson RS, 2007, NEUROLOGY, V69, P1911, DOI 10.1212/01.wnl.0000271087.67782.cb	3	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 2	2008	336	7638					246	248		10.1136/bmj.39462.534630.AD	http://dx.doi.org/10.1136/bmj.39462.534630.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18244994	Green Published			2022-12-28	WOS:000253102900033
J	Gray, NJ				Gray, Nigel J.			Dilemmas over tobacco research	LANCET			English	Editorial Material									Canc Council Victoria, Hawthorn, Vic 3122, Australia	Cancer Council Victoria	Gray, NJ (corresponding author), Canc Council Victoria, Hawthorn, Vic 3122, Australia.	nigel@uicc.org						Schick SF, 2007, TOB CONTROL, V16, P157, DOI 10.1136/tc.2006.017186; *WHO STUD GROUP TO, 2007, SCI BAS TOB PROD REG; WILDE A, 2007, WALL STREET J   0621, pA1	3	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					368	370		10.1016/S0140-6736(08)60182-8	http://dx.doi.org/10.1016/S0140-6736(08)60182-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242400				2022-12-28	WOS:000252992700009
J	Burguete, AS; Fenn, TD; Brunger, AT; Pfeffer, SR				Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.; Pfeffer, Suzanne R.			Rab and arl GTPase family members cooperate in the localization of the golgin GCC185	CELL			English	Article							GRIP DOMAIN PROTEIN; STRUCTURAL BASIS; TRANS-GOLGI; COILED-COIL; RECRUITMENT; EFFECTOR; SPECIFICITY; BINDS; VISUALIZATION; VESICLES	GCC185 is a large coiled-coil protein at the trans Golgi network that is required for receipt of transport vesicles inbound from late endosomes and for anchoring noncentrosomal microtubules that emanate from the Golgi. Here, we demonstrate that recruitment of GCC185 to the Golgi is mediated by two Golgi-localized small GTPases of the Rab and Arl families. GCC185 binds Rab6, and mutation of residues needed for Rab binding abolishes Golgi localization. The crystal structure of Rab6 bound to the GCC185 Rab-binding domain reveals that Rab6 recognizes a two-fold symmetric surface on a coiled coil immediately adjacent to a C-terminal GRIP domain. Unexpectedly, Rab6 binding promotes association of Arl1 with the GRIP domain. We present a structure-derived model for dual GTPase membrane attachment that highlights the potential ability of Rab GTPases to reach binding partners at a significant distance from the membrane via their unstructured and membrane-anchored, hypervariable domains.	[Burguete, Alondra Schweizer; Pfeffer, Suzanne R.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Struct Biol & Photon Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Brunger, Axel/0000-0001-5121-2036; Schweizer Burguete, Alondra/0000-0003-0324-3334	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037332, R01DK037332, R37DK037332] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK037332, DK37332, R37 DK037332-19, R37 DK037332-22, R37 DK037332-21, R01 DK037332, R37 DK037332-20, R37 DK037332] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chattopadhyay D, 2000, ACTA CRYSTALLOGR D, V56, P937, DOI 10.1107/S0907444900007575; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gilson PR, 2004, PLANTA, V219, P1050, DOI 10.1007/s00425-004-1311-9; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Latijnhouwers M, 2005, PLANT J, V44, P459, DOI 10.1111/j.1365-313X.2005.02542.x; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Neu M, 1997, PROTEINS, V27, P204, DOI 10.1002/(SICI)1097-0134(199702)27:2<204::AID-PROT6>3.0.CO;2-F; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Sato Y, 2007, STRUCTURE, V15, P245, DOI 10.1016/j.str.2007.01.003; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tsukada M, 1996, J CELL SCI, V109, P2471; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	49	129	136	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					286	298		10.1016/j.cell.2007.11.048	http://dx.doi.org/10.1016/j.cell.2007.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243103	Green Accepted, Bronze			2022-12-28	WOS:000253427700014
J	[Anonymous]				[Anonymous]			BRITISH UNIVERSITIES REBEL	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					1	1						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277981				2022-12-28	WOS:A1990CQ97200001
J	Cox, HS; Morrow, M; Deutschmann, PW				Cox, Helen S.; Morrow, Martha; Deutschmann, Peter W.			Long term efficacy of DOTS regimens for tuberculosis: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; DIAGNOSED PULMONARY TUBERCULOSIS; CONTINUATION PHASE; 6-MONTH REGIMEN; RISK-FACTORS; FOLLOW-UP; RELAPSE; CHEMOTHERAPY; RIFAPENTINE; REINFECTION	Objective To identify published studies assessing tuberculosis recurrence after successful treatment with standard short course regimens for six months to determine the strength and sufficiency of evidence to support current guidelines. Design Systematic review. Data sources Medline, Embase, Cochrane clinical trials register, specialist tuberculosis journals, and reference lists. Only English language publications were eligible. Review methods Studies were included irrespective of methodology or quality. Abstracted information included inclusion and exclusion criteria for participants, duration of follow-up, and definitions of treatment success and disease recurrence. The primary outcome was the proportion of successfully treated patients recorded with recurrent tuberculosis during the follow-up period. Results 17 study arms from 16 studies met the inclusion criteria; 10 were controlled clinical trials and six were either studies done under programmatic conditions or observational studies from functioning tuberculosis programmes. Although several clinical trials supported the use of daily treatment regimens, studies reporting tuberculosis recurrence after intermittent regimens were limited. Few studies carried out under routine programmatic conditions reported disease recurrence. Overall there was wide variation in recurrence after successful treatment, ranging from 0% to 14%. Considerable heterogeneity across studies precluded the systematic assessment of factors contributing to tuberculosis recurrence. Conclusions Despite DOTS (directly observed treatment, short course) being implemented for more than 10 years and millions of patients treated for tuberculosis, few studies have assessed the ability of standard DOTS regimens to result in lasting cure for patients treated under routine programmatic conditions.	[Cox, Helen S.; Morrow, Martha; Deutschmann, Peter W.] Univ Melbourne, Australian Int Hlth Inst, Melbourne, Vic 3010, Australia	University of Melbourne	Cox, HS (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia.	hcox@burnet.edu.au		Cox, Helen/0000-0002-6538-7192				Aber V R, 1978, Bull Int Union Tuberc, V53, P276; Algerian Working Group, 1984, American Review of Respiratory Disease, V129, P921; ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; [Anonymous], 1979, Am Rev Respir Dis, V119, P579; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409; Banda H, 2000, INT J TUBERC LUNG D, V4, P968; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; *BRIT MED RES COUN, 1986, TUBERCLE, V67, P5; *BRIT MED RES COUN, 1983, TUBERCLE, V64, P153; *BRIT THOR ASS, 1981, BR J DIS CHEST, V75, P141; BRITISH THORACIC ASSOCIATION, 1982, American Review of Respiratory Disease, V126, P460; Cao JP, 1998, INT J TUBERC LUNG D, V2, P360; Chaisson RE, 1996, AM J RESP CRIT CARE, V154, P1034, DOI 10.1164/ajrccm.154.4.8887603; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; DUTT AK, 1984, AM J MED, V77, P233, DOI 10.1016/0002-9343(84)90697-1; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; FOX W, 1986, AM REV RESPIR DIS, V133, P779; FOX W, 1985, AM REV RESPIR DIS, V132, P374; Girling D. J., 1991, American Review of Respiratory Disease, V143, P707; GIRLING DJ, 1988, AM REV RESPIR DIS, V137, P1147; GONZALEZMONTANER LJ, 1994, TUBERCLE LUNG DIS, V75, P341, DOI 10.1016/0962-8479(94)90079-5; Hargreaves S, 2007, LANCET INFECT DIS, V7, P309, DOI 10.1016/S1473-3099(07)70093-2; Huong NT, 2006, INT J TUBERC LUNG D, V10, P963; Iseman MD, 1999, INT J TUBERC LUNG D, V3, P87; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnson JL, 1997, INT J TUBERC LUNG D, V1, P446; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Malkin JE, 1997, INT J TUBERC LUNG D, V1, P68; MOHANTY KC, 1993, CHEST, V104, P1194, DOI 10.1378/chest.104.4.1194; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Mwandumba HC, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD00097; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; *SING TUB SERV BRI, 1981, TUBERCLE, V62, P95; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Styblo K, 1988, Bull Int Union Tuberc Lung Dis, V63, P39; Tam CM, 2000, INT J TUBERC LUNG D, V4, P262; Tam CM, 2002, INT J TUBERC LUNG D, V6, P3; Tam CM, 1998, AM J RESP CRIT CARE, V157, P1726, DOI 10.1164/ajrccm.157.6.9707037; Teo SK, 1999, INT J TUBERC LUNG D, V3, P126; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Vernon AA, 2004, AM J RESP CRIT CARE, V170, P1040, DOI 10.1164/rccm.2409005; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; VIJAY S, 2004, INDIAN J TUBERC, V51, P199; WHO, 2007, WHOHTMTB2007376; World Health Organization, 1995, WHOTB95183; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, STOP TB STRAT BUILD; Yatin Dholakia, 2000, Indian Journal of Tuberculosis, V47, P233	54	96	99	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2008	336	7642					484	487		10.1136/bmj.39463.640787.BE	http://dx.doi.org/10.1136/bmj.39463.640787.BE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18250104	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000253997500040
J	Besselink, MGH; van Santvoort, HC; Buskens, E; Boermeester, MA; van Goor, H; Timmerman, HM; Nieuwenhuijs, VB; Bollen, TL; van Ramshorst, B; Witteman, BJM; Rosman, C; Ploeg, RJ; Brink, MA; Schaapherder, AFM; Dejong, CHC; Wahab, PJ; van Laarhoven, CJHM; van der Harst, E; van Eijck, CHJ; Cuesta, MA; Akkermans, LMA; Gooszen, HG				Besselink, Marc G. H.; van Santvoort, Hjalmar C.; Buskens, Erik; Boermeester, Marja A.; van Goor, Harry; Timmerman, Harro M.; Nieuwenhuijs, Vincent B.; Bollen, Thomas L.; van Ramshorst, Bert; Witteman, Ben J. M.; Rosman, Camiel; Ploeg, Rutger J.; Brink, Menno A.; Schaapherder, Alexander F. M.; Dejong, Cornelis H. C.; Wahab, Peter J.; van Laarhoven, Cees J. H. M.; van der Harst, Erwin; van Eijck, Casper H. J.; Cuesta, Miguel A.; Akkermans, Louis M. A.; Gooszen, Hein G.		Dutch Acute Pancreatitis Study Grp	Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							EARLY ENTERAL NUTRITION; NONOCCLUSIVE MESENTERIC ISCHEMIA; BACTERIAL-INFECTION RATES; CRITICALLY-ILL PATIENTS; FIBER SUPPLEMENT; CLINICAL-TRIAL; ANTIBIOTIC-TREATMENT; BARRIER FAILURE; LACTOBACILLUS; TRANSLOCATION	Background Infectious complications and associated mortality are a major concern in acute pancreatitis. Enteral administration of probiotics could prevent infectious complications, but convincing evidence is scarce. Our aim was to assess the effects of probiotic prophylaxis in patients with predicted severe acute pancreatitis. Methods In this multicentre randomised, double-blind, placebo-controlled trial, 298 patients with predicted severe acute pancreatitis (Acute Physiology and Chronic Health Evaluation [APACHE II] score >= 8, Imrie score >= 3, or C-reactive protein >150 mg/L) were randomly assigned within 72 h of onset of symptoms to receive a multispecies probiotic preparation (n=153) or placebo (n=145), administered enterally twice daily for 28 days. The primary endpoint was the composite of infectious complications-ie, infected pancreatic necrosis, bacteraemia, pneumonia, urosepsis, or infected ascites-during admission and 90-day follow-up. Analyses were by intention to treat. This study is registered, number ISRCTN38327949. Findings One person in each group was excluded from analyses because of incorrect diagnoses of pancreatitis; thus, 152 individuals in the probiotics group and 144 in the placebo group were analysed. Groups were much the same at baseline in terms of patients' characteristics and disease severity. Infectious complications occurred in 46 (30%) patients in the probiotics group and 41 (28%) of those in the placebo group (relative risk 1.06, 95% CI 0.75-1.51). 24 (16%) patients in the probiotics group died, compared with nine (6%) in the placebo group (relative risk 2.53, 95% CI 1.22-5.25). Nine patients in the probiotics group developed bowel ischaemia (eight with fatal outcome), compared with none in the placebo group (p=0.004). Interpretation In patients with predicted severe acute pancreatitis, probiotic prophylaxis with this combination of probiotic: strains did not reduce the risk of infectious complications and was associated with an increased risk of mortality. Probiotic prophylaxis should therefore not be administered in this category of patients.	[Besselink, Marc G. H.; van Santvoort, Hjalmar C.; Timmerman, Harro M.; Akkermans, Louis M. A.; Gooszen, Hein G.] Univ Med Ctr Utrecht, Dept Surg, NL-3508 GA Utrecht, Netherlands; [Buskens, Erik] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Nieuwenhuijs, Vincent B.; Ploeg, Rutger J.] Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Bollen, Thomas L.] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [van Ramshorst, Bert] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands; [Witteman, Ben J. M.] Gelderse Vallei Hosp, Dept Gastroenterol, Ede, Netherlands; [Rosman, Camiel] Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; [Brink, Menno A.] Meander Med Ctr, Dept Gastroenterol, Amersfoort, Netherlands; [Schaapherder, Alexander F. M.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Dejong, Cornelis H. C.] Univ Hosp Maastricht, Dept Surg, Maastricht, Netherlands; [Dejong, Cornelis H. C.] Univ Hosp Maastricht, NUTRIM, Maastricht, Netherlands; [Wahab, Peter J.] Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands; [van Laarhoven, Cees J. H. M.] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands; [van der Harst, Erwin] Med Ctr Rijnmond Zuid, Dept Surg, Rotterdam, Netherlands; [van Eijck, Casper H. J.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Cuesta, Miguel A.] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Gelderse Vallei Hospital; Canisius-Wilhelmina Hospital; Meander Medisch Centrum; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Rijnstate Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Gooszen, HG (corresponding author), Univ Med Ctr Utrecht, Dept Surg, POB 85500,HP G04-228, NL-3508 GA Utrecht, Netherlands.	h.gooszen@umcutrecht.nl	van+Goor, Harry/AAS-7712-2020; rosman, camiel/F-9059-2016; Besselink, Marc G/R-4268-2019; Van Eijck, Casper/ABD-1655-2020	rosman, camiel/0000-0002-9152-3987; Besselink, Marc G/0000-0003-2650-9350; buskens, erik/0000-0002-6463-1106				Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; ANDERSSON R, 1995, PANCREAS, V11, P365, DOI 10.1097/00006676-199511000-00008; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2; Besselink Marc G H, 2004, BMC Surg, V4, P12, DOI 10.1186/1471-2482-4-12; BLARNEY SL, 1984, GUT, V25, P1340; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; de Vries AC, 2007, PANCREATOLOGY, V7, P531, DOI 10.1159/000108971; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; Dellinger EP, 2007, ANN SURG, V245, P674, DOI 10.1097/01.sla.0000250414.09255.84; Frey CF, 2006, PANCREAS, V33, P336, DOI 10.1097/01.mpa.0000236727.16370.99; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Hirota M, 2003, PANCREATOLOGY, V3, P316, DOI 10.1159/000071770; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Isenmann R, 2004, GASTROENTEROLOGY, V126, P997, DOI 10.1053/j.gastro.2003.12.050; Jain PK, 2004, CLIN NUTR, V23, P467, DOI 10.1016/j.clnu.2003.12.002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolkman JJ, 2003, BEST PRACT RES CL GA, V17, P457, DOI 10.1016/S1521-6918(03)00021-0; Mazaki T, 2006, BRIT J SURG, V93, P674, DOI 10.1002/bjs.5389; McClave Stephen A, 2003, Nutr Clin Pract, V18, P279, DOI 10.1177/0115426503018004279; Melis M, 2006, ARCH SURG-CHICAGO, V141, P701, DOI 10.1001/archsurg.141.7.701; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Olah A, 2002, BRIT J SURG, V89, P1103, DOI 10.1046/j.1365-2168.2002.02189.x; Olah A, 2007, HEPATO-GASTROENTEROL, V54, P590; Omata J, 2007, J SURG RES, V143, P260, DOI 10.1016/j.jss.2006.12.004; Rahman SH, 2003, J GASTROINTEST SURG, V7, P26, DOI 10.1016/S1091-255X(02)00090-2; Rahman SH, 2003, BRIT J SURG, V90, P123, DOI 10.1002/bjs.4097; Rayes N, 2005, AM J TRANSPLANT, V5, P125, DOI 10.1111/j.1600-6143.2004.00649.x; Rayes N, 2007, ANN SURG, V246, P36, DOI 10.1097/01.sla.0000259442.78947.19; Ridwan BU, 2008, LETT APPL MICROBIOL, V46, P61, DOI 10.1111/j.1472-765X.2007.02260.x; Singhi S, 2007, PEDIATR CRIT CARE ME, V8, P499, DOI 10.1097/01.PCC.0000282165.04260.59; Sukhotnik I, 2007, DIGEST DIS SCI, V52, P1497, DOI 10.1007/s10620-006-9629-8; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Weale R, 2003, BRIT J SURG, V90, P122, DOI 10.1002/bjs.4089; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; 2005, GUT S3, V54, P1	40	848	923	0	112	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					651	659		10.1016/S0140-6736(08)60207-X	http://dx.doi.org/10.1016/S0140-6736(08)60207-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18279948				2022-12-28	WOS:000253436700029
J	Dayan, B; Parkins, AS; Aoki, T; Ostby, EP; Vahala, KJ; Kimble, HJ				Dayan, Barak; Parkins, A. S.; Aoki, Takao; Ostby, E. P.; Vahala, K. J.; Kimble, H. J.			A photon turnstile dynamically regulated by one atom	SCIENCE			English	Article							STRONGLY INTERACTING PHOTONS; NONLINEAR CAVITY; RESONANT-CAVITY; SINGLE-ATOM; QUANTUM; QUBITS; LIGHT	Beyond traditional nonlinear optics with large numbers of atoms and photons, qualitatively new phenomena arise in a quantum regime of strong interactions between single atoms and photons. By using a microscopic optical resonator, we achieved such interactions and demonstrated a robust, efficient mechanism for the regulated transport of photons one by one. With critical coupling of the input light, a single atom within the resonator dynamically controls the cavity output conditioned on the photon number at the input, thereby functioning as a photon turnstile. We verified the transformation from a Poissonian to a sub- Poissonian photon stream by photon counting measurements of the input and output fields. The results have applications in quantum information science, including for controlled interactions of single light quanta and for scalable quantum processing on atom chips.	[Dayan, Barak; Parkins, A. S.; Aoki, Takao; Kimble, H. J.] CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; [Aoki, Takao; Ostby, E. P.; Vahala, K. J.] CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Dayan, Barak/Q-7480-2017	Dayan, Barak/0000-0001-8592-8550; Parkins, Andrew/0000-0002-5922-4506				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Bimbaum K. M., 2005, NATURE, V436, P87; CARMICHAEL HJ, 1985, PHYS REV LETT, V55, P2790, DOI 10.1103/PhysRevLett.55.2790; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; Gorodetsky ML, 2000, J OPT SOC AM B, V17, P1051, DOI 10.1364/JOSAB.17.001051; Grangier P, 1998, PHYS REV LETT, V81, P2833, DOI 10.1103/PhysRevLett.81.2833; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; Kimble HJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.249801; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Mandel L, 1995, OPTICAL COHERENCE QU; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Raimond JM, 2005, J PHYS B-AT MOL OPT, V38, pS535, DOI 10.1088/0953-4075/38/9/006; Rebic S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063804; Rebic S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.043806; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; TIAN L, 1992, PHYS REV A, V46, pR6801, DOI 10.1103/PhysRevA.46.R6801; Treutlein P, 2006, FORTSCHR PHYS, V54, P702, DOI 10.1002/prop.200610325; TURCHETTE QA, 1995, APPL PHYS B-LASERS O, V60, pS1; Walther H, 2004, FORTSCHR PHYS, V52, P1154, DOI 10.1002/prop.200410185; Werner M. J., 1999, PHYS REV A, V61; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	31	489	501	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1062	1065		10.1126/science.1152261	http://dx.doi.org/10.1126/science.1152261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292335				2022-12-28	WOS:000253311700035
J	Rodriguez-Munoz, R; Ojanguren, AF; Tregenza, T				Rodriguez-Munoz, Rolando; Ojanguren, Alfredo F.; Tregenza, Tom			Comment on international conservation policy delivers benefits for birds in Europe	SCIENCE			English	Editorial Material									[Rodriguez-Munoz, Rolando; Tregenza, Tom] Univ Exeter, Ctr Ecol & Conservat, Tremough, Penryn, England; [Ojanguren, Alfredo F.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX 78373 USA	University of Exeter; University of Texas System; University of Texas Austin	Rodriguez-Munoz, R (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Tremough, Penryn, England.	R.Rodriguez-Munoz@exeter.ac.uk	Ojanguren, Alfredo/F-1672-2011; Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222; Ojanguren, Alfredo/0000-0001-6273-1122	Natural Environment Research Council [NE/E005403/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BirdLife International, 2004, BIRDS EUR POP EST TR; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; OBRIAIN M, 2000, NATURA 2000, P6; Tucker G., 1994, BIRDLIFE CONSERVATIO; 2004, NATURA 2000, P10	6	2	2	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866								10.1126/science.1151810	http://dx.doi.org/10.1126/science.1151810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292325				2022-12-28	WOS:000253311700022
J	Kraal, ER; van Dijk, M; Postma, G; Kleinhans, MG				Kraal, Erin R.; van Dijk, Maurits; Postma, George; Kleinhans, Maarten G.			Martian stepped-delta formation by rapid water release	NATURE			English	Article							MODEL; FLOW	Deltas and alluvial fans preserved on the surface of Mars provide an important record of surface water flow(1-3). Understanding how surface water flow could have produced the observed morphology is fundamental to understanding the history of water on Mars. To date, morphological studies have provided only minimum time estimates for the longevity of martian hydrologic events, which range from decades to millions of years(4-7). Here we use sand flume studies to show that the distinct morphology of martian stepped (terraced) deltas(8-11) could only have originated from a single basin- filling event on a timescale of tens of years. Stepped deltas therefore provide a minimum and maximum constraint on the duration and magnitude of some surface flows on Mars. We estimate that the amount of water required to fill the basin and deposit the delta is comparable to the amount of water discharged by large terrestrial rivers, such as the Mississippi. The massive discharge, short timescale, and the associated short canyon lengths favour the hypothesis that stepped fans are terraced delta deposits draped over an alluvial fan and formed by water released suddenly from subsurface storage.	[Kraal, Erin R.; van Dijk, Maurits; Postma, George; Kleinhans, Maarten G.] Univ Utrecht, Fac Geosci, NL-3508 TC Utrecht, Netherlands	Utrecht University	Kraal, ER (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, 4044 Derring Hall 0420, Blacksburg, VA 24061 USA.	ekraal@vt.edu	Kleinhans, Maarten G./L-6697-2016	Kleinhans, Maarten G./0000-0002-9484-1673				Bhattacharya JP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022747; Blair T. C., 1994, GEOMORPHOLOGY DESERT, P354, DOI [10.1007/978-94-015-8254-4_14, DOI 10.1007/978-94-015-8254-4_14, 10.1007/978-94-015-8254-4, DOI 10.1007/978-94-015-8254-4]; BLAIR TC, 1994, J SEDIMENT RES A, V64, P450; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; Di Achille G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025435; Dobrea EZN, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002431; Hecht MH, 2002, ICARUS, V156, P373, DOI 10.1006/icar.2001.6794; Hunt AG, 2006, J HYDROL, V322, P192, DOI 10.1016/j.jhydrol.2005.02.034; Irwin RP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002460; Jerolmack DJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021326; KLEINHANS MG, 2005, MARS J GEOPHYS RES, V110, DOI DOI 10.1029/2005JE002521; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Melosh H. J., 1996, IMPACT CRATERING GEO; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Moore JM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002352; MOORE JM, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GRL019002; Muto T, 2001, GEOLOGY, V29, P771, DOI 10.1130/0091-7613(2001)029<0771:ADTTGO>2.0.CO;2; NANNINGA PM, 1985, MATH GEOL, V17, P53; Ori GG, 2000, J GEOPHYS RES-PLANET, V105, P17629, DOI 10.1029/1999JE001219; Peakall J, 1996, BING SYMP G, P221; PIERSON TC, 1985, WATER RESOUR RES, V21, P1511, DOI 10.1029/WR021i010p01511; Sears DWG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023443; van Heijst MWIM, 2001, BASIN RES, V13, P243, DOI 10.1046/j.1365-2117.2001.00150.x; Weitz CM, 2006, ICARUS, V184, P436, DOI 10.1016/j.icarus.2006.05.024; WILLIAMS RME, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2005GRL025618	25	70	71	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					973	U2		10.1038/nature06615	http://dx.doi.org/10.1038/nature06615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288190				2022-12-28	WOS:000253313100044
J	Jonklaas, J; Davidson, B; Bhagat, S; Soldin, SJ				Jonklaas, Jacqueline; Davidson, Bruce; Bhagat, Supna; Soldin, Steven J.			Triiodothyronine levels in athyreotic individuals during levothyroxine therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	78th Annual Meeting of the American-Thyroid-Association	OCT 05, 2007	New York, NY	Amer Thyroid Assoc			THYROXINE PLUS TRIIODOTHYRONINE; RANDOMIZED CONTROLLED-TRIAL; PATIENTS RECEIVING THYROXINE; IMPROVE DEPRESSIVE SYMPTOMS; CONTROLLED CLINICAL-TRIAL; REPLACEMENT THERAPY; PRIMARY HYPOTHYROIDISM; DOUBLE-BLIND; LIOTHYRONINE; MONOTHERAPY	Context Thyroidal production of triiodothyronine ( T-3) is absent in athyreotic patients, leading to the suggestion that T-3 deficiency may be unavoidable during levothyroxine ( LT4) therapy. However, trials evaluating therapy with combined LT4 and T-3 have failed to demonstrate any consistent advantage of combination therapy. Objective To determine whether T-3 levels in patients treated with LT4 therapy were truly lower than in the same patients with native thyroid function. Design, Setting, and Patients A prospective study conducted in the General Clinical Research Center, Georgetown University Medical Center, Washington, DC, between January 30, 2004, and June 20, 2007, of 50 euthyroid study participants aged 18 to 65 years who were scheduled for total thyroidectomy for goiter, benign nodular disease, suspected thyroid cancer, or known thyroid cancer. Following thyroidectomy, patients were prescribed LT4. Patients with benign thyroid disease and thyroid cancer were treated to achieve a normal and suppressed serum thyroid- stimulating hormone ( TSH) level, respectively. The LT4 dose was adjusted as necessary postoperatively to achieve the desired TSH goal. Main Outcome Measure Thyroxine ( tetraiodothyronine [ T-4]), T-3, and TSH levels were measured twice preoperatively and twice postoperatively. Results By the end of the study, there were no significant decreases in T-3 concentrations in patients receiving LT4 therapy compared with their prethyroidectomy T-3 levels ( mean, 127.2 ng/ dL; 95% confidence interval [ CI], 119.5- 134.9 ng/ dL vs 129.3 ng/ dL; 95% CI, 121.9- 136.7 ng/ dL; P=. 64). However, free T-4 concentrations were significantly higher in patients treated with LT4 therapy ( mean, 1.41 ng/ dL; 95% CI, 1.33- 1.49 ng/ dL) compared with their native free T-4 levels ( 1.05 ng/ dL; 95% CI, 1.00-1.10 ng/ dL; P <. 001). Serum TSH values of 4.5 mIU/ L or less were achieved in 94% of patients by the end of the study. The T-3 concentrations were lower in the subgroup of patients whose therapy had not resulted in a TSH level of 4.5 mIU/ L or less ( P <. 001). Conclusion In our study, normal T-3 levels were achieved with traditional LT4 therapy alone in patients who had undergone near- total or total thyroidectomy, which suggests that T-3 administration is not necessary to maintain serum T-3 values at their endogenous prethyroidectomy levels.	[Jonklaas, Jacqueline] Georgetown Univ, Med Ctr, Div Endocrinol, Washington, DC 20007 USA; [Jonklaas, Jacqueline; Bhagat, Supna] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Davidson, Bruce] Georgetown Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Washington, DC 20007 USA; [Soldin, Steven J.] Georgetown Univ, Med Ctr, Bioanalyt Core Lab, Gen Clin Res Ctr, Washington, DC 20007 USA; [Soldin, Steven J.] Childrens Natl Med Ctr, Dept Lab Med, Washington, DC 20010 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Children's National Health System	Jonklaas, J (corresponding author), Georgetown Univ Hosp, Div Endocrinol, Ste 232,Bldg D,4000 Reservoir Rd NW, Washington, DC 20007 USA.	jj@bc.georgetown.edu	Jonklaas, Jacqueline/G-2807-2010	Jonklaas, Jacqueline/0000-0002-2238-2666	NCRR NIH HHS [M01-RR-023942-01, K23 RR16524, M01-RR-020359] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR023942, K23RR016524, M01RR020359] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; BINDELS AJCH, 1988, NETH J MED, V32, P59; BRAVERMAN LE, 1973, J CLIN INVEST, V52, P1010, DOI 10.1172/JCI107265; BRAVERMAN LE, 1970, J CLIN INVEST, V49, P855, DOI 10.1172/JCI106304; Bunevicius R, 2000, INT J NEUROPSYCHOPH, V3, P167, DOI 10.1017/S1461145700001826; Bunevicius R, 2002, ENDOCRINE, V18, P129, DOI 10.1385/ENDO:18:2:129; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Clyde PW, 2003, JAMA-J AM MED ASSOC, V290, P2952, DOI 10.1001/jama.290.22.2952; Cooper DS, 2003, JAMA-J AM MED ASSOC, V290, P3002, DOI 10.1001/jama.290.22.3002; de Jong FJ, 2007, J CLIN ENDOCR METAB, V92, P636, DOI 10.1210/jc.2006-1331; Escobar-Morreale HF, 2005, J CLIN ENDOCR METAB, V90, P4946, DOI 10.1210/jc.2005-0184; Escobar-Morreale HF, 2005, ANN INTERN MED, V142, P412, DOI 10.7326/0003-4819-142-6-200503150-00007; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; EscobarMorreale HF, 1995, J CLIN INVEST, V96, P2828, DOI 10.1172/JCI118353; Fadeyev Valentin V, 2005, Hormones (Athens), V4, P101; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; JENNINGS PE, 1984, BRIT MED J, V289, P1645, DOI 10.1136/bmj.289.6459.1645; Joffe RT, 2004, ANN NY ACAD SCI, V1032, P287, DOI 10.1196/annals.1314.040; Kahric-Janicic N, 2007, THYROID, V17, P303, DOI 10.1089/thy.2006.0303; Ladenson PW, 2002, CLIN ENDOCRINOL, V57, P575, DOI 10.1046/j.1365-2265.2002.01682.x; LIEWENDAHL K, 1987, ACTA ENDOCRINOL-COP, V116, P418, DOI 10.1530/acta.0.1160418; LUM SMC, 1984, J CLIN INVEST, V73, P570, DOI 10.1172/JCI111245; MURCHISON LE, 1976, HORM METAB RES, V8, P324, DOI 10.1055/s-0028-1095619; Nicoloff J T, 1984, Horm Metab Res Suppl, V14, P74; PEARCE CJ, 1984, BRIT MED J, V288, P693, DOI 10.1136/bmj.288.6418.693; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Regalbuto C, 2007, THYROID, V17, P323, DOI 10.1089/thy.2006.0084; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Saravanan P, 2005, J CLIN ENDOCR METAB, V90, P805, DOI 10.1210/jc.2004-1672; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P4551, DOI 10.1210/jc.2003-030139; Siegmund W, 2004, CLIN ENDOCRINOL, V60, P750, DOI 10.1111/j.1365-2265.2004.02050.x; SMITH RN, 1970, BRIT MED J, V4, P145, DOI 10.1136/bmj.4.5728.145; Soukhova N, 2004, CLIN CHIM ACTA, V343, P185, DOI 10.1016/j.cccn.2004.01.007; SURKS MI, 1972, J CLIN INVEST, V51, P3104, DOI 10.1172/JCI107137; Walsh JP, 2003, J CLIN ENDOCR METAB, V88, P4543, DOI 10.1210/jc.2003-030249; Walsh JP, 2002, CURR OPIN PHARMACOL, V2, P717, DOI 10.1016/S1471-4892(02)00209-6; Woeber KA, 2002, J ENDOCRINOL INVEST, V25, P106, DOI 10.1007/BF03343972	39	129	132	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					769	777		10.1001/jama.299.7.769	http://dx.doi.org/10.1001/jama.299.7.769			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	263OR	18285588	Bronze			2022-12-28	WOS:000253226900019
J	Druce, M; Goldstone, AP; Tan, TMM; Meeran, K				Druce, Maralyn; Goldstone, Anthony P.; Tan, Tricia M. M.; Meeran, Karim			The pursuit of beauty	LANCET			English	Editorial Material									[Druce, Maralyn; Goldstone, Anthony P.; Tan, Tricia M. M.; Meeran, Karim] Hammersmith Hosp, Endocrine Unit, Dept Investigat Med, Imperial Coll Healthcare NHS Trust, London W12 0HS, England	Imperial College London	Tan, TMM (corresponding author), Hammersmith Hosp, Endocrine Unit, Dept Investigat Med, Imperial Coll Healthcare NHS Trust, Du Cane Rd, London W12 0HS, England.	t.tan@imperial.ac.uk	Tan, Tricia/ABD-5502-2020; Tan, Tricia M.M./C-7140-2011	Tan, Tricia M.M./0000-0001-5873-3432; Goldstone, Anthony/0000-0001-8179-7071					0	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2008	371	9612					596	596		10.1016/S0140-6736(08)60272-X	http://dx.doi.org/10.1016/S0140-6736(08)60272-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263FI	18280330	Bronze			2022-12-28	WOS:000253202600026
J	Peter, JV; Prabhakar, AT; Pichamuthu, K				Peter, John Victor; Prabhakar, Appaswamy T.; Pichamuthu, Kishore			In-laws, insecticide - and a mimic of brain death	LANCET			English	Editorial Material									[Peter, John Victor; Prabhakar, Appaswamy T.; Pichamuthu, Kishore] Christian Med Coll & Hosp, Med Intens Care Unit, Dept Med Intens Care, Vellore 632004, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Peter, JV (corresponding author), Christian Med Coll & Hosp, Med Intens Care Unit, Dept Med Intens Care, Vellore 632004, Tamil Nadu, India.	peterjohnvictor@yahoo.com.au	Peter, John Victor/R-7700-2019; Pichamuthu, Kishore/AAH-4002-2020	Pichamuthu, Kishore/0000-0002-6977-1183				DAVIES JE, 1975, ARCH ENVIRON HEALTH, V30, P608, DOI 10.1080/00039896.1975.10666790; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Peter JV, 2000, ANAESTH INTENS CARE, V28, P11, DOI 10.1177/0310057X0002800102; Yardan T, 2007, CLIN TOXICOL, V45, P733, DOI 10.1080/15563650701502733	5	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2008	371	9612					622	622		10.1016/S0140-6736(08)60273-1	http://dx.doi.org/10.1016/S0140-6736(08)60273-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280331				2022-12-28	WOS:000253202600029
J	Fan, WW; Waymire, KG; Narula, N; Li, P; Rocher, C; Coskun, PE; Vannan, MA; Narula, J; MacGregor, GR; Wallace, DC				Fan, Weiwei; Waymire, Katrina G.; Narula, Navneet; Li, Peng; Rocher, Christophe; Coskun, Pinar E.; Vannan, Mani A.; Narula, Jagat; MacGregor, Grant R.; Wallace, Douglas C.			A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations	SCIENCE			English	Article							FOLLICLE-STIMULATING-HORMONE; ADAPTIVE SELECTION; APOPTOSIS; GENE; DNA	The majority of mitochondrial DNA ( mtDNA) mutations that cause human disease are mild to moderately deleterious, yet many random mtDNA mutations would be expected to be severe. To determine the fate of the more severe mtDNA mutations, we introduced mtDNAs containing two mutations that affect oxidative phosphorylation into the female mouse germ line. The severe ND6 mutation was selectively eliminated during oogenesis within four generations, whereas the milder COI mutation was retained throughout multiple generations even though the offspring consistently developed mitochondrial myopathy and cardiomyopathy. Thus, severe mtDNA mutations appear to be selectively eliminated from the female germ line, thereby minimizing their impact on population fitness.	[Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; MacGregor, Grant R.; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Narula, Navneet] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Li, Peng; Vannan, Mani A.; Narula, Jagat] Univ Calif Irvine, Div Cardiol, Dept Med, Irvine, CA 92697 USA; [MacGregor, Grant R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [MacGregor, Grant R.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu	Vannan, Mani/AAQ-5992-2020; Fan, Weiwei/B-3782-2010	Rocher, Christophe/0000-0003-1859-9704	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573, R01AG013154, R01AG024373] Funding Source: NIH RePORTER; NIA NIH HHS [AG13154, AG24373, AG16573] Funding Source: Medline; NICHD NIH HHS [U01 HD045913-03, U01 HD045913-02, U01 HD045913-01, HD45913, U01 HD045913-04] Funding Source: Medline; NIDDK NIH HHS [DK73691] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; MACGREGOR GR, 2006, EMBRYONIC STEM CELLS, P72; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; Wallace D. C., 2007, EMERY RIMOINS PRINCI, V1, P194; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	19	321	329	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					958	962		10.1126/science.1147786	http://dx.doi.org/10.1126/science.1147786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276892	Green Accepted			2022-12-28	WOS:000253165700048
J	Gill, R; Aranki, SF				Gill, Ritu; Aranki, Sary F.			Left atrial myxoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gill, Ritu; Aranki, Sary F.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Gill, R (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	rgill@partners.org	Gill, Ritu R/AAP-2280-2021	aranki, sary/0000-0002-3129-3403					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					728	728		10.1056/NEJMicm0708551	http://dx.doi.org/10.1056/NEJMicm0708551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272896				2022-12-28	WOS:000253127700009
J	McFarland, HF				McFarland, Henry F.			Focus on research: The B cell - Old player, new position on the team	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MULTIPLE-SCLEROSIS		[McFarland, Henry F.] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McFarland, HF (corresponding author), Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002204, Z01NS002204] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820	5	45	47	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					664	665		10.1056/NEJMp0708143	http://dx.doi.org/10.1056/NEJMp0708143			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272890				2022-12-28	WOS:000253127700002
J	Mannion, R; Davies, H				Mannion, Russell; Davies, Huw			Payment for performance in health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAY-FOR-PERFORMANCE; FINANCIAL INCENTIVES; QUALITY; IMPACT; IMPROVE		[Mannion, Russell] Univ York, Ctr Hlth & Publ Serv Management, York YO10 5DD, N Yorkshire, England; [Davies, Huw] Univ Dundee, Social Dimens Hlth Inst, Dundee DD1 4HN, Scotland; [Davies, Huw] Univ St Andrews, Social Dimens Hlth Inst, St Andrews KY16 9AJ, Fife, Scotland	University of York - UK; University of Dundee; University of St Andrews	Mannion, R (corresponding author), Univ York, Ctr Hlth & Publ Serv Management, York YO10 5DD, N Yorkshire, England.	rm15@york.ac.uk		Mannion, Russell/0000-0002-0680-8049; Davies, Huw/0000-0002-2653-3695				Bierman AS, 2007, BMJ-BRIT MED J, V334, P1333, DOI 10.1136/bmj.39251.660127.AD; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fairbrother G, 2001, AMBUL PEDIATR, V1, P206, DOI 10.1367/1539-4409(2001)001<0206:IOFIOD>2.0.CO;2; Frey B., 1997, NOT JUST MONEY EC TH; GRAVELLE H, 2007, 28 CHE U YORK; Hahn J, 2006, PAY PERFORMANCE HLTH; Hillman AL, 1998, AM J PUBLIC HEALTH, V88, P1699, DOI 10.2105/AJPH.88.11.1699; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2007, REW PROV PERF AL INC; Le Grand J., 2003, MOTIVATION AGENCY PU; Maynard A, 2007, BMJ-BRIT MED J, V334, P234, DOI 10.1136/bmj.39066.452847.68; McDonald R, 2007, BMJ-BRIT MED J, V334, P1357, DOI 10.1136/bmj.39238.890810.BE; NORTON EC, 1992, J HEALTH ECON, V11, P105, DOI 10.1016/0167-6296(92)90030-5; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Roland M, 2006, PRIM HEALTH CARE RES, V7, P18, DOI DOI 10.1191/1463423606PC2720A; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Shekelle P, 2003, BRIT MED J, V326, P457, DOI 10.1136/bmj.326.7387.457; Shen YJ, 2003, HEALTH SERV RES, V38, P535, DOI 10.1111/1475-6773.00132; SMITH PC, 2006, INT J PUB ADM, V18, P277	20	69	69	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					306	308		10.1136/bmj.39463.454815.94	http://dx.doi.org/10.1136/bmj.39463.454815.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18258966	Green Published, Green Submitted			2022-12-28	WOS:000253437400030
J	Chien, Y; Lowe, SW				Chien, Yuchen; Lowe, Scott W.			Secreting tumor suppression	CELL			English	Editorial Material							SENESCENCE; P53; CANCER	Cellular senescence limits the proliferative capacity of damaged cells and thereby acts as an intrinsic mechanism of tumor suppression. In this issue, Wajapeyee et al. (2008) identify insulin growth factor binding protein 7 (IGFBP7) as a secreted factor that mediates senescence induced by oncogenic BRAF in normal melanocytes. In addition, IGFBP7 triggers apoptosis in cells that have progressed to melanoma, suggesting a new approach for melanoma treatment.	[Chien, Yuchen; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIA NIH HHS [R01 AG016379, R01 AG016379-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016379] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	10	5	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					339	341		10.1016/j.cell.2008.01.022	http://dx.doi.org/10.1016/j.cell.2008.01.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267066	Green Accepted, Bronze			2022-12-28	WOS:000253180700009
J	Qayyum, R; Khalid, MR; Adornaityte, J; Papadakos, SP; Messineo, FC				Qayyum, Rehan; Khalid, M. Rizwan; Adornaityte, Jurga; Papadakos, Stylianos P.; Messineo, Frank C.			Systematic review: Comparing routine and selective invasive strategies for the acute coronary syndrome	ANNALS OF INTERNAL MEDICINE			English	Review							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; ASSOCIATION TASK-FORCE; RANDOMIZED-TRIAL; UNSTABLE ANGINA; CONSERVATIVE STRATEGIES; WRITING COMMITTEE; AMERICAN-COLLEGE; METAANALYSIS; MANAGEMENT	Background: Patients with non-ST-segment elevation acute coronary syndrome (ACS) are managed with either a routine invasive strategy, in which all patients receive coronary angiography, or a selective invasive strategy, in which only patients with refractory or inducible ischemia receive coronary angiography. Purpose: To evaluate whether a routine invasive strategy improves cardiovascular outcomes more than a selective invasive strategy in patients with non-ST-segment elevation ACS. Data Sources: English-language publications in PubMed, EMBASE and the Cochrane Central Register of Controlled Trials from 196 to 18 September 2007. Study Selection: Two investigators independently reviewed searches and selected trials that compared death or myocardial infarction outcomes among adults with non-ST-segment elevation ACS by randomly assigning patients to either a routine invasive strategy or a selective invasive strategy. Data Extraction: Three investigators independently abstracted data from trial reports by using standardized forms. Data Synthesis: 10 trials with a total of 10 648 patients (mean age, 62 years; 71% male; median follow-up, 16.5 months) were found. Trial participants had typical symptoms of unstable angina and frequently had a positive electrocardiogram or marker evidence of myocardial ischemia. Of the 5330 participants assigned to the routine invasive strategy group, 847 had the composite outcome of death or nonfatal myocardial infarction, compared with 928 of 5318 participants assigned to the selective invasive strategy group (relative risk, 0.90 [95% CI, 0.74 to 1.08]). Four hundred thirty-eight patients in the routine invasive strategy group and 463 in the selective invasive strategy group died (relative risk, 0.95 [CI, 0.80 to 1.14)). Four hundred ninety and 569 nonfatal myocardial infarctions, respectively, occurred in the 2 groups (relative risk, 0.86 [CI, 0.68 to 1.08]). Limitations: Methodology, protocols, and outcome definitions differed substantially among the trials. The lower bound of the Cl for the pooled results did not rule out the superiority of the routine invasive strategy. Conclusion: Available trial evidence is heterogeneous and insufficient for comparing routine and selective invasive strategies. Therefore, in patients with non-ST-segment elevation ACS a routine invasive strategy cannot be proven to reduce deaths or nonfatal myocardial infarction.	[Qayyum, Rehan] Johns Hopkins Univ Hosp, Hospistalist Program, Baltimore, MD 21287 USA; New York Hosp Queens, Flushing, NY USA	Johns Hopkins University; Johns Hopkins Medicine; NewYork-Presbyterian Hospital	Qayyum, R (corresponding author), Johns Hopkins Univ Hosp, Hospistalist Program, 600 N Wolfe St,Pk 307 A, Baltimore, MD 21287 USA.	rqayyum@jhmi.edu		Qayyum, Rehan/0000-0003-3086-8014				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boden WE, 2005, NEW ENGL J MED, V353, P1159, DOI 10.1056/NEJMe058169; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; CANNON CP, 2005, BRAUNWALDS HEART DIS, P1243; Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eisenberg MJ, 2005, AM HEART J, V149, P813, DOI 10.1016/j.ahj.2004.08.040; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Hirsch A, 2007, LANCET, V369, P827, DOI 10.1016/S0140-6736(07)60410-3; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; LAPOSTOLLE F, COMPARISON 2 TREATME; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MCALISTER FA, 2001, SYSTEMATIC REV HLTH, P373; McCullough PA, 1998, J AM COLL CARDIOL, V32, P596, DOI 10.1016/S0735-1097(98)00284-8; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Michalis LK, 2000, EUR HEART J, V21, P1954, DOI 10.1053/euhj.2000.2397; SAVONITTO S, EARLY AGGRESSIVE VS; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; SWAHN E, 2007, EUR SOC CARD C 1 5 S; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; THIELE H, RANDOMIZED TRAIAL IM	27	29	30	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					186	196		10.7326/0003-4819-148-3-200802050-00005	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18252682				2022-12-28	WOS:000252849700003
J	Hainaut, P; Boyle, P				Hainaut, Pierre; Boyle, Peter			Curbing the liver cancer epidemic in Africa	LANCET			English	Editorial Material							HEPATITIS-B; WEST-AFRICA; INFECTION; GAMBIA		[Hainaut, Pierre; Boyle, Peter] Int Agcy Res Canc, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Boyle, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	director@iarc.fr	Boyle, Peter/A-4380-2014; Hainaut, Pierre/B-6018-2012	Boyle, Peter/0000-0001-6251-0610; Hainaut, Pierre/0000-0002-1303-1610				Boyle P, 2006, LANCET, V368, P629, DOI 10.1016/S0140-6736(06)69225-8; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kirk GD, 2006, CARCINOGENESIS, V27, P2070, DOI 10.1093/carcin/bgl060; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; VANDERSANDE MA, PLOS ONE, V2, pE753; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4	8	36	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					367	368		10.1016/S0140-6736(08)60181-6	http://dx.doi.org/10.1016/S0140-6736(08)60181-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242399				2022-12-28	WOS:000252992700008
J	De Robertis, EM				De Robertis, E. M.			Evo-Devo: Variations on ancestral themes	CELL			English	Review							DEVELOPMENTAL BASIS; HOMEOBOX GENE; EVOLUTION; SEGMENTATION; TRANSFORMATION; CONSERVATION; DUPLICATION; COMPLEXITY; PROTEINS; INSIGHTS	Most animals evolved from a common ancestor, Urbilateria, which already had in place the developmental genetic networks for shaping body plans. Comparative genomics has revealed rather unexpectedly that many of the genes present in bilaterian animal ancestors were lost by individual phyla during evolution. Reconstruction of the archetypal developmental genomic tool-kit present in Urbilateria will help to elucidate the contribution of gene loss and developmental constraints to the evolution of animal body plans.	[De Robertis, E. M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [De Robertis, E. M.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		De Robertis, Edward/0000-0002-7843-1869	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502, R37HD021502] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD021502-21A1, HD21502-21, R01 HD021502, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Akiyama-Oda Y, 2006, DEVELOPMENT, V133, P2347, DOI 10.1242/dev.02400; [Anonymous], 1861, ORIGIN SPECIES MEANS; APPEL TA, 1987, CUVIERGEOFFROY DEBAT; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; BAGNALL KM, 1988, DEVELOPMENT, V103, P69; CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 2005, ENDLESS FORMS MOST B; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gehring WJ., 1998, MASTER CONTROL GENES; Gould S.J., 2002, STRUCTURE EVOLUTIONA, P1025; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Henry CA, 2002, DEVELOPMENT, V129, P3693; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Kirschner M, 2005, PLAUSIBILITY LIFE RE; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Minguillon C, 2003, DEVELOPMENT, V130, P5903, DOI 10.1242/dev.00811; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Ohno S., 1970, EVOLUTION GENE DUPLI; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Schrag DP, 2001, NATURE, V409, P306, DOI 10.1038/35053170; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1983, CELL, V35, P763, DOI 10.1016/0092-8674(83)90109-5; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; VALENTINE JW, 2004, ORIGIN PHYLA; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WEINBERG RA, 2006, BIOL CANC, P119; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	73	230	232	0	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					185	195		10.1016/j.cell.2008.01.003	http://dx.doi.org/10.1016/j.cell.2008.01.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243095	Green Accepted, Bronze			2022-12-28	WOS:000253427700006
J	Ramagopalan, SV; Ebers, GC				Ramagopalan, Sreeram V.; Ebers, George C.			Genes for multiple sclerosis	LANCET			English	Editorial Material							GENOME-WIDE ASSOCIATION; INTERLEUKIN-7 RECEPTOR; RISK LOCI; LINKAGE; SUSCEPTIBILITY; REGIONS		[Ramagopalan, Sreeram V.; Ebers, George C.] Wellcome Trust Ctr Human Genet, Oxford, England; [Ramagopalan, Sreeram V.; Ebers, George C.] John Radcliffe Hosp, Univ Dept Clin Neurol, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Ebers, GC (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	george.ebers@clneuro.ox.ac.uk		Ebers, George/0000-0003-4771-4177				Akesson E, 2003, J NEUROIMMUNOL, V143, P31, DOI 10.1016/j.jneuroim.2003.08.008; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Herrera BM, 2006, GENES IMMUN, V7, P366, DOI 10.1038/sj.gene.6364308; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	12	35	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2008	371	9609					283	285		10.1016/S0140-6736(08)60145-2	http://dx.doi.org/10.1016/S0140-6736(08)60145-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294983				2022-12-28	WOS:000252616500008
J	ANDERSON, A				ANDERSON, A			INTERNATIONAL-COOPERATION - JAPAN STILL AN ISLAND ACADEMICALLY	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					7	7		10.1038/344007b0	http://dx.doi.org/10.1038/344007b0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277994	Bronze			2022-12-28	WOS:A1990CQ97200019
J	HALLIDAY, AN; SHEPHERD, TJ; DICKIN, AP; CHESLEY, JT				HALLIDAY, AN; SHEPHERD, TJ; DICKIN, AP; CHESLEY, JT			SM-ND EVIDENCE FOR THE AGE AND ORIGIN OF A MISSISSIPPI VALLEY TYPE ORE DEPOSIT	NATURE			English	Article									BRITISH GEOL SURVEY,LONDON WC1X 8NG,ENGLAND; MCMASTER UNIV,DEPT GEOL,HAMILTON L8S 4M1,ONTARIO,CANADA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; McMaster University	HALLIDAY, AN (corresponding author), UNIV MICHIGAN,DEPT GEOL SCI,ANN ARBOR,MI 48109, USA.							Beales F.W., 1966, I MINING METALLURG B, V75, P278; BILLINGS GK, 1969, ECON GEOL, V64, P385, DOI 10.2113/gsecongeo.64.4.385; Bott M.H.P., 1957, Q J GEOL SOC LOND, V113, P93, DOI [10.1144/GSL.JGS.1957.113.01-04.05, DOI 10.1144/GSL.JGS.1957.113.01-04.05]; BROWN GC, 1987, T I MIN METALL B, V96, P365; CATHLES LM, 1983, ECON GEOL, V78, P983, DOI 10.2113/gsecongeo.78.5.983; DAVIES G, 1985, EARTH PLANET SC LETT, V75, P1, DOI 10.1016/0012-821X(85)90045-7; DOZY JJ, 1970, I MINING METALLURG B, V79, P163; DUNHAM K. C, 1965, QUART J GEOL SOC LONDON, V121, P383; DUNHAM KC, 1961, NATURE, V190, P899, DOI 10.1038/190899a0; DUNHAM KC, 1968, PROC R SOC LON SER-A, V307, P251, DOI 10.1098/rspa.1968.0188; Dunham KC., 1948, MEM GEOL SURV UK, V1; DUNHAM KC, 1983, P INT C MISSISSIPPI, P85; DUNHAM KC, 1934, Q J GEOLOGICAL SOC L, V0090, P00689; EVANS AM, 1976, MINING MAG, V134, P401; GARVEN G, 1989, GEOL SOC AM ABSTR PR, V9; HALLIDAY AN, 1984, EARTH PLANET SC LETT, V68, P229, DOI 10.1016/0012-821X(84)90155-9; HALLIDAY AN, 1984, EARTH PLANET SC LETT, V68, P379, DOI 10.1016/0012-821X(84)90123-7; HALLIDAY AN, 1989, EARTH PLANET SC LETT, V94, P274, DOI 10.1016/0012-821X(89)90146-5; HALLIDAY AN, 1984, NATURE, V307, P229, DOI 10.1038/307229a0; KELLY WC, 1983, GEOLOGY, V11, P309, DOI 10.1130/0091-7613(1983)11<309:HAGOOG>2.0.CO;2; KESLER SE, 1977, ECON GEOL, V72, P204, DOI 10.2113/gsecongeo.72.2.204; Mitchell J.G., 1976, T I MIN METALL B, V85, P159; MITCHELL JG, 1988, EARTH PLANET SC LETT, V88, P69, DOI 10.1016/0012-821X(88)90047-7; Noble E.A., 1963, ECON GEOL, V58, P1145; OLIVER J, 1986, GEOLOGY, V14, P99, DOI 10.1130/0091-7613(1986)14<99:FETFOB>2.0.CO;2; RANKIN AH, 1988, T I MIN METALL B, V97, P99; Roedder E, 1976, HDB STRATABOUND STRA, V2, P67; RUSSELL MJ, 1978, GEOL J, P297; RUSSELL MJ, 1979, T I MIN METALL B, V88, P30; RUSSELL MJ, 1978, PETROLOGY GEOCHEMIST, P173; SAWKINS FJ, 1966, ECON GEOL, V61, P385, DOI 10.2113/gsecongeo.61.2.385; SHEPHERD TJ, 1982, B BUR MECH GITES MIN, V11, P371; Smith F.W., 1975, FORTSCHRITTE MINERAL, V52, P491; SMITH FW, 1974, T SOC MIN ENG, V245, P95; SMITH FW, 1974, THESIS U DURHAM; Solomon M., 1971, T I MINING METALLU B, V80, P259; SVERJENSKY DA, 1986, ANNU REV EARTH PL SC, V14, P177, DOI 10.1146/annurev.ea.14.050186.001141; SVERJENSKY DA, 1984, ECON GEOL, V79, P23, DOI 10.2113/gsecongeo.79.1.23; VANALSTINE RE, 1976, ECON GEOL, V71, P977, DOI 10.2113/gsecongeo.71.6.977; White D.E., 1958, GEOLOGICAL SOC AM B, V69, P1660	40	63	85	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					54	56		10.1038/344054a0	http://dx.doi.org/10.1038/344054a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278025	Green Submitted			2022-12-28	WOS:A1990CQ97200057
J	OSTRIKER, JP; VIETRI, M				OSTRIKER, JP; VIETRI, M			ARE SOME BL LACS ARTIFACTS OF GRAVITATIONAL LENSING	NATURE			English	Article									OSSERV ASTROFIS ARCETRI,I-50125 FLORENCE,ITALY	Istituto Nazionale Astrofisica (INAF)	OSTRIKER, JP (corresponding author), PRINCETON UNIV OBSERV,PRINCETON,NJ 08544, USA.							ARP H, 1979, ASTROPHYS J, V230, P68, DOI 10.1086/157062; BLADES JC, 1986, IAU S, V119, P571; BRACCESI A, 1980, ASTRON ASTROPHYS, V85, P80; BURBIDGE G, 1987, ASTRON J, V93, P1, DOI 10.1086/114283; DEGUCHI S, 1988, ASTROPHYS J, V335, P67, DOI 10.1086/166906; HUCHRA J, 1985, ASTRON J, V90, P691, DOI 10.1086/113777; KAYSER R, 1988, ASTRON ASTROPHYS, V206, pL8; NARAYAN R, 1989, ASTROPHYS J, V339, pL53, DOI 10.1086/185418; OSTRIKER J, 1983, APJ, V267, P488; OSTRIKER JP, 1985, NATURE, V318, P446, DOI 10.1038/318446a0; PACZYNSKI B, 1986, ASTROPHYS J, V301, P503, DOI 10.1086/163919; SCHNEIDER DP, 1988, ASTRON J, V95, P1619, DOI 10.1086/114758; STICKEL M, 1988, ASTRON ASTROPHYS, V198, pL13; STICKEL M, IN PRESS P BL LAC OB; TURNER EL, 1984, ASTROPHYS J, V284, P1, DOI 10.1086/162379; TURNER EL, 1980, ASTROPHYS J, V242, pL135, DOI 10.1086/183418; VIETRI M, 1986, ASTROPHYS J, V300, P68	17	60	60	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					45	47		10.1038/344045a0	http://dx.doi.org/10.1038/344045a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278021				2022-12-28	WOS:A1990CQ97200053
J	Fargione, J; Hill, J; Tilman, D; Polasky, S; Hawthorne, P				Fargione, Joseph; Hill, Jason; Tilman, David; Polasky, Stephen; Hawthorne, Peter			Land clearing and the biofuel carbon debt	SCIENCE			English	Article							CLIMATE POLICY; SWITCHGRASS; CONSERVATION; AMAZON; LEGUME; FUEL	Increasing energy use, climate change, and carbon dioxide ( CO2) emissions from fossil fuels make switching to low- carbon fuels a high priority. Biofuels are a potential low- carbon energy source, but whether biofuels offer carbon savings depends on how they are produced. Converting rainforests, peatlands, savannas, or grasslands to produce food crop - based biofuels in Brazil, Southeast Asia, and the United States creates a "biofuel carbon debt" by releasing 17 to 420 times more CO2 than the annual greenhouse gas ( GHG) reductions that these biofuels would provide by displacing fossil fuels. In contrast, biofuels made from waste biomass or from biomass grown on degraded and abandoned agricultural lands planted with perennials incur little or no carbon debt and can offer immediate and sustained GHG advantages.	[Hill, Jason; Tilman, David; Polasky, Stephen; Hawthorne, Peter] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Fargione, Joseph] Nature Conservancy, Minneapolis, MN 55415 USA; [Hill, Jason; Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; Nature Conservancy; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Polasky, Stephen/AAC-5341-2019; Hill, Jason/A-8919-2008; Molina, Carolina/E-3898-2015	Hill, Jason/0000-0001-7609-6713; Molina, Carolina/0000-0001-6659-994X; Hawthorne, Peter/0000-0003-1125-5239; Fargione, Joseph/0000-0002-0636-5380				Basiron Y, 2007, EUR J LIPID SCI TECH, V109, P289, DOI 10.1002/ejlt.200600223; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P58, DOI 10.1016/j.agee.2007.01.008; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; George JR, 1995, AGRON J, V87, P1147, DOI 10.2134/agronj1995.00021962008700060018x; Graham DJ, 2002, J TRANSP ECON POLICY, V36, P1; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hammerschlag R, 2006, ENVIRON SCI TECHNOL, V40, P1744, DOI 10.1021/es052024h; Hooijer A., 2006, PEAT CO2 ASSESSMENT; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; IPCC, 2019, 2006 IPCC GUIDELINES, DOI DOI 10.35-10.49; JUNG GA, 1985, AGRON J, V77, P846, DOI 10.2134/agronj1985.00021962007700060005x; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Robles MD, 1997, ECOL APPL, V7, P345, DOI 10.1890/1051-0761(1997)007[0345:LGACRP]2.0.CO;2; SAMPLE DW, 1989, THESIS U WISCONSIN; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; SECCHI S, 2007, 07WP447 IOW STAT U C; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Sterner T, 2007, ENERG POLICY, V35, P3194, DOI 10.1016/j.enpol.2006.10.025; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; West TO, 2004, ENVIRON MANAGE, V33, P507, DOI 10.1007/s00267-003-9108-3; Winjum JK, 1998, FOREST SCI, V44, P272	28	2479	2530	30	1439	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1235	1238		10.1126/science.1152747	http://dx.doi.org/10.1126/science.1152747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258862				2022-12-28	WOS:000253530600041
J	Ravi, M; Marimuthu, MPA; Siddiqi, I				Ravi, Maruthachalam; Marimuthu, Mohan P. A.; Siddiqi, Imran			Gamete formation without meiosis in Arabidopsis	NATURE			English	Article							THALIANA PLANTS; APOMIXIS; GENE; MARKERS; IDENTIFICATION; PROGRESSION; STRATEGIES; TRIPSACUM; EVOLUTION; APOSPORY	Apomixis, the formation of asexual seeds in plants, leads to populations that are genetically uniform maternal clones. The transfer of apomixis to crop plants holds great promise in plant breeding for fixation of heterozygosity and hybrid vigour because it would allow the propagation of hybrids over successive generations(1,2). Apomixis involves the production of unreduced ( diploid) female gametes that retain the genotype of the parent plant ( apomeiosis), followed by parthenogenetic development of the egg cell into an embryo and the formation of functional endosperm(3). The molecular mechanisms underlying apomixis are unknown. Here we show that mutation of the Arabidopsis gene DYAD/ SWITCH1 (SWI1)(4,5), a regulator of meiotic chromosome organization, leads to apomeiosis. We found that most fertile ovules in dyad plants form seeds that are triploid and that arise from the fertilization of an unreduced female gamete by a haploid male gamete. The unreduced female gametes fully retain parental heterozygosity across the genome, which is characteristic of apomeiosis. Our results show that the alteration of a single gene in a sexual plant can bring about functional apomeiosis, a major component of apomixis.	[Ravi, Maruthachalam; Marimuthu, Mohan P. A.; Siddiqi, Imran] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Siddiqi, I (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	imran@ccmb.res.in		Maruthachalam, Ravi/0000-0003-0036-3330				Agashe B, 2002, DEVELOPMENT, V129, P3935; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; ALTMANN T, 1994, PLANT CELL REP, V13, P652, DOI 10.1007/BF00232939; BARONE A, 1995, THEOR APPL GENET, V91, P98, DOI 10.1007/BF00220864; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Blakey CA, 2001, GENOME, V44, P222, DOI 10.1139/gen-44-2-222; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; CURTIS CA, 1992, J HERED, V83, P335, DOI 10.1093/oxfordjournals.jhered.a111227; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; DOUCHES DS, 1988, EUPHYTICA, V38, P247, DOI 10.1007/BF00023528; FINCH RA, 1979, HEREDITY, V43, P87, DOI 10.1038/hdy.1979.62; Grimanelli D, 1998, HEREDITY, V80, P33, DOI 10.1046/j.1365-2540.1998.00263.x; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Hamant O, 2006, ANNU REV PLANT BIOL, V57, P267, DOI 10.1146/annurev.arplant.57.032905.105255; Huanca-Mamani W, 2005, P NATL ACAD SCI USA, V102, P17231, DOI 10.1073/pnas.0508186102; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; KOLTUNOW AM, 1995, PLANT PHYSIOL, V108, P1345, DOI 10.1104/pp.108.4.1345; Mercier R, 2001, GENE DEV, V15, P1859, DOI 10.1101/gad.203201; MOGIE M, 1988, BIOL J LINN SOC, V35, P127, DOI 10.1111/j.1095-8312.1988.tb00462.x; Noyes RD, 2005, HEREDITY, V94, P193, DOI 10.1038/sj.hdy.6800597; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Pessino SC, 1998, HEREDITAS, V128, P153, DOI 10.1111/j.1601-5223.1998.00153.x; Pupilli F, 2004, MOL GENET GENOMICS, V270, P539, DOI 10.1007/s00438-003-0949-5; RHOADES MM, 1966, GENETICS, V54, P505; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Savidan Y., 2000, Plant Breeding Reviews, V18, P13; Siddiqi I, 2000, DEVELOPMENT, V127, P197; Spielman M, 2001, TRENDS GENET, V17, P705, DOI 10.1016/S0168-9525(01)02519-7; Spillane C, 2001, SEX PLANT REPROD, V14, P179, DOI 10.1007/s00497-001-0117-1; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; VORSA L, 1997, J HERED, V8, P423	33	150	165	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1121	U10		10.1038/nature06557	http://dx.doi.org/10.1038/nature06557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18272967				2022-12-28	WOS:000253453600045
J	O'Carroll, N; Fitzsimons, J; Carr, S				O'Carroll, Niamh; Fitzsimons, John; Carr, Siobhan			10-minute consultation - Asthma unresponsive to simple treatment in a child	BRITISH MEDICAL JOURNAL			English	Editorial Material									[O'Carroll, Niamh] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Social Med, London W6 8RP, England; [Fitzsimons, John; Carr, Siobhan] Barts & London Childrens Hosp, London E1 1BB, England	Imperial College London	O'Carroll, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Social Med, London W6 8RP, England.	n.ocarroll@imperial.ac.uk	Fitzsimons, John/AAH-1499-2021						0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					447	447		10.1136/bmj.39364.672940.47	http://dx.doi.org/10.1136/bmj.39364.672940.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292172	Green Published			2022-12-28	WOS:000253664000043
J	Cross, M; Pringle, M				Cross, Michael; Pringle, Mike			No job for the spineless	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					356	357		10.1136/bmj.39476.472789.0F	http://dx.doi.org/10.1136/bmj.39476.472789.0F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276709	Green Published			2022-12-28	WOS:000253550600035
J	Kwon, C; Neu, C; Pajonk, S; Yun, HS; Lipka, U; Humphry, M; Bau, S; Straus, M; Kwaaitaal, M; Rampelt, H; El Kasmi, F; Jurgens, G; Parker, J; Panstruga, R; Lipka, V; Schulze-Lefert, P				Kwon, Chian; Neu, Christina; Pajonk, Simone; Yun, Hye Sup; Lipka, Ulrike; Humphry, Matt; Bau, Stefan; Straus, Marco; Kwaaitaal, Mark; Rampelt, Heike; El Kasmi, Farid; Juergens, Gerd; Parker, Jane; Panstruga, Ralph; Lipka, Volker; Schulze-Lefert, Paul			Co-option of a default secretory pathway for plant immune responses	NATURE			English	Article							DISEASE-RESISTANCE; NONHOST RESISTANCE; SNARE-PROTEIN; PENETRATION RESISTANCE; ARABIDOPSIS-THALIANA; CALLOSE SYNTHASE; MEMBRANE-FUSION; COMPLEX; CELLS; REORGANIZATION	Cell- autonomous immunity is widespread in plant - fungus interactions and terminates fungal pathogenesis either at the cell surface or after pathogen entry. Although post- invasive resistance responses typically coincide with a self- contained cell death of plant cells undergoing attack by parasites, these cells survive pre- invasive defence. Mutational analysis in Arabidopsis identified PEN1 syntaxin as one component of two pre- invasive resistance pathways against ascomycete powdery mildew fungi(1-3). Here we show that plasma- membrane- resident PEN1 promiscuously forms SDS- resistant soluble N- ethylmaleimide sensitive factor attachment protein receptor ( SNARE) complexes together with the SNAP33 adaptor and a subset of vesicle- associated membrane proteins ( VAMPs). PEN1- dependent disease resistance acts in vivo mainly through two functionally redundant VAMP72 subfamily members, VAMP721 and VAMP722. Unexpectedly, the same two VAMP proteins also operate redundantly in a default secretory pathway, suggesting dual functions in separate biological processes owing to evolutionary co- option of the default pathway for plant immunity. The disease resistance function of the secretory PEN1 - SNAP33 - VAMP721/ 722 complex and the pathogen- induced subcellular dynamics of its components are mechanistically reminiscent of immunological synapse formation in vertebrates, enabling execution of immune responses through focal secretion.	[Kwon, Chian; Neu, Christina; Pajonk, Simone; Yun, Hye Sup; Lipka, Ulrike; Humphry, Matt; Bau, Stefan; Straus, Marco; Kwaaitaal, Mark; Parker, Jane; Panstruga, Ralph; Lipka, Volker; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Lipka, Ulrike; Rampelt, Heike; Lipka, Volker] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Lipka, V (corresponding author), John Innes Inst, John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	panstrug@mpiz-koeln.mpg.de; Volker.Lipka@sainsbury-laboratory.ac.uk; schlef@mpiz-koeln.mpg.de	El Kasmi, Farid/AHC-5099-2022; Schulze-Lefert, Paul/A-7746-2008; Panstruga, Ralph/F-3340-2011; Humphry, Matthew/A-8136-2008	Panstruga, Ralph/0000-0002-3756-8957; El Kasmi, Farid/0000-0002-4634-7689; Rampelt, Heike/0000-0002-5458-5652; Straus, Marco R/0000-0003-1087-2091				Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Baluska F, 2005, TRENDS PLANT SCI, V10, P106, DOI 10.1016/j.tplants.2005.01.002; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; KWON C, IN PRESS TRENDS IMMU; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x	28	332	344	5	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					835	U10		10.1038/nature06545	http://dx.doi.org/10.1038/nature06545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273019	Green Published			2022-12-28	WOS:000253191400044
J	Hausenloy, DJ; Pagano, D; Keogh, B				Hausenloy, Derek J.; Pagano, Domenico; Keogh, Bruce			Aprotinin - still courting controversy	LANCET			English	Editorial Material							RENAL DYSFUNCTION; SURGERY		[Hausenloy, Derek J.] UCL Hosp & Med Sch, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Pagano, Domenico] Univ Hosp Birmingham, Dept Cardiothorac Surg, Birmingham, W Midlands, England; [Keogh, Bruce] UCL, Heart Hosp, Natl Inst Clin Outcomes Res, London, England	University of London; University College London; University of Birmingham; University College London Hospitals NHS Foundation Trust; University of London; University College London	Hausenloy, DJ (corresponding author), UCL Hosp & Med Sch, Hatter Cardiovasc Inst, London WC1E 6HX, England.	d.hausenloy@ucl.ac.uk		Hausenloy, Derek/0000-0003-0729-4956				Backer CL, 2007, J THORAC CARDIOV SUR, V134, P1421, DOI 10.1016/j.jtcvs.2007.08.006; FUMARY AP, 2007, CIRCULATION S, V116, P127; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mouton R, 2008, LANCET, V371, P475, DOI 10.1016/S0140-6736(08)60237-8; PAGANO D, IN PRESS J THORAC CA; Royston D, 2007, EUR J ANAESTH, V24, P6, DOI 10.1017/S0265021506001955; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Szekely A, 2008, PEDIATR ANESTH, V18, P151, DOI 10.1111/j.1460-9592.2007.02398.x; TREASURE T, 2006, DONT LIKE EVIDENCE E; *US FDA, 2007, EARL COMM ONG SAF RE; *US FDA, 2007, FDA REQ MARK SUSP TR; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	14	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					449	450		10.1016/S0140-6736(08)60212-3	http://dx.doi.org/10.1016/S0140-6736(08)60212-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262023				2022-12-28	WOS:000253169200004
J	Stouffer, AL; Acharya, R; Salom, D; Levine, AS; Di Costanzo, L; Soto, CS; Tereshko, V; Nanda, V; Stayrook, S; DeGrado, WF				Stouffer, Amanda L.; Acharya, Rudresh; Salom, David; Levine, Anna S.; Di Costanzo, Luigi; Soto, Cinque S.; Tereshko, Valentina; Nanda, Vikas; Stayrook, Steven; DeGrado, William F.			Structural basis for the function and inhibition of an influenza virus proton channel	NATURE			English	Article							M-2 ION-CHANNEL; A VIRUS; ADAMANTANE RESISTANCE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; M2; MECHANISM; MODEL; HELIX; STATE	The M2 protein from influenza A virus is a pH- activated proton channel that mediates acidification of the interior of viral particles entrapped in endosomes. M2 is the target of the anti- influenza drugs amantadine and rimantadine; recently, resistance to these drugs in humans, birds and pigs has reached more than 90% ( ref. 1). Here we describe the crystal structure of the transmembrane- spanning region of the homotetrameric protein in the presence and absence of the channel- blocking drug amantadine. pH- dependent structural changes occur near a set of conserved His and Trp residues that are involved in proton gating(2). The drug- binding site is lined by residues that are mutated in amantadine- resistant viruses(3,4). Binding of amantadine physically occludes the pore, and might also perturb the pK(a) of the critical His residue. The structure provides a starting point for solving the problem of resistance to M2- channel blockers.	[Stouffer, Amanda L.; Acharya, Rudresh; Salom, David; Levine, Anna S.; Soto, Cinque S.; Nanda, Vikas; Stayrook, Steven; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Stouffer, Amanda L.; Di Costanzo, Luigi; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Tereshko, Valentina] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Pennsylvania; University of Pennsylvania; University of Chicago	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Acharya, Rudresh/AAD-1247-2021; Di Costanzo, Luigi Franklin/AAL-6761-2020	Acharya, Rudresh/0000-0002-9012-9849; Di Costanzo, Luigi Franklin/0000-0002-4795-2573; Nanda, Vikas/0000-0003-2786-8347; Stayrook, Steven/0000-0002-1677-8293; Salom, David/0000-0002-3208-1509	NIAID NIH HHS [U01 AI074571] Funding Source: Medline; NIGMS NIH HHS [T32 GM008275, R01 GM054616, R01 GM056423, R37 GM054616, R01 GM088204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204, R37GM054616, T32GM008275, R01GM056423, R01GM054616] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton GS, 2007, J STRUCT BIOL, V157, P570, DOI 10.1016/j.jsb.2006.10.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer CM, 1999, VIROLOGY, V254, P196, DOI 10.1006/viro.1998.9552; Betakova T, 2005, J GEN VIROL, V86, P181, DOI 10.1099/vir.0.80358-0; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *BRUK AXS INC, 2000, SMART SAINT SADABS X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cady SD, 2007, J AM CHEM SOC, V129, P5719, DOI 10.1021/ja070305e; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Czabotar PE, 2004, VIRUS RES, V99, P57, DOI 10.1016/j.virusres.2003.10.004; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Stouffer AL, 2005, J MOL BIOL, V347, P169, DOI 10.1016/j.jmb.2005.01.023; Takeuchi H, 2003, FEBS LETT, V552, P35, DOI 10.1016/S0014-5793(03)00781-6; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Zhong QF, 2000, FEBS LETT, V473, P195, DOI 10.1016/S0014-5793(00)01522-2	42	480	500	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					596	U13		10.1038/nature06528	http://dx.doi.org/10.1038/nature06528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235504	Green Accepted			2022-12-28	WOS:000252739900047
J	Barabas, O; Ronning, DR; Guynet, C; Hickman, AB; Ton-Hoang, B; Chandler, M; Dyda, F				Barabas, Orsolya; Ronning, Donald R.; Guynet, Catherine; Hickman, Alison Burgess; Ton-Hoang, Bao; Chandler, Michael; Dyda, Fred			Mechanism of IS200/IS605 family DNA transposases: Activation and transposon-directed target site selection	CELL			English	Article							CRYSTAL-STRUCTURE; HELICOBACTER-PYLORI; INSERTION; BINDING; ISHP608; DOMAIN	The smallest known DNA transposases are those from the IS200/IS605 family. Here we show how the interplay of protein and DNA activates TnpA, the Helicobacter pylori IS608 transposase, for catalysis. First, transposon end binding causes a conformational change that aligns catalytically important protein residues within the active site. Subsequent precise cleavage at the left and right ends, the steps that liberate the transposon from its donor site, does not involve a site-specific DNA-binding domain. Rather, cleavage site recognition occurs by complementary base pairing with a TnpA-bound subterminal transposon DNA segment. Thus, the enzyme active site is constructed from elements of both protein and DNA, reminiscent of the interdependence of protein and RNA in the ribosome. Our structural results explain why the transposon ends are asymmetric and how the transposon selects a target site for integration, and they allow us to propose a molecular model for the entire transposition reaction.	[Barabas, Orsolya; Ronning, Donald R.; Hickman, Alison Burgess; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Guynet, Catherine; Ton-Hoang, Bao; Chandler, Michael] Natl Rech Sci, Microbiol Lab, F-31062 Toulouse, France; [Guynet, Catherine; Ton-Hoang, Bao; Chandler, Michael] Natl Rech Sci, Ctr Mol Genet, F-31062 Toulouse, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dyda, F (corresponding author), NIDDK, Mol Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	fred.dyda@nih.gov	Barabas, Orsolya/F-3961-2012; Guynet, Catherine/A-4815-2011; Guynet, Catherine/GPX-0917-2022	Barabas, Orsolya/0000-0002-2873-5872; Ronning, Donald/0000-0003-2583-8849; Chandler, Michael/0000-0002-0292-6662	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036154] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036154-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Belfort Marlene, 2002, P761; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Debets-Ossenkopp YJ, 1999, ANTIMICROB AGENTS CH, V43, P2657, DOI 10.1128/AAC.43.11.2657; DeLano W.L, PYMOL MOL GRAPHICS S; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Garcillan-Barcia MD, 2001, MOL MICROBIOL, V39, P494, DOI 10.1046/j.1365-2958.2001.02261.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; GUYNET C, 2008, IN PRESS MOL CELL; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin C, 2005, STRUCTURE, V13, P1533, DOI 10.1016/j.str.2005.06.013; Lee HH, 2006, J BIOL CHEM, V281, P4261, DOI 10.1074/jbc.M511567200; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mennecier S, 2006, MOL MICROBIOL, V59, P317, DOI 10.1111/j.1365-2958.2005.04936.x; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	32	85	87	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					208	220		10.1016/j.cell.2007.12.029	http://dx.doi.org/10.1016/j.cell.2007.12.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243097	Green Accepted, Bronze			2022-12-28	WOS:000253427700008
J	DIAKUN, GP				DIAKUN, GP			EXAFS - A PROBE FOR METALLOPROTEINS	NATURE			English	Review											DIAKUN, GP (corresponding author), SERC,DARESBURY LAB,MRC,BIOL SUPPORT LAB,WARRINGTON WA4 4AD,CHESHIRE,ENGLAND.							ASHLEY CA, 1975, PHYS REV B, V11, P1279, DOI 10.1103/PhysRevB.11.1279; BLACKBURN NJ, 1984, BIOCHEM J, V219, P985, DOI 10.1042/bj2190985; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; Feiters M. C., 1986, Journal de Physique Colloque, V47, P1169, DOI 10.1051/jphyscol:19868228; GEORGE GN, 1986, BIOCHEM SOC T, V14, P651, DOI 10.1042/bst0140651; GURMAN SJ, 1984, J PHYS C SOLID STATE, V17, P143, DOI 10.1088/0022-3719/17/1/019; HASNAIN SS, 1990, SYNCHROTRON RAD BIOP, P104; KINCAID BM, 1975, PHYS REV LETT, V34, P1361, DOI 10.1103/PhysRevLett.34.1361; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; POWERS L, 1987, BIOCHEMISTRY-US, V26, P4785, DOI 10.1021/bi00389a028; SAYERS DE, 1971, PHYS REV LETT, V27, P1204, DOI 10.1103/PhysRevLett.27.1204; SHULMAN RG, 1975, P NATL ACAD SCI USA, V72, P4003, DOI 10.1073/pnas.72.10.4003; WATENPAUGH KD, 1973, ACTA CRYSTALLOGR B, V29, P943, DOI 10.1107/S0567740873003675; WATENPAUGH KD, 1980, J MOL BIOL, V138, P615, DOI 10.1016/S0022-2836(80)80020-9	14	6	6	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					83	84		10.1038/344083a0	http://dx.doi.org/10.1038/344083a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278028				2022-12-28	WOS:A1990CQ97200070
J	DICKMAN, S				DICKMAN, S			TOWARDS REUNIFICATION OF GERMAN UNIVERSITIES	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					2	2		10.1038/344002a0	http://dx.doi.org/10.1038/344002a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277982	Bronze			2022-12-28	WOS:A1990CQ97200002
J	MADDOX, J				MADDOX, J			COSMIC-RAYS LOSE DRAMATIC QUALITY	NATURE			English	Editorial Material																		WDOWCZYK J, 1990, ASTROPHYS J, V349, P35, DOI 10.1086/168290	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					15	15		10.1038/344015a0	http://dx.doi.org/10.1038/344015a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278005				2022-12-28	WOS:A1990CQ97200031
J	MORRIS, JD; LEEMAN, WP; TERA, F				MORRIS, JD; LEEMAN, WP; TERA, F			THE SUBDUCTED COMPONENT IN ISLAND-ARC LAVAS - CONSTRAINTS FROM BE ISOTOPES AND B-BE SYSTEMATICS	NATURE			English	Article									RICE UNIV,DEPT GEOL & GEOPHYS,HOUSTON,TX 77251	Rice University	MORRIS, JD (corresponding author), CARNEGIE INST WASHINGTON,DEPT TERR MAGNETISM,5241 BROAD BRANCH RD NW,WASHINGTON,DC 20015, USA.							[Anonymous], 1986, GEOLOGICAL SOC LONDO, DOI [DOI 10.1144/GSL.SP.1986.024.01.24, 10.1144/GSL.SP.1986.024.01.24]; ARNOLD JR, 1956, SCIENCE, V124, P584, DOI 10.1126/science.124.3222.584; BONATTI E, 1984, EARTH PLANET SC LETT, V70, P88, DOI 10.1016/0012-821X(84)90211-5; BOURLES D, 1989, GEOCHIM COSMOCHIM AC, V53, P443, DOI 10.1016/0016-7037(89)90395-5; CAMPBELL AC, 1988, NATURE, V335, P514, DOI 10.1038/335514a0; CARR MJ, 1982, ANDESITES OROGENIC A; COOPER P, 1987, TECTONICS, V6, P53, DOI 10.1029/TC006i001p00053; ELLAM RM, 1988, CONTRIB MINERAL PETR, V98, P72, DOI 10.1007/BF00371911; ENGDAHL ER, 1977, ISLAND ARCS DEEP SEA, P259; FEIGENSON MD, 1986, GEOLOGY, V14, P79, DOI 10.1130/0091-7613(1986)14<79:PCNASI>2.0.CO;2; Gill J., 1981, OROGENIC ANDESITES P; HAWKESWORTH CJ, IN PRESS GEOLOGY; HIGGINS MD, 1984, NATURE, V308, P172, DOI 10.1038/308172a0; KU TL, 1985, INITIAL REP DEEP SEA, V86, P539; Lal D., 1967, HANDBUCH PHYSIK    2, V46, P551, DOI [DOI 10.1007/978-3-642-46079-1_7, 10.1007/978-3-642-46079-1_7]; LANGMUIR CH, 1978, EARTH PLANET SC LETT, V37, P380, DOI 10.1016/0012-821X(78)90053-5; Leeman W.P, 1987, EOS, V68, P462; LEEMAN WP, 1988, GEOSTANDARD NEWSLETT, V12, P61, DOI 10.1111/j.1751-908X.1988.tb00043.x; LEEMAN WP, IN PRESS J GEOPHYS R; MARSH BD, 1982, ANDESITES OROGENIC A, P99; MONAGHAN MC, 1988, EARTH PLANET SC LETT, V89, P288, DOI 10.1016/0012-821X(88)90117-3; MORRIS J, 1989, GEOCHIM COSMOCHIM AC, V53, P3197, DOI 10.1016/0016-7037(89)90100-2; RYAN JG, 1988, GEOCHIM COSMOCHIM AC, V52, P237, DOI 10.1016/0016-7037(88)90073-7; RYAN JG, 1989, THESIS COLUMBIA U; RYAN JG, 1989, EOS, V70, P1388; SEYFRIED WE, 1984, GEOCHIM COSMOCHIM AC, V48, P557, DOI 10.1016/0016-7037(84)90284-9; Shaw D.M., 1967, CAN J EARTH SCI, V4, P829, DOI [DOI 10.1139/E67-058, 10.1139/e67-058]; SOUTHON JR, 1987, EARTH PLANET SC LETT, V85, P356, DOI 10.1016/0012-821X(87)90133-6; SPIVACK AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1033, DOI 10.1016/0016-7037(87)90198-0; TANAKA S, 1982, GEOCHEM J, V16, P321, DOI 10.2343/geochemj.16.321; TATSUMI Y, 1988, GEOPHYS RES LETT, V15, P180, DOI 10.1029/GL015i002p00180; TATSUMI Y, 1986, J VOLCANOL GEOTH RES, V29, P293, DOI 10.1016/0377-0273(86)90049-1; TERA F, 1986, GEOCHIM COSMOCHIM AC, V50, P535, DOI 10.1016/0016-7037(86)90103-1; THOMPSON G, 1970, EARTH PLANET SC LETT, V8, P61, DOI 10.1016/0012-821X(70)90100-7; Thompson G, 1984, HYDROTHERMAL PROCESS, P225; Thorpe R.S., 1982, ANDES, P187; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; VALETTESILVER JN, 1987, J GEOPHYS RES-SOLID, V92, P11364, DOI 10.1029/JB092iB11p11364; YIOU F, 1972, PHYS REV LETT, V29, P372, DOI 10.1103/PhysRevLett.29.372	39	471	487	1	49	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					31	36		10.1038/344031a0	http://dx.doi.org/10.1038/344031a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278019				2022-12-28	WOS:A1990CQ97200050
J	Liu, CI; Liu, GY; Song, YC; Yin, FL; Hensler, ME; Jeng, WY; Nizet, V; Wang, AHJ; Oldfield, E				Liu, Chia-I; Liu, George Y.; Song, Yongcheng; Yin, Fenglin; Hensler, Mary E.; Jeng, Wen-Yih; Nizet, Victor; Wang, Andrew H. -J.; Oldfield, Eric			A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence	SCIENCE			English	Article							SQUALENE SYNTHASE INHIBITOR; TARGET	Staphylococcus aureus produces hospital- and community- acquired infections, with methicillin- resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus, staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil- based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis. We determined the crystal structures of S. aureus dehydrosqualene synthase ( CrtM) at 1.58 angstrom resolution, finding structural similarity to human squalene synthase ( SQS). We screened nine SQS inhibitors and determined the structures of three, bound to CrtM. One, previously tested for cholesterol- lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro ( median inhibitory concentration similar to 100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model. This finding represents proof of principle for a virulence factor - based therapy against S. aureus.	[Hensler, Mary E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Liu, Chia-I; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Liu, Chia-I; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 11529, Taiwan; [Liu, Chia-I; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei 10098, Taiwan; [Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Song, Yongcheng; Oldfield, Eric] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Yin, Fenglin; Oldfield, Eric] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu; ahjwang@gate.sinica.edu.tw; eo@chad.scs.uiuc.edu	Liu, Guang Yu/A-8802-2008; Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	NIAID NIH HHS [AI07482] Funding Source: Medline; NICHD NIH HHS [HD051796] Funding Source: Medline; NIGMS NIH HHS [GM65307, R01 GM073216-29, R01 GM065307-07, R01 GM073216, GM073216, R01 GM065307] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073216, R01GM065307] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; [Anonymous], 2006, TREAT INF DIS MICR W, P21; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hiyoshi H, 2000, J LIPID RES, V41, P1136; Ishihara T, 2003, BIOORGAN MED CHEM, V11, P2403, DOI 10.1016/S0968-0896(03)00143-3; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Magnin DR, 1996, J MED CHEM, V39, P657, DOI 10.1021/jm9507340; Nishimoto T, 2003, BRIT J PHARMACOL, V139, P911, DOI 10.1038/sj.bjp.0705332; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Sharma A, 1998, PHARMACEUT RES, V15, P1782, DOI 10.1023/A:1011977116543; Sharma A, 1998, J CLIN PHARMACOL, V38, P1116; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316	17	322	337	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1391	1394		10.1126/science.1153018	http://dx.doi.org/10.1126/science.1153018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	270HW	18276850	Green Accepted, Green Published			2022-12-28	WOS:000253712900044
J	Matsuo, N; Reijmers, L; Mayford, M				Matsuo, Naoki; Reijmers, Leon; Mayford, Mark			Spine-type-specific recruitment of newly synthesized AMPA receptors with learning	SCIENCE			English	Article							GLUTAMATE RECEPTORS; SURFACE EXPRESSION; DENDRITIC SPINES; MEMORY FORMATION; HIPPOCAMPUS; SYNAPSES; FEAR; LTP; REDISTRIBUTION; TRAFFICKING	The stabilization of long- term memories requires de novo protein synthesis. How can proteins, synthesized in the soma, act on specific synapses that participate in a given memory? We studied the dynamics of newly synthesized AMPA- type glutamate receptors ( AMPARs) induced with learning using transgenic mice expressing the GluR1 subunit fused to green fluorescent protein ( GFP- GluR1) under control of the c- fos promoter. We found learning- associated recruitment of newly synthesized GFP- GluR1 selectively to mushroom- type spines in adult hippocampal CA1 neurons 24 hours after fear conditioning. Our results are consistent with a "synaptic tagging" model to allow activated synapses to subsequently capture newly synthesized receptor and also demonstrate a critical functional distinction in the mushroom spines with learning.	[Matsuo, Naoki; Reijmers, Leon; Mayford, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Matsuo, Naoki; Reijmers, Leon; Mayford, Mark] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Matsuo, N (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan.	n-matsuo@fujita-hu.ac.jp; mmayford@scripps.edu	Matsuo, Naoki/B-9929-2008	Matsuo, Naoki/0000-0003-0988-4706; Mayford, Mark/0000-0002-9001-5024	NIMH NIH HHS [R01 MH057368, MH57368, R21 MH070020, MH070020, R01 MH057368-04, R01 MH057368-03, R21 MH070020-02, R21 MH070020-03, R21 MH070020-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057368, R21MH070020] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Knafo S, 2004, HIPPOCAMPUS, V14, P819, DOI 10.1002/hipo.10219; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	29	222	227	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1104	1107		10.1126/science.1149967	http://dx.doi.org/10.1126/science.1149967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292343	Green Accepted			2022-12-28	WOS:000253311700047
J	Abedin, M; King, N				Abedin, Monika; King, Nicole			The premetazoan ancestry of cadherins	SCIENCE			English	Article							CELL-ADHESION; ANIMAL EVOLUTION; GENOMES; MORPHOGENESIS; CYTOSKELETON; PROTEINS; INSIGHTS; RECEPTOR; ORIGINS	Cadherin- mediated cell adhesion and signaling is essential for metazoan development and yet is absent from all other multicellular organisms. We found cadherin genes at numbers similar to those observed in complex metazoans in one of the closest single- celled relatives of metazoans, the choanoflagellate Monosiga brevicollis. Because the evolution of metazoans from a single- celled ancestor required novel cell adhesion and signaling mechanisms, the discovery of diverse cadherins in choanoflagellates suggests that cadherins may have contributed to metazoan origins.	[Abedin, Monika; King, Nicole] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Abedin, Monika; King, Nicole] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [King, Nicole] Univ Calif Berkeley, Dept Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	King, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	nking@berkeley.edu		Sigg, Monika/0000-0001-8522-9127				Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brooke NM, 2003, CURR OPIN GENET DEV, V13, P599, DOI 10.1016/j.gde.2003.09.002; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HIBBERD DJ, 1975, J CELL SCI, V17, P191; James-Clark H., 1868, BOWERBANK ANN MAG NA, V1, P133; James-Clark H, 1868, ANN MAG NAT HIST, V1, P250; James-Clark H, 1868, ANN MAG NAT HIST, V1, P188; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; MARENGERE LEM, 1994, J CELL SCI, P97; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Telford MJ, 2006, CURR BIOL, V16, pR981, DOI 10.1016/j.cub.2006.10.048; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7	35	168	170	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					946	948		10.1126/science.1151084	http://dx.doi.org/10.1126/science.1151084			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276888				2022-12-28	WOS:000253165700044
J	Lee, S; Pirogov, A; Kang, MS; Jang, KH; Yonemura, M; Kamiyama, T; Cheong, SW; Gozzo, F; Shin, N; Kimura, H; Noda, Y; Park, JG				Lee, Seongsu; Pirogov, A.; Kang, Misun; Jang, Kwang-Hyun; Yonemura, M.; Kamiyama, T.; Cheong, S. -W.; Gozzo, F.; Shin, Namsoo; Kimura, H.; Noda, Y.; Park, J. -G.			Giant magneto-elastic coupling in multiferroic hexagonal manganites	NATURE			English	Article								The motion of atoms in a solid always responds to cooling or heating in a way that is consistent with the symmetry of the given space group of the solid to which they belong(1,2). When the atoms move, the electronic structure of the solid changes, leading to different physical properties. Therefore, the determination of where atoms are and what atoms do is a cornerstone of modern solid- state physics. However, experimental observations of atomic displacements measured as a function of temperature are very rare, because those displacements are, in almost all cases, exceedingly small(3-5). Here we show, using a combination of diffraction techniques, that the hexagonal manganites RMnO3 ( where R is a rare- earth element) undergo an isostructural transition with exceptionally large atomic displacements: two orders of magnitude larger than those seen in any other magnetic material, resulting in an unusually strong magneto- elastic coupling. We follow the exact atomic displacements of all the atoms in the unit cell as a function of temperature and find consistency with theoretical predictions based on group theories. We argue that this gigantic magneto- elastic coupling in RMnO3 holds the key to the recently observed magneto- electric phenomenon in this intriguing class of materials(6).	[Lee, Seongsu; Pirogov, A.; Kang, Misun; Jang, Kwang-Hyun; Park, J. -G.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Lee, Seongsu; Pirogov, A.; Park, J. -G.] Seoul Natl Univ, Ctr Strongly Correlated Mat Res, Seoul 151742, South Korea; [Kamiyama, T.; Park, J. -G.] KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Cheong, S. -W.] Rutgers State Univ, Rutgers Ctr Emergent Mat, Piscataway, NJ 08854 USA; [Cheong, S. -W.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Gozzo, F.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Shin, Namsoo] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Kimura, H.; Noda, Y.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Sungkyunkwan University (SKKU); Seoul National University (SNU); High Energy Accelerator Research Organization (KEK); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Pohang University of Science & Technology (POSTECH); Tohoku University	Park, JG (corresponding author), Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea.	jgpark@skku.edu	Park, Je Geun/K-8571-2013; MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; Noda, Yukio/K-8551-2014; Pirogov, Alexander N/B-3544-2017	Yonemura, Masao/0000-0002-4444-1997				BERTAUT EF, 1963, PHYS LETT, V5, P27, DOI 10.1016/S0375-9601(63)80014-6; BRUCE AD, 1981, STRUCTURAL PHASE TRA; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; dela Cruz C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060407; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fiebig M, 2002, NATURE, V419, P818, DOI 10.1038/nature01077; GILLEO MA, 1957, ACTA CRYSTALLOGR, V10, P161, DOI 10.1107/S0365110X57000535; Gozzo F, 2006, J APPL CRYSTALLOGR, V39, P347, DOI 10.1107/S0021889806009319; Hahn T., 1996, INT TABLES CRYSTALLO, VA; Huang ZJ, 1997, PHYS REV B, V56, P2623, DOI 10.1103/PhysRevB.56.2623; Izumi F, 2000, MATER SCI FORUM, V321-3, P198, DOI 10.4028/www.scientific.net/MSF.321-324.198; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; Lee S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.180413; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Mizokawa T, 1999, PHYS REV B, V60, P7309, DOI 10.1103/PhysRevB.60.7309; Park J, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104426; Rai RC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184414; Ramirez A. P., 2001, HDB MAGNETIC MAT, V13; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; Sato TJ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014432; SCOTT JF, 1974, REV MOD PHYS, V46, P83, DOI 10.1103/RevModPhys.46.83; Sharma PA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.177202; Smolenskii G. A., 1982, Soviet Physics - Uspekhi, V25, P475, DOI 10.1070/PU1982v025n07ABEH004570; Souchkov AB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.027203; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Van Aken BB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134113; Wyckoff R.W.G, 1986, CRYSTAL STRUCTURES; YAKEL HL, 1963, ACTA CRYSTALLOGR, V16, P957, DOI 10.1107/S0365110X63002589	28	318	321	9	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					805	U4		10.1038/nature06507	http://dx.doi.org/10.1038/nature06507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273014				2022-12-28	WOS:000253191400037
J	Gould, EA; Solomon, T				Gould, E. A.; Solomon, T.			Pathogenic flaviviruses	LANCET			English	Article							WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; TRANS-OVARIAL TRANSMISSION; DENGUE HEMORRHAGIC-FEVER; YELLOW-FEVER; AEDES-AEGYPTI; NEUROLOGICAL MANIFESTATIONS; NEUTRALIZING ANTIBODIES; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS	Haemorrhagic disease, encephalitis, biphasic fever, flaccid paralysis, and jaundice are typical manifestations of diseases in human beings after infections by mosquito-borne or tick-borne flaviviruses such as yellow fever, dengue, West Nile, St Louis encephalitis, Japanese encephalitis, tick-borne encephalitis, Kyasanur Forest disease, and Omsk haemorrhagic fever. Although the characteristics of these viruses are well defined, they are stiff unpredictable with increases in disease severity, unusual clinical manifestations, unexpected methods of transmission, long-term persistence, and the discovery of new species. This Seminar will compare the epidemiological and clinical features of the medically important flaviviruses, consider the effect of human activity on their evolution and dispersal, and draw attention to new findings and some of the unanswered questions, unresolved issues, and controversies that remain.	[Gould, E. A.] CEH Oxford, Oxford OX1 3SR, England; [Solomon, T.] Univ Liverpool, Viral Brain Infect Grp, Dept Neurol Sci, Walton Ctr Neurol & Neurosurg, Liverpool L69 3BX, Merseyside, England	UK Centre for Ecology & Hydrology (UKCEH); University of Liverpool; Walton Centre	Gould, EA (corresponding author), CEH Oxford, Mansfield Rd, Oxford OX1 3SR, England.	eag@ceh.ac.uk		Solomon, Tom/0000-0001-7266-6547	MRC [G116/194] Funding Source: UKRI; Medical Research Council [G116/194] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Bhatt TR, 2000, AM J TROP MED HYG, V62, P480, DOI 10.4269/ajtmh.2000.62.480; Blitvich BJ, 2004, EMERG INFECT DIS, V10, P1314; Bloom Khaled J., 1993, MISSISSIPPI VALLEYS; BOSHELL J, 1969, AM J TROP MED HYG, V18, P67, DOI 10.4269/ajtmh.1969.18.67; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71; Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7; Chambers TJ, 2006, J GEN VIROL, V87, P3131, DOI 10.1099/vir.0.81909-0; Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610; COOPER WC, 1964, BMJ-BRIT MED J, V2, P1626; DAVIDSON MM, 1991, J INFECTION, V23, P241, DOI 10.1016/0163-4453(91)92756-U; Eidex RB, 2004, LANCET, V364, P936, DOI 10.1016/S0140-6736(04)17017-7; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gould EA, 2003, EPIDEMIOL INFECT, V131, P583, DOI 10.1017/S0950268803008707; Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3; GOULD EA, 2004, ARCH VIROL         S, V18, P65; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96; HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; HULL B, 1984, AM J TROP MED HYG, V33, P1248, DOI 10.4269/ajtmh.1984.33.1248; Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2; Juricova Z, 1998, AVIAN DIS, V42, P182, DOI 10.2307/1592593; KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590; KOKERNOT RH, 1961, ANN TROP MED PARASIT, V55, P73, DOI 10.1080/00034983.1961.11686021; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Kramer LD, 1997, AM J TROP MED HYG, V57, P222, DOI 10.4269/ajtmh.1997.57.222; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; LVOV DK, 2004, ARCH VIROL         S, V18, P85; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1; MCINTOSH BM, 1976, J MED ENTOMOL, V12, P641, DOI 10.1093/jmedent/12.6.641; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; PEIRIS JSM, 1992, T ROY SOC TROP MED H, V86, P307, DOI 10.1016/0035-9203(92)90325-7; Phuong CXT, 2002, TROP MED INT HEALTH, V7, P125, DOI 10.1046/j.1365-3156.2002.00841.x; Rodhain Francois, 1997, P45; Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223; ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108; ROSEN L, 1987, AM J TROP MED HYG, V37, P398; SMITH CEG, 1986, MED HIST, V30, P322, DOI 10.1017/S0025727300045737; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T., 2002, PATHOGENESIS CLIN FE; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Strode GK, 1951, YELLOW FEVER; SWAMINATHAN S, 2003, DENGUE B, V26, P181; Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242; Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945; Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0; WHO, 1997, DENG HAEM FEV DIAGN; *WHO, 2002, DENG DENG HAEM FEV W; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	78	485	513	0	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					500	509		10.1016/S0140-6736(08)60238-X	http://dx.doi.org/10.1016/S0140-6736(08)60238-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262042	Bronze			2022-12-28	WOS:000253169200030
J	Belonoshko, AB; Skorodumova, NV; Rosengren, A; Johansson, B				Belonoshko, Anatoly B.; Skorodumova, Natalia V.; Rosengren, Anders; Johansson, Boerje			Elastic anisotropy of Earth's inner core	SCIENCE			English	Article							CENTERED-CUBIC PHASE; TRAVEL-TIMES; IRON; PRESSURE; PKIKP; MODEL	Earth's solid- iron inner core is elastically anisotropic. Sound waves propagate faster along Earth's spin axis than in the equatorial plane. This anisotropy has previously been explained by a preferred orientation of the iron alloy hexagonal crystals. However, hexagonal iron becomes increasingly isotropic on increasing temperature at pressures of the inner core and is therefore unlikely to cause the anisotropy. An alternative explanation, supported by diamond anvil cell experiments, is that iron adopts a body- centered cubic form in the inner core. We show, by molecular dynamics simulations, that the body- centered cubic iron phase is extremely anisotropic to sound waves despite its high symmetry. Direct simulations of seismic wave propagation reveal an anisotropy of 12%, a value adequate to explain the anisotropy of the inner core.	[Belonoshko, Anatoly B.; Johansson, Boerje] Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden; [Belonoshko, Anatoly B.; Rosengren, Anders] Royal Inst Technol, Dept Theoret Phys, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden; [Skorodumova, Natalia V.; Johansson, Boerje] Uppsala Univ, Dept Phys, Condensed Matter Theory Grp, Uppsala, Sweden; [Rosengren, Anders] AlbaNova Univ Ctr, NORDITA, SE-10691 Stockholm, Sweden; [Johansson, Boerje] Dalian Univ Technol, Sch Phys & Optoelect Technol, Dalian 116024, Peoples R China; [Johansson, Boerje] Royal Inst Technol, Coll Adv Sci & Technol, SE-10044 Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; Uppsala University; Nordic Institute for Theoretical Physics; Dalian University of Technology; Royal Institute of Technology	Belonoshko, AB (corresponding author), Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden.	anatoly.belonoshko@fysik.uu.se	Belonoshko, Anatoly/AAC-4815-2021	Belonoshko, Anatoly/0000-0001-7531-3210				Beghein C, 2003, SCIENCE, V299, P552, DOI 10.1126/science.1078159; Belonoshko AB, 2006, PHYS REV B, V74, DOI [10.1103/PhysRevB.74.214102, 10.1103/PhysRevB.214102]; Belonoshko AB, 2000, PHYS REV LETT, V84, P3638, DOI 10.1103/PhysRevLett.84.3638; Belonoshko AB, 2003, NATURE, V424, P1032, DOI 10.1038/nature01954; Belonoshko AB, 2007, SCIENCE, V316, P1603, DOI 10.1126/science.1141374; Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Buffett BA, 2001, NATURE, V413, P60, DOI 10.1038/35092543; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; Cao A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029384; CREAGER KC, 1992, NATURE, V356, P309, DOI 10.1038/356309a0; Dubrovinsky L, 2007, SCIENCE, V316, P1880, DOI 10.1126/science.1142105; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Gannarelli CMS, 2005, PHYS EARTH PLANET IN, V152, P67, DOI 10.1016/j.pepi.2005.06.003; Hemley RJ, 2001, INT GEOL REV, V43, P1; Ishii M, 2002, P NATL ACAD SCI USA, V99, P14026, DOI 10.1073/pnas.172508499; KARATO S, 1993, SCIENCE, V262, P1708, DOI 10.1126/science.262.5140.1708; Koci L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224113; Ledenev B., 1958, SOV PHYS JETP, V34, P874; Lehmann I., 1936, BUR CENT SEISMOL INT, V14, P3; Matsui M, 1997, PHYS EARTH PLANET IN, V103, P55, DOI 10.1016/S0031-9201(97)00020-4; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; Romanowicz B, 1996, SCIENCE, V274, P963, DOI 10.1126/science.274.5289.963; ROSS M, 1990, J GEOPHYS RES-SOLID, V95, P21713, DOI 10.1029/JB095iB13p21713; Sha XW, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.064103; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; SONG XD, 1995, J GEOPHYS RES-SOL EA, V100, P9805, DOI 10.1029/95JB00244; Souriau A, 1997, PHYS EARTH PLANET IN, V101, P33, DOI 10.1016/S0031-9201(96)03242-6; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; Vocadlo L, 2003, NATURE, V424, P536, DOI 10.1038/nature01829; Yoshida S, 1998, J PHYS-CONDENS MAT, V10, P11215, DOI 10.1088/0953-8984/10/49/011	32	71	72	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					797	800		10.1126/science.1150302	http://dx.doi.org/10.1126/science.1150302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258912				2022-12-28	WOS:000252963000057
J	Chibalin, AV; Leng, Y; Vieira, E; Krook, A; Bjoernholm, M; Long, YC; Kotova, O; Zhong, ZH; Sakane, F; Steiler, T; Nylen, C; Wang, JJ; Laakso, M; Topham, MK; Gilbert, M; Wallberg-Henriksson, H; Zierath, JR				Chibalin, Alexander V.; Leng, Ying; Vieira, Elaine; Krook, Anna; Bjoernholm, Marie; Long, Yun Chau; Kotova, Olga; Zhong, Zhihui; Sakane, Fumio; Steiler, Tatiana; Nylen, Carolina; Wang, Jianjun; Laakso, Markku; Topham, Matthew K.; Gilbert, Marc; Wallberg-Henriksson, Harriet; Zierath, Juleen R.			Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance	CELL			English	Article							TYPE-2 DIABETIC-PATIENTS; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; METABOLIC SYNDROME; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; RECEPTOR; EXPRESSION; TOLERANCE; MECHANISM	Type 2 (non-insulin-dependent) diabetes mellitus is a progressive metabolic disorder arising from genetic and environmental factors that impair beta cell function and insulin action in peripheral tissues. We identified reduced diacylglycerol kinase delta (DGK delta) expression and DGK activity in skeletal muscle from type 2 diabetic patients. In diabetic animals, reduced DGK delta protein and DGK kinase activity were restored upon correction of glycemia. DGK delta haploinsufficiency increased diacylglycerol content, reduced peripheral insulin sensitivity, insulin signaling, and glucose transport, and led to age-dependent obesity. Metabolic flexibility, evident by the transition between lipid and carbohydrate utilization during fasted and fed conditions, was impaired in DGK delta haploinsufficient mice. We reveal a previously unrecognized role for DGK delta in contributing to hyperglycemia-induced peripheral insulin resistance and thereby exacerbating the severity of type 2 diabetes. DGK delta deficiency causes peripheral insulin resistance and metabolic inflexibility. These defects in glucose and energy homeostasis contribute to mild obesity later in life.	[Chibalin, Alexander V.; Leng, Ying; Vieira, Elaine; Bjoernholm, Marie; Long, Yun Chau; Kotova, Olga; Zhong, Zhihui; Nylen, Carolina; Gilbert, Marc; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Krook, Anna; Steiler, Tatiana; Wallberg-Henriksson, Harriet] Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, S-17177 Stockholm, Sweden; [Sakane, Fumio; Topham, Matthew K.] Univ Kuopio, Huntsman Canc Inst, Kuopio 70210, Finland; [Wang, Jianjun; Laakso, Markku] Univ Kuopio, Dept Med, Kuopio 70210, Finland; [Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; University of Eastern Finland; Utah System of Higher Education; University of Utah	Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.	juleen.zierath@ki.se	Sakane, Fumio/H-2693-2017; Vieira, Elaine/AAG-1127-2020; Vieira, Elaine/F-7273-2019; Krook, Anna/K-1192-2015; NylÃ©n, Carolina/AAD-5207-2021	Sakane, Fumio/0000-0003-0857-0377; Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Krook, Anna/0000-0002-0891-0258; Zierath, Juleen/0000-0001-6891-7497; Chibalin, Alexander/0000-0002-6339-6271				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; CHANG PY, 1994, J BIOL CHEM, V269, P16034; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Laakso M, 2005, CURR MOL MED, V5, P365, DOI 10.2174/1566524053766040; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Lee IK, 1999, DIABETES RES CLIN PR, V45, P183, DOI 10.1016/S0168-8227(99)00048-0; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Moller DE, 1996, ENDOCRINOLOGY, V137, P2397, DOI 10.1210/en.137.6.2397; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nagaya H, 2002, MOL BIOL CELL, V13, P302, DOI 10.1091/mbc.01-05-0255; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song XM, 1999, DIABETES, V48, P664, DOI 10.2337/diabetes.48.3.664; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Teran-Garcia M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1168, DOI 10.1152/ajpendo.00467.2004; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; WALLBERGHENRIKSSON H, 1987, ACTA PHYSIOL SCAND, V131, P1; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; ZIERATH JR, 1994, DIABETOLOGIA, V37, P270, DOI 10.1007/BF00398054; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	51	167	174	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					375	386		10.1016/j.cell.2007.12.035	http://dx.doi.org/10.1016/j.cell.2007.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267070	Bronze			2022-12-28	WOS:000253180700013
J	Delaval, B; Doxsey, S				Delaval, Benedicte; Doxsey, Stephen			Genetics - Dwarfism, where pericentrin gains stature	SCIENCE			English	Editorial Material							CENTROSOMES; CALMODULIN; MITOSIS		[Delaval, Benedicte; Doxsey, Stephen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Delaval, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	stephen.doxsey@umassmed.edu						Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; O'Driscoll M, 2006, CELL CYCLE, V5, P2339, DOI 10.4161/cc.5.20.3358; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Stirling DA, 1996, J CELL SCI, V109, P1297; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	11	16	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					732	733		10.1126/science.1154513	http://dx.doi.org/10.1126/science.1154513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258883				2022-12-28	WOS:000252963000025
J	Montgomery, MR				Montgomery, Mark R.			The urban transformation of the developing world	SCIENCE			English	Editorial Material							CHINA; CITIES	Sometime in the next 20 to 30 years, developing countries in Asia and Africa are likely to cross a historic threshold, joining Latin America in having a majority of urban residents. The urban demographic transformation is described here, with an emphasis on estimates and forecasts of urban population aggregates. To provide policy-makers with useful scientific guidance in the upcoming urban era, demographic researchers will need to refine their data sets to include spatial factors as well as urban vital rates and to make improvements to forecasting methods currently in use.	SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; Poverty Gender & Youth Program Populat Council, New York, NY 10017 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Montgomery, MR (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.	mmontgomery@notes.cc.sunysb.edu						Angel S., 2005, DYNAMICS GLOBAL URBA; [Anonymous], 2003, CITIES TRANSFORMED D; Balk D., 2005, P URB REM SENS C INT; Bocquier P, 2005, DEMOGR RES, V12, P197, DOI 10.4054/DemRes.2005.12.9; CHAMPION T, 2006, WHERE DO WE STAND LE; Chan KW, 2007, EURASIAN GEOGR ECON, V48, P383, DOI 10.2747/1538-7216.48.4.383; Chen N, 1998, MIGRATION, URBANIZATION, AND DEVELOPMENT : NEW DIRECTIONS AND ISSUES, P59; Hu Y., 2003, CHINA REV, V3, P49, DOI DOI 10.2307/23461904; MCGEE TG, 1991, EXTENDED METROPOLIS, P3; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; MONTGOMERY MR, 2008, GLOBAL URBANIZATION; Nicholls R.J., 2007, OECD ENV WORKING PAP, V1; Pinto da Cunha J., 2004, NEW FORMS URBANIZATI, P191; Schneider A, 2005, ENVIRON PLANN B, V32, P323, DOI 10.1068/b31142; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; SIVARAMAKRISHNA.K, 2005, HDB URBANIZATION IND; Small C, 2005, INT J REMOTE SENS, V26, P661, DOI 10.1080/01431160310001654950; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; UN-Habitat, 2006, M DEV GOALS SMALL UR; UNDESA, 2018, STESASERA420 UNDESA, DOI [10.4054/demres.2005.12.9, DOI 10.4054/DEMRES.2005.12.9]; *UNFPA, 2007, STAT WORLD POP 2007; United Nations, 2007, MILL DEV GOALS REP 2	22	367	394	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					761	764		10.1126/science.1153012	http://dx.doi.org/10.1126/science.1153012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258903				2022-12-28	WOS:000252963000046
J	Clark, CM; Tilman, D				Clark, Christopher M.; Tilman, David			Loss of plant species after chronic low-level nitrogen deposition to prairie grasslands	NATURE			English	Article							NUTRIENT-ENRICHMENT; ECOSYSTEM RECOVERY; VEGETATION; DIVERSITY; HEATHLAND; FERTILIZATION; ACIDIFICATION; PRODUCTIVITY; COMMUNITIES; LIMITATION	Rates of atmospheric deposition of biologically active nitrogen ( N) are two to seven times the pre- industrial rates in many developed nations because of combustion of fossil fuels and agricultural fertilization(1,2). They are expected to increase similarly over the next 50 years in industrializing nations of Asia and South America(2). Although the environmental impacts of high rates of nitrogen addition have been well studied(3-8), this is not so for the lower, chronic rates that characterize much of the globe. Here we present results of the first multi- decadal experiment to examine the impacts of chronic, experimental nitrogen addition as low as 10 kg N ha(-1) yr(-1) above ambient atmospheric nitrogen deposition ( 6 kg N ha(-1) yr(-1) at our site). This total input rate is comparable to terrestrial nitrogen deposition in many industrialized nations(2). We found that this chronic low- level nitrogen addition rate reduced plant species numbers by 17% relative to controls receiving ambient N deposition. Moreover, species numbers were reduced more per unit of added nitrogen at lower addition rates, suggesting that chronic but low- level nitrogen deposition may have a greater impact on diversity than previously thought. A second experiment showed that a decade after cessation of nitrogen addition, relative plant species number, although not species abundances, had recovered, demonstrating that some effects of nitrogen addition are reversible.	[Clark, Christopher M.; Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Clark, CM (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 100 Ecol,1987 Upper Buford Circle, St Paul, MN 55108 USA.	clark134@umn.edu	Tilman, David/ABD-5309-2021					Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BOBBINK R, 1991, J APPL ECOL, V28, P28, DOI 10.2307/2404111; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; BOBBINK R, 2002, MANUAL METHODOLOGIES, P40; Bouwman AF, 2002, WATER AIR SOIL POLL, V141, P349, DOI 10.1023/A:1021398008726; Boxman AW, 1998, FOREST ECOL MANAG, V101, P155, DOI 10.1016/S0378-1127(97)00132-1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; MOUNTFORD JO, 1993, J APPL ECOL, V30, P321, DOI 10.2307/2404634; Mountford JO, 1996, J VEG SCI, V7, P219, DOI 10.2307/3236322; NILSSON J, 1988, WORKSH HELD STOKH SW; Power SA, 2006, GLOBAL CHANGE BIOL, V12, P1241, DOI 10.1111/j.1365-2486.2006.01161.x; Roem WJ, 2002, J APPL ECOL, V39, P937, DOI 10.1046/j.1365-2664.2002.00768.x; Smart SM, 2005, BIOL CONSERV, V124, P355, DOI 10.1016/j.biocon.2004.12.013; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Strengbom J, 2001, FUNCT ECOL, V15, P451, DOI 10.1046/j.0269-8463.2001.00538.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; van den Berg LJL, 2005, ENVIRON POLLUT, V138, P77, DOI 10.1016/j.envpol.2005.02.024; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Williams MW, 2000, ECOL APPL, V10, P1648, DOI 10.1890/1051-0761(2000)010[1648:CLFIND]2.0.CO;2	28	670	791	40	695	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					712	715		10.1038/nature06503	http://dx.doi.org/10.1038/nature06503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256670				2022-12-28	WOS:000252929500040
J	Goldston, D				Goldston, David			A debatable proposition	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com						Goldston D, 2007, NATURE, V449, P962, DOI 10.1038/449962a	1	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					621	621		10.1038/451621a	http://dx.doi.org/10.1038/451621a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256639	Bronze			2022-12-28	WOS:000252929500011
J	Horowitz, HW				Horowitz, Harold W.			The interpreter of facts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												harold.horowitz@med.nyu.edu						FRANK P, 2002, EINSTEIN HIS LIFE TI, P185	1	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					497	498		10.1001/jama.299.5.497	http://dx.doi.org/10.1001/jama.299.5.497			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252874				2022-12-28	WOS:000252886100001
J	Kufer, SK; Puchner, EM; Gumpp, H; Liedl, T; Gaub, HE				Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Liedl, T.; Gaub, H. E.			Single-molecule cut-and-paste surface assembly	SCIENCE			English	Article							DNA; SPECTROSCOPY; CELLS	We introduce a method for the bottom- up assembly of biomolecular structures that combines the precision of the atomic force microscope ( AFM) with the selectivity of DNA hybridization. Functional units coupled to DNA oligomers were picked up from a depot area by means of a complementary DNA strand bound to an AFM tip. These units were transferred to and deposited on a target area to create basic geometrical structures, assembled from units with different functions. Each of these cut- and- paste events was characterized by single- molecule force spectroscopy and single- molecule fluorescence microscopy. Transport and deposition of more than 5000 units were achieved, with less than 10% loss in transfer efficiency.	[Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Gaub, H. E.] Univ Munich, Ctr Nanosci, D-80799 Munich, Germany; [Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Gaub, H. E.] Univ Munich, Dept Phys, D-80799 Munich, Germany; [Liedl, T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liedl, T.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	University of Munich; University of Munich; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Kufer, SK (corresponding author), Univ Munich, Ctr Nanosci, Amalienstr 54, D-80799 Munich, Germany.		Liedl, Tim/O-7539-2014	Liedl, Tim/0000-0002-0040-0173; Puchner, Elias M./0000-0002-7129-2309				Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Cuberes MT, 1996, APPL PHYS LETT, V69, P3016, DOI 10.1063/1.116824; Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Griessl SJH, 2004, J PHYS CHEM B, V108, P11556, DOI 10.1021/jp049521p; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380; Jaschke M, 1996, BIOSENS BIOELECTRON, V11, P601, DOI 10.1016/0956-5663(96)83295-7; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Morfill J, 2007, BIOPHYS J, V93, P2400, DOI 10.1529/biophysj.107.106112; Neuert G, 2007, BIOPHYS J, V93, P1215, DOI 10.1529/biophysj.106.100511; NIEMEYER CM, 1994, NUCLEIC ACIDS RES, V22, P5530, DOI 10.1093/nar/22.25.5530; Pellegrino T, 2005, SMALL, V1, P48, DOI 10.1002/smll.200400071; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Ringler M, 2007, NANO LETT, V7, P2753, DOI 10.1021/nl0712466; Schitter G, 2007, IEEE T CONTR SYST T, V15, P906, DOI 10.1109/TCST.2007.902953; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vettiger P, 2000, IBM J RES DEV, V44, P323, DOI 10.1147/rd.443.0323	33	229	237	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					594	596		10.1126/science.1151424	http://dx.doi.org/10.1126/science.1151424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239119				2022-12-28	WOS:000252772000033
J	Silva, JM; Marran, K; Parker, JS; Silva, J; Golding, M; Schlabach, MR; Elledge, SJ; Hannon, GJ; Chang, K				Silva, Jose M.; Marran, Krista; Parker, Joel S.; Silva, Javier; Golding, Michael; Schlabach, Michael R.; Elledge, Stephen J.; Hannon, Gregory J.; Chang, Kenneth			Profiling essential genes in human mammary cells by multiplex RNAi screening	SCIENCE			English	Article							MAMMALIAN-CELLS; SHRNA LIBRARIES; CANCER-CELLS; IN-VIVO; INTERFERENCE; IDENTIFICATION; CHECKPOINT; APOPTOSIS; PATHWAY; PROTEIN	By virtue of their accumulated genetic alterations, tumor cells may acquire vulnerabilities that create opportunities for therapeutic intervention. We have devised a massively parallel strategy for screening short hairpin RNA ( shRNA) collections for stable loss- of- function phenotypes. We assayed from 6000 to 20,000 shRNAs simultaneously to identify genes important for the proliferation and survival of five cell lines derived from human mammary tissue. Lethal shRNAs common to these cell lines targeted many known cell- cycle regulatory networks. Cell line - specific sensitivities to suppression of protein complexes and biological pathways also emerged, and these could be validated by RNA interference ( RNAi) and pharmacologically. These studies establish a practical platform for genome- scale screening of complex phenotypes in mammalian cells and demonstrate that RNAi can be used to expose genotype- specific sensitivities.	[Silva, Jose M.; Marran, Krista; Silva, Javier; Golding, Michael; Hannon, Gregory J.; Chang, Kenneth] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Brigham & Womens Hosp, Ctr Genet & Genom,Dept Genet, Boston, MA 02115 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27713 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Parker, Joel/AAG-1108-2019; Hannon, Gregory/AAB-3568-2019	GOLDING, MICHAEL/0000-0003-1631-2175	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-36, P01 CA013106, P01 CA013106-37] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Farah Mohamed H., 2007, Current Drug Delivery, V4, P161, DOI 10.2174/156720107780362276; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Moyer JD, 1997, CANCER RES, V57, P4838; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Natt F, 2007, CURR OPIN MOL THER, V9, P242; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Scherer L, 2004, CURR PHARM BIOTECHNO, V5, P355, DOI 10.2174/1389201043376724; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Snove O, 2006, NAT METHODS, V3, P689, DOI 10.1038/NMETH927; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	29	235	252	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					617	620		10.1126/science.1149185	http://dx.doi.org/10.1126/science.1149185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239125	Green Accepted, Green Submitted			2022-12-28	WOS:000252772000040
J	LaPorte, SL; Juo, ZS; Vaclavikova, J; Colf, LA; Qi, XL; Heller, NM; Keegan, AD; Garcia, KC				LaPorte, Sherry L.; Juo, Z. Sean; Vaclavikova, Jana; Colf, Leremy A.; Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.; Garcia, K. Christopher			Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system	CELL			English	Article							COMMON GAMMA-CHAIN; SEVERE COMBINED IMMUNODEFICIENCY; CRYSTAL-STRUCTURE; FUNCTIONAL COMPONENT; JUXTAMEMBRANE DOMAIN; IL-4 RECEPTOR; ALPHA-CHAIN; BINDING; COMPLEX; CLONING	Interleukin-4 and Interleukin-13 are cytokines critical to the development of T cell-mediated humoral immune responses, which are associated with allergy and asthma, and exert their actions through three different combinations of shared receptors. Here we present the crystal structures of the complete set of type I (IL-4R alpha/gamma(c)/IL-4) and type II (IL-4R alpha/IL-13R alpha 1/ IL-4, IL-4R alpha/IL-13R alpha 1/IL-13) ternary signaling complexes. The type I complex reveals a structural basis for gamma(c)'s ability to recognize six different gamma(c)-cytokines. The two type II complexes utilize an unusual top-mounted Ig-like domain on IL-13R alpha 1 for a novel mode of cytokine engagement that contributes to a reversal in the IL-4 versus IL-13 ternary complex assembly sequences, which are mediated through substantially different recognition chemistries. We also show that the type II receptor heterodimer signals with different potencies in response to IL-4 versus IL-13 and suggest that the extracellular cytokine-receptor interactions are modulating intracellular membrane-proximal signaling events.	[LaPorte, Sherry L.; Juo, Z. Sean; Vaclavikova, Jana; Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI051321, R37AI051321, R01AI038985] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007698] Funding Source: Medline; NIAID NIH HHS [R01 AI051321-05, R37 AI051321, AI51321, R29 AI038985, R01 AI038985, AI38985, R01 AI051321] Funding Source: Medline; PHS HHS [HHMI_GARCIA_K] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes PJ, 2002, ANNU REV PHARMACOL, V42, P81, DOI 10.1146/annurev.pharmtox.42.111901.111143; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; DeLano W.L, PYMOL MOL GRAPHICS S; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Keller Y, 2003, IEEE T CIRC SYST VID, V13, P300, DOI 10.1109/TCSVT.2003.811360; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Lai SY, 1996, P NATL ACAD SCI USA, V93, P231, DOI 10.1073/pnas.93.1.231; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; LEONARD WJ, 1994, ADV EXP MED BIOL, V365, P225; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Moy FJ, 2001, J MOL BIOL, V310, P219, DOI 10.1006/jmbi.2001.4764; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Murata T, 1998, BLOOD, V91, P3884; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER MR, 1992, J BIOL CHEM, V267, P20371; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Williams J, 2004, HEALTH ECON, V13, P123, DOI 10.1002/hec.796; WLODAVER A, 1992, FEBS LETT, V309, P59, DOI 10.1016/0014-5793(92)80739-4; Zamorano J, 1996, J IMMUNOL, V157, P4926; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x; Zhang JL, 2002, J MOL BIOL, V315, P399, DOI 10.1006/jmbi.2001.5243	55	371	403	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					259	272		10.1016/j.cell.2007.12.030	http://dx.doi.org/10.1016/j.cell.2007.12.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243101	Green Accepted, Bronze			2022-12-28	WOS:000253427700012
J	Kong, A; Thorleifsson, G; Stefansson, H; Masson, G; Helgason, A; Gudbjartsson, DF; Jonsdottir, GM; Gudjonsson, SA; Sverrisson, S; Thorlacius, T; Jonasdottir, A; Hardarson, GA; Palsson, ST; Frigge, ML; Gulcher, JR; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Stefansson, Hreinn; Masson, Gisli; Helgason, Agnar; Gudbjartsson, Daniel F.; Jonsdottir, Gudrun M.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Thorlacius, Theodora; Jonasdottir, Aslaug; Hardarson, Gudmundur A.; Palsson, Stefan T.; Frigge, Michael L.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Stefansson, Kari			Sequence variants in the RNF212 gene associate with genome-wide recombination rate	SCIENCE			English	Article							MEIOTIC RECOMBINATION; HUMAN MALES; MEIOSIS; MAP; HUMANS	The genome- wide recombination rate varies between individuals, but the mechanism controlling this variation in humans has remained elusive. A genome- wide search identified sequence variants in the 4p16.3 region correlated with recombination rate in both males and females. These variants are located in the RNF212 gene, a putative ortholog of the ZHP- 3 gene that is essential for recombinations and chiasma formation in Caenorhabditis elegans. It is noteworthy that the haplotype formed by two single- nucleotide polymorphisms ( SNPs) associated with the highest recombination rate in males is associated with a low recombination rate in females. Consequently, if the frequency of the haplotype changes, the average recombination rate will increase for one sex and decrease for the other, but the sex- averaged recombination rate of the population can stay relatively constant.	[Kong, Augustine; Thorleifsson, Gudmar; Stefansson, Hreinn; Masson, Gisli; Helgason, Agnar; Gudbjartsson, Daniel F.; Jonsdottir, Gudrun M.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Thorlacius, Theodora; Jonasdottir, Aslaug; Hardarson, Gudmundur A.; Palsson, Stefan T.; Frigge, Michael L.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Inc, IS-101 Reykjavik, Iceland		Kong, A (corresponding author), deCODE Genet Inc, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Kong, Augustine/0000-0001-8193-5438; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carrington M, 2004, TRENDS GENET, V20, P196, DOI 10.1016/j.tig.2004.02.006; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Costa Y, 2007, CHROMOSOME RES, V15, P579, DOI 10.1007/s10577-007-1142-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	25	137	144	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1398	1401		10.1126/science.1152422	http://dx.doi.org/10.1126/science.1152422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18239089				2022-12-28	WOS:000253712900046
J	Gerszten, RE; Wang, TJ				Gerszten, Robert E.; Wang, Thomas J.			The search for new cardiovascular biomarkers	NATURE			English	Article							CORONARY-ARTERY-DISEASE; PLASMA-PROTEOME; IDENTIFICATION; CHEMOKINE; RECEPTOR; ASSOCIATION; DATABASE; EVENTS; RISK	Despite considerable advances in the treatment of cardiovascular disease, it remains the leading cause of death in developed countries. Assessment of classic cardiovascular risk factors-including high blood pressure, diabetes and smoking-has a central role in disease prevention. However, many individuals with coronary heart disease (a narrowing of the blood vessels that supply the heart) have only one, or none, of the classic risk factors. Thus, new biomarkers are needed to augment the information obtained from traditional indicators and to illuminate disease mechanisms.	[Gerszten, Robert E.; Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Gerszten, RE (corresponding author), Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA.	rgerszten@partners.org		Wang, Thomas/0000-0003-4063-6508				Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Frazier DM, 2006, J INHERIT METAB DIS, V29, P76, DOI 10.1007/s10545-006-0228-9; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; PEPE MS, 2000, BIOSTATISTICS, V1, P123, DOI DOI 10.1093/BI0STATISTICS/1.2.123; ROE CR, 1986, J CLIN INVEST, V77, P1391, DOI 10.1172/JCI112446; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Wilson PWF, 2004, CIRCULATION, V110, pE568, DOI 10.1161/01.CIR.0000149077.87074.DE; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	26	247	259	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					949	952		10.1038/nature06802	http://dx.doi.org/10.1038/nature06802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288185				2022-12-28	WOS:000253313100036
J	Miller, FG; Emanuel, EJ				Miller, Franklin G.; Emanuel, Ezekiel J.			Perspective: Quality-improvement research, and informed consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miller, Franklin G.; Emanuel, Ezekiel J.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Miller, FG (corresponding author), NIH, Dept Bioeth, Bldg 10, Bethesda, MD 20892 USA.							Borror K.C., 2007, HUMAN RES PROTECTION; GAWANDE A, 2007, NY TIMES        1230, P8; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268	4	94	94	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					765	767		10.1056/NEJMp0800136	http://dx.doi.org/10.1056/NEJMp0800136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287598				2022-12-28	WOS:000253257700001
J	Peberdy, MA; Ornato, JP; Larkin, GL; Braithwaite, RS; Kashner, TM; Carey, SM; Meaney, PA; Cen, L; Nadkarni, VM; Praestgaard, AH; Berg, RA				Peberdy, Mary Ann; Ornato, Joseph P.; Larkin, G. Luke; Braithwaite, R. Scott; Kashner, T. Michael; Carey, Scott M.; Meaney, Peter A.; Cen, Liyi; Nadkarni, Vinay M.; Praestgaard, Amy H.; Berg, Robert A.		Natl Registry Cardiopulm Resuscita	Survival from in-hospital cardiac arrest during nights and weekends	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHIFT-WORK; CARDIOPULMONARY-RESUSCITATION; PERFORMANCE; SLEEP; CARE; MODAFINIL; INJURIES; QUALITY; ADULTS; RHYTHM	Context Occurrence of in- hospital cardiac arrest and survival patterns have not been characterized by time of day or day of week. Patient physiology and process of care for in- hospital cardiac arrest may be different at night and on weekends because of hospital factors unrelated to patient, event, or location variables. Objective To determine whether outcomes after in- hospital cardiac arrest differ during nights and weekends compared with days/ evenings and weekdays. Design and Setting We examined survival from cardiac arrest in hourly time segments, defining day/ evening as 7: 00 AM to 10: 59 PM, night as 11: 00 PM to 6: 59 AM, and weekend as 11: 00 PM on Friday to 6: 59 AM on Monday, in 86 748 adult, consecutive in- hospital cardiac arrest events in the National Registry of Cardiopulmonary Resuscitation obtained from 507 medical/ surgical participating hospitals from January 1, 2000, through February 1, 2007. Main Outcome Measures The primary outcome of survival to discharge and secondary outcomes of survival of the event, 24- hour survival, and favorable neurological outcome were compared using odds ratios and multivariable logistic regression analysis. Point estimates of survival outcomes are reported as percentages with 95% confidence intervals ( 95% CIs). Results A total of 58 593 cases of in- hospital cardiac arrest occurred during day/ evening hours ( including 43 483 on weekdays and 15 110 on weekends), and 28 155 cases occurred during night hours ( including 20 365 on weekdays and 7790 on weekends). Rates of survival to discharge ( 14.7% [ 95% CI, 14.3%- 15.1%] vs 19.8% [ 95% CI, 19.5%- 20.1%], return of spontaneous circulation for longer than 20 minutes ( 44.7% [ 95% CI, 44.1%- 45.3%] vs 51.1% [ 95% CI, 50.7%- 51.5%]), survival at 24 hours ( 28.9% [ 95% CI, 28.4%- 29.4%] vs 35.4% [ 95% CI, 35.0%- 35.8%]), and favorable neurological outcomes ( 11.0% [ 95% CI, 10.6%- 11.4%] vs 15.2% [ 95% CI, 14.9%-15.5%]) were substantially lower during the night compared with day/ evening ( all P values <. 001). The first documented rhythm at night was more frequently asystole ( 39.6% [ 95% CI, 39.0%- 40.2%] vs 33.5% [ 95% CI, 33.2%- 33.9%], P <. 001) and less frequently ventricular fibrillation ( 19.8% [ 95% CI, 19.3%- 20.2%] vs 22.9% [ 95% CI, 22.6%- 23.2%], P <. 001). Among in- hospital cardiac arrests occurring during day/ evening hours, survival was higher on weekdays ( 20.6% [ 95% CI, 20.3%- 21%]) than on weekends ( 17.4% [ 95% CI, 16.8%- 18%]; odds ratio, 1.15 [ 95% CI, 1.09- 1.22]), whereas among in- hospital cardiac arrests occurring during night hours, survival to discharge was similar on weekdays ( 14.6% [ 95% CI, 14.1%- 15.2%]) and on weekends ( 14.8% [ 95% CI, 14.1%- 15.2%]; odds ratio, 1.02 [ 95% CI, 0.94- 1.11]). Conclusion Survival rates from in- hospital cardiac arrest are lower during nights and weekends, even when adjusted for potentially confounding patient, event, and hospital characteristics.	[Peberdy, Mary Ann; Ornato, Joseph P.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Larkin, G. Luke; Braithwaite, R. Scott] Yale Univ, Sch Med, New Haven, CT USA; [Kashner, T. Michael] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Carey, Scott M.] Digital Innovat, Forest Hill, MD USA; [Meaney, Peter A.; Nadkarni, Vinay M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Cen, Liyi; Praestgaard, Amy H.] Univ Penn, Biostat Anal Ctr, Philadelphia, PA 19104 USA; [Berg, Robert A.] Univ Arizona, Coll Med, Tucson, AZ USA	Virginia Commonwealth University; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Arizona	Peberdy, MA (corresponding author), Virginia Commonwealth Univ, Box 980204, Richmond, VA 23298 USA.	mpeberdy@aol.com		LARKIN, GREGORY LUKE/0000-0002-8655-7824; Meaney, Peter/0000-0001-9898-6928; Braithwaite, Ronald Scott/0000-0001-7067-3655				Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Dumot JA, 2001, ARCH INTERN MED, V161, P1751, DOI 10.1001/archinte.161.14.1751; Gill M, 2006, ACAD EMERG MED, V13, P158, DOI 10.1197/j.aem.2005.08.013; Hall LM, 2004, J NURS CARE QUAL, V19, P27, DOI 10.1097/00001786-200401000-00007; Herlitz J, 2002, RESUSCITATION, V53, P127, DOI 10.1016/S0300-9572(02)00014-X; Horwitz IB, 2004, OCCUP MED-OXFORD, V54, P556, DOI 10.1093/occmed/kqh093; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jones-Crawford JL, 2007, AM J MED, V120, P158, DOI 10.1016/j.amjmed.2006.06.032; Kuhn G, 2001, ANN EMERG MED, V37, P88, DOI 10.1067/mem.2001.111571; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; Marcu Constantin B, 2005, Conn Med, V69, P389; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; NEUBERGER JS, 1984, AM J INFECT CONTROL, V12, P171, DOI 10.1016/0196-6553(84)90094-4; Parish DC, 1999, CRIT CARE MED, V27, P2137, DOI 10.1097/00003246-199910000-00010; Parks DK, 2000, CHRONOBIOL INT, V17, P61, DOI 10.1081/CBI-100101032; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peng T C, 1989, Ma Zui Xue Za Zhi, V27, P137; Rollinson DC, 2003, ANN EMERG MED, V41, P400, DOI 10.1067/mem.2003.77; SMITHCOGGINS R, 1994, ANN EMERG MED, V24, P928, DOI 10.1016/S0196-0644(94)70209-8; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; WRIGHT D, 1994, EUR HEART J, V15, P631, DOI 10.1093/oxfordjournals.eurheartj.a060559	23	409	414	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					785	792		10.1001/jama.299.7.785	http://dx.doi.org/10.1001/jama.299.7.785			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285590	Bronze			2022-12-28	WOS:000253226900021
J	Acheson, AG; Scholefield, JH				Acheson, Austin G.; Scholefield, John H.			Management of haemorrhoids	BRITISH MEDICAL JOURNAL			English	Review							RUBBER BAND LIGATION; THROMBOSED EXTERNAL HEMORRHOIDS; RANDOMIZED-TRIAL; DOUBLE-BLIND; PAIN; METAANALYSIS; INJECTION; COMPLICATIONS; PREVALENCE; OINTMENT		[Acheson, Austin G.; Scholefield, John H.] Univ Nottingham Hosp, Queens Med Ctr, Sect Gastrointestinal Surg, Nottingham NG7 2UH, England	University of Nottingham	Acheson, AG (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Sect Gastrointestinal Surg, Nottingham NG7 2UH, England.	austin.acheson@nottingham.ac.uk						Alonso-Coello P, 2006, BRIT J SURG, V93, P909, DOI 10.1002/bjs.5378; Alonso-Coello P, 2006, AM J GASTROENTEROL, V101, P181, DOI 10.1111/j.1572-0241.2005.00359.x; BARRON J, 1963, Dis Colon Rectum, V6, P109, DOI 10.1007/BF02633461; Carapeti EA, 1998, LANCET, V351, P169, DOI 10.1016/S0140-6736(97)09003-X; Chau NG, 2007, CAN J GASTROENTEROL, V21, P601, DOI 10.1155/2007/106946; Cheetham MJ, 2000, LANCET, V356, P730, DOI 10.1016/S0140-6736(00)02632-5; FERGUSON J A, 1959, Dis Colon Rectum, V2, P176, DOI 10.1007/BF02616713; GAZET JC, 1970, P ROY SOC MED, V63, P78; Greenspon J, 2004, DIS COLON RECTUM, V47, P1493, DOI 10.1007/s10350-004-0607-y; Guy RJ, 2003, BRIT J SURG, V90, P147, DOI 10.1002/bjs.4008; Ho Y H, 2007, Tech Coloproctol, V11, P135, DOI 10.1007/s10151-007-0343-0; Jayaraman S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005393.pub2; JOHANSON JF, 1990, GASTROENTEROLOGY, V98, P380, DOI 10.1016/0016-5085(90)90828-O; KHUBCHANDANI IT, 1983, DIS COLON RECTUM, V26, P705, DOI 10.1007/BF02554977; Law WL, 1999, DIS COLON RECTUM, V42, P363, DOI 10.1007/BF02236354; MACRAE HM, 1995, DIS COLON RECTUM, V38, P687, DOI 10.1007/BF02048023; Patti R, 2006, DIS COLON RECTUM, V49, P1741, DOI 10.1007/s10350-006-0677-0; Perrotti P, 2001, DIS COLON RECTUM, V44, P405, DOI 10.1007/BF02234741; POON GP, 1986, DIS COLON RECTUM, V29, P836, DOI 10.1007/BF02555358; Scheyer M, 2006, AM J SURG, V191, P89, DOI 10.1016/j.amjsurg.2005.10.007; SENAPATI A, 1988, INT J COLORECTAL DIS, V3, P124, DOI 10.1007/BF01645317; Silverman R, 2005, DIS COLON RECTUM, V48, P1913, DOI 10.1007/s10350-005-0135-4; THOMSON JPS, 1992, COLOPROCTOLOGY PELVI, P373; THOMSON WHF, 1975, BRIT J SURG, V62, P542, DOI 10.1002/bjs.1800620710; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P878, DOI 10.1007/s10350-006-0852-3; WALKER AJ, 1990, INT J COLORECTAL DIS, V5, P113, DOI 10.1007/BF00298482	26	68	70	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					380	383		10.1136/bmj.39465.674745.80	http://dx.doi.org/10.1136/bmj.39465.674745.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276714	Green Published			2022-12-28	WOS:000253550600042
J	Danchin, N; Armstrong, PA				Danchin, Nicolas; Armstrong, Paul W.			PCI at non-PCI centres: immediate or rescue?	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ABCIXIMAB RETEPLASE STENT; ST-ELEVATION; ANGIOPLASTY; THROMBOLYSIS; FIBRINOLYSIS; REPERFUSION; STANDARD; REGISTRY; THERAPY		[Danchin, Nicolas] Univ Paris 05, Dept Coronary Artery Dis & Intens Care, Hop Europeen Georges Pompidou Assistance Publ, Hop Paris, F-75015 Paris, France; [Armstrong, Paul W.] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Alberta	Danchin, N (corresponding author), Univ Paris 05, Dept Coronary Artery Dis & Intens Care, Hop Europeen Georges Pompidou Assistance Publ, Hop Paris, F-75015 Paris, France.	Nicolas.danchin@egp.ap-hop-paris-fr	Danchin, Nicolas/AAN-8291-2020	Armstrong, Paul/0000-0002-0460-3445				Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Cantor WJ, 2008, AM HEART J, V155, P19, DOI 10.1016/j.ahj.2007.08.025; Danchin N, 2004, CIRCULATION, V110, P1909, DOI 10.1161/01.CIR.0000143144.82338.36; Di Mario C, 2004, AM HEART J, V148, P378, DOI 10.1016/j.ahj.2004.03.038; Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8; ELLIS S, 2007, FINESSE TRIAL FACILI; Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Labarere J, 2007, ARCH INTERN MED, V167, P913, DOI 10.1001/archinte.167.9.913; Topol EJ, 2001, LANCET, V357, P1905	13	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					534	536		10.1016/S0140-6736(08)60246-9	http://dx.doi.org/10.1016/S0140-6736(08)60246-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280311				2022-12-28	WOS:000253202600005
J	Horton, R				Horton, Richard			The NHS is dead ... long live the UK's health system	LANCET			English	Editorial Material									[Horton, Richard] Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							CARVEL J, 2008, GUARDIAN        0109, P3; *DEP HLTH, 2007, CMO UPD; DIXON A, 2008, GOVERNING NHS ALTERN	3	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2008	371	9612					533	534		10.1016/S0140-6736(08)60245-7	http://dx.doi.org/10.1016/S0140-6736(08)60245-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263FI	18280310				2022-12-28	WOS:000253202600004
J	Renehan, AG; Tyson, M; Egger, M; Heller, RF; Zwahlen, M				Renehan, Andrew G.; Tyson, Margaret; Egger, Matthias; Heller, Richard F.; Zwahlen, Marcel			Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies	LANCET			English	Article							RENAL-CELL CARCINOMA; EPITHELIAL OVARIAN-CANCER; META-REGRESSION ANALYSIS; MILLION NORWEGIAN MEN; SELF-REPORTED HEIGHT; TO-HIP RATIO; BREAST-CANCER; MULTIETHNIC COHORT; PANCREATIC-CANCER; FAT DISTRIBUTION	Background Excess bodyweight, expressed as increased body-mass index (BMI), is associated with the risk of some common adult cancers. We did a systematic review and meta-analysis to assess the strength of associations between BMI and different sites of cancer and to investigate differences in these associations between sex and ethnic groups. Methods We did electronic searches on Medline and Embase (1966 to November 2007), and searched reports to identify prospective studies of incident cases of 20 cancer types. We did random-effects meta-analyses and meta-regressions of study-specific incremental estimates to determine the risk of cancer associated with a 5 kg/m(2) increase in BMI. Findings We analysed 221 datasets (141 articles), including 282137 incident cases. In men, a 5 kg/m(2) increase in BMI was strongly associated with oesophageal adenocarcinoma (RR 1.52, p<0.0001) and with thyroid (1.33, p=0. 02), colon (1 . 24, p< 0.0001), and renal (1.34, p <0 .0001) cancers. In women, we recorded strong associations between a 5 kg/m(2) increase in BMI and endometrial (1 . 59, p<0.0001), gallbladder (1 .59, p=0.04), oesophageal adenocarcinoma (1 . 51, p<0. 0001), and renal (1. 34, p<0.0001) cancers. We noted weaker positive associations (RR <1 .20) between increased BMI and rectal cancer and malignant melanoma in men; postmenopausal breast, pancreatic, thyroid, and colon cancers in women; and leukaemia, multiple myeloma, and non-Hodgkin lymphoma in both sexes. Associations were stronger in men than in women for colon (p<0.0001) cancer. Associations were generally similar in studies from North America, Europe and Australia, and the Asia-Pacific region, but we recorded stronger associations in Asia-Pacific populations between increased BMI and premenopausal (p=0.009) and postmenopausal (p=0.06) breast cancers. Interpretation Increased BMI is associated with increased risk of common and less common malignancies. For some cancer types, associations differ between sexes and populations of different ethnic origins. These epidemiological observations should inform the exploration of biological mechanisms that link obesity with cancer.	[Renehan, Andrew G.] Univ Manchester, Christie Hosp NHS Trust, Dept Surg, Sch Canc Studies, Manchester M20 4BX, Lancs, England; [Tyson, Margaret; Heller, Richard F.] Univ Manchester, Evidence Populat Hlth Unit, Manchester M20 4BX, Lancs, England; [Egger, Matthias; Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Egger, Matthias] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester; University of Bern; University of Bristol	Renehan, AG (corresponding author), Univ Manchester, Christie Hosp NHS Trust, Dept Surg, Sch Canc Studies, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	arenehan@picr.man.ac.uk	Zwahlen, Marcel/AFF-8559-2022; Renehan, Andrew/K-5992-2015	Zwahlen, Marcel/0000-0002-6772-6346; Renehan, Andrew/0000-0003-4309-4396; Egger, Matthias/0000-0001-7462-5132; Heller, Richard/0000-0003-3161-5967				Awakura Y, 2007, UROLOGY, V70, P50, DOI 10.1016/j.urology.2007.03.034; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bergstrom A, 2001, BRIT J CANCER, V85, P984, DOI 10.1038/sj.bjc.6692040; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bianchini F, 2002, WEIGHT CONTROL PHYS; Bjorge T, 2004, AM J EPIDEMIOL, V160, P1168, DOI 10.1093/aje/kwh345; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Carmichael AR, 2006, OBES REV, V7, P333, DOI 10.1111/j.1467-789X.2006.00261.x; Connolly BS, 2002, NUTR CANCER, V44, P127, DOI 10.1207/S15327914NC4402_02; Dal Maso L, 2000, CANCER CAUSE CONTROL, V11, P137, DOI 10.1023/A:1008938520101; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dignam JJ, 2006, J NATL CANCER I, V98, P1647, DOI 10.1093/jnci/djj442; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; FRIEDMAN GD, 1994, CANCER CAUSE CONTROL, V5, P479, DOI 10.1007/BF01694762; Gago-Dominguez M, 2002, CANCER CAUSE CONTROL, V13, P287, DOI 10.1023/A:1015044518505; Gong ZH, 2007, CANCER-AM CANCER SOC, V109, P1192, DOI 10.1002/cncr.22534; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Haydon AMM, 2006, GUT, V55, P689, DOI 10.1136/gut.2005.081547; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Iwasaki M, 2007, ANN EPIDEMIOL, V17, P304, DOI 10.1016/j.annepidem.2006.09.003; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kanashiki A, 2005, CHEST, V128, P1490, DOI 10.1378/chest.128.3.1490; KARK JD, 1995, ARCH INTERN MED, V155, P2409, DOI 10.1001/archinte.155.22.2409; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Kjaerbye-Thygesen A, 2006, CANCER EPIDEM BIOMAR, V15, P798, DOI 10.1158/1055-9965.EPI-05-0897; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kuriyama S, 2005, INT J CANCER, V113, P148, DOI 10.1002/ijc.20529; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Larsson SC, 2007, BRIT J CANCER, V96, P1457, DOI 10.1038/sj.bjc.6603703; Larsson SC, 2008, INT J CANCER, V122, P1418, DOI 10.1002/ijc.23176; Larsson SC, 2007, INT J CANCER, V121, P2512, DOI 10.1002/ijc.22968; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Larsson SC, 2007, INT J CANCER, V121, P1564, DOI 10.1002/ijc.22762; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Li Hong-lan, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P488; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Mellemkjaer L, 2006, OBESITY, V14, P1854, DOI 10.1038/oby.2006.214; Nothlings U, 2007, CANCER CAUSE CONTROL, V18, P165, DOI 10.1007/s10552-006-0100-0; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Olsen CM, 2007, EUR J CANCER, V43, P690, DOI 10.1016/j.ejca.2006.11.010; Olson JE, 2002, AM J EPIDEMIOL, V156, P606, DOI 10.1093/aje/kwf084; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Palmer JR, 2007, CANCER EPIDEM BIOMAR, V16, P1795, DOI 10.1158/1055-9965.EPI-07-0336; Purdie DM, 2001, CANCER CAUSE CONTROL, V12, P855, DOI 10.1023/A:1012267619561; REEVES GK, 2007, BMJ              NOV, DOI DOI 10.1136/BMJ.39367.495995.AE; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; Setiawan VW, 2007, AM J EPIDEMIOL, V165, P262, DOI 10.1093/aje/kwk010; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tobias A., 1999, STATA TECHNICAL B, V8, P15; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; von Gruenigen VE, 2006, CANCER-AM CANCER SOC, V107, P2786, DOI 10.1002/cncr.22351; WCRF/ AICR, 2007, FOOD NUTR PHYS ACT P; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zaninotto P., 2006, FORECASTING OBESITY	75	3363	3473	31	523	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					569	578		10.1016/S0140-6736(08)60269-X	http://dx.doi.org/10.1016/S0140-6736(08)60269-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280327				2022-12-28	WOS:000253202600023
J	Furuike, S; Hossain, MD; Maki, Y; Adachi, K; Suzuki, T; Kohori, A; Itoh, H; Yoshida, M; Kinosita, K				Furuike, Shou; Hossain, Mohammad Delawar; Maki, Yasushi; Adachi, Kengo; Suzuki, Toshiharu; Kohori, Ayako; Itoh, Hiroyasu; Yoshida, Masasuke; Kinosita, Kazuhiko, Jr.			Axle-less F-1-ATPase rotates in the correct direction	SCIENCE			English	Article							ATP SYNTHASE; F-1 MOTOR; F1-ATPASE; RESOLUTION; MITOCHONDRIA; CATALYSIS; MECHANISM	F-1- adenosine triphosphatase ( ATPase) is an ATP- driven rotary molecular motor in which the central gamma subunit rotates inside a cylinder made of three alpha and three beta subunits alternately arranged. The rotor shaft, an antiparallel alpha- helical coiled coil of the amino and carboxyl termini of the gamma subunit, deeply penetrates the central cavity of the stator cylinder. We truncated the shaft step by step until the remaining rotor head would be outside the cavity and simply sat on the concave entrance of the stator orifice. All truncation mutants rotated in the correct direction, implying torque generation, although the average rotary speeds were low and short mutants exhibited moments of irregular motion. Neither a fixed pivot nor a rigid axle was needed for rotation of F-1- ATPase.	[Furuike, Shou; Hossain, Mohammad Delawar; Adachi, Kengo; Kohori, Ayako; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Hossain, Mohammad Delawar] Shahjalal Univ Sci & Technol, Dept Phys, Sch Phys Sci, Sylhet 3114, Bangladesh; [Maki, Yasushi] Osaka Med Coll, Dept Phys, Osaka 5698686, Japan; [Suzuki, Toshiharu; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Suzuki, Toshiharu; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, ICORP, Tokyo 1350064, Japan; [Itoh, Hiroyasu] Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; [Itoh, Hiroyasu] CREST Format Soft Nanomachines Team 13, Tsukuba, Ibaraki 3002635, Japan	Waseda University; Shahjalal University of Science & Technology (SUST); Osaka Medical College; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Hamamatsu Photonics; Japan Science & Technology Agency (JST)	Kinosita, K (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	kazuhiko@waseda.jp						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hossain MD, 2006, BIOPHYS J, V90, P4195, DOI 10.1529/biophysj.105.079087; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	22	88	88	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					955	958		10.1126/science.1151343	http://dx.doi.org/10.1126/science.1151343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276891				2022-12-28	WOS:000253165700047
J	Levitt, SD; List, JA				Levitt, Steven D.; List, John A.			Economics - Homo economicus evolves	SCIENCE			English	Editorial Material							MEASURING SOCIAL PREFERENCES; FAIRNESS; MARKET		[Levitt, Steven D.; List, John A.] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	University of Chicago	Levitt, SD (corresponding author), Univ Chicago, Dept Econ, Chicago, IL 60637 USA.	jlist@uchicago.edu		List, John/0000-0002-1740-3848				Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; Ashraf N, 2005, J ECON PERSPECT, V19, P131, DOI 10.1257/089533005774357897; Bandiera O, 2005, Q J ECON, V120, P917, DOI 10.1093/qje/120.3.917; Becker G. S, 1957, EC DISCRIMINATION; BECKER GS, 1974, J POLIT ECON, V82, P1063, DOI 10.1086/260265; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; List JA, 2006, J POLIT ECON, V114, P1, DOI 10.1086/498587; List JA, 2003, Q J ECON, V118, P41, DOI 10.1162/00335530360535144; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; RABIN M, 1993, AM ECON REV, V83, P1281; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Stigler G. J., 1965, ESSAYS HIST EC; STROTZ RH, 1956, REV ECON STUD, V23, P165	17	108	109	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					909	910		10.1126/science.1153640	http://dx.doi.org/10.1126/science.1153640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	262RM	18276876				2022-12-28	WOS:000253165700030
J	Richter, JD				Richter, Joel D.			Breaking the code of polyadenylation-induced translation	CELL			English	Editorial Material							B1 MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; CPEB; PHOSPHORYLATION; PROGRESSION; MASKIN	The translation of many maternal mRNAs is regulated by dynamic changes in poly(A) tail length. During maturation of Xenopus oocytes, polyadenylation is mediated by three different cis elements in the 3' untranslated region (UTR) of maternal mRNAs. In this issue, Pique et al. (2008) explore the interplay of these elements to elucidate a combinatorial code that predicts the timing of polyadenylation and translation of maternal mRNAs.	Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	joel.richter@umassmed.edu						Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Cao QP, 2006, NAT STRUCT MOL BIOL, V13, P1128, DOI 10.1038/nsmb1169; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; TURNQUIST BJ, 2003, GENE DEV, V17, P683	10	23	23	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					335	337		10.1016/j.cell.2008.01.024	http://dx.doi.org/10.1016/j.cell.2008.01.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267064	Bronze			2022-12-28	WOS:000253180700007
J	Kirkwood, TBL				Kirkwood, Thomas B. L.			A systematic look at an old problem	NATURE			English	Article							MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; LIFE-SPAN; CAENORHABDITIS-ELEGANS; C-ELEGANS; STRESS; DISEASE; GENES; AGE; RESTRICTION		Univ Newcastle, Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle University - UK	Kirkwood, TBL (corresponding author), Univ Newcastle, Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	tom.kirkwood@ncl.ac.uk			Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Esiri MM, 2001, LANCET, V357, P169; Finch C, 2000, CHANCE DEV AGING; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Peto R, 1997, BRIT MED J, V315, P1030, DOI 10.1136/bmj.315.7115.1030; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003	30	224	241	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					644	647		10.1038/451644a	http://dx.doi.org/10.1038/451644a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256658				2022-12-28	WOS:000252929500027
J	Patel, MB; Bhalla, A				Patel, Mayank B.; Bhalla, Ashok			Paget's disease of the mandible	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patel, Mayank B.; Bhalla, Ashok] Royal United Hosp, Bath BA1 3NG, Avon, England		Patel, MB (corresponding author), Royal United Hosp, Bath BA1 3NG, Avon, England.	mayank.patel@suht.swest.nhs.uk							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					625	625		10.1056/NEJMicm066227	http://dx.doi.org/10.1056/NEJMicm066227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256397				2022-12-28	WOS:000252916400009
J	Larsen, G; Parker, H				Larsen, Gitte; Parker, Howard			Patients' safety: think and act locally	LANCET			English	Editorial Material							HARM; EVENTS		[Larsen, Gitte; Parker, Howard] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT 84158 USA	Utah System of Higher Education; University of Utah	Larsen, G (corresponding author), Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT 84158 USA.	gitte.larsen@hsc.utah.edu						American Hospital Association Health Research & Educational Trust Institute for Safe Medication Practices, 2002, PATHW MED SAF ASS BE; Cochran GL, 2007, JT COMM J QUAL PATIE, V33, P293, DOI 10.1016/S1553-7250(07)33034-1; *I MED, 2000, TO ERR IS HUM BUILD; Institute of Medicine, 2001, CROSSING QUALITY CHA; *JOINT COMM, NAT PAT SAF GOALS HO; Larsen GY, 2007, PEDIATR CRIT CARE ME, V8, P331, DOI 10.1097/01.PCC.0000263042.73539.99; *LEAPFR GROUP, 2007, FACT SHEET COMP PHYS; Ligi I, 2008, LANCET, V371, P404, DOI 10.1016/S0140-6736(08)60204-4; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					364	365		10.1016/S0140-6736(08)60179-8	http://dx.doi.org/10.1016/S0140-6736(08)60179-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	260ED	18242397				2022-12-28	WOS:000252992700006
J	Zhao, WH; Kruse, JP; Tang, Y; Jung, SY; Qin, J; Gu, W				Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Jung, Sung Yun; Qin, Jun; Gu, Wei			Negative regulation of the deacetylase SIRT1 by DBC1	NATURE			English	Article							TRANSCRIPTION FACTORS; CELL-SURVIVAL; LIFE-SPAN; P53; RESVERATROL; ACTIVATION; ACETYLATION; PGC-1-ALPHA; CANDIDATE; APOPTOSIS	SIRT1 is an NAD- dependent deacetylase critically involved in stress responses, cellular metabolism and, possibly, ageing(1-15). The tumour suppressor p53 represents the first non- histone substrate functionally regulated by acetylation and deacetylation(16,17); we and others previously found that SIRT1 promotes cell survival by deacetylating p53 ( refs 4-6). These results were further supported by the fact that p53 hyperacetylation and increased radiation- induced apoptosis were observed in Sirt1- deficient mice(10). Nevertheless, SIRT1-mediated deacetylase function is also implicated in p53- independent pathways under different cellular contexts, and its effects on transcriptional factors such as members of the FOXO family and PGC-1 alpha directly modulate metabolic responses(1-15). These studies validate the importance of the deacetylase activity of SIRT1, but how SIRT1 activity is regulated in vivo is not well understood. Here we show that DBC1 ( deleted in breast cancer 1) acts as a native inhibitor of SIRT1 in human cells. DBC1- mediated repression of SIRT1 leads to increasing levels of p53 acetylation and upregulation of p53-mediated function. In contrast, depletion of endogenous DBC1 by RNA interference ( RNAi) stimulates SIRT1- mediated deacetylation of p53 and inhibits p53- dependent apoptosis. Notably, these effects can be reversed in cells by concomitant knockdown of endogenous SIRT1. Our study demonstrates that DBC1 promotes p53- mediated apoptosis through specific inhibition of SIRT1.	[Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu		Jung, Sung Yun/0000-0003-1521-7977; Tang, Yi/0000-0002-3561-8447; ZHAO, WENHUI/0000-0002-7703-7106	NATIONAL CANCER INSTITUTE [R01CA085533, R01CA098821] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA085533, R01 CA098821-06A1, R01 CA098821] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Olaharski AJ, 2005, PLOS GENET, V1, P689, DOI 10.1371/journal.pgen.0010077; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	30	375	396	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					587	U11		10.1038/nature06515	http://dx.doi.org/10.1038/nature06515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235502	Green Accepted			2022-12-28	WOS:000252739900045
J	Chao, JR; Parganas, E; Boyd, K; Hong, CY; Opferman, JT; Ihle, JN				Chao, Jyh-Rong; Parganas, Evan; Boyd, Kelli; Hong, Cheol Yi; Opferman, Joseph T.; Ihle, James N.			Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons	NATURE			English	Article							TROPHIC FACTOR DEPRIVATION; SERINE-PROTEASE HTRA2/OMI; APOPTOTIC PROTEIN; CYTOCHROME-C; CELL-DEATH; BAX; FAMILY; PHOSPHORYLATION; HAX-1; MICE	Cytokines affect a variety of cellular functions, including regulation of cell numbers by suppression of programmed cell death(1). Suppression of apoptosis requires receptor signalling through the activation of Janus kinases and the subsequent regulation of members of the B- cell lymphoma 2 ( Bcl- 2) family. Here we demonstrate that a Bcl- 2- family- related protein, Hax1, is required to suppress apoptosis in lymphocytes and neurons. Suppression requires the interaction of Hax1 with the mitochondrial proteases Parl ( pre-senilin-associated, rhomboid- like) and HtrA2 ( high- temperature-regulated A2, also known as Omi). These interactions allow Hax1 to present HtrA2 to Parl, and thereby facilitates the processing of HtrA2 to the active protease localized in the mitochondrial intermembrane space. In mouse lymphocytes, the presence of processed HtrA2 prevents the accumulation of mitochondrial-outer-membrane- associated activated Bax, an event that initiates apoptosis. Together, the results identify a previously unknown sequence of interactions involving a Bcl- 2- family- related protein and mitochondrial proteases in the ability to resist the induction of apoptosis when cytokines are limiting.	[Chao, Jyh-Rong; Parganas, Evan; Hong, Cheol Yi; Opferman, Joseph T.; Ihle, James N.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Hosp, Anim Resources Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Matsubara K, 2007, HAEMATOLOGICA, V92, pE123, DOI 10.3324/haematol.11973; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Seward RJ, 2003, MOL IMMUNOL, V39, P983, DOI 10.1016/S0161-5890(03)00047-6; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Vaux DL, 2003, CELL, V115, P251, DOI 10.1016/S0092-8674(03)00851-1; Wei MC, 2000, GENE DEV, V14, P2060; White FA, 1998, J NEUROSCI, V18, P1428; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	27	189	191	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					98	U10		10.1038/nature06604	http://dx.doi.org/10.1038/nature06604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288109				2022-12-28	WOS:000253671900054
J	Santorelli, LA; Thompson, CRL; Villegas, E; Svetz, J; Dinh, C; Parikh, A; Sucgang, R; Kuspa, A; Strassmann, JE; Queller, DC; Shaulsky, G				Santorelli, Lorenzo A.; Thompson, Christopher R. L.; Villegas, Elizabeth; Svetz, Jessica; Dinh, Christopher; Parikh, Anup; Sucgang, Richard; Kuspa, Adam; Strassmann, Joan E.; Queller, David C.; Shaulsky, Gad			Facultative cheater mutants reveal the genetic complexity of cooperation in social amoebae	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; MYXOCOCCUS-XANTHUS; MECHANISM; EVOLUTION; BACTERIUM; DNA	Cooperation is central to many major transitions in evolution, including the emergence of eukaryotic cells, multicellularity and eusociality(1). Cooperation can be destroyed by the spread of cheater mutants that do not cooperate but gain the benefits of cooperation from others(1,2). However, cooperation can be preserved if cheaters are facultative, cheating others but cooperating among themselves(2). Several cheater mutants have been studied before, but no study has attempted a genome- scale investigation of the genetic opportunities for cheating. Here we describe such a screen in a social amoeba and show that cheating is multifaceted by revealing cheater mutations in well over 100 genes of diverse types. Many of these mutants cheat facultatively, producing more than their fair share of spores in chimaeras, but cooperating normally when clonal. These findings indicate that phenotypically stable cooperative systems may nevertheless harbour genetic conflicts. The opportunities for evolutionary moves and countermoves in such conflicts may select for the involvement of multiple pathways and numerous genes.	[Santorelli, Lorenzo A.; Kuspa, Adam; Strassmann, Joan E.; Queller, David C.; Shaulsky, Gad] Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA; [Thompson, Christopher R. L.; Villegas, Elizabeth; Svetz, Jessica; Parikh, Anup; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dinh, Christopher; Sucgang, Richard; Kuspa, Adam] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Parikh, Anup; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA	Rice University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA.	gadi@bcm.tmc.edu		Santorelli, Lorenzo/0000-0002-8392-801X; Strassmann, Joan/0000-0003-0638-8440; Kuspa, Adam/0000-0002-9156-149X; Shaulsky, Gad/0000-0002-0532-0551	MRC [G0400103] Funding Source: UKRI; Medical Research Council [G0400103] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Fiegna F, 2005, PLOS BIOL, V3, P1980, DOI 10.1371/journal.pbio.0030370; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; JERMYN KA, 1989, NATURE, V340, P144, DOI 10.1038/340144a0; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Maynard Smith John., 1995, MAJOR TRANSITION EVO; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; SHAULSKY G, 1995, P NATL ACAD SCI USA, V92, P5660, DOI 10.1073/pnas.92.12.5660; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103	28	104	104	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1107	U7		10.1038/nature06558	http://dx.doi.org/10.1038/nature06558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18272966				2022-12-28	WOS:000253453600042
J	Moynihan, R				Moynihan, Ray			The invisible influence	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; PHYSICIANS		[Moynihan, Ray] Univ Newcastle, Fac Hlth, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Fac Hlth, Newcastle, NSW 2308, Australia.	Ray.Moynhihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; *HEALTHED, HEALTHEDS ED CONTENT; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	5	32	33	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					416	417		10.1136/bmj.39496.430336.DB	http://dx.doi.org/10.1136/bmj.39496.430336.DB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292165	Green Published			2022-12-28	WOS:000253664000033
J	Cohen, MD				Cohen, Michael D.			Economics - Learning with regret	SCIENCE			English	Editorial Material							DECISION-MAKING; EMOTION; GAMES		Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cohen, MD (corresponding author), Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA.	mdc@umich.edu						Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; CAMERER C, 2007, EC I BEHAV EC, P235; COHEN MD, 2007, EC I BEHAV EC, P281; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Engelbrecht-Wiggans R, 2007, ECON THEOR, V33, P81, DOI 10.1007/s00199-006-0180-9; Erev I, 1998, AM ECON REV, V88, P848; Erev I, 2007, ECON THEOR, V33, P29, DOI 10.1007/s00199-007-0214-y; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Gibbons R., 1992, GAME THEORY APPL EC; Marchiori D, 2008, SCIENCE, V319, P1111, DOI 10.1126/science.1151185	10	5	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1052	1053		10.1126/science.1155477	http://dx.doi.org/10.1126/science.1155477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264SW	18292330				2022-12-28	WOS:000253311700030
J	Mackman, N				Mackman, Nigel			Triggers, targets and treatments for thrombosis	NATURE			English	Article							TISSUE FACTOR; UNFRACTIONATED HEPARIN; PREVENTION; METAANALYSIS; HEMOSTASIS; INHIBITORS; RECEPTORS; WARFARIN; CLOPIDOGREL; INTEGRIN	Thrombosis-localized clotting of the blood-can occur in the arterial or the venous circulation and has a major medical impact. Acute arterial thrombosis is the proximal cause of most cases of myocardial infarction ( heart attack) and of about 80% of strokes, collectively the most common cause of death in the developed world. Venous thromboembolism is the third leading cause of cardiovascular-associated death. The pathogenic changes that occur in the blood vessel wall and in the blood itself resulting in thrombosis are not fully understood. Understanding these processes is crucial for developing safer and more effective antithrombotic drugs.	Univ N Carolina, Div Hematol Oncol, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Mackman, N (corresponding author), Univ N Carolina, Div Hematol Oncol, Dept Med, Chapel Hill, NC 27599 USA.	nmackman@med.unc.edu			NHLBI NIH HHS [R01 HL095096-01, R01 HL095096] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095096] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; *CLOP UNST ANG PRE, 2007, NEW ENGL J MED, V345, P494; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cushman M, 2007, SEMIN HEMATOL, V44, P62, DOI 10.1053/j.seminhematol.2007.02.004; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; ERIKSSON BI, 2007, BLOOD, V110; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Fisher WD, 2007, THROMB HAEMOSTASIS, V97, P931, DOI 10.1160/TH07-01-0055; Gachet C, 2005, PHARMACOL THERAPEUT, V108, P180, DOI 10.1016/j.pharmthera.2005.03.009; Gailani D, 2007, J THROMB HAEMOST, V5, P1106, DOI 10.1111/j.1538-7836.2007.02446.x; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Hennekens CH, 2006, J CARDIOVASC PHARM T, V11, P170, DOI 10.1177/1074248406292263; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Howard EL, 2007, ARTERIOSCL THROM VAS, V27, P722, DOI 10.1161/01.ATV.0000259363.91070.f1; Hron G, 2007, THROMB HAEMOSTASIS, V97, P119, DOI 10.1160/TH06-03-0141; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Krynetskiy E, 2007, J PHARMACOL EXP THER, V322, P427, DOI 10.1124/jpet.106.117952; LI WX, 1994, BLOOD, V83, P677, DOI 10.1182/blood.V83.3.677.677; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Mackman N, 2005, ARTERIOSCL THROM VAS, V25, P2273, DOI 10.1161/01.ATV.0000183884.06371.52; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Marmur JD, 1996, CIRCULATION, V94, P1226, DOI 10.1161/01.CIR.94.6.1226; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Misumi K, 1998, AM J CARDIOL, V81, P22, DOI 10.1016/S0002-9149(97)00801-1; Monia B, 2007, CIRCULATION S, V116; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; PODREZ EA, 2007, J CLIN INVEST, V13, P1086; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Ratnikov BI, 2005, J THROMB HAEMOST, V3, P1783, DOI 10.1111/j.1538-7836.2005.01362.x; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; Snyder LA, 2008, J THROMB HAEMOST, V6, P306, DOI 10.1111/j.1538-7836.2007.02833.x; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Tremoli E, 1999, ATHEROSCLEROSIS, V144, P273, DOI 10.1016/S0021-9150(99)00063-5; Turpie AGG, 2003, CURR OPIN HEMATOL, V10, P327, DOI 10.1097/00062752-200309000-00001; Turpie AGG, 2007, ARTERIOSCL THROM VAS, V27, P1238, DOI 10.1161/ATVBAHA.107.139402; Virchow RLK., 1856, GESAMMELTE ABH; Weitz JI, 2007, EXPERT OPIN INV DRUG, V16, P271, DOI 10.1517/13543784.16.3.271; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	59	745	781	9	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					914	918		10.1038/nature06797	http://dx.doi.org/10.1038/nature06797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288180	Green Accepted, Green Submitted			2022-12-28	WOS:000253313100031
J	Neu, U				Neu, Urs			Is recent major hurricane activity normal?	NATURE			English	Letter									Swiss Acad Sci, ProClim, CH-3007 Bern, Switzerland		Neu, U (corresponding author), Swiss Acad Sci, ProClim, Schwarztorstr 9, CH-3007 Bern, Switzerland.	neu@scnat.ch						Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; Landsea C, 2007, EOS T AGU, V88, P197, DOI [10.1029/2007EO180001, DOI 10.1029/2007EO180001]; Landsea CW, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P177; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; *US NOAA, BEST TRACK DAT NOAA	6	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					E5	E5		10.1038/nature06576	http://dx.doi.org/10.1038/nature06576			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288135				2022-12-28	WOS:000253313100038
J	Rousseau, P				Rousseau, Paul			Sammy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoc@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					736	736		10.1001/jama.299.7.736	http://dx.doi.org/10.1001/jama.299.7.736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285581				2022-12-28	WOS:000253226900001
J	Kelly, AM; Dwamena, B; Cronin, P; Bernstein, SJ; Carlos, RC				Kelly, Aine M.; Dwamena, Ben; Cronin, Paul; Bernstein, Steven J.; Carlos, Ruth C.			Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PREEXISTING RENAL-INSUFFICIENCY; INTRAVENOUS N-ACETYLCYSTEINE; MEDIA-INDUCED NEPHROTOXICITY; HIGH-RISK PATIENTS; CORONARY-ANGIOGRAPHY; SALINE HYDRATION; RADIOCONTRAST NEPHROPATHY; CARDIAC-CATHETERIZATION; CLINICAL-TRIALS	Background: N-Acetylcysteine, theophylline, and other agents have shown inconsistent results in reducing contrast-induced nephropathy. Purpose: To determine the effect of these agents on preventing nephropathy. Data Sources: Relevant randomized, controlled trials were identified by computerized searches in MEDLINE (from 1966 through 3 November 2006), EMBASE (1980 through November 2006), PubMed, Web of Knowledge (Current Contents Connect, Web of Science, BIOSIS Previews, and ISI Proceedings for the latest 5 years), and the Cochrane Library databases (up to November 2006). Databases were searched for studies in English, Spanish, French, Italian, and German. Study Selection: Randomized, controlled trials that administered N-acetylcysteine, theophylline, fenoldopam, dopamine, iloprost, statin, furosemide, or mannitol to a treatment group; used intravenous iodinated contrast; defined contrast-induced nephropathy explicitly; and reported sufficient data to construct a 2 x 2 table of the primary effect measure. Data Extraction: Abstracted information included patient characteristics, type of contrast media and dose, periprocedural hydration, definition of contrast-induced nephropathy, and prophylactic agent dose and route. Data Synthesis: In the 41 studies included, N-acetylcysteine (relative risk, 0.62 [95% Cl, 0.44 to 0.881) and theophylline (relative risk, 0.49 [Cl, 0.23 to 1.061) reduced the risk for contrast-induced nephropathy more than saline alone, whereas furosemide increased it (relative risk, 3.27 [Cl, 1.48 to 7.26]). The remaining agents did not significantly affect risk. Significant subgroup heterogeneity was present only for N-acetylcysteine. No publication bias was discerned. Limitations: All trials evaluated the surrogate end point of contrast-induced nephropathy as the primary outcome. The lack of a statistically significant renoprotective effect of theophylline may result from insufficient data or study heterogeneity. True study quality remains uncertain. Conclusion: N-Acetylcysteine is more renoprotective than hydration alone. Theophylline may also reduce risk for contrast-induced nephropathy, although the detected association was not significant. Our data support the administration of N-acetylcysteine prophylaxis, particularly in high-risk patients, given its low cost, availability, and few side effects.	Univ Michigan, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Kelly, AM (corresponding author), Univ Michigan Hosp, Dept Radiol, Div Cardiothorac Radiol, B1 132K Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	ainekell@med.umich.edu		Bernstein, Steven/0000-0003-3359-7168; Dwamena, Ben/0000-0001-5092-8577	NCI NIH HHS [1 K07 CA108664 01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA108664] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abizaid AS, 1999, AM J CARDIOL, V83, P260, DOI 10.1016/S0002-9149(98)00833-9; Allaqaband S, 2002, CATHETER CARDIO INTE, V57, P279, DOI 10.1002/ccd.10323; Alonso A, 2004, AM J KIDNEY DIS, V43, P1, DOI 10.1053/j.ajkd.2003.09.009; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Azmus Alexandre D, 2005, J Invasive Cardiol, V17, P80; Bagshaw SM, 2005, ARCH INTERN MED, V165, P1087, DOI 10.1001/archinte.165.10.1087; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; Balderramo Domingo C, 2004, Rev Fac Cien Med Univ Nac Cordoba, V61, P13; BARRETT BJ, 1993, RADIOLOGY, V188, P171, DOI 10.1148/radiology.188.1.8511292; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; CIGARROA RG, 1989, AM J MED, V86, P417, DOI 10.1016/0002-9343(89)90339-2; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; COYLE LC, 2006, AM HEART J, V15, P1032; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; Diez T, 1999, MEDICINA-BUENOS AIRE, V59, P55; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Durham JD, 2002, KIDNEY INT, V62, P2202, DOI 10.1046/j.1523-1755.2002.00673.x; Dussol B, 2006, NEPHROL DIAL TRANSPL, V21, P2120, DOI 10.1093/ndt/gfl133; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EISENBERG RL, 1981, AM J ROENTGENOL, V136, P859, DOI 10.2214/ajr.136.5.859; El Mahmoud R, 2003, ARCH MAL COEUR VAISS, V96, P1157; Erley CM, 1999, NEPHROL DIAL TRANSPL, V14, P1146, DOI 10.1093/ndt/14.5.1146; Fung JWH, 2004, AM J KIDNEY DIS, V43, P801, DOI 10.1053/j.ajkd.2004.01.010; Goldenberg I, 2004, EUR HEART J, V25, P212, DOI 10.1016/j.ehj.2003.11.011; Gomes VO, 2005, HEART, V91, P774, DOI 10.1136/hrt.2004.039636; Gulel O, 2005, J CARDIOVASC PHARM, V46, P464, DOI 10.1097/01.fjc.0000176730.59443.dd; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Huber W, 2003, AM J CARDIOL, V91, P1157, DOI 10.1016/S0002-9149(03)00259-5; Huber W, 2002, RADIOLOGY, V223, P772, DOI 10.1148/radiol.2233010609; Ix JH, 2004, NEPHROL DIAL TRANSPL, V19, P2747, DOI 10.1093/ndt/gfh468; Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047; JO SH, 2005, J CARDIOL, V96, pH1; Kapoor A, 2002, NEPHROL DIAL TRANSPL, V17, P1936, DOI 10.1093/ndt/17.11.1936; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; Kefer JM, 2003, ACTA CARDIOL, V58, P555, DOI 10.2143/AC.58.6.2005321; Liu R, 2005, J GEN INTERN MED, V20, P193, DOI 10.1111/j.1525-1497.2005.30323.x; MacNeill BD, 2003, CATHETER CARDIO INTE, V60, P458, DOI 10.1002/ccd.10684; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morcos SK, 1998, BRIT J RADIOL, V71, P357, DOI 10.1259/bjr.71.844.9659127; Morcos SK, 2004, CLIN RADIOL, V59, P381, DOI 10.1016/j.crad.2003.11.005; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Murphy SW, 2000, J AM SOC NEPHROL, V11, P177, DOI 10.1681/ASN.V111177; NAMGUNG J, 2005, AM J CARDIOL, V95, pA1; Ochoa Anthony, 2004, J Interv Cardiol, V17, P159, DOI 10.1111/j.1540-8183.2004.09880.x; Oldemeyer JB, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00511-8; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Sandhu C, 2006, CARDIOVASC INTER RAD, V29, P344, DOI 10.1007/s00270-005-0127-8; Shyu KG, 2002, J AM COLL CARDIOL, V40, P1383, DOI 10.1016/S0735-1097(02)02308-2; SINHA SK, AM HEART ASS SCI SES; Solomon R, 2006, KIDNEY INT, V69, pS39, DOI 10.1038/sj.ki.5000373; Spargias K, 2006, EUR J CLIN PHARMACOL, V62, P589, DOI 10.1007/s00228-006-0150-y; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thomsen HS, 2006, EUR RADIOL, V16, P1835, DOI 10.1007/s00330-006-0223-4; Thomsen HS, 2006, ABDOM IMAGING, V31, P131, DOI 10.1007/s00261-005-0380-y; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041	68	305	326	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					284	294		10.7326/0003-4819-148-4-200802190-00007	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283206				2022-12-28	WOS:000253316400005
J	Michel, JP; Newton, JL; Kirkwood, TBL				Michel, Jean-Pierre; Newton, Julia L.; Kirkwood, Thomas B. L.			Medical challenges of improving the quality of a longer life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; OLDER-ADULTS; DISABILITY; AGE; MORTALITY; DEMENTIA; OBESITY; MIDLIFE; DECLINE; DISEASE		[Michel, Jean-Pierre] Univ Geneva, Dept Geriatr & Rehabil, Thonex Geneva, Switzerland; [Newton, Julia L.; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Geneva; Newcastle University - UK	Michel, JP (corresponding author), Univ Geneva, Hop Chene Ch Pont Bochet 3, Dept Geriatr & Rehabil, CH-1226 Thonex Geneva, Switzerland.	jean-pierre.michel@hcuge.ch		Newton, Julia/0000-0002-1249-5253				Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; BLOOM DE, 2006, WORLD DEM ASS NOV ST; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hogan DB, 1999, J GERONTOL A-BIOL, V54, pM77, DOI 10.1093/gerona/54.2.M77; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Leveille SG, 1999, AM J EPIDEMIOL, V149, P654; Lockhart BP, 2003, EXP GERONTOL, V38, P119, DOI 10.1016/S0531-5565(02)00163-8; Masoro E, 2006, HDB BIOL AGING; Murray GK, 2007, ANN NEUROL, V62, P128, DOI 10.1002/ana.21120; Rizzoli R, 1999, OSTEOPOROSIS INT, V9, P17, DOI 10.1007/PL00004155; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Vanltallie TB, 2003, METABOLISM, V52, P22, DOI 10.1053/S0026-0495(03)00297-X; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343	25	30	31	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					688	690		10.1001/jama.299.6.688	http://dx.doi.org/10.1001/jama.299.6.688			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261QN	18270358				2022-12-28	WOS:000253095200027
J	Killelea, DR; Campbell, VL; Shuman, NS; Utz, AL				Killelea, Daniel R.; Campbell, Victoria L.; Shuman, Nicholas S.; Utz, Arthur L.			Bond-selective control of a heterogeneously catalyzed reaction	SCIENCE			English	Article							VIBRATIONALLY EXCITED METHANE; GAS-SURFACE REACTIVITY; DISSOCIATIVE CHEMISORPTION; METAL-SURFACES; BIMOLECULAR REACTIONS; CH4 DISSOCIATION; STATE CONTROL; CHEMISTRY; ENERGY; DYNAMICS	Energy redistribution, including the many phonon- assisted and electronically assisted energy- exchange processes at a gas- metal interface, can hamper vibrationally mediated selectivity in chemical reactions. We establish that these limitations do not prevent bond- selective control of a heterogeneously catalyzed reaction. State- resolved gas- surface scattering measurements show that the nu(1) C-H stretch vibration in trideuteromethane ( CHD3) selectively activates C-H bond cleavage on a Ni( 111) surface. Isotope- resolved detection reveals a CD3: CHD2 product ratio > 30: 1, which contrasts with the 1: 3 ratio for an isoenergetic ensemble of CHD3 whose vibrations are statistically populated. Recent studies of vibrational energy redistribution in the gas and condensed phases suggest that other gas- surface reactions with similar vibrational energy flow dynamics might also be candidates for such bond- selective control.	[Killelea, Daniel R.; Campbell, Victoria L.; Shuman, Nicholas S.; Utz, Arthur L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Killelea, Daniel R.; Campbell, Victoria L.; Shuman, Nicholas S.; Utz, Arthur L.] Tufts Univ, WM Keck Fdn Lab Mat Chem, Medford, MA 02155 USA	Tufts University; Tufts University	Utz, AL (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	arthur.utz@tufts.edu		Killelea, Daniel/0000-0001-6965-5644				Abbott HL, 2004, J CHEM PHYS, V121, P3792, DOI 10.1063/1.1777221; Beck RD, 2003, SCIENCE, V302, P98, DOI 10.1126/science.1088996; BRONIKOWSKI MJ, 1991, J CHEM PHYS, V95, P8647, DOI 10.1063/1.461243; Camden JP, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2155434; Carre MN, 1998, J CHEM PHYS, V108, P3722, DOI 10.1063/1.475766; Crim FF, 2007, SCIENCE, V316, P1707, DOI 10.1126/science.1144282; Crim FF, 1999, ACCOUNTS CHEM RES, V32, P877, DOI 10.1021/ar950046a; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; CRIM FF, 1990, SCIENCE, V249, P1387, DOI 10.1126/science.249.4975.1387; Fair JR, 2002, J CHEM PHYS, V116, P1406, DOI 10.1063/1.1429651; Halonen L, 2001, J CHEM PHYS, V115, P5611, DOI 10.1063/1.1398075; Harrison I, 1998, ACCOUNTS CHEM RES, V31, P631, DOI 10.1021/ar9700926; Henkelman G, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2161193; Holiday RJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2352742; JOHNSON AD, 1992, SCIENCE, V257, P223, DOI 10.1126/science.257.5067.223; Juurlink LBF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208303; Juurlink LBF, 1999, PHYS REV LETT, V83, P868, DOI 10.1103/PhysRevLett.83.868; Kim ZH, 2001, J AM CHEM SOC, V123, P12714, DOI 10.1021/ja017180c; Komeda T, 2002, SCIENCE, V295, P2055, DOI 10.1126/science.1069016; Kratzer P, 1996, J CHEM PHYS, V105, P5595, DOI 10.1063/1.472399; LEE MB, 1987, J CHEM PHYS, V87, P2724, DOI 10.1063/1.453060; LEWERENZ M, 1988, J CHEM PHYS, V88, P5408, DOI 10.1063/1.454552; Liu ZH, 2006, SCIENCE, V312, P1024, DOI 10.1126/science.1124529; LUNTZ AC, 1991, SURF SCI, V258, P397, DOI 10.1016/0039-6028(91)90934-K; Maroni P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246104; McCabe PR, 2000, REV SCI INSTRUM, V71, P42, DOI 10.1063/1.1150158; Milot R, 2000, PHYS REV B, V61, P15657, DOI 10.1103/PhysRevB.61.15657; Nave S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173003; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Smith RR, 2004, SCIENCE, V304, P992, DOI 10.1126/science.1096309; Stipe BC, 1998, PHYS REV LETT, V81, P1263, DOI 10.1103/PhysRevLett.81.1263; Tully JC, 2000, ANNU REV PHYS CHEM, V51, P153, DOI 10.1146/annurev.physchem.51.1.153; Venuti E, 1999, J CHEM PHYS, V110, P7339, DOI 10.1063/1.478635; Wodtke AM, 2004, INT REV PHYS CHEM, V23, P513, DOI 10.1080/01442350500037521; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Yoo HS, 2004, J PHYS CHEM A, V108, P1380, DOI 10.1021/jp0275443; Yoon S, 2005, J PHYS CHEM B, V109, P8388, DOI 10.1021/jp0463565; Yoon S, 2003, J CHEM PHYS, V119, P4755, DOI 10.1063/1.1591176; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	40	171	171	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					790	793		10.1126/science.1152819	http://dx.doi.org/10.1126/science.1152819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258910				2022-12-28	WOS:000252963000055
J	Sinha, R; Nwokolo, C; Murphy, PD				Sinha, Rakesh; Nwokolo, Chuka; Murphy, Paul D.			Rational imaging - Magnetic resonance imaging in Crohn's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMALL-BOWEL; CONVENTIONAL ENTEROCLYSIS; MR		[Sinha, Rakesh] Warwick Hosp, S Warwickshire NHS Trust, Dept Radiol, Warwick CV34 5BW, England; [Sinha, Rakesh] Warwick Med Sch, Warwick CV34 5BW, England; [Nwokolo, Chuka] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry CV22 2DX, W Midlands, England; [Murphy, Paul D.] Warwick Hosp, S Warwickshire NHS Trust, Dept Surg, Warwick CV34 5BW, England	University of Warwick; University of Warwick	Sinha, R (corresponding author), Warwick Hosp, S Warwickshire NHS Trust, Dept Radiol, Warwick CV34 5BW, England.	rakslide@gmail.com		Sinha, Rakesh/0000-0003-3090-058X				ENGLEHOLM L, 1989, CLIN RADIOLOGY SMALL, P295; Fraquelli M, 2005, RADIOLOGY, V236, P95, DOI 10.1148/radiol.2361040799; GOLDBERG HI, 1983, AM J ROENTGENOL, V140, P277, DOI 10.2214/ajr.140.2.277; Gourtsoyiannis N, 2004, EUR RADIOL, V14, P1017, DOI 10.1007/s00330-004-2302-8; Lauenstein TC, 2003, RADIOLOGY, V228, P279, DOI 10.1148/radiol.2281020161; MAGLINTE DDT, 1982, RADIOLOGY, V144, P737, DOI 10.1148/radiology.144.4.7111717; Maglinte DDT, 2003, RADIOL CLIN N AM, V41, P285, DOI 10.1016/S0033-8389(02)00117-3; Masselli G, 2004, ABDOM IMAGING, V29, P326, DOI 10.1007/s00261-003-0116-9; Masselli G, 2006, EUR RADIOL, V16, P2817, DOI 10.1007/s00330-006-0338-7; Negaard A, 2007, EUR RADIOL, V17, P2294, DOI 10.1007/s00330-007-0648-4; Prassopoulos P, 2001, RADIOGRAPHICS, V21, pS161, DOI 10.1148/radiographics.21.suppl_1.g01oc02s161; Sempere GAJ, 2005, AM J ROENTGENOL, V184, P1829, DOI 10.2214/ajr.184.6.01841829; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; THOENI RF, 1994, MARGULIS BURHENNES A, P564	15	13	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					273	276		10.1136/bmj.39456.527419.80	http://dx.doi.org/10.1136/bmj.39456.527419.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18245000	Green Published			2022-12-28	WOS:000253102900042
J	Brown, ME; Funk, CC				Brown, Molly E.; Funk, Christopher C.			Climate - Food security under climate change	SCIENCE			English	Editorial Material									[Brown, Molly E.] NASA, Sci Syst & Applicat Inc, Goddard Space Flight Ctr, Biospher Sci Branch, Greenbelt, MD 20771 USA; [Funk, Christopher C.] Univ Calif Santa Barbara, Dept Geog, Climate Hazard Grp, Santa Barbara, CA 93106 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; University of California System; University of California Santa Barbara	Brown, ME (corresponding author), NASA, Sci Syst & Applicat Inc, Goddard Space Flight Ctr, Biospher Sci Branch, Code 614-4, Greenbelt, MD 20771 USA.	molly.brown@nasa.gov; chris@geog.ucsb.edu	Brown, Molly/E-2724-2010; Brown, Molly/M-5146-2013; Zhong, Hong Lin/C-2633-2012; Brown, Molly Elizabeth/L-7270-2019	Brown, Molly/0000-0001-7384-3314; Brown, Molly/0000-0001-7384-3314; Funk, Chris/0000-0002-9254-6718				Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Brown M. E., 2007, EOS T AM GEOPHYS UN, V88, P381, DOI [10.1029/2007EO390001, DOI 10.1029/2007E0390001]; *FOOD AGR ORG, 2007, STAT FOOD AGR; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; *OXFAM, 2006, CAUS HUNG OV FOOD CR; Solomon S., 2007, PHYS SCI BASIS WORKI; Thirtle C, 2003, WORLD DEV, V31, P1959, DOI 10.1016/j.worlddev.2003.07.001; Verdin J, 2005, PHILOS T R SOC B, V360, P2155, DOI 10.1098/rstb.2005.1754	9	330	348	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					580	581		10.1126/science.1154102	http://dx.doi.org/10.1126/science.1154102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239116	Green Submitted			2022-12-28	WOS:000252772000029
J	Dutcher, JR; Ediger, MD				Dutcher, J. R.; Ediger, M. D.			Materials science - Glass surfaces not so glassy	SCIENCE			English	Editorial Material							RELAXATION; DYNAMICS		[Dutcher, J. R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Ediger, M. D.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Guelph; University of Wisconsin System; University of Wisconsin Madison	Dutcher, JR (corresponding author), Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.	ediger@chem.wisc.edu	Ediger, Mark/AGZ-4130-2022	Ediger, Mark/0000-0003-4715-8473				Bell RC, 2003, J AM CHEM SOC, V125, P5176, DOI 10.1021/ja0291437; Buck E, 2004, MACROMOLECULES, V37, P8647, DOI 10.1021/ma049595z; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Kerle T, 2001, MACROMOLECULES, V34, P3484, DOI 10.1021/ma0020335; Roth CB, 2005, SOFT MATERIALS: STRUCTURE AND DYNAMICS, P1; Scheidler P, 2004, J PHYS CHEM B, V108, P6673, DOI 10.1021/jp036593s; Swallen SF, 2007, SCIENCE, V315, P353, DOI 10.1126/science.1135795; Tracht U, 1999, J MAGN RESON, V140, P460, DOI 10.1006/jmre.1999.1854; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Yoshimoto K, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873732	12	28	29	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					577	578		10.1126/science.1155120	http://dx.doi.org/10.1126/science.1155120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239113				2022-12-28	WOS:000252772000026
J	Szoka, F				Szoka, Francis			Molecular biology - The art of assembly	SCIENCE			English	Editorial Material							NONHUMAN-PRIMATES; SIRNA; NANOPARTICLES; DELIVERY; GENE		Univ Calif San Francisco, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Szoka, F (corresponding author), Univ Calif San Francisco, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA.	szoka@cgl.ucsf.edu	FRECHET, Jean M/P-1497-2016					Couzin J, 2002, SCIENCE, V298, P2296, DOI 10.1126/science.298.5602.2296; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Li SD, 2008, MOL THER, V16, P163, DOI 10.1038/sj.mt.6300323; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Ruiz-Perez B, 2003, J INFECT DIS, V188, P378, DOI 10.1086/376556; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	10	16	18	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					578	579		10.1126/science.1154253	http://dx.doi.org/10.1126/science.1154253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239114				2022-12-28	WOS:000252772000027
J	Zdanov, A; Wlodawer, A				Zdanov, Alexander; Wlodawer, Alexander			A new look at cytokine signaling	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; RECEPTOR; COMPLEX; INTERLEUKIN-4; HORMONE	Signal transduction is initiated when a cytokine binds to the extracellular domains of its receptors, bringing them together and triggering a complicated sequence of events inside the cell. In this issue, LaPorte et al. ( 2008) present crystal structures of three signaling complexes of the cytokines interleukin-4 and interleukin-13 with their receptors, showing how events taking place outside the cell may affect the specificity of signal transduction.	[Zdanov, Alexander; Wlodawer, Alexander] NCI, CCR, Macromol Crystallog Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zdanov, A (corresponding author), NCI, CCR, Macromol Crystallog Lab, Frederick, MD 21702 USA.	zdanov@ncifcrf.gov; wlodawer@ncifcrf.gov			NATIONAL CANCER INSTITUTE [Z01BC010348, ZIABC010348] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; GUSTCHINA A, 1995, PROTEINS, V21, P140, DOI 10.1002/prot.340210208; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; LAPORTE SL, 2008, CELL; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	11	5	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 25	2008	132	2					179	181		10.1016/j.cell.2008.01.006	http://dx.doi.org/10.1016/j.cell.2008.01.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243092	Bronze			2022-12-28	WOS:000253427700003
J	AHLBERG, PE				AHLBERG, PE			PALEONTOLOGY - GLIMPSING THE HIDDEN MAJORITY	NATURE			English	Editorial Material											AHLBERG, PE (corresponding author), UNIV OXFORD, DEPT ZOOL, S PARKS RD, OXFORD OX1 3PS, ENGLAND.		Ahlberg, Per/E-8086-2013	Ahlberg, Per/0000-0001-9054-2900				BENGTSON S, 1984, LETHAIA, V17, P307, DOI 10.1111/j.1502-3931.1984.tb00677.x; CONWAYMORRIS S, 1985, PHIL T R SOC B, V307, P507; Gould S. J., 1989, WONDERFUL LIFE; MORRIS SC, 1989, SCIENCE, V246, P339, DOI 10.1126/science.246.4928.339; 1989, DEC PAL ASS ANN C LI	5	1	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					23	23		10.1038/344023a0	http://dx.doi.org/10.1038/344023a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278010	Bronze			2022-12-28	WOS:A1990CQ97200038
J	JONES, D				JONES, D			DAEDALUS - INNER TIDINESS	NATURE			English	Editorial Material																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					24	24		10.1038/344024a0	http://dx.doi.org/10.1038/344024a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278011	Bronze			2022-12-28	WOS:A1990CQ97200040
J	SHULMAN, S				SHULMAN, S			MIT PRESIDENCY - THANKS ... BUT NO THANKS	NATURE			English	Editorial Material																		1990, NATURE, V343, P681	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					3	3		10.1038/344003b0	http://dx.doi.org/10.1038/344003b0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277985	Bronze			2022-12-28	WOS:A1990CQ97200005
J	Futahashi, R; Fujiwara, H				Futahashi, Ryo; Fujiwara, Haruhiko			Juvenile hormone regulates butterfly larval pattern switches	SCIENCE			English	Article									[Futahashi, Ryo; Fujiwara, Haruhiko] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Futahashi, Ryo] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Fujiwara, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Biosci Bldg 501, Chiba 2778562, Japan.	haruh@k.u-tokyo.ac.jp	Futahashi, Ryo/I-2825-2018	Futahashi, Ryo/0000-0003-4791-7054				Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888	3	51	57	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1061	1061		10.1126/science.1149786	http://dx.doi.org/10.1126/science.1149786			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292334				2022-12-28	WOS:000253311700034
J	Lutz, W; Cuaresma, JC; Sanderson, W				Lutz, Wolfgang; Cuaresma, Jesus Crespo; Sanderson, Warren			Economics - The demography of educational attainment and economic growth	SCIENCE			English	Editorial Material							QUALITY		[Lutz, Wolfgang] Austrian Acad Sci, Vienna Inst Demog, A-1040 Vienna, Austria; [Lutz, Wolfgang; Cuaresma, Jesus Crespo; Sanderson, Warren] Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; [Cuaresma, Jesus Crespo] Univ Innsbruck, A-6020 Innsbruck, Austria; [Sanderson, Warren] SUNY Stony Brook, Stony Brook, NY 11794 USA	Austrian Academy of Sciences; International Institute for Applied Systems Analysis (IIASA); University of Innsbruck; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lutz, W (corresponding author), Austrian Acad Sci, Vienna Inst Demog, A-1040 Vienna, Austria.	lutz@iiasa.ac.at	Sanderson, Warren/R-3398-2019	Sanderson, Warren/0000-0002-2205-948X; Lutz, Wolfgang/0000-0001-7975-8145; Crespo Cuaresma, Jesus/0000-0003-3244-6560				Barro RJ, 1996, AM ECON REV, V86, P218; BENHABIB J, 1994, J MONETARY ECON, V34, P143, DOI 10.1016/0304-3932(94)90047-7; Cohen D, 2007, J ECON GROWTH, V12, P51, DOI 10.1007/s10887-007-9011-5; Cohen Joel, 2007, ED ALL CHILDREN GLOB; de la Fuente A, 2006, J EUR ECON ASSOC, V4, P1, DOI 10.1162/jeea.2006.4.1.1; Krueger AB, 2001, J ECON LIT, V39, P1101, DOI 10.1257/jel.39.4.1101; Lutz W., 2007, VIENNA YB POPULATION, V5, P193, DOI DOI 10.1553/POPULATIONYEARBOOK2007S193; Pritchett L, 2001, WORLD BANK ECON REV, V15, P367, DOI 10.1093/wber/15.3.367; Topel R., 1999, HDB LABOUR EC, P2943	9	120	122	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1047	1048		10.1126/science.1151753	http://dx.doi.org/10.1126/science.1151753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264SW	18292326				2022-12-28	WOS:000253311700026
J	Tanaka, S; Kerfeld, CA; Sawaya, MR; Cai, F; Heinhorst, S; Cannon, GC; Yeates, TO				Tanaka, Shiho; Kerfeld, Cheryl A.; Sawaya, Michael R.; Cai, Fei; Heinhorst, Sabine; Cannon, Gordon C.; Yeates, Todd O.			Atomic-level models of the bacterial carboxysome shell	SCIENCE			English	Article							THIOBACILLUS-NEAPOLITANUS; POLYHEDRAL BODIES; ORGANELLES; CYANOBACTERIA; HOMOLOGS; PROTEINS; REVEALS; VIRUSES	The carboxysome is a bacterial microcompartment that functions as a simple organelle by sequestering enzymes involved in carbon fixation. The carboxysome shell is roughly 800 to 1400 angstroms in diameter and is assembled from several thousand protein subunits. Previous studies have revealed the three- dimensional structures of hexameric carboxysome shell proteins, which self- assemble into molecular layers that most likely constitute the facets of the polyhedral shell. Here, we report the three- dimensional structures of two proteins of previously unknown function, CcmL and OrfA ( or CsoS4A), from the two known classes of carboxysomes, at resolutions of 2.4 and 2.15 angstroms. Both proteins assemble to form pentameric structures whose size and shape are compatible with formation of vertices in an icosahedral shell. Combining these pentamers with the hexamers previously elucidated gives two plausible, preliminary atomic models for the carboxysome shell.	[Tanaka, Shiho; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy Inst Genom & Proteom, Los Angeles, CA 90095 USA; [Kerfeld, Cheryl A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Cai, Fei; Heinhorst, Sabine; Cannon, Gordon C.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of Southern Mississippi	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839				Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141, DOI [10.1007/7171_023, DOI 10.1007/7171_023]; Huiskonen JT, 2007, P NATL ACAD SCI USA, V104, P6666, DOI 10.1073/pnas.0608625104; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1991, CAN J BOT, V69, P957, DOI 10.1139/b91-123; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; Shively JM, 2001, CURR OPIN MICROBIOL, V4, P301, DOI 10.1016/S1369-5274(00)00207-1; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Wunderlich Z, 2004, PROTEINS, V56, P181, DOI 10.1002/prot.20091	26	292	300	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1083	1086		10.1126/science.1151458	http://dx.doi.org/10.1126/science.1151458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292340				2022-12-28	WOS:000253311700041
J	Thadhani, R				Thadhani, Ravi			Activated vitamin D sterols in kidney disease	LANCET			English	Editorial Material							HEMODIALYSIS; MORTALITY; SURVIVAL		[Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA; [Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr D Receptor Activat Res, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Thadhani, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA.	thadhani.ravi@mgh.harvard.edu			NCRR NIH HHS [M01 RR00088] Funding Source: Medline; NIDDK NIH HHS [DK 76116, DK 071674] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076116, R21DK071674] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Garg AX, 2008, CLIN J AM SOC NEPHRO, V3, P253, DOI 10.2215/CJN.01430307; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; GRAY R, 1971, SCIENCE, V172, P1232, DOI 10.1126/science.172.3989.1232; HAMDY NAT, 1995, BRIT MED J, V310, P358, DOI 10.1136/bmj.310.6976.358; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MORINIERE P, 1985, NEPHRON, V39, P309, DOI 10.1159/000183396; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; PRZEDLACKI J, 1995, NEPHRON, V69, P433, DOI 10.1159/000188515; Steddon S, 2005, LANCET, V365, P2237, DOI 10.1016/S0140-6736(05)66782-7; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tonelli M, 2007, ANN INTERN MED, V147, P880, DOI 10.7326/0003-4819-147-12-200712180-00009; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451	19	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					542	544		10.1016/S0140-6736(08)60251-2	http://dx.doi.org/10.1016/S0140-6736(08)60251-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280316				2022-12-28	WOS:000253202600010
J	Garau, J; Calbo, E				Garau, Javier; Calbo, Esther			Community-acquired pneumonia	LANCET			English	Editorial Material							ADULTS; GUIDELINES; MANAGEMENT; EFFICACY; AZITHROMYCIN; OUTCOMES; CLARITHROMYCIN; LEVOFLOXACIN; METAANALYSIS; TOLERANCE		[Garau, Javier; Calbo, Esther] Univ Barcelona, Dept Med, Hosp Mutua Terrassa, Barcelona 08221, Spain; [Garau, Javier; Calbo, Esther] Univ Barcelona, Infect Dis Unit, Hosp Mutua Terrassa, Barcelona 08221, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona	Garau, J (corresponding author), Univ Barcelona, Dept Med, Hosp Mutua Terrassa, Barcelona 08221, Spain.	jgarau@garmar.e.telefonica.net		Calbo, Esther/0000-0001-7750-5347				Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Dunbar LM, 2003, CLIN INFECT DIS, V37, P752, DOI 10.1086/377539; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARIE TJ, 1990, SEMIN RESP INFECT, V5, P260; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; O'Doherty B, 1998, EUR J CLIN MICROBIOL, V17, P828, DOI 10.1007/s100960050201; Plouffe JF, 2003, CLIN INFECT DIS, V37, P1475, DOI 10.1086/379329; Sopena N, 2004, J CHEMOTHERAPY, V16, P102, DOI 10.1179/joc.2004.16.1.102; Yu VL, 2004, CHEST, V125, P2135, DOI 10.1378/chest.125.6.2135	20	30	33	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2008	371	9611					455	458		10.1016/S0140-6736(08)60216-0	http://dx.doi.org/10.1016/S0140-6736(08)60216-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262027				2022-12-28	WOS:000253169200008
J	Vaidya, A; Saville, N; Shrestha, BP; Costello, AMD; Manandhar, DS; Osrin, D				Vaidya, Anjana; Saville, Naomi; Shrestha, Bhim Prasad; Costello, Anthony M. de L.; Manandhar, Dharma S.; Osrin, David			Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial	LANCET			English	Article							LOW-BIRTH-WEIGHT; MULTIMICRONUTRIENT SUPPLEMENTATION; PREGNANT-WOMEN; VITAMIN-A; FETAL; IRON; ZINC; CHILDHOOD; MORTALITY; COMMUNITY	Background The negative effects of low birthweight on the later health of children in developing countries have been well studied. However, undertaking programmes to address this issue can be difficult since there is no simple Correlation between increasing birthweight and improving child health. In 2005, we published results of a randomised controlled trial in Nepal, in which 1200 women received either iron and folic acid or a supplement that provided the recommended daily allowance of 15 vitamins and minerals, over the second and third trimesters of pregnancy. Here, we report on 2-3 years' follow-up of children born during the trial. Methods We visited children at home and obtained data for the primary outcomes of weight and height, for childhood illnesses, and maternal blood haemoglobin. The study is registered as an International Standard Randomised Controlled Trial number ISRCTN88625934. Findings Between December, 2005, and December, 2006, we assessed 917 children (455 controls, 462 intervention) at a mean age of 2 . 5 years. Mean birthweight had been 77 g (95% CI 24-130) greater in the micronutrient group than in controls. At 2.5 years old, controls weighed a mean of 10 . 7 kg (SD 1 . 38), and those in the intervention group 10.9 kg (SD 1.54). Children of women who had taken multiple micronutrient supplements during pregnancy were a mean 204 g (95% Cl 27-381) heavier than controls. They also had greater measurements than controls in the Circumference of the head (2.4 mm [95% CI 0 . 6-4.3]), chest (3.2 mm [0 . 4-6 . 0]), and mid-upper arm (2-4 mm [1 . 1-3 . 7]), and in triceps skinfold thickness (2 . 0 mm [0 . 0-0 . 4]). Systolic blood pressure was slightly lower in the intervention group (2 . 5 mm Hg [0 . 5-4.6]). Interpretation In a poor population, the effects of maternal multiple micronutrient supplementation on the fetus persisted into childhood, with increases in both weight and body size. These increases were small, however, since those exposed to micronutrients had an average of 2% higher weight than controls. The public-health implications of changes in weight and blood pressure need to be clarified through further follow-up.	[Saville, Naomi; Costello, Anthony M. de L.; Osrin, David] UCL Ctr Int Hlth & Dev, Inst Child Hlth, London WC1N 1EH, England; [Vaidya, Anjana; Shrestha, Bhim Prasad; Manandhar, Dharma S.] MIRA, Kathmandu, Nepal	University of London; University College London	Osrin, D (corresponding author), UCL Ctr Int Hlth & Dev, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	d.osrin@ich.ucl.ac.uk	Saville, Naomi/J-7244-2015	Saville, Naomi/0000-0002-1735-3684; Osrin, David/0000-0001-9691-9684	Wellcome Trust [081052] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashworth A, 1998, EUR J CLIN NUTR, V52, P223, DOI 10.1038/sj.ejcn.1600553; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1986, LANCET, V1, P1077; Caulfield LE, 1999, J NUTR, V129, P1563, DOI 10.1093/jn/129.8.1563; Caulfield LE, 1999, AM J CLIN NUTR, V69, P1257; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299, DOI 10.1093/ajcn/80.5.1299; Friis H, 2004, AM J CLIN NUTR, V80, P178; FRISANCHO AR, 1981, AM J CLIN NUTR, V34, P2540, DOI 10.1093/ajcn/34.11.2540; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Gluckman PD, 2005, EARLY HUM DEV, V81, P51, DOI 10.1016/j.earlhumdev.2004.10.003; Gupta P, 2007, ARCH PEDIAT ADOL MED, V161, P58, DOI 10.1001/archpedi.161.1.58; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Muslimatun S, 2001, J NUTR, V131, P85, DOI 10.1093/jn/131.1.85; OGUNBODE O, 1992, CURR THER RES CLIN E, V51, P634; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Ramakrishnan U, 2003, AM J CLIN NUTR, V77, P720, DOI 10.1093/ajcn/77.3.720; RollandCachera MF, 1997, AM J CLIN NUTR, V65, P1709, DOI 10.1093/ajcn/65.6.1709; Stevens-Simon C, 1999, BIRTH-ISS PERINAT C, V26, P184, DOI 10.1046/j.1523-536x.1999.00184.x; UNICEF/ WHO/UNU, 1999, COMP MULT SUPPL BE U; VILLAR J, 1982, AM J OBSTET GYNECOL, V143, P793, DOI 10.1016/0002-9378(82)90012-6; Walker CF, 2005, AM J CLIN NUTR, V82, P5, DOI 10.1093/ajcn/82.1.5; WHO, WHO CHILD GROWTH STA; *WHO SCN UNICEF, 2006, WHO SCN UNICEF M REV; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	31	116	118	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					492	499		10.1016/S0140-6736(08)60172-5	http://dx.doi.org/10.1016/S0140-6736(08)60172-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262041	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000253169200029
J	West, KP; Christian, P				West, Keith P., Jr.; Christian, Parul			Antenatal micronutrients in undernourished people	LANCET			English	Editorial Material							NEPAL; SUPPLEMENTATION; CHILDREN; DISEASE; INFANT; TRIAL		[West, Keith P., Jr.; Christian, Parul] Johns Hopkins Univ, Ctr Human Nutr, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	West, KP (corresponding author), Johns Hopkins Univ, Ctr Human Nutr, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	kwest@jhsph.edu						Ashworth CJ, 2001, REPRODUCTION, V122, P527, DOI 10.1530/rep.0.1220527; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Jafar TH, 2005, CIRCULATION, V111, P1291, DOI 10.1161/01.CIR.0000157699.87728.F1; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Joglekar CV, 2007, INT J OBESITY, V31, P1534, DOI 10.1038/sj.ijo.0803679; Krishna P, 2006, INDIAN PEDIATR, V43, P491; Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5	12	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					452	454		10.1016/S0140-6736(08)60214-7	http://dx.doi.org/10.1016/S0140-6736(08)60214-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262025				2022-12-28	WOS:000253169200006
J	Chen, JM; Smith, J; Wolfe, J				Chen, Jer Ming; Smith, John; Wolfe, Joe			Experienced saxophonists learn to tune their vocal tracts	SCIENCE			English	Article							ACOUSTIC-IMPEDANCE SPECTRA; RESONANCE; CLARINET		[Chen, Jer Ming; Smith, John; Wolfe, Joe] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Wolfe, J (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	J.Wolfe@unsw.edu.au	Chen, Jer-Ming/AAM-9842-2021; Smith, John/GYJ-1302-2022; Smith, John/Y-2316-2019	Chen, Jer-Ming/0000-0002-2500-0969; Smith, John/0000-0001-6885-1117; Wolfe, Joe/0000-0001-8030-0561				BACKUS J, 1985, J ACOUST SOC AM, V78, P17, DOI 10.1121/1.392556; CLINCH PG, 1982, ACUSTICA, V50, P280; Dickens P, 2007, J ACOUST SOC AM, V121, P1471, DOI 10.1121/1.2434764; Fritz C, 2005, J ACOUST SOC AM, V118, P3306, DOI 10.1121/1.2041287; Titze I. R., 1985, VOCAL FOLD PHYSL BIO, P425; Wolfe J, 2001, J SOUND VIB, V243, P127, DOI 10.1006/jsvi.2000.3346	6	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					776	776		10.1126/science.1151411	http://dx.doi.org/10.1126/science.1151411			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258908	Green Submitted			2022-12-28	WOS:000252963000051
J	Mullins, CB; Sitz, GO				Mullins, C. Buddie; Sitz, Greg O.			Chemistry - Taking a selective bite out of methane	SCIENCE			English	Editorial Material							DISSOCIATIVE CHEMISORPTION; ENERGY; CH4		[Mullins, C. Buddie] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Sitz, Greg O.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Mullins, CB (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	mullins@che.utexas.edu; gositz@physics.utexas.edu						JOHNSON AD, 1992, SCIENCE, V257, P223, DOI 10.1126/science.257.5067.223; Killelea DR, 2008, SCIENCE, V319, P790, DOI 10.1126/science.1152819; LEE MB, 1986, J CHEM PHYS, V85, P1693, DOI 10.1063/1.451211; RETTNER CT, 1985, PHYS REV LETT, V54, P2716, DOI 10.1103/PhysRevLett.54.2716; Seets DC, 1997, J CHEM PHYS, V107, P10229, DOI 10.1063/1.475306; Seets DC, 1997, J CHEM PHYS, V107, P3986, DOI 10.1063/1.474754; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Sitz GO, 2002, J PHYS CHEM B, V106, P8349, DOI 10.1021/jp020867e; Smith RR, 2004, SCIENCE, V304, P992, DOI 10.1126/science.1096309; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	10	4	4	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					736	737		10.1126/science.1153906	http://dx.doi.org/10.1126/science.1153906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258886				2022-12-28	WOS:000252963000029
J	Gaede, P; Lund-Andersen, H; Parving, HH; Pedersen, O				Gaede, Peter; Lund-Andersen, Henrik; Parving, Hans-Henrik; Pedersen, Oluf			Effect of a multifactorial intervention on mortality in type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MELLITUS; RISK; MICROALBUMINURIA; THERAPY; EVENTS; PEOPLE	Background: Intensified multifactorial intervention -- with tight glucose regulation and the use of renin-angiotensin system blockers, aspirin, and lipid-lowering agents -- has been shown to reduce the risk of nonfatal cardiovascular disease among patients with type 2 diabetes mellitus and microalbuminuria. We evaluated whether this approach would have an effect on the rates of death from any cause and from cardiovascular causes. Methods: In the Steno-2 Study, we randomly assigned 160 patients with type 2 diabetes and persistent microalbuminuria to receive either intensive therapy or conventional therapy; the mean treatment period was 7.8 years. Patients were subsequently followed observationally for a mean of 5.5 years, until December 31, 2006. The primary end point at 13.3 years of follow-up was the time to death from any cause. Results: Twenty-four patients in the intensive-therapy group died, as compared with 40 in the conventional-therapy group (hazard ratio, 0.54; 95% confidence interval [CI], 0.32 to 0.89; P=0.02). Intensive therapy was associated with a lower risk of death from cardiovascular causes (hazard ratio, 0.43; 95% CI, 0.19 to 0.94; P=0.04) and of cardiovascular events (hazard ratio, 0.41; 95% CI, 0.25 to 0.67; P<0.001). One patient in the intensive-therapy group had progression to end-stage renal disease, as compared with six patients in the conventional-therapy group (P=0.04). Fewer patients in the intensive-therapy group required retinal photocoagulation (relative risk, 0.45; 95% CI, 0.23 to 0.86; P=0.02). Few major side effects were reported. Conclusions: In at-risk patients with type 2 diabetes, intensive intervention with multiple drug combinations and behavior modification had sustained beneficial effects with respect to vascular complications and on rates of death from any cause and from cardiovascular causes. (ClinicalTrials.gov number, NCT00320008.).	[Gaede, Peter; Lund-Andersen, Henrik; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Copenhagen, Denmark; [Lund-Andersen, Henrik] Glostrup Univ Hosp, Dept Ophthalmol, Glostrup, Denmark; [Parving, Hans-Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, Copenhagen, Denmark; [Parving, Hans-Henrik; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	Steno Diabetes Center; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University	Pedersen, O (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Copenhagen, Denmark.	oluf@steno.dk	Chen, Chuan-Mu/K-7049-2013; Lund-Andersen, Henrik/C-1003-2012; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Yan, Pearlly S/E-4339-2011	Chen, Chuan-Mu/0000-0003-2461-9150; Pedersen, Oluf/0000-0002-3321-3972; Yan, Pearlly S/0000-0003-1965-4920; Gaede, Peter/0000-0002-1457-2742				ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; Beck-Nielsen H, 2000, UGESKR LAEGER S, V162, pS1; BECKNIELSEN H, 1988, IKKEINSULINKRAEVENDE; Brown LC, 2004, CAN MED ASSOC J, V171, P1189, DOI 10.1503/cmaj.1031965; Carstensen B, 1996, STAT MED, V15, P2177, DOI 10.1002/(SICI)1097-0258(19961030)15:20&lt;2177::AID-SIM345&gt;3.0.CO;2-7; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Collins R, 2003, LANCET, V361, P2005; FABRE J, 1982, KIDNEY INT, V21, P730, DOI 10.1038/ki.1982.90; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Gaede P, 2004, DIABETES, V53, pS39, DOI 10.2337/diabetes.53.suppl_3.S39; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede PH, 2006, DAN MED BULL, V53, P258; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Juel K, 1999, DAN MED BULL, V46, P354; Keech A, 2006, LANCET, V367, P1142, DOI 10.1016/S0140-6736(06)68501-2; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; *MED TEKN, 2003, TYP 2 DIAB MED TEKN, V5; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Simes RJ, 2002, LANCET, V359, P1379; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2002, CLIN SCI, V102, P679, DOI 10.1042/cs1020679; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Stratton IM, 2006, DIABETOLOGIA, V49, P1761, DOI 10.1007/s00125-006-0297-1; The long-term intervention with pravastatin in ischaemic disease (LIPID) study group, 2002, LANCET, V360, P1430; Thomas MC, 2003, KIDNEY INT, V63, P1577, DOI 10.1046/j.1523-1755.2003.00893.x; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1999, BMJ-BRIT MED J, V318, P29; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wingard DL., 1995, DIABETES AM, P429; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3	36	2318	2465	3	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					580	591		10.1056/NEJMoa0706245	http://dx.doi.org/10.1056/NEJMoa0706245			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256393				2022-12-28	WOS:000252916400005
J	Bjornson, CL; Johnson, DW				Bjornson, Candice L.; Johnson, David W.			Croup	LANCET			English	Review							NEBULIZED RACEMIC EPINEPHRINE; RESPIRATORY SYNCYTIAL VIRUS; ORAL DEXAMETHASONE; BACTERIAL TRACHEITIS; DOUBLE-BLIND; PARAINFLUENZA VIRUS; OUTPATIENT TREATMENT; CONTROLLED-TRIAL; VIRAL CROUP; THORACOABDOMINAL ASYNCHRONY	Most children who present with acute onset of barky cough, stridor, and chest-wall indrawing have croup. A careful history and physical examination is the best method to confirm the diagnosis and to rule out potentially serious alternative disorders such as bacterial tracheitis and other rare causes of upper-airway obstruction. Epinephrine delivered via a nebuliser is effective for temporary relief of symptoms of airway obstruction. Corticosteroids are the mainstay of treatment, and benefit is seen in children with all levels of severity of croup, including mild cases.	[Bjornson, Candice L.; Johnson, David W.] Univ Calgary, Fac Med, Dept Paediat, Calgary, AB, Canada	University of Calgary	Johnson, DW (corresponding author), Alberta Childrens Prov Gen Hosp, Child Hlth Res Grp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	David.Johnson@CalgaryHealthRegion.Ca						ADAIR JC, 1971, ANESTH ANAL CURR RES, V50, P649; Al-Mutairi Bandar, 2004, Paediatr Child Health, V9, P25; Alshehri Mohammed, 2005, Biomedical Research (Aligarh), V16, P65; Amir L, 2006, PEDIATR EMERG CARE, V22, P541, DOI 10.1097/01.pec.0000230552.63799.32; Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; Beckman KR, 2000, AM J EMERG MED, V18, P735, DOI 10.1053/ajem.2000.16309; Belshe RB, 2004, J INFECT DIS, V190, P2096, DOI 10.1086/425981; Bernstein T, 1998, CLIN INFECT DIS, V27, P458, DOI 10.1086/514681; Bjornson CL, 2004, NEW ENGL J MED, V351, P1306, DOI 10.1056/NEJMoa033534; BOURCHIER D, 1984, AUST PAEDIATR J, V20, P289; Brook I, 1997, PEDIATR EMERG CARE, V13, P16, DOI 10.1097/00006565-199702000-00005; Brown JC, 2002, BRIT MED BULL, V61, P189, DOI 10.1093/bmb/61.1.189; Brunton L. L., 2006, GOODMAN GILMANS PHAR, P1587; Butte MJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e9; Calhoun WJ, 2003, CHEST, V123, p399S, DOI 10.1378/chest.123.3_suppl.399S; Cetinkaya F, 2004, INT J PEDIATR OTORHI, V68, P453, DOI 10.1016/j.ijporl.2003.11.017; CHAN A, 2001, J PAEDIATR CHILD H, V6, P347; CHAPMAN RS, 1981, AM J EPIDEMIOL, V114, P786, DOI 10.1093/oxfordjournals.aje.a113249; Chin R, 2002, J PAEDIATR CHILD H, V38, P382, DOI 10.1046/j.1440-1754.2002.00011.x; Chub-Uppakarn S, 2007, INT J PEDIATR OTORHI, V71, P473, DOI 10.1016/j.ijporl.2006.11.016; CORKEY CWB, 1981, CRIT CARE MED, V9, P587, DOI 10.1097/00003246-198108000-00007; CORNELI HM, 1992, AM FAM PHYSICIAN, V46, P683; CROWE JE, 1995, VACCINE, V13, P415, DOI 10.1016/0264-410X(95)98266-D; D'Souza RM, 2002, J TROP PEDIATRICS, V48, P72, DOI 10.1093/tropej/48.2.72; DANGELO A, 2001, PEDIATR RES, V49, pA83; DAVIS G, 1985, EXAMINATION PHYSL CO; DAVIS GM, 1993, CHEST, V103, P1842, DOI 10.1378/chest.103.6.1842; DAWSON KP, 1991, NEW ZEAL MED J, V104, P374; DENNY FW, 1983, PEDIATRICS, V71, P871; DiCecco Ron J, 2004, Air Med J, V23, P33, DOI 10.1016/j.amj.2003.12.010; Donaldson D, 2003, ACAD EMERG MED, V10, P16, DOI 10.1197/aemj.10.1.16; DONNELLY BW, 1990, REV INFECT DIS, V12, P729; DOWELL SF, 1993, PEDIATRICS, V92, P223; DUNCAN PG, 1979, CAN ANAESTH SOC J, V26, P206, DOI 10.1007/BF03006983; EDWARDS KM, 1983, PEDIATR INFECT DIS J, V2, P390, DOI 10.1097/00006454-198309000-00015; FANCONI S, 1990, J PEDIATR-US, V117, P701, DOI 10.1016/S0022-3476(05)83324-4; Feigin RD, 2004, TXB PEDIAT INFECT DI, V5th, P252; Fifoot AA, 2007, EMERG MED AUSTRALAS, V19, P51, DOI 10.1111/j.1742-6723.2006.00919.x; Fink James B, 2004, Respir Care, V49, P653; Fisher JD, 2004, PEDIATR EMERG CARE, V20, P35, DOI 10.1097/01.pec.0000106241.72265.64; FOGEL JM, 1982, J PEDIATR-US, V101, P1028, DOI 10.1016/S0022-3476(82)80039-5; FRIEDMAN EM, 1985, LARYNGOSCOPE, V95, P9; GARDNER HG, 1973, PEDIATRICS, V52, P52; Geelhoed GC, 1996, ANN EMERG MED, V28, P621, DOI 10.1016/S0196-0644(96)70084-7; Geelhoed GC, 1997, PEDIATR PULM, V23, P370, DOI 10.1002/(SICI)1099-0496(199705)23:5<370::AID-PPUL9>3.0.CO;2-O; Geelhoed GC, 2005, PEDIATR EMERG CARE, V21, P359, DOI 10.1097/01.pec.0000166724.99555.de; Geelhoed GC, 1995, PEDIATR PULM, V20, P362, DOI 10.1002/ppul.1950200605; Geelhoed GC, 1995, PEDIATR PULM, V20, P355, DOI 10.1002/ppul.1950200604; Gonzalez Valdepena H, 1995, Pediatrics, V96, P424; GORELICK MH, 1994, ARCH PEDIAT ADOL MED, V148, P47, DOI 10.1001/archpedi.1994.02170010049010; GREALLY P, 1990, BRIT MED J, V301, P113, DOI 10.1136/bmj.301.6743.113; Griffin S, 2000, BRIT J GEN PRACT, V50, P135; Gupta Vineet K, 2005, Pediatr Crit Care Med, V6, P204, DOI 10.1097/01.PCC.0000154946.62733.94; HAN BK, 1979, AM J ROENTGENOL, V133, P53, DOI 10.2214/ajr.133.1.53; Havaldar PV, 1997, ANN TROP PAEDIATR, V17, P21, DOI 10.1080/02724936.1997.11747858; HENRY R, 1983, ARCH DIS CHILD, V58, P577, DOI 10.1136/adc.58.8.577; HUSSEY GD, 1990, NEW ENGL J MED, V323, P160, DOI 10.1056/NEJM199007193230304; INNESASHER M, 1999, PEDIAT RESP MED, P530; Janssens HM, 2004, J AEROSOL MED, V17, P51, DOI 10.1089/089426804322994460; Johnson D, 2005, DIAGNOSIS MANAGEMENT; Johnson David, 2004, Clin Evid, P401; Johnson David W., 2001, Pediatric Research, V49, p83A; Johnson DW, 1998, NEW ENGL J MED, V339, P498, DOI 10.1056/NEJM199808203390802; Johnson DW, 2004, PEDIATR RES, V55, p113A; Johnson DW, 1996, ARCH PEDIAT ADOL MED, V150, P349, DOI 10.1001/archpedi.1996.02170290015002; Johnson DW, 2003, PEDIATR RES, V53, p185A; JONES R, 1979, JAMA-J AM MED ASSOC, V242, P721, DOI 10.1001/jama.242.8.721; Kaditis AG, 1998, PEDIATR INFECT DIS J, V17, P827, DOI 10.1097/00006454-199809000-00018; KAIRYS SW, 1989, PEDIATRICS, V83, P683; KAPUSTIAN V, 1994, ZH MIKROBIOL EPIDEMI, V4, P19; KELLEY PB, 1992, AM J EMERG MED, V10, P181, DOI 10.1016/0735-6757(92)90204-B; KEMPER KJ, 1991, CRIT CARE MED, V19, P356, DOI 10.1097/00003246-199103000-00013; KLASSEN TP, 1994, NEW ENGL J MED, V331, P285, DOI 10.1056/NEJM199408043310501; Klassen TP, 1998, JAMA-J AM MED ASSOC, V279, P1629, DOI 10.1001/jama.279.20.1629; Klassen TP, 1999, PEDIATR CLIN N AM, V46, P1167, DOI 10.1016/S0031-3955(05)70180-2; KRISTJANSSON S, 1994, ACTA PAEDIATR, V83, P1156; Kunkel NC, 1996, PEDIATR EMERG CARE, V12, P156, DOI 10.1097/00006565-199606000-00003; Kunzelmann K, 2004, J BIOL CHEM, V279, P48760, DOI 10.1074/jbc.M409747200; LAVINE E, 2001, CAN J EMERG MED, V1, P209; LEBEL MH, 1988, NEW ENGL J MED, V319, P964, DOI 10.1056/NEJM198810133191502; LEDWITH CA, 1995, ANN EMERG MED, V25, P331, DOI 10.1016/S0196-0644(95)70290-3; LENNEY W, 1978, ARCH DIS CHILD, V53, P704, DOI 10.1136/adc.53.9.704; MARGOLIS PA, 1994, J PEDIATR-US, V124, P552, DOI 10.1016/S0022-3476(05)83133-6; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; MCENIERY J, 1991, PEDIATRICS, V87, P847; McGee Douglas L., 1997, Journal of Emergency Medicine, V15, P291, DOI 10.1016/S0736-4679(97)00008-5; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Midwinter KI, 1999, CLIN OTOLARYNGOL, V24, P447, DOI 10.1046/j.1365-2273.1999.00291.x; Moore M, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CDC002870.PUB2; Neto GM, 2002, ACAD EMERG MED, V9, P873, DOI 10.1197/aemj.9.9.873; NEWTH CJL, 1972, J PEDIATR-US, V81, P1068, DOI 10.1016/S0022-3476(72)80233-6; Nichols WG, 2001, BLOOD, V98, P573, DOI 10.1182/blood.V98.3.573; Orth D, 1992, WILLIAMS TXB ENDOCRI, P504; Patel H, 1996, ARCH PEDIAT ADOL MED, V150, P409, DOI 10.1001/archpedi.1996.02170290075012; Pedersen L V, 1998, Ugeskr Laeger, V160, P2253; Phelan P, 1982, RESPIRATORY ILLNESS, V32-3; PLATONOVA T, 1991, PEDIATRIIA, V6, P15; POKROVSKII V, 1985, TERAPEVT ARKH, V57, P199; PRENDERGAST M, 1994, AM J EMERG MED, V12, P613, DOI 10.1016/0735-6757(94)90024-8; Qureshi F, 2001, J PEDIATR-US, V139, P20, DOI 10.1067/mpd.2001.115021; RAPKIN RH, 1972, J PEDIATR-US, V80, P96, DOI 10.1016/S0022-3476(72)80460-8; Rittichier KK, 2000, PEDIATRICS, V106, P1344, DOI 10.1542/peds.106.6.1344; Rizos J D, 1998, J Emerg Med, V16, P535, DOI 10.1016/S0736-4679(98)00055-9; RUSSELL K, 2004, COCHRANE DB SYST REV, V1; Schuepp KG, 2004, J AEROSOL MED, V17, P153, DOI 10.1089/0894268041457228; Scolnik D, 2006, JAMA-J AM MED ASSOC, V295, P1274, DOI 10.1001/jama.295.11.1274; SENDI K, 1992, J OTOLARYNGOL, V21, P20; SIVAN Y, 1990, AM REV RESPIR DIS, V142, P540, DOI 10.1164/ajrccm/142.3.540; SOFER S, 1991, INFECTION, V19, P131, DOI 10.1007/BF01643230; SOFER S, 1983, CLIN PEDIATR, V22, P407, DOI 10.1177/000992288302200602; Sparrow A, 2006, ARCH DIS CHILD, V91, P580, DOI 10.1136/adc.2005.089516; STANKIEWICZ JA, 1985, LARYNGOSCOPE, V95, P1159; Steele DW, 1998, AM J RESP CRIT CARE, V157, P331, DOI 10.1164/ajrccm.157.1.9701071; STONEY PJ, 1991, J LARYNGOL OTOL, V105, P295, DOI 10.1017/S002221510011566X; STOOL SE, 1988, PEDIATR INFECT DIS J, V7, pS157, DOI 10.1097/00006454-198811001-00008; Swischuk LE, 2000, EMERGENCY IMAGING AC; TAN AKW, 1992, J OTOLARYNGOL, V21, P48; TAUSSIG LM, 1975, AM J DIS CHILD, V129, P790, DOI 10.1001/archpedi.1975.02120440016004; Terregino CA, 1998, ACAD EMERG MED, V5, P1130, DOI 10.1111/j.1553-2712.1998.tb02680.x; TIBBALLS J, 1992, LANCET, V340, P745, DOI 10.1016/0140-6736(92)92293-O; To T, 1996, J PAEDIATR CHILD H, V1, P103; Tong MCF, 1996, CHEST, V109, P1659, DOI 10.1378/chest.109.6.1659; TUNNESSEN W, 1983, RESP SYSTEM STRIDOR; Van der Hoek L, 2006, ADV EXP MED BIOL, V581, P485; WAGENER JS, 1986, PEDIATR PULM, V2, P159, DOI 10.1002/ppul.1950020308; WAISMAN Y, 1992, PEDIATRICS, V89, P302; Weber JE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e96; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; WESTLEY CR, 1978, AM J DIS CHILD, V132, P484, DOI 10.1001/archpedi.1978.02120300044008; Wildhaber JH, 2002, J PAEDIATR CHILD H, V38, P115, DOI 10.1046/j.1440-1754.2002.00794.x; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; WONG VK, 1987, PEDIATR INFECT DIS J, V6, P945, DOI 10.1097/00006454-198710000-00023; Zhang Linjie, 2005, J. Pediatr. (Rio J.), V81, P193, DOI 10.1590/S0021-75572005000400004; 1993, NEW DRUG NOT ROUTINE; 1991, FDA MED B, V21; 1997, 1997 RED BOOK REPORT, P702	136	92	94	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					329	339		10.1016/S0140-6736(08)60170-1	http://dx.doi.org/10.1016/S0140-6736(08)60170-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18295000	Bronze, Green Published			2022-12-28	WOS:000252616500029
J	Shamliyan, TA; Kane, RL; Wyman, J; Wilt, TJ				Shamliyan, Tatyana A.; Kane, Robert L.; Wyman, Jean; Wilt, Timothy J.			Systematic review: Randomized, controlled trials of nonsurgical treatments for urinary incontinence in women	ANNALS OF INTERNAL MEDICINE			English	Review							PELVIC FLOOR EXERCISES; GENUINE STRESS-INCONTINENCE; QUALITY-OF-LIFE; BEHAVIORAL-MODIFICATION PROGRAM; ELECTRICAL-STIMULATION; MUSCLE EXERCISE; OLDER WOMEN; POSTMENOPAUSAL WOMEN; OVERACTIVE BLADDER; URGE INCONTINENCE	Background: Urinary incontinence in women is a common problem that adversely affects quality of life. Purpose: To synthesize evidence of management of urinary incontinence in women. Data Sources: MEDLINE, CINAHL, and the Cochrane Library. Study Selection: 96 randomized, controlled trials (RCTs) and 3 systematic reviews published in English from 1990 through May 2007. Data Extraction: Using standardized protocols, reviewers abstracted cases of continence, improvement of urinary incontinence, and prevalence of urinary incontinence to calculate risk difference. Data Synthesis: Compared with regular care, pelvic floor muscle training plus bladder training resolved urinary incontinence (pooled risk difference, 0.13 [95% Cl, 0.07 to 0.20]). Pelvic floor muscle training alone resolved or improved urinary incontinence compared with regular care, although the effect size was inconsistent across studies. Different injectable bulking agents and medical devices were associated with similar continence and improvement rates. Electrical stimulation failed to resolve urinary incontinence. Oral hormone administration increased rates of urinary incontinence compared with placebo in most RCTs (1243 women). Transdermal or vaginal estrogen resulted in inconsistent improvement of urinary incontinence. Adrenergic drugs did not resolve or improve urinary incontinence. Oxybutynin or tolterodine resolved urinary incontinence compared with placebo (pooled risk difference, 0.18 [Cl, 0.13 to 0.221). Duloxetine compared with placebo improved (pooled risk difference, 0.11 [Cl, 0.07 to 0.14]) but did not resolve urinary incontinence, with no significant dose-response association. Limitations: Inconsistent measurements of outcomes limited the findings. Predictors of better effect have not been identified in RCTs. Conclusion: Moderate levels of evidence suggest that pelvic floor muscle training and bladder training resolved urinary incontinence in women. Anticholinergic drugs resolved urinary incontinence, with similar effects from oxybutynin or tolterodine. Duloxetine improved but did not resolve urinary incontinence. The effects of electro-stimulation, medical devices, injectable bulking agents, and local estrogen therapy were inconsistent.	Univ Minnesota, Sch Publ Hlth, Evidence Based Practice Ctr, Sch Nursing,Med Sch, Minneapolis, MN USA; Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Kane, RL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, D351 Mayo MMC 197,420 Delaware St SE, Minneapolis, MN 55455 USA.	kanex001@umn.edu	Shamliyan, Tatyana/AAU-8323-2020	Shamliyan, Tatyana/0000-0003-3584-2008	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063300] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 063300-01A2] Funding Source: Medline; PHS HHS [290-02-0009] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; ABRAMS P, 2005, P 3 INT CONS INC, V2, P798; ABRAMS P, 2005, P 3 INT CONS INC, V1, P1; AHLSTROM K, 1990, GYNECOL OBSTET INVES, V30, P37, DOI 10.1159/000293211; Akhila V, 2006, INT J FERTIL WOMEN M, V51, P64; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; Al-Marzouki S, 2005, BMJ-BRIT MED J, V331, P267, DOI 10.1136/bmj.331.7511.267; Alewijnse D, 2003, NEUROUROL URODYNAM, V22, P284, DOI 10.1002/nau.10122; Alhasso A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001842.pub2; Amaro JL, 2006, ACTA OBSTET GYN SCAN, V85, P619, DOI 10.1080/00016340500495058; Anderson RU, 1999, J UROLOGY, V161, P1809, DOI 10.1016/S0022-5347(05)68810-6; Anger JT, 2006, J UROLOGY, V175, P601, DOI 10.1016/S0022-5347(05)00242-9; Appell RA, 2006, NEUROUROL URODYNAM, V25, P331, DOI 10.1002/nau.20185; Arvonen T, 2001, NEUROUROL URODYNAM, V20, P591, DOI 10.1002/nau.1011; Aschengrau A., 2020, ESSENTIALS EPIDEMIOL; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Aukee P, 2004, ACTA OBSTET GYN SCAN, V83, P973, DOI 10.1111/j.0001-6349.2004.00559.x; BAINTON D, 1982, BRIT MED J, V285, P419, DOI 10.1136/bmj.285.6339.419; Bano F, 2005, INT UROGYNECOL J, V16, P147, DOI 10.1007/s00192-004-1216-y; Berghmans LCM, 1996, NEUROUROL URODYNAM, V15, P37, DOI 10.1002/(SICI)1520-6777(1996)15:1<37::AID-NAU4>3.0.CO;2-G; Bo K, 2000, ACTA OBSTET GYN SCAN, V79, P598, DOI 10.1034/j.1600-0412.2000.079007598.x; Bo K, 2005, OBSTET GYNECOL, V105, P999, DOI 10.1097/01.AOG.0000157207.95680.6d; Bo K, 1999, BMJ-BRIT MED J, V318, P487, DOI 10.1136/bmj.318.7182.487; Bogner HR, 2002, J AM GERIATR SOC, V50, P489, DOI 10.1046/j.1532-5415.2002.50115.x; Borello-France DF, 2006, PHYS THER, V86, P974, DOI 10.1093/ptj/86.7.974; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Brown JS, 2006, DIABETES CARE, V29, P385, DOI 10.2337/diacare.29.02.06.dc05-1781; Brubaker L, 1997, AM J OBSTET GYNECOL, V177, P536, DOI 10.1016/S0002-9378(97)70142-X; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; BURGIO KL, 1991, J UROLOGY, V146, P1255, DOI 10.1016/S0022-5347(17)38063-1; BURNS PA, 1993, J GERONTOL, V48, pM167; BURNS PA, 1990, J AM GERIATR SOC, V38, P341, DOI 10.1111/j.1532-5415.1990.tb03517.x; But I, 2005, J UROLOGY, V173, P1644, DOI 10.1097/01.ju.0000157336.87781.32; But I, 2003, UROLOGY, V61, P558, DOI 10.1016/S0090-4295(02)02249-5; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Cammu H, 1998, EUR J OBSTET GYN R B, V77, P89, DOI 10.1016/S0301-2115(97)00237-6; Cardozo L, 2004, OBSTET GYNECOL, V104, P511, DOI 10.1097/01.AOG.0000134525.86480.0f; CARDOZO L, 1993, MATURITAS, V18, P47, DOI 10.1016/0378-5122(93)90028-G; Chompootaweep S, 1998, CLIN PHARMACOL THER, V64, P204, DOI 10.1016/S0009-9236(98)90154-0; Corcos J, 2005, UROLOGY, V65, P898, DOI 10.1016/j.urology.2004.11.054; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dessole S, 2004, MENOPAUSE, V11, P49, DOI 10.1097/01.GME.0000077620.13164.62; Diokno AC, 2004, J UROLOGY, V171, P1165, DOI 10.1097/01.ju.0000111503.73803.c2; Diokno AC, 2003, MAYO CLIN PROC, V78, P687, DOI 10.4065/78.6.687; Dmochowski RR, 2003, J UROLOGY, V170, P1259, DOI 10.1097/01.ju.0000080708.87092.cc; DuBeau CE, 2005, NEUROUROL URODYNAM, V24, P13, DOI 10.1002/nau.20083; Ebrahim S, 2001, EVAL HEALTH PROF, V24, P152, DOI 10.1177/01632780122034858; Egger M, 2001, SYSTEMATIC REV HLTH; Elser DM, 1999, NEUROUROL URODYNAM, V18, P427, DOI 10.1002/(SICI)1520-6777(1999)18:5<427::AID-NAU3>3.0.CO;2-0; Emmons SL, 2005, OBSTET GYNECOL, V106, P138, DOI 10.1097/01.AOG.0000163258.57895.ec; Eustice S, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd002113, DOI 10.1002/14651858.CD002113]; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Finkelstein MM, 2002, CAN FAM PHYSICIAN, V48, P96; Fujishiro T, 2000, J UROLOGY, V164, P1277, DOI 10.1016/S0022-5347(05)67155-8; Fultz NH, 1999, J GERONTOL A-BIOL, V54, pM299, DOI 10.1093/gerona/54.6.M299; Gartlehner G, 2006, J CLIN EPIDEMIOL, V59, P1040, DOI 10.1016/j.jclinepi.2006.01.011; Ghoniem GM, 2005, J UROLOGY, V173, P1647, DOI 10.1097/01.ju.0000154167.90600.c6; Glazener CM, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003195, DOI 10.1002/14651858.CD003195]; Goldstein SR, 2005, MENOPAUSE, V12, P160, DOI 10.1097/00042192-200512020-00010; Goldstein SR, 2002, AM J OBSTET GYNECOL, V187, P521, DOI 10.1067/mob.2002.123938; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Hay-Smith EJC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001407.pub2; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; HERBISON P, 2006, COCHRANE DB SYST REV; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; HIGGINS J, 2005, COCHRANE HDB SYSTEMA, V2006; Hilton P., 1990, INT UROGYNECOL J, V1, P80; Holtedahl K, 1998, ACTA OBSTET GYN SCAN, V77, P671, DOI 10.1034/j.1600-0412.1998.770616.x; HU TW, 1989, JAMA-J AM MED ASSOC, V261, P2656, DOI 10.1001/jama.261.18.2656; Hurley DJ, 2006, EUR J OBSTET GYN R B, V125, P120, DOI 10.1016/j.ejogrb.2005.08.006; Hvidman L, 2003, INT UROGYNECOL J, V14, P56, DOI 10.1007/s00192-002-1012-5; HVIDMAN L, 2003, J PELVIC FLOOR DYSFU, V14, P61; Iglesias FJG, 2000, J GERONTOL A-BIOL, V55, pM207, DOI 10.1093/gerona/55.4.M207; Ishiko O, 2000, INT J GYNECOL OBSTET, V71, P39, DOI 10.1016/S0020-7292(00)00254-X; Jackson S, 1999, BRIT J OBSTET GYNAEC, V106, P711, DOI 10.1111/j.1471-0528.1999.tb08372.x; Jackson SL, 2006, OBSTET GYNECOL, V108, P855, DOI 10.1097/01.AOG.0000236446.17153.21; Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730; Janssen CCM, 2001, BJU INT, V87, P201, DOI 10.1046/j.1464-410x.2001.02040.x; Kahn HA, 1989, STAT METHODS EPIDEMI; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Kim JI, 2001, PUBLIC HEALTH NURS, V18, P64, DOI 10.1046/j.1525-1446.2001.00064.x; Kinchen KS, 2005, INT UROGYNECOL J, V16, P337, DOI 10.1007/s00192-004-1270-5; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kok ALM, 1999, MATURITAS, V31, P143, DOI 10.1016/S0378-5122(98)00093-0; LAGACE EA, 1993, J FAM PRACTICE, V36, P610; LAGROJANSSEN ALM, 1992, FAM PRACT, V9, P284, DOI 10.1093/fampra/9.3.284; LAGROJANSSEN TLM, 1991, BRIT J GEN PRACT, V41, P445; Laycock J, 2001, Br J Community Nurs, V6, P230; Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037; LEHTONEN T, 1986, ANN CHIR GYNAECOL FE, V75, P236; Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7; Long CY, 2006, FERTIL STERIL, V85, P155, DOI 10.1016/j.fertnstert.2005.06.042; Lose G, 2000, BRIT J OBSTET GYNAEC, V107, P1029, DOI 10.1111/j.1471-0528.2000.tb10408.x; LOSE G, 1988, UROL INT, V43, P11, DOI 10.1159/000281294; Luber KM, 1997, NEUROUROL URODYNAM, V16, P543, DOI 10.1002/(SICI)1520-6777(1997)16:6<543::AID-NAU4>3.0.CO;2-E; Manonai J, 2006, MATURITAS, V54, P135, DOI 10.1016/j.maturitas.2005.09.011; Mariappan P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004742.pub2; McClurg D, 2006, NEUROUROL URODYNAM, V25, P337, DOI 10.1002/nau.20209; McFall SL, 2000, J AGING HEALTH, V12, P250, DOI 10.1177/089826430001200206; MIKKELSEN AL, 1995, GYNECOL OBSTET INVES, V40, P125, DOI 10.1159/000292320; Millard RJ, 2004, BJU INT, V93, P311, DOI 10.1111/j.1464-410X.2004.04607.x; Moehrer B, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001405; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moore KH, 2003, BJOG-INT J OBSTET GY, V110, P649, DOI 10.1046/j.1471-0528.2003.02264.x; Morkved S, 2002, OBSTET GYNECOL, V100, P730, DOI 10.1016/S0029-7844(02)02160-9; Mulcahy J. J., 1996, Neurourology and Urodynamics, V15, P395; Nabi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003781.pub2; NIELSEN KK, 1993, BRIT J UROL, V72, P428, DOI 10.1111/j.1464-410X.1993.tb16171.x; NORBERG A, 1980, EUR J CLIN PHARMACOL, V18, P497, DOI 10.1007/BF00874662; Norton PA, 2002, AM J OBSTET GYNECOL, V187, P40, DOI 10.1067/mob.2002.124840; NYGAARD I, 1995, J REPROD MED, V40, P89; Nygaard IE, 1996, J AM GERIATR SOC, V44, P1049, DOI 10.1111/j.1532-5415.1996.tb02936.x; Ostaszkiewicz J., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002802.pub2, DOI 10.1002/14651858.CD002802.PUB2]; Ostaszkiewicz J., 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD002801.PUB2, 10.1002/14651858.CD002801.pub2]; P Abrams, 2002, INCONTINENCE; Pages IH, 2001, AM J PHYS MED REHAB, V80, P494, DOI 10.1097/00002060-200107000-00006; PALMER J, 1983, J INT MED RES, V11, P11; PICKARD R, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003881; RANNIKKO S, 1986, J INFECTION, V12, P221, DOI 10.1016/S0163-4453(86)94138-1; Robinson H, 2003, INT UROGYNECOL J PEL, V14, P199, DOI 10.1007/s00192-002-1021-4; ROBINSON JM, 1983, BRIT J UROL, V55, P371, DOI 10.1111/j.1464-410X.1983.tb03325.x; Roe B, 2000, COCHRANE DB SYST REV; Rufford J, 2003, INT UROGYNECOL J, V14, P78, DOI 10.1007/s00192-003-1054-3; Sampselle CM, 2005, INT UROGYNECOL J, V16, P441, DOI 10.1007/s00192-005-1284-7; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; SCHNELLE JF, 1989, J AM GERIATR SOC, V37, P1051, DOI 10.1111/j.1532-5415.1989.tb06919.x; Schulz JA, 2004, INT UROGYNECOL J, V15, P261, DOI 10.1007/s00192-004-1148-6; Seo JT, 2004, YONSEI MED J, V45, P879; SHAIKH S, 2006, COCHRANE DB SYST REV, V3; Smith JJ, 1996, J UROLOGY, V155, P127, DOI 10.1016/S0022-5347(01)66567-4; Spruijt J, 2003, ACTA OBSTET GYN SCAN, V82, P1043, DOI 10.1034/j.1600-0412.2003.00130.x; Steers WD, 2007, BJU INT, V100, P337, DOI 10.1111/j.1464-410X.2007.06980.x; Steinauer JE, 2005, OBSTET GYNECOL, V106, P940, DOI 10.1097/01.AOG.0000180394.08406.15; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Strasser H, 2007, LANCET, V369, P2179, DOI 10.1016/S0140-6736(07)61014-9; Subak LL, 2005, J UROLOGY, V174, P190, DOI 10.1097/01.ju.0000162056.30326.83; Subak LL, 2002, OBSTET GYNECOL, V100, P72, DOI 10.1016/S0029-7844(02)01993-2; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Sze EHM, 2002, OBSTET GYNECOL, V99, P572, DOI 10.1016/S0029-7844(01)01781-1; Teleman P, 2005, ACTA OBSTET GYN SCAN, V84, P1108, DOI 10.1111/j.0001-6349.2005.00770.x; Thom DH, 1997, OBSTET GYNECOL, V90, P983, DOI 10.1016/S0029-7844(97)00537-1; Thyssen H, 2001, BJU INT, V88, P889, DOI 10.1046/j.1464-4096.2001.01548.x; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; Tseng IJ, 2000, J FORMOS MED ASSOC, V99, P753; *US AG HEALTHC RES, 2002, SYST RAT STRENGTH SC; *US AG HLTH CAR PO, 1996, MAN AC CHRON UR INC; *US AG HLTH CAR PO, 1992, AHCPR PUBL; van Kerrebroeck P, 2004, BJOG-INT J OBSTET GY, V111, P249, DOI 10.1111/j.1471-0528.2004.00067.x; Vardy MD, 2003, AM J OBSTET GYNECOL, V189, P81, DOI 10.1067/mob.2003.374; Vestergaard P, 2003, MATURITAS, V46, P123, DOI 10.1016/S0378-5122(03)00181-6; Viechtbauer W, 2007, STAT MED, V26, P37, DOI 10.1002/sim.2514; Waetjen LE, 2005, OBSTET GYNECOL, V106, P946, DOI 10.1097/01.AOG.0000182576.48290.6d; Waetjen LE, 2004, OBSTET GYNECOL, V103, P261, DOI 10.1097/01.AOG.0000109429.67671.d1; WALTER S, 1990, INT UROGYNECOL J, V1, P74; Wang AC, 2004, UROLOGY, V63, P61, DOI 10.1016/j.urology.2003.08.047; Warming L, 2003, MATURITAS, V44, P189, DOI 10.1016/S0378-5122(02)00342-0; WELLS TJ, 1991, J AM GERIATR SOC, V39, P785, DOI 10.1111/j.1532-5415.1991.tb02701.x; WHITEHEAD A, 2002, META ANAL CONTROLLED; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Yamanishi T, 1997, J UROLOGY, V158, P2127, DOI 10.1016/S0022-5347(01)68176-X; Yamanishi T, 2000, UROLOGY, V55, P353, DOI 10.1016/S0090-4295(99)00476-8; YASUDA K, 1993, INT UROGYNECOL J, V4, P146; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; ZINNER N, 1998, NEUROUROL URODYNAM, V17, P173; 1996, M FAM PHYS, V54, P1661	174	150	159	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					459	473		10.7326/0003-4819-148-6-200803180-00211	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00211			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18268288				2022-12-28	WOS:000254354800006
J	Manheimer, E; Zhang, G; Udoff, L; Haramati, A; Langenberg, P; Berman, BM; Bouter, LM				Manheimer, Eric; Zhang, Grant; Udoff, Laurence; Haramati, Aviad; Langenberg, Patricia; Berman, Brian M.; Bouter, Lex M.			Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSISTED REPRODUCTION; EFFICACY TRIALS; QUALITY; DESIGN	Objective To evaluate whether acupuncture improves rates of pregnancy and live birth when used as an adjuvant treatment to embryo transfer in women undergoing in vitro fertilisation. Design Systematic review and meta-analysis. Data sources Medline, Cochrane Central, Embase, Chinese Biomedical Database, hand searched abstracts, and reference lists. Review methods Eligible studies were randomised controlled trials that compared needle acupuncture administered within one day of embryo transfer with sham acupuncture or no adjuvant treatment, with reported outcomes of at least one of clinical pregnancy, ongoing pregnancy, or live birth. Two reviewers independently agreed on eligibility; assessed methodological quality; and extracted outcome data. For all trials, investigators contributed additional data not included in the original publication (such as live births). Meta-analyses included all randomised patients. Data synthesis Seven trials with 1366 women undergoing in vitro fertilisation were included in the meta-analyses. There was little clinical heterogeneity. Trials with sham acupuncture and no adjuvant treatment as controls were pooled for the primary analysis. Complementing the embryo transfer process with acupuncture was associated with significant and clinically relevant improvements in clinical pregnancy(odds ratio 1.65, 95% confidence interval 1.27 to 2.14; number needed to treat (NNT) 10 (7 to 17); seven trials), ongoing pregnancy (1.87, 1.40 to 2.49; NNT 9 (6 to 15); five trials), and live birth (1.91, 1.39 to 2.64; NNT 9 (6 to 17); four trials). Because we were unable to obtain outcome data on live births for three of the included trials, the pooled odds ratio for clinical pregnancy more accurately represents the true combined effect from these trials rather than the odds ratio for live birth. The results were robust to sensitivity analyses on study validity variables. A prespecified subgroup analysis restricted to the three trials with the higher rates of clinical pregnancy in the control group, however, suggested a smaller non-significant benefit of acupuncture (odds ratio 1.24, 0.86 to 1.77). Conclusions Current preliminary evidence suggests that acupuncture given with embryo transfer improves rates of pregnancy and live birth among women undergoing in vitro fertilisation.	[Manheimer, Eric; Zhang, Grant; Berman, Brian M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21207 USA; [Udoff, Laurence] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Serv, Baltimore, MD 21207 USA; [Haramati, Aviad] Georgetown Univ, Sch Med, Dept Physiol & Biophys & Med, Washington, DC USA; [Langenberg, Patricia] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Bouter, Lex M.] Free Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Georgetown University; University System of Maryland; University of Maryland Baltimore; Vrije Universiteit Amsterdam	Manheimer, E (corresponding author), Univ Maryland, Sch Med, Ctr Integrat Med, 2200 Kernan Dr,Kernan Hosp Mans, Baltimore, MD 21207 USA.	emanheimer@compmed.umm.edu	Bouter, Lex/X-1003-2019; Haramati, Aviad/ABB-1587-2020	Bouter, Lex/0000-0002-2659-5482; 	NCCIH NIH HHS [R24 AT001293] Funding Source: Medline; National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; [Anonymous], FREQ ASK QUEST INF; Arce JC, 2005, HUM REPROD, V20, P1757, DOI 10.1093/humrep/deh818; BIRCH S, 2001, CLIN ACUPUNCT ORIENT, V2, P17; Chang R, 2002, FERTIL STERIL, V78, P1149, DOI 10.1016/S0015-0282(02)04348-0; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; CLARKE J, 2006, MENSTRUAL DISORDERS; Daya S, 2003, HUM REPROD, V18, P1005, DOI 10.1093/humrep/deg238; Daya S, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004830, 10.1002/14651858.CD004830]; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; Domar AD, 2006, FERTIL STERIL, V85, P1359, DOI 10.1016/j.fertnstert.2005.10.063; FERIN M, 1984, EUR J OBSTET GYN R B, V18, P365, DOI 10.1016/0028-2243(84)90059-5; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Ludwig M, 2000, HUM REPROD, V15, P319, DOI 10.1093/humrep/15.2.319; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maciocia G, 1997, OBSTET GYNECOLOGY CH; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; MAYER DJ, 1977, BRAIN RES, V121, P368, DOI 10.1016/0006-8993(77)90161-5; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Myers ER, 2006, FERTIL STERIL, V85, P1362, DOI 10.1016/j.fertnstert.2005.10.062; PIANTADOSI S, 1997, TREATMENT ALLOCATION, P203; Pinborg A, 2004, HUM REPROD, V19, P1052, DOI 10.1093/humrep/deh228; StenerVictorin E, 1996, HUM REPROD, V11, P1314; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485	25	124	132	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					545	+		10.1136/bmj.39471.430451.BE	http://dx.doi.org/10.1136/bmj.39471.430451.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18258932	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000253998500030
J	Wheeler, BW; Gunnell, D; Metcalfe, C; Stephens, P; Martin, RM				Wheeler, Benedict W.; Gunnell, David; Metcalfe, Chris; Stephens, Peter; Martin, Richard M.			The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; RANDOMIZED CONTROLLED-TRIALS; ASSISTED REPRODUCTION; OOCYTE ASPIRATION; SYSTEMATIC REVIEWS; SSRI PRESCRIPTIONS; RELEVANT STANDARD; ANALGESIC METHOD; INFERTILE WOMEN; EFFICACY TRIALS	Objective To investigate the population impact on the incidence of suicide and non-fatal self harm of regulatory action in 2003 to restrict the use of selective serotonin reuptake inhibitors (SSRIs) in under 18s. Design Ecological time series study. Setting United Kingdom. Populations Young people in the UK aged 12-19 years (prescribing trends), in England and Wales aged 12-17 years (mortality), and in England aged 12-17 years (hospital admissions). Main outcome measures Deaths from suicide and hospital admissions for self harm. Results Antidepressant prescribing doubled between 1999 and 2003 but fell to the 1999 level between 2004 and 2005. These large changes in prescribing did not seem to be associated with temporal trends in suicide or self harm. In the years 1993 to 2005 the annual percentage reduction for suicide among 1 2-17 year olds was -3.9% (95% confidence interval -6.2% to -1.5%) in mates and -3.0% (-6.6% to 0.6%) in females, with no indication of a substantial change in this rate of decrease during that period. Similarly, hospital admission rates for self harm in the years 1999 to 2005 indicated an annual percentage increase for mates of 1.1% (-0.5% to 2.7%) and for females of 5.7% (3.6% to 7.8%), again with no statistical evidence of a change in rate after the regulatory action. Conclusions The noticeable reduction in prescribing of antidepressants since regulatory action in 2003 to restrict the use of SSRIs in under 18s does not seem to have been associated with changes in suicidal behaviour in young people. Specifically, these data for England do not indicate that reductions in antidepressant use have led to an increase in suicidal behaviour.	[Wheeler, Benedict W.; Gunnell, David; Metcalfe, Chris; Martin, Richard M.] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Stephens, Peter] IMS Hlth, London, England	University of Bristol	Wheeler, BW (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	ben.wheeler@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Wheeler, Benedict/G-1711-2012	Gunnell, David/0000-0002-0829-6470; Wheeler, Benedict/0000-0001-9404-5936; Martin, Richard/0000-0002-7992-7719; Metcalfe, Chris/0000-0001-8318-8907				Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; ALDERSON P, 2002, COCHRANE COLLABORATI; Altman DG, 1996, BRIT MED J, V313, P570; Andersen AN, 2004, HUM REPROD, V19, P490, DOI 10.1093/humrep/deh129; [Anonymous], FREQ ASK QUEST INF; Arce JC, 2005, HUM REPROD, V20, P1757, DOI 10.1093/humrep/deh818; Benson MR, 2006, FERTIL STERIL, V86, pS135, DOI 10.1016/j.fertnstert.2006.07.362; BIRCH S, 2001, CLIN ACUPUNCT ORIENT, V2, P17; *CDCP, 2005, ASS REPR TECHN SUCC; Chang R, 2002, FERTIL STERIL, V78, P1149, DOI 10.1016/S0015-0282(02)04348-0; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; CLARKE J, 2006, MENSTRUAL DISORDERS; Collins J, 2006, FERTIL STERIL, V85, P1364, DOI 10.1016/j.fertnstert.2005.10.064; Daya S, 2003, HUM REPROD, V18, P1005, DOI 10.1093/humrep/deg238; Daya S, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004830, 10.1002/14651858.CD004830]; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; *DEP HLTH, 2007, HOSP EP STAT DAT; Dieterle S, 2006, FERTIL STERIL, V85, P1347, DOI 10.1016/j.fertnstert.2005.09.062; Domar AD, 2006, FERTIL STERIL, V86, pS378, DOI 10.1016/j.fertnstert.2006.07.1042; Domar AD, 2006, FERTIL STERIL, V85, P1359, DOI 10.1016/j.fertnstert.2005.10.063; Elden H, 2005, BMJ-BRIT MED J, V330, P761, DOI 10.1136/bmj.38397.507014.E0; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; FERIN M, 1984, EUR J OBSTET GYN R B, V18, P365, DOI 10.1016/0028-2243(84)90059-5; Gejervall AL, 2005, HUM REPROD, V20, P728, DOI 10.1093/humrep/deh665; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Griesinger G, 2004, HUM REPROD, V19, P1239, DOI 10.1093/humrep/deh237; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Humaidan P, 2004, HUM REPROD, V19, P1367, DOI 10.1093/humrep/deh229; *IMS HLTH, 2007, INT MED STAT; JOHNSON NP, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002125.PUB2; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kvorning N, 2004, ACTA OBSTET GYN SCAN, V83, P246; Lee H, 2004, AM J OBSTET GYNECOL, V191, P1573, DOI 10.1016/j.ajog.2004.05.027; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lineberry TW, 2007, MAYO CLIN PROC, V82, P518, DOI 10.4065/82.4.518; Ludwig M, 2000, HUM REPROD, V15, P319, DOI 10.1093/humrep/15.2.319; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maciocia G, 1997, OBSTET GYNECOLOGY CH; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; MAYER DJ, 1977, BRAIN RES, V121, P368, DOI 10.1016/0006-8993(77)90161-5; *MED HEALTHC PROD, 2005, SEL SER REUPT INH SS; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Murray ML, 2005, DRUG SAFETY, V28, P1151, DOI 10.2165/00002018-200528120-00009; Myers ER, 2006, FERTIL STERIL, V85, P1362, DOI 10.1016/j.fertnstert.2005.10.062; *NAT I HLTH CLIN E, 2005, 28 BRIT PSYCH SOC NA; *OFF NAT STAT, 2007, NAT STAT; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Olfson M, 2007, AM J PSYCHIAT, V164, P1907, DOI 10.1176/appi.ajp.2007.07091467; Paulus WE, 2003, HUM REPROD, V18, P18; Paulus WE, 2002, FERTIL STERIL, V77, P721, DOI 10.1016/S0015-0282(01)03273-3; PIANTADOSI S, 1997, TREATMENT ALLOCATION, P203; Pinborg A, 2004, HUM REPROD, V19, P1052, DOI 10.1093/humrep/deh228; Quintero R, 2004, FERTIL STERIL, V81, pS11; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Sator-Katzenschlager SM, 2006, HUM REPROD, V21, P2114, DOI 10.1093/humrep/del110; Smith C, 2002, COMPLEMENT THER MED, V10, P78, DOI 10.1054/ctim.2002.0523; Smith CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003521.pub2; Smith C, 2006, FERTIL STERIL, V85, P1352, DOI 10.1016/j.fertnstert.2005.12.015; Smith R, 1998, BMJ-BRIT MED J, V317, P291, DOI 10.1136/bmj.317.7154.291; Stener-Victorin E, 1999, HUM REPROD, V14, P2480, DOI 10.1093/humrep/14.10.2480; Stener-Victorin E, 2003, HUM REPROD, V18, P1454, DOI 10.1093/humrep/deg277; StenerVictorin E, 1996, HUM REPROD, V11, P1314; Udoff LC, 2006, FERTIL STERIL, V86, pS145, DOI 10.1016/j.fertnstert.2006.07.389; Vail A, 2003, HUM REPROD, V18, P1000, DOI 10.1093/humrep/deg133; [张明敏 Zhang Mingmin], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P3; Wedenberg K, 2000, ACTA OBSTET GYN SCAN, V79, P331, DOI 10.1034/j.1600-0412.2000.079005331.x; Westergaard LG, 2006, FERTIL STERIL, V85, P1341, DOI 10.1016/j.fertnstert.2005.08.070; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; WOOD L, 2006, 14 COCHR C DUBL IR O; Zegers-Hochschild F, 2006, HUM REPROD, V21, P1968, DOI 10.1093/humrep/del171; Zhang M, 2001, FERTIL STERIL, V76, pS75, DOI 10.1016/S0015-0282(01)02231-2; [张民 Zhang Min], 2002, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V8, P507	80	63	63	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					542	545		10.1136/bmj.39462.375613.BE	http://dx.doi.org/10.1136/bmj.39462.375613.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18276667	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000253998500029
J	Jones, KE; Patel, NG; Levy, MA; Storeygard, A; Balk, D; Gittleman, JL; Daszak, P				Jones, Kate E.; Patel, Nikkita G.; Levy, Marc A.; Storeygard, Adam; Balk, Deborah; Gittleman, John L.; Daszak, Peter			Global trends in emerging infectious diseases	NATURE			English	Article							PUBLIC-HEALTH; RISK-FACTORS; HOST-RANGE; EMERGENCE; ECOLOGY	Emerging infectious diseases (EIDs) are a significant burden on global economies and public health(1-3). Their emergence is thought to be driven largely by socio- economic, environmental and ecological factors(1-9), but no comparative study has explicitly analysed these linkages to understand global temporal and spatial patterns of EIDs. Here we analyse a database of 335 EID 'events' (origins of EIDs) between 1940 and 2004, and demonstrate non-random global patterns. EID events have risen significantly over time after controlling for reporting bias, with their peak incidence (in the 1980s) concomitant with the HIV pandemic. EID events are dominated by zoonoses (60.3% of EIDs): the majority of these (71.8%) originate in wildlife (for example, severe acute respiratory virus, Ebola virus), and are increasing significantly over time. We find that 54.3% of EID events are caused by bacteria or rickettsia, reflecting a large number of drug- resistant microbes in our database. Our results confirm that EID origins are significantly correlated with socio- economic, environmental and ecological factors, and provide a basis for identifying regions where new EIDs are most likely to originate (emerging disease 'hotspots'). They also reveal a substantial risk of wildlife zoonotic and vector-borne EIDs originating at lower latitudes where reporting effort is low. We conclude that global resources to counter disease emergence are poorly allocated, with the majority of the scientific and surveillance effort focused on countries from where the next important EID is least likely to originate.	[Patel, Nikkita G.; Daszak, Peter] Wildlife Trust, Consortium Conservat Med, Beijing 100011, Peoples R China; [Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Levy, Marc A.; Storeygard, Adam; Balk, Deborah] Columbia Univ, Ctr Int Earth Sci Informat Network, Palisades, NY 10964 USA; [Gittleman, John L.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Zoological Society of London; Columbia University; University System of Georgia; University of Georgia	Daszak, P (corresponding author), Wildlife Trust, Consortium Conservat Med, 460 W 34th St,17th Floor, Beijing 100011, Peoples R China.	daszak@conservationmedicine.org	Levy, Marc A/K-3557-2015; Levy, Marc/F-6183-2010; Patel, Nikkita/GRJ-5319-2022; Jones, Kate/Y-3317-2019; Storeygard, Adam/H-2633-2017	Levy, Marc A/0000-0002-1111-2222; Jones, Kate/0000-0001-5231-3293; Balk, Deborah/0000-0002-9028-7898; Patel, Nikkita/0000-0001-6300-6731	FIC NIH HHS [R01 TW005869] Funding Source: Medline; NIAID NIH HHS [R01 AI079231] Funding Source: Medline; NICHD NIH HHS [T32 HD007338] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007338] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079231] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; BURKE DS, 1998, PATHOLOGY EMERGING I, P00001; [CIAT CIESIN], 2005, GRIDD POP WORLD VERS; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; *ESRI, 2005, DAT MAPS VERS 9 1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Houghton J. T., 2001, CLIMATE CHANGE 2001; IIASA/FAO, 2000, GLOB AGR EC ZON GAEZ; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lederberg J., 1992, I MED US COMMITTEE; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse Stephen S., 1993, P10; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; R Development Core Team. R, 2005, LANG ENV STAT COMP R; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; SECHREST W, 2003, GLOBAL DIVERSITY END; Smolinsky M.S., 2003, MICROBIAL THREATS HL; *SPSS INC, 2006, SPSS WIND VERS 12 0; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	29	4118	4282	82	2605	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					990	U4		10.1038/nature06536	http://dx.doi.org/10.1038/nature06536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288193	Bronze, Green Published			2022-12-28	WOS:000253313100048
J	Collins, FS; Gray, GM; Bucher, JR				Collins, Francis S.; Gray, George M.; Bucher, John R.			Toxicology - Transforming environmental health protection	SCIENCE			English	Editorial Material							CHEMICALS; PROGRAM		[Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Gray, George M.] US EPA, Off Res & Dev, Washington, DC 20460 USA; [Bucher, John R.] NIEHS, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Environmental Protection Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	francisc@mail.nih.gov			Intramural NIH HHS [Z99 ES999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2004, CURR DIR EV STRAT GO; Bucher JR, 2004, TOXICOL SCI, V82, P363, DOI 10.1093/toxsci/kfh293; Chiu WA, 2007, J APPL TOXICOL, V27, P218, DOI 10.1002/jat.1225; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; KAVLOCK R, 2007, IN PRESS TOXICO  DEC; Mathema S., 2021, REBUILDING US REFUGE; National Research Council, 2007, TOXICITY TESTING 21; National Research Council-NRC, 2006, TOX TEST ASS ENV AG; Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373; XIA M, 2007, IN PRESS ENV HL 1122	11	480	502	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					906	907		10.1126/science.1154619	http://dx.doi.org/10.1126/science.1154619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276874	Green Accepted			2022-12-28	WOS:000253165700028
J	Vannucchi, P; Remitti, F; Bettelli, G				Vannucchi, Paola; Remitti, Francesca; Bettelli, Giuseppe			Geological record of fluid flow and seismogenesis along an erosive subducting plate boundary	NATURE			English	Article							NORTHERN APENNINES; SEDIMENT SUBDUCTION; SEAMOUNT SUBDUCTION; MELANGE FORMATION; ACCRETION; ZONES; FAULT; SUCCESSION; DILATANCY; MARGINS	Tectonic erosion of the overriding plate by the downgoing slab is believed to occur at half the Earth's subduction zones(1,2). In situ investigation of the geological processes at active erosive margins is extremely difficult owing to the deep marine environment and the net loss of forearc crust to deeper levels in the subduction zone. Until now, a fossil erosive subduction channel - the shear zone marking the plate boundary(3) - has not been recognized in the field, so that seismic observations have provided the only information on plate boundary processes at erosive margins. Here we show that a fossil erosive margin is preserved in the Northern Apennines of Italy. It formed during the Tertiary transition from oceanic subduction to continental collision, and was preserved by the late deactivation and fossilization of the plate boundary. The outcropping erosive subduction channel is similar to 500 m thick. It is representative of the first 5 km of depth, with its deeper portions reaching similar to 150 degrees C. The fossil zone records several surprises. Two decollements were simultaneously active at the top and base of the subduction channel. Both deeper basal erosion and near- surface frontal erosion occurred. At shallow depths extension was a key deformation component within this erosive convergent plate boundary, and slip occurred without an observable fluid pressure cycle. At depths greater than about 3 km a fluid cycle is clearly shown by the development of veins and the alternation of fast ( co- seismic) and slow ( inter- seismic) slip. In the deepest portions of the outcropping subduction channel, extension is finally overprinted by compressional structures. In modern subduction zones the onset of seismic activity is believed to occur at similar to 150 degrees C, but in the fossil channel the onset occurred at cooler palaeo- temperatures.	[Vannucchi, Paola] Univ Florence, Dipartimento Sci Terra, I-50121 Florence, Italy; [Remitti, Francesca; Bettelli, Giuseppe] Univ Modena, Dipartimento Sci Terra, I-41100 Modena, Italy	University of Florence; Universita di Modena e Reggio Emilia	Vannucchi, P (corresponding author), Univ Florence, Dipartimento Sci Terra, Via Pira 4, I-50121 Florence, Italy.	paola.vannucchi@unifi.it	vannucchi, paola/L-9474-2019; remitti, francesca/E-7856-2012	vannucchi, paola/0000-0002-1457-5476; remitti, francesca/0000-0002-0720-1927; VANNUCCHI, Paola/0000-0001-5996-8743				Amorosi A, 1996, GEOL MIJNBOUW, V75, P295; Bangs NLB, 2006, GEOLOGY, V34, P701, DOI 10.1130/G22451.1; Bilek SL, 1999, NATURE, V400, P443, DOI 10.1038/22739; Cibin U, 2001, GEOL SOC AM BULL, V113, P4, DOI 10.1130/0016-7606(2001)113<0004:CCHFAO>2.0.CO;2; Clift P, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000127; CLOOS M, 1988, PURE APPL GEOPHYS, V128, P455, DOI 10.1007/BF00874548; Dominguez S, 2000, TECTONICS, V19, P182, DOI 10.1029/1999TC900055; Eusslin R., 1992, MEMORIE CARTA GEOLOG, V46, P257; Healy D, 2006, NATURE, V439, P64, DOI 10.1038/nature04346; HILDE TWC, 1983, TECTONOPHYSICS, V99, P381, DOI 10.1016/0040-1951(83)90114-2; Landuzzi, 1994, MEMORIE SOC GEOLOGIC, V48, P523; LEPICHON X, 1993, ANNU REV EARTH PL SC, V21, P307; Moore JC, 2001, GEOLOGY, V29, P183, DOI 10.1130/0091-7613(2001)029<0183:ULOTSZ>2.0.CO;2; MOORE JC, 1987, GEOLOGY, V15, P1040, DOI 10.1130/0091-7613(1987)15<1040:TOFZAM>2.0.CO;2; OBANA K, 2003, J GEOPHYS RES, V108; RANERO CR, 2004, EOS T AGU S, P85; RECHES Z, 1983, TECTONOPHYSICS, V95, P133, DOI 10.1016/0040-1951(83)90264-0; Remitti F, 2007, GEODIN ACTA, V20, P37, DOI 10.3166/ga.20.37-51; Sage F, 2006, GEOLOGY, V34, P997, DOI 10.1130/G22790A.1; SEGALL P, 1995, J GEOPHYS RES-SOL EA, V100, P22155, DOI 10.1029/95JB02403; Sibson R.H., 1992, TECTONOPHYSICS, V18, P1031; SIBSON RH, 1981, NATURE, V289, P665, DOI 10.1038/289665a0; SIBSON RH, 1974, NATURE, V249, P542, DOI 10.1038/249542a0; SIBSON RH, 1990, GEOLOGICAL SOC LONDO, V54, P15; von Huene R, 2004, GEOLOGY, V32, P913, DOI 10.1130/G20563.1; VONHUENE R, 1991, REV GEOPHYS, V29, P279, DOI 10.1029/91RG00969; Wang K., 2002, GEOPHYS RES LETT, V29; Zattin M, 2000, J GEOL SOC LONDON, V157, P629, DOI 10.1144/jgs.157.3.629	28	119	120	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					699	703		10.1038/nature06486	http://dx.doi.org/10.1038/nature06486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256668				2022-12-28	WOS:000252929500037
J	Ho, PM; Peterson, ED; Wang, L; Magid, DJ; Fihn, SD; Larsen, GC; Jesse, RA; Rumsfeld, JS				Ho, P. Michael; Peterson, Eric D.; Wang, Li; Magid, David J.; Fihn, Stephan D.; Larsen, Greg C.; Jesse, Robert A.; Rumsfeld, John S.			Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIPLATELET THERAPY; PLATELET ACTIVATION; ASPIRIN THERAPY; UNSTABLE ANGINA; DRUG-THERAPY; WITHDRAWAL; RISK; PREVENTION; HEPARIN; DISCONTINUATION	Context It is unknown whether patients are at increased short- term risk for adverse events following clopidogrel cessation. Objective To assess the rates of adverse events after stopping treatment with clopidogrel in a national sample of patients with acute coronary syndrome ( ACS). Design, Setting, and Patients Retrospective cohort study of 3137 patients with ACS discharged from 127 Veterans Affairs hospitals between October 1, 2003, and March 31, 2005, with posthospital treatment with clopidogrel. Main Outcome Measure Rate of all- cause mortality or acute myocardial infarction ( AMI) after stopping treatment with clopidogrel. Results Mean ( SD) follow- up after stopping treatment with clopidogrel was 196 ( 152) days for medically treated patients with ACS without stents ( n= 1568) and 203 ( 148) days for patients with ACS treated with percutaneous coronary intervention ( PCI) ( n= 1569). Among medically treated patients, mean ( SD) duration of clopidogrel treatment was 302 ( 151) days and death or AMI occurred in 17.1%( n= 268) of patients, with 60.8%( n= 163) of events occurring during 0 to 90 days, 21.3% ( n= 57) during 91 to 180 days, and 9.7% ( n= 26) during 181 to 270 days after stopping treatment with clopidogrel. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90- day interval after stopping treatment with clopidogrel was associated with a significantly higher risk of adverse events ( incidence rate ratio [ IRR], 1.98; 95% confidence interval [ CI], 1.46- 2.69 vs the interval of 91- 180 days). Similarly, among PCI- treated patients with ACS, mean( SD) duration of clopidogrel treatment was 278 ( 169) days and death or AMI occurred in 7.9% ( n= 124) of patients, with 58.9% ( n= 73) of events occurring during 0 to 90 days, 23.4% ( n= 29) during 91 to 180 days, and 6.5% ( n= 8) during 181 to 270 days after stopping clopidogrel treatment. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90- day interval after stopping clopidogrel treatment was associated with a significantly higher risk of adverse events ( IRR, 1.82; 95% CI, 1.17- 2.83). Conclusions We observed a clustering of adverse events in the initial 90 days after stopping clopidogrel among both medically treated and PCI- treated patients with ACS, supporting the possibility of a clopidogrel rebound effect. Additional studies are needed to confirm the clustering of events after stopping clopidogrel, including associations with cardiovascular mortality and reasons for stopping clopidogrel, as well as to determine the mechanism of this phenomenon, and to identify strategies to reduce early events after clopidogrel cessation.	[Ho, P. Michael; Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO 80220 USA; [Ho, P. Michael; Magid, David J.; Rumsfeld, John S.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Wang, Li; Fihn, Stephan D.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Ho, P. Michael; Magid, David J.; Rumsfeld, John S.] Kaiser Permanente Colorado, Inst Hlth Res, Aurora, CO USA; [Larsen, Greg C.] VA Med Ctr, Portland, OR USA; [Jesse, Robert A.] Richmond VA Med Ctr, Richmond, VA USA; [Jesse, Robert A.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Kaiser Permanente; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Rumsfeld, JS (corresponding author), Denver VA Med Ctr, 111B,1055 Clermont St, Denver, CO 80220 USA.	John.Rumsfeld@va.gov	Fihn, Stephan/ABA-1040-2020; Peterson, Eric David/ABF-5033-2021					Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Campo G, 2007, J AM COLL CARDIOL, V50, P1132, DOI 10.1016/j.jacc.2007.04.092; Collet JP, 2006, EUR HEART J SUPPL, V8, pG46, DOI 10.1093/eurheartj/sul055; Collet JP, 2004, CIRCULATION, V110, P2361, DOI 10.1161/01.CIR.0000145171.89690.B4; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; GRANGER CB, 1995, CIRCULATION, V91, P1929, DOI 10.1161/01.CIR.91.7.1929; Grines CL, 2007, J AM DENT ASSOC, V138, P652, DOI 10.14219/jada.archive.2007.0237; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Holmes DR, 2007, J AM COLL CARDIOL, V50, P109, DOI 10.1016/j.jacc.2007.04.032; Lauer MA, 2001, CIRCULATION, V104, P2772, DOI 10.1161/hc4801.100358; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; Maynard C, 2006, ARCH INTERN MED, V166, P1410, DOI 10.1001/archinte.166.13.1410; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Serebruany VL, 2006, INT J CLIN PRACT, V60, P863, DOI 10.1111/j.1742-1241.2006.00999.x; Serebruany VL, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.007; Sohn Min-Woong, 2006, Popul Health Metr, V4, P7, DOI 10.1186/1478-7954-4-7; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; THEROUX P, 1992, NEW ENGL J MED, V327, P141, DOI 10.1056/NEJM199207163270301; Valgimigli M, 2007, J AM COLL CARDIOL, V50, P138, DOI 10.1016/j.jacc.2007.04.029; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	289	307	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					532	539		10.1001/jama.299.5.532	http://dx.doi.org/10.1001/jama.299.5.532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252883	Bronze			2022-12-28	WOS:000252886100018
J	Park, SY; Lytton-Jean, AKR; Lee, B; Weigand, S; Schatz, GC; Mirkin, CA				Park, Sung Yong; Lytton-Jean, Abigail K. R.; Lee, Byeongdu; Weigand, Steven; Schatz, George C.; Mirkin, Chad A.			DNA-programmable nanoparticle crystallization	NATURE			English	Article							DISSIPATIVE PARTICLE DYNAMICS; ASYMMETRIC FUNCTIONALIZATION; COLLOIDAL CRYSTALS; GOLD NANOPARTICLES; BUILDING-BLOCKS; OLIGONUCLEOTIDES; SUPERLATTICES	It was first shown(1,2) more than ten years ago that DNA oligonucleotides can be attached to gold nanoparticles rationally to direct the formation of larger assemblies. Since then, oligonucleotide-functionalized nanoparticles have been developed into powerful diagnostic tools(3,4) for nucleic acids and proteins, and into intracellular probes(5) and gene regulators(6). In contrast, the conceptually simple yet powerful idea that functionalized nanoparticles might serve as basic building blocks that can be rationally assembled through programmable base- pairing interactions into highly ordered macroscopic materials remains poorly developed. So far, the approach has mainly resulted in polymerization, with modest control over the placement of, the periodicity in, and the distance between particles within the assembled material. That is, most of the materials obtained thus far are best classified as amorphous polymers(7-16), although a few examples of colloidal crystal formation exist(8,16). Here, we demonstrate that DNA can be used to control the crystallization of nanoparticle - oligonucleotide conjugates to the extent that different DNA sequences guide the assembly of the same type of inorganic nanoparticle into different crystalline states. We show that the choice of DNA sequences attached to the nanoparticle building blocks, the DNA linking molecules and the absence or presence of a non- bonding single- base flexor can be adjusted so that gold nanoparticles assemble into micrometresized face- centred- cubic or body- centred- cubic crystal structures. Our findings thus clearly demonstrate that synthetically programmable colloidal crystallization is possible, and that a single-component system can be directed to form different structures.	[Park, Sung Yong; Lytton-Jean, Abigail K. R.; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Park, Sung Yong; Lytton-Jean, Abigail K. R.; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lee, Byeongdu] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Weigand, Steven] Northwestern Univ, DND CAT Synchrotron Res Ctr, Argonne, IL 60439 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Schatz, George C./ABF-1341-2020; Weigand, Steven/G-6181-2015; Lee, Byeongdu/AAO-8096-2020; Mirkin, Chad A/E-3911-2010	Weigand, Steven/0000-0003-3137-0672; Lee, Byeongdu/0000-0003-2514-8805; Lytton-Jean, Abigail/0000-0002-1582-0066; Mirkin, Chad/0000-0002-6634-7627				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bartlett P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128302; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Cullity B.D., 1978, ANSWERS PROBLEMS ELE; Donev A, 2004, J COMPUT PHYS, V197, P139, DOI 10.1016/j.jcp.2003.11.022; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Frenkel D, 2006, NAT MATER, V5, P85, DOI 10.1038/nmat1572; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; MIRKIN CA, 1996, NATURE, V382, P609; Nykypanchuk D, 2007, LANGMUIR, V23, P6305, DOI 10.1021/la0637566; Ozin G.A., 2015, NANOCHEMISTRY CHEM A; Park SJ, 2001, ANGEW CHEM INT EDIT, V40, P2909, DOI 10.1002/1521-3773(20010803)40:15<2909::AID-ANIE2909>3.0.CO;2-O; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Park SY, 2006, J PHYS CHEM B, V110, P12673, DOI 10.1021/jp062212+; Park SY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224201; Park SY, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.212202; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850; Velev OD, 2006, SCIENCE, V312, P376, DOI 10.1126/science.1125800; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b	30	1258	1284	15	740	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					553	556		10.1038/nature06508	http://dx.doi.org/10.1038/nature06508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235497				2022-12-28	WOS:000252739900037
J	Go, AS; Singer, DE				Go, Alan S.; Singer, Daniel E.			Stroke prevention in atrial fibrillation: another step sideways	LANCET			English	Editorial Material							ANTITHROMBOTIC THERAPY; ANTICOAGULATION		[Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Singer, Daniel E.] Massachusetts Gen Hosp, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; [Singer, Daniel E.] Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA.	alan.s.go@kp.org	Go, Alan S./AAE-7745-2019					Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Boulanger L, 2006, INT J CLIN PRACT, V60, P258, DOI 10.1111/j.1368-5031.2006.00790.x; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; GO AS, 1999, CIRCULATION S, V100, P1; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Lip GYH, 2005, PATHOPHYSIOL HAEMO T, V34, P25, DOI 10.1159/000083081; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Snapinn S, 2008, STAT MED, V27, P382, DOI 10.1002/sim.3073	12	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					278	280		10.1016/S0140-6736(08)60143-9	http://dx.doi.org/10.1016/S0140-6736(08)60143-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294981				2022-12-28	WOS:000252616500005
J	Semba, RD; de Pee, S; Sun, K; Sari, M; Akhter, N; Bloem, MW				Semba, Richard D.; de Pee, Saskia; Sun, Kai; Sari, Mayang; Akhter, Nasima; Bloem, Martin W.			Effect of parental formal education on risk of child stunting in Indonesia and Bangladesh: a cross-sectional study	LANCET			English	Article							MALNUTRITION; COUNTRIES; NUTRITION; AGE	Background Child stunting is associated with poor child development and increased mortality. Our aim was to determine the effect of length of maternal and paternal education on stunting in children under the age of 5 years. Methods Data for indicators of child growth and of parental education and socioeconomic status were gathered from 590570 families in Indonesia and 395122 families in Bangladesh as part of major nutritional surveillance programmes. Findings The prevalence of stunting in families in Indonesia was 33.2%, while that in Bangladesh was 50.7%. In Indonesia, greater maternal formal education led to a decrease of between 4.4% and 5% in the odds of child stunting (odds ratio per year 0.950, 95% CI 0.946-0.954 in rural settings; 0.956, 0.950-0.961 in urban settings); greater paternal formal education led to a decrease of 3% in the odds of child stunting (0 . 970, 0 . 967-0.974). In Bangladesh, greater maternal formal education led to a 4.6% decrease in the odds of child stunting (0.954, 0 .951-0 .957), while greater paternal formal education led to a decrease of between 2.9% and 5.4% in the odds of child stunting (0 . 971, 0. 969-0.974 in rural settings; 0 . 946, 0.941-0.951 in urban settings). In Indonesia, high levels of maternal and paternal education were both associated with protective caregiving behaviours, including vitamin A capsule receipt, complete childhood immunisations, better sanitation, and use of iodised salt (all p<0. 0001). Interpretation Both maternal and paternal education are strong determinants of child stunting in families in Indonesia and Bangladesh.	[Semba, Richard D.; Sun, Kai] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [de Pee, Saskia; Bloem, Martin W.] World Food Programme, Policy Strategy & Programme Support Div, Nutr Serv, Rome, Italy; [Bloem, Martin W.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bloem, Martin W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Sari, Mayang] Helen Keller Int Asia Pacific, Phnom Penh, Cambodia; [Akhter, Nasima] Helen Keller Int Asia Pacific, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tufts University	Semba, RD (corresponding author), Johns Hopkins Univ, Sch Med, 550 N Broadway,Suite 700, Baltimore, MD 21205 USA.	rdsemba@jhmi.edu	Ebot, Jane/B-6983-2012; Akhter, Nasima/AAL-3670-2020	Akhter, Nasima/0000-0002-5424-1593				Adair LS, 1997, J NUTR, V127, P314, DOI 10.1093/jn/127.2.314; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; *BANK CAN, EXCH RAT MONTHL AV R; Bushamuka Victor N., 2005, Food and Nutrition Bulletin, V26, P17; Chopra M, 2003, PUBLIC HEALTH NUTR, V6, P645, DOI 10.1079/PHN2003477; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HABICHT JP, 1973, NUTR REP INT, V7, P533; KELLER W, 1988, LINEAR GROWTH RETARD; KHAN SR, 2001, SOCIOLEGAL STAT BENG; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; MARTORELL R, 1981, HUM BIOL, V53, P303; Mason JB, 1984, NUTR SURVEILLANCE; Milman A, 2005, J NUTR, V135, P1415, DOI 10.1093/jn/135.6.1415; Pee S. de, 2001, Nutrition and health in developing countries, P483; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; POLLITT E, 1992, MALNUTRITION INFECT; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Ricci JA, 1996, AM J CLIN NUTR, V63, P966, DOI 10.1093/ajcn/63.6.966; Royston E, 1989, PREVENTING MATERNAL; Sakisaka K, 2006, PUBLIC HEALTH, V120, P400, DOI 10.1016/j.puhe.2005.10.018; SPURR GB, 1977, AM J CLIN NUTR, V30, P316, DOI 10.1093/ajcn/30.3.316; Wamani H, 2006, PUBLIC HEALTH NUTR, V9, P320, DOI 10.1079/PHN2006854; World Health Organization, 2006, WHO CHILD GROWTH STA; [No title captured]	29	197	200	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					322	328		10.1016/S0140-6736(08)60169-5	http://dx.doi.org/10.1016/S0140-6736(08)60169-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254VQ	18294999				2022-12-28	WOS:000252616500028
J	JACKSON, RB; MANWARING, JH; CALDWELL, MM				JACKSON, RB; MANWARING, JH; CALDWELL, MM			RAPID PHYSIOLOGICAL ADJUSTMENT OF ROOTS TO LOCALIZED SOIL ENRICHMENT	NATURE			English	Article									UTAH STATE UNIV,CTR ECOL,LOGAN,UT 84322	Utah System of Higher Education; Utah State University	JACKSON, RB (corresponding author), UTAH STATE UNIV,DEPT RANGE SCI,LOGAN,UT 84322, USA.			Jackson, Robert/0000-0001-8846-7147				ADAMS WW, 1988, ECOLOGY PHOTOSYNTHES, P123; ALLEN MF, 1989, BIOL FERT SOILS, V8, P285, DOI 10.1007/BF00263155; [Anonymous], 1977, SOLUTE MOVEMENT SOIL; Barber S. A., 1984, SOIL NUTRIENT BIOAVA; BARKWORTH ME, 1985, AM J BOT, V72, P767, DOI 10.2307/2443691; BARTA AL, 1977, PHYSIOL PLANTARUM, V39, P211, DOI 10.1111/j.1399-3054.1977.tb04038.x; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BLOOM AJ, 1988, PLANT PHYSIOL, V87, P794, DOI 10.1104/pp.87.4.794; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CALDWELL MM, 1987, NATURE, V327, P615, DOI 10.1038/327615a0; CAMPBELL BD, 1989, NEW PHYTOL, V112, P261, DOI 10.1111/j.1469-8137.1989.tb02382.x; Chapin F. S. III., 1988, Advances in Plant Nutrition., P161; CHAPIN FS, 1986, OECOLOGIA, V69, P238, DOI 10.1007/BF00377628; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CHAPIN FS, 1976, OIKOS, V26, P111; CLARKSON DT, 1978, PLANTA, V139, P47, DOI 10.1007/BF00390809; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77, DOI 10.1146/annurev.pp.36.060185.000453; CRICK JC, 1987, NEW PHYTOL, V107, P403, DOI 10.1111/j.1469-8137.1987.tb00192.x; DONAHUE RL, 1983, SOILS INTRO SOILS PL, P508; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; GRIME JP, 1986, ECOLOGICAL SIGNIFICA, P5; GRUNDON NJ, 1972, J ECOL, V60, P171, DOI 10.2307/2258049; JACKSON RB, 1989, OECOLOGIA, V81, P149, DOI 10.1007/BF00379798; JEFFREY DW, 1973, J ECOL, V61, P85, DOI 10.2307/2258918; KARLSSON PS, 1985, HOLARCTIC ECOL, V8, P1; LAUCHLI A, 1969, INT J APPL RADIAT IS, V20, P265, DOI 10.1016/0020-708X(69)90054-4; LEE RB, 1982, ANN BOT-LONDON, V50, P429, DOI 10.1093/oxfordjournals.aob.a086383; PASSIOURA JB, 1972, PLANT SOIL, V36, P461, DOI 10.1007/BF01373498; ROBINSON D, 1983, NEW PHYTOL, V94, P263, DOI 10.1111/j.1469-8137.1983.tb04499.x; SILBERBUSH M, 1983, PLANT SOIL, V74, P93, DOI 10.1007/BF02178744; SOUTHARD A, 1978, 31 UT AGR EXP STA RE, V31; TAYLOR RJ, 1976, CAN J BOT, V54, P1094, DOI 10.1139/b76-117; TORQUEBIAU EF, 1988, ECOLOGY PHOTOSYNTHES, P327; WILLIS AJ, 1961, J ECOL, V49, P377, DOI 10.2307/2257270	34	307	350	4	69	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					58	60		10.1038/344058a0	http://dx.doi.org/10.1038/344058a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278027				2022-12-28	WOS:A1990CQ97200059
J	KEVLES, DJ				KEVLES, DJ			REFLECTIONS ON INTELLIGENCE - JONES,RV	NATURE			English	Book Review											KEVLES, DJ (corresponding author), CALTECH,DIV HUMANITIES & SOCIAL SCI,PASADENA,CA 91125, USA.							JONES RV, 1989, REFLECTIONS INTELLIG	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					29	29		10.1038/344029a0	http://dx.doi.org/10.1038/344029a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278017	Bronze			2022-12-28	WOS:A1990CQ97200048
J	Marsan, D; Lengline, O				Marsan, David; Lengline, Olivier			Extending earthquakes' reach through cascading	SCIENCE			English	Article							AFTERSHOCK IDENTIFICATION; SOUTHERN-CALIFORNIA; CLUSTER-ANALYSIS; FORESHOCKS	Earthquakes, whatever their size, can trigger other earthquakes. Mainshocks cause aftershocks to occur, which in turn activate their own local aftershock sequences, resulting in a cascade of triggering that extends the reach of the initial mainshock. A long- lasting difficulty is to determine which earthquakes are connected, either directly or indirectly. Here we show that this causal structure can be found probabilistically, with no a priori model nor parameterization. Large regional earthquakes are found to have a short direct influence in comparison to the overall aftershock sequence duration. Relative to these large mainshocks, small earthquakes collectively have a greater effect on triggering. Hence, cascade triggering is a key component in earthquake interactions.	[Marsan, David; Lengline, Olivier] Univ Savoie, Lab Geophys Interne & Tectonophys, CNRS, F-73376 Le Bourget Du Lac, France	Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Marsan, D (corresponding author), Univ Savoie, Lab Geophys Interne & Tectonophys, CNRS, F-73376 Le Bourget Du Lac, France.	david.marsan@univ-savoie.fr	Marsan, David/E-1351-2011					DAVIS SD, 1991, GEOPHYS J INT, V104, P289, DOI 10.1111/j.1365-246X.1991.tb02512.x; Felzer KR, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000911; Felzer KR, 2004, B SEISMOL SOC AM, V94, P88, DOI 10.1785/0120030069; GARDNER JK, 1974, B SEISMOL SOC AM, V64, P1363; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hainzl S, 2006, B SEISMOL SOC AM, V96, P313, DOI 10.1785/0120050053; Helmstetter A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003286; Helmstetter A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058501; Helmstetter AS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002503; Marsan D, 2005, GEOPHYS J INT, V163, P141, DOI 10.1111/j.1365-246X.2005.02700.x; MOLCHAN GM, 1992, GEOPHYS J INT, V109, P501, DOI 10.1111/j.1365-246X.1992.tb00113.x; Ouillon G, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003311; REASENBERG P, 1985, J GEOPHYS RES-SOLID, V90, P5479, DOI 10.1029/JB090iB07p05479; SCHOLZ CH, 1991, MECH EARTHQUAKES FAU; SHAW BE, 1993, GEOPHYS RES LETT, V20, P907, DOI 10.1029/93GL01058; Shearer P, 2005, B SEISMOL SOC AM, V95, P904, DOI 10.1785/0120040168; Sornette D, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003621; TAJIMA F, 1985, PHYS EARTH PLANET IN, V40, P77, DOI 10.1016/0031-9201(85)90066-4; Zhuang J, 2002, J AM STAT ASSOC, V97, P369, DOI 10.1198/016214502760046925	19	240	243	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1076	1079		10.1126/science.1148783	http://dx.doi.org/10.1126/science.1148783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292339				2022-12-28	WOS:000253311700039
J	Cordier, P; Tournilhac, F; Soulie-Ziakovic, C; Leibler, L				Cordier, Philippe; Tournilhac, Francois; Soulie-Ziakovic, Corinne; Leibler, Ludwik			Self-healing and thermoreversible rubber from supramolecular assembly	NATURE			English	Article							HYDROGEN-BONDING NETWORKS; THERMOPLASTIC ELASTOMERS; POLYMERS; DYNAMICS; POLYBUTADIENE; COPOLYMERS	Rubbers exhibit enormous extensibility up to several hundred per cent, compared with a few per cent for ordinary solids, and have the ability to recover their original shape and dimensions on release of stress(1,2). Rubber elasticity is a property of macromolecules that are either covalently cross- linked(1,2) or connected in a network by physical associations such as small glassy or crystalline domains(3-5), ionic aggregates(6) or multiple hydrogen bonds(7-16). Covalent cross-links or strong physical associations prevent flow and creep. Here we design and synthesize molecules that associate together to form both chains and cross-links via hydrogen bonds. The system shows recoverable extensibility up to several hundred per cent and little creep under load. In striking contrast to conventional cross-linked or thermoreversible rubbers made of macromolecules, these systems, when broken or cut, can be simply repaired by bringing together fractured surfaces to self- heal at room temperature. Repaired samples recuperate their enormous extensibility. The process of breaking and healing can be repeated many times. These materials can be easily processed, re- used and recycled. Their unique self-repairing properties, the simplicity of their synthesis, their availability from renewable resources and the low cost of raw ingredients (fatty acids and urea) bode well for future applications.	[Cordier, Philippe; Tournilhac, Francois; Soulie-Ziakovic, Corinne; Leibler, Ludwik] Ecole Super Phys & Chim Ind Ville Paris, CNRS ESPCI, UMR 7167, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Leibler, L (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS ESPCI, UMR 7167, 10 Rue Vauquelin, F-75005 Paris, France.	ludwik.leibler@espci.fr	Cordier, Philippe/AAS-3134-2020	Cordier, Philippe/0000-0002-6439-9263				AULT WC, 1964, KIRKOTHMER ENCY CHEM, V8, P845; Bosman AW, 2003, MACROMOL SYMP, V201, P143, DOI 10.1002/masy.200351117; Bouteiller L, 2007, ADV POLYM SCI, V207, P79, DOI 10.1007/12_2006_110; CATES ME, 1987, MACROMOLECULES, V20, P2289, DOI 10.1021/ma00175a038; Chino K, 2001, MACROMOLECULES, V34, P9201, DOI 10.1021/ma011253v; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; Cloitre M, 2000, PHYS REV LETT, V85, P4819, DOI 10.1103/PhysRevLett.85.4819; Colby R.H., 2003, POLYM PHYS; Colombani O, 2005, MACROMOLECULES, V38, P1752, DOI 10.1021/ma048006m; DRYE TJ, 1992, J CHEM PHYS, V96, P1367, DOI 10.1063/1.462172; Elkins CL, 2005, J POLYM SCI POL CHEM, V43, P4618, DOI 10.1002/pola.20961; Fakirov S, 2005, HANDBOOK OF CONDENSATION THERMOPLASTIC ELASTOMERS, P1, DOI 10.1002/3527606610; Fouquey C., 1990, ADV MATER, V2, P254; HANDLIN DL, 2007, MACROMOLECULAR ENG, V4, P2001; Holden G., 2004, THERMOPLASTIC ELASTO, V3; Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z; Kolomiets E, 2006, MACROMOLECULES, V39, P1173, DOI 10.1021/ma0523522; Lange RFM, 1999, J POLYM SCI POL CHEM, V37, P3657, DOI 10.1002/(SICI)1099-0518(19991001)37:19<3657::AID-POLA1>3.0.CO;2-6; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Ligthart G.B.W.L, 2007, MACROMOL ENG, V1, P351; MACKNIGHT WJ, 2004, THERMOPLASTIC ELASTO, P261; Muller M, 1996, MACROMOLECULES, V29, P2577, DOI 10.1021/ma950984q; Peng CC, 2005, MACROMOLECULES, V38, P5575, DOI 10.1021/ma050419f; Rubinstein M, 2001, MACROMOLECULES, V34, P1058, DOI 10.1021/ma0013049; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; STADLER R, 1986, COLLOID POLYM SCI, V264, P773, DOI 10.1007/BF01500752; STADLER R, 1993, KAUT GUMMI KUNSTST, V46, P619; STPOURCAIN CB, 1995, MACROMOLECULES, V28, P4116, DOI 10.1021/ma00116a010; Tabor D., 1991, LIQUIDS SOLIDS OTHER; Warner M, 1996, PROG POLYM SCI, V21, P853, DOI 10.1016/S0079-6700(96)00013-5	30	2167	2262	76	2925	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					977	980		10.1038/nature06669	http://dx.doi.org/10.1038/nature06669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288191				2022-12-28	WOS:000253313100045
J	Eddleston, M; Juszczak, E; Buckley, NA; Senarathna, L; Mohamed, F; Dissanayake, W; Hittarage, A; Azher, S; Jeganathan, K; Jayamanne, S; Sheriff, MHR; Warrell, DA				Eddleston, Michael; Juszczak, Edmund; Buckley, Nick A.; Senarathna, Lalith; Mohamed, Fahim; Dissanayake, Wasantha; Hittarage, Ariyasena; Azher, Shifa; Jeganathan, K.; Jayamanne, Shaluka; Sheriff, M. H. Rezvi; Warrell, David A.		Ox-Cal Poisoning Study Collaborato	Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial	LANCET			English	Article							YELLOW OLEANDER; GASTROINTESTINAL DECONTAMINATION; SINGLE	Background The case-fatality for intentional self-poisoning in the rural developing world is 10-50-fold higher than that in industrialised countries, mostly because of the use of highly toxic pesticides and plants. We therefore aimed to assess whether routine treatment with multiple-dose activated charcoal, to interrupt enterovascular or enterohepatic circulations, offers benefit compared with no charcoal in such an environment. Methods We did an open-label, parallel group, randomised, controlled trial of six 50 g doses of activated charcoal at 4-h intervals versus no charcoal versus one 50 g dose of activated charcoal in three Sri Lankan hospitals. 4632 patients were randomised to receive no charcoal (n=1554), one dose of charcoal (n=1545), or six doses of charcoal (n=1533); outcomes were available for 4629 patients. 2338 (51%) individuals had ingested pesticides, whereas 1647 (36%) had ingested yellow oleander (Thevetia peruviana) seeds. Mortality was the primary outcome measure. Analysis was by intention to treat. The trial is registered with controlled-trials.com as ISRCTN02920054. Findings Mortality did not differ between the groups. 97 (6.3%) of 1531 participants in the multiple-dose group died, compared with 105 (6.8%) of 1554 in the no charcoal group (adjusted odds ratio 0.96, 95% CI 0.70-1.33). No differences were noted for patients who took particular poisons, were severely ill on admission, or who presented early. Interpretation We cannot recommend the routine use of multiple-dose activated charcoal in rural Asia Pacific; although further studies of early charcoal administration might be useful, effective affordable treatments are urgently needed.	[Eddleston, Michael; Warrell, David A.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England; [Eddleston, Michael; Senarathna, Lalith; Mohamed, Fahim; Sheriff, M. H. Rezvi] Univ Colombo, Ox Cal Collaborat, Dept Clin Med, Fac Med, Colombo, Sri Lanka; [Juszczak, Edmund] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; [Buckley, Nick A.] Australian Natl Univ, Dept Clin Pharmacol & Toxicol, Canberra, ACT, Australia; [Dissanayake, Wasantha; Hittarage, Ariyasena; Jeganathan, K.] Anuradhapura Gen Hosp, Anuradhapura, Sri Lanka; [Azher, Shifa; Jayamanne, Shaluka] Polonnaruwa Gen Hosp, Polonnaruwa, Sri Lanka	University of Oxford; University of Colombo; University of Oxford; Australian National University	Eddleston, M (corresponding author), New Royal Infirm, Scottish Poisons Informat Bur, 51 Little France, Edinburgh EH16 4SA, Midlothian, Scotland.	eddlestonm@yahoo.com	Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711; Mohamed, Fahim/0000-0003-2849-7269; Senarathna, Lalith/0000-0002-7073-5788	Wellcome Trust [063560, 071669] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Am Acad Clin Toxicol, 2005, CLIN TOXICOL, V43, P61, DOI 10.1081/CLT-200051867; Am Acad Clin Toxicology, 1999, J TOXICOL-CLIN TOXIC, V37, P731; Ardagh M, 2001, NEW ZEAL MED J, V114, P423; Bateman DN, 1999, J ACCID EMERG MED, V16, P84; Bond GR, 2002, ANN EMERG MED, V39, P273, DOI 10.1067/mem.2002.122058; Bradberry SM, 2003, CLIN MED, V3, P107; Buckley NA, 2004, J TOXICOL-CLIN TOXIC, V42, P113, DOI 10.1081/CLT-120028756; de Silva HA, 2003, LANCET, V361, P1935, DOI 10.1016/S0140-6736(03)13581-7; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2003, LANCET, V362, P1041, DOI 10.1016/S0140-6736(03)14415-7; Eddleston M, 1999, TROP MED INT HEALTH, V4, P266, DOI 10.1046/j.1365-3156.1999.00397.x; Eddleston M, 2000, LANCET, V355, P967, DOI 10.1016/S0140-6736(00)90014-X; Eddleston M, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-2; Eddleston M, 2007, CLIN TOXICOL, V45, P136, DOI 10.1080/15563650601006009; GUVEN H, 1994, J TOXICOL-CLIN TOXIC, V32, P157, DOI 10.3109/15563659409000445; Henry JA, 1998, LANCET, V352, P420, DOI 10.1016/S0140-6736(05)79183-2; Kapur N, 2005, QJM-INT J MED, V98, P589, DOI 10.1093/qjmed/hci089; KEYES DC, 2004, MED TOXICOL, P21; Krenzelok E, 1997, J TOXICOL-CLIN TOXIC, V35, P695; Krenzelok E. P., 1997, J TOXICOL-CLIN TOXIC, V35, P699; LEVY G, 1982, NEW ENGL J MED, V307, P676, DOI 10.1056/NEJM198209093071109; Lotti M, 2001, HDB PESTICIDE TOXICO, V2, P1043, DOI DOI 10.1016/B978-012426260-7.50054-9; Mohamed F, 2007, CLIN TOXICOL, V45, P132, DOI 10.1080/15563650600981145; PROUDFOOT AT, 1984, ARCH EMERG MED, V1, P65; Roberts DM, 2006, THER DRUG MONIT, V28, P784, DOI 10.1097/FTD.0b013e31802bfd69; Roberts DM, 2005, ANN EMERG MED, V46, P275, DOI 10.1016/j.annemergmed.2005.03.016; Shannon MW, 1998, CLIN MANAGEMENT POIS, P2; VALE JA, 1993, BRIT MED J, V306, P78, DOI 10.1136/bmj.306.6870.78; Vale JA, 1997, J TOXICOL-CLIN TOXIC, V35, P711; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	31	111	114	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					579	587		10.1016/S0140-6736(08)60270-6	http://dx.doi.org/10.1016/S0140-6736(08)60270-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280328	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000253202600024
J	Eyer, P; Eyer, F				Eyer, Peter; Eyer, Florian			Is this the epitaph for multiple-dose activated charcoal?	LANCET			English	Editorial Material							EXSORPTION; ADSORPTION		[Eyer, Peter] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Eyer, Florian] Tech Univ Munich, Toxicol Dept Med Clin 2, Munich, Germany	University of Munich; Technical University of Munich	Eyer, P (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany.	peter.eyer@lrz.uni-muenchen.de	Eyer, Florian/S-5801-2019; Eyer, Florian/D-2135-2010	Eyer, Florian/0000-0002-4753-2747; 				Am Acad Clin Toxicology, 1999, J TOXICOL-CLIN TOXIC, V37, P731; Bailey DN, 2003, THER DRUG MONIT, V25, P310, DOI 10.1097/00007691-200306000-00011; BISMUTH C, 2005, PARAQUAT POISONING M, P195; de Silva HA, 2003, LANCET, V361, P1935, DOI 10.1016/S0140-6736(03)13581-7; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2008, LANCET, V371, P579, DOI 10.1016/S0140-6736(08)60270-6; Eyer F, 2008, BASIC CLIN PHARMACOL, V102, P337, DOI 10.1111/j.1742-7843.2007.00193.x; Eyer F, 2007, BASIC CLIN PHARMACOL, V101, P163, DOI 10.1111/j.1742-7843.2007.00107.x; KRENZELOK EP, 2005, CRITICAL CARE TOXICO, P61; Malhas AN, 2002, J IMMUNOL METHODS, V264, P37, DOI 10.1016/S0022-1759(02)00087-X; Tomimaru A, 1996, J PHARM PHARMACOL, V48, P351, DOI 10.1111/j.2042-7158.1996.tb05932.x; Wigton A, 2004, ENVIRON SCI TECHNOL, V38, P5825, DOI 10.1021/es049676a	12	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					538	539		10.1016/S0140-6736(08)60248-2	http://dx.doi.org/10.1016/S0140-6736(08)60248-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280313				2022-12-28	WOS:000253202600007
J	Ruel, MT; Menon, P; Habicht, JP; Loechl, C; Bergeron, G; Pelto, G; Arimond, M; Maluccio, J; Michaud, L; Hankebo, B				Ruel, Marie T.; Menon, Purnima; Habicht, Jean-Pierre; Loechl, Cornelia; Bergeron, Gilles; Pelto, Gretel; Arimond, Mary; Maluccio, John; Michaud, Lesly; Hankebo, Bekele			Age-based preventive targeting of food assistance and behaviour change and communication for reduction of childhood undernutrition in Haiti: a cluster randomised trial	LANCET			English	Article							DEVELOPING-COUNTRIES; NUTRITIONAL SUPPLEMENTATION; CHILDREN; GROWTH; MALNUTRITION; IMPACT	Background Food-assisted maternal and child health and nutrition programmes usually target underweight children younger than 5 years of age. Previous evidence suggests that targeting nutrition interventions earlier in life, before children become undernourished, might be more effective for reduction of childhood undernutrition. Methods We used a cluster randomised trial to compare two World Vision programmes for maternal and child health and nutrition, which included a behaviour change and communication component: a preventive model, targeting all children aged 6-23 months; and a recuperative model, targeting underweight (weight-for-age Z score <-2) children aged 6-60 months. Both models also targeted pregnant and lactating women. Clusters of communities (n=20) were paired on access to services and other factors and were randomly assigned to each model. Using two cross-sectional surveys (at baseline and 3 years later), we tested differences in undernutrition in children aged 12-41 months (roughly 1500 children per survey). Analyses were by intention to treat, both by pair-wise community-level comparisons and by child-level analyses adjusting for the clustering effect and child age and sex. This study is registered with ClinicalTrials.gov, number NCT00210418. Findings There were no differences between programme groups at baseline. At follow-up, stunting, underweight, and wasting (using WHO 2006 reference data) were 4-6 percentage points lower in preventive than in recuperative communities; and mean anthropometric indicators were higher by +0 .14 Z scores (height for age; p=0. 07), and +0. 24 Z scores (weight for age and weight for height; p<0. 0001). The effect was greater in children exposed to the preventive programme for the full span between 6 and 23 months of age than in children exposed for shorter durations during this period. The quality of implementation did not differ between the two programmes; nor did use of services for maternal and child health and nutrition. Interpretation The preventive programme was more effective for the reduction of childhood undernutrition than the traditional recuperative model.	[Ruel, Marie T.; Arimond, Mary] Int Food Policy Res Inst, Food Consumpt & Nutr Div, Washington, DC 20006 USA; [Menon, Purnima; Habicht, Jean-Pierre; Pelto, Gretel] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Loechl, Cornelia] Int Potato Ctr, Kampala, Uganda; [Bergeron, Gilles] Acad Educ Dev, Food & Nutr Tech Assistance Project, Washington, DC USA; [Maluccio, John] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Michaud, Lesly; Hankebo, Bekele] World Vis, Port Au Prince, Haiti	CGIAR; International Food Policy Research Institute (IFPRI); Cornell University; CGIAR; International Potato Center (CIP)	Ruel, MT (corresponding author), Int Food Policy Res Inst, Food Consumpt & Nutr Div, Washington, DC 20006 USA.	m.ruel@cgiar.org						BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Gragnolati M, 2005, INDIAS UNDERNOURISHE; Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P53; Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P4; LUTTER CK, 1990, AM J CLIN NUTR, V51, P359, DOI 10.1093/ajcn/51.3.359; MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S; Mason J. B., 2006, COMMUNITY HLTH NUTR; MENON P, 2003, 170 INT FOOD POL RES; *MSPP IHE ORCO MAC, 2007, EMMUS 4 2000 2001; Murray DM, 1998, DESIGN ANAL GROUP RA; *PAHO WHO, 2003, GUID PRINC COMPL FEE; Rivera JA, 1996, AM J PUBLIC HEALTH, V86, P1430, DOI 10.2105/AJPH.86.10.1430; Rivera JA, 2002, B WORLD HEALTH ORGAN, V80, P926; Ruel MT, 2001, NESTLE NUTR WORKS SE, V47, P123; Save the Children, 2003, THIN GROUND QUEST EV; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; SWINDALE A, 2004, IMPACT TITLE 2 MATER; W.H.O, 1983, MEAS CHANG NUTR STAT; Wachs Theodore D., 1999, Food and Nutrition Bulletin, V20, P7; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; *WORLD BANK, 2005, BANG DEV SER WORLD B, V8; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization (WHO), 2006, WHO ANTHR 2005 BET V	27	110	111	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2008	371	9612					588	595		10.1016/S0140-6736(08)60271-8	http://dx.doi.org/10.1016/S0140-6736(08)60271-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280329				2022-12-28	WOS:000253202600025
J	Balch, WE; Morimoto, RI; Dillin, A; Kelly, JW				Balch, William E.; Morimoto, Richard I.; Dillin, Andrew; Kelly, Jeffery W.			Adapting proteostasis for disease intervention	SCIENCE			English	Review							RESTRICTION-INDUCED LONGEVITY; UNFOLDED PROTEIN RESPONSE; HEAT-SHOCK RESPONSE; ENDOPLASMIC-RETICULUM; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; ER STRESS; C-ELEGANS; TOXICITY	The protein components of eukaryotic cells face acute and chronic challenges to their integrity. Eukaryotic protein homeostasis, or proteostasis, enables healthy cell and organismal development and aging and protects against disease. Here, we describe the proteostasis network, a set of interacting activities that maintain the health of proteome and the organism. Deficiencies in proteostasis lead to many metabolic, oncological, neurodegenerative, and cardiovascular disorders. Small- molecule or biological proteostasis regulators that manipulate the concentration, conformation, quaternary structure, and/ or the location of protein( s) have the potential to ameliorate some of the most challenging diseases of our era.	[Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA; [Dillin, Andrew] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Northwestern University; Salk Institute	Kelly, JW (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu	Longo, Kenneth A/A-5631-2010		NIA NIH HHS [AG026647, AG 18917, AG04342] Funding Source: Medline; NIDDK NIH HHS [DK75295, DK46336] Funding Source: Medline; NIGMS NIH HHS [R37 GM038109, GM38109] Funding Source: Medline; NINDS NIH HHS [NS50636] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038109, R37GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342, R01AG026647, R01AG018917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Derham BK, 1997, BIOCHEM J, V328, P763; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD; Massey AC, 2006, CELL CYCLE, V5, P1292, DOI 10.4161/cc.5.12.2865; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Namba Y, 1991, No To Shinkei, V43, P57; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang Yun-Chi, 2007, Cell, V128, P412; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101	39	1673	1715	10	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					916	919		10.1126/science.1141448	http://dx.doi.org/10.1126/science.1141448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276881				2022-12-28	WOS:000253165700035
J	Naeem, S				Naeem, Shahid			Ecology - Green with complexity	SCIENCE			English	Editorial Material							ECOSYSTEM FUNCTION; BIODIVERSITY		Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	Columbia University	Naeem, S (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	sn2121@columbia.edu						Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HAIRSTON NGS, 1960, AM NAT, V106, P421; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; RUSSELLSMITH A, 1994, J TROP ECOL, V10, P545, DOI 10.1017/S0266467400008221; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	13	7	9	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					913	914		10.1126/science.1154770	http://dx.doi.org/10.1126/science.1154770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276879				2022-12-28	WOS:000253165700033
J	Wald, HS				Wald, Hedy S.			In the here and now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hedy_wald@brown.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					613	614		10.1001/jama.299.6.613	http://dx.doi.org/10.1001/jama.299.6.613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270345				2022-12-28	WOS:000253095200001
J	Ash, C; Jasny, BR; Roberts, L; Stone, R; Sugden, A				Ash, Caroline; Jasny, Barbara R.; Roberts, Leslie; Stone, Richard; Sugden, Andrewm.			Reimagining cities - Introduction	SCIENCE			English	Editorial Material																			0	56	57	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					739	739		10.1126/science.319.5864.739	http://dx.doi.org/10.1126/science.319.5864.739			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258888				2022-12-28	WOS:000252963000031
J	Middaugh, JP				Middaugh, John P.			Pandemic influenza preparedness and community resiliency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTIONS		[Middaugh, John P.] Florida Dept Hlth, Tallahassee, FL 32399 USA	Florida Department of Health	Middaugh, JP (corresponding author), Florida Dept Hlth, 4052 Bald Cypress Way,Bin A07, Tallahassee, FL 32399 USA.	john_middaugh@doh.state.fl.us						*AM AC PED, 2003, RED BOOK REP COMM IN; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; BENENSON AS, 1980, CONTROL COMMUNICABLE; BLENDON RJ, 2006, FOR MICR THREATS SEP; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; *CDCP, 2006, INFL PAND OP PLAN OP; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; *COMM MOD CONT PAN, 2006, MOD COMM CONT PAND I; CROSBY AW, 1989, AM FORGOTTEN PANDEMI, P115; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Heymann DL, 2004, CONTROL COMMUNICABLE, V18th; Inglesby TV, 2006, BIOSECUR BIOTERROR, V4, P366, DOI 10.1089/bsp.2006.4.366; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; NOWAK G, 2005, THREAT PANDEMIC INFL; Reissman DB, 2006, J HOMEL SECUR EMERG, V3	18	9	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					566	568		10.1001/jama.299.5.566	http://dx.doi.org/10.1001/jama.299.5.566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252886				2022-12-28	WOS:000252886100022
J	Nygren, P; Fu, R; Freeman, M; Bougatsos, C; Klebanoff, M; Guise, JM				Nygren, Peggy; Fu, Rongwei; Freeman, Michele; Bougatsos, Christina; Klebanoff, Mark; Guise, Jeanne-Marie			Evidence on the benefits and harms of screening and treating pregnant women who are asymptornatic for bacterial vaginosis: An update review for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; LOW-BIRTH-WEIGHT; PRETERM BIRTH; INTRAVAGINAL CLINDAMYCIN; ANTIBIOTIC-TREATMENT; VAGINAL CLINDAMYCIN; RISK-FACTORS; DELIVERY; INFECTIONS; METRONIDAZOLE	Background: Bacterial vaginosis is the most common lower genital tract syndrome among women of reproductive age. There has been continued debate about the value of screening and treating asymptomatic pregnant women for bacterial vaginosis. Purpose: To examine new evidence on the benefits and harms of screening and treating bacterial vaginosis in asymptomatic pregnant women. Data Sources: English-language studies on Ovid MEDLINE (2000 to September 2007) and Cochrane Library databases (through September 2007), reference lists, and expert suggestions. Study Selection: Screening, treatment, or adverse effect studies with pregnancy outcome data in women who are asymptomatic for bacterial vaginosis. Data Extraction: Study and patient characteristics, treatment variables, adverse pregnancy outcomes, and internal validity quality criteria from the U.S. Preventive Services Task Force (USPSTF) and Jadad scale were abstracted. Data Synthesis: 7 new randomized, controlled treatment trials and 2001 report data were combined in a series of meta-analyses to estimate the pooled effect of treatment on preterm delivery (<37, <34, and <32 weeks); low birthweight; and preterm, premature rupture of membranes. Limitations: No screening studies that compared a screened population with a nonscreened population were found. Significant heterogeneity was found among the high-risk treatment trials (P < 0.001). It is not clear from the detailed description of the studies which factors explain the differences in preterm delivery rates and potentially the association of treatment effect; however, both raise concern for the unintended potential for harm. Conclusion: No benefit was found in treating women with low- or average-risk pregnancies for asymptomatic bacterial vaginosis. More research is needed to better understand these groups and the conditions under which treatment can be harmful or helpful, and to explore the relevance of bacterial vaginosis to other adverse pregnancy outcomes, such as delivery before 34 weeks.	[Nygren, Peggy] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; US Dept HHS, Bethesda, MD USA	Oregon Health & Science University	Nygren, P (corresponding author), Oregon Hlth & Sci Univ, Mail Code B1CC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nygrenp@ohsu.edu		Guise, Jeanne-Marie/0000-0002-8961-488X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002535, ZIAHD002535] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Azargoon Azam, 2006, Arch Iran Med, V9, P213; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; CAREY JC, 1993, CLIN OBSTET GYNECOL, V36, P809, DOI 10.1097/00003081-199312000-00005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; French JI, 2006, AM J OBSTET GYNECOL, V194, P1717, DOI 10.1016/j.ajog.2006.03.004; Goldenberg R L, 1996, Am J Obstet Gynecol, V174, P1618; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013; GRAVETT MG, 1986, JAMA-J AM MED ASSOC, V256, P1899; Guaschino S, 2003, EUR J OBSTET GYN R B, V110, P149, DOI 10.1016/S0301-2115(03)00107-6; Guerra B, 2006, EUR J OBSTET GYN R B, V128, P40, DOI 10.1016/j.ejogrb.2005.12.024; Guise JM, 2001, AM J PREV MED, V20, P62, DOI 10.1016/S0749-3797(01)00256-2; GUISE JM, 2001, PUBLICATION AGENCY H; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x; HEYBORNE KD, 1994, AM J OBSTET GYNECOL, V171, P55, DOI 10.1016/S0002-9378(94)70077-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hoyert DL, 2006, PEDIATRICS, V117, P168, DOI 10.1542/peds.2005-2587; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOESOEF MR, 1995, AM J OBSTET GYNECOL, V173, P1527, DOI 10.1016/0002-9378(95)90644-4; Kekki M, 2001, OBSTET GYNECOL, V97, P643, DOI 10.1016/S0029-7844(01)01321-7; Kigozi GG, 2003, AM J OBSTET GYNECOL, V189, P1398, DOI 10.1067/S0002-9378(03)00777-4; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017; Klebanoff MA, 2004, AM J OBSTET GYNECOL, V190, P363, DOI 10.1016/j.ajog.2003.08.020; Klebanoff MA, 2007, AM J OBSTET GYNECOL, V197, p10A, DOI 10.1016/j.ajog.2007.02.030; Koumans EH, 2002, CLIN INFECT DIS, V35, pS152, DOI 10.1086/342103; KURKI T, 1992, OBSTET GYNECOL, V80, P173; Kurkinen-Raty M, 2000, BRIT J OBSTET GYNAEC, V107, P1427, DOI 10.1111/j.1471-0528.2000.tb11660.x; Lamont RF, 2003, OBSTET GYNECOL, V101, P516, DOI 10.1016/S0029-7844(02)03054-5; Larsson PG, 2006, BJOG-INT J OBSTET GY, V113, P629, DOI 10.1111/j.1471-0528.2006.00946.x; Leitich H, 2003, AM J OBSTET GYNECOL, V188, P752, DOI 10.1067/mob.2003.167; McDonald HM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub3; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2; MINKOFF H, 1984, AM J OBSTET GYNECOL, V150, P965, DOI 10.1016/0002-9378(84)90392-2; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; NYGREN P, 2007, SCREENING TREATMENT; Odendaal HJ, 2002, SAMJ S AFR MED J, V92, P231; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; Pastore LM, 1999, OBSTET GYNECOL, V93, P117, DOI 10.1016/S0029-7844(98)00336-6; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Riggs MA, 2004, CLIN OBSTET GYNECOL, V47, P796, DOI 10.1097/01.grf.0000141450.61310.81; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Tebes Christine C, 2003, Infect Dis Obstet Gynecol, V11, P123, DOI 10.1080/10647440300025509; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thinkhamrop J., 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002250; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tolosa JE, 2006, AM J OBSTET GYNECOL, V195, P1198, DOI 10.1016/j.ajog.2006.08.016; US Preventive Services Task Force, 2008, ANN INTERN MED, V148, P214, DOI 10.7326/0003-4819-148-3-200802050-00007; Varma R, 2006, EUR J OBSTET GYN R B, V124, P10, DOI 10.1016/j.ejogrb.2005.07.015; Vermeulen GM, 1999, BRIT J OBSTET GYNAEC, V106, P652, DOI 10.1111/j.1471-0528.1999.tb08363.x; Yudin MH, 2005, CLIN PERINATOL, V32, P617, DOI 10.1016/j.clp.2005.05.007	62	60	69	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					220	233		10.7326/0003-4819-148-3-200802050-00008	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18252684				2022-12-28	WOS:000252849700006
J	Degos, L; Romaneix, F; Michel, P; Bacou, J				Degos, Laurent; Romaneix, Francois; Michel, Philippe; Bacou, Jean			Can France keep its patients happy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Degos, Laurent; Romaneix, Francois; Michel, Philippe; Bacou, Jean] Natl Author Hlth, F-93218 Paris, France		Bacou, J (corresponding author), Natl Author Hlth, F-93218 Paris, France.	j.bacou@has-sante.fr	michel, philippe/J-9443-2017	michel, philippe/0000-0001-8455-8332				ALLONIER C, 2006, QUEST EC SANTE, P105; Dourgnon P, 2007, QUEST ECO SANTE, P124; *EUR ANT RES SURV, ANN REP 2005; *EUR COMM, 2006, MED ERR SPEC EUR 241; *EUR COMM, 2007, EUR 67 1 RES; *EUR COMM EUR, 2005, HLTH EUR; FENINA A, 2005, ETUDES RESULTATS; GIROUD M, 2007, SAMU SYSTEM EMERGENC; Gosden T, 1999, QJM-MON J ASSOC PHYS, V92, P47, DOI 10.1093/qjmed/92.1.47; *HAUT COM SANT PUB, 2003, HLTH FRANC 2002; Hergon E, 2005, TRANSFUS MED REV, V19, P273, DOI 10.1016/j.tmrv.2005.04.004; *IPSOS, RAPP FRANC EUR ORD M; Michel P, 2007, QUAL SAF HEALTH CARE, V16, P369, DOI 10.1136/qshc.2005.016964; *OFF NAT IND ACC M, 2007, RAPP ACT 2 SEM 2006; *ORG EC COOP DEV, 2006, HLTH DAT 2006; PETINICOLAS C, 2006, FIGARO          0712; PISON G, 2006, POPUL SOC, P421; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Sardon JP, 2006, POPULATION, V61, P301, DOI 10.3917/popu.603.0301; SPURGEON B, 2007, BRIT MED J, V335, P1128; VASSELLE A, PROJET FINANCEMENT S; Williams A, 2001, HEALTH ECON, V10, P93, DOI 10.1002/hec.594; World Health Organization, WORLD HLTH REP 2000; 2004, COUNTRIES EUROPEANS	24	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					254	257		10.1136/bmj.39451.406123.AD	http://dx.doi.org/10.1136/bmj.39451.406123.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18244998	Green Published			2022-12-28	WOS:000253102900037
J	Lobell, DB; Burke, MB; Tebaldi, C; Mastrandrea, MD; Falcon, WP; Naylor, RL				Lobell, David B.; Burke, Marshall B.; Tebaldi, Claudia; Mastrandrea, Michael D.; Falcon, Walter P.; Naylor, Rosamond L.			Prioritizing climate change adaptation needs for food security in 2030	SCIENCE			English	Article								Investments aimed at improving agricultural adaptation to climate change inevitably favor some crops and regions over others. An analysis of climate risks for crops in 12 food- insecure regions was conducted to identify adaptation priorities, based on statistical crop models and climate projections for 2030 from 20 general circulation models. Results indicate South Asia and Southern Africa as two regions that, without sufficient adaptation measures, will likely suffer negative impacts on several crops that are important to large food- insecure human populations. We also find that uncertainties vary widely by crop, and therefore priorities will depend on the risk attitudes of investment institutions.	[Lobell, David B.; Burke, Marshall B.; Mastrandrea, Michael D.; Falcon, Walter P.; Naylor, Rosamond L.] Stanford Univ, Woods Inst Environm, Food Secur & Environm Program, Stanford, CA 94305 USA; [Lobell, David B.; Burke, Marshall B.; Falcon, Walter P.; Naylor, Rosamond L.] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Lobell, David B.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Tebaldi, Claudia] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Center Atmospheric Research (NCAR) - USA	Lobell, DB (corresponding author), Stanford Univ, Woods Inst Environm, Food Secur & Environm Program, Stanford, CA 94305 USA.	dlobell@stanford.edu	tebaldi, claudia/E-3089-2013; Zhong, Hong Lin/C-2633-2012	tebaldi, claudia/0000-0001-9233-8903; Burke, Marshall/0000-0003-4288-5858; Lobell, David/0000-0002-5969-3476				Alston J. M., 2000, META ANAL RATES RETU; Burton I, 2004, LOOK YOU LEAP RISK M; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Smit B, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P877	7	1706	1768	27	949	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					607	610		10.1126/science.1152339	http://dx.doi.org/10.1126/science.1152339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239122				2022-12-28	WOS:000252772000037
J	Schlabach, MR; Luo, J; Solimini, NL; Hu, G; Xu, QK; Li, MZ; Zhao, ZM; Smogorzewska, A; Sowa, ME; Ang, XLL; Westbrook, TF; Liang, AC; Chang, K; Hackett, JA; Harper, JW; Hannon, GJ; Elledge, SJ				Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Sowa, Mathew E.; Ang, Xiaolu L.; Westbrook, Thomas F.; Liang, Anthony C.; Chang, Kenneth; Hackett, Jennifer A.; Harper, J. Wade; Hannon, Gregory J.; Elledge, Stephen J.			Cancer proliferation gene discovery through functional Genomics	SCIENCE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; P53 PATHWAY; SCREEN; PHOSPHATASE; CELLS; MDM2	Retroviral short hairpin RNA (shRNA) - mediated genetic screens in mammalian cells are powerful tools for discovering loss- of- function phenotypes. We describe a highly parallel multiplex methodology for screening large pools of shRNAs using half- hairpin barcodes for microarray deconvolution. We carried out dropout screens for shRNAs that affect cell proliferation and viability in cancer cells and normal cells. We identified many shRNAs to be antiproliferative that target core cellular processes, such as the cell cycle and protein translation, in all cells examined. Moreover, we identified genes that are selectively required for proliferation and survival in different cell lines. Our platform enables rapid and cost- effective genome-wide screens to identify cancer proliferation and survival genes for target discovery. Such efforts are complementary to the Cancer Genome Atlas and provide an alternative functional view of cancer cells.	[Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Westbrook, Thomas F.; Liang, Anthony C.; Hackett, Jennifer A.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Westbrook, Thomas F.; Liang, Anthony C.; Hackett, Jennifer A.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Genet & Genom,Dept Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sowa, Mathew E.; Ang, Xiaolu L.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chang, Kenneth; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Luo, Ji/G-5693-2017; Hu, Guang/E-7474-2016; Hannon, Gregory/AAB-3568-2019; Cambronne, Xiaolu Ang/GRY-7149-2022; Smogorzewska, Agata/B-8891-2011	Luo, Ji/0000-0001-5063-1626; Hu, Guang/0000-0003-0437-4723; Cambronne, Xiaolu Ang/0000-0002-3547-448X; Harper, Jeffrey/0000-0002-6944-7236; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [P01CA013106, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-36, P01 CA013106, T32CA09216, T32 CA009216, P01 CA013106-37] Funding Source: Medline; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	18	298	312	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					620	624		10.1126/science.1149200	http://dx.doi.org/10.1126/science.1149200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239126	Green Accepted			2022-12-28	WOS:000252772000041
J	Boyle, AP; Davis, S; Shulha, HP; Meltzer, P; Margulies, EH; Weng, Z; Furey, TS; Crawford, GE				Boyle, Alan P.; Davis, Sean; Shulha, Hennady P.; Meltzer, Paul; Margulies, Elliott H.; Weng, Zhiping; Furey, Terrence S.; Crawford, Gregory E.			High-resolution mapping and characterization of open chromatin across the genome	CELL			English	Article							I HYPERSENSITIVE SITES; DNASE-I; REGULATORY ELEMENTS; PROTEIN CTCF; 5 ENDS; GENE; TRANSCRIPTION; SENSITIVITY; ENHANCER; REGION	Mapping DNase I hypersensitive (HS) sites is an accurate method of identifying the location of genetic regulatory elements, including promoters, enhancers, silencers, insulators, and locus control regions. We employed high-throughput sequencing and whole-genome tiled array strategies to identify DNase I HS sites within human primary CD4(+) T cells. Combining these two technologies, we have created a comprehensive and accurate genome-wide open chromatin map. Surprisingly, only 16%-21% of the identified 94,925 DNase I HS sites are found in promoters or first exons of known genes, but nearly half of the most open sites are in these regions. In conjunction with expression, motif, and chromatin immunoprecipitation data, we find evidence of cell-type-specific characteristics, including the ability to identify transcription start sites and locations of different chromatin marks utilized in these cells. In addition, and unexpectedly, our analyses have uncovered detailed features of nucleosome structure.	[Boyle, Alan P.; Furey, Terrence S.; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Shulha, Hennady P.; Weng, Zhiping] Boston Univ, Dept Biomed Engn, Boston, MA 02115 USA; [Davis, Sean; Meltzer, Paul] NCI, Natl Inst Hlth, Ctr Canc Res, Bethesda, MD 20892 USA; [Margulies, Elliott H.] NHGRI, Natl Inst Hlth, Bethesda, MD 20892 USA	Duke University; Boston University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Crawford, GE (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	terry.furey@duke.edu; greg.crawford@duke.edu	Davis, Sean/AAD-1801-2021; Boyle, Alan/I-1848-2014	Davis, Sean/0000-0002-8991-6458; Boyle, Alan/0000-0002-2081-1105; Furey, Terry/0000-0001-5546-9672	NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200341, K22HG003169] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [HG003169, K22 HG003169-03, K22 HG003169] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; Cousins DJ, 2004, J MOL BIOL, V335, P1199, DOI 10.1016/j.jmb.2003.11.052; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; KEENE MA, 1981, P NATL ACAD SCI-BIOL, V78, P143, DOI 10.1073/pnas.78.1.143; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; MCGHEE JD, 1981, CELL, V27, P45, DOI 10.1016/0092-8674(81)90359-7; Meraro D, 1999, J IMMUNOL, V163, P6468; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; SOLLNERWEBB B, 1978, CELL, V14, P611, DOI 10.1016/0092-8674(78)90246-5; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	42	890	933	4	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					311	322		10.1016/j.cell.2007.12.014	http://dx.doi.org/10.1016/j.cell.2007.12.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243105	Bronze, Green Accepted			2022-12-28	WOS:000253427700016
J	Beral, V; Doll, R; Hermon, C; Peto, R; Reeves, G; Brinton, L; Green, AC; Marchbanks, P; Negri, E; Ness, R; Peeters, P; Vessey, M; Calle, EE; Rodriguez, C; Dal Maso, L; Talamini, R; Cramer, D; Hankinson, SE; Tworoger, SS; Chetrit, A; Hirsh-Yechezkel, G; Lubin, F; Sadetzki, S; Appleby, P; Banks, E; de Gonzalez, AB; Bull, D; Crossley, B; Goodill, A; Green, I; Green, J; Key, T; Collins, R; Gonzalez, CA; Lee, N; Ory, HW; Peterson, HB; Wingo, PA; Martin, N; Pardthaisong, T; Silpisornkosol, S; Theetranont, C; Boosiri, B; Chutivongse, S; Jimakorn, P; Virutamasen, P; Wongsrichanalai, C; Titus-Ernstoff, L; Mosgaard, BJ; Yeates, D; Chang-Claude, J; Rossing, MA; Thomas, D; Weiss, N; Franceschi, S; La Vecchia, C; Adami, HO; Magnusson, C; Riman, T; Weiderpass, E; Wolk, A; Brinton, LA; Freedman, DM; Hartge, P; Lacey, JM; Hoover, R; Schouten, LJ; van den Brandt, PA; Chantarakul, N; Koetsawang, S; Rachawat, D; Graff-Iversen, S; Selmer, R; Bain, CJ; Green, AC; Purdie, DM; Siskind, V; Webb, PM; McCann, SE; Hannaford, P; Kay, C; Binns, CW; Lee, AH; Zhang, M; Nasca, P; Coogan, PF; Kelsey, J; Paffenbarger, R; Whittemore, A; Katsouyanni, K; Trichopoulou, A; Trichopoulos, D; Tzonou, A; Dabancens, A; Martinez, L; Molina, R; Salas, O; Goodman, MT; Laurie, G; Carney, ME; Wilkens, LR; Bladstrom, A; Olsson, H; Ness, RB; Grisso, JA; Morgan, M; Wheeler, JE; Peeters, P; Casagrande, J; Pike, MC; Ross, RK; Wu, AH; Kumle, M; Lund, E; McGowan, L; Shu, XO; Zheng, W; Farley, TMM; Holck, S; Meirik, O; Risch, HA				Beral, V.; Doll, R.; Hermon, C.; Peto, R.; Reeves, G.; Brinton, L.; Green, A. C.; Marchbanks, P.; Negri, E.; Ness, R.; Peeters, P.; Vessey, M.; Calle, E. E.; Rodriguez, C.; Dal Maso, L.; Talamini, R.; Cramer, D.; Hankinson, S. E.; Tworoger, S. S.; Chetrit, A.; Hirsh-Yechezkel, G.; Lubin, F.; Sadetzki, S.; Appleby, P.; Banks, E.; de Gonzalez, A. Berrington; Bull, D.; Crossley, B.; Goodil, A.; Green, I.; Green, J.; Key, T.; Collins, R.; Gonzalez, C. A.; Lee, N.; Ory, H. W.; Peterson, H. B.; Wingo, P. A.; Martin, N.; Pardthaisong, T.; Silpisornkosol, S.; Theetranont, C.; Boosiri, B.; Chutivongse, S.; Jimakorn, P.; Virutamasen, P.; Wongsrichanalai, C.; Titus-Ernstoff, L.; Mosgaard, M. J.; Yeates, D.; Chang-Claude, J.; Rossing, M. A.; Thomas, D.; Weiss, N.; Franceschi, S.; La Vecchia, C.; Adami, H. O.; Magnusson, C.; Riman, T.; Weiderpass, E.; Wolk, A.; Brinton, L. A.; Freedman, D. M.; Hartge, P.; Lacey, J. M.; Hoover, R.; Schouten, L. J.; van den Brandt, P. A.; Chantarakul, N.; Koetsawang, S.; Rachawat, D.; Graff-Iversen, S.; Selmer, R.; Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.; McCann, S. E.; Hannaford, P.; Kay, C.; Binns, C. W.; Lee, A. H.; Zhang, M.; Nasca, P.; Coogan, P. F.; Kelsey, J.; Paffenbarger, R.; Whittemore, A.; Katsouyanni, K.; Trichopoulou, A.; Trichopoulos, D.; Tzonou, A.; Dabancens, A.; Martinez, L.; Molina, R.; Salas, O.; Goodman, M. T.; Laurie, G.; Carney, M. E.; Wilkens, L. R.; Bladstrom, A.; Olsson, H.; Ness, R. B.; Grisso, J. A.; Morgan, M.; Wheeler, J. E.; Peeters, P.; Casagrande, J.; Pike, M. C.; Ross, R. K.; Wu, A. H.; Kumle, M.; Lund, E.; McGowan, L.; Shu, X. O.; Zheng, W.; Farley, T. M. M.; Holck, S.; Meirik, O.; Risch, H. A.		Collaborative Grp Epidemiological	Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; HORMONE REPLACEMENT THERAPY; RISK-FACTORS; PHYSICAL-ACTIVITY; DIETARY-INTAKE; LIFE-STYLE; COHORT; INFERTILITY; CARCINOMA; DESIGN	Background Oral contraceptives were introduced almost 50 years ago, and over 100 million women currently use them. Oral contraceptives can reduce the risk of ovarian cancer, but the eventual public-health effects of this reduction will depend on how long the protection lasts after use ceases. We aimed to assess these effects. Methods Individual data for 23 257 women with ovarian cancer (cases) and 87 303 without ovarian cancer (controls) from 45 epidemiological studies in 21 countries were checked and analysed centrally. The relative risk of ovarian cancer in relation to oral contraceptive use was estimated, stratifying by study, age, parity, and hysterectomy. Findings Overall 7308 (31%) cases and 32 717 (37%) controls had ever used oral contraceptives, for average durations among users of 4 . 4 and 5 . 0 years, respectively. The median year of cancer diagnosis was 1993, when cases were aged an average of 56 years. The longer that women had used oral contraceptives, the greater the reduction in ovarian cancer risk (p<0. 0001). This reduction in risk persisted for more than 30 years after oral contraceptive use had ceased but became somewhat attenuated over time the proportional risk reductions per 5 years of use were 29% (95% CI 23-34%) for use that had ceased less than 10 years previously, 19% (14-24%) for use that had ceased 10-19 years previously, and 15% (9-21%) for use that had ceased 20-29 years previously. Use during the 1960s, 1970s, and 1980s was associated with similar proportional risk reductions, although typical oestrogen doses in the 1960s were more than double those in the 1980s. The incidence of mucinous tumours (12% of the total) seemed little affected by oral contraceptives, but otherwise the proportional risk reduction did not vary much between different histological types. In high-income countries, 10 years use of oral contraceptives was estimated to reduce ovarian cancer incidence before age 75 from 1 . 2 to 0 . 8 per 100 users and mortality from 0 . 7 to 0 . 5 per 100; for every 5000 woman-years of use, about two ovarian cancers and one death from the disease before age 75 are prevented. Interpretation Use of oral contraceptives confers long-term protection against ovarian cancer. These findings suggest that oral contraceptives have already prevented some 200000 ovarian cancers and 100000 deaths from the disease, and that over the next few decades the number of cancers prevented will rise to at least 30 000 per year.	[Beral, V.; Appleby, P.] Canc Res UK Epidemiol Unit, Oxford OX3 7LF, England; Amer Canc Soc, Atlanta, GA USA; [Calle, E. E.; Rodriguez, C.] Aviano Canc Ctr, Pordenone, Italy; [Chetrit, A.; Hirsh-Yechezkel, G.; Lubin, F.; Sadetzki, S.] Canc Epidemiol Unit, Oxford, England; [Beral, V.; Hermon, C.; Appleby, P.; Banks, E.; de Gonzalez, A. Berrington; Bull, D.; Crossley, B.; Goodil, A.; Green, I.; Green, J.; Key, T.] Canc Res UK MRC BHF, Clin Trial Serv Unit, Oxford, England; [Beral, V.; Hermon, C.; Appleby, P.; Banks, E.; de Gonzalez, A. Berrington; Bull, D.; Crossley, B.; Goodil, A.; Green, I.; Green, J.; Key, T.] Canc Res UK MRC BHF, Epidemiol Studies Unit, Oxford, England; [Doll, R.; Peto, R.; Collins, R.] Catalan Inst Oncol, Barcelona, Spain; Ctr Dis Control & Prevent, Atlanta, GA USA; Chiang Mai Univ, Chiang Mai, Thailand; Chulalongkorn Univ, Bangkok, Thailand; Dept Publ Hlth, Oxford, England; Deutsches Krebforschungszentrum, Heidelberg, Germany; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; Int Agcy Res Canc, Lyon, France; Univ Milan, Ist Mario Negri, I-20122 Milan, Italy; Karolinska Inst, Stockholm, Sweden; Maastricht Univ, Maastricht, Netherlands; Mahidol Univ, Bangkok, Thailand; Norwegian Inst Publ Hlth, Oslo, Norway; Univ Queensland, St Lucia, Qld 4067, Australia; Rosewell Pk Canc Inst, New York, NY USA; Curtin Univ Technol, Sch Publ Hlth, Perth, WA, Australia; Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; Stanford Univ, Stanford, CA 94305 USA; Univ Athens, Sch Med, Athens, Greece; Univ Chile, Santiago, Chile; Univ Hawaii, Honolulu, HI 96822 USA; Univ Hosp Lund, Lund, Sweden; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Utrecht, Med Ctr, Utrecht, Netherlands; Univ Tromso, N-9001 Tromso, Norway; WHO, UNDP UNFPA, World Bank Special Programme Res Dev & Res Trainin, Geneva, Switzerland	Cancer Research UK; American Cancer Society; University of Oxford; Cancer Research UK; University of Oxford; Cancer Research UK; University of Oxford; Catalan Institute of Oncology; Centers for Disease Control & Prevention - USA; Chiang Mai University; Chulalongkorn University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; Karolinska Institutet; Maastricht University; Mahidol University; Norwegian Institute of Public Health (NIPH); University of Queensland; Curtin University; University of Massachusetts System; University of Massachusetts Amherst; Boston University; Stanford University; Athens Medical School; National & Kapodistrian University of Athens; Universidad de Chile; University of Hawaii System; Lund University; Skane University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Utrecht University; UiT The Arctic University of Tromso; The World Bank; United Nations Population Fund; World Health Organization	Appleby, P (corresponding author), Canc Res UK Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	collaborations@ceu.ox.ac.uk	Weiderpass, Elisabete/M-4029-2016; Negri, Eva/B-7244-2013; Green, Adele C/B-5324-2011; Negri, Eva Vanna Lorenza/AAC-5698-2019; Webb, Penelope/D-5736-2013; de gonzalez, amy berrington/L-7017-2017; franceschi, silvia/M-2452-2014; Brinton, Louise A/G-7486-2015; Binns, Colin W/A-6012-2008; Schouten, Leo J/G-3713-2012; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Schouten, Leo J/AAB-2275-2019; dal maso, luigino/J-3616-2018; Grisso, Jeane Ann/C-2027-2012; Katsouyanni, Klea/D-4856-2014; Weiderpass, Elisabete/AAP-2747-2021	Weiderpass, Elisabete/0000-0003-2237-0128; Negri, Eva/0000-0001-9712-8526; Negri, Eva Vanna Lorenza/0000-0001-9712-8526; Webb, Penelope/0000-0003-0733-5930; de gonzalez, amy berrington/0000-0002-7332-8387; franceschi, silvia/0000-0003-4181-8071; Brinton, Louise A/0000-0003-3853-8562; Binns, Colin W/0000-0002-6220-3933; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Schouten, Leo J/0000-0003-3361-7560; dal maso, luigino/0000-0001-6163-200X; Katsouyanni, Klea/0000-0002-0132-9575; Weiderpass, Elisabete/0000-0003-2237-0128; Banks, Emily/0000-0002-4617-1302; Tworoger, Shelley/0000-0002-6986-7046; van den Brandt, Piet/0000-0001-8781-8099; Coogan, Patricia/0000-0003-3671-7663; La Vecchia, Carlo/0000-0003-1441-897X; Olsson, Hakan/0000-0002-8794-9635; Lund, Eiliv/0000-0002-8071-8711; Magnusson, Cecilia/0000-0002-8567-6725	MRC [G0700474] Funding Source: UKRI; Medical Research Council [G0700474] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP010152] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agudo A, 1999, EUR J CLIN NUTR, V53, P174, DOI 10.1038/sj.ejcn.1600694; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Bongaarts J, 2002, STUD FAMILY PLANN, V33, P24, DOI 10.1111/j.1728-4465.2002.00024.x; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; Calle EE, 1996, CONTRACEPTION, V54, pS1; *CANC STER HORM ST, 1987, NEW ENGL J MED, V316, P650, DOI DOI 10.1056/NEJM198703123161102; CASAGRANDE JT, 1979, LANCET, V2, P170; CHEN Y, 1992, INT J EPIDEMIOL, V21, P23, DOI 10.1093/ije/21.1.23; Chiaffarino F, 2001, ANN ONCOL, V12, P337, DOI 10.1023/A:1011128408146; COULTER A, 1986, CONTRACEPTION, V33, P127, DOI 10.1016/0010-7824(86)90079-X; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; Cramer DW, 2000, CANCER EPIDEM BIOMAR, V9, P95; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Doody MM, 2006, CANCER-AM CANCER SOC, V106, P2707, DOI 10.1002/cncr.21876; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Goodman MT, 2002, AM J EPIDEMIOL, V156, P148, DOI 10.1093/aje/kwf022; HANKINSON SE, 1995, CANCER, V76, P284, DOI 10.1002/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5; Hannan LM, 2004, CANCER EPIDEM BIOMAR, V13, P765; HARTGE P, 1989, AM J OBSTET GYNECOL, V161, P10, DOI 10.1016/0002-9378(89)90221-4; HILDRETH NG, 1981, AM J EPIDEMIOL, V114, P398, DOI 10.1093/oxfordjournals.aje.a113207; KOCH M, 1988, CANCER DETECT PREV, V13, P131; Kumle M, 2004, BRIT J CANCER, V90, P1386, DOI 10.1038/sj.bjc.6601715; McCann SE, 2003, J NUTR, V133, P1937, DOI 10.1093/jn/133.6.1937; McCann SE, 2001, NUTR CANCER, V39, P19, DOI 10.1207/S15327914nc391_3; MCGOWAN L, 1979, GYNECOL ONCOL, V7, P325, DOI 10.1016/0090-8258(79)90111-2; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Mommers M, 2006, BRIT J CANCER, V94, P165, DOI 10.1038/sj.bjc.6602890; Mosgaard BJ, 1997, FERTIL STERIL, V67, P1005, DOI 10.1016/S0015-0282(97)81431-8; NASCA PC, 1984, AM J EPIDEMIOL, V119, P705, DOI 10.1093/oxfordjournals.aje.a113791; Ness RB, 2000, AM J EPIDEMIOL, V152, P233, DOI 10.1093/aje/152.3.233; NEWHOUSE ML, 1977, BRIT J PREV SOC MED, V31, P148; Olsson HL, 2003, CANCER, V97, P1387, DOI 10.1002/cncr.11205; PARAZZINI F, 1991, EUR J CANCER, V27, P594, DOI 10.1016/0277-5379(91)90226-4; Patel AV, 2006, AM J EPIDEMIOL, V163, P709, DOI 10.1093/aje/kwj098; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 1995, MORTALITY SMOKING DE; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; PIPER JM, 1987, INT J EPIDEMIOL, V16, P215, DOI 10.1093/ije/16.2.215; POLYCHRONOPOULOU A, 1993, INT J CANCER, V55, P402, DOI 10.1002/ijc.2910550312; PURDIE D, 1995, INT J CANCER, V62, P678, DOI 10.1002/ijc.2910620606; Riman T, 2002, AM J EPIDEMIOL, V156, P363, DOI 10.1093/aje/kwf048; RISCH HA, 1994, AM J EPIDEMIOL, V140, P585, DOI 10.1093/oxfordjournals.aje.a117296; RODRIGUEZ C, 1995, AM J EPIDEMIOL, V141, P828, DOI 10.1093/oxfordjournals.aje.a117518; ROSENBERG L, 1994, AM J EPIDEMIOL, V139, P654, DOI 10.1093/oxfordjournals.aje.a117055; Rossing MA, 2004, AM J EPIDEMIOL, V160, P1070, DOI 10.1093/aje/kwh315; Royar J, 2001, INT J CANCER, V95, P370, DOI 10.1002/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T; SHU XO, 1989, CANCER RES, V49, P3670; Shushan A, 1996, FERTIL STERIL, V65, P13, DOI 10.1016/S0015-0282(16)58020-0; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; THOMAS DB, 1989, INT J EPIDEMIOL, V18, P538; THOROGOOD M, 1993, BRIT MED BULL, V49, P124, DOI 10.1093/oxfordjournals.bmb.a072592; VESSEY MP, 1995, BRIT J CANCER, V71, P1340, DOI 10.1038/bjc.1995.260; WEISS NS, 1981, INT J CANCER, V28, P669, DOI 10.1002/ijc.2910280602; WHITTEMORE AS, 1988, AM J EPIDEMIOL, V128, P1228, DOI 10.1093/oxfordjournals.aje.a115077; World Health Organization, 2022, INT CLASS DIS, V11th; WU ML, 1988, AM J EPIDEMIOL, V128, P1216, DOI 10.1093/oxfordjournals.aje.a115076; Zhang M, 2004, GYNECOL ONCOL, V92, P320, DOI 10.1016/j.ygyno.2003.10.025	60	399	415	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					303	314		10.1016/s0140-6736(08)60167-1	http://dx.doi.org/10.1016/s0140-6736(08)60167-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294997	Green Submitted			2022-12-28	WOS:000252616500026
J	Bousser, MG; Bouthier, J; Buller, HR; Cohen, AT; Crijns, H; Davidson, BL; Halperin, J; Hankey, G; Levy, S; Pengo, V; Prandoni, P; Prins, MH; Tomkowski, W; Thorp-Pedersen, C; Wyse, DG				Bousser, M. G.; Bouthier, J.; Buller, H. R.; Cohen, A. T.; Crijns, H.; Davidson, B. L.; Halperin, J.; Hankey, G.; Levy, S.; Pengo, V.; Prandoni, P.; Prins, M. H.; Tomkowski, W.; Thorp-Pedersen, C.; Wyse, D. G.		Amadeus Investigators	Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial	LANCET			English	Article							ANTITHROMBOTIC THERAPY; STROKE	Background Vitamin K antagonists, the current standard treatment for prophylaxis against stroke and systemic embolism in patients with atrial fibrillation, require regular monitoring and dose adjustment; an unmonitored, fixed-dose anticoagulant regimen would be preferable. The aim of this randomised, open-label non-inferiority trial was to compare the efficacy and safety of idraparinux with vitamin K antagonists. Methods Patients with atrial fibrillation at risk for thromboembolism were randomly assigned to receive either subcutaneous idraparinux (2.5 mg weekly) or adjusted-dose vitamin K antagonists (target of an international normalised ratio of 2-3). Assessment of outcome was done blinded to treatment. The primary efficacy outcome was bleeding. Analyses were done by intention to treat; the non-inferiority hazard ratio was set at 1 . 5. This trial is registered with ClinicalTrials.gov, number NCT00070655. Findings The trial was stopped after randomisation of 4576 patients (2283 to receive idraparinux, 2293 to receive vitamin K antagonists) and a mean follow-up period of 10 . 7 (SD 5.4) months because of excess clinically relevant bleeding with idraparinux (346 cases vs 226 cases; 19.7 vs 11 . 3 per 100 patient-years; p<0. 0001). There were 21 instances of intracranial bleeding with idraparinux and nine with vitamin K antagonists (1 . 1 vs 0 . 4 per 100 patient-years; p=0. 014); elderly patients and those with renal impairment were at greater risk of such complications. There were 18 cases of thromboembolism with idraparinux and 27 cases with vitamin K antagonists (0 . 9 vs 1 . 3 per 100 patient-years; hazard ratio 0 . 71, 95% CI 0 . 39-1.30; p=0. 007), satisfying the non-inferiority criterion. There were 62 deaths with idraparinux and 61 with vitamin K anatagonists (3 . 2 vs 2.9 per 100 patient-years; p=0 . 49). Interpretation In patients with atrial fibrillation at risk for thromboembolism, long-term treatment with idraparinux was no worse than vitamin K antagonists in terms of efficacy, but caused significantly more bleeding.	[Buller, H. R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.m.veendorp@amc.uva.nl	Lindley, Richard/B-8148-2013; Hankey, Graeme J/H-4968-2014; Moia, Marco/J-2888-2015; Tait, Campbell/AFQ-8204-2022	Lindley, Richard/0000-0002-0104-5679; Hankey, Graeme J/0000-0002-6044-7328; Moia, Marco/0000-0002-7041-7755; Tait, Campbell/0000-0003-4842-6783; Gommans, John/0000-0003-3750-765X; samson, yves/0000-0002-8080-1427				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Buller HR, 2004, J THROMB HAEMOST, V2, P47; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Diener HC, 2006, CEREBROVASC DIS, V21, P279, DOI 10.1159/000091265; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Herbert JM, 1998, BLOOD, V91, P4197, DOI 10.1182/blood.V91.11.4197.411k09_4197_4205; Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015; Pengo V, 2001, THROMB HAEMOSTASIS, V85, P418; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Wang SJ, 2002, CONTROL CLIN TRIALS, V23, P15, DOI 10.1016/S0197-2456(01)00155-6; Weitz JI, 2005, J THROMB HAEMOST, V3, P1843, DOI 10.1111/j.1538-7836.2005.01374.x	14	229	242	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					315	321						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294998				2022-12-28	WOS:000252616500027
J	Gollisch, T; Meister, M				Gollisch, Tim; Meister, Markus			Rapid neural coding in the retina with relative spike latencies	SCIENCE			English	Article							GANGLION-CELLS; RECEPTIVE-FIELD; CONTRAST; ORGANIZATION; INFORMATION; RESPONSES; PATTERN; CODE	Natural vision is a highly dynamic process. Frequent body, head, and eye movements constantly bring new images onto the retina for brief periods, challenging our understanding of the neural code for vision. We report that certain retinal ganglion cells encode the spatial structure of a briefly presented image in the relative timing of their first spikes. This code is found to be largely invariant to stimulus contrast and robust to noisy fluctuations in response latencies. Mechanistically, the observed response characteristics result from different kinetics in two retinal pathways ("ON" and "OFF") that converge onto ganglion cells. This mechanism allows the retina to rapidly and reliably transmit new spatial information with the very first spikes emitted by a neural population.	[Gollisch, Tim; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gollisch, Tim; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	meister@fas.harvard.edu		Meister, Markus/0000-0003-2136-6506; Gollisch, Tim/0000-0003-3998-533X	NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014737] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; ASHMORE JF, 1980, NATURE, V288, P84, DOI 10.1038/288084a0; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1435, DOI 10.1152/jn.1978.41.6.1435; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Greschner M, 2006, J NEUROPHYSIOL, V96, P2845, DOI 10.1152/jn.01131.2005; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kara P, 2003, J NEUROSCI, V23, P8547; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Sawtell NB, 2005, CURR OPIN NEUROBIOL, V15, P437, DOI 10.1016/j.conb.2005.06.006; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; WERNER C, 1985, ZOOL JAHRB ALLG ZOOL, V89, P359; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002	30	408	454	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1108	1111		10.1126/science.1149639	http://dx.doi.org/10.1126/science.1149639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292344				2022-12-28	WOS:000253311700048
J	Muller, DA; Kourkoutis, LF; Murfitt, M; Song, JH; Hwang, HY; Silcox, J; Dellby, N; Krivanek, OL				Muller, D. A.; Kourkoutis, L. Fitting; Murfitt, M.; Song, J. H.; Hwang, H. Y.; Silcox, J.; Dellby, N.; Krivanek, O. L.			Atomic-scale chemical imaging of composition and bonding by aberration-corrected microscopy	SCIENCE			English	Article							INELASTICALLY SCATTERED ELECTRONS; ENERGY-LOSS SPECTROSCOPY; SPATIAL-RESOLUTION; STEM; EELS	Using a fifth- order aberration- corrected scanning transmission electron microscope, which provides a factor of 100 increase in signal over an uncorrected instrument, we demonstrated two- dimensional elemental and valence- sensitive imaging at atomic resolution by means of electron energy- loss spectroscopy, with acquisition times of well under a minute ( for a 4096- pixel image). Applying this method to the study of a La0.7Sr0.3MnO3/SrTiO3 multilayer, we found an asymmetry between the chemical intermixing on the manganese- titanium and lanthanum- strontium sublattices. The measured changes in the titanium bonding as the local environment changed allowed us to distinguish chemical interdiffusion from imaging artifacts.	[Muller, D. A.; Kourkoutis, L. Fitting; Silcox, J.] Cornell Univ, Ithaca, NY 14853 USA; [Muller, D. A.; Silcox, J.] Cornell Univ, Kavli Inst Cornell, Ithaca, NY 14853 USA; [Murfitt, M.; Dellby, N.; Krivanek, O. L.] Nion Co, Kirkland, WA 98033 USA; [Song, J. H.] Chungnam Natl Univ, Dept Phys, Taejon 305764, South Korea; [Song, J. H.; Hwang, H. Y.] Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; [Hwang, H. Y.] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Cornell University; Cornell University; Chungnam National University; University of Tokyo; Japan Science & Technology Agency (JST)	Muller, DA (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	dm24@cornell.edu	Muller, David/A-7745-2010; Hwang, Harold Y/I-6943-2012; Kourkoutis, Lena/B-4229-2010	Muller, David/0000-0003-4129-0473; Kourkoutis, Lena/0000-0002-1303-1362; Song, Jonghyun/0000-0002-1742-1122				Allen LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.105503; BATSON PE, 1993, NATURE, V366, P727, DOI 10.1038/366727a0; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Bosman M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086102; Brink HA, 2003, ULTRAMICROSCOPY, V96, P367, DOI 10.1016/S0304-3991(03)00102-5; Chen JG, 1997, SURF SCI REP, V30, P1, DOI 10.1016/S0167-5729(97)00011-3; Cosgriff EC, 2005, ULTRAMICROSCOPY, V102, P317, DOI 10.1016/j.ultramic.2004.11.001; Dorr K, 2001, J APPL PHYS, V89, P6973, DOI 10.1063/1.1362649; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Hong X, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1897076; Izumi M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.064429; Kimoto K, 2007, NATURE, V450, P702, DOI 10.1038/nature06352; KOHL H, 1985, ADV IMAG ELECTR PHYS, V65, P173, DOI 10.1016/S0065-2539(08)60878-1; KRIVANEK OL, 2007, ULTRAMICROSCOPY; Muller DA, 2004, NATURE, V430, P657, DOI 10.1038/nature02756; MULLER DA, 1993, NATURE, V366, P725, DOI 10.1038/366725a0; MULLER DA, 1995, ULTRAMICROSCOPY, V59, P195, DOI 10.1016/0304-3991(95)00029-Z; Okumshi E., 2006, MICROSC MICROANAL S2, V12, P1150; SPENCE JCH, 1982, ULTRAMICROSCOPY, V9, P267, DOI 10.1016/0304-3991(82)90211-X; Stallknecht P, 1996, ULTRAMICROSCOPY, V66, P261, DOI 10.1016/S0304-3991(97)00007-7; TREBBIA P, 1990, ULTRAMICROSCOPY, V34, P165, DOI 10.1016/0304-3991(90)90070-3	21	452	461	5	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1073	1076		10.1126/science.1148820	http://dx.doi.org/10.1126/science.1148820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292338				2022-12-28	WOS:000253311700038
J	Diep, BA; Chambers, HF; Graber, CJ; Szumowski, JD; Miller, G; Han, LL; Chen, JH; Lin, F; Lin, J; Phan, TH; Carleton, HA; McDougal, LK; Tenover, FC; Cohen, DE; Mayer, KH; Sensabaugh, GF; Perdreau-Remington, F				Diep, Binh An; Chambers, Henry F.; Graber, Christopher J.; Szumowski, John D.; Miller, G.; Han, Linda L.; Chen, Jason H.; Lin, Felice; Lin, Jessica; Phan, Tiffany HaiVan; Carleton, Heather A.; McDougal, Linda K.; Tenover, Fred C.; Cohen, Daniel E.; Mayer, Kenneth H.; Sensabaugh, George F.; Perdreau-Remington, Francoise			Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men	ANNALS OF INTERNAL MEDICINE			English	Article							SOFT-TISSUE INFECTIONS; RISK-FACTORS; SKIN INFECTIONS; SAN-FRANCISCO; SEQUENCE; TRANSMISSION; PNEUMONIA; EVOLUTION; OUTBREAK; PEOPLE	Background: Infection with multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus (MRSA) has been reported but seems to be isolated. Objective: To determine the incidence of a multidrug-resistant MRSA clone (USA300) in San Francisco, and to determine risk factors for the infection. Design: Population-based survey and cross-sectional study using chart review. Setting: 9 hospitals in San Francisco (population-based survey) and 2 outpatient clinics in San Francisco and Boston (cross-sectional study). Patients: Persons with culture-proven MRSA infections in 2004 to 2006. Measurements: Annual incidence, spatial clustering, and risk factors for multidrug-resistant USA300 infection. Pulsed-field gel electrophoresis, polymerase chain reaction assays, and DNA sequencing were used to characterize MRSA isolates. Results: The overall incidence of multidrug-resistant USA300 infection in San Francisco was 26 cases per 100 000 persons (95% CI, 16 to 36 cases per 100 000 persons); the incidence was higher in 8 contiguous ZIP codes with a higher proportion of male same-sex couples. Male-male sex was a risk factor for multidrug-resistant USA300 infection (relative risk, 13.2 [CI, 1.7 to 101.6]; P < 0.001) independent of past MRSA infection (relative risk, 2.1 [CI, 1.2 to 3.7]; P=0.007) or clinclamycin use (relative risk, 2.1 [1.2 to 3.61; P=0.007). The risk seemed to be independent of HIV infection. In San Francisco, multidrug-resistant USA300 manifested most often as infection of the buttocks, genitals, or perineum. In Boston, the infection was recovered exclusively from men who had sex with men. Limitations: The study was retrospective, and sexual risk behavior was not assessed. Conclusion: Infection with multidrug-resistant USA300 MRSA is common among men who have sex with men, and multidrug-resistant MRSA infection might be sexually transmitted in this population. Further research is needed to determine whether existing efforts to control epidemics of other sexually transmitted infections can control spread of community-associated, multidrug-resistant MRSA.	Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94110 USA; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Beth Israel Deaconess Med Ctr, Massachusetts Dept Publ Hlth, Boston, MA 02215 USA; Fenway Inst Fenway Community Hlth, Boston, MA USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Brown Univ, Providence, RI 02912 USA; Miriam Hosp, Providence, RI 02906 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Berkeley; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Department of Public Health; Centers for Disease Control & Prevention - USA; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Diep, BA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, 1001 Potrero Ave,Bldg 30,Rm 3300, San Francisco, CA 94110 USA.				NIAID NIH HHS [5T32AI060537-02, 5T32AI060530-02] Funding Source: Medline; PHS HHS [R01/CCR923419, R01/CCR923381] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, T32AI060530] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adam H, 2007, Can Commun Dis Rep, V33, P45; [Anonymous], 2006, MED LETT DRUGS THER, V48, P13; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; CARLETON HA, 2006, INT C ANT AG CHEM SA, pC2; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; Coronado F, 2007, EPIDEMIOL INFECT, V135, P492, DOI 10.1017/S0950268806006960; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Gordon RJ, 2005, CLIN INFECT DIS, V40, P1028, DOI 10.1086/428612; Groves RM., 2011, SURV METHODOL; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Haque NZ, 2007, INT J ANTIMICROB AG, V30, P72, DOI 10.1016/j.ijantimicag.2007.02.007; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Hota B, 2007, ARCH INTERN MED, V167, P1026, DOI 10.1001/archinte.167.10.1026; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Kalorin CM, 2007, J UROLOGY, V177, P967, DOI 10.1016/j.juro.2006.10.041; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kearns AM, 2007, INT J ANTIMICROB AG, V29, pS27, DOI 10.1016/S0924-8579(07)70087-0; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klausner JD, 2005, SEX TRANSM DIS, V32, pS11, DOI 10.1097/01.olq.0000180456.15861.92; LARSEN AR, 2007, EURO SURVEILL, V12; Lee NE, 2005, CLIN INFECT DIS, V40, P1529, DOI 10.1086/429827; LY LT, 2004, ANN M INF DIS SOC AM; Martin JN, 1999, J INFECT DIS, V180, P1809, DOI 10.1086/315132; Mayer K, 2001, AM J PUBLIC HEALTH, V91, P892, DOI 10.2105/AJPH.91.6.892; MAYER KH, 1986, ANN INTERN MED, V104, P194, DOI 10.7326/0003-4819-104-2-194; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2007, CLIN INFECT DIS, V44, P471, DOI 10.1086/511033; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Ruppitsch W, 2007, EUROSURVEILLANCE, V12; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shastry L, 2007, ARCH INTERN MED, V167, P854, DOI 10.1001/archinte.167.8.854; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2000, MICROB DRUG RESIST, V6, P239, DOI 10.1089/mdr.2000.6.239; SIMMONS T, 2000, MARRIED COUPLE UNMAR; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tietz A, 2005, NEW ENGL J MED, V353, P532, DOI 10.1056/NEJM200508043530522; TINELLI M, 2007, EUROSURVEILLANCE, V12; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Wannet W J B, 2004, Euro Surveill, V9, P3, DOI 10.2807/esm.09.11.00484-en; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; WENER KM, 2006, 44 ANN M INF DIS SOC	52	305	314	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					249	257		10.7326/0003-4819-148-4-200802190-00204	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00204			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264UR	18283202				2022-12-28	WOS:000253316400001
J	O'Gorman, C				O'Gorman, Carmel			We need better data on smoking in pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material									Good Hope Hosp, Birmingham, W Midlands, England	Birmingham City University; Heart of England NHS Foundation Trust; Good Hope Hospital	O'Gorman, C (corresponding author), Good Hope Hosp, Birmingham, W Midlands, England.	carmel.ogorman@heartofengland.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					330	330		10.1136/bmj.39479.677188.BD	http://dx.doi.org/10.1136/bmj.39479.677188.BD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18258970	Green Published			2022-12-28	WOS:000253437400037
J	Merideth, MA; Gordon, LB; Clauss, S; Sachdev, V; Smith, ACM; Perry, MB; Brewer, CC; Zalewski, C; Kim, HJ; Solomon, B; Brooks, BP; Gerber, LH; Turner, ML; Domingo, DL; Hart, TC; Graf, J; Reynolds, JC; Gropman, A; Yanovski, JA; Gerhard-Herman, M; Collins, FS; Nabel, EG; Cannon, RO; Gahl, WA; Introne, WJ				Merideth, Melissa A.; Gordon, Leslie B.; Clauss, Sarah; Sachdev, Vandana; Smith, Ann C. M.; Perry, Monique B.; Brewer, Carmen C.; Zalewski, Christopher; Kim, H. Jeffrey; Solomon, Beth; Brooks, Brian P.; Gerber, Lynn H.; Turner, Maria L.; Domingo, Demetrio L.; Hart, Thomas C.; Graf, Jennifer; Reynolds, James C.; Gropman, Andrea; Yanovski, Jack A.; Gerhard-Herman, Marie; Collins, Francis S.; Nabel, Elizabeth G.; Cannon, Richard O., III; Gahl, William A.; Introne, Wendy J.			Phenotype and course of Hutchinson-Gilford progeria syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							6-MINUTE WALK TEST; MUTANT LAMIN-A; CARDIOVASCULAR RISK; INHIBITING FARNESYLATION; AMERICAN-SOCIETY; CHILDREN; DISEASE; PROTEIN; ECHOCARDIOGRAPHY; ATHEROSCLEROSIS	Background: Hutchinson-Gilford progeria syndrome is a rare, sporadic, autosomal dominant syndrome that involves premature aging, generally leading to death at approximately 13 years of age due to myocardial infarction or stroke. The genetic basis of most cases of this syndrome is a change from glycine GGC to glycine GGT in codon 608 of the lamin A (LMNA) gene, which activates a cryptic splice donor site to produce abnormal lamin A; this disrupts the nuclear membrane and alters transcription. Methods: We enrolled 15 children between 1 and 17 years of age, representing nearly half of the world's known patients with Hutchinson-Gilford progeria syndrome, in a comprehensive clinical protocol between February 2005 and May 2006. Results: Clinical investigations confirmed sclerotic skin, joint contractures, bone abnormalities, alopecia, and growth impairment in all 15 patients; cardiovascular and central nervous system sequelae were also documented. Previously unrecognized findings included prolonged prothrombin times, elevated platelet counts and serum phosphorus levels, measured reductions in joint range of motion, low-frequency conductive hearing loss, and functional oral deficits. Growth impairment was not related to inadequate nutrition, insulin unresponsiveness, or growth hormone deficiency. Growth hormone treatment in a few patients increased height growth by 10% and weight growth by 50%. Cardiovascular studies revealed diminishing vascular function with age, including elevated blood pressure, reduced vascular compliance, decreased ankle-brachial indexes, and adventitial thickening. Conclusions: Establishing the detailed phenotype of Hutchinson-Gilford progeria syndrome is important because advances in understanding this syndrome may offer insight into normal aging. Abnormal lamin A (progerin) appears to accumulate with aging in normal cells. (ClinicalTrials.gov number, NCT00365092.).	[Merideth, Melissa A.; Smith, Ann C. M.; Gropman, Andrea; Collins, Francis S.; Gahl, William A.; Introne, Wendy J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Merideth, Melissa A.] NIH, Intramural Off Rare Dis, Bethesda, MD 20892 USA; [Sachdev, Vandana; Nabel, Elizabeth G.; Cannon, Richard O., III] NHLBI, Bethesda, MD 20892 USA; [Perry, Monique B.; Solomon, Beth] NIH, Dept Rehabil Med, Bethesda, MD 20892 USA; [Reynolds, James C.] NIH, Dept Nucl Med, Ctr Clin, Bethesda, MD 20892 USA; [Brewer, Carmen C.; Zalewski, Christopher; Kim, H. Jeffrey] Natl Inst Deafness & Other Communicat Disorders, Bethesda, MD USA; [Brooks, Brian P.] NEI, Bethesda, MD 20892 USA; NCI, Bethesda, MD 20892 USA; [Domingo, Demetrio L.; Hart, Thomas C.] Natl Inst Dent & Craniofacial Res, Bethesda, MD USA; [Yanovski, Jack A.] NICHHD, Bethesda, MD 20892 USA; [Gordon, Leslie B.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Clauss, Sarah; Gropman, Andrea] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Smith, Ann C. M.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Gerber, Lynn H.] George Mason Univ, Ctr Chron Illness & Disabil, Fairfax, VA 22030 USA; [Gerhard-Herman, Marie] Brigham & Womens Hosp, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brown University; Children's National Health System; Georgetown University; George Mason University; Harvard University; Brigham & Women's Hospital	Gahl, WA (corresponding author), NHGRI, NIH, Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	SMITH, ANN C.M./C-1122-2008; Gordon, Leslie B./AAJ-5793-2021	Yanovski, Jack/0000-0001-8542-1637; Gerber, Lynn/0000-0001-7525-680X	Intramural NIH HHS [Z99 HD999999, Z01 HD000641-12] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000215, ZIAHG200305, Z01HG200352, Z01HG200334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CALLOWAY DH, 1971, J NUTR, V101, P205, DOI 10.1093/jn/101.2.205; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; CAPELL BC, 2006, 56 ANN M AM SOC HUM, P18; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; CUMMING GR, 1978, AM J CARDIOL, V41, P69, DOI 10.1016/0002-9149(78)90134-0; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; *FOOD NUTR BOARD, 2005, DIET REF INT EN CARB, P168; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2005, J PEDIATR-US, V146, P336, DOI 10.1016/j.jpeds.2004.10.064; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Greulich WW., 1959, CALIF MED, V91, P53; HAGG U, 1985, ANGLE ORTHOD, V55, P93; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mazereeuw-Hautier J, 2007, BRIT J DERMATOL, V156, P1308, DOI 10.1111/j.1365-2133.2007.07897.x; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; Mora S, 1998, CALCIFIED TISSUE INT, V63, P369, DOI 10.1007/s002239900542; Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004; Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Stehbens WE, 2001, CARDIOVASC PATHOL, V10, P133, DOI 10.1016/S1054-8807(01)00069-2; STEINBERG AH, 1957, ARCH DIS CHILD, V32, P401, DOI 10.1136/adc.32.165.401; van Rijn RR, 2003, EUR RADIOL, V13, P700, DOI 10.1007/s00330-002-1676-8; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	42	440	453	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					592	604		10.1056/NEJMoa0706898	http://dx.doi.org/10.1056/NEJMoa0706898			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256394	Green Accepted			2022-12-28	WOS:000252916400006
J	Siddiq, MA; Samra, MJ				Siddiq, M. A.; Samra, M. J.			10-minute consultation - Otalgia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Siddiq, M. A.] New Cross Hosp, Dept Otorhinolaryngol Head & Neck Surg, Wolverhampton, England; [Samra, M. J.] Penn Manor Med Ctr, Wolverhampton, England	New Cross Hospital	Siddiq, MA (corresponding author), Manchester Royal Infirm, Dept Otorhinolaryngol Head & Neck Surg, Oxford Rd, Manchester M13 9WL, Lancs, England.	azhersiddiq@hotmail.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					276	277		10.1136/bmj.39364.643275.47	http://dx.doi.org/10.1136/bmj.39364.643275.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18245001	Green Published			2022-12-28	WOS:000253102900043
J	Kim, JE; Chen, JJ; Lou, ZK				Kim, Ja-Eun; Chen, Junjie; Lou, Zhenkun			DBC1 is a negative regulator of SIRT1	NATURE			English	Article							CALORIE RESTRICTION; CELL-SURVIVAL; LIFE-SPAN; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; DNA-DAMAGE; DEACETYLASE; CANCER; STRESS; NAD	The NAD- dependent protein deacetylase Sir2 ( silent information regulator 2) regulates lifespan in several organisms(1-3). SIRT1, the mammalian orthologue of yeast Sir2, participates in various cellular functions(4-7) and possibly tumorigenesis(8). Whereas the cellular functions of SIRT1 have been extensively investigated, less is known about the regulation of SIRT1 activity. Here we show that Deleted in Breast Cancer- 1 ( DBC1), initially cloned from a region ( 8p21) homozygously deleted in breast cancers(9), forms a stable complex with SIRT1. DBC1 directly interacts with SIRT1 and inhibits SIRT1 activity in vitro and in vivo. Downregulation of DBC1 expression potentiates SIRT1- dependent inhibition of apoptosis induced by genotoxic stress. Our results shed new light on the regulation of SIRT1 and have important implications in understanding the molecular mechanism of ageing and cancer.	[Kim, Ja-Eun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Lou, Zhenkun] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu; Lou.Zhenkun@mayo.edu	Kim, Ja-Eun/AAI-1896-2020	Kim, Ja-Eun/0000-0002-9132-1277				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; PRUITT K, 2006, PLOS GENET, V2, P344, DOI ARTN e40; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	30	394	409	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					583	U10		10.1038/nature06500	http://dx.doi.org/10.1038/nature06500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235501				2022-12-28	WOS:000252739900044
J	Lokker, C; McKibbon, KA; McKinlay, RJ; Wilczynski, NL; Haynes, RB				Lokker, Cynthia; McKibbon, K. Ann; McKinlay, R. James; Wilczynski, Nancy L.; Haynes, R. Brian			Prediction of citation counts for clinical articles at two years using data available within three weeks of publication: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPACT; INFORMATION; INDICATORS; QUALITY; RATES; BIAS	Objective To determine if citation counts at two years could be predicted for clinical articles that pass basic criteria for critical appraisal using data within three weeks of publication from external sources and an online article rating service. Design Retrospective cohort study. Setting Online rating service, Canada. Participants 1274 articles from 105 journals published from January to June 2005, randomly divided into a 60:40 split to provide derivation and validation datasets. Main outcome measures 20 article and journal features, including ratings of clinical relevance and newsworthiness, routinely collected by the McMaster online rating of evidence system, compared with citation counts at two years. Results The derivation regression equation accounted for 60% of the variation (R-2=0.60, 95% confidence interval 0.538 to 0.629). This model applied to the validation dataset gave a similar prediction (R-2=0. 56, 0.476 to 0.596, shrinkage 0.04; shrinkage measures how welt the derived equation matches data from the validation dataset). Cited articles in the top half and top third were predicted with 83% and 61% sensitivity and 72% and 82% specificity. Higher citations were predicted by indexing in numerous databases; number of authors; abstraction in synoptic journals; clinical relevance scores; number of cited references; and original, multicentred, and therapy articles from journals with a greater proportion of articles abstracted. Conclusion Citation counts can be reliably predicted at two years using data within three weeks of publication.	[Lokker, Cynthia; McKibbon, K. Ann; McKinlay, R. James; Wilczynski, Nancy L.; Haynes, R. Brian] McMaster Univ, Fac Hlth Sci, Hlth Informat Res Unit, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada	McMaster University	Lokker, C (corresponding author), McMaster Univ, Fac Hlth Sci, Hlth Informat Res Unit, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.	lokkerc@mcmaster.ca	Lokker, Cynthia/L-4177-2017	Lokker, Cynthia/0000-0003-2436-4290; Haynes, Robert Brian/0000-0002-1453-3196				Adams Alexander B, 2004, Respir Care, V49, P276; Barbui C, 2006, J CLIN PSYCHIAT, V67, P37, DOI 10.4088/JCP.v67n0106; Bhandari M, 2007, CAN J SURG, V50, P119; BOMMANN L, 2007, J AM SOC INFORM SCI, V58, P1100; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1100, DOI 10.1002/asi.20531; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; CAMPBELL FM, 1990, B MED LIBR ASSOC, V78, P376; Coats AJS, 2005, INT J CARDIOL, V105, P123, DOI 10.1016/j.ijcard.2005.08.004; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Fenton JE, 2005, RHINOLOGY, V43, P221; Figg WD, 2006, PHARMACOTHERAPY, V26, P759, DOI 10.1592/phco.26.6.759; Fricke M, 2005, AM J MED, V118, P168, DOI 10.1016/j.amjmed.2004.04.032; Griffiths KM, 2005, J MED INTERNET RES, V7, P80, DOI 10.2196/jmir.7.5.e59; Hamilton L. C., 2006, STAT STATA UPDATED V; HAYNES RB, 2006, JAMA-J AM MED ASSOC, P1801; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Motamed M, 2002, CLIN OTOLARYNGOL, V27, P318, DOI 10.1046/j.1365-2273.2002.00574.x; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; OSBORNE JW, 2000, PRACTICAL ASSESSMENT; OSBORNE JW, 2000, PRACT ASSESS RES EVA, V7; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perneger TV, 2004, BRIT MED J, V329, P546, DOI 10.1136/bmj.329.7465.546; Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102; West R, 2002, ADDICTION, V97, P501, DOI 10.1046/j.1360-0443.2002.00104.x; Wilczynski NL, 2001, STUD HEALTH TECHNOL, V84, P390	28	94	95	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					655	657		10.1136/bmj.39482.526713.BE	http://dx.doi.org/10.1136/bmj.39482.526713.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	280RH	18292132	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000254443400026
J	Colina, R; Costa-Mattioli, M; Dowling, RJO; Jaramillo, M; Tai, LH; Breitbach, CJ; Martineau, Y; Larsson, O; Rong, LW; Svitkin, YV; Makrigiannis, AP; Bell, JC; Sonenberg, N				Colina, Rodney; Costa-Mattioli, Mauro; Dowling, Ryan J. O.; Jaramillo, Maritza; Tai, Lee-Hwa; Breitbach, Caroline J.; Martineau, Yvan; Larsson, Ola; Rong, Liwei; Svitkin, Yuri V.; Makrigiannis, Andrew P.; Bell, John C.; Sonenberg, Nahum			Translational control of the innate immune response through IRF-7	NATURE			English	Article							DOUBLE-STRANDED-RNA; TARGETED DISRUPTION; INITIATION-FACTORS; RIG-I; INTERFERON; RECOGNITION; GENE; PHOSPHORYLATION; KINASE; CELLS	Transcriptional activation of cytokines, such as type-I interferons ( interferon ( IFN)- alpha and IFN- beta), constitutes the first line of antiviral defence. Here we show that translational control is critical for induction of type- I IFN production. In mouse embryonic fibroblasts lacking the translational repressors 4E- BP1 and 4E- BP2, the threshold for eliciting type- I IFN production is lowered. Consequently, replication of encephalomyocarditis virus, vesicular stomatitis virus, influenza virus and Sindbis virus is markedly suppressed. Furthermore, mice with both 4E- BP1 and 4E- BP2 genes ( also known as Eif4ebp1 and Eif4ebp2, respectively) knocked out are resistant to vesicular stomatitis virus infection, and this correlates with an enhanced type- I IFN production in plasmacytoid dendritic cells and the expression of IFN- regulated genes in the lungs. The enhanced type- I IFN response in 4E-BP1(-/-) 4E-BP2(-/-) double knockout mouse embryonic fibroblasts is caused by upregulation of interferon regulatory factor 7 ( Irf7) messenger RNA translation. These findings highlight the role of 4E- BPs as negative regulators of type- I IFN production, via translational repression of Irf7 mRNA.	[Colina, Rodney; Costa-Mattioli, Mauro; Dowling, Ryan J. O.; Jaramillo, Maritza; Martineau, Yvan; Larsson, Ola; Rong, Liwei; Svitkin, Yuri V.; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Tai, Lee-Hwa; Makrigiannis, Andrew P.] Univ Montreal, Inst Rech Clin Montreal, Lab Mol Immunol, Montreal, PQ H2W 1R7, Canada; [Breitbach, Caroline J.; Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada	McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	mauro.costa-mattioli@mail.mcgill.ca; nahum.sonenberg@mcgill.ca	Jaramillo, Maritza/T-7467-2019; Martineau, Yvan/G-2387-2017; Larsson, Ola/F-8151-2013; Dowling, Ryan/Q-8912-2018	Jaramillo, Maritza/0000-0002-1910-5684; Martineau, Yvan/0000-0002-0575-4085; Dowling, Ryan/0000-0002-5381-8805; Colina, Rodney/0000-0003-3731-5383; Svitkin, Yuri/0000-0003-3819-2143; Larsson, Ola/0000-0003-1412-1308; Makrigiannis, Andrew/0000-0002-7258-9411	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BELKOWSKI LS, 1987, J VIROL, V61, P653, DOI 10.1128/JVI.61.3.653-660.1987; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOHR IJ, 2007, TRANSLATIONAL CONTRO, P545; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	44	241	244	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					323	U2		10.1038/nature06730	http://dx.doi.org/10.1038/nature06730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18272964	Green Published			2022-12-28	WOS:000254117400040
J	Han, MH; Hwang, SI; Roy, DB; Lundgren, DH; Price, JV; Ousman, SS; Fernald, GH; Gerlitz, B; Robinson, WH; Baranzini, SE; Grinnell, BW; Raine, CS; Sobel, RA; Han, DK; Steinman, L				Han, May H.; Hwang, Sun-Il; Roy, Dolly B.; Lundgren, Deborah H.; Price, Jordan V.; Ousman, Shalina S.; Fernald, Guy Haskin; Gerlitz, Bruce; Robinson, William H.; Baranzini, Sergio E.; Grinnell, Brian W.; Raine, Cedric S.; Sobel, Raymond A.; Han, David K.; Steinman, Lawrence			Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALPHA-B-CRYSTALLIN; PROTEIN-C; PLAQUE; CHROMATOGRAPHY; PATHOGENESIS; ASTROCYTES; ACTIVATION; ANTIBODIES; SEPSIS	Understanding the neuropathology of multiple sclerosis ( MS) is essential for improved therapies. Therefore, identification of targets specific to pathological types of MS may have therapeutic benefits. Here we identify, by laser- capture microdissection and proteomics, proteins unique to three major types of MS lesions: acute plaque, chronic active plaque and chronic plaque. Comparative proteomic profiles identified tissue factor and protein C inhibitor within chronic active plaque samples, suggesting dysregulation of molecules associated with coagulation. In vivo administration of hirudin or recombinant activated protein C reduced disease severity in experimental autoimmune encephalomyelitis and suppressed Th1 and Th17 cytokines in astrocytes and immune cells. Administration of mutant forms of recombinant activated protein C showed that both its anticoagulant and its signalling functions were essential for optimal amelioration of experimental autoimmune encephalomyelitis. A proteomic approach illuminated potential therapeutic targets selective for specific pathological stages of MS and implicated participation of the coagulation cascade.	[Han, May H.; Price, Jordan V.; Ousman, Shalina S.; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Robinson, William H.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Hwang, Sun-Il; Lundgren, Deborah H.; Han, David K.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA; [Roy, Dolly B.] Northridge Neurol Ctr, Northridge, CA 91325 USA; [Fernald, Guy Haskin; Baranzini, Sergio E.] Univ Calif San Francisco, Sch Dent, Dept Neurol, San Francisco, CA 94143 USA; [Gerlitz, Bruce; Grinnell, Brian W.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Raine, Cedric S.] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Sobel, Raymond A.] Dept Pathol Neuropathol, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Connecticut; University of California System; University of California San Francisco; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine	Steinman, L (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Baranzini, Sergio/A-9422-2013	Baranzini, Sergio/0000-0003-0067-194X; Sobel, Raymond/0000-0002-0477-9002; Robinson, William/0000-0003-4385-704X; Hwang, Sunil/0000-0003-0600-3694; Steinman, Lawrence/0000-0002-2437-2250	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bagnato C, 2007, MOL CELL PROTEOMICS, V6, P1088, DOI 10.1074/mcp.M600259-MCP200; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; de Kleijn ED, 2003, CRIT CARE MED, V31, P1839, DOI 10.1097/01.CCM.0000072121.61120.D8; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; Greenfield EA, 2006, J NEUROSCI RES, V83, P415, DOI 10.1002/jnr.20748; GRINNELL BW, 2007, CRIT CARE MED S, V35; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hwang SI, 2006, MOL CELL PROTEOMICS, V5, P1131, DOI 10.1074/mcp.M500162-MCP200; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Kirichuk VF, 2003, ZH NEVROPATOL PSIKH, P34; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; LIDER O, 1989, J CLIN INVEST, V83, P752, DOI 10.1172/JCI113953; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lundgren DH, 2003, MOL CELL PROTEOMICS, V2, P1164, DOI 10.1074/mcp.M300059-MCP200; MASCHMEYER J, 1961, Bull Los Angel Neuro Soc, V26, P165; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Platten M, 2006, SCIENCE, V311, P954; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Riewald M, 2002, TRENDS CARDIOVAS MED, V12, P149, DOI 10.1016/S1050-1738(02)00153-6; Rubinsztein DC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-229; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Song XH, 1999, CIRCULATION, V100, P1528, DOI 10.1161/01.CIR.100.14.1528; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Wekerle H, 2005, NEUROL SCI, V26, pS1, DOI 10.1007/s10072-005-0386-9; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	38	422	441	0	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1076	U2		10.1038/nature06559	http://dx.doi.org/10.1038/nature06559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18278032				2022-12-28	WOS:000253453600035
J	Timonen, M; Liukkonen, T				Timonen, Markku; Liukkonen, Tim			Management of depression in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN REUPTAKE INHIBITORS; PRIMARY-CARE; MENTAL-DISORDERS; LOW-INCOME; HEALTH; INTERVENTIONS; DRUG		[Timonen, Markku] Univ Oulu, Inst Hlth Sci, FIN-90014 Oulu, Finland; [Liukkonen, Tim] Savonlinna Cent Hosp, Dept Psychiat, Savonlinna, Finland	University of Oulu	Timonen, M (corresponding author), Univ Oulu, Inst Hlth Sci, Box 5000, FIN-90014 Oulu, Finland.	markku.timonen@oulu.fi						[Anonymous], 2000, Am J Psychiatry, V157, P1; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Barbato A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004188.pub2; Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P67, DOI 10.1080/15622970701227829; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Guaiana G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004186.pub2; Henken HT, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006728; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; *NAT I CLIN EXC, 2004, 23 NICE; National Institute for Health and Clinical Excellence, 2006, TECHN APPR 97 COMP C; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Ruhe HG, 2006, BRIT J PSYCHIAT, V189, P309, DOI 10.1192/bjp.bp.105.018325; Ruhe HG, 2006, J CLIN PSYCHIAT, V67, P1836, DOI 10.4088/JCP.v67n1203; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Tylee A, 2007, J CLIN PSYCHIAT, V68, P27; Tylee Andre, 2005, Prim Care Companion J Clin Psychiatry, V7, P167; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van Weel-Baumgarten EM, 2000, J FAM PRACTICE, V49, P1113; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; Wolf NJ, 2008, CLIN PSYCHOL REV, V28, P131, DOI 10.1016/j.cpr.2007.04.004	28	35	45	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					435	439		10.1136/bmj.39478.609097.BE	http://dx.doi.org/10.1136/bmj.39478.609097.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292169	Green Published			2022-12-28	WOS:000253664000040
J	White, H				White, Howard			Tackling childhood undernutrition	LANCET			English	Editorial Material							NUTRITION; PROGRAM		[White, Howard] World Bank, Independent Evaluat Grp, Washington, DC 20433 USA	The World Bank	White, H (corresponding author), World Bank, Independent Evaluat Grp, 1818 H St NW, Washington, DC 20433 USA.	hwhite@worldbank.org		White, Howard/0000-0002-6298-0310				Alderman H, 2007, WORLD DEV, V35, P1376, DOI 10.1016/j.worlddev.2007.04.003; Banerjee A.V, 2007, MAKING AID WORK; Cent. Glob. Dev. Eval. Gap Work. Group, 2006, WILL WE EV LEARN IMP; Hossain SMM, 2005, HEALTH POLICY PLANN, V20, P35, DOI 10.1093/heapol/czi004; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; White Howard, 2007, J INT DEV, V19, P627, DOI DOI 10.1002/(ISSN)1099-1328; *WORLD BANK OP EV, 2005, MAING MOM 2015 IMP E; *WORLD IND EV GROU, 2006, IMP EV EXP IND EV GR	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					539	541		10.1016/S0140-6736(08)60249-4	http://dx.doi.org/10.1016/S0140-6736(08)60249-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280314				2022-12-28	WOS:000253202600008
J	Tepe, G; Zeller, T; Albrecht, T; Heller, S; Schwarzwalder, U; Beregi, JP; Claussen, CD; Oldenburg, A; Scheller, B; Speck, U				Tepe, Gunnar; Zeller, Thomas; Albrecht, Thomas; Heller, Stephan; Schwarzwaelder, Uwe; Beregi, Jean-Paul; Claussen, Claus D.; Oldenburg, Anja; Scheller, Bruno; Speck, Ulrich			Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUPERFICIAL FEMORAL-ARTERY; PALMAZ STENT PLACEMENT; CONTRAST-MEDIA; LOWER-EXTREMITY; ELUTING STENTS; NITINOL STENTS; DRUG DELIVERY; CORONARY; ANGIOGRAPHY; DISEASE	Background: Drug-eluting stents reduce restenosis in coronary arteries, but clinical trials have failed to prove their efficacy in peripheral arteries. We investigated the use of paclitaxel-coated angioplasty balloons and paclitaxel dissolved in the angiographic contrast medium during angioplasty of the leg. Methods: In a small, multicenter trial, we randomly assigned 154 patients with stenosis or occlusion of a femoropopliteal artery to treatment with standard balloon catheters coated with paclitaxel, uncoated balloons with paclitaxel dissolved in the contrast medium, or uncoated balloons without paclitaxel (control). The primary end point was late lumen loss at 6 months. Results: The mean (+/-SD) age of the patients was 68+/-8 years, 24% were smokers, and 49% had diabetes. Twenty-seven percent of the lesions were total occlusions, and 36% were restenotic lesions. The mean lesion length was 7.4+/-6.5 cm. There were no significant differences in baseline characteristics between the groups. There were no adverse events attributable to the paclitaxel-coated balloons. At 6 months, the mean late lumen loss was 1.7+/-1.8 mm in the control group, as compared with 0.4+/-1.2 mm (P<0.001) in the group treated with paclitaxel-coated balloons and 2.2+/-1.6 mm (P=0.11) in the group treated with paclitaxel in the contrast medium. The rate of revascularization of target lesions at 6 months was 20 of 54 (37%) in the control group, 2 of 48 (4%) in the group treated with paclitaxel-coated balloons (P<0.001 vs. control), and 15 of 52 (29%) in the group treated with paclitaxel in the contrast medium (P=0.41 vs. control); at 24 months, the rates increased to 28 of 54 (52%), 7 of 48 (15%), and 21 of 52 (40%), respectively. Conclusions: Use of paclitaxel-coated angioplasty balloons during percutaneous treatment of femoropopliteal disease is associated with significant reductions in late lumen loss and target-lesion revascularization. No significant benefit is seen with the use of a paclitaxel-containing contrast medium. (ClinicalTrials.gov number, NCT00156624.).	[Tepe, Gunnar; Heller, Stephan; Claussen, Claus D.] Univ Tubingen, Radiol Klin, D-72076 Tubingen, Germany; [Zeller, Thomas; Schwarzwaelder, Uwe] Herz Zentrum Bad Krozingen, Bad Krozingen, Germany; [Albrecht, Thomas; Oldenburg, Anja; Speck, Ulrich] Univ Med Berlin, Charite, Berlin, Germany; [Scheller, Bruno] Univ Klinikum Saarlandes, Innere Med Klin, Homburg, Germany; [Beregi, Jean-Paul] C2RM, Lille, France	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universitatsklinikum des Saarlandes	Tepe, G (corresponding author), Univ Tubingen, Radiol Klin, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	gunnar-tepe@med.uni-tuebingen.de	BEREGI, Jean-Paul/C-2777-2012; Scheller, Bruno/S-5761-2016					Albrecht T, 2007, INVEST RADIOL, V42, P579, DOI 10.1097/RLI.0b013e31804f5a60; Cejna M, 2001, J VASC INTERV RADIOL, V12, P23, DOI 10.1016/S1051-0443(07)61397-9; Duda SH, 2005, J VASC INTERV RADIOL, V16, P331, DOI 10.1097/01.RVI.0000151260.74519.CA; Duda SH, 2003, J VASC INTERV RADIOL, V14, P291, DOI 10.1097/01.RVI.0000058423.01661.57; Duda SH, 2002, CIRCULATION, V106, P1505, DOI 10.1161/01.CIR.0000029746.10018.36; Duda SH, 2006, J ENDOVASC THER, V13, P701, DOI 10.1583/05-1704.1; Grimm J, 2001, J VASC INTERV RADIOL, V12, P935, DOI 10.1016/S1051-0443(07)61572-3; Hirsch AT, 2006, J VASC INTERV RADIOL, V17, P1383, DOI 10.1097/01.RVI.0000240426.53079.46; JOHNSTON KW, 1992, SURG CLIN N AM, V72, P843; JOHNSTON KW, 1992, RADIOLOGY, V183, P767, DOI 10.1148/radiology.183.3.1294068; Minar E, 2000, CIRCULATION, V102, P2694, DOI 10.1161/01.CIR.102.22.2694; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Rutherford RB, 2001, J VASC SURG, V33, P805; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2003, J AM COLL CARDIOL, V42, P1415, DOI 10.1016/S0735-1097(03)01056-8; Scheller B, 2003, EUR HEART J, V24, P1462, DOI 10.1016/S0195-668X(03)00317-8; Scheller B, 2002, INVEST RADIOL, V37, P29, DOI 10.1097/00004424-200201000-00006; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Speck U, 2004, INVEST RADIOL, V39, P182, DOI 10.1097/01.rli.0000116125.96544.64; Speck U, 2006, RADIOLOGY, V240, P411, DOI 10.1148/radiol.2402051248; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1	23	644	748	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					689	699		10.1056/NEJMoa0706356	http://dx.doi.org/10.1056/NEJMoa0706356			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272892				2022-12-28	WOS:000253127700005
J	Yoo, SD; Cho, YH; Tena, G; Xiong, Y; Sheen, J				Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen			Dual control of nuclear EIN3 by bifurcate MAPK cascades in C2H4 signalling	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ETHYLENE-RESPONSE PATHWAY; F-BOX PROTEINS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; STRESS; UBIQUITIN; CTR1; ETR1; ETHYLENE-INSENSITIVE3	A principal question in MAP kinase ( MAPK/ MPK) cascade signalling is how similar components dictate different specificity in the information- processing machineries from yeast to humans and plants. In Arabidopsis, how MPK3/ 6modulates distinct outputs in diverse signal transduction pathways remains elusive. By combining systematic cellular and genetic screens, here we uncover a previously unexpected MKK9 - MPK3/ MPK6 cascade promoting ethylene- insensitive 3 ( EIN3)- mediated transcription in ethylene signalling. The mkk9 mutant exhibits a broad spectrum of moderate ethylene- insensitive phenotypes, and translocated MKK9 governs nuclear signalling downstream of receptors. Breaking a linear model and conventional MAPK signalling, ethylene inactivates the negative regulator constitutive triple response 1 ( CTR1, a Raf- like MAPK kinase kinase ( MAPKKK)) to activate the positive MKK9 - MPK3/ 6 cascade. The bifurcate and antagonistic CTR1 and MKK9 pathways are both critical in determining ethylene- signalling specificity through two MAPK phosphorylation sites with opposite effects on EIN3 stability. The results suggest a new paradigm for linking intertwined MAPK cascades to control quantitative responses and specificity in signalling networks.	[Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	yoo@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu		Tena, Guillaume/0000-0001-8652-905X; Xiong, Yan/0000-0003-0676-8267	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567, R01GM060493] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM070567, R01 GM060493] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Ecker JR, 2004, PLANT CELL, V16, P3169, DOI 10.1105/tpc.104.161210; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; NELJUBOV DN, 1901, BEIH BOT CENTRALBH, V10, P129; Novikova GV, 2000, FEBS LETT, V474, P29, DOI 10.1016/S0014-5793(00)01565-9; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	50	362	404	9	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					789	U1		10.1038/nature06543	http://dx.doi.org/10.1038/nature06543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273012	Bronze, Green Accepted			2022-12-28	WOS:000253191400034
J	Cave, J; Dacre, J				Cave, Judith; Dacre, Jane			The competent novice - Dealing with complaints	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS		[Cave, Judith] UCL Hosp NHS Fdn Trust, Dept Oncol, London NW1 2PG, England; [Dacre, Jane] Royal Free & Univ Coll Med Sch, Div Med Educ, Acad Ctr Med Educ, London N19 5LW, England	University of London; University College London; University of London; University College London	Cave, J (corresponding author), UCL Hosp NHS Fdn Trust, Dept Oncol, London NW1 2PG, England.	j.cave@medsch.ucl.ac.uk						Aasland OG, 2005, QUAL SAF HEALTH CARE, V14, P13, DOI 10.1136/qshc.2002.003657; Bark P, 1994, Qual Health Care, V3, P123, DOI 10.1136/qshc.3.3.123; BARK P, 1997, QUAL HLTH CARE, V6; Deparnuent of Health Expert Group, 2000, ORG MEM; Department of Health, 2003, NHS COMPL REF MAK TH; Donaldson L J, 1992, Qual Health Care, V1, P21, DOI 10.1136/qshc.1.1.21; Friele RD, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-106; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; *GEN MED COUNC, 2007, REF DOCT GMC GUID IN; HOYLE A, 2005, BRIT MED J, V331, P55; *IND COMPL ADV SER, 2004, 1 YEAR ICAS 1 SEPT 2; Johnson D, 2001, BRIT MED J, V322, P563, DOI 10.1136/bmj.322.7285.563; Lau FL, 2000, J ACCID EMERG MED, V17, P251; Lazare A, 2006, JAMA-J AM MED ASSOC, V296, P1401, DOI 10.1001/jama.296.11.1401; *NAT PAT SAF AG, 2005, BEING OP PAT HARM; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; Weiss PM, 2007, OBSTET GYNECOL SURV, V62, P217, DOI 10.1097/01.ogx.0000256810.01598.c1	17	13	14	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					326	328		10.1136/bmj.39455.639340.AD	http://dx.doi.org/10.1136/bmj.39455.639340.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18258968	Green Published			2022-12-28	WOS:000253437400035
J	Hiscock, H; Bayer, JK; Price, A; Ukoumunne, OC; Rogers, S; Wake, M				Hiscock, Harriet; Bayer, Jordana K.; Price, Anna; Ukoumunne, Obioha C.; Rogers, Susan; Wake, Melissa			Universal parenting programme to prevent early childhood behavioural problems: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOME VISITATION; CHILDREN; START	Objective To determine whether a parenting programme, offered universally in primary care, can prevent behavioural problems in children and improve parenting and maternal mental health. Design Cluster randomised trial. Setting 40 primary care nursing centres (clusters) in Victoria, Australia. Participants 733 English speaking mothers of 8 month-old children sequentially recruited from well child appointments; 656 retained at 24 months. Intervention Structured three session programme at age 8-15 months, co-led by well child providers and a parenting expert. The programme covered normal development and behaviour, strategies to increase desired behaviour, and strategies to reduce unwanted behaviour. Main outcome measures Maternal report of child externalising behaviour (child behaviour checklist 1(1)/(2)-5 year old), parenting (parent behaviour checklist), and maternal mental health (depression anxiety stress scales) at 18 and 24 months. Results At 18 months, child behaviour and parenting scores were similar in the two groups. At 24 months, externalising scores in the intervention and control groups were similar (mean 11.9 (SD 7.2) v 12.9 (7.4)); however, on the parent behaviour checklist subscale scores, intervention group parents were less likely to report harsh/abusive parenting (mean 38.9 (SD 7.7) v 40.5 (8.8); adjusted mean difference (-)1.83, 95% confidence interval (-)3.12 to (-)0.55) and unreasonable expectations of child development (40.9 (9.9) v 42.7 (9.6); (-)2.18, (-)3.74 to -0.62). Mean scores for nurturing parenting and maternal mental health were similar in the two groups at both times. Conclusions A universal parenting programme resulted in modest improvement in parenting factors that predict behavioural problems in children but did not reduce externalising behavioural problems or affect maternal mental health at 2 years. Trial registration ISRCTN 77531789.	[Hiscock, Harriet; Bayer, Jordana K.; Price, Anna; Wake, Melissa] Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia; [Hiscock, Harriet; Bayer, Jordana K.; Ukoumunne, Obioha C.; Wake, Melissa] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Hiscock, Harriet; Bayer, Jordana K.; Price, Anna; Ukoumunne, Obioha C.; Wake, Melissa] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ukoumunne, Obioha C.] Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; [Rogers, Susan] Parenting Res Ctr, Carlton, Vic 3053, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Hiscock, H (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	harriet.hiscock@rch.org.au	Wake, Melissa/J-1396-2012; Hiscock, Harriet/M-6882-2013	Wake, Melissa/0000-0001-7501-9257; Price, Anna/0000-0002-8117-8059; Hiscock, Harriet/0000-0003-3017-2770				Achenbach TM., 2000, LANGUAGE DEV SURVEY; Australian Bureau of Statistics Commonwealth of Australia, 2001, SOC IND AR; Barlow J, 2000, J DEV BEHAV PEDIATR, V21, P356, DOI 10.1097/00004703-200010000-00006; Barlow J, 2005, CHILD CARE HLTH DEV, V31, P33, DOI 10.1111/j.1365-2214.2005.00447.x; Bayer JK, 2007, ARCH DIS CHILD, V92, P34, DOI 10.1136/adc.2006.100776; Bennett KJ, 1998, J CHILD PSYCHOL PSYC, V39, P1059, DOI 10.1017/S0021963098003199; BOR W, 2001, JUSTICE SERIES, V201; Bor W, 2001, TRENDS ISSUES CRIME; Brenner V, 1998, J GENET PSYCHOL, V159, P251, DOI 10.1080/00221329809596149; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; Davison AC, 1997, BOOTSTRAP METHODS TH; *DEP HUM SERV, 2005, MAT CHILD HLTH ANN D; Department for Children Schools and Families (DCSF)., 2007, RAIS PART AG ED TRAI; Fergusson DM, 2006, PEDIATRICS, V117, P781, DOI 10.1542/peds.2005-1517; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Heinrichs N, 2005, PREV SCI, V6, P275, DOI 10.1007/s11121-005-0006-1; HISCOCK H, 2005, INT J MENT HEALTH PR, V7, P54; HUTCHINGS H, 2007, BMJ-BRIT MED J, V334, P678; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Morawska A, 2006, J CONSULT CLIN PSYCH, V74, P10, DOI 10.1037/0022-006X.74.1.10; Offord DR, 1998, J AM ACAD CHILD PSY, V37, P686, DOI 10.1097/00004583-199807000-00007; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; SANDERS MR, 2000, EARLY INTERVENTION C; SANSON A, 1991, J CHILD PSYCHOL PSYC, V32, P609, DOI 10.1111/j.1469-7610.1991.tb00338.x; Sawyer MG, 2000, MENTAL HLTH YOUNG PE; Shaw DS, 2006, J CONSULT CLIN PSYCH, V74, P1, DOI 10.1037/0022-006X.74.1.1; STEWARTBROWN S, 1998, PARENTING SCH CHILDR, P21; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Zubrick SR, 2005, PREV SCI, V6, P287, DOI 10.1007/s11121-005-0013-2	34	88	89	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					318	321		10.1136/bmj.39451.609676.AE	http://dx.doi.org/10.1136/bmj.39451.609676.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18244958	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000253437400033
J	Mechali, M; Lutzmann, M				Mechali, Marcel; Lutzmann, Malik			The cell cycle: Now live and in color	CELL			English	Editorial Material							DNA-REPLICATION; LICENSING FACTOR; CDT1; GEMININ	When observing living cells, only mitosis is easily distinguishable from other phases of the cell cycle. In this issue, Sakaue-Sawano et al. (2008) present a method to visually distinguish cells at different phases of the cell cycle by the expression of colored fusion proteins that are under the control of the ubiquitin ligases SCF and APC.	[Mechali, Marcel; Lutzmann, Malik] CNRS, Inst Human Genet, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 41 Rue Cardonille, F-34396 Montpellier, France.	mechali@igh.cnrs.fr						Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x	9	14	16	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					341	343		10.1016/j.cell.2008.01.031	http://dx.doi.org/10.1016/j.cell.2008.01.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267067	Bronze			2022-12-28	WOS:000253180700010
J	Watson, B				Watson, Bob			Bert Bolin (1925-2008) - Obituary	NATURE			English	Biographical-Item									Dept Environm Food & Rural Affairs, London SW1P 3JR, England		Watson, B (corresponding author), Univ E Anglia, Norwich NR4 7TJ, Norfolk, England.	Robert.Watson@defra.gsi.gov.uk							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					642	642		10.1038/451642a	http://dx.doi.org/10.1038/451642a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256656	Bronze			2022-12-28	WOS:000252929500025
J	Ferry, DK				Ferry, David K.			Materials science - Nanowires in nanoelectronics	SCIENCE			English	Editorial Material							INTEGRATION		Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Ferry, DK (corresponding author), Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA.	ferry@asu.edu						Appenzeller J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.226802; Bowler DR, 2004, J PHYS-CONDENS MAT, V16, pR721, DOI 10.1088/0953-8984/16/24/R01; Bryllert T, 2006, IEEE ELECTR DEVICE L, V27, P323, DOI 10.1109/LED.2006.873371; Chau R, 2005, IEEE T NANOTECHNOL, V4, P153, DOI 10.1109/TNANO.2004.842073; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Doyle BS, 2003, IEEE ELECTR DEVICE L, V24, P263, DOI 10.1109/LED.2003.810888; Duesberg GS, 2004, DIAM RELAT MATER, V13, P354, DOI 10.1016/j.diamond.2003.10.021; EVANS C, 1979, MICRO MILLENIUM; Ferry DK, 2008, PHYS STATUS SOLIDI C, V5, P17, DOI 10.1002/pssc.200776580; FORESTER T, 1982, MICROELECTRONICS REV; Frank D. J., 1992, International Electron Devices Meeting 1992. Technical Digest (Cat. No.92CH3211-0), P553, DOI 10.1109/IEDM.1992.307422; Hisamoto D, 2000, IEEE T ELECTRON DEV, V47, P2320, DOI 10.1109/16.887014; Koyanagi M, 2006, IEEE T ELECTRON DEV, V53, P2799, DOI 10.1109/TED.2006.884079; Moore G, 1965, ELECTRONICS, V5, P114	14	102	105	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					579	580		10.1126/science.1154446	http://dx.doi.org/10.1126/science.1154446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239115				2022-12-28	WOS:000252772000028
J	Schnell, JR; Chou, JJ				Schnell, Jason R.; Chou, James J.			Structure and mechanism of the M2 proton channel of influenza A virus	NATURE			English	Article							ION-CHANNEL; MEMBRANE-PROTEIN; AMANTADINE; LOCALIZATION; COUPLINGS; ALIGNMENT; SEQUENCE; REVEALS; FORMS; DRUG	The integral membrane protein M2 of influenza virus forms pH-gated proton channels in the viral lipid envelope(1). The low pH of an endosome activates the M2 channel before haemagglutinin-mediated fusion. Conductance of protons acidifies the viral interior and thereby facilitates dissociation of the matrix protein from the viral nucleoproteins - a required process for unpacking of the viral genome(2). In addition to its role in release of viral nucleoproteins, M2 in the trans- Golgi network ( TGN) membrane prevents premature conformational rearrangement of newly synthesized haemagglutinin during transport to the cell surface by equilibrating the pH of the TGN with that of the host cell cytoplasm(3). Inhibiting the proton conductance of M2 using the anti- viral drug amantadine or rimantadine inhibits viral replication(4-7). Here we present the structure of the tetrameric M2 channel in complex with rimantadine, determined by NMR. In the closed state, four tightly packed transmembrane helices define a narrow channel, in which a 'tryptophan gate' is locked by intermolecular interactions with aspartic acid. A carboxy- terminal, amphipathic helix oriented nearly perpendicular to the transmembrane helix forms an inward- facing base. Lowering the pH destabilizes the transmembrane helical packing and unlocks the gate, admitting water to conduct protons, whereas the C- terminal base remains intact, preventing dissociation of the tetramer. Rimantadine binds at four equivalent sites near the gate on the lipid- facing side of the channel and stabilizes the closed conformation of the pore. Drug-resistance mutations are predicted to counter the effect of drug binding by either increasing the hydrophilicity of the pore or weakening helix - helix packing, thus facilitating channel opening.	[Schnell, Jason R.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIAID NIH HHS [R01 AI067438-02, R01 AI067438-03, R01 AI067438-01A1, R01 AI067438] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067438] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH PE, 1971, J MED CHEM, V14, P535, DOI 10.1021/jm00288a019; ALLERHAN.A, 1966, J CHEM PHYS, V45, P902, DOI 10.1063/1.1727703; Astrahan P, 2004, PROTEINS, V55, P251, DOI 10.1002/prot.20018; BAX A, 1994, METHOD ENZYMOL, V239, P79; Betakova T, 2005, J GEN VIROL, V86, P181, DOI 10.1099/vir.0.80358-0; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Kukol A, 1999, J MOL BIOL, V286, P951, DOI 10.1006/jmbi.1998.2512; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MacKenzie KR, 1996, J BIOMOL NMR, V7, P256; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1995, TRENDS MICROBIOL, V3, P271, DOI 10.1016/S0966-842X(00)88942-8; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Subczynski WK, 1998, J PHARM SCI-US, V87, P1249, DOI 10.1021/js970381n; SUGRUE RJ, 1990, VIROLOGY, V179, P51, DOI 10.1016/0042-6822(90)90272-S; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; SVENSSON TH, 1973, EUR J PHARMACOL, V23, P232, DOI 10.1016/0014-2999(73)90088-5; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	39	857	891	7	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					591	U12		10.1038/nature06531	http://dx.doi.org/10.1038/nature06531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235503	Green Accepted			2022-12-28	WOS:000252739900046
J	Franco, EL; Duarte-Franco, E				Franco, Eduardo L.; Duarte-Franco, Eliane			Ovarian cancer and oral contraceptives	LANCET			English	Editorial Material									[Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Franco, Eduardo L.] McGill Univ, Dept Epidemiol, Montreal, PQ H2W 1S6, Canada; [Duarte-Franco, Eliane] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada	McGill University; McGill University; Institut national de sante publique du Quebec (INSPQ)	Franco, EL (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	Franco, Eduardo/C-6445-2014	Franco, Eduardo/0000-0002-4409-8084				Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Chang G, 2002, J SUBST ABUSE TREAT, V23, P1, DOI 10.1016/S0740-5472(02)00234-9; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; LACEY JV, 2006, CANC EPIDEMIOLOGY PR, P468; Narod SA, 2007, LANCET, V369, P1667, DOI 10.1016/S0140-6736(07)60535-2; Ries LAG, 2007, SEER CANC STAT REV 1; TAYLOR T, 2006, CONTRACEPTION SEXUAL	9	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					277	278		10.1016/S0140-6736(08)60142-7	http://dx.doi.org/10.1016/S0140-6736(08)60142-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294980				2022-12-28	WOS:000252616500004
J	LEBERMAN, R; SOPER, AK				LEBERMAN, R; SOPER, AK			EFFECT OF HIGH-SALT CONCENTRATIONS ON WATER-STRUCTURE	NATURE			English	Article							NEUTRON-SCATTERING	THE characteristic tetrahedral structure of water is known to be disrupted by changes in pressure and temperature(1-3). It has been suggested that ions in solution may have a similar perturbing effect(4,5). Here we use neutron diffraction to compare the effects of applied pressure and high salt concentrations on the hydrogen-bonded network of water. We find that the ions induce a change in structure equivalent to the application of high pressures, and that the size of the effect is ion-specific. Ionic concentrations of a few moles per litre have equivalent pressures that can exceed a thousand atmospheres. We propose that these changes may be understood in terms of the partial molar volume of the ions, relative to those of water molecules. The equivalent induced pressure of a particular ion species is correlated,vith its efficacy in precipitating, or salting-out, proteins from solution(6).	RUTHERFORD APPLETON LAB,ISIS FACIL,DIDCOT OX11 0QX,OXON,ENGLAND	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	LEBERMAN, R (corresponding author), EUROPEAN MOLEC BIOL LAB,GRENOBLE OUTSTN,BP 156,F-38042 GRENOBLE,FRANCE.			Soper, Alan/0000-0002-7903-8356				ENDERBY JE, 1973, CHEM PHYS LETT, V21, P109, DOI 10.1016/0009-2614(73)80025-9; HERDMAN GJ, 1990, J MOL LIQ, V46, P165, DOI 10.1016/0167-7322(90)80052-L; Hofmeister F., 1888, N-S ARCH EXP PATH PH, V24, P247; MILLERO FJ, 1971, CHEM REV, V72, P147; POSTORINO P, 1994, J CHEM PHYS, V101, P4123, DOI 10.1063/1.467462; POSTORINO P, 1993, NATURE, V366, P668, DOI 10.1038/366668a0; Soper A., 1989, ATLAS ANAL TIME FLIG; SOPER AK, 1993, INT J MOD PHYS B, V7, P3049, DOI 10.1142/S0217979293003152; SOPER AK, 1993, CHEM PHYS, V107, P47; SOPER AK, 1993, J CHEM PHYS, V97, P1320; TROMP RH, 1994, J CHEM PHYS, V101, P6210, DOI 10.1063/1.468403; TROMP RH, 1992, J CHEM PHYS, V96, P8460, DOI 10.1063/1.462298; Zubay G., 1993, BIOCHEMISTRY; 1974, HDB CHEM PHYSICS, pD194	14	364	372	4	107	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					364	366		10.1038/378364a0	http://dx.doi.org/10.1038/378364a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	18286746				2022-12-28	WOS:A1995TF89300050
J	WENZ, C				WENZ, C			MUSEUMS MAKE NEWS	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					4	4						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277987				2022-12-28	WOS:A1990CQ97200009
J	Ludlow, AD; Zelevinsky, T; Campbell, GK; Blatt, S; Boyd, MM; de Miranda, MHG; Martin, MJ; Thomsen, JW; Foreman, SM; Ye, J; Fortier, TM; Stalnaker, JE; Diddams, SA; Le Coq, Y; Barber, ZW; Poli, N; Lemke, ND; Beck, KM; Oates, CW				Ludlow, A. D.; Zelevinsky, T.; Campbell, G. K.; Blatt, S.; Boyd, M. M.; de Miranda, M. H. G.; Martin, M. J.; Thomsen, J. W.; Foreman, S. M.; Ye, Jun; Fortier, T. M.; Stalnaker, J. E.; Diddams, S. A.; Le Coq, Y.; Barber, Z. W.; Poli, N.; Lemke, N. D.; Beck, K. M.; Oates, C. W.			Sr lattice clock at 1 x 10(-16) fractional uncertainty by remote optical evaluation with a Ca clock	SCIENCE			English	Article							FREQUENCY; NOISE; LASER		[Ludlow, A. D.; Zelevinsky, T.; Campbell, G. K.; Blatt, S.; Boyd, M. M.; de Miranda, M. H. G.; Martin, M. J.; Thomsen, J. W.; Foreman, S. M.; Ye, Jun] Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Ludlow, A. D.; Zelevinsky, T.; Campbell, G. K.; Blatt, S.; Boyd, M. M.; de Miranda, M. H. G.; Martin, M. J.; Thomsen, J. W.; Foreman, S. M.; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Fortier, T. M.; Stalnaker, J. E.; Diddams, S. A.; Le Coq, Y.; Barber, Z. W.; Poli, N.; Lemke, N. D.; Beck, K. M.; Oates, C. W.] Natl Inst Stand & Technol, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Ye, J (corresponding author), Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	ye@jila.colorado.edu	Blatt, Sebastian/F-8986-2012; Poli, Nicola/B-2166-2012; Lemke, Nathan D/L-9059-2013; Ye, Jun/C-3312-2011; Thomsen, Jan W./M-9087-2016; Campbell, Gretchen K/E-8338-2010; de Miranda, Marcio H. G./J-8293-2016; Martin, Michael/AAV-6857-2021; Diddams, Scott A/L-2819-2013	Blatt, Sebastian/0000-0003-2466-9967; Poli, Nicola/0000-0003-4225-6832; Lemke, Nathan D/0000-0003-4165-0715; Ye, Jun/0000-0003-0076-2112; Thomsen, Jan W./0000-0003-3423-6989; Campbell, Gretchen K/0000-0003-2596-1919; de Miranda, Marcio H. G./0000-0002-4502-3623; Martin, Michael/0000-0002-6022-217X; Diddams, Scott A/0000-0002-2144-0764; Beck, Kristin/0000-0003-2486-4164; Le Coq, Yann/0000-0003-4220-2260				BAILLARD X, 2007, EUR PHYS J D; Barber ZW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.083002; Bize S, 2005, J PHYS B-AT MOL OPT, V38, pS449, DOI 10.1088/0953-4075/38/9/002; BLATT S, IN PRESS PHYS REV LE; Boyd MM, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022510; Boyd MM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083002; Boyd MM, 2006, SCIENCE, V314, P1430, DOI 10.1126/science.1133732; Brusch A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103003; Chang DE, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.023810; Foreman SM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.153601; Fortier TM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070801; Fortier TM, 2006, OPT LETT, V31, P1011, DOI 10.1364/OL.31.001011; Heavner TP, 2005, METROLOGIA, V42, P411, DOI 10.1088/0026-1394/42/5/012; HOLLBERG L, 1984, PHYS REV LETT, V53, P230, DOI 10.1103/PhysRevLett.53.230; Hollberg L, 2005, J PHYS B-AT MOL OPT, V38, pS469, DOI 10.1088/0953-4075/38/9/003; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Ludlow AD, 2007, OPT LETT, V32, P641, DOI 10.1364/OL.32.000641; Ludlow AD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.033003; Margolis HS, 2004, SCIENCE, V306, P1355, DOI 10.1126/science.1105497; Mickelson PG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.223002; OATES CW, 2006, IEEE INT FREQ CONTR, P74; Oskay WH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.020801; Porsev SG, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.020502; Santarelli G, 1998, IEEE T ULTRASON FERR, V45, P887, DOI 10.1109/58.710548; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Schiller S, 2007, NUCL PHYS B-PROC SUP, V166, P300, DOI 10.1016/j.nuclphysbps.2006.12.032; Schmid S, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/159; Schneider T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230801; Takamoto M, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.104302; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250404	33	446	470	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1805	1808		10.1126/science.1153341	http://dx.doi.org/10.1126/science.1153341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18276849	Green Submitted			2022-12-28	WOS:000254394000041
J	Hanahan, D; Weinberg, RA				Hanahan, Douglas; Weinberg, Robert A.			Retrospective - Judah Folkman (1933-2008)	SCIENCE			English	Biographical-Item									[Hanahan, Douglas] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Weinberg, Robert A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Hanahan, D (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	dh@biochem.ucsf.edu							0	6	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1055	1055		10.1126/science.1156080	http://dx.doi.org/10.1126/science.1156080			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292332				2022-12-28	WOS:000253311700032
J	Irby, DM; Wilkerson, L				Irby, David M.; Wilkerson, Luann			Teaching rounds - Teaching when time is limited	BRITISH MEDICAL JOURNAL			English	Editorial Material							ONE-MINUTE PRECEPTOR; CLERKSHIP EXPERIENCES; CARE SETTINGS; EDUCATION; FACULTY; FEEDBACK; LEARNER; MISSION; COMPETENCE; MEDICINE		[Irby, David M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Irby, David M.] Carnegie Fdn Advancement Teaching, Stanford, CA 94305 USA; [Wilkerson, Luann] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Irby, DM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	irbyd@ucsf.edu		Irby, David/0000-0001-5753-8918				Aagaard E, 2004, ACAD MED, V79, P42, DOI 10.1097/00001888-200401000-00010; [Anonymous], CLIN TEACH, DOI DOI 10.1111/J.1743-498X.2004.00013.X; Chacko KM, 2007, CLIN TEACH, V4, P82, DOI 10.1111/j.1743-498X.2007.00153.x; Cunningham AS, 1999, ARCH PEDIAT ADOL MED, V153, P114; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Eckstrom E, 2006, J GEN INTERN MED, V21, P410, DOI 10.1111/j.1525-1497.2006.00418.x; Furney SL, 2001, J GEN INTERN MED, V16, P620, DOI 10.1046/j.1525-1497.2001.016009620.x; Hewson MG, 1998, J GEN INTERN MED, V13, P111, DOI 10.1046/j.1525-1497.1998.00027.x; Irby DM, 2004, ACAD MED, V79, P729, DOI 10.1097/00001888-200408000-00003; Irby DM, 2004, ACAD MED, V79, P50, DOI 10.1097/00001888-200401000-00012; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; IRBY DM, 1992, ACAD MED, V67, P630, DOI 10.1097/00001888-199210000-00002; Kuo AK, 2005, MED EDUC, V39, P518, DOI 10.1111/j.1365-2929.2005.02132.x; Lake FR, 2004, MED J AUSTRALIA, V181, P158, DOI 10.5694/j.1326-5377.2004.tb06208.x; Neher J O, 1992, J Am Board Fam Pract, V5, P419; Regan-Smith M, 2007, TEACH LEARN MED, V19, P278, DOI 10.1080/10401330701366739; Ruedy J, 2003, ACAD MED, V78, P1121, DOI 10.1097/00001888-200311000-00008; Salerno SM, 2002, J GEN INTERN MED, V17, P779, DOI 10.1046/j.1525-1497.2002.11233.x; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Simpson D, 2007, MED EDUC, V41, P1002, DOI 10.1111/j.1365-2923.2007.02844.x; Smith AG, 1999, NEUROLOGY, V52, P317; Stites S, 2005, ACAD MED, V80, P1100, DOI 10.1097/00001888-200512000-00006; Teherani A, 2007, MED TEACH, V29, P323, DOI 10.1080/01421590701287988; Usatine RP, 1997, ACAD MED, V72, P766, DOI 10.1097/00001888-199709000-00010; Watson RT, 1999, ACAD MED, V74, P627, DOI 10.1097/00001888-199906000-00006; Wilkerson L, 1998, ACAD MED, V73, pS67, DOI 10.1097/00001888-199810000-00048; Wimmers PF, 2006, MED EDUC, V40, P450, DOI 10.1111/j.1365-2929.2006.02447.x; Wolpaw TM, 2003, ACAD MED, V78, P893, DOI 10.1097/00001888-200309000-00010	28	76	78	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					384	387		10.1136/bmj.39456.727199.AD	http://dx.doi.org/10.1136/bmj.39456.727199.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276715	Green Published			2022-12-28	WOS:000253550600043
J	Novick, RP				Novick, Richard P.			Medicine - Combating impervious bugs	SCIENCE			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; RESISTANCE; VIRULENCE; PERR		[Novick, Richard P.] NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA	New York University	Novick, RP (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	novick@saturn.med.nyu.edu		Novick, richard/0000-0003-4418-7893				Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIELSKI BHJ, 1985, PHILOS T ROY SOC B, V311, P473, DOI 10.1098/rstb.1985.0158; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; DIEP BA, 2008, ANN INTERN MED; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; LIU CI, 2008, SCIENCE         0214; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; OLSEN RJ, 2008, J CLIN MICROBIOL; TYSKI S, 1987, ZBL BAKT-INT J MED M, V265, P360	15	8	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					910	911		10.1126/science.1154769	http://dx.doi.org/10.1126/science.1154769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276877				2022-12-28	WOS:000253165700031
J	Sheridan, RL; Ryan, DP; Fuzaylov, G; Nimkin, K; Martyn, JAJ				Sheridan, Robert L.; Ryan, Daniel P.; Fuzaylov, Gennadiy; Nimkin, Katherine; Martyn, J. A. Jeevendra			A girl with an advanced neck contracture after a burn - Dermal scarring with severe contractures of the neck and face after a burn injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; TRACHEAL RECONSTRUCTION; MANAGEMENT; ANESTHESIA; AIRWAY		[Sheridan, Robert L.] Massachusetts Gen Hosp, Dept Burn Surg, Boston, MA 02114 USA; [Ryan, Daniel P.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Fuzaylov, Gennadiy; Martyn, J. A. Jeevendra] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Nimkin, Katherine] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sheridan, Robert L.] Shriners Hosp Children, Dept Surg, Boston, MA USA; [Fuzaylov, Gennadiy; Martyn, J. A. Jeevendra] Shriners Hosp Children, Dept Anesthesia, Boston, MA USA; [Sheridan, Robert L.; Ryan, Daniel P.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Fuzaylov, Gennadiy; Martyn, J. A. Jeevendra] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Nimkin, Katherine] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sheridan, RL (corresponding author), Massachusetts Gen Hosp, Dept Burn Surg, Boston, MA 02114 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055082] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055082] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angel C, 2000, PEDIATR SURG INT, V16, P98, DOI 10.1007/s003830050028; Caplan RA, 2003, ANESTHESIOLOGY, V98, P1269; Ceber M, 2006, J BURN CARE RES, V27, P760, DOI 10.1097/01.BCR.0000238091.41737.7C; Cheney FW, 2006, ANESTHESIOLOGY, V105, P1081, DOI 10.1097/00000542-200612000-00007; Eipe N, 2006, ANESTH ANALG, V102, P1911, DOI 10.1213/01.ANE.0000215149.69993.1B; Hines MH, 2003, ANN THORAC SURG, V76, P175, DOI 10.1016/S0003-4975(03)00129-2; Mayhew JF, 2005, PEDIATR ANESTH, V15, P173, DOI 10.1111/j.1460-9592.2005.01505.x; Shah F R, 2002, J Indian Soc Pedod Prev Dent, V20, P16; Sheridan R, 2001, J BURN CARE REHABIL, V22, P150, DOI 10.1097/00004630-200103000-00012; Tiruvoipati R, 2007, J PEDIATR SURG, V42, P1345, DOI 10.1016/j.jpedsurg.2007.03.031; 2004, ANESTHESIOLOGY, V101, P565	11	14	15	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					729	735		10.1056/NEJMcpc0708792	http://dx.doi.org/10.1056/NEJMcpc0708792			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272897				2022-12-28	WOS:000253127700011
J	Parelho, V; Hadjur, S; Spivakov, M; Leleu, M; Sauer, S; Gregson, HC; Jarmuz, A; Canzonetta, C; Webster, Z; Nesterova, T; Cobb, BS; Yokomori, K; Dillon, N; Aragon, L; Fisher, AG; Merkenschiager, M				Parelho, Vania; Hadjur, Suzana; Spivakov, Mikhail; Leleu, Marion; Sauer, Stephan; Gregson, Heather C.; Jarmuz, Adam; Canzonetta, Claudia; Webster, Zoe; Nesterova, Tatyana; Cobb, Bradley S.; Yokomori, Kyoko; Dillon, Niall; Aragon, Luis; Fisher, Amanda G.; Merkenschiager, Matthias			Cohesins functionally associate with CTCF on mammalian chromosome arms	CELL			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; ENHANCER-BLOCKING ACTIVITY; NIPPED-B; GENE-EXPRESSION; HUMAN HOMOLOG; SMC PROTEINS; CELL-CYCLE; ACTIVATION; INSULATOR	Cohesins mediate sister chromatid cohesion, which is essential for chromosome segregation and postreplicative DNA repair. In addition, cohesins appear to regulate gene expression and enhancer-promoter interactions. These noncanonical functions remained unexplained because knowledge of cohesin-binding sites and functional interactors in metazoans was lacking. We show that the distribution of cohesins on mammalian chromosome arms is not driven by transcriptional activity, in contrast to S. cerevisiae. Instead, mammalian cohesins occupy a subset of DNase I hypersensitive sites, many of which contain sequence motifs resembling the consensus for CTCF, a DNA-binding protein with enhancer blocking function and boundary-element activity. We find cohesins at most CTCF sites and show that CTCF is required for cohesin localization to these sites. Recruitment by CTCF suggests a rationale for noncanonical cohesin functions and, because CTCF binding is sensitive to DNA methylation, allows cohesin positioning to integrate DNA sequence and epigenetic state.	[Parelho, Vania; Hadjur, Suzana; Spivakov, Mikhail; Leleu, Marion; Sauer, Stephan; Webster, Zoe; Cobb, Bradley S.; Fisher, Amanda G.; Merkenschiager, Matthias] Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, London W12 0NN, England; [Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Nesterova, Tatyana] Univ London Imperial Coll Sci Technol & Med, Dev Epigenet Grp, MRC Clin Sci Ctr, London W12 0NN, England; [Gregson, Heather C.; Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of California System; University of California Irvine	Merkenschiager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk		Merkenschlager, Matthias/0000-0003-2889-3288; Spivakov, Mikhail/0000-0002-0383-3943; Nesterova, Tatyana/0000-0001-7740-4386; Canzonetta, Claudia/0000-0002-8928-5537	Medical Research Council [MC_U120027516, MC_U120074328, MC_U120036884] Funding Source: Medline; NIGMS NIH HHS [GM59150] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059150] Funding Source: NIH RePORTER; MRC [MC_U120036884, MC_U120027516, MC_U120074328] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; GROVES T, 1995, J IMMUNOL, V154, P5011; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	49	656	674	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					422	433		10.1016/j.cell.2008.01.011	http://dx.doi.org/10.1016/j.cell.2008.01.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18237772	Green Accepted, Bronze			2022-12-28	WOS:000253180700017
J	Grosse, SD; Roy, K				Grosse, Scott D.; Roy, Kakoli			Long-term economic effect of early childhood nutrition	LANCET			English	Editorial Material							HEALTH; WAGES		[Grosse, Scott D.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Roy, Kakoli] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grosse, SD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	sgrosse@cdc.gov		Grosse, Scott/0000-0003-1078-6855				Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HAAS JD, 1995, J NUTR, V125, pS1078; Hoddinott John, 2005, Food and Nutrition Bulletin, V26, pS98; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Maluccio JA, 2006, IMPACT NUTR EARLY CH; SAHN DE, 1988, J DEV ECON, V29, P157, DOI 10.1016/0304-3878(88)90033-8; Strauss J, 1998, J ECON LIT, V36, P766; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8	10	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					365	366		10.1016/S0140-6736(08)60180-4	http://dx.doi.org/10.1016/S0140-6736(08)60180-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	260ED	18242398				2022-12-28	WOS:000252992700007
J	Lee, S; Spencer, ND				Lee, Seunghwan; Spencer, Nicholas D.			Materials science - Sweet, hairy, soft, and slippery	SCIENCE			English	Editorial Material							POLYMER BRUSHES; LUBRICATION; FRICTION; SURFACES; HYDROGELS; FORCES; MUCIN		[Lee, Seunghwan; Spencer, Nicholas D.] ETH, Dept Mat, Surface Sci & Technol Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lee, S (corresponding author), ETH, Dept Mat, Surface Sci & Technol Lab, CH-8093 Zurich, Switzerland.	spencer@mat.ethz.ch	Spencer, NIcholas D./A-5843-2008; Lee, Seunghwan/K-8382-2014; Spencer, Nicholas/M-9647-2019	Spencer, NIcholas D./0000-0002-7873-7905; Lee, Seunghwan/0000-0002-0797-1446; Spencer, Nicholas/0000-0002-7873-7905				BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; Dowson D., 1998, HIST TRIBOLOGY; DROBEK T, 2007, LANGMUIR; Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p; Han L, 2007, BIOPHYS J, V92, P1384, DOI 10.1529/biophysj.106.091397; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Klein J, 1998, ACTA POLYM, V49, P617, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<617::AID-APOL617>3.0.CO;2-8; KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lee S, 2005, TRIBOL INT, V38, P922, DOI 10.1016/j.triboint.2005.07.017; Lee S, 2008, LUBR SCI, V20, P21, DOI 10.1002/ls.50; Moore DF., 1972, FRICTION LUBRICATION, V9, P1; Muller M, 2003, TRIBOL LETT, V15, P395, DOI 10.1023/B:TRIL.0000003063.98583.bb; Raviv U, 2002, LANGMUIR, V18, P7482, DOI 10.1021/la020002s; Tanaka Y, 2005, PROG POLYM SCI, V30, P1, DOI 10.1016/j.progpolymsci.2004.11.003	17	184	191	7	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					575	576		10.1126/science.1153273	http://dx.doi.org/10.1126/science.1153273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239111				2022-12-28	WOS:000252772000024
J	Ahart, M; Somayazulu, M; Cohen, RE; Ganesh, P; Dera, P; Mao, HK; Hemley, RJ; Ren, Y; Liermann, P; Wu, ZG				Ahart, Muhtar; Somayazulu, Maddury; Cohen, R. E.; Ganesh, P.; Dera, Przemyslaw; Mao, Ho-Kwang; Hemley, Russell J.; Ren, Yang; Liermann, Peter; Wu, Zhigang			Origin of morphotropic phase boundaries in ferroelectrics	NATURE			English	Article							RAMAN; PBTIO3	A piezoelectric material is one that generates a voltage in response to a mechanical strain ( and vice versa). The most useful piezoelectric materials display a transition region in their composition phase diagrams, known as a morphotropic phase boundary(1,2), where the crystal structure changes abruptly and the electromechanical properties are maximal. As a result, modern piezoelectric materials for technological applications are usually complex, engineered, solid solutions, which complicates their manufacture as well as introducing complexity in the study of the microscopic origins of their properties. Here we show that even a pure compound, in this case lead titanate, can display a morphotropic phase boundary under pressure. The results are consistent with first-principles theoretical predictions(3), but show a richer phase diagram than anticipated; moreover, the predicted electromechanical coupling at the transition is larger than any known. Our results show that the high electromechanical coupling in solid solutions with lead titanate is due to tuning of the high- pressure morphotropic phase boundary in pure lead titanate to ambient pressure. We also find that complex microstructures or compositions are not necessary to obtain strong piezoelectricity. This opens the door to the possible discovery of high- performance, pure-compound electromechanical materials, which could greatly decrease costs and expand the utility of piezoelectric materials.	[Ahart, Muhtar; Somayazulu, Maddury; Cohen, R. E.; Ganesh, P.; Dera, Przemyslaw; Mao, Ho-Kwang; Hemley, Russell J.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Ren, Yang] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Liermann, Peter] Carnegie Inst Sci, Adv Photon Source, HPCAT, Argonne, IL 60439 USA; [Wu, Zhigang] Univ Calif Berkeley, BNNI, Berkeley, CA 94720 USA	Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Berkeley	Cohen, RE (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	rcohen@ciw.edu	Cohen, Ronald/B-3784-2010; Ganesh, Panchapakesan/E-3435-2012; Ren, Yang/ABD-5801-2021; Dera, Przemyslaw/F-6483-2013; Cohen, Ronald/AAY-2570-2020; Wu, Zhigang/K-2554-2014; Ganesh, Panchapakesan/L-5571-2013; Ye, Shukai/A-2089-2009	Cohen, Ronald/0000-0001-5871-2359; Ganesh, Panchapakesan/0000-0002-7170-2902; Ren, Yang/0000-0001-9831-6035; Wu, Zhigang/0000-0001-8959-2345; Ganesh, Panchapakesan/0000-0002-7170-2902; Liermann, Hanns-Peter/0000-0001-5039-1183				Ahart M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2159568; BURNS G, 1970, PHYS REV LETT, V25, P167, DOI 10.1103/PhysRevLett.25.167; Cohen RE, 2006, NATURE, V441, P941, DOI 10.1038/441941a; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Feng Y, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1938954; Fornari M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.092101; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Ghita M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054114; Goldschmidt VM, 1929, T FARADAY SOC, V25, P0253, DOI 10.1039/tf9292500253; Goncharov AF, 2003, J RAMAN SPECTROSC, V34, P532, DOI 10.1002/jrs.1030; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Groth P., 1870, ANN PHYS CHEM, V217, P31; Guo R, 2000, PHYS REV LETT, V84, P5423, DOI 10.1103/PhysRevLett.84.5423; HEINZ DL, 1984, J APPL PHYS, V55, P885, DOI 10.1063/1.333139; JAFFE B, 1954, J APPL PHYS, V25, P809, DOI 10.1063/1.1721741; Jin YM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.197601; Kornev IA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196804; Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756; Noheda B., 2001, Physical Review B (Condensed Matter), V63, p014103/1, DOI 10.1103/PhysRevB.63.014103; RAMIREZ R, 1990, PHYS REV B, V42, P2604, DOI 10.1103/PhysRevB.42.2604; Rao WF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767146; Rutt U, 2001, NUCL INSTRUM METH A, V467, P1026, DOI 10.1016/S0168-9002(01)00580-0; Sani A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.020105; SANJURJO JA, 1983, PHYS REV B, V28, P7260, DOI 10.1103/PhysRevB.28.7260; Schonau KA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184117; Vanderbilt D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094108; Waghmare UV, 1997, PHYS REV B, V55, P6161, DOI 10.1103/PhysRevB.55.6161; Wu ZG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.037601	28	660	673	8	496	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					545	U2		10.1038/nature06459	http://dx.doi.org/10.1038/nature06459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235495				2022-12-28	WOS:000252739900035
J	BINNEY, J				BINNEY, J			GALACTIC STRUCTURE - SEEING THE WOOD, NOT THE TREES	NATURE			English	Editorial Material											BINNEY, J (corresponding author), UNIV OXFORD,DEPT THEORET PHYS,1 KEBLE RD,OXFORD OX1 3NP,ENGLAND.							GERHARD OE, 1989, ASTROPHYS J, V345, pL33, DOI 10.1086/185545; SCHECHTER PL, 1987, IAU S, V127, P217; ZARITSKY D, 1986, ASTROPHYS J, V303, P66, DOI 10.1086/164052; 1990, JAN AM ASTR SOC M WA	4	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					23	24		10.1038/344023b0	http://dx.doi.org/10.1038/344023b0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278009				2022-12-28	WOS:A1990CQ97200039
J	ROPER, DI				ROPER, DI			PHD STUDENTS	NATURE			English	Letter											ROPER, DI (corresponding author), UNIV LEICESTER,DEPT BIOCHEM,UNIV RD,LEICESTER LE1 7RH,ENGLAND.		Roper, David I/A-2323-2011	Roper, David I/0000-0003-0009-621X					0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					10	10		10.1038/344010c0	http://dx.doi.org/10.1038/344010c0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278000	Bronze			2022-12-28	WOS:A1990CQ97200027
J	SOYFER, VN				SOYFER, VN			AGAINST LYSENKO	NATURE			English	Editorial Material									OHIO STATE UNIV,OHIO STATE BIOTECHNOL CTR,COLUMBUS,OH 43210	Ohio State University	SOYFER, VN (corresponding author), OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210, USA.								0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					14	14		10.1038/344014a0	http://dx.doi.org/10.1038/344014a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278004	Bronze			2022-12-28	WOS:A1990CQ97200030
J	Muruve, DA; Petrilli, V; Zaiss, AK; White, LR; Clark, SA; Ross, PJ; Parks, RJ; Tschopp, J				Muruve, Daniel A.; Petrilli, Virginie; Zaiss, Anne K.; White, Lindsay R.; Clark, Sharon A.; Ross, P. Joel; Parks, Robin J.; Tschopp, Jurg			The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response	NATURE			English	Article							ADENOVIRUS VECTORS; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; GENE-THERAPY; IN-VIVO; INFECTION; EXPRESSION; RECEPTOR; DISEASE; ASC	The innate immune system recognizes nucleic acids during infection and tissue damage. Whereas viral RNA is detected by endosomal toll- like receptors ( TLR3, TLR7, TLR8) and cytoplasmic RIG-I and MDA5, endosomal TLR9 and cytoplasmic DAI bind DNA(1), resulting in the activation of nuclear factor-kappa B and interferon regulatory factor transcription factors. However, viruses also trigger pro- inflammatory responses(2), which remain poorly defined. Here we show that internalized adenoviral DNA induces maturation of pro- interleukin-1 beta in macrophages, which is dependent on NALP3 and ASC, components of the innate cytosolic molecular complex termed the inflammasome. Correspondingly, NALP3- and ASC- deficient mice display reduced innate inflammatory responses to adenovirus particles. Inflammasome activation also occurs as a result of transfected cytosolic bacterial, viral and mammalian ( host) DNA, but in this case sensing is dependent on ASC but not NALP3. The DNA- sensing pro- inflammatory pathway functions independently of TLRs and interferon regulatory factors. Thus, in addition to viral and bacterial components or danger signals in general, inflammasomes sense potentially dangerous cytoplasmic DNA, strengthening their central role in innate immunity.	[Petrilli, Virginie; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Muruve, Daniel A.; White, Lindsay R.; Clark, Sharon A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; [Zaiss, Anne K.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Ross, P. Joel; Parks, Robin J.] Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1Y 4E9, Canada	University of Lausanne; University of Calgary; University of Calgary; University of Ottawa; Ottawa Hospital Research Institute	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Jurg.Tschopp@unil.ch	Ross, Joel/K-3361-2019; Petrilli, Virginie/ABI-8199-2020	Ross, Joel/0000-0001-7105-7117; Petrilli, Virginie/0000-0001-8502-6979				Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; COTTEN M, 1994, VIROLOGY, V205, P254, DOI 10.1006/viro.1994.1641; Cotter MJ, 2005, J VIROL, V79, P14622, DOI 10.1128/JVI.79.23.14622-14631.2005; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fujioka N, 1999, J VIROL, V73, P2401, DOI 10.1128/JVI.73.3.2401-2409.1999; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Shayakhmetov DM, 2005, J IMMUNOL, V174, P7310, DOI 10.4049/jimmunol.174.11.7310; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stilwell JL, 2003, J VIROL, V77, P12881, DOI 10.1128/JVI.77.23.12881-12885.2003; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	30	729	769	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					103	U11		10.1038/nature06664	http://dx.doi.org/10.1038/nature06664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288107				2022-12-28	WOS:000253671900055
J	Christakis, NA				Christakis, Nicholas A.			What networks can teach us about drug use	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, England	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/B-6690-2008; Christakis, Nicholas A/C-3205-2009						0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					420	420		10.1136/bmj.39496.537396.59	http://dx.doi.org/10.1136/bmj.39496.537396.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292167	Green Published			2022-12-28	WOS:000253664000035
J	Rader, DJ; Daugherty, A				Rader, Daniel J.; Daugherty, Alan			Translating molecular discoveries into new therapies for atherosclerosis	NATURE			English	Article							CORONARY-ARTERY-DISEASE; APOE-DEFICIENT MICE; RANDOMIZED CONTROLLED-TRIAL; HIGH-DENSITY-LIPOPROTEINS; SMOOTH-MUSCLE-CELLS; TRANSPORT IN-VIVO; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-E; PLAQUE RUPTURE	Atherosclerosis is characterized by the thickening of the arterial wall and is the primary cause of coronary artery disease and cerebrovascular disease, two of the most common causes of illness and death worldwide. Clinical trials have confirmed that certain lipoproteins and the renin-angiotensin-aldosterone system are important in the pathogenesis of atherosclerotic cardiovascular disease, and that interventions targeted towards these are beneficial. Furthermore, efforts to understand how risk factors such as high blood pressure, dysregulated blood lipids and diabetes contribute to atherosclerotic disease, as well as to understand the molecular pathogenesis of atherosclerotic plaques, are leading to new targets for therapy.	[Rader, Daniel J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Daugherty, Alan] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Daugherty, Alan] Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Kentucky; University of Kentucky	Rader, DJ (corresponding author), Univ Penn, Sch Med, Cardiovasc Inst, 654 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Davies PF, 2007, CIRC RES, V101, P10, DOI 10.1161/CIRCRESAHA.107.156539; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hakonarson H, 2005, JAMA-J AM MED ASSOC, V293, P2245, DOI 10.1001/jama.293.18.2245; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hobbs HH, 1999, J CLIN INVEST, V104, P1015, DOI 10.1172/JCI8509; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P973, DOI 10.1161/01.ATV.0000261545.53586.f0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lu H, 2007, CURR DRUG TARGETS, V8, P1181, DOI 10.2174/138945007782403829; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Michelsen KS, 2006, CURR OPIN HEMATOL, V13, P163, DOI 10.1097/01.moh.0000219662.88409.7c; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schober A, 2006, TRENDS CARDIOVAS MED, V16, P103, DOI 10.1016/j.tcm.2006.01.006; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Webb NR, 2005, CURR OPIN LIPIDOL, V16, P341, DOI 10.1097/01.mol.0000169355.20395.55; Weiss D, 2001, CIRCULATION, V103, P448; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	100	362	386	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					904	913		10.1038/nature06796	http://dx.doi.org/10.1038/nature06796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288179				2022-12-28	WOS:000253313100030
J	Schneeweiss, S; Seeger, JD; Landon, J; Walker, AM				Schneeweiss, Sebastian; Seeger, John D.; Landon, Joan; Walker, Alexander M.			Aprotinin during coronary-artery bypass grafting and risk of death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSILON-AMINOCAPROIC ACID; PROPENSITY SCORE; CARDIAC-SURGERY; TRANEXAMIC ACID; MORTALITY; THERAPY; METAANALYSIS; DATABASE; OUTCOMES; PATIENT	Background Aprotinin (Trasylol) is used to mitigate bleeding during coronary-artery bypass grafting (CABG). Accumulating evidence suggests that this practice increases mortality. Methods Using electronic administrative records of the Premier Perspective Comparative Database, we studied hospitalized patients with operating-room charges for the use of aprotinin (33,517 patients) or aminocaproic acid (44,682 patients) on the day CABG was performed. We tabulated the numbers of patients with a hospital-discharge status of death and performed three types of analyses: a multivariable logistic-regression analysis (primary analysis); propensity-score matching in the highly selected subcohort of patients who received full amounts of the study drug, who underwent CABG by surgeons who performed 50 or more CABG surgeries during the study period, and for whom information on 10 additional covariates was available because the surgery occurred on hospital day 3 or later; and an instrumental-variable analysis of data from patients whose surgeons showed a strong preference for one of the two study drugs. Results In all, 1512 of the 33,517 aprotinin recipients (4.5%) and 1101 of the 44,682 aminocaproic acid recipients (2.5%) died. After adjustment for 41 characteristics of patients and hospitals, the estimated risk of death was 64% higher in the aprotinin group than in the aminocaproic acid group (relative risk, 1.64; 95% confidence interval [CI], 1.50 to 1.78). In the first 7 days after surgery, the adjusted relative risk of in-hospital death in the aprotinin group was 1.78 (95% CI, 1.56 to 2.02). The relative risk in a propensity-score-matched analysis was 1.32 (95% CI, 1.08 to 1.63). In the instrumental-variable analysis, the use of aprotinin was found to be associated with an excess risk of death of 1.59 per 100 patients (95% CI, 0.14 to 3.04). Postoperative revascularization and dialysis were more frequent among recipients of aprotinin than among recipients of aminocaproic acid. Conclusions Patients who received aprotinin alone on the day of CABG surgery had a higher mortality than patients who received aminocaproic acid alone. Characteristics of neither the patients nor the surgeons explain the difference, which persisted through several approaches to control confounding.	[Schneeweiss, Sebastian] Harvard Univ, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Brigham & Womens Hosp,Dept Med, Boston, MA 02120 USA; [Seeger, John D.; Walker, Alexander M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schneeweiss, Sebastian; Seeger, John D.; Landon, Joan] i3 Drug Safety, Waltham, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Schneeweiss, S (corresponding author), Harvard Univ, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Brigham & Womens Hosp,Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	schneeweiss@post.harvard.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], 2007, EARLY COMMUNICATION; *BAYER HEALTHCARE, 2007, BAYER TEMP SUSP GLOB; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; DeLong ER, 2005, BIOMETRICS, V61, P942, DOI 10.1111/j.1541-0420.2005.00358.x; Despotis GJ, 1999, J CARDIOTHOR VASC AN, V13, P18; Greene H., 2003, ECONOMETRIC ANAL; Gunawan B, 2006, ALIMENT PHARM THER, V23, P115, DOI 10.1111/j.1365-2036.2006.02730.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harder S, 2004, CLIN PHARMACOKINET, V43, P963, DOI 10.2165/00003088-200443140-00002; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Jamieson WRE, 1997, CIRCULATION, V96, P96; KAKAIYA R, 2004, CARDIOPULMONARY BYPA; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Munoz JJ, 1999, CIRCULATION, V99, P81, DOI 10.1161/01.CIR.99.1.81; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Peterson ED, 2000, J AM COLL CARDIOL, V36, P2174, DOI 10.1016/S0735-1097(00)01022-6; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schmer Ryan G, 2003, J Extra Corpor Technol, V35, P304; Schneeweiss S, 2006, ARTHRITIS RHEUM-US, V54, P3390, DOI 10.1002/art.22219; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Sievert Alicia, 2003, J Extra Corpor Technol, V35, P39; Spanier TB, 1999, ANN THORAC SURG, V68, P1078, DOI 10.1016/S0003-4975(99)00657-8; SUNDT TM, 1993, ANN THORAC SURG, V55, P1418, DOI 10.1016/0003-4975(93)91082-X; van der Linden J, 2005, CIRCULATION, V112, pI276, DOI 10.1161/CIRCULATIONAHA.104.524611; Villar A, 2002, HAEMOPHILIA, V8, P189, DOI 10.1046/j.1365-2516.2002.00645.x; Walker AM, 1996, EPIDEMIOLOGY, V7, P335; WEST SL, 1994, J CLIN EPIDEMIOL, V47, P165, DOI 10.1016/0895-4356(94)90021-3; Winterstein AG, 2006, PHARMACOEPIDEM DR S, V15, pS120; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	252	256	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					771	783		10.1056/NEJMoa0707571	http://dx.doi.org/10.1056/NEJMoa0707571			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287600	Bronze			2022-12-28	WOS:000253257700003
J	Wen, CP; Tsai, SP; Chung, WSI				Wen, Chi Pang; Tsai, Shan Pou; Chung, Wen-Shen Isabella			A 10-year experience with universal health insurance in Taiwan: Measuring changes in health and health disparity	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE EXPECTANCY; UNITED-STATES; CARE UTILIZATION; MEDICAL-CARE; MORTALITY	Background: Universal national health insurance, financed jointly by payroll taxes, subsidies, and individual premiums, commenced in Taiwan in 1995. Coverage expanded from 57% of the population (before the introduction of national health insurance) to 98%. Objective: To assess the role of national health insurance in improving life expectancy and reducing health disparities in Taiwan. Design: A before-and-after comparison of the decade before the introduction of national health insurance (1982 - 1984 to 1992 - 1994) with the decade after (1992 - 1994 to 2002 - 2004). Setting: Taiwan. Patients: All townships(n=358) in Taiwan were ranked according to overall mortality rates before the introduction of national health insurance and then ranked into 10 health class groups in descending order of health (groups 1 [healthiest] to 10 [least healthy]). Measurements: Health improvement (change in life expectancy after the introduction of national health insurance) and health disparity (reduction in the difference in life expectancy between the highest- and lowest-ranked health class groups). Results: After the introduction of national health insurance, life expectancy increased more in health class groups that had higher mortality rates before the introduction of national health insurance and health disparity narrowed, reversing an earlier trend toward widening disparity. The major contributors to the reduction in disparity were relatively larger reductions in death from cardiovascular diseases, ill-defined conditions, infectious diseases, and accidents in the lower-ranked health class groups. However, death from cancer increased more in the lower-ranked health class groups. Utilization of medical services increased, whereas cost remained at 5% to 6% of the gross domestic product. The per capita average annual number of visits to the physician's office was 14. Limitation: The interpretation of comparisons before and after the introduction of national health insurance assumes that the changes were entirely due to the effect of national health insurance rather than secular trends. Conclusion: Life expectancy after the introduction of national health insurance improved more for lower-ranked health classes, resulting in narrowed health disparity. The magnitude of the reduced disparity was small compared with the size of the remaining gaps. Relying on universal insurance alone to eliminate health disparity does not seem realistic. To further reduce health disparity, universal insurance programs should incorporate primary prevention, focusing on lifestyle risk reductions.	[Wen, Chi Pang] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Zhunan Town 350, Miaoli Cty, Taiwan	National Health Research Institutes - Taiwan	Wen, CP (corresponding author), Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, 35 Kenyan Rd, Zhunan Town 350, Miaoli Cty, Taiwan.	cwengood@nhri.org.cw	Wen, Chi-Pang/E-3851-2010					[Anonymous], 2003, HEALTH AFFAIR, V22, P60; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BLANK RH, 2004, COMP HLTH POLICY; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; *BUR NAT HLTH INS, SURV NHI SAT; *BUR NAT HLTH INS, 1996, NAT HLTH INS ANN STA; *BUR NAT HLTH INS, 2005, NAT HLTH INS ANN STA; Chang HY, 2001, J RHEUMATOL, V28, P1640; Chang WC, 2006, INT J OBESITY, V30, P359, DOI 10.1038/sj.ijo.0803053; Chen LW, 2007, HEALTH ECON, V16, P223, DOI 10.1002/hec.1160; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; Cheng SH, 1998, SOC SCI MED, V47, P613, DOI 10.1016/S0277-9536(98)00103-8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cheng TY, 2005, TOB CONTROL, V14, pI23, DOI 10.1136/tc.2003.005546; Chiang CL, 1984, LIFE TABLE ITS APPL; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; CHUA KP, CASE UNIVERSAL HLTH; *CTR MED MED SERV, 2006, HIGHL; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; *DEP HLTH, 1998, CANC REG ANN REP 199; *DEP HLTH, 2005, CANC REG ANN REP 200; Emanuel EJ, 2005, NEW ENGL J MED, V352, P1255, DOI 10.1056/NEJMsb041704; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; Lai DJ, 2004, AIDS, V18, P1732, DOI 10.1097/01.aids.0000131383.15232.95; Lamm R., 2007, CONDITION CRITICAL N; LOPEZ AD, 1977, STUDIES AUSTR MORALI; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; MCKEOWN T, 1976, ROLE MED; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; PEABODY JW, 1995, JAMA-J AM MED ASSOC, V273, P777, DOI 10.1001/jama.273.10.777; POLLARD JH, 1988, DEMOGRAPHY, V25, P265, DOI 10.2307/2061293; Pollard JH, 1982, J I ACTUARIES, V109, P225, DOI DOI 10.1017/S0020268100036258; RETHERFORD RD, 1972, DEMOGRAPHY, V9, P203, DOI 10.2307/2060633; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Tsai M C, 1999, Inj Prev, V5, P290; TSAI SP, 1992, AM J EPIDEMIOL, V135, P824, DOI 10.1093/oxfordjournals.aje.a116369; TSAI SP, 1982, AM J EPIDEMIOL, V116, P376, DOI 10.1093/oxfordjournals.aje.a113421; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Wen CP, 2005, TOB CONTROL, V14, pI16, DOI 10.1136/tc.2004.008003; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Wen CP, 2004, INT J EPIDEMIOL, V33, P320, DOI 10.1093/ije/dyh009	46	269	270	0	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2008	148	4					258	267		10.7326/0003-4819-148-4-200802190-00004	http://dx.doi.org/10.7326/0003-4819-148-4-200802190-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	264UR	18283203				2022-12-28	WOS:000253316400002
J	Schmitz, OJ				Schmitz, Oswald J.			Effects of predator hunting mode on grassland ecosystem function	SCIENCE			English	Article							TROPHIC CASCADES; ISLE-ROYALE; BIODIVERSITY; PLANT; DIVERSITY; DYNAMICS; FOREST	The way predators control their prey populations is determined by the interplay between predator hunting mode and prey antipredator behavior. It is uncertain, however, how the effects of such interplay control ecosystem function. A 3- year experiment in grassland mesocosms revealed that actively hunting spiders reduced plant species diversity and enhanced aboveground net primary production and nitrogen mineralization rate, whereas sit- and- wait ambush spiders had opposite effects. These effects arise from the different responses to the two different predators by their grasshopper prey- the dominant herbivore species that controls plant species composition and accordingly ecosystem functioning. Predator hunting mode is thus a key functional trait that can help to explain variation in the nature of top- down control of ecosystems.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06511 USA	Yale University; Yale University	Schmitz, OJ (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	oswald.schmitz@yale.edu						Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Chalcraft DR, 2003, AM NAT, V162, P390, DOI 10.1086/378210; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Schmidt Oswald J., 2005, P256; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Schmitz OJ, 2004, ECOL STU AN, V173, P277; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x	30	372	382	2	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					952	954		10.1126/science.1152355	http://dx.doi.org/10.1126/science.1152355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276890				2022-12-28	WOS:000253165700046
J	Shoubridge, EA; Wai, T				Shoubridge, Eric A.; Wai, Timothy			Medicine - Sidestepping mutational meltdown	SCIENCE			English	Editorial Material							MITOCHONDRIAL-DNA; DRIFT		[Shoubridge, Eric A.; Wai, Timothy] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Shoubridge, Eric A.; Wai, Timothy] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca	Wai, Timothy/AAA-7226-2019	Wai, Timothy/0000-0002-6770-6222				Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FELSENSTEIN J, 1974, GENETICS, V78, P737; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606	9	27	27	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					914	915		10.1126/science.1154515	http://dx.doi.org/10.1126/science.1154515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276880				2022-12-28	WOS:000253165700034
J	Brusco, MJ; Kohn, HF				Brusco, Michael J.; Koehn, Hans-Friedrich			Comment on "clustering by passing messages between data points"	SCIENCE			English	Editorial Material							P-MEDIAN PROBLEM		[Brusco, Michael J.] Florida State Univ, Coll Business, Tallahassee, FL 32306 USA; [Koehn, Hans-Friedrich] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA	State University System of Florida; Florida State University; University of Missouri System; University of Missouri Columbia	Brusco, MJ (corresponding author), Florida State Univ, Coll Business, 307 Rovetta Business Bldg, Tallahassee, FL 32306 USA.	mbrusco@cob.fsu.edu						Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; GROTSCHEL M, 1991, MATH PROGRAM, V51, P141, DOI 10.1007/BF01586932; HANJOUL P, 1985, EUR J OPER RES, V20, P387, DOI 10.1016/0377-2217(85)90012-8; Hansen P., 1997, Location Science, V5, P207, DOI 10.1016/S0966-8349(98)00030-8; Hartigan J., 1975, CLUSTERING ALGORITHM; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Mladenovic N, 2007, EUR J OPER RES, V179, P927, DOI 10.1016/j.ejor.2005.05.034; Rolland E, 1997, EUR J OPER RES, V96, P329, DOI 10.1016/S0377-2217(96)00141-5; TEITZ MB, 1968, OPER RES, V16, P955, DOI 10.1287/opre.16.5.955	11	32	39	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864								10.1126/science.1150938	http://dx.doi.org/10.1126/science.1150938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258881				2022-12-28	WOS:000252963000020
J	Knaut, H; Schier, AF				Knaut, Holger; Schier, Alexander F.			Clearing the path for germ cells	CELL			English	Editorial Material							RECEPTOR; MIGRATION	The chemokine SDF-1a and its receptor CXCR4b guide germ cell migration in zebrafish by activating downstream signaling events. Boldajipour et al. (2008) now report that a second SDF-1a receptor, CXCR7, is also required for guided migration but does not function as a signaling receptor, and instead sequesters SDF-1a. These results highlight the importance of ligand clearance during guided cell migration.	[Knaut, Holger] NYU, Dev Genet Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Knaut, Holger] NYU, Med Skirball Inst, New York, NY 10016 USA; [Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Broad Inst, Ctr Brain Sci,Harvard Stem Cell Inst, Cambridge, MA 02138 USA	New York University; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Knaut, H (corresponding author), NYU, Dev Genet Program, Kimmel Ctr Biol, 550 1St Ave, New York, NY 10016 USA.	hknaut@mcb.harvard.edu; schier@fas.harvard.edu		Knaut, Holger/0000-0002-8399-8720; Schier, Alexander Franz/0000-0001-7645-5325				Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Schier AF, 2003, CURR BIOL, V13, pR192, DOI 10.1016/S0960-9822(03)00122-2; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020	11	13	16	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					337	339		10.1016/j.cell.2008.01.023	http://dx.doi.org/10.1016/j.cell.2008.01.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267065	Bronze			2022-12-28	WOS:000253180700008
J	Wajapeyee, N; Serra, RW; Zhu, X; Mahalingam, M; Green, MR				Wajapeyee, Narendra; Serra, Ryan W.; Zhu, Xiaochun; Mahalingam, Meera; Green, Michael R.			Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7	CELL			English	Article							CELL-CYCLE ARREST; MALIGNANT-MELANOMA; CANCER-CELLS; C-JUN; GROWTH; MUTATIONS; KINASE; INHIBITION; EXPRESSION; INDUCTION	Expression of an oncogene in a primary cell can, paradoxically, block proliferation by inducing senescence or apoptosis through pathways that remain to be elucidated. Here we perform genome-wide RNA-interference screening to identify 17 genes required for an activated BRAF oncogene (BRAFV600E) to block proliferation of human primary fibroblasts and melanocytes. Surprisingly, we find a secreted protein, IGFBP7, has a central role in BRAFV600E-mediated senescence and apoptosis. Expression of BRAFV600E in primary cells leads to synthesis and secretion of IGFBP7, which acts through autocrine/paracrine pathways to inhibit BRAF-MEK-ERK signaling and induce senescence and apoptosis. Apoptosis results from IGFBP7-mediated upregulation of BNIP3L, a proapoptotic BCL2 family protein. Recombinant IGFBP7 (rIGFBP7) induces apoptosis in BRAFV600E-positive human melanoma cell lines, and systemically administered rlGFBP7 markedly suppresses growth of BRAFV600E-positive tumors in xenografted mice. Immunohistochemical analysis of human skin, nevi, and melanoma samples implicates loss of IGFBP7 expression as a critical step in melanoma genesis.	[Wajapeyee, Narendra; Serra, Ryan W.; Zhu, Xiaochun; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA; [Mahalingam, Meera] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Green, MR (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012	Mahalingam, Meera/0000-0002-2800-9985	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Mutaguchi K, 2003, CANCER RES, V63, P7717; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; PEEPER DS, 2002, NUCLEIC ACIDS RES, V29, pE45; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Ruan Wen-jing, 2006, J Zhejiang Univ Sci B, V7, P929, DOI 10.1631/jzus.2006.B0929; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sparrow LE, 1998, AM J DERMATOPATH, V20, P255, DOI 10.1097/00000372-199806000-00006; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wang YL, 1996, BRIT J DERMATOL, V134, P269; Wilson EM, 1997, J CLIN ENDOCR METAB, V82, P1301, DOI 10.1210/jc.82.4.1301; Wilson HMP, 2002, CELL GROWTH DIFFER, V13, P205; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	38	668	701	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					363	374		10.1016/j.cell.2007.12.032	http://dx.doi.org/10.1016/j.cell.2007.12.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267069	Bronze, Green Accepted			2022-12-28	WOS:000253180700012
J	Freeman, R				Freeman, Roy			Neurogenic orthostatic hypotension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-SYSTEM ATROPHY; PURE AUTONOMIC FAILURE; PARKINSONS-DISEASE; DOUBLE-BLIND; HYPERTENSION; DYSFUNCTION; NEUROPATHY; MIDODRINE; DIAGNOSIS; DEMENTIA		Harvard Univ, Ctr Autonom & Peripheral Nerve Disorders, Beth Israel Deaconess Med Ctr, Sch Med,Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Freeman, R (corresponding author), Harvard Univ, Ctr Autonom & Peripheral Nerve Disorders, Beth Israel Deaconess Med Ctr, Sch Med,Dept Neurol, 1 Deaconess Rd, Boston, MA 02215 USA.	rfreeman@bidmc.harvard.edu						Adams D, 2001, J NEUROL, V248, P647, DOI 10.1007/s004150170109; Aminoff M, 1996, NEUROLOGY, V46, P873; Axelrod F.B., 2002, CLIN AUTON RES S1, V12, pI2, DOI DOI 10.1007/S102860200014; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Bhattacharya K, 2002, ARCH NEUROL-CHICAGO, V59, P835, DOI 10.1001/archneur.59.5.835; BIAGGIONI I, 1994, ANN INTERN MED, V121, P181, DOI 10.7326/0003-4819-121-3-199408010-00004; Biaggioni I, 2007, HYPERTENSION, V49, P21, DOI 10.1161/01.HYP.0000250920.38461.ed; CHOBANIAN AV, 1979, NEW ENGL J MED, V301, P68, DOI 10.1056/NEJM197907123010202; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; FOUADTARAZI FM, 1995, AM J MED, V99, P604, DOI 10.1016/S0002-9343(99)80246-0; Freeman R, 1999, NEUROLOGY, V53, P2151, DOI 10.1212/WNL.53.9.2151; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Freeman R, 2004, NEUROLOGY, V63, P953, DOI 10.1212/01.WNL.0000142230.98881.6C; Freeman R, 2003, SEMIN NEUROL, V23, P435; Gibbons CH, 2005, CLIN AUTON RES, V15, P40, DOI 10.1007/s10286-005-0227-1; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; Gilman S, 1998, J AUTONOM NERV SYST, V74, P189; Goldstein DS, 2004, ANN NY ACAD SCI, V1018, P231, DOI 10.1196/annals.1296.028; HOELDTKE RD, 1993, NEW ENGL J MED, V329, P611, DOI 10.1056/NEJM199308263290904; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; Jordan J, 1998, AM J MED, V105, P116, DOI 10.1016/S0002-9343(98)00193-4; Kaufmann H, 2003, CIRCULATION, V108, P724, DOI 10.1161/01.CIR.0000083721.49847.D7; Kaufmann H, 2004, NEUROLOGY, V63, P1093, DOI 10.1212/01.WNL.0000138500.73671.DC; Kaufmann H, 2003, SEMIN NEUROL, V23, P351; KAUFMANN H, 1992, NEUROLOGY, V42, P590, DOI 10.1212/WNL.42.3.590; Lahrmann H, 2006, EUR J NEUROL, V13, P930, DOI 10.1111/j.1468-1331.2006.01512.x; LIPSITZ LA, 1993, CIRCULATION, V87, P391, DOI 10.1161/01.CIR.87.2.391; Low PA, 1997, JAMA-J AM MED ASSOC, V277, P1046, DOI 10.1001/jama.277.13.1046; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; Low PA, 1997, JAMA-J AM MED ASSOC, V278, P388; Low PA, 2003, MUSCLE NERVE, V27, P646, DOI 10.1002/mus.10333; Omboni S, 2001, CLIN SCI, V101, P609, DOI 10.1042/CS20010071; Orimo S, 2007, J NEUROL, V254, P21, DOI 10.1007/s00415-007-4005-y; PERERA R, 1995, CLIN AUTON RES, V5, P211, DOI 10.1007/BF01824009; Robertson D, 1994, Clin Auton Res, V4, P99, DOI 10.1007/BF01845772; Rudnicki SA, 2005, CURR OPIN NEUROL, V18, P598, DOI 10.1097/01.wco.0000173462.17135.ee; Sakakibara R, 2003, CLIN AUTON RES, V13, P106, DOI 10.1007/s10286-003-0052-3; Schatz IJ, 1996, J AUTONOM NERV SYST, V58, P123; SCHRAG A, IN PRESS MOV DISORD; Senard JM, 2001, DRUG AGING, V18, P495, DOI 10.2165/00002512-200118070-00003; Shannon JR, 2000, CIRCULATION, V101, P2710, DOI 10.1161/01.CIR.101.23.2710; Shibao C, 2007, AM J MED, V120, P975, DOI 10.1016/j.amjmed.2007.05.009; Singer W, 2006, ARCH NEUROL-CHICAGO, V63, P513, DOI 10.1001/archneur.63.4.noc50340; Smit AAJ, 1999, J PHYSIOL-LONDON, V519, P1, DOI 10.1111/j.1469-7793.1999.0001o.x; Smit AAJ, 2004, CLIN AUTON RES, V14, P167, DOI 10.1007/s10286-004-0187-x; Thaisetthawatkul P, 2004, NEUROLOGY, V62, P1804, DOI 10.1212/01.WNL.0000125192.69777.6D; Vagaonescu TD, 2000, LANCET, V355, P725, DOI 10.1016/S0140-6736(99)05320-9; van Lieshout JJ, 2000, CLIN AUTON RES, V10, P35, DOI 10.1007/BF02291388; VANLIESHOUT JJ, 1992, LANCET, V339, P897, DOI 10.1016/0140-6736(92)90932-S; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Wieling W, 2002, CLIN AUTON RES, V12, P242, DOI 10.1007/s10286-002-0024-z; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091; Wright RA, 1999, J AUTONOM NERV SYST, V75, P70, DOI 10.1016/S0165-1838(98)00164-7; Wright RA, 1998, NEUROLOGY, V51, P120, DOI 10.1212/WNL.51.1.120	55	238	269	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					615	624		10.1056/NEJMcp074189	http://dx.doi.org/10.1056/NEJMcp074189			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256396				2022-12-28	WOS:000252916400008
J	Kuter, DJ; Bussel, JB; Lyons, RM; Pullarkat, V; Gernsheimer, TB; Senecal, FM; Aledort, LM; George, JN; Kessler, CM; Sanz, MA; Liebman, HA; Slovick, FT; de Wolf, JTM; Bourgeois, E; Guthrie, TH; Newland, A; Wasser, JS; Hamburg, SI; Grande, C; Lefrere, F; Lichtin, AE; Tarantino, MD; Terebelo, HR; Viallard, JF; Cuevas, FJ; Go, RS; Henry, DH; Redner, RL; Rice, L; Schipperus, MR; Guo, DM; Nichol, JL				Kuter, David J.; Bussel, James B.; Lyons, Roger M.; Pullarkat, Vinod; Gernsheimer, Terry B.; Senecal, Francis M.; Aledort, Louis M.; George, James N.; Kessler, Craig M.; Sanz, Miguel A.; Liebman, Howard A.; Slovick, Frank T.; de Wolf, J. Th M.; Bourgeois, Emmanuelle; Guthrie, Troy H., Jr.; Newland, Adrian; Wasser, Jeffrey S.; Hamburg, Solomon I.; Grande, Carlos; Lefrere, Francois; Lichtin, Alan Eli; Tarantino, Michael D.; Terebelo, Howard R.; Viallard, Jean-Francois; Cuevas, Francis J.; Go, Ronald S.; Henry, David H.; Redner, Robert L.; Rice, Lawrence; Schipperus, Martin R.; Guo, D. Matthew; Nichol, Janet L.			Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial	LANCET			English	Article							ADULT PATIENTS; THROMBOPOIETIN LEVELS; PLATELET DESTRUCTION; CHRONIC ITP; IN-VITRO; AMG-531; MEGAKARYOCYTES; AUTOANTIBODIES; SPLENECTOMY; TGF-BETA-1	Background Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated platelet destruction and decreased platelet production. Short-term administration of the thrombopoiesis-stimulating protein, romiplostim, has been shown to increase platelet counts in most patients with chronic ITP. We assessed the long-term administration of romiplostim in splenectomised and non-splenectomised patients with ITP. Methods In two parallel trials, 63 splenectomised and 62 non-splenectomised patients with ITP and a mean of three platelet counts 30x10(9)/L or less were randomly assigned 2:1 to subcutaneous injections of romiplostim (n=42 in splenectomised study and n=41 in non-splenectomised study) or placebo (n=21 in both studies) every week for 24 weeks. Doses of study drug were adjusted to maintain platelet counts of 50x10(9)/L to 200x10(9)/L. The primary objectives were to assess the efficacy of romiplostim as measured by a durable platelet response (platelet count >= 50x10(9)/L during 6 or more of the last 8 weeks of treatment) and treatment safety. Analysis was per protocol. These studies are registered with ClinicalTrials.gov, numbers NCT00102323 and NCT00102336. Findings A durable platelet response was achieved by 16 of 42 splenectomised patients given romplostim versus none of 21 given placebo (difference in proportion of patients responding 38% [95% CI 23.4-52.8], p=0.0013), and by 25 of 41 non-splenectomised patients given romplostim versus one of 21 given placebo (56% [38.7-73.71, p<0.0001). The overall platelet response rate (either durable or transient platelet response) was noted in 88% (36/41) of non-splenectomised and 79% (33/42) of splenectomised patients given romiplostim compared with 14% (three of 21) of non-splenectomised and no splenectomised patients given placebo (p<0.0001). Patients given romiplostim achieved platelet counts of 50x10(9)/L or more on a mean of 13.8 (SE 0.9) weeks (mean 12.3 [1.2] weeks in splenectomised group vs 15.2 [1.2] weeks in non-splenectomised group) compared with 0 . 8 (0.4) weeks for those given placebo (0. 2 [0 . 1] weeks vs 1 . 3 [0.81 weeks). 87% (20/23) of patients given romiplostim (12/12 splenectomised and eight of 11 non-splenectomised patients) reduced or discontinued concurrent therapy compared with 38% (six of 16) of those given placebo (one of six splenectomised and five of ten non-splenectomised patients). Adverse events were much the same in patients given romiplostim and placebo. No antibodies against romiplostim or thrombopoietin were detected. Interpretation Romiplostim was well tolerated, and increased and maintained platelet counts in splenectomised and non-splenectomised patients with ITP. Many patients were able to reduce or discontinue other ITP medications. Stimulation of platelet production by romiplostim may provide a new therapeutic option for patients with ITP.	[Kuter, David J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bussel, James B.] New York Presbyterian Hosp, Div Pediat, New York, NY USA; [Lyons, Roger M.] Hematol Oncol Assoc S Texas, San Antonio, TX USA; [Pullarkat, Vinod] City Hope Natl Med Ctr, Div Hematol, Duarte, CA 91010 USA; [Gernsheimer, Terry B.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Senecal, Francis M.] NW Med Specialties, Tacoma, WA USA; [Aledort, Louis M.] Mt Sinai Hosp, New York, NY 10029 USA; [George, James N.] Univ Oklahoma, Hlth Sci Ctr, Hematol Oncol Sect, Oklahoma City, OK USA; [Kessler, Craig M.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Sanz, Miguel A.] Hosp La Fe, E-46009 Valencia, Spain; [Liebman, Howard A.] Univ So Calif, Keck Sch Med, Div Hematol, Los Angeles, CA USA; [Slovick, Frank T.] Heartland Hematol Oncol Assoc Inc, Kansas City, MO USA; [de Wolf, J. Th M.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Bourgeois, Emmanuelle] CHU Lille, Serv Malad Sang, F-59037 Lille, France; [Guthrie, Troy H., Jr.] Baptist Canc Inst, Jacksonville, FL USA; [Newland, Adrian] Royal London Hosp, Dept Haematol, London E1 1BB, England; [Wasser, Jeffrey S.] DeQuattro Community Canc Ctr, Manchester, CT USA; [Hamburg, Solomon I.] Tower Canc Res Fdn, Beverly Hills, CA USA; [Grande, Carlos] Hosp 12 Octubre, E-28041 Madrid, Spain; [Lefrere, Francois] Hop Necker Enfants Malad, Serv Hematol Adulte, Paris, France; [Lichtin, Alan Eli] Cleveland Clin Fdn, Dept Hematol Oncol, Cleveland, OH 44195 USA; [Tarantino, Michael D.] Comprehens Bleeding Disorders Ctr, Peoria, IL USA; [Terebelo, Howard R.] Newland Med Assoc, Southfield, MI USA; [Viallard, Jean-Francois] Hop Haut Leveque, Pessac, France; [Cuevas, Francis J.] Marshall Univ, Huntington, WV USA; [Go, Ronald S.] Gundersen Lutheran Hlth Syst, La Crosse, WI USA; [Henry, David H.] Penn Oncol Hematol Assoc Inc, Philadelphia, PA USA; [Redner, Robert L.] Univ Pittsburgh, Dept Med, Hillman Canc Ctr, Pittsburgh, PA USA; [Rice, Lawrence] Baylor Coll Med, Houston, TX 77030 USA; [Schipperus, Martin R.] Ziekenhuis Leyenburg, The Hague, Netherlands; [Guo, D. Matthew; Nichol, Janet L.] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Massachusetts General Hospital; NewYork-Presbyterian Hospital; City of Hope; Puget Sound Blood Center; Icahn School of Medicine at Mount Sinai; University of Oklahoma System; University of Oklahoma Health Sciences Center; Georgetown University; Hospital Universitari i Politecnic La Fe; University of Southern California; University of Groningen; Universite de Lille - ISITE; CHU Lille; Barts Health NHS Trust; Royal London Hospital; Hospital Universitario 12 de Octubre; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; CHU Bordeaux; Marshall University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Amgen	Kuter, DJ (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	kuter.david@MGH.harvard.edu	Kuter, David/AAS-1123-2020; Henry, David/AAU-4650-2020; Sanz, Miguel A./F-7485-2018	Henry, David/0000-0001-7169-7704; Sanz, Miguel A./0000-0003-1489-1177	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; BOTTIGER LE, 1972, ACTA MED SCAND, V191, P535; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; BUSSEL JB, 1988, BLOOD, V72, P121; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Cines DB, 2005, BLOOD, V106, P2244, DOI 10.1182/blood-2004-12-4598; Douglas VK, 2002, AM J CLIN PATHOL, V117, P844; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Freund R.J., 1986, SAS SYSTEM LINEAR MO; George JN, 2000, SEMIN HEMATOL, V37, P290, DOI 10.1053/shem.2000.8955; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; George JN, 2000, SEMIN HEMATOL, V37, P31, DOI 10.1016/S0037-1963(00)90116-1; Go RS, 2005, BLOOD REV, V19, P53, DOI 10.1016/j.blre.2004.05.001; Harker LA, 1996, BLOOD, V88, P511, DOI 10.1182/blood.V88.2.511.bloodjournal882511; HEYNS AD, 1982, AM J HEMATOL, V12, P167, DOI 10.1002/ajh.2830120209; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Ichikawa N, 1996, THROMB HAEMOSTASIS, V76, P156; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; KELTON JG, 1982, SEMIN THROMB HEMOST, V8, P83, DOI 10.1055/s-2007-1005045; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Kuter D, 2006, BLOOD, V108, p144A; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; LANDIS RJ, 1978, INT STAT REV, V46, P237; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; MCMILLAN R, 1981, NEW ENGL J MED, V304, P1135, DOI 10.1056/NEJM198105073041904; MYLVAGANAM R, 1989, AM J MED SCI, V298, P215, DOI 10.1097/00000441-198910000-00002; NEWLAND AC, 1983, LANCET, V1, P84; Newland A, 2006, BRIT J HAEMATOL, V135, P547, DOI 10.1111/j.1365-2141.2006.06339.x; Nichol J L, 1998, Curr Opin Hematol, V5, P203, DOI 10.1097/00062752-199805000-00010; Scaradavou A, 1997, BLOOD, V89, P2689, DOI 10.1182/blood.V89.8.2689; Scheffe H, 1959, ANAL VARIANCE; Shehata M, 2004, J CLIN INVEST, V113, P676, DOI 10.1172/JCI200419540; Usuki K, 1996, STEM CELLS, V14, P558, DOI 10.1002/stem.140558; Vesely SK, 2004, ANN INTERN MED, V140, P112, DOI 10.7326/0003-4819-140-3-200402030-00012; Wang B, 2004, CLIN PHARMACOL THER, V76, P628, DOI 10.1016/j.clpt.2004.08.010	39	587	620	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					395	403		10.1016/S0140-6736(08)60203-2	http://dx.doi.org/10.1016/S0140-6736(08)60203-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242413				2022-12-28	WOS:000252992700029
J	Nurden, AT; Nurden, P				Nurden, Alan T.; Nurden, Paquita			Increasing the platelet count in chronic ITP	LANCET			English	Editorial Material									[Nurden, Alan T.; Nurden, Paquita] Hop Xavier Arnosan, Ctr Reference Pathol Plaquettaires, F-33600 Pessac, France	CHU Bordeaux	Nurden, AT (corresponding author), Hop Xavier Arnosan, Ctr Reference Pathol Plaquettaires, F-33600 Pessac, France.	alan.nurden@cnrshl.u-bordeaux2.fr						Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; George JN, 2006, J THROMB HAEMOST, V4, P1664, DOI 10.1111/j.1538-7836.2006.02013.x; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Li SG, 2007, BRIT J HAEMATOL, V139, P605, DOI 10.1111/j.1365-2141.2007.06737.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; Sukati H, 2007, BLOOD, V109, P4528, DOI 10.1182/blood-2006-09-044388	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					362	364		10.1016/S0140-6736(08)60178-6	http://dx.doi.org/10.1016/S0140-6736(08)60178-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242396				2022-12-28	WOS:000252992700005
J	Asagiri, M; Hirai, T; Kunigami, T; Kamano, S; Gober, HJ; Okamoto, K; Nishikawa, K; Latz, E; Golenbock, DT; Aoki, K; Ohya, K; Imai, Y; Morishita, Y; Miyazono, K; Kato, S; Saftig, P; Takayanagi, H				Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Latz, Eicke; Golenbock, Douglas T.; Aoki, Kazuhiro; Ohya, Keiichi; Imai, Yuuki; Morishita, Yasuyuki; Miyazono, Kohei; Kato, Shigeaki; Saftig, Paul; Takayanagi, Hiroshi			Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis	SCIENCE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; ANTIGEN PRESENTATION; DENDRITIC CELLS; INNATE IMMUNITY; BONE LOSS; T-CELLS; PYCNODYSOSTOSIS; AUTOIMMUNITY; ACTIVATION; ADJUVANTS	Cathepsin K was originally identified as an osteoclast- specific lysosomal protease, the inhibitor of which has been considered might have therapeutic potential. We show that inhibition of cathepsin K could potently suppress autoimmune inflammation of the joints as well as osteoclastic bone resorption in autoimmune arthritis. Furthermore, cathepsin K-/- mice were resistant to experimental autoimmune encephalomyelitis. Pharmacological inhibition or targeted disruption of cathepsin K resulted in defective Toll- like receptor 9 signaling in dendritic cells in response to unmethylated CpG DNA, which in turn led to attenuated induction of T helper 17 cells, without affecting the antigen- presenting ability of dendritic cells. These results suggest that cathepsin K plays an important role in the immune system and may serve as a valid therapeutic target in autoimmune diseases.	[Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Tokyo 1138549, Japan; [Asagiri, Masataka; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Tokyo 1138549, Japan; [Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Pharmacol Sect, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Hirai, Toshitake; Kunigami, Toshihiro] Nippon Chemiphar Co Ltd, Saitama 3410005, Japan; [Kamano, Shunya] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1138421, Japan; [Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Imai, Yuuki; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Morishita, Yasuyuki; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Imai, Yuuki; Kato, Shigeaki] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Kawaguchi, Saitama 3320012, Japan; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Juntendo University; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Kiel	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Saftig, Paul/A-7966-2010; Latz, Eicke/H-3951-2014; Imai, Yuuki/ABC-4687-2020; AOKI, Kazuhiro/GRO-6475-2022	Latz, Eicke/0000-0003-1488-5666; AOKI, Kazuhiro/0000-0001-6643-6315				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Ronaghy A, 2002, J IMMUNOL, V168, P51, DOI 10.4049/jimmunol.168.1.51; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Segal BM, 2000, J IMMUNOL, V164, P5683, DOI 10.4049/jimmunol.164.11.5683; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013	25	252	264	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					624	627		10.1126/science.1150110	http://dx.doi.org/10.1126/science.1150110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239127				2022-12-28	WOS:000252772000042
J	Krieg, AM; Lipford, GB				Krieg, Arthur M.; Lipford, Grayson B.			Immunology - The toll of Cathepsin K deficiency	SCIENCE			English	Editorial Material							INNATE IMMUNITY		[Krieg, Arthur M.; Lipford, Grayson B.] Coley Pharmaceut Grp, Wellesley, MA 02481 USA	Coley Pharmaceutical Group	Krieg, AM (corresponding author), Coley Pharmaceut Grp, 93 Worcester St, Wellesley, MA 02481 USA.	akrieg@coleypharma.com	Krieg, Arthur M/K-8109-2019; Krieg, Art/R-6166-2019					Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457	5	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					576	577		10.1126/science.1154207	http://dx.doi.org/10.1126/science.1154207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239112				2022-12-28	WOS:000252772000025
J	CAMPBELL, JA				CAMPBELL, JA			COMPUTERS AND THOUGHT - A PRACTICAL INTRODUCTION TO ARTIFICIAL-INTELLIGENCE - SHARPLES,M, HOGG,D, HUTCHISON,C, TORRANCE,S, YOUNG,D	NATURE			English	Book Review											CAMPBELL, JA (corresponding author), UNIV LONDON UNIV COLL,DEPT COMP SCI,LONDON WC1E 6BT,ENGLAND.							Young D, 1989, COMPUTERS THOUGHT PR	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					28	28		10.1038/344028a0	http://dx.doi.org/10.1038/344028a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278016				2022-12-28	WOS:A1990CQ97200047
J	Mantovani, A; Romero, P; Palucka, AK; Marincola, FM				Mantovani, Alberto; Romero, Pedro; Palucka, A. Karolina; Marincola, Francesco M.			Tumour immunity: effector response to tumour and role of the microenvironment	LANCET			English	Review							REGULATORY T-CELLS; HEPATITIS-C VIRUS; NF-KAPPA-B; DENDRITIC CELLS; MELANOMA PATIENTS; HIGH-FREQUENCY; LYMPH-NODES; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE POLARIZATION; SPONTANEOUS REGRESSION	Substantial evidence shows that inflammation promotes oncogenesis and, occasionally, participates in cancer rejection. This paradox can be accounted for by a dynamic switch from chronic smouldering inflammation promoting cancer-cell survival to florid, tissue-disruptive inflammatory reactions that trigger cancer-cell destruction. Clinical and experimental observations suggest that the mechanism of this switch recapitulates the events associated with pathogen infection, which stimulate immune cells to recognise danger signals and activate immune effector functions. Generally, cancers do not have danger signals and, therefore, they cannot elicit strong immune reactions. Synthetic molecules have been developed that mimic pathogen invasion at the tumour site. These compounds activate dendritic cells to produce proinflammatory cytokines, which in turn trigger cytotoxic mechanisms leading to cancer death. Simultaneously, dendritic cells capture antigen shed by dying cancer cells, undergo activation, and stimulate antigen-specific T and B cells. This process results in massive amplification of the antineoplastic inflammatory process. Thus, although anti-inflammatory drugs can prevent onset of some malignant diseases, induction of T cells specific for tumour antigen by active immunisation, combined with powerful activation signals within the cancer microenvironment, might yield the best strategy for treatment of established cancers.	[Marincola, Francesco M.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Mantovani, Alberto] Univ Milan, Ist Clin Humanitas, Milan, Italy; [Mantovani, Alberto] Univ Milan, Inst Pathol, Milan, Italy; [Romero, Pedro] Ludwig Inst Canc Res, Lausanne Branch, Lausanne, Switzerland; [Palucka, A. Karolina] Baylor Inst Immunol Res, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); IRCCS Humanitas Research Hospital; University of Milan; University of Milan; Ludwig Institute for Cancer Research; Baylor Scott & White Health	Marincola, FM (corresponding author), NIH, Dept Transfus Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	FMarincola@cc.nih.gov	Romero, Pedro/S-6015-2017; Mantovani, Alberto/HCI-7449-2022	Romero, Pedro/0000-0002-9688-2882; Mantovani, Alberto/0000-0001-5578-236X	NATIONAL CANCER INSTITUTE [R01CA085540, R01CA078846, P01CA084512, R01CA089440] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NCI NIH HHS [CA89440, CA085540, CA78846, P01 CA84512] Funding Source: Medline; PHS HHS [U19 AIO57234] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Albers AE, 2005, CANCER IMMUNOL IMMUN, V54, P1072, DOI 10.1007/s00262-005-0670-9; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Andres A, 2005, CRIT REV ONCOL HEMAT, V56, P71, DOI 10.1016/j.critrevonc.2004.11.010; Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Atkins MB, 2004, CLIN CANCER RES, V10, p6342S, DOI 10.1158/1078-0432.CCR-040029; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Bakker AH, 2005, CURR OPIN IMMUNOL, V17, P428, DOI 10.1016/j.coi.2005.06.008; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Benlalam H, 2001, EUR J IMMUNOL, V31, P2007, DOI 10.1002/1521-4141(200107)31:7<2007::AID-IMMU2007>3.3.CO;2-J; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chang W Y, 2000, Hawaii Med J, V59, P379; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Colombo MP, 2005, CANCER RES, V65, P9113, DOI 10.1158/0008-5472.CAN-05-2714; Comin-Anduix B, 2006, CLIN CANCER RES, V12, P107, DOI 10.1158/1078-0432.CCR-05-0136; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Crowe SE, 2005, CURR OPIN GASTROEN, V21, P32; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dahl MV, 2002, J AM ACAD DERMATOL, V47, pS205, DOI 10.1067/mjd.2002.126586; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davis ID, 2003, J LEUKOCYTE BIOL, V73, P3, DOI 10.1189/jlb.0502261; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Eksteen B, 2005, GUT, V54, P4, DOI 10.1136/gut.2004.047084; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Ganss R, 1998, CANCER RES, V58, P4673; Geng H, 2006, INT J CANCER, V118, P2657, DOI 10.1002/ijc.21795; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Ghelani D, 2005, CRIT REV ONCOL HEMAT, V56, P115, DOI 10.1016/j.critrevonc.2005.03.014; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gillmore R, 2006, CLIN CANCER RES, V12, P34, DOI 10.1158/1078-0432.CCR-05-1483; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grillo-Lopez AJ, 1999, SEMIN ONCOL, V26, P66; Haas AR, 2006, CLIN CANCER RES, V12, P214, DOI 10.1158/1078-0432.CCR-05-1178; Hanahan Douglas, 2003, Cancer Research, V63, P3005; Hardin JA, 2005, ANN RHEUM DIS, V64, P86, DOI 10.1136/ard.2005.044560; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hirano F, 2005, CANCER RES, V65, P1089; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Ippoliti G, 2005, CRIT REV ONCOL HEMAT, V56, P101, DOI 10.1016/j.critrevonc.2005.03.013; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kammula US, 2000, J NATL CANCER I, V92, P1336, DOI 10.1093/jnci/92.16.1336; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lokich J, 1997, AM J CLIN ONCOL-CANC, V20, P416, DOI 10.1097/00000421-199708000-00020; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Malmberg KJ, 2004, CANCER IMMUNOL IMMUN, V53, P879, DOI 10.1007/s00262-004-0577-x; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marincola FM, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-16; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; Marincola FM, 1996, J IMMUNOTHER, V19, P266, DOI 10.1097/00002371-199607000-00003; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matzinger P, 2001, SCAND J IMMUNOL, V54, P2, DOI 10.1046/j.1365-3083.2001.00973.x; Meidenbauer N, 2004, CANCER RES, V64, P6319, DOI 10.1158/0008-5472.CAN-04-1341; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Monsurro V, 2003, SEMIN CANCER BIOL, V13, P473, DOI 10.1016/j.semcancer.2003.09.011; Monsurro V, 2004, BLOOD, V104, P1970, DOI 10.1182/blood-2004-02-0525; Morse MA, 1999, CANCER RES, V59, P56; Mortarini R, 2003, CANCER RES, V63, P2535; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Old LJ, 1998, J EXP MED, V187, P1163, DOI 10.1084/jem.187.8.1163; Osanto S, 2000, HUM GENE THER, V11, P739, DOI 10.1089/10430340050015635; Overwijk WW, 2005, CURR OPIN IMMUNOL, V17, P187, DOI 10.1016/j.coi.2005.01.011; Palucka KA, 1998, J IMMUNOL, V160, P4587; Panelli MC, 2000, J IMMUNOL, V164, P495, DOI 10.4049/jimmunol.164.1.495; Panelli MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r8; Panelli MC, 2002, GENOME BIOL, V3; Pardoll D, 2004, NAT MED, V10, P887, DOI 10.1038/nm0904-887; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Printz C, 2001, J NATL CANCER I, V93, P1047, DOI 10.1093/jnci/93.14.1047; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Richwald GA, 1999, DRUGS TODAY, V35, P497, DOI 10.1358/dot.1999.35.7.548263; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Seiter S, 2002, J IMMUNOTHER, V25, P252, DOI 10.1097/00002371-200205000-00008; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 2006, NAT MED, V12, P167, DOI 10.1038/nm0206-167; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Speiser DE, 2004, J IMMUNOTHER, V27, P298, DOI 10.1097/00002371-200407000-00006; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P155, DOI 10.1016/j.critrevonc.2005.03.015; Thomas R, 1999, J LEUKOCYTE BIOL, V66, P286, DOI 10.1002/jlb.66.2.286; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; Urosevic M, 2003, ARCH DERMATOL, V139, P1325, DOI 10.1001/archderm.139.10.1325; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vallejo GH, 2005, CRIT REV ONCOL HEMAT, V56, P87, DOI 10.1016/j.critrevonc.2004.12.011; Valmori D, 2002, CANCER RES, V62, P1743; Valmori D, 1999, CANCER RES, V59, P4050; Valmori D, 2000, CANCER RES, V60, P4499; Valmori D, 2001, CANCER RES, V61, P509; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Vlad AM, 2004, ADV IMMUNOL, V82, P249, DOI 10.1016/S0065-2776(04)82006-6; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Walter S, 2005, EUR J IMMUNOL, V35, P2876, DOI 10.1002/eji.200526207; Wang Ena, 2004, J Transl Med, V2, P34, DOI 10.1186/1479-5876-2-34; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; WOLFEL T, 1989, J EXP MED, V170, P797, DOI 10.1084/jem.170.3.797; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wouters Emiel F M, 2005, Proc Am Thorac Soc, V2, P26, DOI 10.1513/pats.200408-039MS; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; YAMAGUCHI T, 2005, SEMIN CANC BIOL; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	178	394	418	1	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					771	783		10.1016/S0140-6736(08)60241-X	http://dx.doi.org/10.1016/S0140-6736(08)60241-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18275997				2022-12-28	WOS:000253596700031
J	Maeda, K; Kawabata, K; Mazzali, PA; Tanaka, M; Valenti, S; Nomoto, K; Hattori, T; Deng, JS; Pian, E; Taubenberger, S; Iye, M; Matheson, T; Filippenko, AV; Aoki, K; Kosugi, G; Ohyama, Y; Sasaki, T; Takata, T				Maeda, Keiichi; Kawabata, Koji; Mazzali, Paolo A.; Tanaka, Masaomi; Valenti, Stefano; Nomoto, Ken'ichi; Hattori, Takashi; Deng, Jinsong; Pian, Elena; Taubenberger, Stefan; Iye, Masanori; Matheson, Thomas; Filippenko, Alexei V.; Aoki, Kentaro; Kosugi, George; Ohyama, Youichi; Sasaki, Toshiyuki; Takata, Tadafumi			Asphericity in supernova explosions from late-time spectroscopy	SCIENCE			English	Article							GAMMA-RAY BURST; SN 2002AP; OFF-AXIS; CORE; SPECTROPOLARIMETRY; SPECTRA; NUCLEOSYNTHESIS; EMISSION; MODEL	Core- collapse supernovae (CC-SNe) are the explosions that announce the death of massive stars. Some CC- SNe are linked to long- duration gamma- ray bursts ( GRBs) and are highly aspherical. One important question is to what extent asphericity is common to all CC- SNe. Here we present late- time spectra for a number of CC- SNe from stripped- envelope stars and use them to explore any asphericity generated in the inner part of the exploding star, near the site of collapse. A range of oxygen emission- line profiles is observed, including a high incidence of double- peaked profiles, a distinct signature of an aspherical explosion. Our results suggest that all CC- SNe from stripped- envelope stars are aspherical explosions and that SNe accompanied by GRBs exhibit the highest degree of asphericity.	[Maeda, Keiichi; Nomoto, Ken'ichi] Univ Tokyo, IPMU, Kashiwa, Chiba 2778582, Japan; [Maeda, Keiichi; Mazzali, Paolo A.; Taubenberger, Stefan] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Maeda, Keiichi] Univ Tokyo, Coll Arts & Sci, Dept Earth Sci & Astron, Tokyo 1538902, Japan; [Kawabata, Koji] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Mazzali, Paolo A.; Pian, Elena] Natl Inst Astrophys, Osservatorio Astron Trieste, I-34143 Trieste, Italy; [Mazzali, Paolo A.; Nomoto, Ken'ichi] Univ Tokyo, Sch Sci, Res Ctr Early Universe, Tokyo 1130033, Japan; [Tanaka, Masaomi; Nomoto, Ken'ichi] Univ Tokyo, Sch Sci, Dept Astron, Tokyo 1130033, Japan; [Valenti, Stefano] Univ Ferrara, Dept Phys, I-44100 Ferrara, Italy; [Valenti, Stefano] European Org Astron Res So Hemisphere, D-85741 Garching, Germany; [Hattori, Takashi; Aoki, Kentaro; Sasaki, Toshiyuki] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Deng, Jinsong] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Iye, Masanori] NAOJ, Div Opt & Infrared Astron, Tokyo 1818588, Japan; [Matheson, Thomas] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Filippenko, Alexei V.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kosugi, George] NAOJ, Atacama Large Millimeter Submillimeter Array Proj, Tokyo 1818588, Japan; [Ohyama, Youichi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Infrared Astrophys, Sagamihara, Kanagawa 2298510, Japan; [Takata, Tadafumi] NAOJ, Astron Data Ctr, Tokyo 1818588, Japan	University of Tokyo; Max Planck Society; University of Tokyo; Hiroshima University; Istituto Nazionale Astrofisica (INAF); University of Tokyo; University of Tokyo; University of Ferrara; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Chinese Academy of Sciences; National Astronomical Observatory, CAS; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Optical Astronomy Observatory; University of California System; University of California Berkeley; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Maeda, K (corresponding author), Univ Tokyo, IPMU, Kashiwa No Ha 5-1-5, Kashiwa, Chiba 2778582, Japan.	maeda@ea.c.u-tokyo.ac.jp	Takata, Tadafumi/ABD-9196-2021; 大山陽一, Youichi Ohyama/ABA-5890-2020; Tanaka, Masaomi/A-4354-2011; Valenti, Stefano/M-5924-2017; Kawabata, Koji S/G-1957-2017	Takata, Tadafumi/0000-0002-6592-4250; 大山陽一, Youichi Ohyama/0000-0001-9490-3582; Valenti, Stefano/0000-0001-8818-0795; Kawabata, Koji S/0000-0001-6099-9539; Matheson, Thomas/0000-0001-6685-0479; Maeda, Keiichi/0000-0003-2611-7269; Pian, Elena/0000-0001-8646-4858; Mazzali, Paolo/0000-0001-6876-8284				BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; Blondin JM, 2003, ASTROPHYS J, V584, P971, DOI 10.1086/345812; Buras R, 2006, ASTRON ASTROPHYS, V457, P281, DOI 10.1051/0004-6361:20054654; Burrows A, 2007, ASTROPHYS J, V655, P416, DOI 10.1086/509773; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Iwamoto K, 1998, NATURE, V395, P672, DOI 10.1038/27155; Kashikawa N, 2002, PUBL ASTRON SOC JPN, V54, P819, DOI 10.1093/pasj/54.6.819; Kawabata KS, 2002, ASTROPHYS J, V580, pL39, DOI 10.1086/345545; Khokhlov AM, 1999, ASTROPHYS J, V524, pL107, DOI 10.1086/312305; Kotake K, 2004, ASTROPHYS J, V608, P391, DOI 10.1086/392530; Leonard DC, 2006, NATURE, V440, P505, DOI 10.1038/nature04558; Leonard DC, 2002, PUBL ASTRON SOC PAC, V114, P1333, DOI 10.1086/345092; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Maeda K, 2006, ASTROPHYS J, V640, P854, DOI 10.1086/500187; Maeda K, 2003, ASTROPHYS J, V598, P1163, DOI 10.1086/378948; Maeda K, 2002, ASTROPHYS J, V565, P405, DOI 10.1086/324487; Maeda K, 2006, ASTROPHYS J, V645, P1331, DOI 10.1086/504581; Matheson T, 2001, ASTRON J, V121, P1648, DOI 10.1086/319390; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; Mazzali PA, 2002, ASTROPHYS J, V572, pL61, DOI 10.1086/341504; MODJAZ M, 2008, ASTRON J; Moiseenko SG, 2006, MON NOT R ASTRON SOC, V370, P501, DOI 10.1111/j.1365-2966.2006.10517.x; NOMOTO K, 1995, PHYS REP, V256, P173, DOI 10.1016/0370-1573(94)00107-E; NOMOTO K, 2007, IL NOUVO CIMENTO B, V121, P1207; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Wang LF, 2001, ASTROPHYS J, V550, P1030, DOI 10.1086/319822; Wang LF, 2003, ASTROPHYS J, V592, P457, DOI 10.1086/375576	29	176	177	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1220	1223		10.1126/science.1149437	http://dx.doi.org/10.1126/science.1149437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18239091	Green Submitted			2022-12-28	WOS:000253530600036
J	Webb, S				Webb, Sandra			A patient's journey - Xeroderma pigmentosum	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Webb, Sandra] XP Support Grp, Prestwood HP16 0SG, Great Missenden, England		Webb, S (corresponding author), XP Support Grp, 2 Strawberry Close, Prestwood HP16 0SG, Great Missenden, England.	xpsg@btinternet.com							0	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					444	446		10.1136/bmj.39485.698356.AD	http://dx.doi.org/10.1136/bmj.39485.698356.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292171	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000253664000042
J	Custance, O; Morita, S				Custance, Oscar; Morita, Seizo			Materials science - How to move an atom	SCIENCE			English	Editorial Material							SCANNING TUNNELING MICROSCOPE; FORCE MICROSCOPY; SINGLE ATOMS; LATERAL MANIPULATION; SPECTROSCOPY; SENSITIVITY; STEPS; TIP		[Custance, Oscar] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Morita, Seizo] Osaka Univ, Suita, Osaka 5650871, Japan	National Institute for Materials Science; Osaka University	Custance, O (corresponding author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	custance.oscar@nims.go.jp; smorita@eei.eng.osaka-u.ac.jp	清三, 森田/W-1919-2019; CUSTANCE, Oscar/H-2924-2011	Custance, Oscar/0000-0001-7931-603X				ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Nazin GV, 2003, SCIENCE, V302, P77, DOI 10.1126/science.1088971; Oyabu N, 2005, NANOTECHNOLOGY, V16, pS112, DOI 10.1088/0957-4484/16/3/021; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Sugimoto Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106104; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288	15	2	2	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1051	1052		10.1126/science.1154853	http://dx.doi.org/10.1126/science.1154853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292329				2022-12-28	WOS:000253311700029
J	Kay, J; Bazari, H; Avery, LL; Koreishi, AF; Cibotti-Granof, N; Harris, NL; Colvin, RB				Kay, Jonathan; Bazari, Hasan; Avery, Laura L.; Koreishi, Aashiyana F.; Cibotti-Granof, Nancy; Harris, Nancy Lee; Colvin, Robert B.			A woman with renal failure and stiffness of the joints and skin - Nephrogenic systemic fibrosis, involving the skin, heart, lungs, diaphragm and psoas muscles, dura, and possibly the kidney. End-stage renal disease with nephrocalcinosis. Acute and organizing bronchopneumonia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL PROGRESS; DERMOPATHY; GADOLINIUM; INVOLVEMENT; SARCOIDOSIS; NEUROPATHY; COMPLICATIONS; PHOTOPHERESIS; INSIGHTS; TISSUE		[Kay, Jonathan] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Bazari, Hasan] Massachusetts Gen Hosp, Dept Nephrol, Boston, MA 02114 USA; [Avery, Laura L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Koreishi, Aashiyana F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kay, Jonathan; Bazari, Hasan] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Avery, Laura L.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Koreishi, Aashiyana F.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Kay, J (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.		Kay, Jonathan/HGE-1248-2022	Kay, Jonathan/0000-0002-8970-4260				Allen D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005376.pub2; Auron A, 2006, PEDIATR NEPHROL, V21, P1307, DOI 10.1007/s00467-006-0174-7; Boyd AS, 2007, J AM ACAD DERMATOL, V56, P27, DOI 10.1016/j.jaad.2006.10.048; Bryce AH, 2006, AM J HEMATOL, V81, P511, DOI 10.1002/ajh.20643; Cowper SE, 2005, AM J KIDNEY DIS, V46, P763, DOI 10.1053/j.ajkd.2005.08.008; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Daram SR, 2005, AM J KIDNEY DIS, V46, P754, DOI 10.1053/j.ajkd.2005.06.024; Dyck PJ, 2005, BRAIN, V128, P2480, DOI 10.1093/brain/awh662; El-Zammar OA, 2007, HISTOPATHOLOGY, V50, P289, DOI 10.1111/j.1365-2559.2006.02546.x; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Gandhi GY, 2007, MAYO CLIN PROC, V82, P836, DOI 10.4065/82.7.836; Gibson SE, 2006, ARCH PATHOL LAB MED, V130, P209; Gilliet M, 2005, BRIT J DERMATOL, V152, P531, DOI 10.1111/J.1365-2133.2005.06434.X; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1745, DOI 10.1093/ndt/gfl294; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; High WA, 2007, J AM ACAD DERMATOL, V56, P710, DOI 10.1016/j.jaad.2007.01.022; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Jimenez SA, 2004, ARTHRITIS RHEUM, V50, P2660, DOI 10.1002/art.20362; Kay J, 2000, BEST PRACT RES CL RH, V14, P285, DOI 10.1053/berh.2000.0066; KAY J, 2007, ARTHRITIS RHEUM S, V56, pS64; Kiss E, 2005, AM J ROENTGENOL, V185, P1460, DOI 10.2214/AJR.04.1309; Krishnan AV, 2007, MUSCLE NERVE, V35, P273, DOI 10.1002/mus.20713; Levine JM, 2004, MUSCLE NERVE, V30, P569, DOI 10.1002/mus.20153; LOCKWOOD AH, 1989, NEUROL CLIN, V7, P617, DOI 10.1016/S0733-8619(18)30803-X; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; MARTINEZTELLO FJ, 1982, VIRCHOWS ARCH A, V397, P261, DOI 10.1007/BF00496569; MAYENO AN, 1994, TRENDS BIOTECHNOL, V12, P346, DOI 10.1016/0167-7799(94)90035-3; Ortonne N, 2004, BRIT J DERMATOL, V150, P1050, DOI 10.1111/j.1365-2133.2004.05900.x; Richmond H, 2007, ARCH DERMATOL, V143, P1025, DOI 10.1001/archderm.143.8.1025; Sable-Fourtassou G, 2005, ANN INTERN MED, V143, P632, DOI 10.7326/0003-4819-143-9-200511010-00006; Saenz A, 2006, VIRCHOWS ARCH, V449, P389, DOI 10.1007/s00428-006-0246-x; Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989; Steck AJ, 2006, CURR OPIN NEUROL, V19, P458, DOI 10.1097/01.wco.0000245368.36576.0d; Stern BJ, 2004, CURR OPIN NEUROL, V17, P311, DOI 10.1097/00019052-200406000-00013; Swaminathan S, 2007, J AM SOC NEPHROL, V18, P2636, DOI 10.1681/ASN.2007060645; Ting WW, 2003, ARCH DERMATOL, V139, P903, DOI 10.1001/archderm.139.7.903; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925; Umapathi T, 2005, CURR OPIN NEUROL, V18, P574, DOI 10.1097/01.wco.0000180158.34713.aa	40	47	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					827	838		10.1056/NEJMcpc0708697	http://dx.doi.org/10.1056/NEJMcpc0708697			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287606				2022-12-28	WOS:000253257700010
J	Weinstein, JN; Tosteson, TD; Lurie, JD; Tosteson, ANA; Blood, E; Hanscom, B; Herkowitz, H; Cammisa, F; Albert, T; Boden, SD; Hilibrand, A; Goldberg, H; Berven, S; An, H				Weinstein, James N.; Tosteson, Tor D.; Lurie, Jon D.; Tosteson, Anna N. A.; Blood, Emily; Hanscom, Brett; Herkowitz, Harry; Cammisa, Frank; Albert, Todd; Boden, Scott D.; Hilibrand, Alan; Goldberg, Harley; Berven, Sigurd; An, Howard		SPORT Investigators	Surgical versus nonsurgical therapy for lumbar spinal stenosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES TRENDS; RESEARCH TRIAL SPORT; HEALTH SURVEY SF-36; QUALITY-OF-LIFE; NONOPERATIVE TREATMENT; DISK HERNIATION; PATIENT; OUTCOMES; SURGERY; COMPLICATIONS	Background Surgery for spinal stenosis is widely performed, but its effectiveness as compared with nonsurgical treatment has not been shown in controlled trials. Methods Surgical candidates with a history of at least 12 weeks of symptoms and spinal stenosis without spondylolisthesis (as confirmed on imaging) were enrolled in either a randomized cohort or an observational cohort at 13 U.S. spine clinics. Treatment was decompressive surgery or usual nonsurgical care. The primary outcomes were measures of bodily pain and physical function on the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) and the modified Oswestry Disability Index at 6 weeks, 3 months, 6 months, and 1 and 2 years. Results A total of 289 patients were enrolled in the randomized cohort, and 365 patients were enrolled in the observational cohort. At 2 years, 67% of patients who were randomly assigned to surgery had undergone surgery, whereas 43% of those who were randomly assigned to receive nonsurgical care had also undergone surgery. Despite the high level of nonadherence, the intention-to-treat analysis of the randomized cohort showed a significant treatment effect favoring surgery on the SF-36 scale for bodily pain, with a mean difference in change from baseline of 7.8 (95% confidence interval, 1.5 to 14.1); however, there was no significant difference in scores on physical function or on the Oswestry Disability Index. The as-treated analysis, which combined both cohorts and was adjusted for potential confounders, showed a significant advantage for surgery by 3 months for all primary outcomes; these changes remained significant at 2 years. Conclusions In the combined as-treated analysis, patients who underwent surgery showed significantly more improvement in all primary outcomes than did patients who were treated nonsurgically. (ClinicalTrials.gov number, NCT00000411.)	[Weinstein, James N.; Blood, Emily; Hanscom, Brett] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Dept Orthoped, Lebanon, NH 03756 USA; [Tosteson, Tor D.; Lurie, Jon D.; Tosteson, Anna N. A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; [Lurie, Jon D.; Tosteson, Anna N. A.] Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Herkowitz, Harry] William Beaumont Hosp, Royal Oak, MI 48072 USA; [Cammisa, Frank] Hosp Special Surg, New York, NY 10021 USA; [Albert, Todd; Hilibrand, Alan] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA; [Boden, Scott D.] Emory Univ, Emory Spine Ctr, Atlanta, GA 30322 USA; [Goldberg, Harley] Kaiser Permanente, San Francisco, CA USA; [Berven, Sigurd] Univ Calif San Francisco, San Francisco, CA 94143 USA; [An, Howard] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Beaumont Health; Jefferson University; Rothman Institute; Emory University; Kaiser Permanente; University of California System; University of California San Francisco; Rush University	Weinstein, JN (corresponding author), Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Dept Orthoped, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	sport@dartmouth.edu	Hilibrand, Alan/AAL-5114-2020		FOGARTY INTERNATIONAL CENTER [D43TW000018] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045444, K23AR048138, P60AR048094] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000018] Funding Source: Medline; NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIAMS NIH HHS [U01-AR45444-01A1, 1-K23-AR-048138-01, P60-AR048094-01A1, U01 AR045444-09, P60 AR048094, U01 AR045444, K23 AR048138] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AG HLTH CAR POL R, 1994, AHCPR PUBL; Atlas SJ, 1996, SPINE, V21, P1787, DOI 10.1097/00007632-199608010-00012; Atlas SJ, 2000, SPINE, V25, P556, DOI 10.1097/00007632-200003010-00005; Balding DJ, 2004, APPL LONGITUDINAL AN; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cummins J, 2006, SPINE, V31, P806, DOI 10.1097/01.brs.0000207473.09030.0d; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; DEYO RA, 1993, SPINE, V18, P1463; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; JOHNSSON KE, 1991, SPINE, V16, P615, DOI 10.1097/00007632-199106000-00003; Kuppermann M, 2004, JAMA-J AM MED ASSOC, V291, P1447, DOI 10.1001/jama.291.12.1447; MALMIVAARA A, 2004, P INT SOC STUD LUMB; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Mariconda M, 2002, J SPINAL DISORD TECH, V15, P39, DOI 10.1097/00024720-200202000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Meinert CL., 1986, CLIN TRIALS DESIGN C; *N AM SPIN SOC, 2000, N AM SPIN SOC PHAS 3; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Phelan EA, 2001, SPINE, V26, P206, DOI 10.1097/00007632-200101150-00016; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; WEINSTEIN J, 2000, DARTMOUTH ATLAS MUSC; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; Weinstein JN, 2005, SPINE, V30, P269, DOI 10.1097/01.brs.0000155479.88200.32	35	746	773	4	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					794	810		10.1056/NEJMoa0707136	http://dx.doi.org/10.1056/NEJMoa0707136			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287602	Green Published, Green Accepted			2022-12-28	WOS:000253257700005
J	Mizgerd, JP				Mizgerd, Joseph P.			Mechanisms of disease: Acute lower respiratory tract infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NF-KAPPA-B; ESCHERICHIA-COLI PNEUMONIA; TOLL-LIKE RECEPTOR-4; COMMUNITY-ACQUIRED PNEUMONIA; ADENOVIRUS-MEDIATED TRANSFER; EARLY RESPONSE CYTOKINES; COMPLEMENT COMPONENT C3; INNATE IMMUNE-RESPONSE; HEME OXYGENASE-1 CDNA; STREPTOCOCCUS-PNEUMONIAE		Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mizgerd, JP (corresponding author), Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, 665 Huntington Ave, Boston, MA 02115 USA.	jmizgerd@hsph.harvard.edu	Mizgerd, Joseph/GRY-6369-2022	Mizgerd, Joseph/0000-0002-4042-3169	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068153, R01HL079392] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079392-03, R01 HL068153-05A1, HL-79392, R01 HL079392, HL-68153, R01 HL068153] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Branger J, 2004, INT IMMUNOL, V16, P1605, DOI 10.1093/intimm/dxh161; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Roux A, 2006, EUR RESPIR J, V27, P795, DOI 10.1183/09031936.06.00058605; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Fredenburgh LE, 2005, CELL MOL BIOL, V51, P513, DOI 10.1170/T657; Frevert CW, 2000, J IMMUNOL, V164, P5439, DOI 10.4049/jimmunol.164.10.5439; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gomi K, 2004, CHEST, V126, P95, DOI 10.1378/chest.126.1.95; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Hashiba T, 2001, GENE THER, V8, P1499, DOI 10.1038/sj.gt.3301540; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Honda K, 2006, IMMUNITY, V25, P849, DOI 10.1016/j.immuni.2006.10.004; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Inoue Y, 2007, J INFECT DIS, V195, P1618, DOI 10.1086/516790; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kiyotani K, 2007, VIROLOGY, V359, P82, DOI 10.1016/j.virol.2006.08.053; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee JH, 2003, AM J RESP CRIT CARE, V168, P1462, DOI 10.1164/rccm.200302-303OC; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 2002, NAT REV IMMUNOL, V2, P975, DOI 10.1038/nri968; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Matsuzaki Y, 2006, J IMMUNOL, V177, P527, DOI 10.4049/jimmunol.177.1.527; Meduri GU, 1999, AM J RESP CRIT CARE, V160, P961, DOI 10.1164/ajrccm.160.3.9807080; Metchnikoff E, 1905, IMMUNITY INFECT DIS, P175; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mizgerd JP, 2004, AM J PHYSIOL-LUNG C, V286, pL1302, DOI 10.1152/ajplung.00353.2003; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Mizgerd JP, 2002, SEMIN IMMUNOL, V14, P123, DOI 10.1006/smim.2001.0349; Mizgerd JP, 2001, J IMMUNOL, V166, P4042, DOI 10.4049/jimmunol.166.6.4042; Mold C, 2002, J IMMUNOL, V168, P6375, DOI 10.4049/jimmunol.168.12.6375; Mueller-Ortiz SL, 2004, INFECT IMMUN, V72, P2899, DOI 10.1128/IAI.72.5.2899-2906.2004; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Rano A, 2006, CURR OPIN INFECT DIS, V19, P179, DOI 10.1097/01.qco.0000216629.51563.f8; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Schaaf B, 2005, CYTOKINE, V31, P324, DOI 10.1016/j.cyto.2005.05.008; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Thomas-Rudolph D, 2007, J IMMUNOL, V178, P7283, DOI 10.4049/jimmunol.178.11.7283; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Tsuburai T, 2004, HUM GENE THER, V15, P273, DOI 10.1089/104303404322886129; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Wang EJ, 2005, J ANTIMICROB CHEMOTH, V55, P721, DOI 10.1093/jac/dki085; Wattanathum A, 2005, CHEST, V128, P1690, DOI 10.1378/chest.128.3.1690; Weber DJ, 2007, INFECT CONT HOSP EP, V28, P825, DOI 10.1086/518460; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yasuda H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035824; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38; Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702	133	302	314	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					716	727		10.1056/NEJMra074111	http://dx.doi.org/10.1056/NEJMra074111			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272895	Green Accepted			2022-12-28	WOS:000253127700008
J	Bukovinszky, T; van Veen, FJF; Jongema, Y; Dicke, M				Bukovinszky, Tibor; van Veen, F. J. Frank; Jongema, Yde; Dicke, Marcel			Direct and indirect effects of resource quality on food web structure	SCIENCE			English	Article							APPARENT COMPETITION; COMMUNITIES; HERBIVORE; ECOSYSTEMS; DIVERSITY; STABILITY	The diversity and complexity of food webs ( the networks of feeding relationships within an ecological community) are considered to be important factors determining ecosystem function and stability. However, the biological processes driving these factors are poorly understood. Resource quality affects species interactions by limiting energy transfer to consumers and their predators, affecting life history and morphological traits. We show that differences in plant traits affect the structure of an entire food web through a series of direct and indirect effects. Three trophic levels of consumers were influenced by plant quality, as shown by quantitative herbivore - parasitoid - secondary parasitoid food webs. We conclude, on the basis of our data, that changes in the food web are dependent on both trait- and density- mediated interactions among species.	[Bukovinszky, Tibor; Jongema, Yde; Dicke, Marcel] Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [van Veen, F. J. Frank] Univ London Imperial Coll Sci Technol & Med, Nat Environm Res Council Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England	Wageningen University & Research; Imperial College London	Bukovinszky, T (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	tibor.bukovinszky@wur.nl	van Veen, Franciscus JF/H-2101-2013; Bukovinszky, Tibor/B-1262-2011; Dicke, Marcel/B-2300-2010	Dicke, Marcel/0000-0001-8565-8896; van Veen, Frank/0000-0003-0708-5492	Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Godfray H. C. J, 1994, PARASITOIDS BEHAV EV, P9; GOMEZCAMPO C, 1999, DEV PLANT GENETICS B, pCH4; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; HUNTER MD, 1992, ECOLOGY, V73, P724; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Sullivan DJ, 1999, ANNU REV ENTOMOL, V44, P291, DOI 10.1146/annurev.ento.44.1.291; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	22	186	189	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					804	807		10.1126/science.1148310	http://dx.doi.org/10.1126/science.1148310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258913				2022-12-28	WOS:000252963000059
J	Hayden, MS; Ghosh, S				Hayden, Matthew S.; Ghosh, Sankar			Shared principles in NF-kappa B signaling	CELL			English	Review							TOLL-LIKE RECEPTOR; UBIQUITIN-CONJUGATING ENZYME; KINASE IKK COMPLEX; NEGATIVE REGULATION; TNF RECEPTOR; MEDIATED PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; DISTINCT ROLES; CELL-SURVIVAL; BETA-SUBUNIT	The transcription factor NF-kappa B has served as a standard for inducible transcription factors for more than 20 years. The numerous stimuli that activate NF-kappa B, and the large number of genes regulated by NF-kappa B, ensure that this transcription factor is still the subject of intense research. Here, we attempt to synthesize some of the basic principles that have emerged from studies of NF-kappa B, and we aim to generate a more unified view of NF-kappa B regulation.	[Hayden, Matthew S.; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Ghosh, Sankar] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	sankar.ghosh@yale.edu	Hayden, Matthew/C-1263-2008	Ghosh, Sankar/0000-0002-3227-0588; Hayden, Matthew/0000-0003-1670-6430	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI033443, R01AI068977, R01AI059440, R01AI066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NIAID NIH HHS [AI068977, AI033443, R01 AI059440, AI059440, R01 AI066109, R37 AI033443, AI066109] Funding Source: Medline; NIGMS NIH HHS [GM07205] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Amir RE, 2004, ONCOGENE, V23, P2540, DOI 10.1038/sj.onc.1207366; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Britanova LV, 2008, BIOCHEM BIOPH RES CO, V365, P583, DOI 10.1016/j.bbrc.2007.10.200; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; Cohen S, 2001, J BIOL CHEM, V276, P26769, DOI 10.1074/jbc.M102448200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drew D, 2007, BIOCHEMISTRY-US, V46, P12482, DOI 10.1021/bi701137a; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fong A, 2002, J BIOL CHEM, V277, P40697, DOI 10.1074/jbc.M205330200; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goudeau B, 2003, P NATL ACAD SCI USA, V100, P15800, DOI 10.1073/pnas.2535880100; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harhaj EW, 1996, ONCOGENE, V12, P2385; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; HUG GM, 2003, GENE DEV, V17, P873; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Khoshnan A, 1999, J IMMUNOL, V163, P5444; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Kwak YT, 2000, J BIOL CHEM, V275, P14752, DOI 10.1074/jbc.M001039200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Marienfeld RB, 2006, MOL CELL BIOL, V26, P9209, DOI 10.1128/MCB.00478-06; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McKenzie FR, 2000, MOL CELL BIOL, V20, P2635, DOI 10.1128/MCB.20.8.2635-2649.2000; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Samson SI, 2004, BLOOD, V103, P4573, DOI 10.1182/blood-2003-08-2975; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Simonson SJS, 2007, DEV CELL, V13, P601, DOI 10.1016/j.devcel.2007.10.009; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Webster GA, 1999, MOL CELL BIOL, V19, P3485; WEST R, 2001, CHEM ORGANIC SILICON, V3, P1; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	172	3365	3579	8	341	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					344	362		10.1016/j.cell.2008.01.020	http://dx.doi.org/10.1016/j.cell.2008.01.020			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267068	Bronze			2022-12-28	WOS:000253180700011
J	Moon, CR; Mattos, LS; Foster, BK; Zeltzer, G; Ko, WH; Manoharan, HC				Moon, Christopher R.; Mattos, Laila S.; Foster, Brian K.; Zeltzer, Gabriel; Ko, Wonhee; Manoharan, Hari C.			Quantum phase extraction in isospectral electronic nanostructures	SCIENCE			English	Article							SHAPE; CORRALS; SURFACE; DRUMS; MANIPULATION; COMPUTATION; MOLECULES; HEARING; STATES; WAVES	Quantum phase is not directly observable and is usually determined by interferometric methods. We present a method to map complete electron wave functions, including internal quantum phase information, from measured single-state probability densities. We harness the mathematical discovery of drum-like manifolds bearing different shapes but identical resonances, and construct quantum isospectral nanostructures with matching electronic structure but divergent physical structure. Quantum measurement (scanning tunneling microscopy) of these "quantum drums" degenerate two-dimensional electron states on the copper(111) surface confined by individually positioned carbon monoxide molecules-reveals that isospectrality provides an extra topological degree of freedom enabling robust quantum state transplantation and phase extraction.	[Moon, Christopher R.; Mattos, Laila S.; Manoharan, Hari C.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Foster, Brian K.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Zeltzer, Gabriel; Ko, Wonhee] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Manoharan, HC (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	manoharan@stanford.edu	Ko, Wonhee/ABG-1509-2020; Zeltzer, Gabriel/L-1475-2016	Zeltzer, Gabriel/0000-0001-7573-4170; Ko, Wonhee/0000-0002-6155-1485				Aligia AA, 2005, J PHYS-CONDENS MAT, V17, pS1095, DOI 10.1088/0953-8984/17/13/005; BERARD P, 1992, MATH ANN, V292, P547, DOI 10.1007/BF01444635; BERARD P, 1993, J LOND MATH SOC, V48, P565, DOI 10.1112/jlms/s2-48.3.565; BUSER P, 1986, ANN I FOURIER, V36, P167, DOI 10.5802/aif.1054; Buser P., 1994, INT MATH RES NOTICES, V9, P391; CHAPMAN SJ, 1995, AM MATH MON, V102, P124, DOI 10.2307/2975346; CIPRA B, 1992, SCIENCE, V255, P1642, DOI 10.1126/science.255.5052.1642; Cormen T.H., 2001, INTRO ALGORITHMS, V2nd ed.; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Driscoll TA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016702; Duan LM, 2001, SCIENCE, V292, P1695, DOI 10.1126/science.1058835; Even C, 1999, EUROPHYS LETT, V47, P531, DOI 10.1209/epl/i1999-00420-8; Fradkin E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050404; GORDON C, 1992, INVENT MATH, V110, P1, DOI 10.1007/BF01231320; HEILBRONNER E, 1978, J AM CHEM SOC, V100, P6506, DOI 10.1021/ja00488a043; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; HELLER EJ, 1994, NATURE, V369, P464, DOI 10.1038/369464a0; HERNDON WC, 1975, TETRAHEDRON, V31, P99, DOI 10.1016/0040-4020(75)85002-2; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; KAC M, 1966, AM MATH MON, V73, P1, DOI 10.2307/2313748; Kliewer J, 2000, SCIENCE, V288, P1399, DOI 10.1126/science.288.5470.1399; Knipp PA, 1996, PHYS REV B, V54, P1880, DOI 10.1103/PhysRevB.54.1880; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Marchesini S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2403783; McKean H.P., 1967, J DIFFERENTIAL GEOME, V1, P43; Nielsen MA, 2006, SCIENCE, V311, P1133, DOI 10.1126/science.1121541; SRIDHAR S, 1994, PHYS REV LETT, V72, P2175, DOI 10.1103/PhysRevLett.72.2175; STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319; Weinacht TC, 1998, PHYS REV LETT, V80, P5508, DOI 10.1103/PhysRevLett.80.5508; Weyl H., 1911, NACHR GES WISS GO MP, V1911, P110; YACOBY A, 1995, PHYS REV LETT, V74, P4047, DOI 10.1103/PhysRevLett.74.4047	32	58	60	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					782	787		10.1126/science.1151490	http://dx.doi.org/10.1126/science.1151490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258909	Green Submitted			2022-12-28	WOS:000252963000053
J	Wallace, MB; Pascual, JMS; Raimondo, M; Woodward, TA; McComb, BL; Crook, JE; Johnson, MM; Al-Haddad, MA; Gross, SA; Pungpapong, S; Hardee, JN; Odell, JA				Wallace, Michael B.; Pascual, Jorge M. S.; Raimondo, Massimo; Woodward, Timothy A.; McComb, Barbara L.; Crook, Julia E.; Johnson, Margaret M.; Al-Haddad, Mohammad A.; Gross, Seth A.; Pungpapong, Surakit; Hardee, Joy N.; Odell, John A.			Minimally invasive endoscopic staging of suspected lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; GUIDELINES 2ND EDITION; POSITRON-EMISSION-TOMOGRAPHY; ULTRASOUND-GUIDED BIOPSY; MEDIASTINAL LYMPH-NODES; ENDOBRONCHIAL ULTRASOUND; COMPUTED-TOMOGRAPHY; TRANSESOPHAGEAL; LESIONS; ULTRASONOGRAPHY	Context In patients with suspected lung cancer, the presence of mediastinal lymph node metastasis is a critical determinant of therapy and prognosis. Invasive staging with pathologic confirmation is recommended. Many methods for staging exist; mediastinoscopy, an invasive procedure requiring general anesthesia, is currently regarded as the diagnostic standard. Objective To compare the diagnostic accuracy of 3 methods of minimally invasive endoscopic staging ( and their combinations): traditional transbronchial needle aspiration ( TBNA), endobronchial ultrasound- guided fine- needle aspiration ( EBUS- FNA), and transesophageal endoscopic ultrasound- guided fine- needle aspiration ( EUS-FNA). In particular, we aimed to compare EBUS- FNA with TBNA. Design, Setting, and Participants Invasive staging of the mediastinum among consecutive patients with suspected lung cancer at a US academic medical center from November 2004 through October 2006. Intervention TBNA, EBUS- FNA, and EUS- FNA performed sequentially as a single combined procedure. Main Outcome Measure Sensitivity for detecting mediastinal lymph node metastases, using pathologic confirmation and 6- to 12- month clinical follow- up as the criterion standard. Results Among 138 patients who met all study criteria, 42 ( 30%) had malignant lymph nodes. EBUS- FNA was more sensitive than TBNA, detecting 29 ( 69%) vs 15 ( 36%) malignant lymph nodes ( P=. 003). The combination of EUS- FNA and EBUS-FNA ( EUS plus EBUS) had higher estimated sensitivity ( 93% [ 39/ 42]; 95% confidence interval, 81%- 99%) and negative predictive value ( 97% [ 96/ 99]; 95% confidence interval, 91%- 99%) compared with either method alone. EUS plus EBUS also had higher sensitivity and higher negative predictive value for detecting lymph nodes in any mediastinal location and for patients without lymph node enlargement on chest computed tomography. Conclusions These findings suggest that EBUS- FNA has higher sensitivity than TBNA and that EUS plus EBUS may allow near- complete minimally invasive mediastinal staging in patients with suspected lung cancer. These results require confirmation in other studies but suggest that EUS plus EBUS may be an alternative approach for mediastinal staging in patients with suspected lung cancer.	[Wallace, Michael B.; Raimondo, Massimo; Woodward, Timothy A.; Al-Haddad, Mohammad A.; Gross, Seth A.] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA; [Pascual, Jorge M. S.; Johnson, Margaret M.] Mayo Clin, Dept Pulm Med, Jacksonville, FL 32224 USA; [McComb, Barbara L.] Mayo Clin, Dept Radiol, Jacksonville, FL 32224 USA; [Crook, Julia E.] Mayo Clin, Biostat Unit, Jacksonville, FL 32224 USA; [Johnson, Margaret M.] Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA; [Hardee, Joy N.] Mayo Clin, Clin Studies Unit, Jacksonville, FL 32224 USA; [Odell, John A.] Mayo Clin, Div Transplant Surg, Jacksonville, FL 32224 USA; [Pungpapong, Surakit] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Wallace, MB (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	wallace.michael@mayo.edu	odell, john/AAA-5834-2022; Wallace, Michael/GZL-9731-2022	Wallace, Michael/0000-0002-6446-5785; Pungpapong, Surakit/0000-0001-6455-959X; Raimondo, Massimo/0000-0002-3750-1541	NATIONAL CANCER INSTITUTE [R33CA097875] Funding Source: NIH RePORTER; NCI NIH HHS [R33CA97875] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aabakken L, 1999, ENDOSCOPY, V31, P707, DOI 10.1055/s-1999-74; Chin R, 2002, AM J RESP CRIT CARE, V166, P377, DOI 10.1164/rccm.2106153; Colice GL, 2007, CHEST, V132, p161S, DOI 10.1378/chest.07-1359; Detterbeck FC, 2003, CHEST, V123, p167S, DOI 10.1378/chest.123.1_suppl.167S; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Harewood GC, 2002, MAYO CLIN PROC, V77, P155; Herth F, 2004, CHEST, V125, P322, DOI 10.1378/chest.125.1.322; Herth FJF, 2006, EUR RESPIR J, V28, P910, DOI 10.1183/09031936.06.00124905; Herth FJF, 2006, THORAX, V61, P795, DOI 10.1136/thx.2005.047829; Herth FJF, 2006, EUR RESPIR J, V28, P1264, DOI 10.1183/09031936.00013806; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Larsen SS, 2005, LUNG CANCER-J IASLC, V48, P85, DOI 10.1016/j.lungcan.2004.10.002; LeBlanc JK, 2005, AM J RESP CRIT CARE, V171, P177, DOI 10.1164/rccm.200405-581OC; MILLER A B, 1992, Current Opinion in Oncology, V4, P286, DOI 10.1097/00001622-199204000-00009; Monso E, 2007, MED CLIN-BARCELONA, V128, P481, DOI 10.1157/13100934; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Plat G, 2006, EUR RESPIR J, V27, P276, DOI 10.1183/09031936.06.00139204; Rintoul RC, 2005, EUR RESPIR J, V25, P416, DOI 10.1183/09031936.05.00095404; Rintoul RC, 2004, CHEST, V126, P2020, DOI 10.1378/chest.126.6.2020; Silvestri GA, 2003, CHEST, V123, p147S, DOI 10.1378/chest.123.1_suppl.147S; Tango T, 1998, STAT MED, V17, P891, DOI 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; Vilmann P, 2005, ENDOSCOPY, V37, P833, DOI 10.1055/s-2005-870276; Vilmann P, 2003, GASTROINTEST ENDOSC, V57, pAB75; Wallace MB, 2004, ANN THORAC SURG, V77, P1763, DOI 10.1016/j.athoracsur.2003.10.009; Wallace MB, 2001, ANN THORAC SURG, V72, P1861, DOI 10.1016/S0003-4975(01)03205-2; Wallace MB, 2001, GASTROINTEST ENDOSC, V54, P441, DOI 10.1067/mge.2001.117764; Yasufuku K, 2004, ONCOL REP, V11, P293; Yasufuku K, 2005, LUNG CANCER, V50, P347, DOI 10.1016/j.lungcan.2005.07.013; Yasufuku K, 2004, CHEST, V126, P122, DOI 10.1378/chest.126.1.122; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710	32	298	317	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					540	546		10.1001/jama.299.5.540	http://dx.doi.org/10.1001/jama.299.5.540			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252884	Bronze			2022-12-28	WOS:000252886100019
J	Hawkes, N				Hawkes, Nigel			How do we get the measure of patient care?	BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY					nigel.hawkes@thetimes.co.uk						Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD	2	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 2	2008	336	7638					249	249		10.1136/bmj.39470.702627.59	http://dx.doi.org/10.1136/bmj.39470.702627.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18244995	Green Published			2022-12-28	WOS:000253102900034
J	BURNS, G; BILLARD, TC; MATSUI, KM				BURNS, G; BILLARD, TC; MATSUI, KM			SALINITY THREAT TO UPPER EGYPT	NATURE			English	Letter											BURNS, G (corresponding author), UNIV TORONTO,DEPT CHEM,TORONTO M5S 1A1,ONTARIO,CANADA.							BILLARD TC, 1980, NATURE, V285, P654, DOI 10.1038/285654a0; BILLARD TC, 1985, THESIS U TORONTO; PILLSBURY AF, 1981, SCI AM, V55, P55; TRAUNECKER C, 1970, KEMI, V20, P213; Traunecker C., 1971, KEMI, V21, P177	5	11	11	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					25	25		10.1038/344025a0	http://dx.doi.org/10.1038/344025a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278013	Bronze			2022-12-28	WOS:A1990CQ97200041
J	COLES, P				COLES, P			ROCKET LAUNCHERS - NEW SETBACK FOR ARIANE	NATURE			English	Editorial Material																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					7	7		10.1038/344007c0	http://dx.doi.org/10.1038/344007c0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277993	Bronze			2022-12-28	WOS:A1990CQ97200020
J	Mendez-Ferrer, S; Lucas, D; Battista, M; Frenette, PS				Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.			Haematopoietic stem cell release is regulated by circadian oscillations	NATURE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; MYELOID PROGENITOR CELLS; BONE-MARROW; TARGETED DISRUPTION; PROTEIN-KINASE; STROMAL CELLS; RECEPTOR GENE; E-SELECTIN; MOBILIZATION; NICHE	Haematopoietic stem cells ( HSCs) circulate in the bloodstream under steady- state conditions, but the mechanisms controlling their physiological trafficking are unknown. Here we show that circulating HSCs and their progenitors exhibit robust circadian fluctuations, peaking 5 h after the initiation of light and reaching a nadir 5 h after darkness. Circadian oscillations are markedly altered when mice are subjected to continuous light or to a 'jet lag' ( defined as a shift of 12 h). Circulating HSCs and their progenitors fluctuate in antiphase with the expression of the chemokine CXCL12 in the bone marrow microenvironment. The cyclical release of HSCs and expression of Cxcl12 are regulated by core genes of the molecular clock through circadian noradrenaline secretion by the sympathetic nervous system. These adrenergic signals are locally delivered by nerves in the bone marrow, transmitted to stromal cells by the beta(3)- adrenergic receptor, leading to a decreased nuclear content of Sp1 transcription factor and the rapid downregulation of Cxcl12. These data indicate that a circadian, neurally driven release of HSC during the animal's resting period may promote the regeneration of the stem cell niche and possibly other tissues.	[Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Frenette, Paul S.] Black Family Stem Cell Inst, New York, NY 10029 USA; [Frenette, Paul S.] Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	paul.frenette@mssm.edu	Lucas, Daniel/ABB-6893-2021; Méndez-Ferrer, Simón/ABG-8547-2020; Méndez-Ferrer, Simón/L-8088-2014; Frenette, Paul S/J-8272-2012	Lucas, Daniel/0000-0002-0147-5425; Méndez-Ferrer, Simón/0000-0002-9805-9988; Méndez-Ferrer, Simón/0000-0002-9805-9988; Frenette, Paul S/0000-0003-0862-9922				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arraj M, 2006, CHRONOBIOL INT, V23, P795, DOI 10.1080/07420520600827111; Benestad HB, 1998, BLOOD, V91, P1280, DOI 10.1182/blood.V91.4.1280; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Katayama Y, 2004, BLOOD, V104, P2020, DOI 10.1182/blood-2003-12-4157; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2003, IMMUNITY, V18, P789, DOI 10.1016/S1074-7613(03)00150-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; ROSS DD, 1980, EXP HEMATOL, V8, P954; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Soeder KJ, 1999, J BIOL CHEM, V274, P12017, DOI 10.1074/jbc.274.17.12017; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; VERMA DS, 1980, AM J HEMATOL, V9, P185, DOI 10.1002/ajh.2830090206; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Ye XB, 2002, J BIOL CHEM, V277, P31863, DOI 10.1074/jbc.M205544200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	48	892	916	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					442	U4		10.1038/nature06685	http://dx.doi.org/10.1038/nature06685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18256599				2022-12-28	WOS:000254341300025
J	Jack, A				Jack, Andrew			Balancing big pharma's books	BRITISH MEDICAL JOURNAL			English	Editorial Material												Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*FOOD DRUG ADM, 2006, PFIZ STOPS ALL TORC; *I QUAL EFF HEALTH, 2006, EV EFF STAT PART CON; *PFIZ, 2007, 3 QUART EARN TEL	3	22	22	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					418	419		10.1136/bmj.39491.469005.94	http://dx.doi.org/10.1136/bmj.39491.469005.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292166	Green Published			2022-12-28	WOS:000253664000034
J	Ozgediz, D; Kijjambu, S; Galukande, M; Dubowitz, G; Mabweijano, J; Mijumbi, C; Cherian, M; Kaggwa, S; Luboga, S				Ozgediz, Doruk; Kijjambu, Stephen; Galukande, Moses; Dubowitz, Gerald; Mabweijano, Jackie; Mijumbi, Cephas; Cherian, Meena; Kaggwa, Sam; Luboga, Sam			Africa's neglected surgical workforce crisis	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; SERVICES; SURGERY		[Ozgediz, Doruk] Univ Calif San Francisco, Dept Surg & Global Hlth Sci, San Francisco, CA 94143 USA; [Dubowitz, Gerald] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Kijjambu, Stephen; Galukande, Moses; Mabweijano, Jackie; Kaggwa, Sam; Luboga, Sam] Makerere Univ, Dept Surg, Kampala, Uganda; [Mijumbi, Cephas] Makerere Univ, Dept Anaesthesia, Kampala, Uganda; [Cherian, Meena] WHO, Dept Essential Hlth Technol, Clin Procedures Unit, Emergency Essential Surg Care Project, CH-1211 Geneva, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; Makerere University; World Health Organization	Ozgediz, D (corresponding author), Univ Calif San Francisco, Dept Surg & Global Hlth Sci, San Francisco, CA 94143 USA.	dozgediz@hotmail.com						*BELL ESS SURG GRO, 2007, IMPR ACC SURG SUBS A; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; El Khamlichi Abdeslam, 2005, Clin Neurosurg, V52, P214; Galukande M., 2006, East and Central African Journal of Surgery, V11, P17; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Kruk ME, 2007, BJOG-INT J OBSTET GY, V114, P1253, DOI 10.1111/j.1471-0528.2007.01443.x; MacGowan W A, 1987, Bull Am Coll Surg, V72, P5; MacGowan WA, 1987, B AM COLL SURG, V72, P9; NORDBERG E, 1995, TROP GEOGR MED, V47, P206; Pincock S, 2007, LANCET, V370, P1817, DOI 10.1016/S0140-6736(07)61759-0; SMITH ED, 1994, AUST NZ J SURG, V64, P1, DOI 10.1111/j.1445-2197.1994.tb02121.x; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3	13	55	56	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					627	628		10.1016/S0140-6736(08)60279-2	http://dx.doi.org/10.1016/S0140-6736(08)60279-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295007				2022-12-28	WOS:000253436700006
J	Huissoon, A; Krishna, MT				Huissoon, Aarnoud; Krishna, Mamidipudi Thirumala			Images in clinical medicine: Cold-induced urticaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huissoon, Aarnoud; Krishna, Mamidipudi Thirumala] Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham	Huissoon, A (corresponding author), Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England.	aarnoud.huissoon@heartofengland.nhs.uk							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					E9	E9		10.1056/NEJMicm072431	http://dx.doi.org/10.1056/NEJMicm072431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287597				2022-12-28	WOS:000253257700009
J	Jakobsson, M; Scholz, SW; Scheet, P; Gibbs, JR; VanLiere, JM; Fung, HC; Szpiech, ZA; Degnan, JH; Wang, K; Guerreiro, R; Bras, JM; Schymick, JC; Hernandez, DG; Traynor, BJ; Simon-Sanchez, J; Matarin, M; Britton, A; van de Leemput, J; Rafferty, I; Bucan, M; Cann, HM; Hardy, JA; Rosenberg, NA; Singleton, AB				Jakobsson, Mattias; Scholz, Sonja W.; Scheet, Paul; Gibbs, J. Raphael; VanLiere, Jenna M.; Fung, Hon-Chung; Szpiech, Zachary A.; Degnan, James H.; Wang, Kai; Guerreiro, Rita; Bras, Jose M.; Schymick, Jennifer C.; Hernandez, Dena G.; Traynor, Bryan J.; Simon-Sanchez, Javier; Matarin, Mar; Britton, Angela; van de Leemput, Joyce; Rafferty, Ian; Bucan, Maja; Cann, Howard M.; Hardy, John A.; Rosenberg, Noah A.; Singleton, Andrew B.			Genotype, haplotype and copy-number variation in worldwide human populations	NATURE			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; POLYMORPHISMS; DISTANCE; AFRICA; MODEL	Genome-wide patterns of variation across individuals provide a powerful source of data for uncovering the history of migration, range expansion, and adaptation of the human species. However, high-resolution surveys of variation in genotype, haplotype and copy number have generally focused on a small number of population groups(1-3). Here we report the analysis of high-quality genotypes at 525,910 single-nucleotide polymorphisms ( SNPs) and 396 copy-number-variable loci in a worldwide sample of 29 populations. Analysis of SNP genotypes yields strongly supported fine-scale inferences about population structure. Increasing linkage disequilibrium is observed with increasing geographic distance from Africa, as expected under a serial founder effect for the out-of-Africa spread of human populations. New approaches for haplotype analysis produce inferences about population structure that complement results based on unphased SNPs. Despite a difference from SNPs in the frequency spectrum of the copy-number variants (CNVs) detected-including a comparatively large number of CNVs in previously unexamined populations from Oceania and the Americas-the global distribution of CNVs largely accords with population structure analyses for SNP data sets of similar size. Our results produce new inferences about inter-population variation, support the utility of CNVs in human population-genetic research, and serve as a genomic resource for human-genetic studies in diverse worldwide populations.	[Jakobsson, Mattias; Scheet, Paul; VanLiere, Jenna M.; Szpiech, Zachary A.; Degnan, James H.; Rosenberg, Noah A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Jakobsson, Mattias; Degnan, James H.; Rosenberg, Noah A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Scheet, Paul; Rosenberg, Noah A.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scholz, Sonja W.; Gibbs, J. Raphael; Fung, Hon-Chung; Guerreiro, Rita; Bras, Jose M.; Schymick, Jennifer C.; Hernandez, Dena G.; Traynor, Bryan J.; Simon-Sanchez, Javier; Matarin, Mar; Britton, Angela; van de Leemput, Joyce; Rafferty, Ian; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Scholz, Sonja W.; Gibbs, J. Raphael; van de Leemput, Joyce; Hardy, John A.] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Scholz, Sonja W.; Gibbs, J. Raphael; van de Leemput, Joyce; Hardy, John A.] UCL, Reta Lila Weston Inst Neurol Studies, Inst Neurol, London WC1N 3BG, England; [Fung, Hon-Chung] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Fung, Hon-Chung] Chang Gung Univ, Coll Med, Taipei 10591, Taiwan; [Wang, Kai; Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Guerreiro, Rita; Bras, Jose M.] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal; [Schymick, Jennifer C.] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Traynor, Bryan J.] Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Simon-Sanchez, Javier] CSIC, Unidad Genet Mol, Dept Genom & Proteom, Inst Biomed Valencia, Valencia 46010, Spain; [Cann, Howard M.] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Singleton, Andrew B.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; Chang Gung Memorial Hospital; Chang Gung University; University of Pennsylvania; Universidade de Coimbra; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Foundation Jean Dausset-CEPH; University of Virginia	Rosenberg, NA (corresponding author), Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA.	rnoah@umich.edu; singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009; Scholz, Sonja W./R-5524-2017; Traynor, Bryan J/G-5690-2010; Matarin, Mar/F-1771-2016; Bras, Jose/D-3366-2009; Scholz, Sonja/AAN-6601-2021; Jakobsson, Mattias/A-6116-2011; Guerreiro, Rita J L/A-1327-2011; Degnan, James/A-4489-2008; Bras, Jose MT/A-1428-2011; Gibbs, J. Raphael/A-3984-2010	Hardy, John/0000-0002-3122-0423; Scholz, Sonja W./0000-0002-6623-0429; Matarin, Mar/0000-0002-4717-5735; Scholz, Sonja/0000-0002-6623-0429; Jakobsson, Mattias/0000-0001-7840-7853; Gibbs, J. Raphael/0000-0002-6985-0658; van de Leemput, Joyce/0000-0003-1903-7295; Simon Sanchez, Javier/0000-0001-5141-5829; Rosenberg, Noah/0000-0002-1829-8664; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333; Canzoniero, Jenna/0000-0003-1084-6918	NATIONAL INSTITUTE ON AGING [Z01AG000932, ZIAAG000932] Funding Source: NIH RePORTER; MRC [G0701075] Funding Source: UKRI; Intramural NIH HHS Funding Source: Medline; Medical Research Council [MR/K01417X/1, G0701075] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Falush D, 2003, GENETICS, V164, P1567; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McVean GAT, 2002, GENETICS, V162, P987; Need AC, 2006, NAT GENET, V38, P1227, DOI 10.1038/ng1106-1227; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabatti C, 2002, GENETICS, V160, P1707; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	30	623	638	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					998	1003		10.1038/nature06742	http://dx.doi.org/10.1038/nature06742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288195	Green Published			2022-12-28	WOS:000253313100050
J	Banerjee, R; Phan, A; Wang, B; Knobler, C; Furukawa, H; O'Keeffe, M; Yaghi, OM				Banerjee, Rahul; Phan, Anh; Wang, Bo; Knobler, Carolyn; Furukawa, Hiroyasu; O'Keeffe, Michael; Yaghi, Omar M.			High-throughput synthesis of zeolitic imidazolate frameworks and application to CO2 capture	SCIENCE			English	Article							HYDROTHERMAL SYNTHESIS; ZMOFS	A high- throughput protocol was developed for the synthesis of zeolitic imidazolate frameworks ( ZIFs). Twenty- five different ZIF crystals were synthesized from only 9600 microreactions of either zinc( II)/ cobalt( II) and imidazolate/ imidazolate- type linkers. All of the ZIF structures have tetrahedral frameworks: 10 of which have two different links ( heterolinks), 16 of which are previously unobserved compositions and structures, and 5 of which have topologies as yet unobserved in zeolites. Members of a selection of these ZIFs ( termed ZIF- 68, ZIF- 69, and ZIF- 70) have high thermal stability ( up to 390 degrees C) and chemical stability in refluxing organic and aqueous media. Their frameworks have high porosity ( with surface areas up to 1970 square meters per gram), and they exhibit unusual selectivity for CO2 capture from CO2/CO mixtures and extraordinary capacity for storing CO2: 1 liter of ZIF- 69 can hold similar to 83 liters of CO2 at 273 kelvin under ambient pressure.	[Banerjee, Rahul; Phan, Anh; Wang, Bo; Knobler, Carolyn; Furukawa, Hiroyasu; Yaghi, Omar M.] Univ Calif Los Angeles, Ctr Reticular Chem, Calif Nanosyst Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [O'Keeffe, Michael] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe	Banerjee, R (corresponding author), Univ Calif Los Angeles, Ctr Reticular Chem, Calif Nanosyst Inst, Dept Chem & Biochem, 607 E Charles E Young Dr, Los Angeles, CA 90095 USA.	rahul@chem.ucla.edu; yaghi@chem.ucla.edu	Furukawa, Hiroyasu/C-5910-2008; Yaghi, Omar M/C-6749-2013; WANG, BO/D-9762-2012; yarasi, soujanya/F-5531-2011; BANERJEE, RAHUL/Q-7260-2019	Furukawa, Hiroyasu/0000-0002-6082-1738; WANG, BO/0000-0001-9092-3252; BANERJEE, RAHUL/0000-0002-3547-4746; Yaghi, Omar/0000-0002-5611-3325				Akporiaye DE, 1998, ANGEW CHEM INT EDIT, V37, P609, DOI 10.1002/(SICI)1521-3773(19980316)37:5<609::AID-ANIE609>3.0.CO;2-X; Blatov VA, 2007, ACTA CRYSTALLOGR A, V63, P418, DOI 10.1107/S0108767307038287; Choi K, 1999, ANGEW CHEM INT EDIT, V38, P2891, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2891::AID-ANIE2891>3.0.CO;2-X; Corma A, 2006, NATURE, V443, P842, DOI 10.1038/nature05238; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Forster PM, 2005, ANGEW CHEM INT EDIT, V44, P7608, DOI 10.1002/anie.200501766; Friedrichs OD, 2003, ACTA CRYSTALLOGR A, V59, P22, DOI 10.1107/S0108767302018494; Hayashi H, 2007, NAT MATER, V6, P501, DOI 10.1038/nmat1927; Klein J, 1998, ANGEW CHEM INT EDIT, V37, P3369, DOI 10.1002/(SICI)1521-3773(19981231)37:24<3369::AID-ANIE3369>3.0.CO;2-H; Lai R, 2001, ANGEW CHEM INT EDIT, V40, P408, DOI 10.1002/1521-3773(20010119)40:2<408::AID-ANIE408>3.0.CO;2-V; LEHNERT R, 1980, Z ANORG ALLG CHEM, V464, P187, DOI 10.1002/zaac.19804640117; Liu YL, 2006, CHEM COMMUN, P1488, DOI 10.1039/b600188m; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Rettig SJ, 2000, J CHEM SOC DALTON, P3931, DOI 10.1039/b002574g; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Rouquerol F., 1999, ADSORPTION POWDERS P; Sircar S, 1996, CARBON, V34, P1, DOI 10.1016/0008-6223(95)00128-X; Stock N, 2004, ANGEW CHEM INT EDIT, V43, P749, DOI 10.1002/anie.200351718; Tian YQ, 2007, CHEM-EUR J, V13, P4146, DOI 10.1002/chem.200700181; Zhang JP, 2006, CHEM COMMUN, P1689, DOI 10.1039/b516367f	20	3006	3135	194	3435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					939	943		10.1126/science.1152516	http://dx.doi.org/10.1126/science.1152516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276887				2022-12-28	WOS:000253165700042
J	Ehringhaus, SH; Weissman, JS; Sears, JL; Goold, SD; Feibelmann, S; Campbell, EG				Ehringhaus, Susan H.; Weissman, Joel S.; Sears, Jacqueline L.; Goold, Susan Dorr; Feibelmann, Sandra; Campbell, Eric G.			Responses of medical schools to institutional conflicts of interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUSTRY	Context Institutional financial conflicts of interest may affect research results. No national data exist on the extent to which US medical schools have formally responded to challenges associated with institutional conflicts of interest ( ICOI). Objective To assess the current state of ICOI policies and practices in US medical schools using the recommendations issued by 2 national higher education and research organizations as the standard. Design, Setting, and Participants National survey of deans of all 125 accredited allopathic medical schools in the United States, administered between February 2006 and December 2006. Main Outcome Measures The extent to which medical schools have adopted ICOI policies applicable to their institution and to their institutional officials; the scope of these policies in terms of those covered entities, offices, and financial relationships; the existence of recommended organizational structures as means to address ICOI; and the institutions' linkages between ICOI and their institutional review boards ( IRBs). Results Responses were received from a total of 86 ( 69%) of 125 US medical schools. Although only 30 ( 38%) respondents ( not all overall respondents answered all questions) have adopted an ICOI policy applicable to financial interests held by the institutions, a much higher number have adopted ICOI policies applicable to the financial interests of the officials: 55 ( 71%) for senior officials, 55 ( 69%) for midlevel officials, 62 ( 81%) for IRB members, and 51 ( 66%) for governing board members. Most institutions treat as potential ICOI the financial interests held by an institutional research official for a research sponsor ( 43 [ 78%]) or for a product that is the subject of research ( 43 [ 78%]). The majority of institutions have adopted organizational structures that separate research responsibility from investment management and from technology transfer responsibility. Gaps exist in institutions informing their IRBs of potential ICOI in research projects under review. Conclusions This study provides the first national data on the existence and nature of policies and practices of US medical schools for addressing potential ICOI. The gaps identified suggest the need for continuing attention by the academic medical community to address the challenges presented by ICOI more consistently and comprehensively.	[Ehringhaus, Susan H.; Sears, Jacqueline L.] Assoc Amer Med Coll, Washington, DC 20037 USA; [Weissman, Joel S.; Feibelmann, Sandra; Campbell, Eric G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Goold, Susan Dorr] Univ Michigan, Ann Arbor, MI 48109 USA	Association of American Medical Colleges; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan	Ehringhaus, SH (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	sehringhaus@aamc.org	Goold, Susan Dorr/N-6930-2014	Goold, Susan Dorr/0000-0002-0258-9774				ARMSTRONG D, 2005, WALL STREET J   1212, pA1; *ASS AM MED COLL T, 2002, PROT SUBJ PRES TRUST, V2; *ASS AM U TASK FOR, 2001, REP IND I FIN CONFL; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Campbell NJH, 1998, MOL BIOL EVOL, V15, P1786, DOI 10.1093/oxfordjournals.molbev.a025904; Ehringhaus S., 2004, US MED SCH POLICIES; EMANUEL EJ, 1995, NEW ENGL J MED, V332, P262, DOI 10.1056/NEJM199501263320412; *GOV ACC OFF, GAO07750; Johns MME, 2003, JAMA-J AM MED ASSOC, V289, P741, DOI 10.1001/jama.289.6.741; Kassirer J. P., 2005, TAKE MED COMPLICITY; *US DEP HHS, 1995, FED REGISTER, V42, P39076; *US DEP HHS, 2004, FED REGISTER, V69, P26393; *US SEN COMM FIN, 34364 US SEN COMM FI; Washburn J, 2005, U INC CORPORATE CORR	16	49	50	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					665	671		10.1001/jama.299.6.665	http://dx.doi.org/10.1001/jama.299.6.665			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270355	Bronze			2022-12-28	WOS:000253095200024
J	Feldman, DR; Bosl, GJ; Sheinfeld, J; Motzer, RJ				Feldman, Darren R.; Bosl, George J.; Sheinfeld, Joel; Motzer, Robert J.			Medical treatment of advanced testicular cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GERM-CELL TUMORS; LONG-TERM SURVIVORS; HIGH-DOSE CHEMOTHERAPY; CISPLATIN-BASED CHEMOTHERAPY; LYMPH-NODE DISSECTION; COUNCIL EUROPEAN ORGANIZATION; PACLITAXEL PLUS GEMCITABINE; COOPERATIVE-ONCOLOGY-GROUP; SINGLE-AGENT CARBOPLATIN; C-KIT GENE	Context The medical treatment of advanced testicular germ cell tumors has changed over the past 30 years, with long- term survival now achieved in the majority of patients. Clinicians need to be familiar with the available treatment regimens for testicular cancer and their associated toxic effects. Objective To review the treatments used for advanced testicular germ cell tumors and their associated short- term and long- term complications. Evidence Acquisition A search was performed of all English- language literature ( 1966 to October 2007) within the MEDLINE database using the terms neoplasms, germ cell, or embryonal or testicular neoplasms restricted to humans, drug therapy, complications, and mortality. The Cochrane Register of Controlled Trials Databases ( through October 2007) was also searched using the terms testicular cancer or germ cell tumors. Bibliographies were reviewed to extract other relevant articles. One hundred eighty- six articles were selected based on pertinence to advanced testicular cancer treatment, associated complications, and late relapses with an emphasis on randomized controlled trials. Data Synthesis The treatment of advanced testicular germ cell tumors with cisplatin combination chemotherapy is based on risk stratification ( good, intermediate, or poor prognosis) according to pretreatment clinical features of prognostic value. Clinical trials have demonstrated that approximately 90% of patients classified as having a good prognosis achieve a durable complete remission to either 4 cycles of etoposide and cisplatin or 3 cycles of cisplatin, etoposide, and bleomycin. Complete responses are achieved less frequently for patients with intermediate- and poor- risk germ cell tumors, in whom 4 cycles of bleomycin, etoposide, and cisplatin remains the standard of care. Second- and third- line programs, including high- dose chemotherapy, also have curative potential. Chronic toxicities associated with therapy include cardiovascular disease, infertility, and secondary malignancies. Late relapses may also occur. Conclusions Clinical trials have led to evidence- based treatment recommendations for advanced testicular cancer based on risk stratification. Clinicians should be familiar with the potential complications of these therapies.	[Feldman, Darren R.; Bosl, George J.; Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Genitourinary Oncol Serv, New York, NY 10065 USA; [Sheinfeld, Joel] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Bosl, George J.; Motzer, Robert J.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; [Sheinfeld, Joel] Cornell Univ, Weill Med Coll, Dept Surg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10065 USA.	motzerr@mskcc.org		Bosl, George/0000-0002-7842-6584; Motzer, Robert/0000-0001-6925-2327; Feldman, Darren/0000-0003-2424-4635				AASS N, 1991, EUR J CANCER, V27, P1087, DOI 10.1016/0277-5379(91)90298-R; Albers P, 2004, J UROLOGY, V171, P1835, DOI 10.1097/01.ju.0000119121.36427.09; Albers P, 2000, J UROLOGY, V164, P381, DOI 10.1016/S0022-5347(05)67365-X; [Anonymous], 1997, J Clin Oncol, V15, P594; Bachmeyer C, 2000, TUMORI, V86, P428, DOI 10.1177/030089160008600513; BAJORIN DF, 1993, J NATL CANCER I, V85, P60, DOI 10.1093/jnci/85.1.60; BAJORIN DF, 1993, J CLIN ONCOL, V11, P598, DOI 10.1200/JCO.1993.11.4.598; BANIEL J, 1995, J UROLOGY, V153, P976, DOI 10.1016/S0022-5347(01)67616-X; BANIEL J, 1995, J CLIN ONCOL, V13, P1170, DOI 10.1200/JCO.1995.13.5.1170; BANIEL J, 1994, J UROLOGY, V152, P424, DOI 10.1016/S0022-5347(17)32754-4; Beck SDW, 2005, UROL ONCOL-SEMIN ORI, V23, P423, DOI 10.1016/j.urolonc.2005.06.007; Beck SDW, 2005, J CLIN ONCOL, V23, P6149, DOI 10.1200/JCO.2005.11.684; Bedano PM, 2006, J CLIN ONCOL, V24, P5403, DOI 10.1200/JCO.2006.05.8065; Berger CC, 1995, EUR J CANCER, V31A, P2229, DOI 10.1016/0959-8049(95)00460-2; BEYER J, 1995, J CLIN ONCOL, V13, P1328, DOI 10.1200/JCO.1995.13.6.1328; Beyer J, 2002, ANN ONCOL, V13, P599, DOI 10.1093/annonc/mdf112; Beyer J, 1996, J CLIN ONCOL, V14, P2638, DOI 10.1200/JCO.1996.14.10.2638; BOKEMEYER C, 1993, J CLIN ONCOL, V11, P1703, DOI 10.1200/JCO.1993.11.9.1703; Bokemeyer C, 2004, BRIT J CANCER, V91, P683, DOI 10.1038/sj.bjc.6602020; Bokemeyer C, 1996, J CLIN ONCOL, V14, P2923, DOI 10.1200/JCO.1996.14.11.2923; Bokemeyer C, 1998, BRIT J CANCER, V77, P1355, DOI 10.1038/bjc.1998.226; Bokemeyer C, 1996, ANN ONCOL, V7, P1015; BORGE N, 1988, J CLIN ONCOL, V6, P1248, DOI 10.1200/JCO.1988.6.8.1248; BOSHOFF C, 1995, ANN ONCOL, V6, P35, DOI 10.1093/oxfordjournals.annonc.a059037; BOSL GJ, 1988, J CLIN ONCOL, V6, P1231, DOI 10.1200/JCO.1988.6.8.1231; BOSL GJ, 1981, LANCET, V2, P970; Brennemann W, 1997, J UROLOGY, V158, P844, DOI 10.1016/S0022-5347(01)64333-7; Brydoy M, 2005, JNCI-J NATL CANCER I, V97, P1580, DOI 10.1093/jnci/dji339; CANTWELL BMJ, 1988, LANCET, V2, P1086; Carver BS, 2007, J CLIN ONCOL, V25, P4365, DOI 10.1200/JCO.2007.11.2078; Carver BS, 2006, J UROLOGY, V176, P100, DOI 10.1016/S0022-5347(06)00508-8; Chan PTK, 2001, CANCER, V92, P1632, DOI 10.1002/1097-0142(20010915)92:6<1632::AID-CNCR1489>3.0.CO;2-I; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CLEMM C, 2000, P ASCO, V19, pA326; COHEN MB, 1989, AM J CLIN PATHOL, V92, P101, DOI 10.1093/ajcp/92.1.101; Coogan CL, 1996, J UROLOGY, V156, P1656, DOI 10.1016/S0022-5347(01)65476-4; Culine S, 2007, ANN ONCOL, V18, P917, DOI 10.1093/annonc/mdm062; Cullen M, 2005, NEW ENGL J MED, V353, P988, DOI 10.1056/NEJMoa050078; Cullen MH, 2007, J CLIN ONCOL, V25, P4821, DOI 10.1200/JCO.2006.08.7395; Dahl AA, 2005, J CLIN ONCOL, V23, P2389, DOI 10.1200/JCO.2005.05.061; Damani MN, 2002, J CLIN ONCOL, V20, P930, DOI 10.1200/JCO.2002.20.4.930; DAUGAARD G, 1993, EUR J CANCER, V29A, P2220, DOI 10.1016/0959-8049(93)90209-X; De Santis M, 2004, J CLIN ONCOL, V22, P1034, DOI 10.1200/JCO.2004.07.188; de Wit R, 2001, J CLIN ONCOL, V19, P1629, DOI 10.1200/JCO.2001.19.6.1629; de Wit R, 1998, BRIT J CANCER, V78, P828, DOI 10.1038/bjc.1998.587; de Wit R, 2006, J CLIN ONCOL, V24, P5482, DOI 10.1200/JCO.2006.07.9434; DELEO MJ, 1988, CANCER, V62, P985, DOI 10.1002/1097-0142(19880901)62:5<985::AID-CNCR2820620524>3.0.CO;2-8; DEWIT R, 1995, BRIT J CANCER, V71, P1311, DOI 10.1038/bjc.1995.254; deWit R, 1997, J CLIN ONCOL, V15, P1837, DOI 10.1200/JCO.1997.15.5.1837; Dieckmann KP, 2005, J UROLOGY, V173, P824, DOI 10.1097/01.ju.0000154013.96349.36; DINEEN MK, 1986, J UROLOGY, V136, P473, DOI 10.1016/S0022-5347(17)44914-7; DOLL DC, 1986, ANN INTERN MED, V105, P48, DOI 10.7326/0003-4819-105-1-48; DONOHUE JP, 1993, J UROLOGY, V149, P237, DOI 10.1016/S0022-5347(17)36046-9; DONOHUE JP, 1981, J UROLOGY, V125, P338, DOI 10.1016/S0022-5347(17)55029-6; DRASGA RE, 1983, J CLIN ONCOL, V1, P179, DOI 10.1200/JCO.1983.1.3.179; Droz JP, 2007, EUR UROL, V51, P739, DOI 10.1016/j.eururo.2006.10.035; EDWARDS GS, 1979, CANCER TREAT REP, V63, P551; Einhorn LH, 2007, NEW ENGL J MED, V357, P340, DOI 10.1056/NEJMoa067749; Einhorn LH, 2007, J CLIN ONCOL, V25, P513, DOI 10.1200/JCO.2006.07.7271; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; EINHORN LH, 1989, J CLIN ONCOL, V7, P387, DOI 10.1200/JCO.1989.7.3.387; Fizazi K, 2001, J CLIN ONCOL, V19, P2647, DOI 10.1200/JCO.2001.19.10.2647; FOSSA AD, 2007, JNCI-J NATL CANCER I, V99, P533; FOSSA SD, 1990, BRIT J CANCER, V61, P639, DOI 10.1038/bjc.1990.142; Fossa SD, 2005, JNCI-J NATL CANCER I, V97, P1056, DOI 10.1093/jnci/dji185; Fossa SD, 2004, BRIT J CANCER, V90, P607, DOI 10.1038/sj.bjc.6601558; Fossa SD, 2002, ANN ONCOL, V13, P222, DOI 10.1093/annonc/mdf048; Fossa SD, 1999, BRIT J CANCER, V80, P1392, DOI 10.1038/sj.bjc.6690534; FOSTER RS, 1991, INT J ANDROL, V14, P179, DOI 10.1111/j.1365-2605.1991.tb01080.x; FOX EP, 1993, J CLIN ONCOL, V11, P1294, DOI 10.1200/JCO.1993.11.7.1294; Gandini L, 2006, HUM REPROD, V21, P2882, DOI 10.1093/humrep/del167; Geldart TR, 2006, BJU INT, V98, P353, DOI 10.1111/j.1464-410X.2006.06250.x; George DW, 2003, J CLIN ONCOL, V21, P113, DOI 10.1200/JCO.2003.03.019; GERL A, 1991, LANCET, V338, P385, DOI 10.1016/0140-6736(91)90521-P; Gerl A, 1997, ANN ONCOL, V8, P41, DOI 10.1023/A:1008253323854; Gerl A, 2001, CANCER, V91, P1297, DOI 10.1002/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z; Gerl A, 1996, ANTI-CANCER DRUG, V7, P716, DOI 10.1097/00001813-199608000-00014; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GIETEMA JA, 1992, ANN INTERN MED, V116, P709, DOI 10.7326/0003-4819-116-9-709; GUAZZIERI S, 1985, UROLOGY, V26, P139, DOI 10.1016/0090-4295(85)90046-9; HALL MR, 1988, LANCET, V2, P1259; HANSEN SW, 1988, J CLIN ONCOL, V6, P1728, DOI 10.1200/JCO.1988.6.11.1728; HANSEN SW, 1989, J CLIN ONCOL, V7, P1457, DOI 10.1200/JCO.1989.7.10.1457; HARSTRICK A, 1991, J CLIN ONCOL, V9, P1549, DOI 10.1200/JCO.1991.9.9.1549; Hartmann JT, 1997, EUR J CANCER, V33, P843, DOI 10.1016/S0959-8049(96)00517-5; Hartmann JT, 2005, ANN SURG, V242, P260, DOI 10.1097/01.sla.0000171303.32006.a2; Haugnes HS, 2007, ANN ONCOL, V18, P241, DOI 10.1093/annonc/mdl372; Heidenreich A, 2003, J UROLOGY, V169, P1710, DOI 10.1097/01.ju.0000060960.18092.54; HENDRY WF, 1983, BRIT J UROL, V55, P769, DOI 10.1111/j.1464-410X.1983.tb03423.x; Hinton S, 2003, CANCER-AM CANCER SOC, V97, P1869, DOI 10.1002/cncr.11271; Hinton S, 2002, J CLIN ONCOL, V20, P1859, DOI 10.1200/JCO.2002.07.158; Hisamatsu E, 2005, INT J UROL, V12, P751, DOI 10.1111/j.1442-2042.2005.01123.x; HOBARTH K, 1994, UROL INT, V52, P162; Horwich A, 2000, BRIT J CANCER, V83, P1623, DOI 10.1054/bjoc.2000.1498; Horwich A, 1997, J CLIN ONCOL, V15, P1844, DOI 10.1200/JCO.1997.15.5.1844; Huddart RA, 2005, BRIT J CANCER, V93, P200, DOI 10.1038/sj.bjc.6602677; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Huyghe E, 2004, CANCER-AM CANCER SOC, V100, P732, DOI 10.1002/cncr.11950; Jacobsen KD, 1999, BRIT J CANCER, V80, P249, DOI 10.1038/sj.bjc.6690347; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kader H A, 1991, Clin Oncol (R Coll Radiol), V3, P37; Kaye SB, 1998, J CLIN ONCOL, V16, P692, DOI 10.1200/JCO.1998.16.2.692; Kollmannsberger C, 1998, J CLIN ONCOL, V16, P3386, DOI 10.1200/JCO.1998.16.10.3386; Kollmannsberger C, 2004, J CLIN ONCOL, V22, P108, DOI 10.1200/JCO.2004.06.068; Kondagunta GV, 2007, UROL CLIN N AM, V34, P179, DOI 10.1016/j.ucl.2007.02.005; Kondagunta GV, 2007, J CLIN ONCOL, V25, P85, DOI 10.1200/JCO.2006.06.9401; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kuczyk MA, 2004, WORLD J UROL, V22, P55, DOI 10.1007/s00345-003-0353-0; Kwan ASL, 2006, AM J OPHTHALMOL, V141, P196, DOI 10.1016/j.ajo.2005.07.046; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lampe H, 1997, J CLIN ONCOL, V15, P239, DOI 10.1200/JCO.1997.15.1.239; LEDERMAN GS, 1987, J UROLOGY, V137, P1236, DOI 10.1016/S0022-5347(17)44466-1; Lesterhuis W Joost, 2005, Lancet Oncol, V6, P910, DOI 10.1016/S1470-2045(05)70428-9; LEVI JA, 1993, J CLIN ONCOL, V11, P1300, DOI 10.1200/JCO.1993.11.7.1300; Lipphardt ME, 2004, WORLD J UROL, V22, P47, DOI 10.1007/s00345-004-0397-9; LOEHRER PJ, 1995, J CLIN ONCOL, V13, P470, DOI 10.1200/JCO.1995.13.2.470; Loehrer PJ, 1998, J CLIN ONCOL, V16, P2500, DOI 10.1200/JCO.1998.16.7.2500; LOEHRER PJ, 1988, ANN INTERN MED, V109, P540, DOI 10.7326/0003-4819-109-7-540; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lowe GDO, 2004, EUR HEART J, V25, P252, DOI 10.1016/j.ehj.2003.11.004; Madani A, 2003, ANN ONCOL, V14, P873, DOI 10.1093/annonc/mdg244; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mano Max Senna, 2006, Sao Paulo Med. J., V124, P343, DOI 10.1590/S1516-31802006000600009; McCaffrey JA, 1997, J CLIN ONCOL, V15, P2559, DOI 10.1200/JCO.1997.15.7.2559; McGuire MS, 2003, BJU INT, V91, P469, DOI 10.1046/j.1464-410X.2003.04128.x; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Meinardi MT, 2000, J CLIN ONCOL, V18, P1725, DOI 10.1200/JCO.2000.18.8.1725; MEISTRICH ML, 1993, HUM REPROD, V8, P8, DOI 10.1093/oxfordjournals.humrep.a137880; Mosharafa AA, 2003, J UROLOGY, V169, P2126, DOI 10.1097/01.ju.0000060121.33899.4b; MOTZER RJ, 1991, CANCER-AM CANCER SOC, V67, P1305, DOI 10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J; MOTZER RJ, 1992, SEMIN ONCOL, V19, P8; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; Nakai Y, 2005, BIOCHEM BIOPH RES CO, V337, P289, DOI 10.1016/j.bbrc.2005.09.042; NICHOLS CR, 1991, J CLIN ONCOL, V9, P1163, DOI 10.1200/JCO.1991.9.7.1163; Nichols CR, 1998, J CLIN ONCOL, V16, P1287, DOI 10.1200/JCO.1998.16.4.1287; NICHOLS CR, 1989, J CLIN ONCOL, V7, P932, DOI 10.1200/JCO.1989.7.7.932; NICHOLS CR, 1990, NEW ENGL J MED, V322, P1425, DOI 10.1056/NEJM199005173222004; Nord C, 2003, BRIT J CANCER, V88, P36, DOI 10.1038/sj.bjc.6600714; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Nuver J, 2005, J CLIN ONCOL, V23, P3718, DOI 10.1200/JCO.2005.02.176; Nuver J, 2004, EUR J CANCER, V40, P701, DOI 10.1016/j.ejca.2003.12.012; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Sullivan JM, 2003, ANN ONCOL, V14, P91, DOI 10.1093/annonc/mdg020; OHL DA, 1991, J UROLOGY, V145, P980, DOI 10.1016/S0022-5347(17)38507-5; Oldenburg J, 2006, BRIT J CANCER, V94, P820, DOI 10.1038/sj.bjc.6603014; Oldenburg J, 2003, J CLIN ONCOL, V21, P3310, DOI 10.1200/JCO.2003.03.184; Oldenburg J, 2006, J CLIN ONCOL, V24, P5503, DOI 10.1200/JCO.2006.08.1836; Pectasides D, 2004, ANN ONCOL, V15, P493, DOI 10.1093/annonc/mdh103; Petersen PM, 1999, J CLIN ONCOL, V17, P941, DOI 10.1200/JCO.1999.17.3.941; PETERSEN PM, 1994, ANN ONCOL, V5, P355, DOI 10.1093/oxfordjournals.annonc.a058840; Petersen PM, 1999, J CLIN ONCOL, V17, P173, DOI 10.1200/JCO.1999.17.1.173; Petersen PM, 1999, ANN ONCOL, V10, P1475, DOI 10.1023/A:1008322909836; Pico JL, 2005, ANN ONCOL, V16, P1152, DOI 10.1093/annonc/mdi228; RAGHAVAN D, 1992, J CLIN ONCOL, V10, P1386, DOI 10.1200/JCO.1992.10.9.1386; Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa; Ravi R, 1997, BRIT J UROL, V80, P647, DOI 10.1046/j.1464-410X.1997.00410.x; Rayson D, 1998, CANCER, V83, P337, DOI 10.1002/(SICI)1097-0142(19980715)83:2<337::AID-CNCR18>3.0.CO;2-U; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robinson D, 2007, BRIT J CANCER, V96, P529, DOI 10.1038/sj.bjc.6603589; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Ronnen EA, 2005, J CLIN ONCOL, V23, P6999, DOI 10.1200/JCO.2005.21.956; Rudberg L, 2000, J PSYCHOSOC ONCOL, V18, P19, DOI 10.1300/J077v18n03_02; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Sagstuen H, 2005, J CLIN ONCOL, V23, P4980, DOI 10.1200/JCO.2005.06.882; Sakuma Y, 2003, CANCER SCI, V94, P486, DOI 10.1111/j.1349-7006.2003.tb01470.x; SAMANIEGO F, 1990, GENE CHROMOSOME CANC, V1, P289, DOI 10.1002/gcc.2870010406; Schairer C, 2007, JNCI-J NATL CANCER I, V99, P1248, DOI 10.1093/jnci/djm081; Schrader M, 2003, UROLOGY, V61, P421, DOI 10.1016/S0090-4295(02)02264-1; Shahidi M, 2002, CANCER, V95, P520, DOI 10.1002/cncr.10691; Shlebak AA, 1997, CANCER CHEMOTH PHARM, V39, P462, DOI 10.1007/s002800050599; Simpson AB, 1998, BRIT J CANCER, V78, P1061, DOI 10.1038/bjc.1998.628; Spermon JR, 2003, FERTIL STERIL, V79, P1543, DOI 10.1016/S0015-0282(03)00335-2; Spiess PE, 2006, CANCER, V107, P1483, DOI 10.1002/cncr.22182; STEFENELLI T, 1988, EUR HEART J, V9, P552, DOI 10.1093/oxfordjournals.eurheartj.a062542; Stephenson Andrew J, 2005, Curr Treat Options Oncol, V6, P367, DOI 10.1007/s11864-005-0040-z; STEYERBERG EW, 1995, J CLIN ONCOL, V13, P1177, DOI 10.1200/JCO.1995.13.5.1177; Strumberg D, 2002, ANN ONCOL, V13, P229, DOI 10.1093/annonc/mdf058; Sugimura J, 2004, CLIN CANCER RES, V10, P2368, DOI 10.1158/1078-0432.CCR-03-0341; TEREBELO HR, 1983, J CLIN ONCOL, V1, P566, DOI 10.1200/JCO.1983.1.9.566; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; TONER GC, 1990, J CLIN ONCOL, V8, P1683, DOI 10.1200/JCO.1990.8.10.1683; Toner GC, 2001, LANCET, V357, P739, DOI 10.1016/S0140-6736(00)04165-9; TONER GC, 1990, AM J MED, V89, P651, DOI 10.1016/0002-9343(90)90185-G; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; Travis LB, 2000, JNCI-J NATL CANCER I, V92, P1165, DOI 10.1093/jnci/92.14.1165; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Vaena DA, 2003, J CLIN ONCOL, V21, P4100, DOI 10.1200/JCO.2003.06.067; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; van den Belt-Dusebout AW, 2006, J CLIN ONCOL, V24, P467, DOI 10.1200/JCO.2005.02.7193; VANLEEUWEN FE, 1993, J CLIN ONCOL, V11, P415, DOI 10.1200/JCO.1993.11.3.415; Vaughn DJ, 2002, ANN INTERN MED, V136, P463, DOI 10.7326/0003-4819-136-6-200203190-00010; VOGELZANG NJ, 1981, ANN INTERN MED, V95, P288, DOI 10.7326/0003-4819-95-3-288; Vos AH, 2001, NETH J MED, V59, P295, DOI 10.1016/S0300-2977(01)00173-5; WELJL NI, 2000, J CLIN ONCOL, V18, P2169; WHITE DA, 1984, CHEST, V86, P723, DOI 10.1378/chest.86.5.723; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; WOOD DP, 1992, CANCER, V70, P2354, DOI 10.1002/1097-0142(19921101)70:9<2354::AID-CNCR2820700924>3.0.CO;2-U; YOUSEM SA, 1985, CHEST, V88, P103, DOI 10.1378/chest.88.1.103; Zagars GK, 2004, J CLIN ONCOL, V22, P640, DOI 10.1200/JCO.2004.05.205	202	261	265	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					672	684		10.1001/jama.299.6.672	http://dx.doi.org/10.1001/jama.299.6.672			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270356	Bronze			2022-12-28	WOS:000253095200025
J	Keel, SB; Doty, RT; Yang, Z; Quigley, JG; Chen, J; Knoblaugh, S; Kingsley, PD; De Domenico, I; Vaughn, MB; Kaplan, J; Palis, J; Abkowitz, JL				Keel, Sioban B.; Doty, Raymond T.; Yang, Zhantao; Quigley, John G.; Chen, Jing; Knoblaugh, Sue; Kingsley, Paul D.; De Domenico, Ivana; Vaughn, Michael B.; Kaplan, Jerry; Palis, James; Abkowitz, Janis L.			A heme export protein is required for red blood cell differentiation and iron homeostasis	SCIENCE			English	Article							FELINE LEUKEMIA-VIRUS; ERYTHROPOIETIN RECEPTOR; SUBGROUP-C; BFU-E; HEPCIDIN; EXPRESSION; RETROVIRUS; IDENTIFICATION; FERROPORTIN; PROGENITORS	Hemoproteins are critical for the function and integrity of aerobic cells. However, free heme is toxic. Therefore, cells must balance heme synthesis with its use. We previously demonstrated that the feline leukemia virus, subgroup C, receptor ( FLVCR) exports cytoplasmic heme. Here, we show that FLVCR- null mice lack definitive erythropoiesis, have craniofacial and limb deformities resembling those of patients with Diamond- Blackfan anemia, and die in midgestation. Mice with FLVCR that is deleted neonatally develop a severe macrocytic anemia with proerythroblast maturation arrest, which suggests that erythroid precursors export excess heme to ensure survival. We further demonstrate that FLVCR mediates heme export from macrophages that ingest senescent red cells and regulates hepatic iron. Thus, the trafficking of heme, and not just elemental iron, facilitates erythropoiesis and systemic iron balance.	[Keel, Sioban B.; Doty, Raymond T.; Yang, Zhantao; Quigley, John G.; Chen, Jing; Abkowitz, Janis L.] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Knoblaugh, Sue] Fred Hutchinson Canc Res Ctr, Anim Hlth Shared Resources, Seattle, WA 98109 USA; [Kingsley, Paul D.; Palis, James] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [De Domenico, Ivana; Vaughn, Michael B.; Kaplan, Jerry] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Rochester; Utah System of Higher Education; University of Utah	Abkowitz, JL (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.	janabk@u.washington.edu	Quigley, John/X-4366-2019	Doty, Raymond/0000-0002-9312-8622; Palis, James/0000-0001-7324-1049; quigley, john/0000-0003-3116-4545				ABKOWITZ JL, 1991, BLOOD, V77, P1442; ABKOWITZ JL, 1987, J CLIN INVEST, V80, P1056, DOI 10.1172/JCI113160; CATHIE IAB, 1950, ARCH DIS CHILD, V25, P313, DOI 10.1136/adc.25.124.313; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; RIEDEL N, 1988, P NATL ACAD SCI USA, V85, P2758, DOI 10.1073/pnas.85.8.2758; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; TESTA NG, 1983, LEUKEMIA RES, V7, P103, DOI 10.1016/0145-2126(83)90001-2; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Watanabe S, 2004, PLACENTA, V25, P387, DOI 10.1016/j.placenta.2003.10.012; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	23	279	292	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					825	828		10.1126/science.1151133	http://dx.doi.org/10.1126/science.1151133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258918				2022-12-28	WOS:000252963000066
J	O'Sullivan, MJ; Morrow, M				O'Sullivan, Martin J.; Morrow, Monica			Blue hives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Sullivan, Martin J.; Morrow, Monica] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	O'Sullivan, MJ (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					E6	E6		10.1056/NEJMicm066872	http://dx.doi.org/10.1056/NEJMicm066872			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256388				2022-12-28	WOS:000252916400010
J	Yawar, A				Yawar, Athar			Time and humanity on psychiatric wards	LANCET			English	Editorial Material							SCHIZOPHRENIA; PSYCHOSIS		The Lancet, London NW1 7BY, England		Yawar, A (corresponding author), The Lancet, London NW1 7BY, England.							Bola JR, 2003, J NERV MENT DIS, V191, P219, DOI 10.1097/00005053-200304000-00002; Brekke JS, 2001, PSYCHIATR SERV, V52, P1358, DOI 10.1176/appi.ps.52.10.1358; Ellenberger H., 1970, DISCOV UNCONSCIOUS; Goffman Erving, 1991, ASYLUMS; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Leff J., 2001, UNBALANCED MIND; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Martel Y., 2002, LIFE PI; Micale Mark S., 1985, APPROACHING HYSTERIA; Proctor Robert N., 1988, RACIAL HYGIENE MED N; Radcliffe J, 2007, PSYCHIATR BULL, V31, P167, DOI 10.1192/pb.bp.105.009290; Ragins M, 2005, PSYCHIAT SERV, V56, P1489, DOI 10.1176/appi.ps.56.12.1489; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; Thornicroft G, 2004, SCHIZOPHR RES, V69, P125, DOI 10.1016/S0920-9964(03)00191-9; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Whitaker R., 2002, MAD AM	16	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2008	371	9609					285	286		10.1016/S0140-6736(08)60146-4	http://dx.doi.org/10.1016/S0140-6736(08)60146-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254VQ	18294984				2022-12-28	WOS:000252616500009
J	ANDERSON, A				ANDERSON, A			ELECTRONIC PUBLISHING - CAUTIOUS START FOR AAAS	NATURE			English	Editorial Material																			0	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					6	6		10.1038/344006a0	http://dx.doi.org/10.1038/344006a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277992	Bronze			2022-12-28	WOS:A1990CQ97200016
J	ANDERSON, GC				ANDERSON, GC			JOURNALS - ERRANT SURVEY DRAWS FIRE	NATURE			English	Editorial Material																		1989, NATURE, V341	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					3	3		10.1038/344003a0	http://dx.doi.org/10.1038/344003a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277986	Bronze			2022-12-28	WOS:A1990CQ97200004
J	AZOZ, N; CALVERT, PD; KADIM, M; MCCAFFERY, AJ; SEDDON, KR				AZOZ, N; CALVERT, PD; KADIM, M; MCCAFFERY, AJ; SEDDON, KR			A NOVEL HIGH-EFFICIENCY CRYSTAL POLYMER COMPOSITE-MATERIAL FOR NONLINEAR OPTICS	NATURE			English	Article									UNIV ARIZONA,ARIZONA MAT LAB,TUCSON,AZ 85712	University of Arizona	AZOZ, N (corresponding author), UNIV SUSSEX,SCH CHEM & MOLEC SCI,BRIGHTON BN1 9QJ,E SUSSEX,ENGLAND.							CALVERT PD, 1989, ORGANIC MATERIALS NO, P308; CALVERT PD, 1988, MATER RES SOC S P, V109, P357; DOUGHERTY JP, 1976, J APPL CRYSTALLOGR, V9, P145, DOI 10.1107/S0021889876010789; HERINGTON EFG, 1963, ZONE MELTING ORGANIC; Mann S., 1989, BIOMINERALISATION; PANTELIS P, 1988, Patent No. 4746577; Pantelis P., 1988, U.S. Pat., Patent No. [4,748,074, 4748074]; PFANN WG, 1958, ZONE MELTING, P254; SINGER KD, 1986, APPL PHYS LETT, V49, P248, DOI 10.1063/1.97184; 1988, OPTOELECTRONICS BUIL	10	19	19	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					49	51		10.1038/344049a0	http://dx.doi.org/10.1038/344049a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278023				2022-12-28	WOS:A1990CQ97200055
J	Westphal, V; Rizzoli, SO; Lauterbach, MA; Kamin, D; Jahn, R; Hell, SW				Westphal, Volker; Rizzoli, Silvio O.; Lauterbach, Marcel A.; Kamin, Dirk; Jahn, Reinhard; Hell, Stefan W.			Video-rate far-field optical nanoscopy dissects synaptic vesicle movement	SCIENCE			English	Article							FLUORESCENCE MICROSCOPY; NERVE-TERMINALS; STED MICROSCOPY; RESOLUTION; BOUTONS; SYNAPSES; DYNAMICS; RECOVERY; MOBILITY; POOLS	We present video-rate (28 frames per second) far-field optical imaging with a focal spot size of 62 nanometers in living cells. Fluorescently labeled synaptic vesicles inside the axons of cultured neurons were recorded with stimulated emission depletion (STED) microscopy in a 2.5-micrometer by 1.8-micrometer field of view. By reducing the cross-sectional area of the focal spot by about a factor of 18 below the diffraction limit (260 nanometers), STED allowed us to map and describe the vesicle mobility within the highly confined space of synaptic boutons. Although restricted within boutons, the vesicle movement was substantially faster in nonbouton areas, consistent with the observation that a sizable vesicle pool continuously transits through the axons. Our study demonstrates the emerging ability of optical microscopy to investigate intracellular physiological processes on the nanoscale in real time.	[Westphal, Volker; Lauterbach, Marcel A.; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.; Kamin, Dirk] European Neurosci Inst, STED Microscopy Synapt Funct, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany.	shell@gwdg.de	Rizzoli, Silvio/ABG-2227-2020	Jahn, Reinhard/0000-0003-1542-3498; Rizzoli, Silvio/0000-0002-1667-7839				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Gaffield MA, 2006, NEURON, V51, P317, DOI 10.1016/j.neuron.2006.06.031; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HELL S, 1992, J OPT SOC AM A, V9, P2159, DOI 10.1364/JOSAA.9.002159; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henkel AW, 1996, J NEUROSCI, V16, P3960; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tinnefeld P, 2003, J PHYS CHEM A, V107, P323, DOI 10.1021/jp026565u; Westphal V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/435; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yeung C, 2007, BIOPHYS J, V92, P2271, DOI 10.1529/biophysj.106.081794	27	581	607	2	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					246	249		10.1126/science.1154228	http://dx.doi.org/10.1126/science.1154228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18292304				2022-12-28	WOS:000254836700048
J	Cokus, SJ; Feng, SH; Zhang, XY; Chen, ZG; Merriman, B; Haudenschild, CD; Pradhan, S; Nelson, SF; Pellegrini, M; Jacobsen, SE				Cokus, Shawn J.; Feng, Suhua; Zhang, Xiaoyu; Chen, Zugen; Merriman, Barry; Haudenschild, Christian D.; Pradhan, Sriharsa; Nelson, Stanley F.; Pellegrini, Matteo; Jacobsen, Steven E.			Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning	NATURE			English	Article							5-METHYLCYTOSINE RESIDUES; EPIGENETIC INHERITANCE; NUCLEOSOMAL STRUCTURE; GENES	Cytosine DNA methylation is important in regulating gene expression and in silencing transposons and other repetitive sequences(1,2). Recent genomic studies in Arabidopsis thaliana have revealed that many endogenous genes are methylated either within their promoters or within their transcribed regions, and that gene methylation is highly correlated with transcription levels(3-5). However, plants have different types of methylation controlled by different genetic pathways, and detailed information on the methylation status of each cytosine in any given genome is lacking. To this end, we generated a map at single- base- pair resolution of methylated cytosines for Arabidopsis, by combining bisulphite treatment of genomic DNA with ultra- high- throughput sequencing using the Illumina 1G Genome Analyser and Solexa sequencing technology(6). This approach, termed BS- Seq, unlike previous microarray- based methods, allows one to sensitively measure cytosine methylation on a genome- wide scale within specific sequence contexts. Here we describe methylation on previously inaccessible components of the genome and analyse the DNA methylation sequence composition and distribution. We also describe the effect of various DNA methylation mutants on genome- wide methylation patterns, and demonstrate that our newly developed library construction and computational methods can be applied to large genomes such as that of mouse.	[Cokus, Shawn J.; Feng, Suhua; Zhang, Xiaoyu; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Chen, Zugen; Merriman, Barry; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Haudenschild, Christian D.] Illumina Inc, Hayward, CA 94545 USA; [Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Illumina; New England Biolabs	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; jacobsen@ucla.edu	Hu, Ruogu/B-2203-2008; Nelson, Stanley F/D-4771-2009; Zhang, xiaoyu/GXA-3206-2022; jia, xu/A-8386-2016; Christian, Haudenschild C/D-1602-2009	Nelson, Stanley F/0000-0002-2082-3114; Pellegrini, Matteo/0000-0001-9355-9564	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; BERS EP, 1992, PLANT MOL BIOL, V20, P1089, DOI 10.1007/BF00028895; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Dieguez MJ, 1998, MOL GEN GENET, V259, P207, DOI 10.1007/s004380050806; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fulnecek J, 1998, MOL GEN GENET, V259, P133, DOI 10.1007/s004380050798; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; NGERNPRASIRTSIRI J, 1988, P NATL ACAD SCI USA, V85, P4750, DOI 10.1073/pnas.85.13.4750; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vershinin AV, 1998, PLANT MOL BIOL, V36, P149, DOI 10.1023/A:1005912822671; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	26	1561	1662	8	355	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					215	219		10.1038/nature06745	http://dx.doi.org/10.1038/nature06745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18278030	Green Accepted			2022-12-28	WOS:000253925600040
J	Whitley, R				Whitley, Richard			Focus on research: The new age of molecular diagnostics for microbiol agents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Alabama, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Whitley, R (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.							Frenzen PD, 2004, EMERG INFECT DIS, V10, P1536, DOI 10.3201/eid1009.030403; Ley RE, 2007, ENVIRON MICROBIOL, V9, P3, DOI 10.1111/j.1462-2920.2006.01222_3.x; LIPKIN WI, 2007, GLOBAL INFECT DIS SU, P177; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244	4	23	24	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					988	989		10.1056/NEJMp0708085	http://dx.doi.org/10.1056/NEJMp0708085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18256386				2022-12-28	WOS:000253644700002
J	Omaswa, F				Omaswa, Francis			Human resources for global health: time for action is now	LANCET			English	Editorial Material									WHO, Global Hlth Workforce Alliance, CH-1211 Geneva 27, Switzerland	World Health Organization	Omaswa, F (corresponding author), WHO, Global Hlth Workforce Alliance, CH-1211 Geneva 27, Switzerland.	OmaswaF@who.int						[Anonymous], 2004, HUM RES HLTH OV CRIS; *GLOB HLTH WORKF A, WORK GROUP TOOLS GUI; *GLOB HLTH WORKF A, WORKPL 2006 2007; *GLOB HLTH WORKF A, 2006, STRAT PLAN; *WHO, 1 GLOB FOR HLTH HUM; *WHO, 2006, NEW GLOB ALL SEEKS A; *WHO, 2005, 3 HIGH LEV FOR HLTH; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; *WORLD HLTH ALL, 2006, RAP SCAL HLTH WORKF; *WORLD HLTH ALL, 2004, INT MIGR HLTH PERS C; *WORLD HLTH ALL, 2005, INT MIGR HLTH PERS C	11	17	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					625	626		10.1016/S0140-6736(08)60277-9	http://dx.doi.org/10.1016/S0140-6736(08)60277-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LL	18295005				2022-12-28	WOS:000253436700004
J	Lohmueller, KE; Indap, AR; Schmidt, S; Boyko, AR; Hernandez, RD; Hubisz, MJ; Sninsky, JJ; White, TJ; Sunyaev, SR; Nielsen, R; Clark, AG; Bustamante, CD				Lohmueller, Kirk E.; Indap, Amit R.; Schmidt, Steffen; Boyko, Adam R.; Hernandez, Ryan D.; Hubisz, Melissa J.; Sninsky, John J.; White, Thomas J.; Sunyaev, Shamil R.; Nielsen, Rasmus; Clark, Andrew G.; Bustamante, Carlos D.			Proportionally more deleterious genetic variation in European than in African populations	NATURE			English	Article							BRAIN SIZE; MUTATIONS; SELECTION; EVOLUTION; GENOME	Quantifying the number of deleterious mutations per diploid human genome is of crucial concern to both evolutionary and medical geneticists(1-3). Here we combine genome- wide polymorphism data from PCR- based exon resequencing, comparative genomic data across mammalian species, and protein structure predictions to estimate the number of functionally consequential singlenucleotide polymorphisms (SNPs) carried by each of 15 African American (AA) and 20 European American (EA) individuals. We find that AAs show significantly higher levels of nucleotide heterozygosity than do EAs for all categories of functional SNPs considered, including synonymous, non- synonymous, predicted 'benign', predicted 'possibly damaging' and predicted 'probably damaging' SNPs. This result is wholly consistent with previous work showing higher overall levels of nucleotide variation in African populations than in Europeans(4). EA individuals, in contrast, have significantly more genotypes homozygous for the derived allele at synonymous and non- synonymous SNPs and for the damaging allele at ` probably damaging' SNPs than AAs do. For SNPs segregating only in one population or the other, the proportion of non-synonymous SNPs is significantly higher in the EA sample (55.4%) than in the AA sample (47.0%; P < 2.33 X 10(-37)). We observe a similar proportional excess of SNPs that are inferred to be 'probably damaging' (15.9% in EA; 12.1% in AA; P < 3.33 X 10(-11)). Using extensive simulations, we show that this excess proportion of segregating damaging alleles in Europeans is probably a consequence of a bottleneck that Europeans experienced at about the time of the migration out of Africa.	[Lohmueller, Kirk E.; Indap, Amit R.; Boyko, Adam R.; Hernandez, Ryan D.; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Lohmueller, Kirk E.; Boyko, Adam R.; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Schmidt, Steffen] Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany; [Hubisz, Melissa J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Sninsky, John J.; White, Thomas J.] Celera Diagnost, Alameda, CA 94592 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nielsen, Rasmus] Univ Copenhagen, Ctr Comparat Genom, Dept Biol, DK-2100 Copenhagen O, Denmark	Cornell University; Cornell University; Max Planck Society; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Copenhagen	Bustamante, CD (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Biotechnol Bldg, Ithaca, NY 14853 USA.	cdb28@cornell.edu	Nielsen, Rasmus/D-4405-2009; Pepper, John W/O-1662-2013	Nielsen, Rasmus/0000-0003-0513-6591; Pepper, John W/0000-0001-9888-0437; Schmidt, Steffen/0000-0001-9077-6010; Indap, Amit/0000-0002-3322-4735; Hubisz, Melissa/0000-0002-9561-6830; Clark, Andrew/0000-0001-7159-8511; Bustamante, Carlos D./0000-0002-4187-7920	NHGRI NIH HHS [R01 HG003229, R01 HG003229-03] Funding Source: Medline; NHLBI NIH HHS [R01 HL072904] Funding Source: Medline; NIGMS NIH HHS [P50 GM065509-070006, P50 GM065509] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fay JC, 2001, GENETICS, V158, P1227; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	30	286	291	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					994	U5		10.1038/nature06611	http://dx.doi.org/10.1038/nature06611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288194	Bronze, Green Accepted			2022-12-28	WOS:000253313100049
J	Shaw, AD; Stafford-Smith, M; White, WD; Phillips-Bute, B; Swaminathan, M; Milano, C; Welsby, IJ; Aronson, S; Mathew, JP; Peterson, ED; Newman, MF				Shaw, Andrew D.; Stafford-Smith, Mark; White, William D.; Phillips-Bute, Barbara; Swaminathan, Madhav; Milano, Carmelo; Welsby, Ian J.; Aronson, Solomon; Mathew, Joseph P.; Peterson, Eric D.; Newman, Mark F.			The effect of aprotinin on outcome after coronary-artery bypass grafting.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-SURGERY; TRANSFUSION; RISK	Background Aprotinin has recently been associated with adverse outcomes in patients undergoing cardiac surgery. We reviewed our experience with this agent in patients undergoing cardiac surgery at Duke University Medical Center. Methods We retrieved data on 10,275 consecutive patients undergoing surgical coronary revascularization at Duke between January 1, 1996, and December 31, 2005. We fit data to a logistic-regression model predicting each patient's likelihood of receiving aprotinin on the basis of preoperative characteristics and to models predicting long-term survival (up to 10 years) and decline in renal function, as measured by increases in serum creatinine levels. Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproic acid, and 2029 patients (20.0%) received no antifibrinolytic therapy. All patients underwent coronary-artery bypass grafting, and 1181 patients (11.5%) underwent combined coronary-artery bypass grafting and valve surgery. In the risk-adjusted model, survival was worse among patients treated with aprotinin, with a main-effects hazard ratio for death of 1.32 (95% confidence interval [CI], 1.12 to 1.55) for the comparison with patients receiving no antifibrinolytic therapy (P=0.003) and 1.27 (95% CI, 1.10 to 1.46) for the comparison with patients receiving aminocaproic acid (P=0.004). As compared with the use of aminocaproic acid or no antifibrinolytic agent, aprotinin use was also associated with a larger risk-adjusted increase in the serum creatinine level (P<0.001) but not with a greater risk-adjusted incidence of dialysis (P=0.56). Conclusions Patients who received aprotinin had a higher mortality rate and larger increases in serum creatinine levels than those who received aminocaproic acid or no antifibrinolytic agent.	[Shaw, Andrew D.; Stafford-Smith, Mark; White, William D.; Phillips-Bute, Barbara; Swaminathan, Madhav; Welsby, Ian J.; Aronson, Solomon; Mathew, Joseph P.; Newman, Mark F.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27516 USA; [Milano, Carmelo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27516 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27516 USA	Duke University; Duke University; Duke University	Shaw, AD (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27516 USA.	andrew.shaw@duke.edu	Peterson, Eric David/ABF-5033-2021	Swaminathan, Madhav/0000-0001-9136-8609; Mathew, Joseph/0000-0002-3815-4131; Shaw, Andrew/0000-0002-0566-8005; Welsby, Ian/0000-0002-2789-5612				Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Chelemer SB, 2002, ANN THORAC SURG, V73, P138, DOI 10.1016/S0003-4975(01)03308-2; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dietrich W, 2007, ANN THORAC SURG, V84, P1144, DOI 10.1016/j.athoracsur.2007.05.015; Dietrich W, 2006, ANESTH ANALG, V103, P1074, DOI 10.1213/01.ane.0000238446.30034.c8; *FOOD DRUG ADM, 2007, FDA REQ MARK SUSP TR; Furnary AP, 2007, CIRCULATION, V116, pI127, DOI 10.1161/CIRCULATIONAHA.106.681395; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Kertai MD, 2007, J CARDIOVASC SURG, V48, P761; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; MAZER CD, 2007, HEART SURG FORUM, V5, P10; PARSONNET V, 1989, CIRCULATION, V79, P3; PARSONNET V, 1990, CIRCULATION, V82, P1078; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROYSTON D, 1987, LANCET, V2, P1289; Sodha NR, 2007, DRUG SAFETY, V30, P731, DOI 10.2165/00002018-200730090-00001; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Van der Linden PJ, 2007, BRIT J ANAESTH, V99, P646, DOI 10.1093/bja/aem252	20	149	153	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					784	793		10.1056/NEJMoa0707768	http://dx.doi.org/10.1056/NEJMoa0707768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287601	Bronze			2022-12-28	WOS:000253257700004
J	Di Mario, C; Dudek, D; Piscione, F; Mielecki, W; Savonitto, S; Murena, E; Dimopoulos, K; Manari, A; Gaspardone, A; Ochala, A; Zmudka, K; Bolognese, L; Steg, PG; Flather, M				Di Mario, Carlo; Dudek, Dariusz; Piscione, Federico; Mielecki, Waldemar; Savonitto, Stefano; Murena, Ernesto; Dimopoulos, Konstantinos; Manari, Antonio; Gaspardone, Achille; Ochala, Andrzej; Zmudka, Krzysztof; Bolognese, Leonardo; Steg, Philippe Gabriel; Flather, Marcus		CARESS AMI Investigators	Immediate angioplasty versus standard therapy with rescue 3 angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; REPERFUSION THERAPY; FIBRINOLYTIC THERAPY; EUROPEAN-SOCIETY; DOSE RETEPLASE; CLOPIDOGREL; TIME; CARDIOLOGY; ASPIRIN	Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarction (STEMI) when primary percutaneous coronary intervention (PCI) cannot be done within 90 min. However, the best subsequent management of patients after thrombolytic therapy remains unclear. To assess the best management, we randomised patients with STEMI treated by thrombolysis and abciximab at a non-interventional hospital to immediate transfer for PCI, or to standard medical therapy with transfer for rescue angioplasty. Methods 600 patients aged 75 years or younger with one or more high-risk features (extensive ST-segment elevation, new-onset left bundle branch block, previous myocardial infarction, Killip class >2, or left ventricular ejection fraction <= 35%) in hospitals in France, Italy, and Poland were treated with half-dose reteplase, abciximab, heparin, and aspirin, and randomly assigned to immediate transfer to the nearest interventional Centre for PCI, or to management in the local hospital with transfer only in case of persistent ST-segment elevation or clinical deterioration. The primary outcome was a composite of death, reinfarction, or refractory ischaemia at 30 days, and analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number 00220571. Findings Of the 299 patients assigned to immediate PCI, 289 (97.0%) underwent angiography, and 255 (85.6%) received PCI. Rescue PCI was done in 91 patients (30.3%) in the standard care/rescue PCI group. The primary outcome occurred in 13 patients (4.4%) in the immediate PCI group compared with 32 (10.7%) in the standard care/rescue PCI group (hazard ratio 0 . 40; 95% CI 0 . 21-0.76, log rank p=0. 004). Major bleeding was seen in ten patients in the immediate group and seven in the standard care/rescue group (3.4% vs 2.3%, p=0.47). Strokes occurred in two patients in the immediate group and four in the standard care/rescue group (0.7% vs 1.3%, p=0 . 50). Interpretation Immediate transfer for PCI improves outcome in high-risk patients with STEMI treated at a non-interventional Centre with half-dose reteplase and abciximab.	[Di Mario, Carlo; Dimopoulos, Konstantinos; Flather, Marcus] Royal Brompton Hosp, London SW3 6NP, England; [Di Mario, Carlo; Dimopoulos, Konstantinos; Flather, Marcus] Univ London Imperial Coll Sci Technol & Med, London, England; [Dudek, Dariusz; Mielecki, Waldemar] Jagiellonian Univ, Coll Med, Krakow, Poland; [Piscione, Federico] Univ Naples Federico II, Naples, Italy; [Savonitto, Stefano] Osped Niguarda Ca Granda, Milan, Italy; [Murena, Ernesto] Osped S Maria Grazie, Naples, Italy; [Manari, Antonio] Arcispedale San Maria Nuova, Reggio Emilia, Italy; [Gaspardone, Achille] Osped Sant Eugenio, Rome, Italy; [Ochala, Andrzej] Gornoslaskie Ctr Kardiol, Katowice, Poland; [Zmudka, Krzysztof] Spital Jana Pawla 2, Krakow, Poland; [Bolognese, Leonardo] Osped San Donato, Arezzo, Italy; [Steg, Philippe Gabriel] Univ Paris 07, Hop Bichat, INSERM, U 698, Paris, France; [Steg, Philippe Gabriel] Univ Paris 07, Hop Bichat, INSERM, APHP, Paris, France	Royal Brompton Hospital; Imperial College London; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Naples Federico II; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Arcispedale S. Maria Nuova; Sant'Eugenio Hospital; IRCCS Policlinico San Donato; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Di Mario, C (corresponding author), Royal Brompton Hosp, Sydney St, London SW3 6NP, England.	c.dimario@rbht.nhs.uk	Gaspardone, Achille/AAC-1762-2022; Ochala, Andrzej/AAH-3855-2020; Di Mario, Carlo/K-5185-2018; STEG, Philippe Gabriel/Z-1567-2019; Dimopoulos, Konstantinos/AAD-5229-2019	Di Mario, Carlo/0000-0002-4461-2055; Dimopoulos, Konstantinos/0000-0003-1300-0504; STEG, Philippe Gabriel/0000-0001-6896-2941				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman EM, 2000, EUR HEART J, V21, P1944, DOI 10.1053/euhj.2000.2243; Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Bassand JP, 2005, EUR HEART J, V26, P2733, DOI 10.1093/eurheartj/ehi673; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Di Mario C, 2004, AM HEART J, V148, P378, DOI 10.1016/j.ahj.2004.03.038; ELLIS S, FINESSE TRIAL; Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1; Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8; Le May MR, 2005, J AM COLL CARDIOL, V46, P417, DOI 10.1016/j.jacc.2005.04.042; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Philippe F, 2004, CATHETER CARDIO INTE, V61, P67, DOI 10.1002/ccd.10675; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Savonitto S, 2003, EUR HEART J, V24, P1807, DOI 10.1016/j.ehj.2003.07.004; Scheller B, 2003, J AM COLL CARDIOL, V42, P634, DOI 10.1016/S0735-1097(03)00763-0; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stone GW, 2006, LANCET, V367, P543, DOI 10.1016/S0140-6736(06)68149-X; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Topol EJ, 2000, CIRCULATION, V101, P2788; Topol EJ, 2001, LANCET, V357, P1905; Valsecchi Orazio, 2003, Ital Heart J, V4, P329; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2	33	286	304	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					559	568		10.1016/S0140-6736(08)60268-8	http://dx.doi.org/10.1016/S0140-6736(08)60268-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280326				2022-12-28	WOS:000253202600022
J	Chan, F; Barth, JA; Lubchenco, J; Kirincich, A; Weeks, H; Peterson, WT; Menge, BA				Chan, F.; Barth, J. A.; Lubchenco, J.; Kirincich, A.; Weeks, H.; Peterson, W. T.; Menge, B. A.			Emergence of anoxia in the California current large marine ecosystem	SCIENCE			English	Article							HYPOXIA		[Chan, F.; Lubchenco, J.; Menge, B. A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Barth, J. A.; Kirincich, A.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Weeks, H.] Oregon Dept Fish & Wildlife, Newport, OR 97365 USA; [Peterson, W. T.] Natl Ocean & Atmospher Adm, NW Fisheries Sci Ctr, Newport, OR 97365 USA	Oregon State University; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Chan, F (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	chanft@science.oregonstate.edu	Menge, Bruce/I-6571-2012	Kirincich, Anthony/0000-0001-7954-8543				Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Childress JJ, 1998, J EXP BIOL, V201, P1223; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0	8	393	404	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					920	920		10.1126/science.1149016	http://dx.doi.org/10.1126/science.1149016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276882	Green Submitted			2022-12-28	WOS:000253165700036
J	Morley, CJ; Davis, PG; Doyle, LW; Brion, LP; Hascoet, JM; Carlin, JB				Morley, Colin J.; Davis, Peter G.; Doyle, Lex W.; Brion, Luc P.; Hascoet, Jean-Michel; Carlin, John B.		COIN Trial Investigators	Nasal CPAP or intubation at birth for very preterm infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC LUNG-DISEASE; WEIGHT INFANTS; DELIVERY ROOM; BRONCHOPULMONARY DYSPLASIA; PREMATURE-INFANTS; EARLY SURFACTANT; OUTCOMES; TRIALS	Background: Bronchopulmonary dysplasia is associated with ventilation and oxygen treatment. This randomized trial investigated whether nasal continuous positive airway pressure (CPAP), rather than intubation and ventilation, shortly after birth would reduce the rate of death or bronchopulmonary dysplasia in very preterm infants. Methods: We randomly assigned 610 infants who were born at 25-to-28-weeks' gestation to CPAP or intubation and ventilation at 5 minutes after birth. We assessed outcomes at 28 days of age, at 36 weeks' gestational age, and before discharge. Results: At 36 weeks' gestational age, 33.9% of 307 infants who were assigned to receive CPAP had died or had bronchopulmonary dysplasia, as compared with 38.9% of 303 infants who were assigned to receive intubation (odds ratio favoring CPAP, 0.80; 95% confidence interval [CI], 0.58 to 1.12; P=0.19). At 28 days, there was a lower risk of death or need for oxygen therapy in the CPAP group than in the intubation group (odds ratio, 0.63; 95% CI, 0.46 to 0.88; P=0.006). There was little difference in overall mortality. In the CPAP group, 46% of infants were intubated during the first 5 days, and the use of surfactant was halved. The incidence of pneumothorax was 9% in the CPAP group, as compared with 3% in the intubation group (P<0.001). There were no other serious adverse events. The CPAP group had fewer days of ventilation. Conclusions: In infants born at 25-to-28-weeks' gestation, early nasal CPAP did not significantly reduce the rate of death or bronchopulmonary dysplasia, as compared with intubation. Even though the CPAP group had more incidences of pneumothorax, fewer infants received oxygen at 28 days, and they had fewer days of ventilation. (Australian New Zealand Clinical Trials Registry number, 12606000258550.).	[Morley, Colin J.; Davis, Peter G.; Doyle, Lex W.] Royal Hosp Women, Serv Neonatol, Carlton, Vic 3053, Australia; [Morley, Colin J.; Davis, Peter G.; Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Doyle, Lex W.; Carlin, John B.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Morley, Colin J.] Royal Childrens Hosp, Dept Neonatol, Melbourne, Vic, Australia; [Carlin, John B.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; [Brion, Luc P.] Childrens Hosp Montefiore, Div Neonatol, Albert Einstein Coll Med, Bronx, NY USA; [Hascoet, Jean-Michel] Univ Nancy 1, Dept Neonatol, Nancy, France	University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Universite de Lorraine	Morley, CJ (corresponding author), Royal Hosp Women, Serv Neonatol, 132 Grattan St, Carlton, Vic 3053, Australia.	colin.morley@rwh.org.au	Pritchard, Margo A/G-5188-2010; Doyle, Lex/AAJ-5205-2021; Carlin, John/AAG-4332-2020; Carlin, John B/B-3492-2012	Pritchard, Margo A/0000-0002-1058-9117; Doyle, Lex/0000-0002-7667-7312; Carlin, John/0000-0002-2694-9463; Carlin, John B/0000-0002-2694-9463; Morley, Colin/0000-0001-5388-0214				Aly H, 2005, PEDIATRICS, V115, P1660, DOI 10.1542/peds.2004-2493; Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; AVERY ME, 1987, PEDIATRICS, V79, P26; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Davis PG, 2002, J PEDIATR-US, V140, P555, DOI 10.1067/mpd.2002.123291; De Klerk AM, 2001, J PAEDIATR CHILD H, V37, P161, DOI 10.1046/j.1440-1754.2001.00624.x; Donoghue DA, 1998, REPORT AUSTR NZ NEON; Dunn Michael S, 2003, Paediatr Respir Rev, V4, P2, DOI 10.1016/S1526-0542(02)00305-6; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Elgellab A, 2001, INTENS CARE MED, V27, P1782, DOI 10.1007/s00134-001-1117-1; Escobedo MB, 2004, J PEDIATR-US, V144, P804, DOI 10.1016/j.jpeds.2004.03.024; Finer NN, 2004, PEDIATRICS, V114, P651, DOI 10.1542/peds.2004-0394; Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620; GREGORY GA, 1971, NEW ENGL J MED, V284, P1333, DOI 10.1056/NEJM197106172842401; HALIDAY HL, 1993, ACTA PAEDIATR, V82, P1028; HANSEN T, 1998, AVERYS DIS NEWBORN, P602; Ho JJ, 2002, COCHRANE DB SYST REV, V2; JACOBSEN T, 1993, ACTA PAEDIATR, V82, P934, DOI 10.1111/j.1651-2227.1993.tb12603.x; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jonsson B, 1997, ACTA PAEDIATR, V86, P4; Joris N, 2000, SCHWEIZ MED WSCHR, V130, P1887; KAMPER J, 1990, ACTA PAEDIATR SCAND, V79, P581, DOI 10.1111/j.1651-2227.1990.tb11520.x; KAMPER J, 1993, ACTA PAEDIATR, V82, P193, DOI 10.1111/j.1651-2227.1993.tb12637.x; KRAYBILL EN, 1989, J PEDIATR-US, V115, P115, DOI 10.1016/S0022-3476(89)80345-2; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Leone TA, 2005, J PEDIATR-US, V146, P638, DOI 10.1016/j.jpeds.2005.01.029; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Lundstrom KE, 2003, ACTA PAEDIATR, V92, P1124, DOI 10.1080/08035250310005288; LUNDSTROM KE, 1993, ACTA PAEDIATR, V82, P856, DOI 10.1111/j.1651-2227.1993.tb12579.x; Millet V, 1997, ARCH PEDIATRIE, V4, P15, DOI 10.1016/S0929-693X(97)84297-2; O'Donnell CPF, 2006, PEDIATRICS, V117, pE16, DOI 10.1542/peds.2005-0901; Poets CF, 1996, PEDIATRICS, V98, P24; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Soll RF, 2000, COCHRANE DB SYST REV, V2; SOLL RF, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000510, 10.1002/14651858.CD000510]; SOLL RF, 2000, COCHRANE DB SYST REV, V2; SUBRAMANIAM P, 2005, COCHRANE DB SYST REV, V3; Thome U, 1998, EUR J PEDIATR, V157, P831, DOI 10.1007/s004310050946; Thomson MA, 2002, BIOL NEONATE, V81, P16, DOI 10.1159/000056766; Van Marter LJ, 2001, J PEDIATR-US, V138, P198, DOI 10.1067/mpd.2001.110980; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24; Walsh M, 2005, PEDIATRICS, V116, P857, DOI 10.1542/peds.2004-2411	43	830	867	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					700	708		10.1056/NEJMoa072788	http://dx.doi.org/10.1056/NEJMoa072788			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272893				2022-12-28	WOS:000253127700006
J	Boldajipour, B; Mahabaleshwar, H; Kardash, E; Reichman-Fried, M; Blaser, H; Minina, S; Wilson, D; Xu, QL; Raz, E				Boldajipour, Bijan; Mahabaleshwar, Harsha; Kardash, Elena; Reichman-Fried, Michal; Blaser, Heiko; Minina, Sofia; Wilson, Duncan; Xu, Qiling; Raz, Erez			Control of chemokine-guided cell migration by ligand sequestration	CELL			English	Article							PRIMORDIAL GERM-CELLS; DROSOPHILA EMBRYO; RECEPTOR CXCR4; T-LYMPHOCYTES; ZEBRAFISH; CHEMOTAXIS; EXPRESSION; SDF-1; GENE; INFLAMMATION	Primordial germ cell (PGC) migration in zebrafish is directed by the chemokine SDF-1a that activates its receptor CXCR4b. Little is known about the molecular mechanisms controlling the distribution of this chemoattractant in vivo. We demonstrate that the activity of a second SDF-1/CXCL12 receptor, CXCR7, is crucial for proper migration of PGCs toward their targets. We show that CXCR7 functions primarily in the somatic environment rather than within the migrating cells. In CXCR7 knocked-down embryos, the PGCs exhibit a phenotype that signifies defects in SDF-1a gradient formation as the cells fail to polarize effectively and to migrate toward their targets. Indeed, somatic cells expressing CXCR7 show enhanced internalization of the chemokine suggesting that CXCR7 acts as a sink for SDF-1a, thus allowing the dynamic changes in the transcription of sdf-1a to be mirrored by similar dynamics at the protein level.	[Boldajipour, Bijan; Mahabaleshwar, Harsha; Kardash, Elena; Reichman-Fried, Michal; Raz, Erez] Ctt Mol Biol Inflammat, D-48149 Munster, Germany; [Minina, Sofia] Max Planck Inst Biophys Chem, Germ Cell Dev, D-37077 Gottingen, Germany; [Wilson, Duncan; Xu, Qiling] Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England	Max Planck Society; MRC National Institute for Medical Research	Raz, E (corresponding author), Ctt Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	erez.raz@uni-muenster.de		Boldajipour, Bijan/0000-0003-2065-555X; Kardash, Elena/0000-0002-7425-9862	MRC [MC_U117560481] Funding Source: UKRI; Medical Research Council [MC_U117560481] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ANDREWS S, 2007, SCI STKE, pCM2; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; D Renault A, 2006, CURR OPIN GENET DEV, V16, P348, DOI 10.1016/j.gde.2006.06.015; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; HANSELL C, 2007, SCI STKE, pPE18; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koprunner M, 2001, GENE DEV, V15, P2877; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muller K, 2002, MECH DEVELOP, V117, P253, DOI 10.1016/S0925-4773(02)00174-0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	484	500	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					463	473		10.1016/j.cell.2007.12.034	http://dx.doi.org/10.1016/j.cell.2007.12.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267076	Green Submitted, Bronze			2022-12-28	WOS:000253180700020
J	Dye, C				Dye, Christopher			Health and urban living	SCIENCE			English	Editorial Material							URBANIZATION; BURDEN; RISK	The majority of people now live in urban areas and will do so for the foreseeable future. As a force in the demographic and health transition, urbanization is associated with falling birth and death rates and with the shift in burden of illness from acute childhood infections to chronic, noncommunicable diseases of adults. Urban inhabitants enjoy better health on average than their rural counterparts, but the benefits are usually greater for the rich than for the poor, thus magnifying the differences between them. Subject to better evidence, I suggest that the main obstacles to improving urban health are not technical or even financial, but rather are related to governance and the organization of civil society.	WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				[Anonymous], 2004, WORLD REP ROAD TRAFF; APHRC (African Population and Health Research Centre), 2002, POP HLTH DYN NAIR IN; Barnes D., 2006, GREAT STINK PARIS 19; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Clark G, 2007, PRINC ECON HIST W WO; EASTERLIN RA, 2006, EUR REV ECON HIST, V3, P257; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; GARENNE M, 2006, AFRICA MOVE AFRICAN, P252; Godfrey R, 2005, CLIN MED, V5, P137, DOI 10.7861/clinmedicine.5-2-137; GWATKIN D, 2007, POVERTYNET LIB SOCIO; Hamlin C, 1998, BMJ-BRIT MED J, V317, P587, DOI 10.1136/bmj.317.7158.587; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; POSTELVINAY G, 2006, EXPLAINING STUNTING; RAVALLION M, 2007, FINANC DEV, P15; Reader J, 2004, CITIES; Satterthwaite D, 2005, HUMAN SETTLEMENTS DI; Stephens C, 1996, ENVIRON URBAN, V8, P9, DOI 10.1177/095624789600800211; Timaus IM., 1995, HLTH TRANSIT REV, V5, P163; *UN POP FUND POP R, 2005, COUNTR PROF POP REPR; UNAIDS, 2006, REP GLOB AIDS EP; UNFPA, 2007, STAT WORLD POP 2007; United Nations Human Settlements Programme (UN-HABITAT), 2005, GLOB URB OBS URB IND; United Nations Population Division, 2006, WORLD URB PROSP 2005; Wagstaff A., 2002, INEQUALITIES HLTH DE; World Bank, 2022, WORLD DEV IND 2022; World Health Organization, 2007, OUR CIT OUR HLTH OUR; Wrigley E.A., 2004, POVERTY PROGR POPULA; Yusuf S, 2007, J URBAN HEALTH, V84, pI35, DOI 10.1007/s11524-007-9186-2	30	278	286	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					766	769		10.1126/science.1150198	http://dx.doi.org/10.1126/science.1150198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258905				2022-12-28	WOS:000252963000048
J	Grimm, NB; Faeth, SH; Golubiewski, NE; Redman, CL; Wu, JG; Bai, XM; Briggs, JM				Grimm, Nancy B.; Faeth, Stanley H.; Golubiewski, Nancy E.; Redman, Charles L.; Wu, Jianguo; Bai, Xuemei; Briggs, John M.			Global change and the ecology of cities	SCIENCE			English	Review							LAND-USE CHANGE; URBAN ECOSYSTEMS; URBANIZATION; STREAMS; IMPACT; GROWTH; CONSERVATION; BIODIVERSITY; DIVERSITY; PREDATION	Urban areas are hot spots that drive environmental change at multiple scales. Material demands of production and human consumption alter land use and cover, biodiversity, and hydrosystems locally to regionally, and urban waste discharge affects local to global biogeochemical cycles and climate. For urbanites, however, global environmental changes are swamped by dramatic changes in the local environment. Urban ecology integrates natural and social sciences to study these radically altered local environments and their regional and global effects. Cities themselves present both the problems and solutions to sustainability challenges of an increasingly urbanized world.	[Grimm, Nancy B.; Faeth, Stanley H.; Wu, Jianguo; Briggs, John M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Golubiewski, Nancy E.] New Zealand Ctr Ecol Econ, Palmerston North, New Zealand; [Redman, Charles L.; Wu, Jianguo] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Bai, Xuemei] CSIRO Sustainable Ecosyst, Canberra, ACT 2601, Australia	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Grimm, NB (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	nbgrimm@asu.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Wu, Jianguo/G-6267-2010; Bai, Xuemei/A-5443-2012; Grimm, Nancy B/D-2840-2009; Bai, Xuemei/H-7072-2012	Wu, Jianguo/0000-0002-1182-3024; Bai, Xuemei/0000-0001-6556-8041; Grimm, Nancy B/0000-0001-9374-660X; 				Anderies JM, 2007, J THEOR BIOL, V247, P36, DOI 10.1016/j.jtbi.2007.01.030; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; Bai XM, 2006, ENVIRONMENT, V48, P22, DOI 10.3200/ENVT.48.7.22-38; Bernhardt ES, 2007, FRESHWATER BIOL, V52, P738, DOI 10.1111/j.1365-2427.2006.01718.x; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Briggs JM, 2006, FRONT ECOL ENVIRON, V4, P180, DOI 10.1890/1540-9295(2006)004[0180:WENAAA]2.0.CO;2; Brown Lester, 2001, ECOECONOMY BUILDING, P121; Burhans DE, 2006, ECOL APPL, V16, P394, DOI 10.1890/04-0927; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Carreiro MM, 2005, ECOSYSTEMS, V8, P568, DOI 10.1007/s10021-003-0172-6; Cerveny RS, 1998, NATURE, V394, P561, DOI 10.1038/29043; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chocat B, 2001, WATER SCI TECHNOL, V43, P61, DOI 10.2166/wst.2001.0251; COLLINS SL, MISCELLANEOUS PUBLIC; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez JE, 2007, J IND ECOL, V11, P99, DOI 10.1162/jie.2007.1199; Fischer-Kowalski Marina, 1998, J IND ECOL, V2, P61, DOI [10.1162/jiec.1998.2.1.61, DOI 10.1162/JIEC.1998.2.1.61]; Folke C, 1997, AMBIO, V26, P167; Gering JC, 1999, ECOGRAPHY, V22, P532, DOI 10.1111/j.1600-0587.1999.tb00542.x; Graedel TE, 2004, ENVIRON SCI TECHNOL, V38, P1242, DOI 10.1021/es030433c; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Groffman PM, 2005, J N AM BENTHOL SOC, V24, P613, DOI 10.1899/04-026.1; Groffman PM, 2004, ECOSYSTEMS, V7, P393, DOI 10.1007/s10021-003-0039-x; Grove JM, 2006, ECOSYSTEMS, V9, P578, DOI 10.1007/s10021-006-0116-z; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Kahn ME, 2000, J POLICY ANAL MANAG, V19, P569, DOI 10.1002/1520-6688(200023)19:4<569::AID-PAM3>3.0.CO;2-P; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kaye JP, 2008, ECOL APPL, V18, P132, DOI 10.1890/06-1952.1; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; LANG RE, 2007, METROPLEX EXAMINING; Lewis DB, 2006, GLOBAL CHANGE BIOL, V12, P703, DOI 10.1111/j.1365-2486.2006.01126.x; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; Luck MA, 2001, ECOSYSTEMS, V4, P782, DOI 10.1007/s10021-001-0046-8; Marzluff John M., 2005, Urban Ecosystems, V8, P157, DOI 10.1007/s11252-005-4378-6; MCGEE T, 1999, E W PERSPECTIVES 21, P37; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McPherson E.G., 1994, ECOLOGICAL CITY PRES, P151; Meyerson FAB, 2007, FRONT ECOL ENVIRON, V5, P182, DOI 10.1890/1540-9295(2007)5[182:MAEITC]2.0.CO;2; Molina MJ, 2004, J AIR WASTE MANAGE, V54, P644, DOI 10.1080/10473289.2004.10470936; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Oke R.T., 1997, APPL CLIMATOLOGY PRI, P273; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pavao-Zuckerman MA, 2007, APPL SOIL ECOL, V35, P329, DOI 10.1016/j.apsoil.2006.07.008; Pickett STA, 2005, ECOSYSTEMS, V8, P225, DOI 10.1007/s10021-004-0098-7; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; REDMAN CL, 1999, HUMAN IMPACT ANCIENT, P127; Robinson L, 2005, LANDSCAPE URBAN PLAN, V71, P51, DOI 10.1016/j.landurbplan.2004.02.005; Rosenzweig M.L., 2003, WIN WIN ECOLOGY; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Shen L, 2005, CITIES, V22, P287, DOI 10.1016/j.cities.2005.05.007; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Stoddard JL, 2006, ECOL APPL, V16, P1267, DOI 10.1890/1051-0761(2006)016[1267:SEFTEC]2.0.CO;2; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; *UN DEV PROGR, 2006, SCARC POW POV GLOB W; United Nations Population Division, 2006, WORLD URB PROSP 2005; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Warren-Rhodes K, 2001, AMBIO, V30, P429, DOI 10.1639/0044-7447(2001)030[0429:ETITUM]2.0.CO;2; Xiao Y, 2007, ENVIRON MONIT ASSESS, V135, P21, DOI 10.1007/s10661-007-9708-0; Zhao SQ, 2006, FRONT ECOL ENVIRON, V4, P341, DOI 10.1890/1540-9295(2006)004[0341:ECORUE]2.0.CO;2	71	3674	4061	239	3848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					756	760		10.1126/science.1150195	http://dx.doi.org/10.1126/science.1150195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258902				2022-12-28	WOS:000252963000045
J	Helgason, A; Palsson, S; Guobjartsson, DF; Kristjansson, P; Stefansson, K				Helgason, Agnar; Palsson, Snaebjoern; Guobjartsson, Daniel F.; Kristjansson, Porour; Stefansson, Kari			An association between the kinship and fertility of human couples	SCIENCE			English	Article							CONSANGUINEOUS MARRIAGES; POPULATION; MORTALITY	Previous studies have reported that related human couples tend to produce more children than unrelated couples but have been unable to determine whether this difference is biological or stems from socioeconomic variables. Our results, drawn from all known couples of the Icelandic population born between 1800 and 1965, show a significant positive association between kinship and fertility, with the greatest reproductive success observed for couples related at the level of third and fourth cousins. Owing to the relative socioeconomic homogeneity of Icelanders, and the observation of highly significant differences in the fertility of couples separated by very fine intervals of kinship, we conclude that this association is likely to have a biological basis.	[Helgason, Agnar; Palsson, Snaebjoern; Guobjartsson, Daniel F.; Kristjansson, Porour; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, IS-101 Reykjavik, Iceland; [Palsson, Snaebjoern] Univ Iceland, Dept Biol, IS-101 Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Helgason, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	agnar@decode.is	Stefansson, Kari/AAE-7187-2019; Palsson, Snaebjorn/J-9113-2012; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Palsson, Snaebjorn/0000-0002-4297-3500; Gudbjartsson, Daniel/0000-0002-5222-9857				AlHusain M, 1997, ANN TROP PAEDIATR, V17, P155; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1993, INT J EPIDEMIOL, V22, P463, DOI 10.1093/ije/22.3.463; Bittles AH, 2002, ANN HUM BIOL, V29, P111, DOI 10.1080/03014460110075657; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; EDYAL GB, 2003, DEMOGRAPHIC TRENDS I; GUNNLAUGSSON GA, 1993, J FAM HIST, V18, P315, DOI 10.1177/036319909301800403; GUNNLAUGSSON GA, 1997, SAGA SAMFELAG PAETTI; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hussain R, 2004, J HEALTH POPUL NUTR, V22, P1; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; PHILIPPE P, 1974, HUM BIOL, V46, P405; Schull WJ, 1965, EFFECTS INBREEDING J; Villegas MJB, 2006, ANN HUM BIOL, V33, P330, DOI 10.1080/03014460600627529; Watkins K, 2006, HUMAN DEV REPORT	15	105	106	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					813	816		10.1126/science.1150232	http://dx.doi.org/10.1126/science.1150232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258915				2022-12-28	WOS:000252963000062
J	Yingling, J; Youn, YH; Darling, D; Toyo-Oka, K; Pramparo, T; Hirotsune, S; Wynshaw-Boris, A				Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Toyo-Oka, Kazuhito; Pramparo, Tiziano; Hirotsune, Shinji; Wynshaw-Boris, Anthony			Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division	CELL			English	Article							LISSENCEPHALY GENE LIS1; ASYMMETRIC INHERITANCE; CYTOPLASMIC DYNEIN; PROTEIN; CRE; MICROTUBULES; CENTROSOME; EXPRESSION; MIGRATION; DYNACTIN	Mitotic spindle orientation and plane of cleavage in mammals is a determinant of whether division yields progenitor expansion and/or birth of new neurons during radial glial progenitor cell (RGPC) neurogenesis, but its role earlier in neuroepithelial stem cells is poorly understood. Here we report that Lis1 is essential for precise control of mitotic spindle orientation in both neuroepithelial stem cells and radial glial progenitor cells. Controlled gene deletion of Lis1 in vivo in neuroepithelial stem cells, where cleavage is uniformly vertical and symmetrical, provokes rapid apoptosis of those cells, while radial glial progenitors are less affected. Impaired cortical microtubule capture via loss of cortical dynein causes astral and cortical microtubules to be greatly reduced in Lis1-deficient cells. Increased expression of the LIS/dynein binding partner NDEL1 restores cortical microtubule and dynein localization in Lis1-deficient cells. Thus, control of symmetric division, essential for neuroepithelial stem cell proliferation, is mediated through spindle orientation determined via LIS1/NDEL1/dynein-mediated cortical microtubule capture.	[Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Pramparo, Tiziano; Wynshaw-Boris, Anthony] UCSD Sch Med, Dept Med, Ctr Human Genet & Genom, La Jolla, CA 92098 USA; [Yingling, Jessica] UCSD Sch Med, Biomed Sci Grad Program, La Jolla, CA 92098 USA; [Toyo-Oka, Kazuhito; Hirotsune, Shinji] Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Osaka 5458585, Japan; [Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Toyo-Oka, Kazuhito; Pramparo, Tiziano; Wynshaw-Boris, Anthony] UCSD Sch Med, Dept Pediat, Ctr Human Genet & Genom, La Jolla, CA 92098 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Osaka Metropolitan University; University of California System; University of California San Diego	Wynshaw-Boris, A (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, Inst Human Genet, 513 Parnassus Ave,HSE901F, San Francisco, CA 94143 USA.	wynshawborist@peds.ucsf.edu	Toyooka, Kazuhito/AAQ-6928-2020; Toyooka, Kazuhito/AAH-7175-2019	Toyooka, Kazuhito/0000-0002-0173-0430; Toyooka, Kazuhito/0000-0002-0173-0430	NICHD NIH HHS [R01 HD047380-03, R01 HD047380-01A1, R01 HD047380, HD047380, R01 HD047380-02] Funding Source: Medline; NINDS NIH HHS [R01 NS041030-01A2, R01 NS041030-05, R01 NS041030, R01 NS041030-06, NS041310, R01 NS041310, P30 NS047101, R01 NS041030-03, R01 NS041030-02, R01 NS041030-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041030, P30NS047101, R01NS041310] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chai Y, 2000, DEVELOPMENT, V127, P1671; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	43	212	215	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					474	486		10.1016/j.cell.2008.01.026	http://dx.doi.org/10.1016/j.cell.2008.01.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267077	Bronze, Green Accepted			2022-12-28	WOS:000253180700021
J	Horsley, V; Aliprantis, AO; Polak, L; Glimcher, LH; Fuchs, E				Horsley, Valerie; Aliprantis, Antonios O.; Polak, Lisa; Glimcher, Laurie H.; Fuchs, Elaine			NFATc1 balances quiescence and proliferation of skin stem cells	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; CYCLOSPORINE-A; BETA-CATENIN; HUMAN KERATINOCYTES; TRANSIENT ACTIVATION; EPIDERMAL STEM; GROWTH; DIFFERENTIATION; CALCINEURIN; INHIBITION	Quiescent adult stem cells reside in specialized niches where they become activated to proliferate and differentiate during tissue homeostasis and injury. How stem cell quiescence is governed is poorly understood. We report here that NFATc1 is preferentially expressed by hair follicle stem cells in their niche, where its expression is activated by BMP signaling upstream and it acts downstream to transcriptionally repress CDK4 and maintain stem cell quiescence. As stem cells become activated during hair growth, NFATc1 is downregulated, relieving CDK4 repression and activating proliferation. When calcineurin/NFATc1 signaling is suppressed, pharmacologically or via complete or conditional NFATc1 gene ablation, stem cells are activated prematurely, resulting in precocious follicular growth. Our findings may explain why patients receiving cyclosporine A for immunosuppressive therapy display excessive hair growth, and unveil a functional role for calcium-NFATc1-CDK4 circuitry in governing stem cell quiescence.	[Horsley, Valerie; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Infect Dis & Immunol, Boston, MA 02115 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Harvard Univ, Sch Med, Boston, MA USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIAID NIH HHS [U19 AI031541, AI31541, P01 AI031541] Funding Source: Medline; NIAMS NIH HHS [R01-AR31737, K99 AR054775, R01 AR031737-25, K99-AR054775, R01 AR031737, R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031541, P01AI031541, U01AI031541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452, K99AR054775] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Canning MT, 2006, J MOL HISTOL, V37, P285, DOI 10.1007/s10735-006-9034-9; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Gafter-Gvili A, 2004, ARCH DERMATOL RES, V296, P265, DOI 10.1007/s00403-004-0516-x; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hennings H, 1980, Curr Probl Dermatol, V10, P3; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Karashima T, 1996, J DERMATOL SCI, V12, P246, DOI 10.1016/0923-1811(95)00480-7; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Maurer M, 1997, AM J PATHOL, V150, P1433; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; PAUS R, 1994, AM J PATHOL, V144, P719; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SAWADA M, 1987, LAB INVEST, V56, P684; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yamamoto S, 1994, J Dermatol Sci, V7 Suppl, pS47, DOI 10.1016/0923-1811(94)90035-3; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x; Yu BD, 2003, P NATL ACAD SCI USA, V100, P14881, DOI 10.1073/pnas.2431391100; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	62	315	334	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					299	310		10.1016/j.cell.2007.11.047	http://dx.doi.org/10.1016/j.cell.2007.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243104	Bronze, Green Accepted			2022-12-28	WOS:000253427700015
J	Jelluma, N; Brenkman, AB; van den Broek, NJF; Cruijsen, CWA; van Osch, MHJ; Lens, SMA; Medema, RH; Kops, GJPL				Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; Cruijsen, Carin W. A.; van Osch, Maria H. J.; Lens, Susanne M. A.; Medema, Rene H.; Kops, Geert J. P. L.			Mps1 phosphorylates borealin to control aurora B activity and chromosome alignment	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASE-1; KINETOCHORE LOCALIZATION; PASSENGER COMPLEX; PROTEIN-KINASE; CENP-E; MICROTUBULE DYNAMICS; INCENP; BUB1	Maintenance of chromosomal stability relies on coordination between various processes that are critical for proper chromosome segregation in mitosis. Here we show that monopolar spindle 1 (Mps1) kinase, which is essential for the mitotic checkpoint, also controls correction of improper chromosome attachments. We report that Borealin/DasraB, a member of the complex that regulates the Aurora B kinase, is directly phosphorylated by Mps1 on residues that are crucial for Aurora B activity and chromosome alignment. As a result, cells lacking Mps1 kinase activity fail to efficiently align chromosomes due to impaired Aurora B function at centromeres, leaving improper attachments uncorrected. Strikingly, Borealin/DasraB bearing phosphomimetic mutations restores Aurora B activity and alignment in Mps1-depleted cells. Mps1 thus coordinates attachment error correction and checkpoint signaling, two crucial responses to unproductive chromosome attachments.	[Jelluma, Nannette; Cruijsen, Carin W. A.; Lens, Susanne M. A.; Medema, Rene H.; Kops, Geert J. P. L.] UMC Utrecht, Expt Oncol Lab, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; van Osch, Maria H. J.; Kops, Geert J. P. L.] UMC Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; van Osch, Maria H. J.; Kops, Geert J. P. L.] UMC Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kops, GJPL (corresponding author), UMC Utrecht, Expt Oncol Lab, Dept Med Oncol, Universiteitsweg 100, NL-3584 CG Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl	Medema, Rene H/G-5415-2011; Medema, Rene H/E-2981-2013	Medema, Rene/0000-0002-6754-0381; Kops, Geert/0000-0003-3555-5295				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; CHEESEMAN IM, 2005, SCI STKE, V266, pPL1; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	60	206	222	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					233	246		10.1016/j.cell.2007.11.046	http://dx.doi.org/10.1016/j.cell.2007.11.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243099	Bronze			2022-12-28	WOS:000253427700010
J	Viscidi, RP; Shah, KV				Viscidi, Raphael P.; Shah, Keerti V.			Cancer - A skin cancer virus?	SCIENCE			English	Editorial Material									[Viscidi, Raphael P.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Shah, Keerti V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Viscidi, RP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA.	rviscid1@jhmi.edu; kvshah@jhsph.edu		Viscidi, Raphael/0000-0002-7906-8002				Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Perez-Losada M, 2006, J VIROL, V80, P5663, DOI 10.1128/JVI.00056-06	5	17	19	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1049	1050		10.1126/science.1155048	http://dx.doi.org/10.1126/science.1155048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292327				2022-12-28	WOS:000253311700027
J	Halpern, BS; Walbridge, S; Selkoe, KA; Kappel, CV; Micheli, F; D'Agrosa, C; Bruno, JF; Casey, KS; Ebert, C; Fox, HE; Fujita, R; Heinemann, D; Lenihan, HS; Madin, EMP; Perry, MT; Selig, ER; Spalding, M; Steneck, R; Watson, R				Halpern, Benjamin S.; Walbridge, Shaun; Selkoe, Kimberly A.; Kappel, Carrie V.; Micheli, Fiorenza; D'Agrosa, Caterina; Bruno, John F.; Casey, Kenneth S.; Ebert, Colin; Fox, Helen E.; Fujita, Rod; Heinemann, Dennis; Lenihan, Hunter S.; Madin, Elizabeth M. P.; Perry, Matthew T.; Selig, Elizabeth R.; Spalding, Mark; Steneck, Robert; Watson, Reg			A global map of human impact on marine ecosystems	SCIENCE			English	Article							COASTAL; FISHERIES; BIODIVERSITY; CONSERVATION; OCEAN; WORLD; AQUACULTURE; DEPLETION; HOTSPOTS; THREATS	The management and conservation of the world's oceans require synthesis of spatial data on the distribution and intensity of human activities and the overlap of their impacts on marine ecosystems. We developed an ecosystem- specific, multiscale spatial model to synthesize 17 global data sets of anthropogenic drivers of ecological change for 20 marine ecosystems. Our analysis indicates that no area is unaffected by human influence and that a large fraction ( 41%) is strongly affected by multiple drivers. However, large areas of relatively little human impact remain, particularly near the poles. The analytical process and resulting maps provide flexible tools for regional and global efforts to allocate conservation resources; to implement ecosystem- based management; and to inform marine spatial planning, education, and basic research.	[Halpern, Benjamin S.; Walbridge, Shaun; Selkoe, Kimberly A.; Kappel, Carrie V.; Ebert, Colin; Perry, Matthew T.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Selkoe, Kimberly A.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [D'Agrosa, Caterina] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Casey, Kenneth S.; Selig, Elizabeth R.] NOAA, Natl Oceanog Data Ctr, Silver Spring, MD 20910 USA; [Fox, Helen E.] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA; [Fujita, Rod] Environm Def, Oakland, CA 94618 USA; [Heinemann, Dennis] Ocean Conservancy, Washington, DC 20006 USA; [Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Madin, Elizabeth M. P.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Selig, Elizabeth R.] Univ N Carolina, Curriculum Ecol, Chapel Hill, NC 27599 USA; [Spalding, Mark] Nature Conservancy, Conservat Strategies Div, Newmarket CB8 8AW, Suffolk, England; [Steneck, Robert] Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04353 USA; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	National Center for Ecological Analysis & Synthesis; Stanford University; Wildlife Conservation Society; University of North Carolina; University of North Carolina Chapel Hill; National Oceanic Atmospheric Admin (NOAA) - USA; World Wildlife Fund; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of North Carolina; University of North Carolina Chapel Hill; University of Maine System; University of Maine Orono; University of British Columbia	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu; selkoe@nceas.ucsb.edu	Casey, Kenneth S/D-4065-2013; Spalding, Mark/GVU-0739-2022; Fox, Helen E/C-3543-2009; Kappel, Carrie Vanessa/B-9534-2009; Langhamer, Olivia/J-3425-2012; Watson, Reg A/F-4850-2012	Casey, Kenneth S/0000-0002-6052-7117; Kappel, Carrie Vanessa/0000-0003-2507-8042; Watson, Reg A/0000-0001-7201-8865; Micheli, Fiorenza/0000-0002-6865-1438; Spalding, Mark/0000-0001-9456-4533; Heinemann, Dennis/0000-0002-1434-2445; Fox, Helen/0000-0002-0541-7484				AIROLDI L, 2007, ANN REV OCEANOGR MAR, V45, P347; BAN N, 2007, AQUAT CONSERV MAR FR, V16; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; BRYANT D, 1998, RISK MAP BASED INDIC; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Dalton R, 2004, NATURE, V431, P502, DOI 10.1038/431502a; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; HALPERN BS, 2008, OCEAN COAST MANAGE; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Overland JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030808; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; *POC, 2003, AM LIV OC CHART COUR; Price ARG, 2002, MAR ECOL PROG SER, V241, P23, DOI 10.3354/meps241023; Reid W.V, 2005, MILLENNIUM ECOSYSTEM; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; *US COMM OC POL, 2004, OC BLUEPR 21 CENT; Vander Schaaf D., 2006, CONSERVATION ASSESSM; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Witherell D, 2000, ICES J MAR SCI, V57, P771, DOI 10.1006/jmsc.2000.0719	34	4047	4210	102	2525	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					948	952		10.1126/science.1149345	http://dx.doi.org/10.1126/science.1149345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276889				2022-12-28	WOS:000253165700045
J	de Vries, W; Solberg, S; Dobbertin, M; Sterba, H; Laubhahn, D; Reinds, GJ; Nabuurs, GJ; Gundersen, P; Sutton, MA				de Vries, Wim; Solberg, Svein; Dobbertin, Matthias; Sterba, Hubert; Laubhahn, Daniel; Reinds, Gert Jan; Nabuurs, Gert-Jan; Gundersen, Per; Sutton, Mark A.			Ecologically implausible carbon response?	NATURE			English	Letter							NITROGEN DEPOSITION; TEMPERATE FORESTS; SEQUESTRATION; ECOSYSTEMS; FLUXES; SOILS; SITES		[de Vries, Wim; Reinds, Gert Jan; Nabuurs, Gert-Jan] Univ Wageningen & Res Ctr, Alterra, NL-6700 AA Wageningen, Netherlands; [Solberg, Svein] Norwegian Forest & Landscape Inst, N-1431 As, Norway; [Dobbertin, Matthias] Swiss Fed Inst Forest Snow & Landscape Res WSL, CH-8903 Birmensdorf, Switzerland; [Sterba, Hubert; Laubhahn, Daniel] Univ Nat Resources & Appl Life Sci, A-1190 Vienna, Austria; [Gundersen, Per] Univ Copenhagen, Danish Ctr Forest Landscape & Planning, Horsholm, Denmark; [Sutton, Mark A.] Edinburgh Res Stn, Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	Wageningen University & Research; The Norwegian Forest & Landscape Institute; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Natural Resources & Life Sciences, Vienna; University of Copenhagen; UK Centre for Ecology & Hydrology (UKCEH)	de Vries, W (corresponding author), Univ Wageningen & Res Ctr, Alterra, POB 47, NL-6700 AA Wageningen, Netherlands.	wim.devries@wur.nl	Nabuurs, Gert-Jan/D-8048-2015; Gundersen, Per/B-2192-2008; Sutton, Mark/K-2700-2012	Gundersen, Per/0000-0002-9199-4033; Sutton, Mark/0000-0002-1342-2072; de Vries, Wim/0000-0001-9974-0612	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BROUWER R, 1983, NETH J AGR SCI, V31, P335; de Vries W, 2007, ENVIRON POLLUT, V148, P501, DOI 10.1016/j.envpol.2006.12.001; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; Evans CD, 2006, ENVIRON POLLUT, V143, P468, DOI 10.1016/j.envpol.2005.12.004; Gundersen P, 2006, ENVIRON REV, V14, P1, DOI [10.1139/a05-015, 10.1139/A05-015]; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; HYVONEN R, 2007, BIOGEOCHEMISTRY; Jenkinson DS, 1999, NATURE, V400, P629, DOI 10.1038/23174; Levy P.E., 2004, WATER AIR SOIL POLL, V4, P67; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Sievering H, 2000, GLOBAL BIOGEOCHEM CY, V14, P1153, DOI 10.1029/2000GB001250; Sievering H, 1999, NATURE, V400, P629, DOI 10.1038/23176; Simpson D, 2006, BIOGEOSCIENCES, V3, P337, DOI 10.5194/bg-3-337-2006; WOODWELL GM, 1968, AM ZOOL, V8, P19	15	113	119	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					E1	E3		10.1038/nature06579	http://dx.doi.org/10.1038/nature06579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18272968				2022-12-28	WOS:000253191400031
J	Liu, M; Duke, JL; Richter, DJ; Vinuesa, CG; Goodnow, CC; Kleinstein, SH; Schatz, DG				Liu, Man; Duke, Jamie L.; Richter, Daniel J.; Vinuesa, Carola G.; Goodnow, Christopher C.; Kleinstein, Steven H.; Schatz, David G.			Two levels of protection for the B cell genome during somatic hypermutation	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; GENE-EXPRESSION; C-MYC; AID; IG; TRANSLOCATIONS; IMMUNOGLOBULIN; MUTATION; PROTOONCOGENES	Somatic hypermutation introduces point mutations into immunoglobulin genes in germinal centre B cells during an immune response. The reaction is initiated by cytosine deamination by the activation- induced deaminase ( AID) and completed by error- prone processing of the resulting uracils by mismatch and base excision repair factors(1). Somatic hypermutation represents a threat to genome integrity(2) and it is not known how the B cell genome is protected from the mutagenic effects of somatic hypermutation nor how often these protective mechanisms fail. Here we show, by extensive sequencing of murine B cell genes, that the genome is protected by two distinct mechanisms: selective targeting of AID and gene- specific, high- fidelity repair of AID- generated uracils. Numerous genes linked to B cell tumorigenesis, including Myc, Pim1, Pax5, Ocab ( also called Pou2af1), H2afx, Rhoh and Ebf1, are deaminated by AID but escape acquisition of most mutations through the combined action of mismatch and base excision repair. However, approximately 25% of expressed genes analysed were not fully protected by either mechanism and accumulated mutations in germinal centre B cells. Our results demonstrate that AID acts broadly on the genome, with the ultimate distribution of mutations determined by a balance between high- fidelity and error- prone DNA repair.	[Liu, Man; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Richter, Daniel J.] MIT, Broad Inst, Cambridge, MA 02141 USA; [Richter, Daniel J.] Harvard Univ, Cambridge, MA 02141 USA; [Vinuesa, Carola G.; Goodnow, Christopher C.] Australian Natl Univ, Div Immunol & Genet, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Goodnow, Christopher C.] Australian Phenom Facil, Canberra, ACT 2601, Australia; [Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Australian National University; John Curtin School of Medical Research; Howard Hughes Medical Institute	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013; Goodnow, Christopher C/V-8108-2018; Vinuesa, Carola G/B-1108-2010	Schatz, David/0000-0002-5669-1176; Goodnow, Christopher C/0000-0001-5296-6155; Vinuesa, Carola G/0000-0001-9799-0298; Duke, Jamie/0000-0002-4768-0846; Richter, Daniel/0000-0002-9238-5571				Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Auer RL, 2005, GENE CHROMOSOME CANC, V43, P1, DOI 10.1002/gcc.20159; Bindra RS, 2007, CANCER LETT, V252, P93, DOI 10.1016/j.canlet.2006.12.011; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Duquette ML, 2007, CANCER RES, V67, P2586, DOI 10.1158/0008-5472.CAN-06-2419; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Parsa JY, 2007, MOL IMMUNOL, V44, P567, DOI 10.1016/j.molimm.2006.02.003; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Poltoratsky V, 2007, DNA REPAIR, V6, P244, DOI 10.1016/j.dnarep.2006.10.003; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123	48	449	460	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					841	U11		10.1038/nature06547	http://dx.doi.org/10.1038/nature06547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273020				2022-12-28	WOS:000253191400045
J	Liu, X; Wang, L; Zhao, KH; Thompson, PR; Hwang, Y; Marmorstein, R; Cole, PA				Liu, Xin; Wang, Ling; Zhao, Kehao; Thompson, Paul R.; Hwang, Yousang; Marmorstein, Ronen; Cole, Philip A.			The structural basis of protein acetylation by the p300/CBP transcriptional coactivator	NATURE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; CBP; INHIBITORS; CANCER; CELLS; HAT; MUTATIONS; ROLES; PCAF; GENE	The transcriptional coactivator p300/ CBP ( CREBBP) is a histone acetyltransferase ( HAT) that regulates gene expression by acetylating histones and other transcription factors. Dysregulation of p300/ CBP HAT activity contributes to various diseases including cancer(1-4). Sequence alignments, enzymology experiments and inhibitor studies on p300/ CBP have led to contradictory results about its catalytic mechanism and its structural relation to the Gcn5/ PCAF and MYST HATs(5-9). Here we describe a high- resolution X- ray crystal structure of a semi- synthetic heterodimeric p300 HAT domain in complex with a bi- substrate inhibitor, Lys- CoA. This structure shows that p300/ CBP is a distant cousin of other structurally characterized HATs, but reveals several novel features that explain the broad substrate specificity and preference for nearby basic residues. Based on this structure and accompanying biochemical data, we propose that p300/ CBP uses an unusual 'hitandrun' ( Theorell - Chance) catalytic mechanism that is distinct from other characterized HATs. Several disease- associated mutations can also be readily accounted for by the p300 HAT structure. These studies pave the way for new epigenetic therapies involving modulation of p300/ CBP HAT activity.	[Liu, Xin; Zhao, Kehao; Marmorstein, Ronen] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Liu, Xin; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Wang, Ling; Thompson, Paul R.; Hwang, Yousang; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	The Wistar Institute; University of Pennsylvania; Johns Hopkins University	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, Program Gene Express & Regulat, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org; pcole@jhmi.edu						Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Cebrat M, 2003, BIOORGAN MED CHEM, V11, P3307, DOI 10.1016/S0968-0896(03)00265-7; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hwang Y, 2007, ANGEW CHEM INT EDIT, V46, P7621, DOI 10.1002/anie.200702485; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Karanam B, 2007, BIOCHEMISTRY-US, V46, P8207, DOI 10.1021/bi7000054; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Marmorstein R, 2001, J MOL BIOL, V311, P433, DOI 10.1006/jmbi.2001.4859; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Muraoka M, 1996, ONCOGENE, V12, P1565; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Segel I.H., 1975, ENZYME KINETICS; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Varier RA, 2006, CURR PHARM DESIGN, V12, P1975, DOI 10.2174/138161206777442092; Yuan LWC, 2002, ONCOGENE, V21, P2253, DOI 10.1038/sj.onc.1205283; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	30	305	317	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					846	850		10.1038/nature06546	http://dx.doi.org/10.1038/nature06546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273021				2022-12-28	WOS:000253191400046
J	Voss, R; Nelemans, G				Voss, Rasmus; Nelemans, Gijs			Discovery of the progenitor of the type Ia supernova 2007on	NATURE			English	Article							WHITE-DWARF MODELS; X-RAY SOURCES; BINARIES; EVOLUTION; COLORS	Type Ia supernovae are exploding stars that are used to measure the accelerated expansion of the Universe(1,2) and are responsible for most of the iron ever produced(3). Although there is general agreement that the exploding star is a white dwarf in a binary system, the exact configuration and trigger of the explosion is unclear(4), which could hamper their use for precision cosmology. Two families of progenitor models have been proposed. In the first, a white dwarf accretes material from a companion until it exceeds the Chandrasekhar mass, collapses and explodes(5,6). Alternatively, two white dwarfs merge, again causing catastrophic collapse and an explosion(7,8). It has hitherto been impossible to determine if either model is correct. Here we report the discovery of an object in pre- supernova archival X- ray images at the position of the recent type Ia supernova ( 2007on) in the elliptical galaxy NGC 1404. Deep optical images ( also archival) show no sign of this object. From this we conclude that the X- ray source is the progenitor of the supernova, which favours the accretion model for this supernova, although the host galaxy is older ( 6 - 9 Gyr) than the age at which the explosions are predicted in the accreting models.	[Voss, Rasmus] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Voss, Rasmus] Excellence Cluster Universe, D-85748 Garching, Germany; [Nelemans, Gijs] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; University of Munich; Radboud University Nijmegen	Voss, R (corresponding author), Max Planck Inst Extraterr Phys, Giessenbach Str, D-85748 Garching, Germany.	rvoss@mpe.mpg.de; nelemans@astro.ru.nl	Nelemans, Gijs/D-3177-2012	Nelemans, Gijs/0000-0002-0752-2974				Bregman JN, 2006, ASTROPHYS J, V647, P265, DOI 10.1086/505190; Cowley AP, 1998, ASTROPHYS J, V504, P854, DOI 10.1086/306123; GALYAM A, 2007, ASTRON TEL, V1263; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; Han Z, 2004, MON NOT R ASTRON SOC, V350, P1301, DOI 10.1111/j.1365-2966.2004.07713.x; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; IMMLER S, 2007, ASTRON TEL, V1261; Leonard DC, 2007, ASTROPHYS J, V670, P1275, DOI 10.1086/522367; Li Z, 2007, ASTRON ASTROPHYS, V464, P853, DOI 10.1051/0004-6361:20066337; Luna GJM, 2007, ASTROPHYS J, V671, P741, DOI 10.1086/522576; Mannucci F, 2006, MON NOT R ASTRON SOC, V370, P773, DOI 10.1111/j.1365-2966.2006.10501.x; Mattila S, 2005, ASTRON ASTROPHYS, V443, P649, DOI 10.1051/0004-6361:20052731; NOMOTO K, 1982, ASTROPHYS J, V253, P798, DOI 10.1086/159682; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Piersanti L, 2003, ASTROPHYS J, V598, P1229, DOI 10.1086/378952; POLLAS C, 2007, CENTRAL BUREAU ELECT, V1121; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; Saio H, 1998, ASTROPHYS J, V500, P388, DOI 10.1086/305696; Scannapieco E, 2005, ASTROPHYS J, V629, pL85, DOI 10.1086/452632; Tonry JL, 2001, ASTROPHYS J, V546, P681, DOI 10.1086/318301; Tutukov A, 1996, MON NOT R ASTRON SOC, V280, P1035, DOI 10.1093/mnras/280.4.1035; VANDENHEUVEL EPJ, 1992, ASTRON ASTROPHYS, V262, P97; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Yoon SC, 2007, MON NOT R ASTRON SOC, V380, P933, DOI 10.1111/j.1365-2966.2007.12161.x; Yungelson LR, 2005, ASTROPHYS SPACE SC L, P163	29	62	63	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					802	804		10.1038/nature06602	http://dx.doi.org/10.1038/nature06602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273013	Green Submitted			2022-12-28	WOS:000253191400036
J	Wu, AW; Lipshutz, AKM; Pronovost, PJ				Wu, Albert W.; Lipshutz, Angela K. M.; Pronovost, Peter J.			Effectiveness and efficiency of root cause analysis in medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SAFETY		[Wu, Albert W.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lipshutz, Angela K. M.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Pronovost, Peter J.] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Wu, AW (corresponding author), WHO, World Alliance Patient Safety, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	awu@jhsph.edu	Wu, Albert/AAJ-4780-2021					Bagian J P, 2001, Jt Comm J Qual Improv, V27, P522; Bagian James P, 2002, Jt Comm J Qual Improv, V28, P531; Braithwaite J, 2006, QUAL SAF HEALTH CARE, V15, P393, DOI 10.1136/qshc.2005.017525; Carroll JS, 1998, J MANAGE STUD, V35, P699, DOI 10.1111/1467-6486.00116; DRURY CG, 2003, P ERG SOC ANN C 2003; Iedema RAM, 2006, SOC SCI MED, V62, P1605, DOI 10.1016/j.socscimed.2005.08.049; IGNACZAK A, 2007, TOP PAT SAF BROAD UT, V9, P2; *JOINT COMM, SENT EV GLOSS TERMS; *JOINT COMM, THIS MONTH APR 2007; Mills PD, 2005, JT COMM J QUAL PATIE, V31, P21, DOI 10.1016/S1553-7250(05)31004-X; Mills PD, 2006, JT COMM J QUAL PATIE, V32, P130, DOI 10.1016/S1553-7250(06)32018-1; *NAT AC STAT HLTH, 2005, QUAL PAT SAF STAT AD; Pronovost PJ, 2006, INTENS CARE MED, V32, P1467, DOI 10.1007/s00134-006-0291-6; Pronovost PJ, 2004, ANN INTERN MED, V140, P1025, DOI 10.7326/0003-4819-140-12-200406150-00013; *US DEP VET AFF, NAT CTR PAT SAF ROOT; *VA NAT CTR PAT SA, VHA PAT SAF AL ADV; Wallace LM, 2006, EVALUATION NPSAS 3 D	17	209	212	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					685	687		10.1001/jama.299.6.685	http://dx.doi.org/10.1001/jama.299.6.685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261QN	18270357				2022-12-28	WOS:000253095200026
J	Black, MM; Walker, SP; Wachs, TD; Ulkuer, N; Gardner, JM; Grantham-McGregor, S; Lozoff, B; Engle, PL; de Mello, MC				Black, Maureen M.; Walker, Susan P.; Wachs, Theodore D.; Ulkuer, Nurper; Gardner, Julie Meeks; Grantham-McGregor, Sally; Lozoff, Betsy; Engle, Patrice L.; de Mello, Meena Cabral			Policies to reduce undernutrition include child development	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; NUTRITIONAL SUPPLEMENTATION; PSYCHOSOCIAL STIMULATION		[Black, Maureen M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Walker, Susan P.; Gardner, Julie Meeks] Univ W Indies, Kingston 7, Jamaica; [Wachs, Theodore D.] Purdue Univ, W Lafayette, IN 47907 USA; [Ulkuer, Nurper] UNICEF, New York, NY USA; [Grantham-McGregor, Sally] UCL, Inst Child Hlth, London, England; [Lozoff, Betsy] Univ Michigan, Ann Arbor, MI 48109 USA; [Engle, Patrice L.] Cal Poly State Univ, San Luis Obispo, CA USA; [de Mello, Meena Cabral] WHO, CH-1211 Geneva, Switzerland	University System of Maryland; University of Maryland Baltimore; University West Indies Mona Jamaica; Purdue University System; Purdue University; Purdue University West Lafayette Campus; UNICEF; University of London; University College London; University of Michigan System; University of Michigan; California State University System; California Polytechnic State University San Luis Obispo; World Health Organization	Black, MM (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	mblack@peds.umaryland.edu		Black, Maureen/0000-0002-6427-4639				[Anonymous], 2005, CHILD DEV, V76, P795; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Love JM, 2005, DEV PSYCHOL, V41, P885, DOI 10.1037/0012-1649.41.6.885; Nelson C. A., 2006, NEUROSCIENCE COGNITI; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2006, BRIT MED J, V333, P472, DOI 10.1136/bmj.38897.555208.2F	10	28	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					454	455		10.1016/S0140-6736(08)60215-9	http://dx.doi.org/10.1016/S0140-6736(08)60215-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262026	Green Submitted			2022-12-28	WOS:000253169200007
J	Bloom, DE; Canning, D; Fink, G				Bloom, David E.; Canning, David; Fink, Guenther			Urbanization and the wealth of nations	SCIENCE			English	Review							URBAN BIAS; PRODUCTIVITY; GROWTH; LIFE	The proportion of a country's population living in urban areas is highly correlated with its level of income. Urban areas offer economies of scale and richer market structures, and there is strong evidence that workers in urban areas are individually more productive, and earn more, than rural workers. However, rapid urbanization is also associated with crowding, environmental degradation, and other impediments to productivity. Overall, we find no evidence that the level of urbanization affects the rate of economic growth. Our findings weaken the rationale for either encouraging or discouraging urbanization as part of a strategy for economic growth.	[Bloom, David E.; Canning, David; Fink, Guenther] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, DE (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	dbloom@hsph.harvard.edu	Canning, David/A-1917-2008	Canning, David/0000-0003-4041-1229				ABDELRAHMAN H, 1990, J REGIONAL SCI, V30, P165, DOI 10.1111/j.1467-9787.1990.tb00091.x; [Anonymous], 2005, WORLD POP PROSP 2004; [Anonymous], [No title captured]; Becker C.M., 2008, INT HDB DEV EC, V1, P516; BECKER R, 2000, EC CITIES THEORETICA; BERTINELLI L, 0314 CREDIT U NOTT; Black D, 1999, J POLIT ECON, V107, P252, DOI 10.1086/250060; BRADSHAW YW, 1989, AM SOCIOL REV, V54, P986, DOI 10.2307/2095719; Bruno GSF, 2005, ECON LETT, V87, P361, DOI 10.1016/j.econlet.2005.01.005; CAPLIN A, 1998, ECON J, V108, P62; Ciccone A, 1996, AM ECON REV, V86, P54; DIXIT AK, 1977, AM ECON REV, V67, P297; Easterly W, 1999, J ECON GROWTH, V4, P239, DOI 10.1023/A:1009882702130; Fay M., 2000, 2412 WORLD BANK; FUJITA M, 1982, PRINC BERT S DYN FIR; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Henderson V, 2003, J ECON GROWTH, V8, P47, DOI 10.1023/A:1022860800744; Heston A., 2006, PENN WORLD TABLE VER; HUGO G, 2006, AFRICA MOVE AFRICAN; KEYFITZ N, 1980, GEOGR ANAL, V12, P142; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; LIPTON M, 1993, J DEV STUD, V29, P229, DOI 10.1080/00220389308422301; LIPTON M, 1984, J DEV STUD, V20, P139, DOI 10.1080/00220388408421910; Lipton M, 1993, INCLUDING POOR; MONTGOMERY MR, 2003, CITIES TRANSFORMED D, V273; PRESTON SH, 1979, POPUL DEV REV, V5, P195, DOI 10.2307/1971823; RAUCH JE, 1993, J URBAN ECON, V34, P380, DOI 10.1006/juec.1993.1042; Sala-I-Martin X, 2004, AM ECON REV, V94, P813, DOI 10.1257/0002828042002570; SATTERTHWAITE D, 2007, 4 IIED; *UN HABITAT DFID, 2002, UN HABITAT DFID NAIR; *UN OFF COORD HUM, 2007, REL; UN-HABITAT, 2007, STAT WORLDS CIT 2006; *UNFPA, 2007, 45 UNFPA; WILLIAMSON JG, 1965, ECON DEV CULT CHANGE, V13, P1, DOI 10.1086/450136	34	271	292	17	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					772	775		10.1126/science.1153057	http://dx.doi.org/10.1126/science.1153057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258907				2022-12-28	WOS:000252963000050
J	Setoguchi, R; Tachibana, M; Naoe, Y; Muroi, S; Akiyama, K; Tezuka, C; Okuda, T; Taniuchi, I				Setoguchi, Ruka; Tachibana, Masashi; Naoe, Yoshinori; Muroi, Sawako; Akiyama, Kaori; Tezuka, Chieko; Okuda, Tsukasa; Taniuchi, Ichiro			Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development	SCIENCE			English	Article							LINEAGE DIFFERENTIATION; POSITIVE SELECTION; GENE-EXPRESSION; CD4; COMMITMENT; PROTEINS; DURATION; SILENCER; FATE	Mouse CD4(+) CD8(+) double- positive ( DP) thymocytes differentiate into CD4(+) helper- lineage cells upon expression of the transcription factor Th- POK but commit to the CD8(+) cytotoxic lineage in its absence. We report the redirected differentiation of class I - restricted thymocytes into CD4(+) CD8(-) helper- like T cells upon loss of Runx transcription factor complexes. A Runx- binding sequence within the Th- POK locus acts as a transcriptional silencer that is essential for Th- POK repression and for development of CD8(+) T cells. Thus, Th- POK expression and genetic programming for T helper cell development are actively inhibited by Runx- dependent silencer activity, allowing for cytotoxic T cell differentiation. Identification of the transcription factors network in CD4 and CD8 lineage choice provides insight into how distinct T cell subsets are developed for regulating the adaptive immune system.	[Setoguchi, Ruka; Tachibana, Masashi; Naoe, Yoshinori; Muroi, Sawako; Akiyama, Kaori; Tezuka, Chieko; Taniuchi, Ichiro] RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Muroi, Sawako; Akiyama, Kaori; Taniuchi, Ichiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Okuda, Tsukasa] Kyoto Prefectural Univ Med, Kamigyo Ku, Kyoto 6028566, Japan	RIKEN; Japan Science & Technology Agency (JST); Kyoto Prefectural University of Medicine	Taniuchi, I (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	taniuchi@rcai.riken.jp	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Tachibana, Masashi/0000-0002-0376-508X				Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nishimura M, 2004, BLOOD, V103, P562, DOI 10.1182/blood-2003-06-2109; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; ROY M, 1993, J IMMUNOL, V151, P2497; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Singer A, 2004, ADV IMMUNOL, V83, P91; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	21	189	198	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					822	825		10.1126/science.1151844	http://dx.doi.org/10.1126/science.1151844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258917				2022-12-28	WOS:000252963000065
J	Jenkins, JT; O'Dwyer, PJ				Jenkins, John T.; O'Dwyer, Patrick J.			Inguinal hernias	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GENERAL-ANESTHESIA; CLINICAL-TRIAL; MESH REPAIR; RISK; PAIN; HERNIORRHAPHY; LICHTENSTEIN; METAANALYSIS; NATIONWIDE; DENMARK		[Jenkins, John T.; O'Dwyer, Patrick J.] Univ Glasgow, Western Infirm, Dept Surg, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	Jenkins, JT (corresponding author), Univ Glasgow, Western Infirm, Dept Surg, Glasgow G11 6NT, Lanark, Scotland.	mrianjenkins@hotmail.com						Aufenacker TJ, 2006, BRIT J SURG, V93, P5, DOI 10.1002/bjs.5186; Bay-Nielsen M, 2004, BRIT J SURG, V91, P362, DOI 10.1002/bjs.4437; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Berndsen Fritz H, 2007, Hernia, V11, P307, DOI 10.1007/s10029-007-0214-7; Bisgaard T, 2007, BRIT J SURG, V94, P1038, DOI 10.1002/bjs.5756; Butters M, 2007, BRIT J SURG, V94, P562, DOI 10.1002/bjs.5733; Chow A., 2007, BMJ CLIN EVI, V9, P1; Collaboration EH, 2000, BRIT J SURG, V87, P860; Devlin HB, 1995, PROBL GEN SURG, V12, P85; Fitzgibbons RJ, 2006, JAMA-J AM MED ASSOC, V295, P285, DOI 10.1001/jama.295.3.285; Fitzgibbons RJ, 2005, ANN SURG, V241, P559, DOI 10.1097/01.sla.0000157210.80440.b7; Fitzgibbons RJ, 2003, J AM COLL SURGEONS, V196, P737, DOI 10.1016/S1072-7515(03)00003-6; Franneby U, 2006, ANN SURG, V244, P212, DOI 10.1097/01.sla.0000218081.53940.01; GALLEGOS NC, 1991, BRIT J SURG, V78, P1171, DOI 10.1002/bjs.1800781007; Grant AM, 2004, BRIT J SURG, V91, P1570, DOI 10.1002/bjs.4799; Grant AM, 2002, ANN SURG, V235, P322; Haapaniemi S., 1999, HERNIA, V3, P205, DOI 10.1007/BF01194428; Kehlet H, 2005, ACTA ANAESTH SCAND, V49, P143, DOI 10.1111/j.1399-6576.2004.00600.x; Kingsnorth A, 2005, ANN ROY COLL SURG, V87, P59; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; McGugan E, 2000, J ROY COLL SURG EDIN, V45, P183; Memon MA, 2003, BRIT J SURG, V90, P1479, DOI 10.1002/bjs.4301; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; *NIH CLIN EXC, 2004, LAP SURG ING HERN RE; Nordin P, 2007, BRIT J SURG, V94, P500, DOI 10.1002/bjs.5543; Nordin P, 2003, LANCET, V362, P853, DOI 10.1016/S0140-6736(03)14339-5; O'Dwyer PJ, 2006, ANN SURG, V244, P167, DOI 10.1097/01.sla.0000217637.69699.ef; O'Dwyer PJ, 2003, ANN SURG, V237, P574, DOI 10.1097/00000658-200304000-00020; Page B, 2002, BRIT J SURG, V89, P1315, DOI 10.1046/j.1365-2168.2002.02186.x; Sanchez-Manuel FJ, 2004, COCHRANE DB SYST REV, V4	31	207	211	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					269	272		10.1136/bmj.39450.428275.AD	http://dx.doi.org/10.1136/bmj.39450.428275.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18244999	Green Published			2022-12-28	WOS:000253102900041
J	Dor, Y; Melton, DA				Dor, Yuval; Melton, Douglas A.			Facultative endocrine progenitor cells in the adult pancreas	CELL			English	Editorial Material							BETA-CELLS; REGENERATION; GROWTH	Using a unique injury model of the pancreas in mouse, Xu et al. ( 2008) now reveal the involvement of neurogenin3, a marker for embryonic-type endocrine progenitor cells, in the formation of new insulin-producing beta cells. These neurogenin3-positive facultative endocrine progenitor cells in the adult pancreas may be of potential value for treating diabetes.	[Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; [Melton, Douglas A.] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Harvard University; Harvard University; Howard Hughes Medical Institute	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il; dmelton@harvard.edu	Young, Richard A/F-6495-2012; Dor, Yuval/C-2405-2011	Young, Richard A/0000-0001-8855-8647; 				Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Halban PA, 2004, NAT CELL BIOL, V6, P1021, DOI 10.1038/ncb1104-1021; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; XU X, 2008, CELL	10	45	48	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					183	184		10.1016/j.cell.2008.01.004	http://dx.doi.org/10.1016/j.cell.2008.01.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243094	Bronze			2022-12-28	WOS:000253427700005
J	DICKMAN, S				DICKMAN, S			COMPUTER SECURITY - KGB HACKERS GET OFF LIGHTLY	NATURE			English	Editorial Material																		1988, NATURE, V333, P105	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					6	6		10.1038/344006b0	http://dx.doi.org/10.1038/344006b0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18277991	Bronze			2022-12-28	WOS:A1990CQ97200017
J	MACKAY, A				MACKAY, A			QUASI-CRYSTALS TURN TO THE 6TH-DIMENSION	NATURE			English	Editorial Material											MACKAY, A (corresponding author), UNIV LONDON BIRKBECK COLL,DEPT CRYSTALLOG,LONDON WC1E 7HX,ENGLAND.							Coxeter H. S. M, 1948, REGULAR POLYTOPES; KRAMER P, 1984, ACTA CRYSTALLOGR A, V40, P580, DOI 10.1107/S0108767384001203; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; TORRES M, 1989, J PHYS-CONDENS MAT, V1, P6877, DOI 10.1088/0953-8984/1/38/012; TORRES M, 1989, PHIL MAG LETT, V59, P181, DOI 10.1080/09500838908206341	5	10	10	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					21	21		10.1038/344021a0	http://dx.doi.org/10.1038/344021a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278008	Bronze			2022-12-28	WOS:A1990CQ97200036
J	WEEDMAN, DW				WEEDMAN, DW			GRAVITATIONAL LENSES - DISTORTED VIEWS OF THE UNIVERSE	NATURE			English	Editorial Material											WEEDMAN, DW (corresponding author), PENN STATE UNIV,DEPT ASTRON,UNIV PK,UNIVERSITY PK,PA 16802, USA.							LACEY C, 1990, NATURE, V340, P67; LANGSTON GI, 1990, NATURE, V344, P43, DOI 10.1038/344043a0; MEYLAN G, 1990, JAN AM ASTR SOC M WA; OSTRIKER JP, 1990, NATURE, V344, P45, DOI 10.1038/344045a0; TYSON JA, 1990, ASTROPHYS J, V349, pL1, DOI 10.1086/185636	5	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					18	19		10.1038/344018a0	http://dx.doi.org/10.1038/344018a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278007				2022-12-28	WOS:A1990CQ97200034
J	Landefeld, CS; Bowers, BJ; Feld, AD; Hartmann, KE; Hoffman, E; Ingber, MJ; King, JT; McDougal, WS; Nelson, H; Orav, EJ; Pignone, M; Richardson, LH; Rohrbaugh, RM; Siebens, HC; Trock, BJ				Landefeld, C. Seth; Bowers, Barbara J.; Feld, Andrew D.; Hartmann, Katherine E.; Hoffman, Eileen; Ingber, Melvin J.; King, Joseph T., Jr.; McDougal, W. Scott; Nelson, Heidi; Orav, Endel John; Pignone, Michael; Richardson, Lisa H.; Rohrbaugh, Robert M.; Siebens, Hilary C.; Trock, Bruce J.			National institutes of health state-of-the-science conference statement: Prevention of fecal and urinary incontinence in adults	ANNALS OF INTERNAL MEDICINE			English	Article									San Francisco VA Med Ctr, San Francisco, CA USA; Univ Wisconsin, Madison, WI USA; Univ Washington, Seattle, WA 98195 USA; Vanderbilt Inst Med & Publ Hlth, Nashville, TN USA; NYU, Sch Med, New York, NY USA; RTI Int, Washington, DC USA; Yale Univ, Sch Med, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Mayo Clin & Mayo Grad Sch Med, Rochester, MN USA; Univ N Carolina Hosp, Chapel Hill, NC USA; Crohns Colitis Fdn Amer, Houston, TX USA; Univ Virginia, Charlottesville, VA USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; New York University; Research Triangle Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Mayo Clinic; University North Carolina Hospital; University of Virginia; Johns Hopkins University; University of California System; University of California San Francisco	Landefeld, CS (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Hartmann, Katherine Eubanks/AAV-5288-2020	Ingber, Melvin/0000-0003-4848-932X; Hartmann, Katherine/0000-0002-7051-8185; Pignone, Michael/0000-0002-6657-7342; Bowers, Barbara/0000-0002-3226-0718					0	182	191	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					449	458		10.7326/0003-4819-148-6-200803180-00210	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00210			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18268289				2022-12-28	WOS:000254354800005
J	Sivertsen, A; Wilcox, AJ; Skjaerven, R; Vindenes, HA; Abyholm, F; Harville, E; Lie, RT				Sivertsen, Ase; Wilcox, Allen J.; Skjaerven, Rov; Vindenes, Hallvard Andreas; Abyholm, Frank; Harville, Emily; Lie, Rolv Terje			Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-DEFECTS; RECURRENCE; PALATE; LIP; SURVIVAL; GENETICS; CHILDREN	Objective To estimate the relative risk of recurrence of oral cleft in first degree relatives in relation to cleft morphology. Design Population based cohort study. Setting Data from the medical birth registry of Norway linked with clinical data on virtually all cleft patients treated in Norway over a 35 year period. Participants 2.1 million children born in Norway between 1967 and 2001, 4138 of whom were treated for an oral cleft. Main outcome measure Relative risk of recurrence of isolated clefts from parent to child and between full siblings, for anatomic subgroups of clefts. Results Among first degree relatives, the relative risk of recurrence of cleft was 32 (95% confidence interval 24.6 to 40.3) for any cleft lip and 56 (37.2 to 84.8) for cleft palate only (P difference=0.02). The risk of clefts among children of affected mothers and affected fathers was similar. Risks of recurrence were also similar for parent-offspring and sibling-sibling pairs. The "crossover" risk between any cleft lip and cleft palate only was 3.0 (1.3 to 6.7). The severity of the primary case was unrelated to the risk of recurrence. Conclusions The stronger family recurrence of cleft palate only suggests a larger genetic component for cleft palate only than for any cleft lip. The weaker risk of crossover between the two types of cleft indicates relatively distinct causes. The similarity of mother-offspring, father-offspring, and sibling-sibling risks is consistent with genetic risk that works chiefly through fetal genes. Anatomical severity does not affect the recurrence risk in first degree relatives, which argues against a multifactorial threshold model of causation.	[Sivertsen, Ase; Vindenes, Hallvard Andreas] Haukeland Hosp, Dept Plast Surg, NO-5021 Bergen, Norway; [Sivertsen, Ase; Skjaerven, Rov; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Abyholm, Frank] Univ Oslo, Rikshosp, Dept Plast Surg, N-0027 Oslo, Norway; [Harville, Emily] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA	University of Bergen; Haukeland University Hospital; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oslo; National Hospital Norway; Tulane University	Sivertsen, A (corresponding author), Haukeland Hosp, Dept Plast Surg, NO-5021 Bergen, Norway.	ase.sivertsen@isf.uib.no	Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [2R01 DE-11948-04] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1970, MULTIFACTORIAL INHER; Christensen K, 1996, AM J HUM GENET, V58, P182; Firth HV, 2005, OXFORD DESK REFERENC; Fogh-Andersen, 1942, INHERITANCE HARELIP; FOGHANDERSEN P, 1942, THESIS U COPENHAGEN; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; Gorlin RJ, 2001, OROFACIAL CLEFTING S; HARPER PS, 1998, PRACTICAL GENETIC CO; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; Lie RT, 2007, PAEDIATR PERINAT EP, V21, P13, DOI 10.1111/j.1365-3016.2007.00832.x; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MELNICK M, 1992, AM J MED GENET, V42, P10, DOI 10.1002/ajmg.1320420104; Mitchell LE, 1996, AM J MED GENET, V61, P371, DOI 10.1002/(SICI)1096-8628(19960202)61:4<371::AID-AJMG12>3.0.CO;2-P; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Mossey P., 2002, CLEFT LIP PALATE, P127; Mueller Robert F., 2001, EMERYS ELEMENTS MED; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; Robert E, 1996, J CRAN GENET DEV BIO, V16, P234; SIVERTSEN A, IN PRESS PLAST RECON; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2	25	118	124	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					432	434A		10.1136/bmj.39458.563611.AE	http://dx.doi.org/10.1136/bmj.39458.563611.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18250102	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000253664000039
J	Peppercorn, J; Buss, WG; Fost, N; Godley, PA				Peppercorn, Jeffery; Buss, William G.; Fost, Norm; Godley, Paul A.			The dilemma of data-safety monitoring: provision of significant new data to research participants	LANCET			English	Editorial Material							INFORMED-CONSENT; CLINICAL-RESEARCH; ATTITUDES; TRIALS		[Peppercorn, Jeffery; Godley, Paul A.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Buss, William G.] Univ Iowa, Coll Law, Iowa City, IA 52242 USA; [Fost, Norm] Univ Wisconsin Hosp, Dept Pediat, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; University of Wisconsin System; University of Wisconsin Madison	Peppercorn, J (corresponding author), Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA.	jpepper@med.unc.edu						[Anonymous], 1996, BRIT MED J, V313, P1448; BEAUCHAMP TL, 1994, PRINCIPLES BIOMEDICA, P148; Burstein HJ, 2003, NEW ENGL J MED, V349, P1857, DOI 10.1056/NEJMe038174; Daugherty CK, 1998, J CLIN ONCOL, V16, P2305, DOI 10.1200/JCO.1998.16.7.2305; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; JOFFE S, 2003, P AM SOC CLIN ONCOL, V22; Kodish ED, 1998, CANCER-AM CANCER SOC, V82, P2467; Madsen SM, 2002, J INTERN MED, V251, P156, DOI 10.1046/j.1365-2796.2002.00949.x; *NAT COMM PROT HUM, 1978, BELM REP, V1; Partridge AH, 2005, LANCET, V365, P963, DOI 10.1016/S0140-6736(05)71085-0; Rosenbaum JR, 2005, J CLIN EPIDEMIOL, V58, P1109, DOI 10.1016/j.jclinepi.2005.03.014; Slutsky AS, 2004, NEW ENGL J MED, V350, P1143, DOI 10.1056/NEJMsb033476; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; 1949, NUREMBERG CODE, P181	19	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					527	529		10.1016/S0140-6736(08)60239-1	http://dx.doi.org/10.1016/S0140-6736(08)60239-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262043				2022-12-28	WOS:000253169200032
J	Sakaue-Sawano, A; Kurokawa, H; Morimura, T; Hanyu, A; Hama, H; Osawa, H; Kashiwagi, S; Fukami, K; Miyata, T; Miyoshi, H; Imamura, T; Ogawa, M; Masai, H; Miyawaki, A				Sakaue-Sawano, Asako; Kurokawa, Hiroshi; Morimura, Toshifumi; Hanyu, Aki; Hama, Hiroshi; Osawa, Hatsuki; Kashiwagi, Saori; Fukami, Kiyoko; Miyata, Takaki; Miyoshi, Hiroyuki; Imamura, Takeshi; Ogawa, Masaharu; Masai, Hisao; Miyawaki, Atsushi			Visualizing spatiotemporal dynamics of multicellular cell-cycle progression	CELL			English	Article							TO-MESENCHYMAL TRANSITION; LICENSING FACTOR CDT1; DNA-REPLICATION; FLUORESCENT PROTEINS; UBIQUITIN LIGASES; NEURONS ARISE; S-PHASE; DEGRADATION; GEMININ; PCNA	The cell-cycle transition from G(1) to S phase has been difficult to visualize. We have harnessed antiphase oscillating proteins that mark cell-cycle transitions in order to develop genetically encoded fluorescent probes for this purpose. These probes effectively label individual G, phase nuclei red and those in S/G(2)/M phases green. We were able to generate cultured cells and transgenic mice constitutively expressing the cell-cycle probes, in which every cell nucleus exhibits either red or green fluorescence. We performed time-lapse imaging to explore the spatiotemporal patterns of cell-cycle dynamics during the epithelial-mesenchymal transition of cultured cells, the migration and differentiation of neural progenitors in brain slices, and the development of tumors across blood vessels in live mice. These mice and cell lines will serve as model systems permitting unprecedented spatial and temporal resolution to help us better understand how the cell cycle is coordinated with various biological events.	[Sakaue-Sawano, Asako; Kurokawa, Hiroshi; Hama, Hiroshi; Osawa, Hatsuki; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan; [Morimura, Toshifumi; Kashiwagi, Saori; Ogawa, Masaharu] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama 3510198, Japan; [Kurokawa, Hiroshi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan; [Hanyu, Aki; Miyata, Takaki] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Syowa Ku, Aichi 4668550, Japan; [Miyoshi, Hiroyuki] RIKEN Tsukuba Inst, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Gen Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Tokyo University of Pharmacy & Life Sciences; Japanese Foundation for Cancer Research; Nagoya University; RIKEN; Tokyo Metropolitan Institute of Medical Science	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	Miyoshi, Hiroyuki/G-9808-2013; MIYATA, TAKAKI/I-7066-2014; Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390				Ang X. L., 2004, SCI STKE, V242, ppe31; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Easwaran HP, 2005, CELL CYCLE, V4, P453, DOI 10.4161/cc.4.3.1525; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kisielewska J, 2005, BIOL CELL, V97, P221; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Piek E, 1999, J CELL SCI, V112, P4557; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047	47	1413	1437	10	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					487	498		10.1016/j.cell.2007.12.033	http://dx.doi.org/10.1016/j.cell.2007.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267078	Bronze			2022-12-28	WOS:000253180700022
J	Boat, TF; Chao, SM; O'Neill, PH				Boat, Thomas F.; Chao, Samantha M.; O'Neill, Paul H.			From waste to value in health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY IMPROVEMENT; REGIONAL-VARIATIONS		[Boat, Thomas F.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH USA; [Chao, Samantha M.] Natl Acad Sci, Inst Med, Board Hlth Care Serv, Washington, DC 20418 USA	Cincinnati Children's Hospital Medical Center; National Academies of Sciences, Engineering & Medicine	O'Neill, PH (corresponding author), 1 N Shore Ctr,12 Fed St,Ste 100, Pittsburgh, PA 15212 USA.	poneillpa@aol.com						Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Horbar JD, 2004, BMJ-BRIT MED J, V329, P1004, DOI 10.1136/bmj.329.7473.1004; Institute of Medicine, 2007, ADV QUAL IMPR RES CH; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Quinton HB, 2007, CLIN CHEST MED, V28, P459, DOI 10.1016/j.ccm.2007.02.013; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; Smith C, 2006, HEALTH AFFAIR, V25, P186, DOI 10.1377/hlthaff.25.1.186; Sokka T, 2004, RHEUM DIS CLIN N AM, V30, P851, DOI 10.1016/j.rdc.2004.07.002; WENNBERG JE, 2005, VARIATION USE MED SE	12	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					568	571		10.1001/jama.299.5.568	http://dx.doi.org/10.1001/jama.299.5.568			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252887				2022-12-28	WOS:000252886100023
J	Braithwaite, RS; Roberts, MS; Chang, CCH; Goetz, MB; Gibert, CL; Rodrigue-Barradas, MC; Shechter, S; Schaefer, A; Nucifora, K; Koppenhaver, R; Justice, AC				Braithwaite, R. Scott; Roberts, Mark S.; Chang, Chung Chou H.; Goetz, Matthew Bidwell; Gibert, Cynthia L.; Rodrigue-Barradas, Maria C.; Shechter, Steven; Schaefer, Andrew; Nucifora, Kimberly; Koppenhaver, Robert; Justice, Amy C.			Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; INFECTION; COHORT; RESISTANCE; OUTCOMES; ADULTS	Background: The optimal threshold for initiating HIV treatment is unclear. Objective: To compare different thresholds for initiating HIV treatment. Design: A validated computer simulation was used to weigh important harms from earlier initiation of antiretroviral therapy (toxicity, side effects, and resistance accumulation) against important benefits (decreased HIV-related mortality). Data Sources: Veterans Aging Cohort Study (5742 HIV-infected patients and 11 484 matched uninfected controls) and published reports. Target Population: Individuals with newly diagnosed chronic HIV infection and varying viral loads (10 000, 30 000, 100 000, and 300 000 copies/mL) and ages (30, 40, and 50 years). Time Horizon: Unlimited. Perspective: Societal. Intervention: Alternative thresholds for initiating antiretroviral therapy (CD4 counts of 200, 350, and 500 cells/mm(3)). Outcome Measures: Life-years and quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Although the simulation was biased against earlier treatment initiation because it used an upper-bound assumption for therapy-related toxicity, earlier treatment increased life expectancy and QALYs at age 30 years regardless of viral load (life expectancies with CD4 initiation thresholds of 500, 350, and 200 cells/mm(3) were 18.2 years, 17.6 years, and 17.2 years, respectively, for a viral load of 10 000 copies/mL and 17.3 years, 15.9 years, and 14.5 years, respectively, for a viral load of 300000 copies/mL), and increased life expectancies at age 40 years if viral loads were greater than 30000 copies/mL (life expectancies were 12.5 years, 12.0 years, and 11.4 years, respectively, for a viral load of 300000 copies/mL). Results of Sensitivity Analysis: Findings favoring early treatment were generally robust. Limitations: Results favoring later treatment may not be valid. The findings may not be generalizable to women. Conclusion: This simulation suggests that earlier initiation of combination antiretroviral therapy is often favored compared with current recommendations.	[Braithwaite, R. Scott] Yale Univ, West Haven, CT 06516 USA; Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; George Washington Univ, Washington, DC USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Baylor Coll Med, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Houston, TX USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Baylor College of Medicine; University of British Columbia	Braithwaite, RS (corresponding author), Yale Univ, 950 Campbell Ave, West Haven, CT 06516 USA.	Ronald.Braithwaite@va.gov	Goetz, Matthew Bidwell/GPX-4090-2022	Braithwaite, Ronald Scott/0000-0001-7067-3655; Goetz, Matthew/0000-0003-4542-992X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA014483, U10AA013566] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIAAA NIH HHS [U10 AA013566, U10 AA013566-07, 2U10 AA13566, K23 AA14483-01, K23 AA014483] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; BRAITHWAITE RS, IN PRESS VALUE HLTH; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Hertogs K, 2000, AIDS, V14, P1203, DOI 10.1097/00002030-200006160-00018; *HIV HCV COINF STU, 2003, J ACQ IMMUN DEF SYND, V32, P259; *HIV OUTP STUD HOP, 2002, LANCET, V360, P1747; *HIV OUTP STUD INV, 2003, ANN INTERN MED, V138, P620; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; *PAN CLIN PRACT TR, 2006, GUID US ANT AG HIV 1; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sterling TR, 2003, J INFECT DIS, V188, P1659, DOI 10.1086/379741; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Walensky RP, 2002, JAIDS-J ACQ IMM DEF, V31, P27, DOI 10.1097/00126334-200209010-00004; 2002, AIDS, V16, P1371	30	43	43	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					178	185		10.7326/0003-4819-148-3-200802050-00004	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18252681	Green Accepted			2022-12-28	WOS:000252849700002
J	BALL, P				BALL, P			SURFACE PHYSICS - THE ROUGH WITH THE SMOOTH	NATURE			English	Editorial Material																		CAO YJ, 1990, PHYS REV LETT, V64, P447, DOI 10.1103/PhysRevLett.64.447; DEBOER JH, 1958, STRUCTURE PROPERTIES, P76; DENNIJS M, 1985, PHYS REV LETT, V55, P1689, DOI 10.1103/PhysRevLett.55.1689; DENNIJS M, 1990, PHYS REV LETT, V64, P435, DOI 10.1103/PhysRevLett.64.435; FISHER ME, 1981, J CHEM PHYS, V75, P5857, DOI 10.1063/1.442035; FRENKEN JWM, 1985, PHYS REV LETT, V54, P134, DOI 10.1103/PhysRevLett.54.134; GILMER GH, 1972, J APPL PHYS, V43, P1347, DOI 10.1063/1.1661325; GOODSTEIN DL, 1984, SURF SCI, V148, P187, DOI 10.1016/0039-6028(84)90043-8; KIM HK, 1988, PHYS REV B, V37, P3511, DOI 10.1103/PhysRevB.37.3511; PARRY AO, 1990, PHYS REV LETT, V64, P439, DOI 10.1103/PhysRevLett.64.439; SHEN Q, 1990, PHYS REV LETT, V64, P451, DOI 10.1103/PhysRevLett.64.451; WEEKS JD, 1980, ORDERING STRONGLY FL; YANG HN, 1989, PHYS REV LETT, V63, P1621, DOI 10.1103/PhysRevLett.63.1621; YOUN HS, 1990, PHYS REV LETT, V64, P443, DOI 10.1103/PhysRevLett.64.443	14	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					17	18		10.1038/344017a0	http://dx.doi.org/10.1038/344017a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278006				2022-12-28	WOS:A1990CQ97200033
J	BRAHMACHARY, RL; SARKAR, MP; DUTTA, J				BRAHMACHARY, RL; SARKAR, MP; DUTTA, J			THE AROMA OF RICE ... AND TIGER	NATURE			English	Letter									BOSE RES INST,DEPT CHEM,CALCUTTA 700009,INDIA	Department of Science & Technology (India); Bose Institute	BRAHMACHARY, RL (corresponding author), INDIAN STAT INST,DIV BIOL,CALCUTTA 700035,W BENGAL,INDIA.			poddar sarkar, mousumi/0000-0003-4208-9640				BRAHMACHARY RL, 1981, AM NAT, V118, P561, DOI 10.1086/283849; BUTTERY RG, 1982, CHEM IND-LONDON, P958; SCHIEBERLE P, 1989, IN PRESS 196TH P S A	3	33	34	1	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					26	26		10.1038/344026b0	http://dx.doi.org/10.1038/344026b0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	18278014				2022-12-28	WOS:A1990CQ97200044
